Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.23.15 - renin

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
17alpha-hydroxyprogesterone deacetylase deficiency
17alpha-hydroxylase deficiency accompanied by adrenal myelolipoma.
A novel compound heterozygous mutation of K494_V495 deletion plus R496L and D487_F489 deletion in extreme C-terminus of cytochrome P450c17 causes 17alpha-hydroxylase deficiency.
Abnormalities, Multiple
Hypertension in adult onset diabetes mellitus: abnormal renal hemodynamics and endogenous vasoregulatory factors.
Abortion, Threatened
Plasma renin substrate in the prediction of pregnancy outcome in threatened abortion.
Acid-Base Imbalance
[Filtration of active fractions with function of expelling water retention with drastic purgative from Kansui Radix stir-baked with vinegar].
Acidosis
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.
A case of renal tubular acidosis with an abnormally high plasma renin activity.
A case report of Gordon's syndrome in a 20-year-old male with free medical family history.
A molecular update on pseudohypoaldosteronism type II.
A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis.
A Novel Mutation of the
Acute hypercapnic acidosis diminishes renal water excretion in conscious dogs.
Anorexia nervosa, laxative abuse, hypopotassemia and distal renal tubular acidosis.
Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
Captopril-induced metabolic acidosis with hyperkalemia.
Clinical features, genetic background, and outcome in infants with urinary tract infection and type IV renal tubular acidosis.
Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review.
Effect of NH4Cl acidosis on the function of renin-angiotensin-aldosterone system in newborn infants.
Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial.
Effects of NaHCO3, alpha-, and beta-adrenergic blockade on albuminuria after swimming in splenectomized dogs.
Etiological considerations in Gordon's syndrome: possible role of prostaglandins.
Failure to Thrive, Hyponatremia, Hyperkalemia - Differential Diagnostic Reflections of a Rare Genetic Disease.
Gordon syndrome caused by a CUL3 mutation in a patient with short stature in Korea: a case report.
Hormonal and hemodynamic changes during percutaneous nephrolithotomy.
Hyperkalemic distal renal tubular acidosis in salt-losing congenital adrenal hyperplasia.
Hypertension Accompanied by Hyperaldosteronism, Hyperkalemia, and Hyperchloremic Acidosis: A Case Report and Literature Review.
Hypoxemia and hypercapnia in conscious dogs: opioid modulation of catecholamines.
Immune-related potassium-losing interstitial nephritis: a comparison with distal renal tubular acidosis.
Inhibition of renin secretion by HCl is related to chloride in both dog and rat.
Mechanism of effect of hypercapnic acidosis on renin secretion in the dog.
Metabolic Acidosis, Hyperkalemia, and Renal Unresponsiveness to Aldosterone Syndrome: Response to Treatment with Low-Potassium Diet.
Mineralocorticoid resistance.
Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism.
Monogenic forms of hypertension.
Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21.
Possible mechanisms of cardiac contractile dysfunction and electrical changes in ammonium chloride induced chronic metabolic acidosis in Wistar rats.
Pseudo-Hypo Aldosteronism Type II.
Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
Pseudohypoaldosteronism types I and II: little more than a name in common.
Pseudohypoaldosteronism.
Rare Cause of Hyperkalemia in the Newborn Period: Report of Two Cases of Pseudohypoaldosteronism Type 1.
Renal parameters during infancy.
Renal tubular acidosis type 4 in neonatal unilateral kidney diseases.
Renal, cardiovascular and endocrine responses of fetal sheep at 0.8 of gestation to an infusion of amino acids.
Restoration of Epithelial Sodium Channel Function by Synthetic Peptides in Pseudohypoaldosteronism Type 1B Mutants.
Salt-Sensitive Hypertension in Chronic Kidney Disease: Distal Tubular Mechanisms.
Selective hypoaldosteronism in a patient with Sjögren's syndrome: insensitivity to angiotensin II.
Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia.
Synergistic effects of acute hypoxemia and hypercapnic acidosis in conscious dogs. Renal dysfunction and activation of the renin-angiotensin system.
Systemic pseudohypoaldosteronism from deletion of the promoter region of the human Beta epithelial na(+) channel subunit.
Systemic Pseudohypoaldosteronism Type 1 due to 3 Novel Mutations in SCNN1Aand SCNN1BGenes.
Systemic pseudohypoaldosteronism-1 with episodic dyslipidemia in a Sudanese child.
The Co-occurrence of Hypertension and Hyperkalaemia - Gordon's Syndrome: A Case Report.
The effect of acute metabolic acidosis on plasma cortisol, renin activity and aldosterone.
The syndrome of hypertension and hyperkalaemia with normal glomerular filtration rate: is there a deficiency in vasodilator prostaglandins?
The syndrome of hypertension and hyperkalemia with normal GFR (Gordon's syndrome): is there increased proximal sodium reabsorption?
Three cases of Gordon syndrome with dominant KLHL3 mutations.
Uncompensated polyuria in a mouse model of Bartter's syndrome.
[A case of distal renal tubular acidosis complicated with renal diabetes insipidus, showing aggravation of symptoms with occurrence of diabetes mellitus].
[Gordon syndrome: The importance of measuring blood pressure in children].
[Gordon's syndrome. Report of a case]
[Hypertension, hyperpotassemia and normal glomerular filtration (Gordon's syndrome): a case report]
[Mechanisms of renal adaptation to disorders of water-electrolyte balance in metabolic acidosis]
[Plasma renin activity of the rat in systemic alkalosis and acidosis]
[Plasma renin activity, angiotensin II, angiotensin converting enzyme, thromboxane A2 and prostacyclin I2 levels in pigs with severe hypoxia and hypercapnea and acidosis shock]
[Pseudo-hypoaldosteronisms]
[Transient pseudohypoaldosteronism secondary to congenital malformation pathology of the urinary tract (valves of the posterior urethra): a report of a case with elements of a physiopathological nature]
[Type II pseudohypoaldosteronism: proximal tubular acidosis and distal tubular hyperkalemia corrected by DDAVP]
[WNK1 and WNK4, new players in salt and water homeostasis]
Acidosis, Lactic
Metformin and antihypertensive therapy with drugs blocking the renin angiotensin system, a cause of concern?
Acidosis, Renal Tubular
A case of renal tubular acidosis with an abnormally high plasma renin activity.
Anorexia nervosa, laxative abuse, hypopotassemia and distal renal tubular acidosis.
Renal tubular acidosis type 4 in neonatal unilateral kidney diseases.
Selective hypoaldosteronism in a patient with Sjögren's syndrome: insensitivity to angiotensin II.
Acidosis, Respiratory
Plasma renin activity in acute respiratory acidosis.
The effect of beta adrenergic receptor blockade on the renin response to respiratory acidosis.
The effects of respiratory acidosis on plasma renin activity in the dog.
The influence of renal sympathetic nerves on renal hemodynamic and renin responses during hypercapnia in dogs.
[The changes on plasma aldosterone concentration during acute respiratory acidosis in dogs. The relationship to renin-angiotensin system and electrolyte metabolism (author's transl)]
Acquired Immunodeficiency Syndrome
Adrenocortical insufficiency with normal serum cortisol levels and hyporeninaemia in a patient with acquired immunodeficiency syndrome (AIDS).
Aspartic peptidase inhibitors: implications in drug development.
Design of potent aspartic protease inhibitors to treat various diseases.
Dual inhibitors for aspartic proteases HIV-1 PR and renin: advancements in AIDS-hypertension-diabetes linkage via molecular dynamics, inhibition assays, and binding free energy calculations.
Inhibition of the aspartic proteinase from HIV-2.
Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age.
Ischaemic heart disease risk factors in young black Africans from urban Zaire.
Proteases and their inhibitors: today and tomorrow.
Refractory hypertension due to Conn's syndrome.
Structural Biology and the Design of New Therapeutics: From HIV and Cancer to Mycobacterial Infections: A Paper Dedicated to John Kendrew.
Acromegaly
An investigation into the pathogenesis of hypertension in acromegaly.
Conn's syndrome in a patient with acromegaly.
Diuretics as initial and sole treatment in chronic cardiac failure.
Increased activity of digoxin-like substance in low-renin hypertension in acromegaly.
Plasma renin activity and aldosterone secretion in patients with acromegaly.
Plasma renin activity and urinary aldosterone in acromegaly.
Plasma renin activity in acromegaly.
Sodium-sensitive essential hypertension: emerging insights into an old entity.
The diurnal rhythm of plasma aldosterone, plasma renin activity, plasma cortisol and serum growth hormone and subnormal responsiveness of aldosterone to angiotensin-II in the patients with normotensive acromegaly.
[Aldosterone and renin in acromegaly]
ACTH-Secreting Pituitary Adenoma
Presence of renin, angiotensinogen, and converting enzyme in human pituitary lactotroph cells and prolactin adenomas.
Acute Coronary Syndrome
Impact of smoking history on the association between Eicosapentaenoic acid to arachidonic acid ratio and acute coronary syndrome: A multicenter cross-sectional study.
Plasma renin activity has a complex prognostic role in patients with acute coronary syndromes.
Acute Kidney Injury
Activation of the renal pressure system following severe hypotension and its pathophysiologic significance.
Acute Kidney Injury and Death Associated With Renin Angiotensin System Blockade in Cardiothoracic Surgery: A Meta-analysis of Observational Studies.
Acute renal failure associated to renin angiotensin system (RAS) inhibitors--its burden in a nephrology department.
Aldosteronemia in patients with acute renal failure.
Aliskiren-associated acute kidney injury in a patient with pre-existing chronic kidney disease and dilated cardiomyopathy.
Aliskiren-associated acute renal failure with hyperkalemia.
Alleviating effect of pindolol in HgCL2-induced acute renal failure in rats: effect of HgCl2 and pindolol on renin release in vitro.
Association between antihypertensive treatment and adverse events: systematic review and meta-analysis.
beta-Adrenergic blockade reduces the severity of acute renal failure in rats.
Changes in plasma renin substrate, plasma and renal renin, and plasma osmolarity during glycerol-induced acute renal failure in rabbits.
Changes of plasma renin and renal renin concentration in HgCl2 induced acute renal failure in rats.
Chronic saline loading in anoxic renal failure in rats.
Circulating levels of active, total and inactive renin (prorenin), angiotensin I and angiotensinogen in carbon tetrachloride-treated rats.
Clonidine after renal ischemia to lessen acute renal failure and microvascular damage.
Control of hypertension and reversal of renal failure in undifferentiated connective tissue disease by enalapril.
Despite low plasma renin ACE inhibitor treatment causes recovery from acute renal failure in a patient with malignant hypertension.
Distal Tubule [Na+] and juxtaglomerular apparatus Renin activity in uranyl nitrate induced acute renal failure in the rat. An evaluation of the role of tubuloglomerular feedback.
Effect of beta-receptor antagonists on HgCl2-induced acute renal failure in rats.
Elevated plasma renin activity associated with renal dysfunction.
Estimating the risk of acute kidney injury associated with use of diuretics and renin angiotensin aldosterone system inhibitors: A population based cohort study using the clinical practice research datalink.
Failure of renal renin depletion without forced diuresis to protect rats against HgCl2-induced acute renal failure.
Failure of saralasin in preventing renal failure in ischemic transplanted kidneys.
Fiend and friend in the renin angiotensin system: An insight on acute kidney injury.
Glycerol-induced acute renal failure after acute plasma renin activity suppression.
HgCl2-induced acute renal failure in the developing rat.
HgCl2-induced acute renal failure in the Goldblatt rat.
High renin activity accompanying angiotensin II inhibition in rats with ischemic renal failure.
Hypertension and Hydronephrosis: Rapid Resolution of High Blood Pressure Following Relief of Bilateral Ureteric Obstruction.
Hypertensive Emergency in a Woman with Systemic Sclerosis.
In PICU acute kidney injury stage 3 or mortality is associated with early excretion of urinary renin.
Increased susceptibility to structural acute kidney injury in a mouse model of presymptomatic cardiomyopathy.
Induction, prevention and mechanisms of contrast media-induced acute renal failure.
Intrarenal renin and angiotensins in glycerol-induced acute renal failure.
Intrarenal renin, angiotensin II, and plasma renin in rats with uranyl nitrate-induced and glycerol-induced acute renal failure.
Ioxitalamate induces renal tubular apoptosis via activation of renal efferent nerve-mediated adrenergic signaling, renin activity, and reactive oxygen species production in rats.
Kinetic Changes of Plasma Renin Levels Predict Acute Kidney Injury in Cardiac Surgery Patients.
Measurement of urinary renin activity by radioimmunoassay: sequential studies in acute renal failure in man.
Micropuncture studies of the basis for protection of renin depleted rats from glycerol induced acute renal failure.
Mineralocorticoid Antagonism and Diabetic Kidney Disease.
Na intake, renal renin, and the severity of myohemoglobinuric renal failure in rats.
New Insights Into Mechanisms of Acute Kidney Injury in Heart Disease.
No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers.
Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in man.
Plasma renin activity and plasma aldosterone in acute renal failure.
Plasma renin activity during the development of paracetamol (acetaminophen) induced acute renal failure in man.
Plasma renin activity in acute renal failure induced by norepinephrine infusion in unilaterally nephrectomized dogs.
Plasma renin activity in acute renal insufficiency.
Plasma renin activity in folic acid induced acute renal failure.
Plasma renin and angiotensin II in acute renal failure.
Protection of rat kidneys against HgCl2-induced acute renal failure by induction of high urine flow without renin suppression.
Renal microvasculature in acute renal failure.
Renal vasoconstriction in glycerol-induced acute renal failure. Studies in the isolated perfused rat kidney.
Renin acitivity in the juxtaglomerular apparatus of the rat kidney during post-ischemic acute renal failure.
Renin activity in acute renal failure.
Renin and acute renal failure.
Renin and acute renal failure: studies in man.
Renin content of the kidneys during the course of methemoglobing-induced acute renal insufficiency in the rat.
Renin release and the refractoriness to acute renal failure of rats recovering from prior renal failure.
Renin, angiotensin II and III in acute renal failure: note on the measurement of of angiotensin II and III in rat blood.
Resistance to acute renal failure afforded by prior renal failure: examination of the role of renal renin content.
Response to frusemide in acute renal failure: dissociation of renin and diuretic responses.
Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors.
Scleroderma renal crisis: a pathology perspective.
Serial studies of the renin system in rats with glycerol-induced renal failure.
Sodium-chloride-induced protection in nephrotoxic acute renal failure: independence from renin.
The early phase of experimental acute renal failure. V. The influence of suppressing the renin-angiotensin system.
Total kininogen levels, plasma renin activity, dopamine-beta-hydroxylase and plasma catecholamines in chronic and acute renal failure.
Use of Renin Angiotensin System Blockers After Acute Kidney Injury: Balancing Tradeoffs.
Vasopressin and renin in glycerol-induced acute renal failure in the rat.
Water immersion induced alterations of plasma vasopressin levels and activity of the renin-angiotensin-aldosterone system in noninflammatory acute renal failure and end-stage renal failure.
Water immersion-induced alterations of plasma atrial natriuretic peptide level and its relationship to the renin-angiotensin-aldosterone system and vasopressin secretion in acute and chronic renal failure.
[Aldosteroneia in acute kidney failure]
[Chronic Effects on Kidney Function by "Triple Whammy" (Combination of Renin and Angiotensin Type Inhibitor, Diuretic Drug and Nonsteroidal Anti-inflammatory Drug)].
[Effect of naloxone on plasma renin activity and aldosterone level in the blood in patients with acute renal failure]
[Experimental acute kidney failure; relationships between function, morphology and renin activity in the individual disease course]
[Individual course of experimental acute renal failure: morphology, function, plasms renin activity (author's transl)]
[Intrarenal hemodynamics and renin secretion during acute renal failure in man. Preliminary results]
[Osmotherapy of acute kidney failure with special reference to plasma renin activity and mineral balance]
[Plasma renin activity in acute renal insufficiency]
[Plasma renin activity in patients with acute renal failure treated with furosemide (author's transl)]
[Protection against acute renal insufficiency by means of forced diuresis in an ischemic rat model]
[Renal Involvement in Connective Tissue Diseases].
[Role of the renin system in the aggravation of acute renal insufficiency in rats: effects of SQ 14225 (proceedings)]
Acute Lung Injury
A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
Polymorphism of the angiotensin converting enzyme gene and angiotensin converting enzyme activity in transient tachypnea of neonate and respiratory distress syndrome.
Addison Disease
A chronobiological approach to circulating levels of renin, angiotensin-converting enzyme, aldosterone, ACTH, and cortisol in Addison's disease.
Addison's Disease: A Diagnosis Easy to Overlook.
Altering angiotensin levels by administration of captopril or indomethacin, or by angiotensin infusion, contributes to an understanding of atrial natriuretic peptide regulation in man.
Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
Autoimmune Addison's disease.
Biochemical diagnosis of adrenal insufficiency: the added value of dehydroepiandrosterone sulfate measurements.
Control of mineralocorticoid substitution in Addison's disease by plasma renin measurement.
Delayed puberty from partial 17-alpha hydroxylase enzyme deficiency.
Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone.
Enzyme immunoassay for plasma renin activity: II. Clinical application.
From Appearance of Adrenal Autoantibodies to Clinical Symptoms of Addison's Disease: Natural History.
Lack of prostaglandin effect on sodium balance and hyperreninemia in adrenalectomized rats.
Mineralocorticoids in the management of primary adrenocortical insufficiency.
Normal male external genitalia do not rule out CYP11A1 deficiency.
Oedema in patients with Addison's disease on replacement therapy: glucocorticoid excess and mineralocorticoid deficiency?
Plasma renin levels are associated with cardiac function in primary adrenal insufficiency.
Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency.
Predicting the Onset of Addison's Disease: ACTH, Renin, Cortisol, and 21-hydroxylase Autoantibodies.
Quantitation of Plasma Renin Activity in Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Renin and renin substrate in primary adrenal insufficiency: contrasting effects of glucocorticoid and mineralocorticoid deficiency.
Renin, angiotensin, corticosteroids, and electrolyte balance in Addison's disease.
Sideroblastic anaemia and primary adrenal insufficiency due to a mitochondrial respiratory chain disorder in the absence of mtDNA deletion.
The natural history of adrenal function in autoimmune patients with adrenal autoantibodies.
The renin angiotensin system--its physiology and role in disease states.
The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency.
[Clinical and immunological studies in idiopathic adrenal insufficiency]
[Proceedings: Plasma renin activity in management of Addison's disease (author's transl)]
Adenocarcinoma
Activation of renin in an anaplastic pulmonary adenocarcinoma.
Adenocarcinoma of the kidney and hypertension: report of 2 cases with special emphasis on renin.
Correction: Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.
Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.
Renin in blood vessels in human pulmonary tumors. An immunohistochemical and biochemical study.
Adenoma
A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.
A case of normoreninemic, normotensive primary aldosteronism associated with essential hypertension and nephrocalcinosis.
A case of normotensive primary aldosteronism--comparison with 13 previously experienced cases with hypertension.
A case of silent 21-hydroxylase deficiency with persistent adrenal insufficiency after removal of an adrenal incidentaloma.
A new diagnostic test for primary aldosteronism.
A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.
Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
Adrenal Vein Sampling for Primary Aldosteronism: A 2-Week Protocol for Withdrawal of Renin-Stimulating Antihypertensives.
Aldosterone regulation in primary aldosteronism: differences between adenoma and bilateral hyperplasia.
Aldosterone to renin ratios in the evaluation of primary aldosteronism.
Aldosterone-producing adenoma associated with non-suppressed renin: a case series.
Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor.
Altering angiotensin levels by administration of captopril or indomethacin, or by angiotensin infusion, contributes to an understanding of atrial natriuretic peptide regulation in man.
An additional child case of an aldosterone-producing adenoma with an atypical presentation of peripheral paralysis due to hypokalemia.
An unexpected rise in plasma aldosterone to furosemide-upright test in primary aldosteronism due to aldosterone producing adenoma.
Analysis of the renin gene in patients with aldosterone-producing adenomas by polymerase chain reaction-single stranded conformational polymorphisms and long polymerase chain reaction.
Analytical problems with using the ratio of aldosterone to plasma renin activity for screening and diagnosing aldosterone-producing adenomas.
Approach to the patient with hypertension, unexplained hypokalemia, and metabolic alkalosis.
Are calcium antagonists helpful in the management of primary aldosteronism?
Captopril in Cushing's syndrome.
Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism.
Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Coexpression of renin, angiotensinogen, and their messenger ribonucleic acids in adrenal tissues.
Concurrent hypercortisolism and hyperaldosteronism due to an adrenal adenoma.
Concurrent hypercortisolism and hypermineralocorticoidism.
Conn's syndrome (primary hyperaldosteronism) simulating polymyositis.
Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
Detection of renin messenger RNA by polymerase chain reaction in aldosterone-producing adenomas.
Detection of renin mRNA in aldosterone-producing adenomas by polymerase chain reaction.
Determination of the aldosterone/renin ratio in 269 patients with adrenal incidentaloma.
Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.
Diagnosis and treatment of primary hyperaldosteronism.
Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism.
Effect of the circulating renin-angiotensin system on prolactin release in humans.
Elevated Plasma Renin Activity Caused by Accelerated-malignant Hypertension in a Patient with Aldosterone-producing Adenoma Complicated with Renal Insufficiency.
Endocrine Hypertension: Then and Now.
Epicardial Fat Thickness and Primary Aldosteronism.
Epithelial liver hamartoma, systemic arterial hypertension and renin hypersecretion.
Evaluation of patients for secondary hypertension.
Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism.
Exploration Of The Seated Saline Suppression Test For The Diagnosis Of Primary Aldosteronism In The Chinese Population.
Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism.
Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.
Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism.
Genetics of primary aldosteronism.
High and non-suppressible plasma renin activity in a patient with aldosterone producing adenoma: pathophysiologic and diagnostic implications.
High-renin malignant hypertension secondary to an aldosterone-producing adenoma.
Hypertension and adrenal disorders.
Hypertension and aldosterone overproduction without renin suppression in Cushing's syndrome from an adrenal adenoma.
Hypokalemia secondary to primary hyperaldosteronism in a renal transplant recipient.
Idiopathic hyperplasia of the adrenal gland behaving like an aldosterone producing adenoma.
Immunocytochemical and biochemical evidence of renin in human lactotrophic cell cultures.
Immunohistochemical localization of renin in renal tumors.
In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy.
Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Incidentally discovered adrenal masses: a functional and morphological study.
Is primary aldosteronism underdiagnosed in clinical practice?
Local renin-angiotensin system in human adrenals and aldosteronomas.
Medical management of aldosterone-producing adenomas.
Mineralocorticoid hypertension.
Mineralocorticoid production of adrenal cortical adenomas.
Night-day variations of renin-activity in primary aldosteronism.
Normotensive primary aldosteronism.
Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism.
PCR-SSCP analysis of the promoter region of the renin gene in patients with aldosterone-producing adenomas.
Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives.
Pre-operative evaluation of the prognosis of hypertension in primary aldosteronism owing to adenoma.
Presence of renin, angiotensinogen, and converting enzyme in human pituitary lactotroph cells and prolactin adenomas.
Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.
Primary aldosteronism in a general population sample. The Czech post-MONICA study.
Primary aldosteronism.
Primary aldosteronism. Study of twenty-six operated cases.
Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension.
Primary hyperaldosteronism.
PROGRESS IN PRIMARY ALDOSTERONISM: A review of the prevalence of primary aldosteronism in pre-hypertension and hypertension.
Psychological aspects of primary aldosteronism.
Quadriplegia and rhabdomyolysis as a presenting feature of Conn's syndrome.
Recurrence of primary aldosteronism after percutaneous ethanol injection.
Regulation of aldosterone secretion in primary aldosteronism.
Renin gene polymorphism associated with aldosterone responsiveness to the renin-angiotensin system in patients with aldosterone-producing adenomas.
Renin-angiotensin system and plasma aldosterone in Cushing's syndrome.
Reversible suppression of the renin-aldosterone axis after unilateral adrenalectomy for adrenal adenoma.
Selection of patients and operative approach in primary aldosteronism.
Selective hypoaldosteronism despite prolonged pre- and postoperative hyperreninemia in primary aldosteronism.
Serum interleukin-6 in patients with adrenal tumors.
Severe hypertension in a ten-year-old boy secondary to an aldosterone-producing tumour identified by adrenal sonography.
Single dose captopril as a diagnostic test for primary aldosteronism.
Steroid characteristics of mineralocorticoid adrenocortical hypertension.
Stroke disclosing primary aldosteronism: Report on three cases and review of the literature.
Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
Synchronous changes in active and inactive renin secretion after furosemide in patients with primary aldosteronism.
The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma.
The aldosterone/renin ratio as a screening test for primary aldosteronism.
The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
The regulation of the 17-deoxy steroids in man.
The renin gene and aldosterone-producing adenomas.
The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
The syndromes of low-renin hypertension: "separating the wheat from the chaff".
Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism.
[Activity of plasma renin in arterial hypertension with corticoadrenal adenoma. Conn's syndrome]
[Adrenal gland adenoma sensitive to renin]
[Analysis of characteristics of renin, aldosterone and aldosterone/renin ratio in patients with aldosterone-producing adenoma].
[Circulatory reflexes in primary aldosteronism (author's transl)]
[Conn's adenoma. Diagnostic and prognostic value of the measurement of potassium, renin, aldosterone levels and the aldosterone/renin ratio]
[Contribution of CYP11B2, REN and AGT genes in genetic predisposition to arterial hypertension associated with hyperaldosteronism]
[Diagnosis and treatment outcome of primary aldosteronism based on a retrospective analysis of 187 cases]
[Does the captopril test improve the diagnosis of primary hyperaldosteronism?]
[Effect of a calcium inhibitor, nicardipine, on aldosterone secretion in primary hyperaldosteronism]
[Metabolic syndrome in patients with adrenocortical adenoma]
[Plasma renin activity and aldosterone excretion in patients with essential hypertension, with hypertension in bilateral adrenal cortex hyperplasia and with aldosterone-producing adrenal cortex adenomas following various sodium tolerance tests]
[Primary hyperaldosteronism--12 clinical cases]
[State of the endocrine and cardiovascular systems in patients with somatotropin-producing hypophyseal adenoma]
[Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III]
[Surgical treatment of different forms of hyperaldosteronism with low renin activity in the blood plasma]
[The difficulties in differential diagnosis of primary aldosteronism subtypes in women with strokes at a young age]
[The long-term administration of dexamethasone for the differentiation of the 4 types of hyperaldosteronism]
Adenoma, Chromophobe
Aldosterone secretion and plasma renin activity in chromophobe adenoma: effect of acth.
Adenoma, Oxyphilic
[Renal adenocarcinoma with secretion of renin, simulating a oncocytoma. Apropos of a case in a pregnant woman with histological and immunohistochemical study]
Adenomatous Polyposis Coli
OS 15-07 ROLE OF (PRO) RENIN RECEPTOR IN THE ACTIVATION OF WNT/ ?-CATENIN PATHWAY IN COLON CANCER.
Adrenal Cortex Neoplasms
Aldosterone-producing tumors (Conn's syndrome).
[Autopsy case of Cushing's syndrome caused by adrenocortical cancer with a marked increase of plasma renin activity]
Adrenal Gland Neoplasms
Adrenal cancer with hypertension but low plasma renin and aldosterone.
Adrenal Hyperplasia, Congenital
Abnormalities of aldosterone synthesis and action in children.
Altering angiotensin levels by administration of captopril or indomethacin, or by angiotensin infusion, contributes to an understanding of atrial natriuretic peptide regulation in man.
Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age.
Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Congenital adrenal hyperplasia: renin and steroid values during treatment.
Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia.
Dissociation of plasma renin activity and plasma aldosterone level during dexamethasone suppression test in non-salt-losers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Early diagnosis of salt-losing congenital adrenal hyperplasia in a newborn boy.
Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Enzyme immunoassay for plasma renin activity: II. Clinical application.
HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Hypertension due to a deoxycorticosterone-secreting adrenal tumour diagnosed during pregnancy.
New aspects of mineralocorticoid hypertension.
Plasma aldosterone, renin activity, and 17alpha-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effect of 9alpha-fluorocortisol.
Plasma renin activity and aldosterone concentration in normal subjects and patients with salt-losing type of congenital adrenal hyperplasia during infancy.
Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia.
Plasma renin activity and mineralocorticoid replacement therapy in congenital adrenal hyperplasia.
Plasma renin activity and the response to sodium depletion in salt-losing congenital adrenal hyperplasia.
Plasma renin activity in the management of congenital adrenal hyperplasia.
Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency.
Quantitation of Plasma Renin Activity in Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Rare causes of acute hyperkalemia in the 1st week of life. Three case reports.
Renin activity, aldosterone secretion, and congenital adrenal hyperplasia.
Splicing analysis of CYP11B1 mutation in a family affected with 11?-hydroxylase deficiency: case report.
Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia.
Steroids and hypertension.
The effects of long-term normalization of sodium balance on linear growth in disorders with aldosterone deficiency.
The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia.
The measurement of 11 beta-hydroxy-4-pregnene-3,20-dione (21-deoxycorticosterone) by radioimmunoassay in human plasma.
The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia.
Validation of a new automated renin assay.
Value of direct measurement of active renin concentrations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
[Clinical significance of plasma renin, testosterone, 17-alpha-hydroxyprogesterone and ACTH activities in the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. A review of 31 cases]
[Clinical use of fludrocortisone acetate in congenital adrenal hyperplasia. Effect on plasma renin activity and aldosterone (author's transl)]
[Diagnosis, treatment and follow-up of a patient with pseudohypoaldosteronism (author's transl)]
[Study on the corticosteroids and renin in two children with congenital adrenal hyperplasia due to deficiency of 11- -hydroxylase. Effect of salt restriction and therapy]
Adrenal Insufficiency
A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing.
Active and inactive renin in primary and secondary adrenal insufficiency and during ACTH infusion.
Adrenalectomy causes a delayed increase of inactive plasma renin in rats.
Delayed diagnosis of adrenal insufficiency in a patient with severe penoscrotal hypospadias due to two novel P450 side-change cleavage enzyme (CYP11A1) mutations (p.R360W; p.R405X).
Effect of adrenalectomy on renin release in the rat.
Mechanism of increased renin release in the adrenalectomized rat. Adrenal insufficiency and renin.
Overt and Subclinical Adrenal Insufficiency in Pulmonary Tuberculosis.
Partially compensated hypoadrenalism presenting with persistent skin pigmentation.
Plasma renin and aldosterone in pregnancy complicated by adrenal insufficiency.
Plasma renin substrate levels during adrenal insufficiency.
[Effect of ACTH and glucocorticoids on the secretion of renin in normal subjects and in patients with adrenal insufficiency]
[Plasma renin activity in chronic adrenal gland insufficiency]
Adrenocortical Adenoma
Aldosterone-producing adrenocortical adenoma complicated by chronic renal failure. Case report and review of the literature.
Concurrent hypercortisolism and hypermineralocorticoidism.
Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism.
[Pathological and clinical studies on primary aldosteronism]
[The plasma renin activity in arterial hypertension with adrenocortical adenoma (Conn's syndrome)]
Adrenocortical Carcinoma
A case of renin-producing adrenocortical cancer.
A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol.
Newly developed hypertension as an early marker of recurrence of adrenocortical carcinoma with high renin expression.
Adrenocortical Hyperfunction
Captopril in Cushing's syndrome.
Late recurrence of operated adrenocortical carcinoma: atrial natriuretic factor before and after treatment with mitotane.
Plasma aldosterone concentrations and plasma renin activity in healthy dogs and dogs with hyperadrenocorticism.
The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome.
[Paraneoplastic hypercorticism. Hypokalemia, increased plasma renin activity and hypoaldosteronism during cancer of the pancreas]
Adrenogenital Syndrome
A case of adrenal tumor producing renin, aldosterone, and sex steroid hormones.
Agammaglobulinemia
Hyperaldosteronemia and hypogammaglobulinemia secondary to atopic dermatitis-induced exudation in an infant presenting with growth failure.
AIDS-Associated Nephropathy
Inhibition of renin activity slows down the progression of HIV-associated nephropathy.
Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.
Albuminuria
Albumin caused the increasing production of angiotensin II due to the dysregulation of ACE/ACE2 expression in HK2 cells.
Albuminuria as a marker of arterial stiffness in chronic kidney disease patients.
Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
Aliskiren reduces albuminuria after kidney transplantation.
Annual deterioration of renal function in hypertensive patients with and without diabetes.
Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus.
Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin.
Blood pressure-independent effects in rats with human renin and angiotensinogen genes.
Combination of half doses of angiotensin type 1 receptor antagonist and angiotensin-converting enzyme inhibitor in diabetic nephropathy.
Combined Aliskiren and Amlodipine Reduce Albuminuria via Reduction in Renal Inflammation in Diabetic Rats.
Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.
Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.
Despite similar reduction of blood pressure and renal ANG II and ET-1 levels aliskiren but not losartan normalizes albuminuria in hypertensive Ren-2 rats.
Diabetic renal disease in patients with type 2 diabetes mellitus: new strategies for prevention and treatment.
Disputes in the Treatment of Diabetic Nephropathy: The Dual Blockade of Renin-Angiotensin System.
Effect of aldosterone breakthrough on albuminuria during treatment with a direct renin inhibitor and combined effect with a mineralocorticoid receptor antagonist.
Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial.
Effects of Direct Renin Inhibition versus Angiotensin II Receptor Blockade on Angiotensin Profiles in Non-Diabetic Chronic Kidney Disease.
Effects of NaHCO3, alpha-, and beta-adrenergic blockade on albuminuria after swimming in splenectomized dogs.
Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease.
Efficacy of aliskiren and valsartan in hypertensive patients with albuminuria: a randomized parallel-group study.
Elevated serum total renin is insensitive in detecting incipient diabetic nephropathy.
Erythrocyte cation transport systems in insulin-dependent diabetics: correlation with prorenin and albuminuria.
Erythrocyte cation transport systems, plasma-inactive renin and albuminuria in insulin-dependent diabetics.
Galectin-7 Impairs Placentation and Causes Preeclampsia Features in Mice.
Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation.
Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8.
Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications.
Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study.
Is there a role for direct renin inhibitors in chronic kidney disease?
Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy.
Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension.
Nephroprotective Action of Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease Patients: The Landscape After ALTITUDE and VA NEPHRON-D Trails.
Novel therapies of diabetic nephropathy.
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey.
Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus.
Predictors of proteinuria reduction by monotherapy with an angiotensin receptor blocker, olmesartan.
Prorenin and renal function in NIDDM patients with normo- and microalbuminuria.
Prorenin independently causes hypertension and renal and cardiac fibrosis in cyp1a1-prorenin transgenic rats.
Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
Renin angiotensin system blockade reduces urinary levels of soluble urokinase plasminogen activator receptor (suPAR) in patients with type 2 diabetes.
Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions.
Resistant hypertension.
Role of the USF1 transcription factor in diabetic kidney disease.
Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients.
Statins Reverse Postpartum Cardiovascular Dysfunction in a Rat Model of Preeclampsia.
Targeting albumin excretion rate in the treatment of the hypertensive diabetic patient with renal disease.
The Enhanced Renin-Angiotensin-Aldosteron System Pharmacological Blockade - Which is the Best?.
The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.
The Renin-Angiotensin-Aldosterone System in Greyhounds and Non-Greyhound Dogs.
Therapeutic approaches in lowering albuminuria: travels along the Renin-Angiotensin-aldosterone-system pathway.
Urinary Angiotensinogen and Renin Excretion are Associated with Chronic Kidney Disease.
Urinary Renin-Angiotensin Markers in Polycystic Kidney Disease.
Urinary serine proteases and activation of ENaC in kidney-implications for physiological renal salt handling and hypertensive disorders with albuminuria.
Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
Use of vitamin D in chronic kidney disease patients.
[How to Retard Progression of Chronic Kidney Disease].
Alkalosis
A 3-year old girl with seizures, hypokalemia and metabolic alkalosis.
A Bartter's-like syndrome from capreomycin, and a similar gentamicin tubulopathy.
A Bartter-like syndrome after jejunoileal bypass for obesity.
A case of congenital chloride diarrhea: information obtained through long-term follow-up with reduced electrolyte substitution.
A case of Gitelman syndrome associated with idiopathic intracranial hypertension.
A case of Liddle's syndrome; unusual presentation with hypertensive encephalopathy.
A case of normotensive primary aldosteronism with hypopituitarism, epilepsy, and medullary sponge kidney.
A case report of reninoma: radiological and pathological features of the tumour and characterization of tumour-derived juxtaglomerular cells in culture.
A patient with cystinosis presenting transient features of Bartter syndrome.
A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5.
A pediatric Conn syndrome case.
A Rare Cause of Chronic Hypokalemia with Metabolic Alkalosis: Case Report and Differential Diagnosis.
Acquired Bartter-Like Phenotype.
An abnormality in steroid reductive metabolism in a hypertensive syndrome.
An extreme example of the neonatal form of Bartter's syndrome.
An unusual case of an aldosterone-producing adenoma in a prepubertal girl with severe post-surgical adrenal suppression.
An unusual type of hypokalaemic alkalosis with a disturbance of renin and aldosterone.
Anaesthesia for laparoscopic cholecystectomy in Bartter's syndrome.
Anaesthetic management for hiatal hernia repair in a child with Bartter's syndrome: A case report.
Analysis of claudin genes in pediatric patients with Bartter's syndrome.
Anesthetic management of a patient with Bartter's syndrome undergoing orthognathic surgery.
Anesthetic management of a patient with Bartter's syndrome.
Apparent mineralocorticoid excess and deficient 11 beta-oxidation of cortisol in a young female.
Association of Bartter's syndrome and empty sella.
Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome.
Bartter's syndrome in Arabic children: review of 13 cases.
Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
Bartter's syndrome with gouty arthritis.
Bartter's syndrome with type 2 diabetes mellitus.
Bartter's syndrome--case report.
Bartter's syndrome: an overview.
Biochemical examination of mother's urine is useful for prenatal diagnosis of Bartter syndrome.
Channelopathies of inwardly rectifying potassium channels.
Co-Existence of Congenital Adrenal Hyperplasia and Bartter Syndrome due to Maternal Uniparental Isodisomy of HSD3B2 and CLCNKB Mutations.
Cystinosis presenting with findings of bartter syndrome.
Diagnosis of a case of Gitelman's syndrome based on renal clearance studies and gene analysis of a novel mutation of the thiazide-sensitive Na-Cl cotransporter.
Digenetic inheritance of SLC12A3 and CLCNKB genes in a Chinese girl with Gitelman syndrome.
Ectopic production of renin by ileal carcinoma.
Effects in normal subjects of long-term administration of azosemide.
Expanding the spectrum of genetic mutations in antenatal Bartter syndrome type II.
Forms of mineralocorticoid hypertension.
From Bartter's syndrome to renal tubular acidosis in a patient with Hashimoto's thyroiditis: A case report?.
Functional Study of Novel Bartter's Syndrome Mutations in ClC-Kb and Rescue by the Accessory Subunit Barttin Toward Personalized Medicine.
Gitelman's syndrome with exercise-induced ventricular tachycardia.
Hyperaldosteronism: the internist's hypertensive disease.
Hyperprostaglandin E syndrome: use of indomethacin and steroid, and death due to necrotizing enterocolitis and sepsis.
Hypertension in a four-year-old child: gas chromatographic and mass spectrometric evidence for deficient hepatic metabolism of steroids.
Hypertension, hypokalemia and hypoaldosteronism with suppressed renin: a clinical study of a patient with Liddle's syndrome.
Hypertensive Crisis with Neurological Impairment Mimicking a Guillain-Barrè Syndrome: Searching for a Link.
Hypodipsic hypernatremia with intact AVP response to non-osmotic stimuli induced by hypothalamic tumor: a case report.
Hypokalemia and hearing loss in a 3-year-old boy: Questions.
Hypokalemia and metabolic alkalosis: algorithms for combined clinical problem solving.
Hypokalemic metabolic alkalosis in normotensive infants with elevated plasma renin activity and hyperaldosteronism: role of dietary chloride deficiency.
Hypokalemic paralysis in a middle-aged female with classic Bartter syndrome.
Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism.
Idiopathic carpotarsal osteolysis with Bartter's syndrome. A case report and review of the literature.
Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
Impaired water diuresis in a patient with pseudo-Bartter syndrome.
In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess.
Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
Itraconazole induced hypertension and hypokalemia: Mechanistic evaluation.
Liddle syndrome due to a novel mutation in the ? subunit of the epithelial sodium channel (ENaC) in family from Russia: a case report.
Liddle syndrome in a Turkish family with heterogeneous phenotypes.
Liddle's syndrome: a 14-year follow-up of the youngest diagnosed case.
Low-renin, low-aldosterone hypertension and abnormal cortisol metabolism in a 19-month-old child.
Mineralocorticoid hypertension and hypokalemia.
Mineralocorticoid hypertension in childhood.
Monogenic forms of hypertension.
Monogenic mineralocorticoid hypertension.
Neonatal Bartter Syndrome in association with congenital adrenal hyperplasia in a neonate - a rare combination.
Nephrocalcinosis and renal cysts associated with apparent mineralocorticoid excess syndrome.
Neuroblastoma presenting with acute kidney injury, hyponatremic-hypertensive-like syndrome and nephrotic proteinuria in a 10-month-old child.
New-onset resistant hypertension in a newly diagnosed prostate cancer patient.
Paradoxical hypertension and salt wasting in Type II Bartter syndrome.
Plasma aldosterone level in a female case of pseudohyperaldosteronism (Liddle's syndrome).
Possible discrimination of Gitelman's syndrome from Bartter's syndrome by renal clearance study: report of two cases.
Primary aldosteronism due to unilateral adrenal hyperplasia: a case report.
Primary aldosteronism.
Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome.
Pseudo-Bartter's Syndrome in Patients with Cystic Fibrosis: A Case Series and Review of the Literature.
Pseudoaldosteronism in an elderly man believed to be caused by the health food Shin-Gojoshin.
Pseudoaldosteronism with increased serum cortisol associated with pneumonia, hypouricemia, hypocalcemia, and hypophosphatemia.
Pseudohyperaldosteronism (Liddle's syndrome): a case report.
Remission of hypertension and electrolyte abnormalities following renal transplantation in a patient with apparent mineralocorticoid excess well documented throughout childhood.
Review and Analysis of Two Gitelman Syndrome Pedigrees Complicated with Proteinuria or Hashimoto's Thyroiditis Caused by Compound Heterozygous SLC12A3 Mutations.
Risk Factors for Pseudoaldosteronism with Rhabdomyolysis Caused by Consumption of Drugs Containing Licorice and Differences Between Incidence of These Conditions in Japan and Other Countries: Case Report and Literature Review.
Self-induced vomiting presenting as Bartter's syndrome.
Shakuyaku-kanzo-to induces pseudoaldosteronism characterized by hypokalemia, rhabdomyolysis, metabolic alkalosis with respiratory compensation, and increased urinary cortisol levels.
Sodium chloride deficiency in cystic fibrosis patients.
The mechanism of mineralocorticoid action of carbenoxolone.
The patient with metabolic alkalosis.
The syndrome of juxtaglomerular hyperplasia with aldosteronism, hypokalemic alkalosis and normal blood pressure.
Transient hyponatremia of prematurity caused by mild Bartter syndrome type II: a case report.
Two neonates with Bartter syndrome.
Two novel homozygous missense mutations identified in the BSND gene in Moroccan patients with Bartter's syndrome.
Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome.
[A 87-year-old woman with mineralocorticoid excess due to 11 beta-HSD2 deficiency]
[A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency]
[A case of idiopathic hyperaldosteronism with normal plasma aldosterone concentrations for 5 years after onset: a 12-year follow-up study]
[A case of pseudo-Bartter's syndrome associated with hypokalemic myopathy]
[A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia]
[Arterial hypertension in renin-producing retroperitoneal leiomyosarcoma]
[Bartter's syndromes]
[Bartter's syndrome]
[Hypermineralcorticism syndrome secondary to topical application of 9-alpha-fluoroprednisolone (author's transl)]
[Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases]
[Hypokalemic nephropathy from the chronic use of diuretics and laxatives]
[Liddle syndrome (or pseudo-hyperaldosteronism). Long-term development and erythrocyte potassium flow study in 4 cases]
[Natural history of arterial hypertension due to primary hyperreninism]
[Plasma renin activity of the rat in systemic alkalosis and acidosis]
[Primary hyperaldosteronism in a population of hypertensive patients].
[Pseudo-Bartter syndrome in a case of cystic fibrosis caused by C1529G and G3978A compound heterozygosity]
[Tetany as a sole manifestation in a patient with Bartter's syndrome and a successful treatment with indomethacin]
[The Bartter-like syndrome in 2 twins]
Alkalosis, Respiratory
Early fluid retention and severe acute mountain sickness.
Evaluation of a blood sample-transfusion protocol in rats: blood gases, renin, and ACTH.
Alveolar Bone Loss
Aliskiren Attenuates the Inflammatory Response and Wound Healing Process in Diabetic Mice With Periodontal Disease.
Functional Local Renin-Angiotensin System in Human and Rat Periodontal Tissue.
Alveolitis, Extrinsic Allergic
Evaluation of Renin and Soluble (Pro)renin Receptor in Patients with IPF. A Comparison with Hypersensitivity Pneumonitis.
Alzheimer Disease
Alzheimer disease is not associated with polymorphisms in the angiotensinogen and renin genes.
Ang (1-7)/Mas receptor-axis activation promotes amyloid beta-induced altered mitochondrial bioenergetics in discrete brain regions of Alzheimer's disease-like rats.
Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease.
Angiotensin receptor blockers for bipolar disorder.
Aspartic peptidase inhibitors: implications in drug development.
Associations of Angiotensin Converting Enzyme-1 and Angiotensin II Blood Levels and Cognitive Function.
Design of potent aspartic protease inhibitors to treat various diseases.
Do angiotensin receptor blockers prevent Alzheimer's disease?
Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.
Neurofibrillary Tangles and Conversion to Mild Cognitive Impairment with Certain Antihypertensives.
New directions for protease inhibitors directed drug discovery†.
The anti-Alzheimer effect of telmisartan in a hyperglycemic ovariectomized rat model; role of central angiotensin and estrogen receptors.
The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.
The renin angiotensin system and Alzheimer's disease.
The Role of the Renin-Angiotensin System in Amyloid Metabolism of Alzheimer's Disease.
Upregulation of Brain Renin Angiotensin System by 27-Hydroxycholesterol in Alzheimer's Disease.
Amyloidosis
The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients.
Anaphylaxis
Association between the renin angiotensin system and anaphylaxis.
IgE-Mediated Anaphylaxis to Foods, Venom, and Drugs: Influence of Serum Angiotensin Converting Enzyme Levels and Genotype.
Immediate Hypersensitivity Elicits Renin Release from Cardiac Mast Cells.
Plasma renin and angiotensin I converting enzyme activity in anaphylactic shock.
Release of antirenin to human renin by anaphylactic shock or by antihypertensive agents.
Renin angiotensin aldosterone system and drug allergies complicated with hypotension.
The renin angiotensin system and hymenoptera venom anaphylaxis.
The renin-angiotensin system in patients with repeated anaphylactic reactions during hymenoptera venom hyposensitization and sting challenge.
Androgen-Insensitivity Syndrome
Immunocytochemical localization of nerve growth factor, submandibular glands of Tfm/Y mice.
Anemia
Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.
Autosomal dominant mutation in the signal peptide of renin in a kindred with anemia, hyperuricemia, and CKD.
Development of malignant hypertension in patients with uremia under hemodialysis: a case report and discussions on its etiology.
Discovery of a novel dominant mutation in the REN gene after forty years of renal disease: a case report.
Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure.
Erythropoiesis and Blood Pressure Are Regulated via AT1 Receptor by Distinctive Pathways.
Factors Related to the Absence of Anemia in Hemodialysis Patients.
Hereditary interstitial kidney disease.
Left ventricular hypertrophy in renal failure.
Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension.
Possible mechanisms of cardiac contractile dysfunction and electrical changes in ammonium chloride induced chronic metabolic acidosis in Wistar rats.
Renal interstitial fibroblasts coproduce erythropoietin and renin under anaemic conditions.
Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS.
Uromodulin-associated kidney disease.
Anemia, Aplastic
[Renin angiotensin system in bone marrow of patients with aplastic anemia]
Anemia, Hemolytic
Successful treatment of scleroderma renal crisis with enalapril.
Anemia, Megaloblastic
Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences.
Anemia, Sickle Cell
Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy.
Aneurysm
Association of cystathionine beta-synthase polymorphisms and aneurysmal subarachnoid hemorrhage.
Association of Plasminogen Activator Inhibitor 1 (SERPINE1) Polymorphisms and Aneurysmal Subarachnoid Hemorrhage.
Associations of endothelin polymorphisms and aneurysm size at the time of rupture.
AT1-receptor blockade, but not renin inhibition, reduces aneurysm growth and cardiac failure in fibulin-4 mice.
Bilateral renal artery aneurysms: in-situ and extracorporeal repair.
Conundrum of angiotensin II and TGF-? interactions in aortic aneurysms.
Endothelin polymorphisms as a risk factor for cerebral aneurysm rebleeding following aneurysmal subarachnoid hemorrhage.
Hypertension and renal artery aneurysm: spontaneous cure.
Impact of High-Mobility Group Box 1 Polymorphism on Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
Indications for surgery on renal artery aneurysms.
Inhibition of Aneurysm Progression by Direct Renin Inhibition in a Rabbit Model.
Plasma renin activity revealed renal artery stenosis concealed by aneurysms.
Predictors of Shunt Insertion in Aneurysmal Subarachnoid Hemorrhage.
Renal Artery Aneurysm Due to Fenestration of a Branch of the Renal Artery: A Case Study.
Role of left ventricular dysfunction in selective neurohumoral activation in the recovery phase of anterior wall acute myocardial infarction.
Ryanodine receptor 1 polymorphism is not associated with aneurysmal subarachnoid hemorrhage or its clinical sequelae.
Severe hypertension associated with an intrarenal aneurysm.
Aneurysm, Dissecting
Elevation of plasma renin activity during pregnancy and rupture of a dissecting aortic aneurysm in a patient with primary aldosteronism.
The Clinicopathologic Significance of Unilateral Adrenal Cortical Hyperplasia: Report of an Unusual Case and a Review of the Literature.
Valsartan Effective for Malignant Hypertension after Aortic Dissection with Renal Artery Involvement.
Angina Pectoris
S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
The renin-angiotensin--aldosterone system and the clinical course of acute myocardial infarction.
Treatment of hypertension with nifedipine, a calcium antagonistic agent.
Angina, Unstable
Persistent and selective upregulation of renin-angiotensin system in circulating T lymphocytes in unstable angina.
Angioedema
A comparison of the effects of renin inhibition and angiotensin converting enzyme inhibition upon bradykinin potentiation.
Angioedema due to the renin inhibitor aliskiren (MAY 2011).
Angioedema with renin angiotensin system drugs and neutral endopeptidase inhibitors.
Blood pressure lowering efficacy of renin inhibitors for primary hypertension.
Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System.
Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Critical angioedema induced by a renin angiotensin system blocker in the contemporary era of increasing heart failure: A case report and commentary.
Erratum: Renin angiotensin system blockers-associated angioedema in the Thai population.
IgE-Mediated Anaphylaxis to Foods, Venom, and Drugs: Influence of Serum Angiotensin Converting Enzyme Levels and Genotype.
Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck.
Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database.
[Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].
Angioedemas, Hereditary
Plasma kallikrein and prorenin in patients with hereditary angioedema.
Angiolymphoid Hyperplasia with Eosinophilia
Angiolymphoid hyperplasia with eosinophilia associated with arteriovenous malformation: a clinicopathological correlation with angiography and serial estimation of serum levels of renin, eosinophil cationic protein and interleukin 5.
Renin in angiolymphoid hyperplasia with eosinophilia. Its possible effect on vascular proliferation.
Angiomyolipoma
Hepatic angiomyolipoma with striated granules and positivity with melanoma--specific antibody (HMB-45): a report of two cases.
Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum.
Anti-Glomerular Basement Membrane Disease
Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis.
Anuria
A Premature Baby with Severe Oligohydramnios and Hypotension: a Case Report of Renal Tubular Dysgenesis.
Aldosteronemia in patients with acute renal failure.
Can we live without a functional renin-angiotensin system?
Effects of endothelin on hemodynamics, prostaglandins, blood coagulation and renal function.
The patterns of peripheral plasma renin concentration in the early post-renal-transplant period.
[Aldosteroneia in acute kidney failure]
[Anuria due to bilateral renal artery spasm during hysterectomy and oophorectomy]
[Osmotherapy of acute kidney failure with special reference to plasma renin activity and mineral balance]
Aortic Aneurysm
Conundrum of angiotensin II and TGF-? interactions in aortic aneurysms.
Elevation of plasma renin activity during pregnancy and rupture of a dissecting aortic aneurysm in a patient with primary aldosteronism.
Inhibition of Aneurysm Progression by Direct Renin Inhibition in a Rabbit Model.
Renin dependent hypertension by dissecting aortic aneurysm. A case report.
Role of angiotensin II type 1 receptor in cerebral aneurysm formation in rats.
Aortic Aneurysm, Abdominal
Inhibition of Aneurysm Progression by Direct Renin Inhibition in a Rabbit Model.
Aortic Coarctation
Augmented norepinephrine and renin output in response to maximal exercise in hypertensive coarctectomy patients.
Central antihypertensive effects of inhibitors of the renin-angiotensin system in rats.
Cyclooxygenase-2 and the renal renin-angiotensin system.
Decreased perfusion pressure modulates renin and ANG II type 1 receptor gene expression in the rat kidney.
Decreased renal perfusion after correction of experimental coarctation.
Effect of captopril on blood pressure and on the renin-angiotensin-aldosterone system in coarctation of the aorta.
Effects of exercise on plasma renin, aldosterone and catecholamines before and after surgery for aortic coarctation.
Exchangeable sodium and saralasin-blocking, plasma renin and aldosterone in pre- and postoperative young patients with aortic coarctation.
Experimental coarctation of the aorta: effects of diminished pulse pressure on renin activity, juxtaglomerular granulation, and angiotensin sensitivity.
Inappropriate renin secretion and abnormal cardiovascular reflexes in coarctation of the aorta.
Labetalol Infusion Attenuates Paradoxical Hypertension and Decreases Plasma Renin Activity After Repair of Coarctation of the Aorta in Children.
Labetalol Infusion Controls Paradoxical Hypertension and Decreases Plasma Renin Activity Following Repair of Coarctation of the Aorta in Children.
Modulation of kidney renin messenger RNA levels during experimentally induced hypertension.
Multi-Drug-Resistant Hypertension Caused by Severe Aortic Coarctation Presenting in Late Adulthood.
Peripheral and renal vein plasma renin activity in coarctation of the aorta.
Plasma renin activity in children with coarctation of the aorta.
Plasma renin activity in coarctation of the aorta before and after surgical correction.
Plasma renin activity in coarctation of the aorta.
Plasma renin activity in hypertension associated with coarctation of the aorta.
Plasma renin activity in patients with coarctation of the aorta. A comment of the pathogenesis prestenotic hypertension.
Plasma renin in aorta, peripheral and renal veins in young patients with coarctation of the aorta. Comparative study with essential hypertensives.
Plasms renin acitivity in coarctation of aorta before and after surgery.
Preoperative and postoperative renin levels in coarctation of the aorta.
Rat renal prorenin concentration in experimental hypertension.
Renin response to diazoxide stimulation in experimental coarctation of the aorta.
Secondary hypertension. An overview of its causes and management.
Studies of plasma renin activity in coarctation of the aorta.
The importance of the renin angiotensin system in hypertension due to coarctation of the aorta.
The role of renin in coarctation of the aorta.
[Importance of determining the renin activity in the blood plasma of the renal veins in symptomatic hypertension]
[Plasma renin activity and aldosterone excretion in coarctation of the aorta]
[Postoperative hypertension in coarctation of the aorta associated with different plasma renin activities and catecholamine responses in two cases]
[The renin angiotensin system in the pathology of arterial hypertension of aortic coarctation]
Aortic Diseases
Hemodynamics, compartments and the renin-aldosterone system in chronic heart failure.
Twenty-four-hour ambulatory blood pressure and vasoactive hormones in valvular aortic disease.
Aortic Stenosis, Supravalvular
Effects of aortic stenosis on renal renin, angiotensin receptor, endothelin and NOS gene expression in rats.
Role of neurohumoral systems for pressure induced left ventricular hypertrophy in experimental supravalvular aortic stenosis in rats.
Aortic Valve Disease
(Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis.
[Changes in the renin-angiotensin-aldosterone system during open heart surgery. I. Factors involved in renin secretion]
Aortic Valve Insufficiency
(Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis.
Aortic Valve Stenosis
(Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis.
Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves.
Cryoactivation fails to augment plasma renin activity in the cat.
Effect of severe aortic banding above the renal arteries on nitric oxide synthase isotype expression.
Effects of aortic stenosis on renal renin, angiotensin receptor, endothelin and NOS gene expression in rats.
Effects of renal dopamine receptor and beta-adrenoreceptor blockade on rises in blood angiotensin after haemorrhage, renal ischaemia and frusemide diuresis in the dog.
Genetic variants of proteins from the renin angiotensin system are associated with pressure load cardiac hypertrophy.
Neural control of renin release.
Neural factors contributing to renin release during reduction in renal perfusion pressure and blood flow in cats.
Raised plasma concentrations of endothelin-1 and -3 in marmosets with acute aortic stenosis: no relation to the renin-angiotensin system.
Role of the renal nerves in renin release during suprarenal aortic stenosis in cats.
Vasoconstrictor role of vasopressin and angiotensin in experimental aortic stenosis in the rat.
Aortitis
Orthostatic hypertension with nephroptosis and aortitis disease.
Apnea
Associations of Sleep Quality and Awake Physical Activity with Fluctuations in Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors.
Disturbances in volume regulating hormone system--a key to the pathogenesis of hypertension in obstructive sleep apnea syndrome?
[Clinical Characteristics of Aldosterone Producing Adenoma and Idiopathic Hyperaldosteronism with Obstructive Sleep Apnea Hypopnea Syndrome].
Arrhythmia, Sinus
Atrial natriuretic factor attenuates carotid baroreflex-mediated cardioacceleration in humans.
Arrhythmias, Cardiac
Blockade of Renin Angiotensin System Ameliorates the Cardiac Arrythmias and Sympathetic Neural Remodeling in Hearts of Type 2 DM Rat Model.
Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era.
Chemical Communication between Heart Cells is Disrupted by Intracellular Renin and Angiotensin II: Implications for Heart Development and Disease.
Myocardial protective effect of human atrial natriuretic Peptide in cardiac surgery.
The Potential Effects of Aliskiren on Atrial Remodeling Induced by Chronic Intermittent Hypoxia in Rats.
[Plasma renin activity in patients with coronary arteriosclerosis with different types of hyperlipoproteinemia]
Arteriosclerosis
Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease.
Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
Isolated renal artery and combined aortic and renal artery reconstruction for renovascular hypertension. Late results of surgical treatment.
Peripheral renal vascular disease in essential hypertension: hemodynamic, angiographic, and endocrine assessment.
Renin and the juxtaglomerular apparatus in diabetic nephropathy.
[A case of hyporeninemic hypoaldosteronism improved by dexamethasone treatment]
[Reno-vascular hypertension surgery and renal: systemic renin index (author's transl)]
Arteriovenous Fistula
Factors determining electrolyte excretion and renin secretion after closure of an arteriovenous fistula in the dog.
Hypertension and post-traumatic renal arteriovenous fistula: demonstration of unilaterally elevated renin secretion.
Hypertension caused by renal arteriovenous fistula.
Renal arteriovenous fistulas.
Arteriovenous Malformations
Angiolymphoid hyperplasia with eosinophilia associated with arteriovenous malformation: a clinicopathological correlation with angiography and serial estimation of serum levels of renin, eosinophil cationic protein and interleukin 5.
Hemodynamic and plasma renin responses to treatment of a renal arteriovenous malformation.
Arteritis
Pathogenesis of paradoxical hypertension after coarctation resection.
[Diagnostic value of the captopril test in patients with arterial hypertension]
Arthritis
Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.
Arthritis, Reactive
Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus.
Arthritis, Rheumatoid
Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus.
Plasma renin activity as a marker of renovascular injury in patients with rheumatoid arthritis.
Prorenin-renin axis in synovial fluid in patients with rheumatoid arthritis and osteoarthritis.
Raised plasma renin and prorenin in rheumatoid vasculitis.
Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis.
The renal excretion of prostaglandins and changes in plasma renin during treatment with either sulindac or naproxen in patients with rheumatoid arthritis and thiazide treated heart failure.
The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis.
[Urinary excretion of prostaglandins and changes in plasma renin levels in patients with rheumatoid arthritis associated with cardiac decompensation treated with thiazides]
Asthma
Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function.
Investigations on the renin-angiotensin system in acute severe asthma.
Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol.
Serum angiotensin converting enzyme activity in pulmonary diseases: correlation with lung function parameters.
Treatment of status asthmaticus--hormone changes before and after aminophylline i.v. drip therapy.
Atherosclerosis
A Primer to Angiotensin Peptide Isolation, Stability, and Analysis by Nano-Liquid Chromatography with Mass Detection.
Aliskiren effect on plaque progression in established atherosclerosis using high resolution 3D MRI (ALPINE): a double-blind placebo-controlled trial.
Aliskiren Inhibits Neointimal Matrix Metalloproteinases in Experimental Atherosclerosis.
Aliskiren, a direct renin inhibitor, improves vascular endothelial function in patients on hemodialysis independent of antihypertensive effect ? a pilot study?.
Angiotensin (1-7) and Alamandine: Similarities and differences.
Angiotensin II induces CD62L shedding in human neutrophils.
Angiotensin II induces DNA damage in the kidney.
Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice.
Artificial cold air increases the cardiovascular risks in spontaneously hypertensive rats.
Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.
Association of Renin and Aldosterone With Ethnicity and Blood Pressure: The Multi-Ethnic Study of Atherosclerosis.
Atherosclerosis and arterial blood pressure in mice.
Atherosclerotic Renal Artery Stenosis.
Can renin inhibition by Aliskiren prove itself in atherosclerosis prevention?
Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice.
Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.
DD Genotype of the angiotensin - converting enzyme gene and stroke in Slovenian population.
DD genotype of the angiotensin-converting enzyme gene and stroke in Slovenian population.
Deoxycorticosterone acetate salt hypertension in apolipoprotein E-/- mice results in accelerated atherosclerosis: the role of angiotensin II.
Differential effects of dietary sodium intake on blood pressure and atherosclerosis in hypercholesterolemic mice.
Direct renin inhibition with aliskiren improves ischemia-induced neovascularization: blood pressure-independent effect.
Effects of two forms of hypertension on atherosclerosis in the hyperlipidemic baboon.
Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension.
Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5' leader sequence of the receptor mRNA.
Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury.
Genetic variants of the Renin Angiotensin system: effects on atherosclerosis in experimental models and humans.
Higher plasma prorenin concentration plays a role in the development of coronary artery disease.
Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys.
Inflammation, oxidative stress and renin angiotensin system in atherosclerosis.
Influence of pulsatile perfusion upon renin release from the isolated perfused rat kidney.
Is renin a risk factor?
Is the Renal Resistive Index a Marker for Revascularization in Atherosclerotic Renal Artery Stenosis?
KCNK3 Variants Are Associated With Hyperaldosteronism and Hypertension.
Low-dose calcitriol decreases aortic Renin, blood pressure, and atherosclerosis in apoe-null mice.
Management of coronary artery disease in patients with type 2 diabetes mellitus.
Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data.
Mechanisms of benefit of angiotensin receptor blockers in coronary atherosclerosis.
Mineralocorticoid receptor blockade inhibits accelerated atherosclerosis induced by a low sodium diet in apolipoprotein E-deficient mice.
Multilocus analysis in candidate genes ACE, AGT, and AGTR1 and predisposition to peripheral arterial disease: Role of ACE D/-240T haplotype.
Pharmacological basis of different targets for the treatment of atherosclerosis.
Plasma renin responses to mental stress and carotid intima-media thickness in black Africans: the SABPA study.
Prevention of atherosclerosis by interference with the vascular nitric oxide system.
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
Relation of Plasma Renin Activity to Subclinical Peripheral and Coronary Artery Disease (from the Multiethnic Study of Atherosclerosis).
Renin and prorenin activate pathways implicated in organ damage in human mesangial cells independent of angiotensin II production.
Renin angiotensin system and ASCVD.
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
Renin as a risk factor for atherogenesis. Effects of hypercholesterolemia and two-kidney--one-clip hypertension in the rabbit.
Renin as a risk factor for atherogenesis. Part 2. Effects of hypercholesterolemia and hyporeninemia in the rabbit.
Renin as a risk factor for atherogenesis. Part 3. Effects of hypercholesterolemia, hyporeninemia and one-kidney-one clip hypertension in the rabbit.
Renin inhibition and atherosclerosis.
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.
Renin inhibition with aliskiren lowers circulating endothelial progenitor cells in patients with early atherosclerosis.
Renin-sensitive microRNAs correlate with atherosclerosis plaque progression.
Secondary hypertension. An overview of its causes and management.
Symposium on hypertension: part III. Sodium and potassium, catecholamines, renin and adrenal steroids as causal factors. Hypertension and atherosclerosis. Clonidine treatment and the renin axis.
The anti-ageing hormone klotho induces Nrf2-mediated antioxidant defences in human aortic smooth muscle cells.
The associations of adipokines with selected markers of the renin-angiotensinogen-aldosterone system: the multi-ethnic study of atherosclerosis.
The effects of vitamin d on gentamicin-induced acute kidney injury in experimental rat model.
The physiology and pathophysiology of the nitric oxide/superoxide system.
The potential role of the angiotensin subtype 2 receptor in cardiovascular protection.
The relationship between osteopontin and adiponectin in patients with essential hypertension.
The renin angiotensin system as a risk factor for coronary artery disease.
The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice.
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies.
The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013?
The shift in the "paradigm" of the pharmacology of hypertension.
Two Amino Acids Proximate to the Renin Cleavage Site of Human Angiotensinogen Do Not Affect Blood Pressure and Atherosclerosis in Mice-Brief Report.
Vascular wall ACE is not required for atherogenesis in ApoE(-/-) mice.
Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice.
Vitamin D receptor signaling inhibits atherosclerosis in mice.
[Genes in rennin-angiotensin system]
[Inflammation and atherosclerosis: the role of Renin-Angiotensin system and its inhibition].
[Pathophysiology and laboratory examinations of essential hypertension--a review of recent topics]
[Renin content in kidneys of men after death caused by hypertensive disease and in rabbits with experimental hypertension induced by coarctation and with cholesterin-induced atherosclerosis.]
Atrial Fibrillation
Aldosterone to Renin Ratio as a Screening Instrument for Primary Aldosteronism in a Middle-Aged Population with Atrial Fibrillation.
Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.
Atrial fibrillation and arterial hypertension: A common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role.
Clinical trials, the renin angiotensin system and atrial fibrillation.
Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation.
Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.
Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility.
Long-term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization-activated cyclic nucleotide gated channel overexpression.
Oral direct renin inhibitor aliskiren reduces in vivo oxidative stress and serum matrix metalloproteinase-2 levels in patients with permanent atrial fibrillation.
Plasma markers of myocardial inflammation at isolated atrial fibrillation.
Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types.
Relationship Between 25-Hydroxyvitamin D, Renin, and Collagen Remodeling Biomarkers in Atrial Fibrillation.
Relationship between biological variation in B-type natriuretic Peptide and plasma Renin concentration in stable outpatients with dilated cardiomyopathy.
Renin Angiotenin Blocker Pre-treatment and Recurrence After Pulmonary Vein Isolation in Patients with Paroxysmal and Persistent Atrial Fibrillation.
Role of lipid lowering therapy and renin angiotensin blockade in outcomes of patients with atrial fibrillation.
The role of renin angiotensin system blockade in the treatment of atrial fibrillation.
The Role Of Renin Angiotensin System In Atrial Fibrillation.
The role of the renin angiotensin system blocking in the management of atrial fibrillation.
[Analysis of morpho-functional parameters of the heart and polymorphisms of Renin-Angiotensin-aldosterone system genes in patients with different variants of the course of hypertrophic cardiomyopathy]
Atrioventricular Block
Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AV block dog.
Atypical Hemolytic Uremic Syndrome
Aliskiren as an adjunct therapy for atypical hemolytic uremic syndrome.
Autoimmune Diseases
AAV8-Mediated Angiotensin-Converting Enzyme 2 Gene Delivery Prevents Experimental Autoimmune Uveitis by Regulating MAPK, NF-?B and STAT3 Pathways.
Active immunization against renin in normotensive marmoset.
Angiotensin vaccination: what is the prospect of success?
Immunological approach to blockade of the renin-substrate reaction.
Vaccination against high blood pressure.
Vaccination: a novel strategy for inhibiting the renin-angiotensin-aldosterone system.
Autonomic Dysreflexia
Effect of autonomic hyperreflexia on plasma renin.
The determination of vasoactive substances during autonomic dysreflexia.
Avitaminosis
The premenstrual syndrome.
Azotemia
Aspirin injection test to predict angioplasty outcome in unilateral renovascular hypertension: preliminary report.
Development of malignant hypertension in patients with uremia under hemodialysis: a case report and discussions on its etiology.
Indomethacin-induced azotaemia and hyperkalaemia: a case study.
Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate.
Renin, aldosterone and other mineralocorticoids in hyperkalemic patients with chronic renal failure showing mild azotemia.
The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
Thrombotic thrombocytopenic purpura in a patient with rapidly progressive scleroderma.
Treatment of Ascites.
Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;.
Bacterial Infections
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.
Bacteriuria
Tubular proteinuria in reflux nephropathy: post ureteric re-implantation.
Bartter Syndrome
A case of Bartter's syndrome with abnormal renin response to salt load.
A patient with cystinosis presenting transient features of Bartter syndrome.
A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5.
A syndrome resembling Bartter's syndrome in sarcoidosis.
Acquired Bartter-Like Phenotype.
Activation and function of prorenin: different viewpoints.
Aldosterone and other mineralocorticoids in Bartter's syndrome.
Altering angiotensin levels by administration of captopril or indomethacin, or by angiotensin infusion, contributes to an understanding of atrial natriuretic peptide regulation in man.
An infant with poor weight gain and hypochloremic metabolic alkalosis: a case report.
Analysis of claudin genes in pediatric patients with Bartter's syndrome.
Anesthetic management of a patient with Bartter's syndrome undergoing orthognathic surgery.
Anesthetic management of a patient with Bartter's syndrome.
Anorexia nervosa, laxative abuse, hypopotassemia and distal renal tubular acidosis.
Antenatal Bartter Syndrome: A Case Report.
Association of Bartter's syndrome and empty sella.
Bartter syndrome. Typical facies and normal plasma volume.
Bartter's syndrome and captopril scintigraphy: a case report.
Bartter's syndrome in Arabic children: review of 13 cases.
Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
Bartter's syndrome with gouty arthritis.
Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin.
Bartter's syndrome. Study of a 52 year old man with evidence for a defect in proximal tubular sodium reabsorption and comments on therapy.
Bartter's syndrome: an overview.
Bartter's syndrome: renal scintigraphic appearance after captopril administration.
Biochemical examination of mother's urine is useful for prenatal diagnosis of Bartter syndrome.
Channelopathies of inwardly rectifying potassium channels.
Cystinosis presenting with findings of bartter syndrome.
Dynamic changes in plasma inactive renin levels in Bartter's syndrome after administration of captopril and angiotensin II.
Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors.
Expanding the spectrum of genetic mutations in antenatal Bartter syndrome type II.
High level of plasma inactive renin in Bartter's syndrome.
Human renin granules: ultrastructural aspects.
Hypertension and the interrelated renal circulatory effects of prostaglandins and the renin-angiotensin system.
Idiopathic carpotarsal osteolysis with Bartter's syndrome. A case report and review of the literature.
Inactive renin and aldosterone in Bartter's syndrome.
Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies.
Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome.
Kallikrein, kininogen and kinins in control of blood pressure.
Long-term follow-up of patients with Bartter syndrome type I and II.
Neonatal Bartter syndrome.
Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
Plasma "prorenin"-renin in Bartter's syndrome, cystic fibrosis, and chloride deficiency, and the effect of prostaglandin synthetase inhibition.
Plasma renin in Bartter's syndrome: response of depression of stimuli for renin release.
Prenatal diagnosis of Bartter syndrome.
Renal prostaglandins in the control of renin.
Role of prostaglandins in the pathogenesis of Bartter's syndrome.
Self-induced vomiting presenting as Bartter's syndrome.
Successful utilization of aliskiren, a direct renin inhibitor in Bartter syndrome.
The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
The effect of methyldopa on plasma renin activity in a child with Bartter's syndrome.
The intrarenal renin-angiotensin system.
The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
Two neonates with Bartter syndrome.
Two novel homozygous missense mutations identified in the BSND gene in Moroccan patients with Bartter's syndrome.
Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome.
Variant of Bartter's syndrome with a distal tubular rather than loop of Henle defect.
[A patients with chronic renal failure due to Bartter's syndrome]
[Bartter syndrome: a new therapeutic approach].
[Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)]
[Chronization by indomethacin of the circadian rhythm of blood renin and aldosterone in a case of Bartter's syndrome]
[Clinical findings, pathogenesis and treatment of Bartter's syndrome (author's transl)]
[Elevated atrial natriuretic peptide (ANP) levels and normotension in Bartter's syndrome in childhood]
[Hypokalemia in the course of a Bartter syndrome]
[Increased renal prostaglandin E2 secretion in Bartter's syndrome]
[On the delimitation of Bartter's syndrome. A case of angiotensin-resistant vessels, increased plasma renin, increased aldosterone secretion and anovulatory menstrual cycle]
[Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)]
[Renin gene analysis of familial Bartter's syndrome]
[The Bartter-like syndrome in 2 twins]
[The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)]
beta-Thalassemia
A syndrome of post-transfusion hypertension, convulsion and cerebral hemorrhage in beta-thalassemia Hb E disease: a case report with high plasma renin activity.
Plasma renin activity in patients with beta-thalassemia hemoglobin E.
Biliary Atresia
Perioperative plasma concentrations of endothelin and natriuretic peptides in children undergoing living-related liver transplantation.
Blindness
Abnormalities of vascular wall sodium content in dogs with benign and malignant renal hypertension.
Bone Diseases
Immune-related potassium-losing interstitial nephritis: a comparison with distal renal tubular acidosis.
The skeletal renin-angiotensin system: A potential therapeutic target for the treatment of osteoarticular diseases.
Bone Diseases, Developmental
Nicotine exposure during pregnancy programs osteopenia in male offspring rats via ?4?2-nAChR-p300-ACE pathway.
Bone Resorption
Activation of Renin-Angiotensin System Induces Osteoporosis Independently of Hypertension.
Brachydactyly
Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man.
Bradycardia
A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig.
Alteration of cardiovascular, neurogenic, and humoral responses to acute hypovolemic hypotension by administered prostacyclin.
Autonomic control in rats with overactivity of tissue renin-angiotensin or kallikrein-kinin system.
Cerebrospinal fluid angiotensin II immunoreactivity is not derived from the plasma.
Effects of propranolol in chronic two-kidney Goldblatt hypertension in rats.
Hemodynamic and renin responses to (+-)-DOI, a selective 5-HT2 receptor agonist, in conscious rats.
Hyperpotassemia and bradycardia in a bedridden elderly woman with selective hypoaldosteronism associated with low renin activity.
Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol.
Plasma atrial natriuretic factor in low output heart failure syndromes.
Plasma vasopressin in blood pressure homeostasis and in experimental renal hypertension.
Possible mechanisms of cardiac contractile dysfunction and electrical changes in ammonium chloride induced chronic metabolic acidosis in Wistar rats.
Review of therapeutic modalities acting directly via central pathways.
Severe hypotension with bradycardia during renin inhibition with H142 in sodium deplete man.
Studies concerning the mechanism of suppression of renin secretion by clonidine.
The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart.
The mechanism of hypertension and bradycardia following lesions of the caudal ventrolateral medulla in the rabbit: the role of sympathetic nerves, circulating adrenaline, vasopressin and renin.
[Atrial natriuretic factor in cardiogenic shock, in hypovolemic shock and in the bradycardia-hypotension syndrome following acute myocardial infarction]
Brain Death
[Hormone evaluation in brain death]
Brain Diseases
A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II).
An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
Angiotensin receptor blockers for bipolar disorder.
Plasma renin activity during the development of paracetamol (acetaminophen) induced acute renal failure in man.
Posterior reversible encephalopathy syndrome (PRES) in mesenteric leiomyosarcoma: A case report.
The effects of hormones of the hypothalamo-hypophyseal-adrenal, renin-angiotensin, and thyroid hormone systems on the formation of dyscirculatory encephalopathy.
[A clinical analysis of reninoma-induced hypertensive crisis associated with reversible posterior encephalopathy syndrome].
[An aged case of orthostatic hypotension possibly due to parasympathetic neurodysfunction]
[The influence of the hormones of hypothalamo-pituitary-adrenal, renin-angiotensin, and thyroid hormonal systems on formation of vascular encephalopathy]
Brain Infarction
Association of plasma renin activity and echocardiographic left ventricular hypertrophy with frequency of new coronary events and new atherothrombotic brain infarction in older persons with systemic hypertension.
Brain Injuries, Traumatic
Manifestation of renin angiotensin system modulation in traumatic brain injury.
Brain Ischemia
Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes.
Protective Effect of Aliskiren in Experimental Ischemic Stroke: Up-Regulated p-PI3K, p-AKT, Bcl-2 Expression, Attenuated Bax Expression.
[Brain and kidney renin-angiotensin system in rats with simultaneously induced cerebral and renal ischemia]
Brain Neoplasms
[Effect of thiopental anesthesia on plasma renin, adrenaline and noradrenaline in neurosurgical operations with induced hypotension]
Breast Neoplasms
Aspartic peptidase inhibitors: implications in drug development.
Calcitriol derivatives with two different side chains at C-20 III. An epimeric pair of the gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition.
Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer.
RAS polymorphisms in cancerous and benign breast tissue.
Renin angiotensin system-regulating aminopeptidase activities in serum of pre- and postmenopausal women with breast cancer.
The role of insulin and renin in the pathogenesis of hormone-dependent neoplasias. b). Renin.
Bronchitis, Chronic
[RAAS changes due to dysfunction of pulmonary ventilation]
Carcinogenesis
A Rat Model to Study the Effects of Diet-Induced Obesity on Radiation-Induced Mammary Carcinogenesis.
Calcitriol derivatives with two different side chains at C-20 III. An epimeric pair of the gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition.
Chromosome 8 alterations accompany tumorigenesis in renin-SV40 T antigen transgenic mice.
Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma.
Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression.
Cyclic mechanical distension regulates renin gene transcription in As4.1 cells.
Differential expression of the murine and rat renin genes in peripheral subcutaneous tissue.
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.
Role of proximal promoter elements in regulation of renin gene transcription.
The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers.
The renin-angiotensin system mediates EGF receptor-vitamin d receptor cross-talk in colitis-associated colon cancer.
Carcinoid Tumor
Clinical syndromes associated with tumors of the female genital tract.
Excessive muscle paralysis due to pulmonary carcinoid -a case report.
Carcinoma
A case of renin-producing adrenocortical cancer.
A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
Aminoglutethimide: review of pharmacology and clinical use.
AT1 receptor and ACE mRNA are increased in chemically induced carcinoma of rat mammary gland.
Characterization of inactive renin ("prorenin") from renin-secreting tumors of nonrenal origin. Similarity to inactive renin from kidney and normal plasma.
Circulating vascular endothelial growth factor and active renin concentrations and prostaglandin E2 urinary excretion in patients with adrenal tumours.
Dissection of silencer elements in first intron controlling the human renin gene.
Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol.
Ectopic production of renin by ileal carcinoma.
Endogenous human renin expression and promoter activity in CALU-6, a pulmonary carcinoma cell line.
High plasma renin activity in an oat cell carcinoma: a renin-secreting carcinoma?
Hyperplasia of juxtaglomerular cells and renomedullary interstitial cells after renal arterial embolization in patients with renal cell carcinoma.
Immunocytochemistry of renin in renal tumours.
Immunohistochemical expression of renin is a prognostic factor for recurrence in nonmetastatic renal cell carcinoma.
Juxtaglomerular Cell Tumor of the Kidney: Case Report and Differential Diagnosis With Emphasis on Pathologic and Cytopathologic Features.
Localisation of renin-angiotensin system (RAS) components in breast.
Malignant hypertension due to a renin-secreting renal cell carcinoma--an ultrastructural and immunocytochemical study.
Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Rat renin promoter activity in cultured cells and transgenic mice.
Renin and inactive renin (prorenin) in the plasma of patients with malignant renal tumours.
Renin expression in adult renal epithelial tumors with granular cells.
Renin gene expression in the adrenal and kidney of patients with primary aldosteronism.
Renin in blood vessels in human pulmonary tumors. An immunohistochemical and biochemical study.
Renin in renal cell carcinoma--an immunocytochemical study using an antibody to pure human renin.
Renin producing neuroendocrine pancreatic carcinoma--a case report and review of the literature.
Renin-secreting clear cell carcinoma of the kidney.
Transcriptional and posttranscriptional mechanisms regulate human renin gene expression in Calu-6 cells.
[Arterial hypertension: adenocarcinoma of the kidney or bilateral renal artery stenosis$]
[Carcinoma of the kidney with production of renin. A special form of hypertension]
[Detection of renin in chromophobe renal cell carcinomas]
[The contribution of radio-isotopes to urological investigation (author's transl)]
Carcinoma, Ductal
Transcription of the prorenin gene in normal and diseased breast.
Carcinoma, Hepatocellular
Angiotensinogen-producing hepatocellular carcinoma.
Arterial hypertension as a paraneoplastic phenomenon in hepatocellular carcinoma.
Characterization of precursor and secreted forms of rat angiotensinogen.
Cloning and sequence analysis of cDNA for human cathepsin D.
Elevated Renin levels in patients with liver cirrhosis and hepatocellular carcinoma.
In vitro evidence for an intracellular site of angiotensin action.
Species-specific expression of the hepatic renin gene.
[A case of hepatocellular carcinoma probably producing renin]
Carcinoma, Intraductal, Noninfiltrating
Transcription of the prorenin gene in normal and diseased breast.
Carcinoma, Renal Cell
A renal carcinoma secreting inactive renin.
An ultrastructural and immunocytochemical study of a renal carcinoma secreting inactive renin.
Hormones in renal cancer.
Hypernephroma and hypertension. Two case reports.
Hyperplasia of juxtaglomerular cells and renomedullary interstitial cells after renal arterial embolization in patients with renal cell carcinoma.
Immunocytochemistry of renin in renal tumours.
Immunohistochemical expression of renin is a prognostic factor for recurrence in nonmetastatic renal cell carcinoma.
Immunohistochemical localization of renin in renal tumors.
Juxtaglomerular Cell Tumor of the Kidney: Case Report and Differential Diagnosis With Emphasis on Pathologic and Cytopathologic Features.
KRT6 interacting with notch1 contributes to progression of renal cell carcinoma, and aliskiren inhibits renal carcinoma cell lines proliferation in vitro.
Malignant hypertension due to a renin-secreting renal cell carcinoma--an ultrastructural and immunocytochemical study.
Plasma endothelin-1 level in patients with renovascular hypertension - does the kidney with stenosis of the renal artery upregulate production of endthelin-1?
Renin and inactive renin (prorenin) in the plasma of patients with malignant renal tumours.
Renin expression in adult renal epithelial tumors with granular cells.
Renin gene expression in the adrenal and kidney of patients with primary aldosteronism.
Renin in renal cell carcinoma--an immunocytochemical study using an antibody to pure human renin.
Renin-producing Tumour in the Kidney of a Cat.
[Arterial hypertension: adenocarcinoma of the kidney or bilateral renal artery stenosis$]
[Detection of renin in chromophobe renal cell carcinomas]
[Renal adenocarcinoma with secretion of renin, simulating a oncocytoma. Apropos of a case in a pregnant woman with histological and immunohistochemical study]
Carcinoma, Small Cell
High plasma renin activity in an oat cell carcinoma: a renin-secreting carcinoma?
Cardiac Output, High
Hemodynamic and cardiac adaptation in essential hypertension. Consequences for therapy.
[The heart in systolic hypertension]
Cardiac Output, Low
Cardiovascular actions of atrial natriuretic factor in sheep with cardiac failure.
Circulatory and renal control by prostaglandins and renin in low cardiac output in dogs.
Effects of vagal blockade on neurohumoral systems in conscious dogs with heart failure.
Hemodynamic and cardiac adaptation in essential hypertension. Consequences for therapy.
Influence of dobutamine and dopamine on hemodynamics and plasma concentrations of noradrenaline and renin in patients with low cardiac output following acute myocardial infarction.
Pathophysiologic mechanisms in essential hypertension: a clue to the therapeutic approach.
Relationship between renin activity and aldosterone release in the patients with low cardiac output syndrome after open cardiac surgery.
Cardiac Tamponade
Atrial pressure and hormonal and renal responses to acute cardiac tamponade.
Effect of cardiac tamponade on plasma concentrations of atrial natriuretic peptide (ANP) in calves.
Total peripheral resistance during cardiac tamponade: adrenergic and angiotensin roles.
Cardio-Renal Syndrome
Kidney Response to Chemotherapy-Induced Heart Failure: mRNA Analysis in Normotensive and Ren-2 Transgenic Hypertensive Rats.
Neurohumoral interactions contributing to renal vasoconstriction and decreased renal blood flow in heart failure.
Renal dysfunction and heart failure.
Cardiomegaly
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.
2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury.
A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
A simplified technique for the production of heart failure in the dog by rapid ventricular pacing.
Adaptive and genetic alterations of the renin angiotensin system in cardiac hypertrophy and failure.
Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats.
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males.
Aliskiren attenuates myocardial apoptosis and oxidative stress in chronic murine model of cardiomyopathy.
Alteration of intracellular Ca2(+)-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats.
Alterations of angiotensin II receptor contents in hypertrophied hearts.
Altered tension cost in (TG(mREN-2)27) rats overexpressing the mouse renin gene.
Angiotensin II stimulates alpha-skeletal actin expression in cadiomyocytes in vitro and in vivo in the absence of hypertension.
Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension.
Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats.
Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy.
Blood pressure-independent effects in rats with human renin and angiotensinogen genes.
Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27.
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene.
Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems.
Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats.
Chronic beta-adrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin.
Chronic dietary administration of tryptophan prevents the development of deoxycorticosterone acetate salt induced hypertension in rats.
Chronic low-dose treatment with enalapril induced cardiac regression of left ventricular hypertrophy.
Chronic Overexpression of Bradykinin in Kidney Causes Polyuria and Cardiac Hypertrophy.
Control of circulation by arterial baroreceptors and cardiopulmonary receptors in hypertension.
Converting enzyme inhibitors differentially affect expression of genes of the renin-angiotensin system.
Development of a novel murine heart failure model overexpressing human renin and angiotensinogen.
Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats.
Different effects of antihypertensive agents on cardiac and vascular hypertrophy in the transgenic rat line TGR(mRen2)27.
Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure-prone SHHF/Mcc- fa cp rats.
Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.
Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction.
Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat.
Functional significance of prorenin internalization in the rat heart.
Genetic variants of proteins from the renin angiotensin system are associated with pressure load cardiac hypertrophy.
Implications of local angiotensin production in cardiovascular physiology and pharmacology.
Influence of enalapril on established pressure-overload cardiac hypertrophy in low and normal renin states in female rats.
Inhibitory effects of a subdepressor dose of L-158,809, an angiotensin II type 1 receptor antagonist, on cardiac hypertrophy and nephropathy via the activated human renin-angiotensin system in double transgenic mice with hypertension.
Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure.
Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension.
Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy.
Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats.
Mechanism of hyperthyroidism-induced renal hypertrophy in rats.
Mechanisms of blood pressure variability-induced cardiac hypertrophy and dysfunction in mice with impaired baroreflex.
Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy.
Olmesartan inhibits cardiac hypertrophy in mice overexpressing renin independently of blood pressure: its beneficial effects on ACE2/Ang(1-7)/Mas axis and NADPH oxidase expression.
Plasma renin activity and hypertrophy of the right ventricle in hypoxic rats.
Prorenin Contributes to Angiotensin Peptide Formation in Transgenic Rats With Rat Prorenin Expression Targeted to the Liver.
Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II.
Protection of the myocardium against ischemia/reperfusion injury by angiotensin-(1-9) through an AT2R and Akt-dependent mechanism.
Regression of cardiac hypertrophy in the SHR by combined renin-angiotensin system blockade and dietary sodium restriction.
Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension.
Renin angiotensin system and cardiac hypertrophy after sinoaortic denervation in rats.
Renin inhibition mitigates anti-angiogenesis in spontaneously hypertensive rats.
Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
Renin-angiotensin system stimulates cardiac and renal disorders in Tsukuba hypertensive mice.
Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.
Role of nisoldipine on blood pressure, cardiac hypertrophy, and atrial natriuretic peptides in spontaneously hypertensive rats.
Role of sex, gonadectomy and sex hormones in the development of nitric oxide inhibition-induced hypertension.
Role of the renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in transgenic hypertensive mice carrying both human renin and angiotensinogen genes.
Significant role of the increase in renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in double transgenic tsukuba hypertensive mice carrying both human renin and angiotensinogen genes.
TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model.
TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
The production of vascular lesions and cardiac hypertrophy by infusions of renin and noradrenaline in the rabbit.
The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload.
Tissue-localized angiotensin II enhances cardiac and renal disorders in Tsukuba hypertensive mice.
Two polymorphisms in the Cx40 promoter are associated with hypertension and left ventricular hypertrophy preferentially in men.
Vitamin D and human health: lessons from vitamin D receptor null mice.
Vitamin D resistance.
Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.
[Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure]
[Neurohumoral factors in hypertensive patients with and without left ventricular hypertrophy]
[Synthesis of renin and angiotensin-converting enzyme in human heart]
[The heart in systolic hypertension]
Cardiomyopathies
Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and angiotensin-converting enzyme inhibitor.
Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes.
Ischemic versus idiopathic cardiomyopathy: differing neurohumoral profiles despite comparable peak oxygen uptake.
Neuroendocrine response to standing and mild exercise in patients with untreated severe congestive heart failure and chronic constrictive pericarditis.
Purification and characterization of human kidney renin.
Rodent models of cardiopulmonary disease: their potential applicability in studies of air pollutant susceptibility.
Thalamic hemorrhage in a 4-year-old child induced by nephro-vascular hypertension.
The role of Renin Angiotensin system intervention in stage B heart failure.
Cardiomyopathy, Alcoholic
Alcohol puts the heart under pressure: Acetaldehyde activates a localized renin angiotensin aldosterone system within the myocardium in alcoholic cardiomyopathy.
Cardiomyopathy, Dilated
Activation of the renin-angiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy.
Aliskiren Improves Left Ventricular Dysfunction and Reduces Cardiac Dilation in Syrian Cardiomyopathic Hamsters.
Aortic input impedence and neurohormonal activation in patients with mild to moderate chronic congestive heart failure.
Cardiac peptides and plasma renin activity in acute dilated cardiomyopathy.
Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy.
Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32.
Normalizing Plasma Renin Activity in Experimental Dilated Cardiomyopathy: Effects on Edema, Cachexia, and Survival.
Relationship between biological variation in B-type natriuretic Peptide and plasma Renin concentration in stable outpatients with dilated cardiomyopathy.
The influence of various degrees of cardiac failure, chronic medical treatment, and acute additional enoximone application on the parameters of the vasopressor system.
Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
[Influence of cardiac structure, blood flow velocity and heart function on circulating atrial natriuretic peptide and renin-angiotension system]
[Plasma renin activity and aldosterone concentration of patients with congestive cardiomyopathy]
Cardiomyopathy, Hypertrophic
INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy-a Randomised Intervention Trial with losartan).
Cardiotoxicity
Assessment of Pregabalin-Induced Cardiotoxicity in Rats: Mechanistic Role of Angiotensin 1-7.
Protection against tacrolimus-induced cardiotoxicity in rats by olmesartan and aliskiren.
Protective effect of a direct renin inhibitor in acute murine model of cardiotoxicity and nephrotoxicity.
The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity.
Cardiovascular Abnormalities
Chemical Communication between Heart Cells is Disrupted by Intracellular Renin and Angiotensin II: Implications for Heart Development and Disease.
Defective glomerular beta-adrenergic signal transmission in spontaneously diabetic rats.
Neuroinflammation and sympathetic overactivity: Mechanisms and implications in hypertension.
Variability of arterial blood pressure and classification of essential hypertension by multivariate statistical analysis.
Cardiovascular Diseases
(Pro)renin Receptor RNAi Silencing Attenuates Diabetic Cardiomyopathy Pathological Process in Rats.
80-year-old men have elevated plasma concentrations of catecholamines but decreased plasma renin activity and aldosterone as compared to young men.
A functional variant of the NEDD4L gene is associated with beneficial treatment response with ?-blockers and diuretics in hypertensive patients.
A population study of plasma neuropeptide Y: correlations with components of the metabolic syndrome.
A-type K(+) channels contribute to the prorenin increase of firing activity in hypothalamic vasopressin neurosecretory neurons.
Adaptive and genetic alterations of the renin angiotensin system in cardiac hypertrophy and failure.
Advantages of renin-angiotensin system blockade in the treatment of cardiovascular diseases.
AGT rs699 and AGTR1 rs5186 gene variants are associated with cardiovascular-related phenotypes in atherosclerotic peripheral arterial obstructive disease.
Aldosterone, Renin, Cardiovascular Events, and All-Cause Mortality Among African Americans: The Jackson Heart Study.
Aliskiren effect on plaque progression in established atherosclerosis using high resolution 3D MRI (ALPINE): a double-blind placebo-controlled trial.
Aliskiren: the first renin inhibitor for clinical treatment.
An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
An integrated physiology-based model for the interaction of RAA system biomarkers with drugs.
Analysis of homozygosity disequilibrium using whole-genome sequencing data.
Angiotensin (1-7) and other angiotensin peptide.
Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.
Angiotensin converting enzyme gene, smoking and mortality in a population-based study.
Angiotensin II type 1 receptor induced signal-transduction pathways as new targets for pharmacological treatment of the renin-angiotensin system.
Application of 3D QSAR CoMFA/CoMSIA and in silico docking studies on novel renin inhibitors against cardiovascular diseases.
Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes.
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease.
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.
AT1-receptor blockade: Protective effects of irbesartan in cardiomyocytes under hypoxic stress.
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
Cardiovascular and Hematological Medicine in 2013 - Advances and Insights.
Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection?
Cardiovascular disease: Plasma renin and cardiovascular outcome.
Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II.
Clinical pharmacokinetics and pharmacodynamics of aliskiren.
Combination of Statin plus Renin Angiotensin System Inhibition for the Prevention or the Treatment of Atherosclerotic Cardiovascular Disease.
Complex pathologies of angiotensin II-induced abdominal aortic aneurysms.
Concomitant diseases in elderly hypertensives: the position of nicardipine.
Control of vascular tone by renin and angiotensin in cardiovascular disease.
Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population.
Creation and characterization of a renin knockout rat.
Current status of dual Renin Angiotensin aldosterone system blockade for the treatment of cardiovascular diseases.
Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules.
Decreased levels of circulating CD34(+) cells are associated with coronary heart disease in Japanese patients with type 2 diabetes.
Deep neural network modeling based virtual screening and prediction of potential inhibitors for renin protein.
DETERMINATION OF RENIN AS A DIAGNOSTIC METHOD OF CARDIOVASCULAR DISEASE.
Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.
Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis.
Effect of blockade of nitric oxide in heart tissue levels of Renin Angiotensin System components in acute experimental Chagas disease.
Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
Effects of aerobic exercise training on cardiac renin-angiotensin system in an obese Zucker rat strain.
Elevated albumin excretion in nonmodulating essential hypertensive patients.
Emerging markers in cardiovascular disease: where does ACE fit in?
Enduring direct association of baseline plasma renin activity with all-cause and cardiovascular mortality in hypertensive patients.
Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5' leader sequence of the receptor mRNA.
Evaluation of a potent inhibitor of subprimate and primate renins.
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.
First orally active DRI Aliskiren--a new prospect in management of hypertension and beyond.
Hemodynamic effects of inhibitors of the renin-angiotensin system.
Higher plasma renin activity is a risk factor for total mortality in older Japanese individuals: the Takahata study.
Hormonal effects of smoking--I: Effects on plasma renin activity.
Impact of smoking history on the association between Eicosapentaenoic acid to arachidonic acid ratio and acute coronary syndrome: A multicenter cross-sectional study.
Influence of Renin Angiotensin System Gene Polymorphisms on Visit-to-Visit Blood Pressure Variability in Hypertensive Patients.
Inhibition of renin and the (pro)renin receptor system.
Intracellular angiotensin II as a regulator of muscle tone in vascular resistance vessels. Pathophysiological implications.
Investigating the beneficial effect of aliskiren in attenuating neuropathic pain in diabetic Sprague-Dawley rats.
Local Renin Angiotensin Aldosterone Systems and Cardiovascular Diseases.
Local renin-angiotensin systems: the unanswered questions.
Mast cells activate the renin angiotensin system and contribute to migraine: a hypothesis.
Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale Proteomics.
Methods in the evaluation of cardiovascular Renin Angiotensin aldosterone activation and oxidative stress.
Molecular genetic approach to the pathophysiology of cardiovascular disease.
Multifunctional cationic Peptide fractions from flaxseed protein hydrolysates.
New approaches in the study of cardiovascular disease: aldosterone, renin, hypertension and juxtaglomerular cells.
Novel approach to cardiovascular diseases: a promising probability of (pro)renin receptor [(P)RR].
Obstructive sleep apnea and aldosterone.
Plasma renin activity and cardiovascular disease.
Plasma renin activity has a complex prognostic role in patients with acute coronary syndromes.
Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study.
Plasma renin and the incidence of cardiovascular disease.
Plasma renin responses to mental stress and carotid intima-media thickness in black Africans: the SABPA study.
Postnatal early overfeeding induces cardiovascular dysfunction by oxidative stress in adult male Wistar rats.
Potential of RAS Inhibition to Improve Metabolic Bone Disorders.
Potential of renin inhibition in cardiovascular disease.
Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
Prolonged Subcutaneous Administration of Oxytocin Accelerates Angiotensin II-Induced Hypertension and Renal Damage in Male Rats.
Prorenin and active renin levels in paediatrics: a bioanalytical review.
RAAS Inhibition/Blockade in patients with Cardiovascular disease : Implications of recent large scale randomized trials for clinical practice.
Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis and coronary heart disease.
Renin and cardiovascular disease: Worn-out path, or new direction.
Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.
Renin angiotensin system and gender differences in dopaminergic degeneration.
Renin as a biomarker of cardiovascular disease in clinical practice.
Renin inhibition.
Renin inhibition: a novel therapy for cardiovascular disease.
Renin inhibitors: cardiovascular drugs of the future?
Renin-angiotensin system gene polymorphisms and left ventricular hypertrophy. The case against an association.
Renin-angiotensin-aldosterone blockade for cardiovascular disease prevention.
Renin-sensitive microRNAs correlate with atherosclerosis plaque progression.
Results of the ONTARGET and TRANSCEND studies: an update and discussion.
Salt restriction leads to activation of adult renal mesenchymal stromal cell-like cells via prostaglandin E2 and E-prostanoid receptor 4.
SARS-CoV-2 associated COVID-19 in geriatric population: A brief narrative review.
Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19.
Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage.
Some physiological outcomes of renin gene studies.
Structure-based design of aliskiren, a novel orally effective renin inhibitor.
Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.
Suppression of murine autoimmune myocarditis achieved with direct renin inhibition.
The angiotensin II type 2 receptor for pain control.
The association of plasma prorenin level with an oxidative stress marker, 8-OHdG, in nondiabetic hemodialysis patients.
The associations of adipokines with selected markers of the renin-angiotensinogen-aldosterone system: the multi-ethnic study of atherosclerosis.
The clinical potential of renin inhibitors and angiotensin antagonists.
The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?
The critical role of the central nervous system (pro)renin receptor in regulating systemic blood pressure.
The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease.
The development of the direct renin inhibitor aliskiren: treating hypertension and beyond.
The effects of direct renin inhibitor, aliskiren, on arterial hypertension, chronic kidney disease and cardiovascular disease: optimal pharmacotherapy.
The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats.
The evolution of angiotensin blockade in the management of cardiovascular disease.
The potential advantages of a modern antihypertensive therapy in the elderly.
The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases.
The Renin Angiotensin System and Bipolar Disorder: A Systematic Review.
The renin angiotensin system and cardiovascular disease: hope or hype?
The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction.
The renin inhibitor aliskiren as novel treatment for cardiovascular disease.
The Renin-Angiotensin-Aldosterone System in Smokers and Non-Smokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
The Salutary Influence of Forest Bathing on Elderly Patients with Chronic Heart Failure.
Therapeutic inhibition of the renin angiotensin aldosterone system.
Tissue angiotensin II system in the human heart.
Urinary sodium excretion and myocardial infarction in hypertensive patients: a prospective cohort study.
Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats.
[An aged case of orthostatic hypotension possibly due to parasympathetic neurodysfunction]
[Direct renin inhibitors in cardiovascular disease management: opportunities and perspectives]
[Effects of ACE2-Ang 1-7-Mas axis on blood vessel]
[Inflammation and atherosclerosis: the role of Renin-Angiotensin system and its inhibition].
[OP.6D.01] ESTRADIOL INCREASES ENDOTHELIAL ANGIOTENSIN-(1-7) PRODUCTION THROUGH ESTROGEN RECEPTOR ALPHA.
[Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure]
[Polymorphism of the renin-angiotensin-aldosterone system: molecular and epidemiogenetic aspects]
[Scientific statement on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19].
[Synthesis of renin and angiotensin-converting enzyme in human heart]
[The effect of the I/D polymorphism of the angiotensin-converting enzyme gene on the cardiovascular risk and graft survival of kidney transplant patients].
Carotid Artery Diseases
Plasma renin level and aldosterone to renin ratio are associated with presence of carotid plaques in patients with stable coronary artery disease.
Renin and aldosterone are not associated with vulnerable plaque characteristics in patients with carotid artery disease.
Vasculometabolic and Inflammatory Effects of Aldosterone in Obesity.
Carotid Stenosis
Association between polymorphisms of the renin angiotensin system and carotid stenosis.
Attenuation of Brain Damage and Cognitive Impairment by Direct Renin Inhibition in Mice With Chronic Cerebral Hypoperfusion.
Elevated plasma renin activity in aortitis syndrome.
[The correlation between the carotid artery plaque and the change of aldosterone level related indexes during captopril challenge test].
Cataract
Aqueous humor renin, angiotensin I, and angiotensin II activity in primary open-angle glaucoma.
Lenticular rubidium uptake and plasma renin activity in weanling cataract-prone salt-sensitive rats.
Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma.
Therapeutic effects of various renin angiotensin modulators on hyperglycemia-induced cataract formation in Sprague Dawley rats.
Therapeutic targets of renin-angiotensin system in ocular disorders.
Central Nervous System Diseases
Renin Angiotensin System in Central Nervous System diseases and its interaction with COVID-19.
Central Serous Chorioretinopathy
The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.
Cerebral Hemorrhage
A case with primary aldosteronism due to unilateral multiple adrenocortical micronodules.
A syndrome of post-transfusion hypertension, convulsion and cerebral hemorrhage in beta-thalassemia Hb E disease: a case report with high plasma renin activity.
Acute cerebral hemorrhage normalized plasma renin activity in a patient with primary aldosteronism.
Cerebral Infarction
Blood pressure and both venous and urinary catecholamines after cerebral infarction.
High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.
Cerebral Palsy
[Hemodynamics, various aspects of aldosterone metabolism and renin activity in children with cerebral palsy]
Cerebral Small Vessel Diseases
Risk factors and progression of small vessel disease-related cerebral abnormalities.
Cerebrovascular Disorders
Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.
Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease.
Pharmaceutical Modulation of the Renin Angiotensin Aldosterone System for Stroke Prevention: A Review of Experimental and Clinical Evidence.
Pharmaceutical modulation of the Renin Angiotensin aldosterone system for stroke prevention: a review of experimental and clinical evidence.
Plasma renin activity and its association with ischemic heart disease, congestive heart failure, and cerebrovascular disease in a large hypertensive cohort.
Plasma renin activity in acute cerebrovascular disease: preliminary communication.
Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
Chagas Disease
Effect of blockade of nitric oxide in heart tissue levels of Renin Angiotensin System components in acute experimental Chagas disease.
Renin production in Chagas' disease.
Charcot-Marie-Tooth Disease
Regional chromosomal assignment of human renin gene to 1q12----qter and use in linkage studies in Charcot-Marie-Tooth disease.
Chemical and Drug Induced Liver Injury
Metabolism of renin activity in three canine models: isolated liver, acute hepatic necrosis and chronic toxic hepatitis.
Renin activity in canine acute hepatic necrosis and chronic toxic hepatitis.
Cholera
Cyclic AMP selectively increases renin mRNA stability in cultured juxtaglomerular granular cells.
Prorenin secretion from villous placenta: regulation by cyclic AMP and angiotensin.
Chorioamnionitis
Elevated concentrations of prorenin and renin in amniotic fluid of women with chorioamnionitis.
Choriocarcinoma
Functional human renin promoter in transfected cells: evidence for cell-specific expression.
The effects of cyclic AMP, sex steroids and global hypomethylation on the expression of genes controlling the activity of the renin-angiotensin system in placental cell lines.
Choroidal Neovascularization
(Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system.
coagulation factor xiia deficiency
Captopril-induced changes on active and inactive renin in a patient with factor XII congenital deficiency.
Colitis
Activation of the Renin-Angiotensin System Promotes Colitis Development.
Ameliorative potential of aliskiren in experimental colitis in mice.
Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.
Renin-angiotensin system promotes colonic inflammation by inducing TH17 activation via JAK2/STAT pathway.
Colitis, Ischemic
Severe hypertension associated with multiple intrarenal microaneurysms in a patient with systemic lupus erythematosus and antiphospholipid antibodies.
Colitis, Ulcerative
Oral rehydration solution normalizes plasma renin and aldosterone levels in patients with ulcerative colitis after proctocolectomy.
Renin-angiotensin system promotes colonic inflammation by inducing TH17 activation via JAK2/STAT pathway.
Colonic Neoplasms
Calcitriol derivatives with two different side chains at C-20 III. An epimeric pair of the gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition.
OS 15-07 ROLE OF (PRO) RENIN RECEPTOR IN THE ACTIVATION OF WNT/ ?-CATENIN PATHWAY IN COLON CANCER.
The renin-angiotensin system mediates EGF receptor-vitamin d receptor cross-talk in colitis-associated colon cancer.
Colorectal Neoplasms
Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.
Multiple roles of angiotensin in colorectal cancer.
Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system.
Confusion
Effects of beta blockade with acebutolol on hypertension, hemodynamics, and fluid volume.
Uniformity and diversity of calcium metabolism in hypertension. A conceptual framework.
Congenital Abnormalities
The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes.
[Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations]
Congenital Hyperinsulinism
Channelopathies of inwardly rectifying potassium channels.
Congenital Hypothyroidism
Angiotensin II (AII) and adrenal gland AII receptors in rats with congenital hypothyroidism.
Connective Tissue Diseases
[Arterial hypertension in patients with systemic connective tissue diseases and hemorrhagic vasculitis]
Corneal Injuries
NorLeu3A(1-7) Accelerates Clear Corneal Full Thickness Wound Healing.
Coronary Artery Disease
Arrhythmogenic Substrates for Atrial Fibrillation in Obesity.
COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system.
Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease.
DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.
Effects of direct Renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus.
Evaluation of the contribution of renin angiotensin system polymorphisms to the risk of coronary artery disease among Tunisians.
Higher plasma prorenin concentration plays a role in the development of coronary artery disease.
Pharmacogenomics of Renin Angiotensin System inhibitors in coronary artery disease.
Plasma renin activity and coronary heart disease: are they related?
Plasma renin level and aldosterone to renin ratio are associated with presence of carotid plaques in patients with stable coronary artery disease.
Polymorphisms of renin-angiotensin system and natriuretic peptide receptor A genes in patients of Greek origin with a history of myocardial infarction.
Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease.
Relation of Plasma Renin Activity to Subclinical Peripheral and Coronary Artery Disease (from the Multiethnic Study of Atherosclerosis).
Renin angiotensin system and ASCVD.
Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials.
Renin-angiotensin system genetic polymorphisms: Lack of association with CRP levels in patients with coronary artery disease.
Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms.
Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium: The Multi-Ethnic Study of Atherosclerosis.
Successful directional atherectomy of eccentric renal artery stenosis using the Simpson directional coronary atherocath as a primary therapy.
The C4280A (rs5705) gene polymorphism of the renin (REN) gene is associated with risk of developing coronary artery disease, but not with restenosis after coronary stenting.
The renin angiotensin system as a risk factor for coronary artery disease.
The Role of Angiotensin Antagonism in Coronary Plaque Regression: Insights from the Glagovian Model.
The sympathetic nervous system: the muse of primary hypertension.
[Pharmacological basis of antihypertensive drug therapy]
[Plasma renin activity in patients with coronary arteriosclerosis with different types of hyperlipoproteinemia]
Coronary Disease
Aldosterone, Renin, Cardiovascular Events, and All-Cause Mortality Among African Americans: The Jackson Heart Study.
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial.
Genes of renin angiotensin system and coronary heart disease.
Personality, coronary-prone behaviour and adrenergic factors in essential hypertension: possible implications for cardiac prevention.
Plasma renin activity and coronary heart disease: are they related?
Plasma renin and the incidence of cardiovascular disease.
Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the 'ACTION' database in patients with angina.
Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering.
Renin angiotensin system and ASCVD.
Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease.
Treatment of hypertension with calcium channel blockers: European data.
[Changes in the catecholamine plasma level 3 months after aortocoronary bypass operation]
[Clinical significance of fibrinolytic system defectiveness in exercise induced myocardial ischemia and its mechanism]
[Hormone profile of the essential hypertension patient with ischemic cardiopathy. I. Renin, angiotensin and aldosterone]
[Several aspects of the pathogenesis of chronic circulatory failure in ischemic heart disease: role of atrial natriuretic peptide]
[Value of determining plasma renin activity in patients with essential arterial hypertension and coronary disease]
Coronary Occlusion
Acute inhibition of renin release during left circumflex coronary occlusion in dogs.
On the mechanism of renin release during experimental myocardial ischaemia.
Renin-angiotensin system inhibition in acute myocardial infarction in dogs. Effects on systemic hemodynamics, myocardial blood flow, segmental myocardial function and infarct size.
The renin-angiotensin system during acute myocardial ischemia in dogs.
Cough
A comparison of the effects of renin inhibition and angiotensin converting enzyme inhibition upon bradykinin potentiation.
Blood pressure lowering efficacy of renin inhibitors for primary hypertension.
Putative mechanisms of cough after treatment with angiotensin converting enzyme inhibitors.
Reproducibility of angiotensin converting enzyme inhibitor induced cough: a double-blind randomised study.
Treatment of systemic hypertension in patients with pulmonary disease: COPD and asthma.
[Comparison with other antihypertensive drugs, especially with ACEI]
COVID-19
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
A PHARMACOLOGICAL FRAMEWORK FOR INTEGRATING TREATING THE HOST, REPURPOSING AND THE DAMAGE RESPONSE FRAMEWORK IN COVID-19.
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.
Cancer progression in COVID-19: integrating the roles of renin angiotensin aldosterone system, angiopoietin-2, heat shock protein-27 and epithelial mesenchymal transition.
Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era.
Case Report: Posterior Reversible Leukoencephalopathy Syndrome (PRES) as a Biologically Predictable Neurological Association in Severe COVID-19. First Reported Case From Australia and Review of Internationally Published Cases.
Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.
Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic.
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers.
Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?
Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients.
COVID-19 - Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack?
COVID-19 and ischemic stroke.
COVID-19 and Renin Angiotensin Aldosterone System: A Pharmacogenomic View.
COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations.
Covid-19 and the Renin Angiotensin System: Implications for the Older Adults.
COVID-19 and the renin, angiotensin, aldosterone system. A complex relationship.
COVID19 and increased mortality in African Americans: socioeconomic differences or does the renin angiotensin system also contribute?
Delineating clinical characteristics and comorbidities among 206 COVID-19 deceased patients in India: Emerging significance of renin angiotensin system derangement.
Does the direct renin inhibitor have a role to play in attenuating severity of the outbreak coronavirus disease 2019 (COVID-19)?
Drugs acting on renin angiotensin system and use in ill patients with COVID-19.
Elevated baseline renin levels as a possible cause of worse prognosis of COVID-19 in patients with heart disease.
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
Is RAS the Link Between COVID-19 and Increased Stress in Head and Neck Cancer Patients?
Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations.
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.
Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment: An Observational Study Showing that Things Are Not Always as They Seem.
Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
Physical Exercise and the Renin Angiotensin System: Prospects in the COVID-19.
Physiology of Midkine and Its Potential Pathophysiological Role in COVID-19.
Plasma Angiotensin Peptide Profiling and ACE2-Activity in COVID-19 Patients treated with Pharmacological Blockers of the Renin Angiotensin System.
RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance.
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies.
Renin Angiotensin Converting Enzyme 2 and COVID-19: Prevention and Treatment.
Renin Angiotensin System in Central Nervous System diseases and its interaction with COVID-19.
Renin Angiotensin System, COVID-19 and Male Fertility: Any Risk for Conceiving?
Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study.
Role of vitamin D in pathogenesis and severity of COVID-19 infection.
Rooibos, a supportive role to play during the COVID-19 pandemic?
Sarcopenia and COVID-19: A Manifold Insight on Hypertension and the Renin Angiotensin System.
SARS-CoV-2 associated COVID-19 in geriatric population: A brief narrative review.
SARS-CoV2 and pregnancy: An invisible enemy?
Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19.
Serum Renin Levels Increase With Age in Boys Resulting in Higher Renin Levels in Young Men Compared to Young Women, and Soluble Angiotensin-Converting Enzyme 2 Correlates With Renin and Body Mass Index.
The ACE-2 in COVID-19: Foe or Friend?
The Cholinergic and ACE-2-Dependent Anti-Inflammatory Systems in the Lung: New Scenarios Emerging From COVID-19.
The effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on ischemic stroke and the possible underlying mechanisms.
The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection.
The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study.
The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19.
The renin angiotensin aldosterone system and COVID-19.
The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Understanding the cross-talk between mediators of infertility and COVID-19.
Use of renin-angiotensin system inhibitors and clinical predictors of COVID-19 severity in a tertiary hospital in the city of Buenos Aires.
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
[Elevated baseline renin levels as a possible cause of worse prognosis of COVID-19 in patients with heart disease].
[Preliminary clinical study of direct renin inhibitor aliskiren in the treatment of severe COVID-19 patients with hypertension].
Crohn Disease
Renin-angiotensin system promotes colonic inflammation by inducing TH17 activation via JAK2/STAT pathway.
Cushing Syndrome
12 h profile of plasma renin activity and angiotensin II like activity in Cushing's syndrome.
A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
Analysis of various etiologies of hypertension in patients hospitalized in the endocrinology division.
Captopril in Cushing's syndrome.
Circulating vascular endothelial growth factor and active renin concentrations and prostaglandin E2 urinary excretion in patients with adrenal tumours.
Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Clinical syndromes associated with tumors of the female genital tract.
Concurrent hypercortisolism and hypermineralocorticoidism.
Ectopic ACTH syndrome associated with large-cell neuroendocrine carcinoma of the lung.
Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol.
Gene expression of angiotensin II receptor in blood cells of Cushing's syndrome.
Homocysteine, renin and aldosterone in patients with Cushing's syndrome.
Hypertension and aldosterone overproduction without renin suppression in Cushing's syndrome from an adrenal adenoma.
Hypertension due to a deoxycorticosterone-secreting adrenal tumour diagnosed during pregnancy.
Impaired 11?-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid Resistant Patients.
Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Long-term low-dose ketoconazole treatment in bilateral macronodular adrenal hyperplasia.
Markers of vascular function in hypertension due to Cushing's syndrome.
Pathogenesis of hypertension in Cushing's syndrome.
Pathogenetic aspects of hypertension in Cushing's syndrome.
Plasma prolactin levels in patients with essential hypertension, malignant hypertension and secondary hypertension.
Plasma renin activity and urinary aldosterone in Cushing's syndrome.
Plasmatic level of angiotensin I in normal subjects of various ages, in Cushing's syndrome and in normal and pathologic pregnancy.
Prostaglandin E2 and the renin-angiotensin system in primary aldosteronism and Cushing's syndrome.
Renin-angiotensin system and plasma aldosterone in Cushing's syndrome.
Role of adrenal imaging in surgical management.
The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome.
The use of saralasin in the recognition of angiotensinogenic hypertension.
Vascular endothelial growth factor (VEGF), prostaglandin E2(PGE2) and active renin in hypertension of adrenal origin.
[Autopsy case of Cushing's syndrome caused by adrenocortical cancer with a marked increase of plasma renin activity]
[Total blood volume in essential and secondary hypertension]
Cystic Fibrosis
Cystic fibrosis mimicking Bartter's syndrome.
Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
Pulmonary complications of endocrine and metabolic disorders.
Rising behind NO: cGMP-dependent protein kinases.
[Adrenal function and renin activity of plasma in patients with cystic fibrosis]
Cysts
A gammaGT-AT1A receptor transgene protects renal cortical structure in AT1 receptor-deficient mice.
Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease.
Aliskiren corrects recurrent hyperreninemia and hyperaldosteronism in autosomaldominant polycystic kidney disease.
An adrenal cyst associated with 19-nor-deoxycorticosterone excess and low renin hypertension.
Analysis of latent forms of renin using antibodies raised against the propart segment of human prorenin: validation with representative samples of ovarian cyst and follicular fluids.
Expression of components of the renin-angiotensin system in autosomal recessive polycystic kidney disease.
Hereditary renal diseases.
High renin hypertension associated with renal cortical cyst.
High renin hypertension in association with a solitary renal cyst.
Multiple and large simple renal cysts are associated with prehypertension and hypertension.
Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome.
Renal histology in polycystic kidney disease with incipient and advanced renal failure.
Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
Significant association between simple renal cysts and arterial blood pressure.
Simple renal cyst and high renin hypertension cured by cyst decompression.
Simple renal cyst and hypertension: cause or coincidence?
Solitary intrarenal cyst causing hypertension, with plasma renin activity study before and after cyst aspiration.
Solitary renal cyst, hypertension and renin.
Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease.
The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
Urinary angiotensinogen, related factors and clinical implications in normotensive autosomal dominant polycystic kidney disease patients.
Urinary Renin-Angiotensin Markers in Polycystic Kidney Disease.
[An incidental finding of renal cysts: routine occurrence or a finding deserving clarification?]
[Blood pressure observation during renal cyst decompression--case report on a benign solitary renal cyst as a cause of hypertension]
[Change in prostanoid metabolism in cystic kidney lesion]
[Simple renal cysts]
Deafness
Two novel homozygous missense mutations identified in the BSND gene in Moroccan patients with Bartter's syndrome.
[Tubolopaties associated to hypokalemia]
Death, Sudden, Cardiac
Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure.
Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.
Traditional heart failure medications and sudden cardiac death prevention: a review.
[Alcohol and hypertension in sudden cardiac death, features of the status of the renin-angiotensin-aldosterone system]
[Analysis of morpho-functional parameters of the heart and polymorphisms of Renin-Angiotensin-aldosterone system genes in patients with different variants of the course of hypertrophic cardiomyopathy]
[Cardiogenic shock and sudden cardiac death]
[Renin activity in plasma and kidneys upon sudden death of hypertension patients]
Decompression Sickness
Increase of plasma renin activity in male and female rabbits subjected to dysbaric conditions.
Dehydration
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.
A primitive type of renin-expressing lymphocyte protects the organism against infections.
Altered renin synthesis and secretion in the kidneys of heterozygous mice with a null mutation in the TGF-beta(2) gene.
Augmented plasma renin levels in dehydrated sheep with periventricular lesions.
Blood pressure maintenance in awake dehydrated rats: renin, vasopressin, and sympathetic activity.
Dehydration and renal failure in older persons during heatwaves-predictable, hard to identify but preventable?
Dehydration-induced renin secretion: involvement of histaminergic neurons.
Differential effects of water and saline intake on water deprivation-induced c-Fos staining in the rat.
Dissociation of renin and aldosterone during dehydration: studies in a case of diabetes insipidus and adipsia.
Effect of an exercise-heat acclimation program on body fluid regulatory responses to dehydration in older men.
Effect of dehydration and rapid rehydration on renal function and on plasma renin and aldosterone levels in the black Bedouin goat.
Effect of dehydration on plasma renin activity.
Effect of dehydration on stimulation of ADH release by heterologous renin infusions in conscious dogs.
Effect of hydration on plasma volume and endocrine responses to water immersion.
Effects of dehydration and renin on vasopressin concentration in the subfornical organ area.
Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice.
Effects of propranolol on induced water intake and on the subfornical organ surface.
Emerging roles of Sox6 in the renal and cardiovascular system.
Epidermal growth factor as a diuretic in sheep.
Expression of type II cGMP-dependent protein kinase in rat kidney is regulated by dehydration and correlated with renin gene expression.
Failure to Thrive, Hyponatremia, Hyperkalemia - Differential Diagnostic Reflections of a Rare Genetic Disease.
Gene expression for the renin system in the myocardium of hypertensive ISIAH rats.
Hemodynamic response to vasopressin in dehydrated human subjects.
Hgcl2-induced acute renal failure in the rat. Effect of water diuresis, saline loading, and diuretic drugs.
Hormonal regulation during a 60-day confinement (ESA-EXEMSI'92) in humans.
Hormonal responses during treatment of acute diabetic ketoacidosis with constant insulin infusions.
Hypokalemia and alkalosis in adipsic hypernatremia are not associated with hyperaldosteronism.
Influence of converting enzyme inhibition on the hormonal and renal adaptation to hyper- and hyponatraemic dehydration.
Influence of vasoconstrictor systems on leg vasodilation during heating of dehydrated baboons.
Inhibition of plasma vasopressin after drinking in dehydrated humans.
Interrelations between vasopressin and the renin-angiotensin system.
Involvement of sodium retention hormones during rehydration in humans.
Lack of effect of atrial natriuretic peptide on vasopressin release.
Macromolecular changes in the subfornical organ area after dehydration and renin.
Modulation of jejunal ion and water absorption by endogenous angiotensin after dehydration.
Neonatal Bartter syndrome.
Plasma renin activity in Japanese eels (Anguilla japonica) adapted to seawater or in dehydration.
Plasma renin and angiotensin in dehydrated and rehydrated rats.
Regulation of angiotensin II in rat adrenal gland.
Renal and endocrine response to water deprivation in dog.
Renal nerve transection inhibits drinking elicited by eating and by intragastric osmotic loads in rats.
Renin: friend or foe?
Response of the renin-aldosterone system in the camel to acute dehydration.
Restoration of Epithelial Sodium Channel Function by Synthetic Peptides in Pseudohypoaldosteronism Type 1B Mutants.
Restricted Water Intake Adversely Affects Rat Vocal Fold Biology.
Role of angiotensin in the development of the kidney and urinary tract.
Serum angiotensin converting enzyme activity and plasma renin activity in experimental models of rats.
Severe pseudohypoaldosteronism in a pair of twins not associated with hydramnios.
Sodium balance and aldosterone during dehydration and rehydration in the dog.
Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia.
Sympathetic activation cannot fully account for increased plasma renin levels during water deprivation.
Systemic pseudohypoaldosteronism from deletion of the promoter region of the human Beta epithelial na(+) channel subunit.
The subfornical organ: biochemical and neuroendocrine comparisons with the hypothalamo-neurohypophysial system.
Thirst-induced anorexias and the ontogeny of thirst in the rat.
Treatment of status asthmaticus--hormone changes before and after aminophylline i.v. drip therapy.
Vasopressin and renin response to dehydration in aged rats.
Water and sodium retention during short-term administration of growth hormone to short normal children.
Water Deprivation Increases (Pro)renin Receptor Levels in the Kidney and Decreases Plasma Concentrations of Soluble (Pro)renin Receptor.
Water deprivation-induced sodium appetite.
[A case of congenital nephrogenic diabetes insipidus accompanied by hypertension]
[A case of distal renal tubular acidosis complicated with renal diabetes insipidus, showing aggravation of symptoms with occurrence of diabetes mellitus].
[Effect of thermal dehydration on blood levels of hormones regulating volume and electrolyte content of sweat in patients with kidney transplantation]
[Effect of thermal dehydration on blood levels of volume- regulating hormones and sweat electrolytes in patients with essential hypertension treated with propranolol]
[Hormones regulating volume and electrolytes of sweat in patients with essential hypertension. Effect of thermal dehydration and treatment with captopril]
[Hypertension in the elderly: particularities and precautions]
[Influence of thermal dehydration on blood values of hormones which regulate volume and composition of electrolytes in sweat of patients with ic renal failure treated with hemodialysis]
[Measurement of antidiuretic hormone and plasma renin activity in desert rodents]
[Morphometric studies on the effects of dehydration on the renin-immunopositive cells in the kidney of the Mongolian gerbil (Meriones unguiculatus)]
[Severe renal failure during treatment with angiotensin-converting enzyme inhibitors]
[Transient pseudohypoaldosteronism secondary to congenital malformation pathology of the urinary tract (valves of the posterior urethra): a report of a case with elements of a physiopathological nature]
Delirium
Alpha-atrial natriuretic peptide, aldosterone secretion and plasma renin activity during ethanol withdrawal: a correlation with the onset of delirium tremens?
[Arterial hypertension in patients with alcoholic abstinence syndrome and delirium]
Dementia
Antihypertensive drugs and relevant cardiovascular pharmacotherapies and the risk of incident dementia in patients with atrial fibrillation.
Renin Angiotensin aldosterone system inhibition in controlling dementia-related cognitive decline.
The Brain AT2R-a Potential Target for Therapy in Alzheimer's Disease and Vascular Cognitive Impairment: a Comprehensive Review of Clinical and Experimental Therapeutics.
Dementia, Vascular
Attenuation of Brain Damage and Cognitive Impairment by Direct Renin Inhibition in Mice With Chronic Cerebral Hypoperfusion.
Demyelinating Diseases
Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease.
Dengue
Plasma renin activity in children with dengue hemorrhagic fever.
Dent Disease
On the Origin of Urinary Renin: A Translational Approach.
Dermatitis, Atopic
[Antidiuretic hormone in severe cases of atopic dermatitis]
Diabetes Complications
Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients.
Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis.
Pathophysiological significance of plasma total renin and prorenin in patients with diabetes mellitus.
Prorenin and the (pro)renin receptor: do they have a pathogenic role in the retina?
Renal and cardiovascular protection in type 2 diabetes mellitus: angiotensin II receptor blockers.
The choice of antihypertensive drugs in patients with diabetes: angiotensin II and beyond.
The effects of laughter on post-prandial glucose levels and gene expression in type 2 diabetic patients.
Transcriptome analysis of Penaeus vannamei hepatopancreas reveals differences in toxicity mechanisms between phoxim and prometryne.
[A study on inactive renin in the plasma of patients with diabetes mellitus]
Diabetes Insipidus
Angiotensin antogonists as pharmacological tools.
Antidiuretic hormone and renin in rats with diabetes insipidus.
Captopril (SQ 14225) depresses drinking and aldosterone in rats lacking vasopressin.
Cardiovascular effects of central injection of acetylcholine in anaesthetized dogs: a role for vasopressin release.
Discrepancy between aldosterone production and renin-angiotensin system activity in Brattleboro rats.
Dissociation of renin and aldosterone during dehydration: studies in a case of diabetes insipidus and adipsia.
Effect of lithium and antidiuretic hormone on plasma renin concentration in diabetes insipidus rats (Brattleboro rat model).
Effects of extracellular volume expansion on plasma renin concentration in rats with diabetes insipidus.
Evaluation of the renin-angiotensin system in diabetes insipidus and psychogenic polydipsia.
Hypothesis: renin and angiotensin as a mechanism of diuretic-induced antidiuresis in diabetes insipidus.
Lack of effect of vasopressin replacement on renin hypersecretion in Brattleboro rats.
Multiple endocrine disorders and Rathke's cleft cyst with Klinefelter's syndrome: a case report.
Plasma renin activity in diabetes insipidus.
Renin and angiotensin as a mechanism of diuretic-induced antidiuresis in diabetes insipidus.
Renin in diabetes insipidus.
Renin release and water-salt balance after central serotonin depletion by p-chlorophenylalanine in Brattleboro and Wistar rats: possible role of ADH.
The effects of vasopressin on pituitary oxytocin content and plasma renin activity in rats with hypothalamic diabetes insipidus (Brattleboro strain).
The renin and isorenin-angiotensin system in rats with hereditary hypothalamic diabetes insipidus.
The renin angiotensin system in conscious Brattleboro strain rats.
The renin-aldosterone axis in patients with diabetes insipidus.
The soluble (Pro) renin receptor does not influence lithium-induced diabetes insipidus but does provoke beiging of white adipose tissue in mice.
Water-balance hormones during long-term follow-up of oral dDAVP treatment in diabetes insipidus.
[Plasma renin activity in diabetes insipidus]
[Plasma renin activity in vasopressin-sensitive diabetes insipidus and changes in the same produced by clofibrate, carbamazepine and exogenous ADH]
[Proceedings: Plasma renin activity in diabetes insipidus: with special reference to the effect of chlorpropamide treatment]
[The plasma renin activity in decompensated and non-decompensated diabetes insipidus. Simultaneously a contribution to the regulation of renin secretion]
Diabetes Insipidus, Nephrogenic
Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism.
Evaluation of the renin-angiotensin system in diabetes insipidus and psychogenic polydipsia.
Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
Normal hemodynamic and coagulation responses to 1-deamino-8-D-arginine vasopressin in a case of lithium-induced nephrogenic diabetes insipidus. Results of treatment by a prostaglandin synthesis inhibitor (indomethacin).
The soluble (Pro) renin receptor does not influence lithium-induced diabetes insipidus but does provoke beiging of white adipose tissue in mice.
[Exploration of the renin aldosterone axis in nephrogenic diabetes insipidus in an infant. Biological study, effect of ethacrynic acid and ultrastructural aspect of the kidney]
[Plasma renin activity and catecholamines in familial diabetes insipidus renalis]
Diabetes Insipidus, Neurogenic
Evaluation of the renin-angiotensin system in diabetes insipidus and psychogenic polydipsia.
Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
Inhibition of the isoprenaline-induced renin release by bilateral vagotomy is mediated by vasopressin.
Lack of effect of vasopressin replacement on renin hypersecretion in Brattleboro rats.
Water-balance hormones during long-term follow-up of oral dDAVP treatment in diabetes insipidus.
Diabetes Mellitus
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy.
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study.
Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study.
Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice.
Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus.
Angiotensin I-converting enzyme: a pathogenetic role in diabetic renal damage?
Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
ANNALS EXPRESS: Associations between glycaemic control and activation of the Renin Angiotensin Aldosterone System in participants with Type 2 Diabetes Mellitus and Hypertension.
Association of high plasma prorenin with diabetic retinopathy.
Associations between the levels of soluble (pro)renin receptor in maternal and umbilical cord blood and hypertensive disorder of pregnancy.
Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
Big renin and biosynthetic defect of aldosterone in diabetes mellitus.
Blunted suppression of plasma renin activity in diabetes.
Body sodium and renin activity in diabetes mellitus.
Both Specific Endothelial and Proximal Tubular Adam17 Deletion Protect against Diabetic Nephropathy.
Chronic Increases in Circulating Prorenin Are not Associated With Renal or Cardiac Pathologies.
Chronic kidney disease is associated with oxidative stress independent of hypertension.
Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity.
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials.
Diabetes, nephropathy, and the renin system.
Diabetic nephropathy: newer therapeutic perspectives.
Dramatic reduction of proteinuria in diabetic nephropathy by the use of spironolactone.
Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat.
Effect of a Rational Drug Use Policy on the prescribing safety in outpatient settings in Thailand.
Effect of the renin-angiotensin system in the vascular disease of type II diabetes mellitus.
Effects of amiloride on oral glucose loading, serum potassium, renin, and aldosterone in diet-controlled diabetes.
Effects of Antihypertensive Agents on Intestinal Contractility in the Spontaneously Hypertensive Rat: Angiotensin Receptor System Downregulation by Losartan.
Effects of direct Renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus.
Effects of insulin on plasma renin activity, plasma atrial natriuretic peptide and body fluid volume in diabetes mellitus.
Elevated Plasma Levels of Soluble (Pro)Renin Receptor in Patients with Obstructive Sleep Apnea Syndrome in Parallel with the Disease Severity.
Evidence for cardiovascular effects of prorenin.
Gene expression of the renin-angiotensin system in human kidney.
Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography.
Guideline-Recommended Medications and Physical Function in Older Adults with Multiple Chronic Conditions.
High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.
High plasma prorenin in diabetes mellitus and its correlation with some complications.
Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus.
Human prorenin: pathophysiology and clinical implications.
Hydrogen and potassium regulation of (pro)renin processing and secretion.
Hyperreninemia due to increased renal renin synthesis in BioBreeding Worcester rats.
Hypertension Cure Following Laparoscopic Adrenalectomy for Hyperaldosteronism is not Universal: Trends Over Two Decades.
Hypertension in experimental diabetes mellitus. Renin-prostaglandin interaction.
Hyporeninemic hypoaldosteronism in diabetes mellitus. Studies of the autonomic nervous system's control of renin release.
Hyporeninemic hypoaldosteronism in diabetic patients with chronic renal failure.
Hypovolemia contributes to the pathogenesis of orthostatic hypotension in patients with diabetes mellitus.
Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus.
Increased inactive renin in diabetes mellitus without evidence of nephropathy.
Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus.
Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications.
Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study.
Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1-7)/Mas and the ACE/Ang II/AT1 axes?
Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism.
Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.
Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus.
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.
Low plasma aldosterone despite normal plasma renin activity in uncomplicated type 1 diabetes mellitus: effects of RAAS stimulation.
Low plasma renin activity in normotensive patients with diabetes mellitus: relationship to neuropathy.
Minoxidil.
Multiple endocrine disorders and Rathke's cleft cyst with Klinefelter's syndrome: a case report.
Nonmodulation as the Mechanism for Salt Sensitivity of Blood Pressure in Individuals with Hypertension and Type 2 Diabetes Mellitus.
Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.
OS 31-04 COMPARISON OF CALCIUM CHANNEL BLOCKERS VERSUS CALCIUM CHANNEL BLOCKERS WITH RENIN ANGIOTENSIN SYSTEM BLOCKERS ON THE DEVELOPMENT OF NEW-ONSET DIABETES MELLITUS IN HYPERTENSIVE PATIENTS.
Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus.
Pathophysiological significance of plasma total renin and prorenin in patients with diabetes mellitus.
Plasma active and inactive renin in patients with diabetes mellitus.
Plasma aldosterone concentration in the patient with diabetes mellitus.
Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
Plasma catecholamines and renin in diabetes mellitus. Relationships with posture, age, sodium, and blood pressure.
Plasma cryoactivated renin and active renin in diabetes mellitus.
Plasma inactive renin in patients with diabetes mellitus: effects of standing and the relation to serum protease inhibitor.
Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus.
Plasma prorenin as an early marker of microvascular disease in patients with diabetes mellitus.
Plasma renin activity (PRA) in type I diabetes mellitus: PRA and metabolic control in diabetes.
Plasma renin activity and hypertension in diabetes mellitus.
Plasma renin activity and plasma prorenin assays.
Plasma renin activity in diabetes mellitus.
Plasma renin activity in juvenile diabetes mellitus and effect of diazoxide.
Plasma renin and prorenin (inactive renin) in diabetes mellitus: effects of intravenous furosemide.
Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity.
Pleiotropic effects of inhibitors of the RAAS in the diabetic population: above and beyond blood pressure lowering.
PREDICTORS OF RESIDUAL RENAL FUNCTION DECLINE IN PERITONEAL DIALYSIS PATIENTS: THE balANZ TRIAL.
Prevention, protection, and the intrarenal renin-angiotensin systems.
Prorenin in diabetes mellitus.
Raised plasma renin and prorenin in rheumatoid vasculitis.
Relationship between prorenin, IGF-I, IGF-binding proteins and retinopathy in diabetic patients.
Relationship of biomarkers of extracellular matrix with myocardial function in Type 2 diabetes mellitus.
Renal excretion of prostaglandin E2 and plasma renin activity in type I diabetes mellitus: relationship to normoglycemia achieved with artificial pancreas.
Renal sensitivity to angiotensin II in type 1 diabetes.
Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus.
Renin angiotensin-aldosterone system (RAAS) blockers usage among type II diabetes mellitus patients-A Retrospective Study.
Renin regulation in type II diabetes mellitus: influence of dietary sodium.
Renin release in response to Renin system blockade: activation of the Renin system in type 1 diabetes mellitus.
Renin System Blockade, the Eye, and the Kidney in Type 1 Diabetes Mellitus.
Renin-aldosterone responsiveness in uncomplicated juvenile-type diabetes mellitus.
Renin-aldosterone system can respond to furosemide in patients with hyperkalemic hyporeninism.
Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).
Renin-Angiotensin-Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA.
Response of plasma immunoreactive active renin, inactive renin, plasma renin activity, and aldosterone to hemodialysis in patients with diabetic nephropathy.
Responsiveness of plasma renin and aldosterone in diabetes mellitus.
Sandwich radioimmunoassay of human plasma renin using two monoclonal antibodies.
SARS-CoV-2 associated COVID-19 in geriatric population: A brief narrative review.
Serum total renin is increased before microalbuminuria in diabetes.
Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.
Short-term dietary salt supplementation blunts telmisartan induced increases in plasma renin activity in hypertensive patients with type 2 diabetes mellitus.
Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus.
Soluble (pro)renin receptor in preeclampsia and diabetic pregnancies.
Successful directional atherectomy of eccentric renal artery stenosis using the Simpson directional coronary atherocath as a primary therapy.
SY 07-2 SHOULD DIABETES MELLITUS REMAIN A COMPELLING INDICATION FOR USE OF RENIN ANGIOTENSIN SYSTEM BLOCKERS?
The (pro)renin receptor blocker handle region peptide upregulates endothelium-derived contractile factors in aliskiren-treated diabetic transgenic (mREN2)27 rats.
The (pro)renin receptor: a new addition to the renin-angiotensin system?
The collecting duct is the major source of prorenin in diabetes.
The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention.
The expanding role of oxidative stress, renin angiotensin system, and beta-cell dysfunction in the cardiometabolic syndrome and Type 2 diabetes mellitus.
The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension.
The intrarenal renin-angiotensin system.
The paradox of the low-renin state in diabetic nephropathy.
The physiology and pathophysiology of the nitric oxide/superoxide system.
The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
The Role of Direct Renin Inhibition in Clinical Practice: Focus on Combination Therapy.
The significance of autonomic neuropathy in the elevation of inactive renin in diabetes mellitus.
The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade.
Thirst and plasma levels of vasopressin, angiotensin II and atrial natriuretic peptide in patients with non-insulin-dependent diabetes mellitus.
Transmembrane cationic fluxes in erythrocytes of diabetics and normal men.
Urinary Renin in Patients and Mice With Diabetic Kidney Disease.
Vascular and adrenal reninlike activity in chronically diabetic rats.
[A study on inactive renin in the plasma of patients with diabetes mellitus]
[A study on the pathogenesis of hyporeninemia in diabetics]
[Acute retinpathia praematurorum. Is plasma prorenin level of prognostic value?]
[Comparison of the morphological changes in the capillaries and the state of the renin-angiotensin-aldosterone system in diabetes mellitus]
[Diabetes mellitus, arterial hypertension and serum levels of renin]
[Endothelium and endogenous fibrinolysis]
[Increased endogenous dopamine activity in diabetes mellitus. Inhibition of plasma renin activity, aldosterone and prolactin secretion]
[Pathogenesis of arterial hypertension in diabetes mellitus]
[Plasma prorenin as an index of prognostic evaluation in diabetes]
[Proceedings: Plasma renin activity in diabetes mellitus]
[Relationship between mineralocorticoid function of the adrenals and plasma renin activity in patients with diabetes mellitus]
[Renin profiles in patients with diabetes mellitus]
[SGLT2 inhibitors: A new era for our patients].
[Sodium-glucose co-transporter 2 inhibitors: mechanisms of renal action. Implications for diabetes and heart failure].
[Studies on the mechanism for suppression of plasma renin activity in diabetes mellitus (author's transl)]
[The influence of autonomic diabetic neuropathy and human atrial natriuretic peptide on adrenal gland function in postural changes]
[The role of the sympatho-adrenomedullary system and adrenergic receptors in the pathogenesis of orthostatic hypotension in diabetes mellitus]
Diabetes Mellitus, Experimental
Decreases in renin and aldosterone secretion in alloxan diabetes: an effect of insulin deficiency.
Renin and angiotensinogen gene expression in experimental diabetes mellitus.
Renin, angiotensin, and norepinephrine in alloxan diabetes.
Diabetes Mellitus, Type 1
A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes.
Age is a Determinant of Acute Hemodynamic Responses to Hyperglycemia and Angiotensin II in Humans with Uncomplicated Type 1 Diabetes Mellitus.
Altered synthesis of renin in patients with insulin-dependent diabetes: plasma prorenin as a marker predicting the evolution of nephropathy.
Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes.
Both Specific Endothelial and Proximal Tubular Adam17 Deletion Protect against Diabetic Nephropathy.
Decreased prorenin processing develops before autonomic dysfunction in type 1 diabetes.
Diabetic nephropathy: newer therapeutic perspectives.
Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study.
Effects of alpha 2-adrenergic blockade on renal hemodynamics in patients with insulin dependent diabetes mellitus.
Effects of hyperglycaemia on kidney function, atrial natriuretic factor and plasma renin in patients with insulin-dependent diabetes mellitus.
Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltering type 1 (insulin-dependent) diabetic children.
Erythrocyte cation transport systems in insulin-dependent diabetics: correlation with prorenin and albuminuria.
Factors in the control of plasma renin activity and concentration in Type 1 (insulin-dependent) diabetes.
Glomerular hyperfiltration in insulin-dependent diabetes mellitus: no evidence for enhanced activity of the renin-angiotensin-aldosterone system.
Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations - a registry-based analysis.
High plasma prorenin in non diabetic siblings of non insulin-dependent diabetes mellitus patients.
High total serum renin concentrations are associated with the development of background retinopathy in adolescents with type 1 diabetes.
Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus.
Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes.
Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus.
Increased plasma renin activity in type 1 diabetes with microvascular disease.
Increased red cell sodium lithium countertransport activity, total exchangeable sodium, and hormonal control of sodium balance in normoalbuminuric type 1 diabetes.
Involvement of receptor-bound prorenin in development of nephropathy in diabetic db/db mice.
Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus.
Low plasma aldosterone despite normal plasma renin activity in uncomplicated type 1 diabetes mellitus: effects of RAAS stimulation.
Microalbuminuria and increased plasma prorenin. Prevalence in diabetics followed up for four years.
Oxidative stress and autonomic nerve function in early type 1 diabetes.
Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus.
Plasma prorenin as an early marker of nephropathy in diabetic (IDDM) adolescents.
Plasma renin and aldosterone in youngsters with insulin-dependent diabetes mellitus.
Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy.
Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
Prorenin and vascular complications of diabetes.
Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes.
Relationship between prorenin, IGF-I, IGF-binding proteins and retinopathy in diabetic patients.
Relationships between renin, aldosterone, blood pressure and renal function in hypertensive insulin-dependent diabetes mellitus.
Renal excretion of prostaglandin E2 and plasma renin activity in type I diabetes mellitus: relationship to normoglycemia achieved with artificial pancreas.
Renal sensitivity to angiotensin II in type 1 diabetes.
Renin release in response to Renin system blockade: activation of the Renin system in type 1 diabetes mellitus.
Renin System Blockade, the Eye, and the Kidney in Type 1 Diabetes Mellitus.
Serum angiotensin-converting enzyme activity and active renin plasma concentrations in insulin-dependent diabetes mellitus.
Serum total renin is increased before microalbuminuria in diabetes.
Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM.
Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.
The Association Between Uric Acid, Renal Hemodynamics and Arterial Stiffness Over the Natural History of Type 1 Diabetes.
The Effect of Direct Renin Inhibition Alone and in Combination With ACE Inhibition on Endothelial Function, Arterial Stiffness, and Renal Function in Type 1 Diabetes.
The relationship between active renin concentration and plasma renin activity in Type 1 diabetes.
The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.
The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
Time course of the antiproteinuric and renal haemodynamic responses to losartan in microalbuminuric IDDM.
Urinary endothelin in adolescents and young adults with insulin-dependent diabetes mellitus: relation to urinary albumin, blood pressure, and other factors.
Urinary free cortisol and its nyctohemeral variation in adolescents and young adults with IDDM: relation to endothelin 1 and indices of diabetic angiopathy.
Urinary Renin in Patients and Mice With Diabetic Kidney Disease.
Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease.
[Renal hemodynamics and its regulation in recently diagnosed type 1 diabetes mellitus (insulin-dependent diabetes mellitus). The effect of hyperglycemia]
[SGLT2 inhibitors: A new era for our patients].
Diabetes Mellitus, Type 2
Aliskiren combined with losartan in type 2 diabetes and nephropathy.
Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus.
Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes.
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study.
Angiotensin blockade improves cardiac and renal complications of type II diabetic rats.
ANNALS EXPRESS: Associations between glycaemic control and activation of the Renin Angiotensin Aldosterone System in participants with Type 2 Diabetes Mellitus and Hypertension.
Antihypertensive medication uses and serum ACE2 levels: ACEIs/ARBs treatment does not raise serum levels of ACE2.
Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes.
Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
Blunted suppression of plasma renin activity in diabetes.
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
Changes in diabetes distress among people with type 2 diabetes during a risk screening programme for diabetic kidney disease - Longitudinal observations of the PRIORITY study.
Combination of half doses of angiotensin type 1 receptor antagonist and angiotensin-converting enzyme inhibitor in diabetic nephropathy.
Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.
Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.
Dataset of the associations of aldosterone to renin ratio with MR-proANP and MR-proADM.
Diabetic nephropathy: newer therapeutic perspectives.
Direct Renin Inhibition: Promising Treatment in Renoprotection?
Dual inhibition with losartan and aliskiren: a promising therapeutic option for type 2 diabetic nephropathy?
Dual renin-angiotensin system blockade for nephroprotection: still under scrutiny.
Effects of direct Renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus.
Effects of hormone replacement therapy on cardiovascular responses in postmenopausal women with and without type 2 diabetes.
Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations - a registry-based analysis.
High plasma prorenin in non diabetic siblings of non insulin-dependent diabetes mellitus patients.
Higher levels of prorenin predict development of diabetic retinopathy in patients with type 2 diabetes.
Hyporeninemia and hypoaldosteronism in diabetes mellitus.
Immunohistochemical examination of cyclooxygenase-2 and renin in a KK-A(y) mouse model of diabetic nephropathy.
Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study.
Involvement of receptor-bound prorenin in development of nephropathy in diabetic db/db mice.
Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1-7)/Mas and the ACE/Ang II/AT1 axes?
Laughter modulates prorenin receptor gene expression in patients with type 2 diabetes.
Laughter therapy modulates the parameters of renin-angiotensin system in patients with type 2 diabetes.
Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation.
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.
Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy.
Managing chronic kidney disease in type 2 diabetes in family practice.
Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.
Multiple endocrine disorders and Rathke's cleft cyst with Klinefelter's syndrome: a case report.
New and old markers of progression of diabetic nephropathy.
Nodular glomerulosclerosis and renin angiotensin system in Chinese patients with type 2 diabetes.
Non-insulin-dependent diabetes mellitus, nephropathy, and the renin system.
Nonmodulation as the Mechanism for Salt Sensitivity of Blood Pressure in Individuals with Hypertension and Type 2 Diabetes Mellitus.
Novel angiotensin II inhibitors in cardiovascular medicine.
Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
Plasma prorenin and renin levels in non-insulin-dependent diabetes mellitus.
Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension.
Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.
Prorenin and renal function in NIDDM patients with normo- and microalbuminuria.
Prorenin and vascular complications of diabetes.
Reduction of erythrocyte (Na(+)-K+) ATPase activities in non-insulin-dependent diabetic patients with hyperkalemia.
Relationship of biomarkers of extracellular matrix with myocardial function in Type 2 diabetes mellitus.
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study.
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study.
Renin angiotensin system blockade reduces urinary levels of soluble urokinase plasminogen activator receptor (suPAR) in patients with type 2 diabetes.
Renin angiotensin system inhibitors may attenuate low LDL cholesterol-related cancer risk in type 2 diabetes.
Renin-angiotensin-aldosterone system genotypes and haplotypes affect the susceptibility to nephropathy in type 2 diabetes patients.
Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay.
Sex differences in soluble prorenin receptor in patients with type 2 diabetes.
The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention.
The expanding role of oxidative stress, renin angiotensin system, and beta-cell dysfunction in the cardiometabolic syndrome and Type 2 diabetes mellitus.
The paradox of the low-renin state in diabetic nephropathy.
The role of the renin angiotensin hormonal system in the metabolic syndrome and type 2 diabetes.
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes.
Treatment of renovascular hypertension using stent implantation in an elderly patient with NIDDM.
Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan.
Urinary angiotensin converting enzyme 2 is strongly related to urinary nephrin in type 2 diabetes patients.
Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin?
Vasopeptidase inhibition attenuates proteinuria and podocyte injury in Zucker diabetic fatty rats.
[Clinical study of the month. Nephroprotective role of angiotensin II receptor antagonists in type 2 diabetes: results of the IDNT and RENAAL trials]
[Endothelium and endogenous fibrinolysis]
[OP.1D.10] THE CKD273 URINARY PROTEOMIC CLASSIFIER IS NOT A MARKER OF GENERALISED VASCULAR DISEASE IN TYPE 2 DIABETIC PATIENTS WITH NORMAL RENAL FUNCTION.
[SGLT2 inhibitors: A new era for our patients].
[Sodium-glucose co-transporter 2 inhibitors: mechanisms of renal action. Implications for diabetes and heart failure].
[The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism]
Diabetes, Gestational
Association of Soluble (PRO) Renin Receptor with Gestational Diabetes Mellitus.
Prorenin and secreted frizzled-related protein 4 levels in women with gestational diabetes mellitus.
Soluble (Pro) Renin Receptor is a predictor of gestational diabetes mellitus.
Soluble (pro)renin receptor in preeclampsia and diabetic pregnancies.
Diabetic Angiopathies
Plasma active and inactive renin in patients with diabetes mellitus.
Plasma inactive renin in patients with diabetes mellitus: effects of standing and the relation to serum protease inhibitor.
Plasma prorenin levels may predict persistent microalbuminuria in children with diabetes.
Reduced plasma aldosterone concentrations in randomly selected patients with insulin-dependent diabetes mellitus.
Sex difference and possible relationship to microvascular complications of serum prorenin levels in type 2 diabetic patients, measured by a novel antibody-activating direct enzyme kinetic assay.
[Diabetic vascular complications and circulating prorenin]
Diabetic Cardiomyopathies
Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor.
Diabetic Ketoacidosis
Atrial natriuretic peptide and other vasoactive hormones during treatment of severe diabetic ketoacidosis in children.
Hormonal responses during treatment of acute diabetic ketoacidosis with constant insulin infusions.
Plasma renin activity and blood volume in uncontrolled diabetes. Ketoacidosis, a state of secondary aldosteronism.
Diabetic Nephropathies
Activated prorenin as a therapeutic target for diabetic nephropathy.
Activation and characterization of inactive big renin in plasma of patients with diabetic nephropathy and unusual active renin.
Activation and function of prorenin: different viewpoints.
Activation of a local renin angiotensin system in podocytes by glucose.
Advances in the renin-angiotensin-aldosterone system: relevance to diabetic nephropathy.
Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study.
Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats.
Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats.
Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes.
Angiotensin III: a physiological relevant peptide of the renin angiotensin system.
Angiotensin receptor antagonists in patients with nephropathy due to type 2 diabetes.
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
AT2 receptor agonist Compound 21: A silver lining for diabetic nephropathy.
Big renin: identification, chemical properties and clinical implications.
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.
CD39-adenosinergic axis in renal pathophysiology and therapeutics.
Changes in diabetes distress among people with type 2 diabetes during a risk screening programme for diabetic kidney disease - Longitudinal observations of the PRIORITY study.
Characterization studies of inactive renin from human kidney and from several plasma sources.
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
Comments to: Tarnow L, Kjeld T, Knudsen E et al. (2000) lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients. Diabetologia 43: 794-799.
Connectivity mapping of glomerular proteins identifies dimethylaminoparthenolide as a new inhibitor of diabetic kidney disease.
Connexin mRNA distribution in adult mouse kidneys.
Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
Diabetic nephropathy: important pathophysiologic mechanisms.
Diabetic nephropathy: newer therapeutic perspectives.
Diabetic nephropathy: Time to withhold development and progression - A review.
Direct renin inhibition in chronic kidney disease.
Dual blockade of Renin Angiotensin system in reducing the early changes of diabetic retinopathy and nephropathy in a diabetic rat model.
Effect of captopril on renal hemodynamics in the treatment of resistant renal hypertension.
Effect of Combination Therapy with Angiotensin Receptor Blocker and 1,25-Dihydroxyvitamin D(3) in Type 2 Diabetic Nephropathy in KK-A/Ta Mice.
Effect of direct renin inhibitor monotherapy on proteinuria in overt diabetic nephropathy.
Effect of Vitamin D therapy on urinary albumin excretion, renal functions, and plasma renin among patients with diabetic nephropathy: A randomized, double-blind clinical trial.
Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria: A Randomized, Controlled Trial.
Egr1 Knockdown Combined with an ACE Inhibitor Ameliorates Diabetic Kidney Disease in Mice: Blockade of Compensatory Renin Increase.
Elevated serum total renin is insensitive in detecting incipient diabetic nephropathy.
eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists.
Expression of (pro)renin receptor in human kidneys with end-stage kidney disease due to diabetic nephropathy.
Feasibility of fluorescence energy transfer system for imaging the renoprotective effects of aliskiren in diabetic mice.
Glomerular Diseases in Diabetic Patients: Implications for Diagnosis and Management.
High glucose and renin release: the role of succinate and GPR91.
High plasma concentrations of prorenin in a transgenic animal model of nephropathy with overexpression of transforming growth factor-beta1 in the kidneys.
Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus.
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade.
Human Glomerular Endothelium: Interplay Among Glucose, Free Fatty Acids Angiotensin II And Oxidative Stress In Hyperglycemia.
Immunohistochemical examination of cyclooxygenase-2 and renin in a KK-A(y) mouse model of diabetic nephropathy.
Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy.
Inactive renin of high molecular weight (big renin) in normal human plasma. Activation by pepsin, trypsin, or dialysis to pH 3.3 and 7.5.
Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus.
Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats.
Increased urinary angiotensinogen precedes the onset of albuminuria in normotensive type 2 diabetic patients.
Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.
Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats.
Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients.
Laughter modulates prorenin receptor gene expression in patients with type 2 diabetes.
Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans.
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.
Mast cell population in the development of diabetic nephropathy: Effects of renin angiotensin system inhibition.
MicroRNA in diabetic nephropathy: renin angiotensin, aGE/RAGE, and oxidative stress pathway.
Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
New pharmacological treatments for improving renal outcomes in diabetes.
Nodular glomerulosclerosis and renin angiotensin system in Chinese patients with type 2 diabetes.
On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy.
Patiromer: The First Potassium Binder Approved in Over 50 Years.
Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy.
PLZF and the (pro)renin receptor.
Podocytes as a target of prorenin in diabetes.
Prorenin and the renin-angiotensin system in diabetic nephropathy.
Prorenin independently causes hypertension and renal and cardiac fibrosis in cyp1a1-prorenin transgenic rats.
Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
Prospective analysis of the efficacy of beraprost sodium combined with alprostadil on diabetic nephropathy and influence on rennin-angiotensin system and TNF-?.
Protective effects of aliskiren and valsartan in mice with diabetic nephropathy.
Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.
Receptor-mediated nonproteolytic activation of prorenin and induction of TGF-?1 and PAI-1 expression in renal mesangial cells.
Relationship between blood glucose control, pathogenesis and progression of diabetic nephropathy.
Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients.
Renin and the juxtaglomerular apparatus in diabetic nephropathy.
Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes.
Renin Angiotensin Aldosterone System (RAAS): its biology and drug targets for treating diabetic nephropathy.
Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Renin inhibition in the treatment of diabetic kidney disease.
Renin inhibitors.
Renin secretion in advanced diabetic nephropathy.
Renin Secretion in Advanced Diabetic Nephropathy.
Renin similar to the submaxillary gland form is expressed in mouse mesangial cells: subcellular localization and all generation under control and glucose-stimulated conditions.
Renin-angiotensin-aldosterone system genotypes and haplotypes affect the susceptibility to nephropathy in type 2 diabetes patients.
Reno-protective potential of sodium glucose cotransporter-2 (SGLT2) inhibitors: Summary evidence from clinical and real-world data.
Response of plasma immunoreactive active renin, inactive renin, plasma renin activity, and aldosterone to hemodialysis in patients with diabetic nephropathy.
Role of the renin angiotensin system in diabetic nephropathy.
Role of the USF1 transcription factor in diabetic kidney disease.
Role of upstream stimulatory factor 2 in diabetic nephropathy.
Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy.
Smoking in diabetic nephropathy: sparks in the fuel tank?
Targeted therapies in diabetic nephropathy: an update.
The (pro)renin receptor: pathophysiological roles in cardiovascular and renal pathology.
The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.
The importance of the renin-angiotensin system in cardiovascular disease.
The inactive to active renin ratio in the kidneys and the plasma in diabetic nephropathy.
The intrarenal renin-angiotensin system and diabetic nephropathy.
The paradox of the low-renin state in diabetic nephropathy.
The potential role of prorenin in diabetic nephropathy.
The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
The Role of Direct Renin Inhibition in Clinical Practice: Focus on Combination Therapy.
The Role of Renin Angiotensin Aldosterone System Genes in Diabetic Nephropathy.
The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy.
Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Therapeutic inhibition of the renin angiotensin aldosterone system.
Therapeutic Renin Inhibition in Diabetic Nephropathy-A Review of the Physiological Evidence.
Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.
Transmural pressure control of prorenin processing and secretion in diabetic rat juxtaglomerular cells.
Treatment of Diabetic Kidney Disease With Hypertension Control and Renin Angiotensin System Inhibition.
Twenty years of the (pro)renin receptor.
Update on role of direct renin inhibitor in diabetic kidney disease.
Urinary Renin in Patients and Mice With Diabetic Kidney Disease.
Urinary serine proteases and activation of ENaC in kidney-implications for physiological renal salt handling and hypertensive disorders with albuminuria.
Vitamin D improves diabetic nephropathy in rats by inhibiting renin and relieving oxidative stress.
[Advantages and limitations of renin inhibition with aliskiren].
[Clinical study of the month. Nephroprotective role of angiotensin II receptor antagonists in type 2 diabetes: results of the IDNT and RENAAL trials]
[OP.1D.10] THE CKD273 URINARY PROTEOMIC CLASSIFIER IS NOT A MARKER OF GENERALISED VASCULAR DISEASE IN TYPE 2 DIABETIC PATIENTS WITH NORMAL RENAL FUNCTION.
[OP.6D.04] ASSOCIATION STUDY OF ANGIOTENSINASE A (ENPEP) GENOTYPE WITH DIABETIC NEPHROPATHY.
[Plasma renin activity and plasma aldosterone change in diabetic nephropathy]
[Renin-angiotensin system in diabetic nephropathy]
[The role of genetic studies in finding the etiopathogenesis of diabetes mellitus]
[Therapeutic novelties in the management of arterial hypertension].
[Type 2 diabetes and nephropathy--new studies, new treatment strategies?]
Diabetic Neuropathies
A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy.
Investigating the beneficial effect of aliskiren in attenuating neuropathic pain in diabetic Sprague-Dawley rats.
Plasma renin activity in diabetic autonomic neuropathy.
Diabetic Retinopathy
A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy.
Adeno-Associated Virus Overexpression of Angiotensin-Converting Enzyme-2 Reverses Diabetic Retinopathy in Type 1 Diabetes in Mice.
Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat.
Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats.
Angiotensin-(1-7) Expressed From Lactobacillus Bacteria Protect Diabetic Retina in Mice.
Association of high plasma prorenin with diabetic retinopathy.
Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
Dual blockade of Renin Angiotensin system in reducing the early changes of diabetic retinopathy and nephropathy in a diabetic rat model.
High plasma prorenin in diabetes mellitus and its correlation with some complications.
Higher levels of prorenin predict development of diabetic retinopathy in patients with type 2 diabetes.
Identification and quantification of renin and prorenin in the bovine eye.
Iron Overload Accelerates the Progression of Diabetic Retinopathy in Association with Increased Retinal Renin Expression.
Medical management of diabetic retinopathy: an overview.
Pathophysiological significance of plasma total renin and prorenin in patients with diabetes mellitus.
Plasma prorenin as an early marker of microvascular disease in patients with diabetes mellitus.
Proposed mechanisms of Terminalia catappa in hyperglycaemia and associated diabetic complications.
Prorenin and the (pro)renin receptor: do they have a pathogenic role in the retina?
Receptor-associated prorenin system contributes to development of inflammation and angiogenesis in proliferative diabetic retinopathy.
Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma.
Renal Iron Accelerates the Progression of Diabetic Nephropathy in HFE (High Fe-iron) Gene Knockout Mouse Model of Iron Overload.
Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy.
Retinal Protein O-GlcNAcylation and the Ocular Renin Angiotensin System: Signaling Cross-Roads in Diabetic Retinopathy.
Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay.
Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM.
Therapeutic targets of renin-angiotensin system in ocular disorders.
Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy.
[(Pro) renin receptor in the pathogenesis of proliferative diabetic retinopathy].
[Acute retinpathia praematurorum. Is plasma prorenin level of prognostic value?]
[Role of (pro)renin receptor in diabetic retinopathy].
Diphtheria
Ablation of renin-expressing juxtaglomerular cells results in a distinct kidney phenotype.
Chronic Stimulation of Renin Cells Leads to Vascular Pathology.
Dirofilariasis
Plasma levels of renin and aldosterone in right-sided congestive heart failure due to canine dirofilariasis.
Plasma renin activities, angiotensin II concentrations, atrial natriuretic peptide concentrations and cardiopulmonary function values in dogs with severe heartworm disease.
Disorder of Sex Development, 46,XY
A novel compound heterozygous mutation of K494_V495 deletion plus R496L and D487_F489 deletion in extreme C-terminus of cytochrome P450c17 causes 17alpha-hydroxylase deficiency.
Disorders of Sex Development
Splicing analysis of CYP11B1 mutation in a family affected with 11?-hydroxylase deficiency: case report.
Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia.
Disseminated Intravascular Coagulation
Plasma active renin, inactive renin and kallikrein in patients with disseminated intravascular coagulation.
Drug Hypersensitivity
Renin angiotensin aldosterone system and drug allergies complicated with hypotension.
Drug-Related Side Effects and Adverse Reactions
Early postnatal gentamicin and ceftazidime treatment in normal and food restricted neonatal wistar rats: Implications for kidney development.
The Safety After Fifty Evaluation trial: evaluation of the safety and efficacy of antihypertensive therapy with metoprolol in patients 50 to 75 years of age: study design.
Dysautonomia, Familial
Plasma renin activity and aldosterone in familial dysautonomia.
Plasma renin activity in familial dysautonomia: unresponsiveness to a beta-adrenergic blocker.
Dyslipidemias
Clinical therapeutic strategies for early stage of diabetic kidney disease.
Decreased levels of circulating CD34(+) cells are associated with coronary heart disease in Japanese patients with type 2 diabetes.
Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease.
Fibrinolysis and diabetes.
Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework.
Medical management of diabetic retinopathy: an overview.
Physical Activity and Adiposity-related Inflammation: The MESA.
The beneficial effects on blood pressure, dyslipidemia and oxidative stress of Sambucus nigra extract associated with renin inhibitors.
[Diagnosis and management of diabetic nephropathy].
[Hypertension, atherosclerosis and kidney]
Dyspnea
Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
Eclampsia
Renin gene restriction fragment length polymorphisms do not show linkage with preeclampsia and eclampsia.
Embolism
Epidemiology and management of severe symptomatic neonatal hypertension.
Neonatal renal arterial embolism syndrome.
Renin release and renal sympathetic nerve activity following vertebral artery embolism.
Embolism, Fat
Evidence for angiotensin mediation of the late histopathological effects of pulmonary fat embolism: Protection by losartan in a rat model.
The renin inhibitor aliskiren protects rat lungs from the histopathologic effects of fat embolism.
Encephalitis
Angiotensin Receptor Blockade by Inhibiting Glial Activation Promotes Hippocampal Neurogenesis Via Activation of Wnt/?-Catenin Signaling in Hypertension.
Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial.
Endocrine System Diseases
[An aged case of orthostatic hypotension possibly due to parasympathetic neurodysfunction]
[Interrelationships between prolactin and the renin-aldosterone system in patients with various endocrine diseases]
Endometriosis
Tanshinone IIA contributes to the pathogenesis of endometriosis via renin angiotensin system by regulating the dorsal root ganglion axon sprouting.
Endotoxemia
Alternative pathways for angiotensin II production as an important determinant of kidney damage in endotoxemia.
Dissociation of systemic and renal effects in endotoxemia. Prostaglandin inhibition uncovers an important role of renal nerves.
[Combined therapy of shehuang paste and colonic dialysis with Chinese medicines for treatment of refractory cirrhotic ascites complicated with azotemia]
Eosinophilia
Angiolymphoid hyperplasia with eosinophilia associated with arteriovenous malformation: a clinicopathological correlation with angiography and serial estimation of serum levels of renin, eosinophil cationic protein and interleukin 5.
Renin in angiolymphoid hyperplasia with eosinophilia. Its possible effect on vascular proliferation.
Epilepsy
A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor.
Physiology and pharmacology of the (pro)renin receptor.
Plasma renin concentration and phenobarbital levels in patients with epilepsy.
Epiretinal Membrane
Pathologic Roles of Receptor-Associated Prorenin System in Idiopathic Epiretinal Membrane.
Esophageal Achalasia
Allgrove syndrome: case report of 7 years old boy from Bahawalpur.
Esophageal and Gastric Varices
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.
Upright posture decreases esophageal varices flow velocity in patients with cirrhosis.
Essential Hypertension
"Prorenin" in human plasma?
'Captopril test', with blood pressure and peripheral renin as response variables in hypertensive patients with suspected renal artery stenosis.
'Treasure your exceptions': what we can learn from autosomal-dominant inherited forms of hypertension.
-344C/T polymorphism of CYP11B2 gene in Italian patients with idiopathic low renin hypertension.
19-hydroxyandrostenedione, a new amplifier of the action of aldosterone, in low renin essential hypertension.
19-Hydroxyandrostenedione: a potent hypertensinogenic steroid in man.
A beta-blocker-based antihypertensive drug program guided by age and renin.
A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients.
A circulating renin activator in essential hypertension.
A comparative study of endralazine and captopril in essential hypertension: effect on renin levels, pulmonary function studies and lipid profile.
A composite analysis of renin classification methods.
A delayed suppression of the renin-aldosterone axis following saline infusion in human hypertension.
A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
A genetic defect resulting in mild low-renin hypertension.
A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension.
A new sensitive direct radioimmunoassay for human plasma renin and its clinical application.
A novel variable number of tandem repeat polymorphism of the renin gene and essential hypertension.
A Patient with Bilateral Primary Aldosteronism Refractory to Oral Eplerenone Who Responded to Esaxerenone with Increased Renin Activity.
A polymorphic GT short tandem repeat affecting beta-ENaC mRNA expression is associated with low renin essential hypertension.
A polymorphism of the renin gene rs6682082 is associated with essential hypertension risk and blood pressure levels in Korean women.
A simplified screening test for differentiating primary aldosteronism from essential hypertension with low plasma renin activity.
A very sensitive direct radioimmunoassay system for plasma angiotensin II and its clinical application in various hypertensive diseases.
Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
Abnormal norepinephrine and aldosterone responses to upright posture in nonmodulating hypertension.
Abnormal renin short feedback loop in essential hypertension is reversible with converting enzyme inhibition.
Abnormal responsiveness of the renin aldosterone system to acute stimulation in patients with essential hypertension.
Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension.
Acebutolol and hydrochlorothiazide in essential hypertension.
Active and inactive renin and kidney function in young subjects with different predisposition to develop essential hypertension.
Active and inactive renin in low renin states: studies in human plasma.
Activity of erythropoietin and renin in renal venous blood of hypertensive patients.
Acute calcium entry blockade inhibits the blood pressure but not the hormonal responses to angiotensin II.
Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent.
Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension.
Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients.
Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
Acute stimulation of renin secretion changes the multiple form profile of active plasma renin.
Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension.
Adrenal scintigraphy in low renin essential hypertension.
Adrenal transitional zone steroids, 18-oxo and 18-hydroxycortisol, useful in the diagnosis of primary aldosteronism, are ACTH-dependent.
Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists.
Adrenocortical factors in hypertension. I. Significance of 18-hydroxy-11-deoxycorticosterone.
Age and cardiovascular response adaptation. Determinants of an antihypertensive treatment concept primarily based on beta-blockers and calcium entry blockers.
Age and the renin-aldosterone system.
Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension.
Age, race, blood pressure and renin: predictors for antihypertensive treatment with calcium antagonists.
Age- and sex-related differences in plasma aldosterone in essential hypertension. Relationship to plasma renin activity.
Age-rated profile of cardiovascular reactivity to norepinephrine and angiotensin II in normal and hypertensive man.
Age-related changes in endocrine and renal function in patients with essential hypertension.
Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
Aldosterone and renin in essential hypertension.
Aldosterone in sustained essential hypertension.
Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
Aldosterone metabolic clearance is normal in low-renin essential hypertension.
Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.
Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II.
Aldosterone responsiveness to angiotensin II after sodium restriction in subjects with low renin essential hypertension.
Alpha 1-Adrenoceptor blockade: dissociation of its effects on renin release and arterial blood pressure in man.
alpha-Adrenoceptors and age-dependent decrease in plasma renin activity in essential hypertension.
Alterations in plasma renin activity of patients with essential hypertension induced by NaCl and by salt depletion.
Alterations of dietary calcium intake as a therapeutic modality in essential hypertension.
Altered renin-angiotensin-aldosterone relationships in normal renin essential hypertension.
Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor.
Amlodipine lowers blood pressure without increasing sympathetic activity or activating the renin-angiotensin system in patients with essential hypertension.
An inactive higher-molecular-weight renin in normal subjects and hypertensive patients.
An MboI two-allele polymorphism may implicate the human renin gene in primary hypertension.
Analysis of various etiologies of hypertension in patients hospitalized in the endocrinology division.
Angiotensin blockade in renovascular hypertension: a controlled, prospective study.
Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples.
Angiotensin converting enzyme inhibition and calcium channel blockade as primary antihypertensive therapy.
Angiotensin converting enzyme inhibition reveals an important role for the renin system in the control of normal and high blood pressure in man.
Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapy.
Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension.
Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension.
Angiotensin I-forming angiotensinogenases in extrarenal vasculature and in the kidney.
Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans.
Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
Angiotensin-mediated renin suppression is altered in non-modulating hypertension.
Angiotensinogen gene and hypertension in Chinese.
Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: a case control study.
Anti-hypertensive effect of acebutolol: its relation to sympathetic nervous system responsiveness and to plasma renin and dopamine-beta-hydroxylase activities.
Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension.
Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation.
Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity.
Antihypertensive and renin angiotensin effects of metolazone with and without propranolol.
Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.
Antihypertensive effect of enalapril in essential hypertension: role of prostacyclin.
Antihypertensive effect of indapamide with special emphasis on renal prostaglandin production.
Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
Antihypertensive efficacy of FK906, a novel human renin inhibitor.
Antihypertensive responses to spironolactone in normal renin hypertension.
Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
Antihypertensive treatment and plasma renin activity in essential hypertension.
Are patients with essential hypertension and low renin protected against stroke and heart attack?
Are there unknown mineralocorticoids in low-renin essential hypertension?
Are Women More at Risk of False-Positive Primary Aldosteronism Screening and Unnecessary Suppression Testing than Men?
Aspirin lowers blood pressure in patients with renovascular hypertension.
Aspirin test for differentiation of unilateral renovascular hypertension from hyperreninemic essential hypertension.
Assessment of renin dependency of hypertension with a dipeptide renin inhibitor.
Assessment of serum sodium to urinary sodium divided by (serum potassium)² to urinary potassium as a screening tool for primary aldosteronism.
Association and linkage analyses of restriction fragment length polymorphisms for the human renin and antithrombin III genes in essential hypertension.
Association between plasma renin activity and metabolic cardiovascular risk factors in essential hypertension.
Association between single-nucleotide polymorphisms in six hypertensive candidate genes and hypertension among northern Han Chinese individuals.
Association of Mbo I-RFLP at the Renin Locus (rs2368564) with Essential Hypertension.
Association of renin BglI polymphism with essential hypertension: a meta-analysis involving 1811 cases and 1626 controls.
Association of the renin gene polymorphism with essential hypertension in a Chinese population.
Association of the Renin gene polymorphism, three angiotensinogen gene polymorphisms and the haplotypes with essential hypertension in the mongolian population.
Association study between the human Renin gene and preeclampsia.
Atrial natriuretic factor in essential hypertension: echocardiographic and humoral correlates.
Atrial natriuretic peptide in normal and low renin essential hypertension.
Attenuated renal production of dopamine in patients with low renin essential hypertension.
Beneficial effect of angiotensin II type 1 receptor blocker antihypertensive treatment on arterial stiffness: the role of smoking.
Beneficial effects of angiotensin II type 1 receptor blocker antihypertensive treatment on inflammation indices: the effect of smoking.
Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.
Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
beta-adrenergic blockade in essential hypertension: reduced renin release despite renal vasoconstriction.
Beta-adrenergic regulation of circadian rhythmicity of the renin-angiotensin-aldosterone system in five subtypes of essential hypertension.
Biochemical evaluation of sympathetic nerve tone in essential hypertension.
Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
Blood pressure and hormonal responses to aerobic exercise.
Blood pressure and serum calcium responses to altered sodium intake in high renin hypertension.
Blood pressure changes following chronic administration to rats of 3beta,16beta-dihydroxy-5-androsten-17-one, 3beta,17beta-dihydroxy-5-androsten-16-one and 21-hydroxy-4-pregnene-3,20-dione-21-acetate.
Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren.
Blood pressure regulation on low and high sodium diets in normotensive members of normotensive or hypertensive families.
Blood pressure response to angiotensin converting enzyme inhibitor in essential hypertension: its relation to the renin status and natriuresis during acute sodium loading.
Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
Body fluid balance and fractional excretions of sodium, inorganic phosphorus, potassium and free water in low renin essential hypertension.
Body fluid volumes and the response of renin and aldosterone to short- and long-term thiazide therapy of essential hypertension.
Body sodium-blood volume state, aldosterone, and cardiovascular responsiveness after calcium entry blockade with nifedipine.
Bopindolol: long-term effects on blood pressure, renal function, plasma renin activity, and plasma aldosterone in mild-to-moderate essential hypertension.
C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration.
C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic.
Calcium and magnesium in essential hypertension.
Calcium antagonism--a new concept for treating essential hypertension.
Calcium metabolic indices, vascular retinopathy, and plasma renin activity in essential hypertension.
Calcium metabolism and the renin-aldosterone system in essential hypertension.
Calcium metabolism in essential hypertension: relationship to altered renin system activity.
Calcium metabolism, renin activity, and the antihypertensive effects of calcium channel blockade.
Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism.
Captopril affects blood pressure equally in renovascular and essential hypertension and in the fluid-depleted anephric state.
Captopril enhances vascular and adrenal responsiveness to angiotensin II in essential hypertension.
Captopril-induced proteinuria in hypertensive psoriatic patients.
Captopril-stimulated renal vein renin in hypertensive patients with or without renal artery stenosis.
Captopril-stimulated renin secretion in the diagnosis of renovascular hypertension.
Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.
Captopril: pharmacology, metabolism and disposition.
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.
Cardiopulmonary blood volume and plasma renin activity in man: preliminary report.
Cardiopulmonary receptor regulation of renin release.
Cardiovascular effects of noise.
Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet.
Cardiovascular effects of verapamil in essential hypertension.
Cardiovascular pathophysiology of essential hypertension: a clue to therapy.
Cardiovascular, humoral, and renal effects of phenoxybenzamine in hypertension.
Carotid sinus reflex control of renin release in hypertensive subjects with high renin secretion.
Catecholamines, cyclic AMP and renin in two contrasting forms of essential hypertension.
Central and renal circulation, renin and aldosterone in plasma during prazosin treatment in essential hypertension.
Change in plasma renin activity by cold storage of plasma in normal subjects and patients with essential hypertension and primary aldosteronism.
Changes in active and inactive renin and in angiotensin II across the kidney in essential hypertension and renal artery stenosis.
Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions.
Changes in endocrine activities relative to obesity in patients with essential hypertension.
Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.
Characteristics of lymphocyte beta-adrenoceptors in essential hypertension: effects of propranolol treatment and dynamic exercise.
Circadian rhythm of plasma renin activity in older normal and essential hypertensive men: relation with inactive renin, aldosterone, cortisol and REM sleep.
Circadian rhythms of plasma renin. Aldosterone and cortisol Effect of beta-adrenergic blockade by propranolol in patients with recent, advanced and complicated forms of essential hypertension.
Circulating prorenin and renin in response to intravenous adrenocorticotrophic hormone in essential hypertension.
Circulating renin in essential hypertension: an evaluation of its significance in the Japanese population.
Circulatory volume in essential hypertension. Relationships with age, blood pressure, exchangeable sodium, renin, aldosterone and catecholamines.
Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome.
Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital.
Clinical implications of the molecular biology of the renin-angiotensin system.
Clinical parameters of concern in the pathology and treatment of hypertension.
Clinical significance of plasma renin activity in human renovascular hypertension.
Common genetic variations of the renin-angiotensin-aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension.
Common questions and answers in the management of hypertension: routine measurement of plasma renin activity in the management of patients with essential hypertension: notes from the 19th Annual ASH Meeting.
Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension.
Comparable effect of aliskiren or a diuretic added on an angiotensin II receptor blocker on augmentation index in hypertension: a multicentre, prospective, randomised study.
Comparison between the effects of ST 600 and catapres.
Comparison between the effects of ST 600 and clonidine.
Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
Comparison of immunoreactive renin and plasma renin activity in human plasma.
Comparison of the effects of captopril, diuretic and their combination in low- and normal-renin essential hypertension.
Comparisons of body fluid volumes, plasma renin activity, hemodynamics and pressor responsiveness between juvenile and aged patients with essential hypertension.
Comprehensive studies on the renal kallikrein-kinin system in essential hypertension.
Contrasting effects of acute beta blockade with propranolol on plasma catecholamines and renin in essential hypertension: a possible basis for the delayed antihypertensive response.
Contrasting effects of hypoglycemia on plasma renin activity and cyclic adenosine 3',5'-monophosphate (cyclic AMP) in low renin and normal renin essential hypertension.
Contribution of REN gene MBbo I polymorphism in conferring risk for essential hypertension: a case control study from South India.
Control of renin release: a review of experimental evidence and clinical implications.
Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.
Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Correction of altered noradrenaline reactivity in essential hypertension by indapamide.
Correlation between renin responsiveness to furosemide and antihypertensive effect of captopril in patients with normal-renin essential hypertension.
Correlation of divalent cat ions (Ca++, Mg++) and serum renin in pateints of essential hypertension.
Correlation of glycyrrhetinic acid-like factors (kidney 11beta-HSD2-GALFs) with urinary free cortisol and plasma renin activity in essential hypertension.
Correlation of renin angiotensin system (RAS) candidate gene polymorphisms with response to Ramipril in patients with essential hypertension.
Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure.
Decrease in alpha-adrenoceptor-mediated vasoconstriction parallels the antihypertensive response to propranolol in patients with normal renin essential hypertension.
Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
Decreased venous distensibility and reduced renin responsiveness in hypertension.
Defining the physiologic and pathophysiologic roles of renin: the role of specific inhibitors.
Dependence of plasma renin activity on protaglandin excretion in essential hypertension.
Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
Determination of aliskiren in human serum quantities by HPLC-tandem mass spectrometry appropriate for pediatric trials.
Determination of renin-dependency and sodium-dependency in the three renin sub-groups of essential hypertension.
Diagnosis of secondary forms of hypertension. A comprehensive protocol.
Diagnostic value of captopril test in hypertensive patients with renal artery stenosis.
Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension.
Different effects of eicosapentaenoic acid and olive oil on blood pressure, intracellular free platelet calcium, and plasma lipids in patients with essential hypertension.
Different patterns of renal prostaglandins I2 and E2 in patients with essential hypertension with low to normal or high renin activity.
Different secretion patterns of active and inactive renin in man.
Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension.
Differentiation between renovascular and essential hypertension by means of changes in single kidney 99mTc-DTPA clearance induced by angiotensin-converting enzyme inhibition.
Direct and indirect measurement of urinary kallikrein excretion in patients with essential hypertension and normotensives: relation to age and plasma renin and aldosterone levels.
Direct Renin Inhibition: Focus on Aliskiren.
Disorders of mineralocorticoid synthesis.
Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential hypertension.
Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free') aldosterone in hypertension.
Dissociation of biochemical and hypotensive effects of debrisoquine in hypertensive patients.
Dissociation of blood angiotensin II and plasma renin activity during chronic treatment in essential hypertension.
Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism.
Dissociation of plasma renin activity and aldosterone in essential hypertension.
Dissociation of the effects of alpha 1-adrenergic blockade on blood pressure and renin release in patients with essential hypertension.
Dissociation of the renin lowering and antihypertensive actions of propranolol.
Diuretic therapies in low renin and normal renin essential hypertension.
Diuretic therapy and response of essential hypertension to saralasin.
Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity.
Do weak mineralocorticoids affect the pathogenesis of hypertension in Cushing's disease?
Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?
Dopamine beta-hydroxylase and plasma renin activity in patients with low-, normal-, and high-renin essential hypertension.
Dopaminergic regulation of circadian rhythms of blood pressure, renin and aldosterone in essential hypertension.
Double-blind crossover study of the interaction between perindopril and amlodipine on blood pressure and hormones related to fluid and electrolyte balance in patients with essential hypertension.
Effect of age on active and inactive plasma renin in normal subjects and in patients with essential hypertension.
Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.
Effect of aging on the renin angiotensin system in patients with renovascular hypertension.
Effect of alpha-human atrial natriuretic peptide in low renin essential hypertension and primary aldosteronism.
Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension.
Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.
Effect of captopril on blood pressure and on the renin-angiotensin-aldosterone system in coarctation of the aorta.
Effect of captopril on inactive renin and contact phase of coagulation system.
Effect of captopril on plasma prolactin in patients with essential hypertension.
Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension.
Effect of chronic and acute changes in sodium balance on the urinary excretion of prostaglandins E2 and F2 alpha in patients with essential hypertension.
Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
Effect of erythrocyte deformability on renal hemodynamics and plasma renin activity.
Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension.
Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
Effect of intravenous frusemide on plasma renin concentration: suppression of response in hypertension.
Effect of L-dopa in young patients with hypertension.
Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension.
Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.
Effect of oxprenolol on catecholamines and plasma renin activity: acute response to frusemide in hypertensive patients.
Effect of penbutolol on circadian blood pressure, and renin, aldosterone and cortisol levels in patients with essential hypertension.
Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension.
Effect of posture on the plasma concentrations of aldosterone in hypertension and primary hyperaldosteronism.
Effect of prazosin and oxprenolol on plasma renin activity and blood pressure in patients with essential hypertension.
Effect of prazosin on blood pressure and plasma renin activity in man.
Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
Effect of renin-angiotensin system activation by dietary sodium restriction and upright position on plasma leptin concentration in patients with essential hypertension.
Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension.
Effect of sleep on blood pressure and its correlates.
Effect of somatostatin on plasma renin activity and blood pressure in patients with essential hypertension.
Effect of spironolactone on urinary kallikrein excretion in patients with essential hypertension and in primary aldosteronism.
Effect of upright tilting on kinins as compared to renin activity in the renal venous blood from patients with essential hypertension.
Effectiveness of Sepharose-bound trypsin versus liquid-phase trypsin plus benzamidine for activation of inactive renin in human plasma.
Effects of 1-Sar-8-Ile-angiotensin II on urinary prostaglandin excretion in patients with essential hypertension.
Effects of 1-sarcosine-8-isoleucine-angiotensin II on blood pressure and plasma renin activity in various types of hypertension.
Effects of a novel renin inhibitor in patients with essential hypertension.
Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension.
Effects of amiloride on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in thiazide-treated hypertensive patients.
Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension.
Effects of an orally active renin inhibitor, Ro 42-5892, in patients with essential hypertension.
Effects of angiotensin II blockade on the responses of the pituitary-adrenal axis to corticotropin-releasing factor in humans.
Effects of angiotensin-converting enzyme inhibition on blood pressure and plasma renin activity in essential hypertension.
Effects of antihypertensive drugs and gene variants in the renin-angiotensin system.
Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension.
Effects of converting enzyme inhibition on split renal function in renovascular hypertension.
Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension.
Effects of dietary magnesium supplementation on diurnal variations of blood pressure and plasma Na+, K(+)-ATPase activity in essential hypertension.
Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.
Effects of diltiazem on hormonal and hemodynamic responses to lower body negative pressure and tilt in patients with mild to moderate systemic hypertension.
Effects of furosemide on plasma renin and aldosterone in three subtypes of essential hypertension.
Effects of genetic variation in the aldosterone synthase (CYP11B2) gene on enzyme function.
Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
Effects of group relaxation training and thermal biofeedback on blood pressure and related physiological and psychological variables in essential hypertension.
Effects of guanfacine on growth hormone, prolactin, renin, lipoproteins and glucose in essential hypertension.
Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension.
Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
Effects of intravenous endralazine in essential hypertension.
Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.
Effects of orally administered glandular kallikrein on urinary kallikrein and prostaglandin excretion, plasma immunoreactive prostanoids and platelet aggregation in essential hypertension.
Effects of prostacyclin infusion on blood pressure and plasma renin activity in patients with essential hypertension.
Effects of prostaglandins inhibition on changes in active and inactive renin induced by antihypertensive drugs.
Effects of renin inhibition in systemic hypertension.
Effects of short-term norepinephrine infusion on plasma catecholamines, renin, and aldosterone in normal and hypertensive man.
Effects of single dose administration of angiotension covering enzyme inhibitor (captopril) on blood pressure, plasma renin activity and plasma aldosterone in patients with essential hypertension. A proposal for the captopril test.
Effects of sublingual administration of nifedipine on arterial pressure, plasma renin activity, and glomerular filtration rate in essential hypertension.
Effects of timolol on blood pressure, systemic hemodynamics, plasma renin activity, and glomerular filtration rate in patients with essential hypertension.
Effects of various doses of captopril on plasma aldosterone concentrations in patients with essential hypertension.
Effects on the renin-angiotensin system of agents acting at central and peripheral adrenergic receptors.
Efficacy and mode of action of manidipine: a new calcium antagonist.
Efficacy and safety of lisinopril in older patients with essential hypertension.
Elevated albumin excretion in nonmodulating essential hypertensive patients.
Endocrine mechanisms in the pathogenesis of essential hypertension. III. Special reference on the interrelations between the prostaglandin and kallikrein-kinin systems.
Endogenous angiotensin-aldosterone-pressure relationships during sodium restriction.
Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty.
Endothelin-1 and neuropeptide Y plasma concentrations in renal venous blood of hypertensive patients with unilateral renal artery stenosis.
Enhanced 24-hour norepinephrine and renin secretion in young patients with essential hypertension: relation with the circadian pattern of arterial blood pressure.
Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension.
Enhanced aldosterone response to angiotensin II in human hypertension.
Enhanced calcium-sensitivity of erythrocytes in hypertension--calcium-induced changes of erythrocyte osmotic fragility in essential hypertension.
Enhanced red cell sodium permeability in patients with borderline hypertension.
Epicardial Fat Thickness and Primary Aldosteronism.
Epinephrine and norepinephrine pattern in elderly patients with borderline and established hypertension.
Erythrocyte sodium cannot predict hypotensive effects of calcium channel blockers.
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels.
Essential hypertension of Caribbean Hispanics: sodium, renin, and response to therapy.
Essential hypertension: abnormal renal vascular and endocrine responses to a mild psychological stimulus.
Essential hypertension: relationship between renin and blood pressure.
Essential hypertension: renin and aldosterone, heart attack and stroke.
Estimation of 'total' renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release.
Ethnic differences in blood pressure with observations on noradrenaline and renin. A hospital hypertensive population.
Evaluation of plasma renin activity by blood pressure level (pressure-renin index) in patients with essential hypertension.
Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension.
Evidence for activation of circulating inactive renin by the human kidney.
Evidence for heterogeneity of mineralocorticoids in urine of patients with low renin essential hypertension.
Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension.
Evidence for the existence of an acetone soluble renin inhibiting factor in normal human plasma.
Exaggerated atrial natriuretic peptide release during acute exercise in essential hypertension.
Exploration Of The Seated Saline Suppression Test For The Diagnosis Of Primary Aldosteronism In The Chinese Population.
Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension.
Extraction and measurement of circulating angiotensins I and II.
Factors influencing the hypotensive effects of calcium antagonists.
Fatty acids may regulate aldosterone secretion and mediate some of insulin's effects on blood pressure.
Felodipine, blood pressure, and cardiovascular reflexes in hypertensive humans.
Fibrinogen and the albumin-globulin ratio in essential hypertension: relations to plasma renin system activity.
First report of active renin in rat amniotic fluid.
Follow-up of renin in essential hypertension.
Follow-up of renin in uncomplicated and complicated essential hypertension.
Formation and action of prostaglandins in the kidney.
Frequency of renin gene restriction fragment length polymorphism in hypertensives with a genetic predisposition to hypertension.
Functional derangements in the regulation of aldosterone secretion in hypertension.
Furosemide and plasma renin activity in essential hypertension.
G-protein beta-3 subunit gene C825 T polymorphism: influence on plasma sodium and potassium concentrations in essential hypertensive patients.
Genetic determination of plasma aldosterone levels in essential hypertension.
Genetic Variant of C-5434T REN Enhancer on Serum Renin Levels and Binding Pattern of Signal Transducers and Activators Transcription 3.
Genetic, familial and racial influences on blood pressure control systems in man.
Glucose load and renal sodium handling in mild essential hypertension on different sodium intakes.
Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
Haemodynamic and endocrine responses of the kidney to frusemide in mild essential hypertension.
Haemodynamic effects of treatment and withdrawal of spironolactone in essential hypertension.
Haemodynamic responses to exercise and acute beta-receptor blockade in renin sub-types of essential hypertension.
Haemodynamics during long-term thiazide treatment in essential hypertension: differences between responders and non-responders.
Haplotype analysis of the human renin gene and essential hypertension.
Haplotype-based association of renin gene polymorphisms with essential hypertension in Han population of northern china.
Haplotypes of the human renin gene associated with essential hypertension and stroke.
Hemodynamic and cardiac adaptation in essential hypertension. Consequences for therapy.
Hemodynamic and natriuretic responses to intravenous infusion of dopamine in patients with essential hypertension.
Hemodynamic and plasma renin effects of propranolol in essential hypertension.
Hemodynamic and renin responses to somatostatin in essential hypertension.
Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders.
Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
Hemodynamic effects of head-down tilt in normal subjects and sustained hypertensive patients.
Hemodynamic effects of [Sar1, Ile8] AII, an angiotensin II analog, in the renin subgroups of essential hypertension.
Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension.
High and low renin subgroups of essential hypertension: differences and similarities in their renin and sympathetic responses to neural and nonneural stimuli.
High plasma adrenomedullin concentrations in patients with high-renin essential hypertension.
High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.
High plasma endothelin-1 levels in hypertensive patients with low-renin essential hypertension.
High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertensive patients.
High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.
High salt intake blunts plasma catecholamine and renin responses to exercise: less suppressive epinephrine in borderline essential hypertension.
High-renin essential hypertension: adrenergic cardiovascular correlates.
HSD11B2 CA-repeat and sodium balance.
Human renin gene BglI dimorphism associated with hypertension in two independent populations.
Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
Humoral and renal response to acute volume loading in patients with essential hypertension.
Humoral Na+-K+ pump inhibitory activity in essential hypertension and in normotensive subjects after acute volume expansion.
Humoral sodium transport inhibitor in acute volume expansion and low renin hypertension.
Hypertension and hyperkalaemia responding to bendrofluazide.
Hypertension in Africa and effectiveness of its management with various classes of antihypertensive drugs and in different socio-economic and cultural environments.
Hypertension in kidney transplantation.
Hypertension in the elderly: haemodynamic, fluid volume and endocrine findings.
Identification of 19-nor-deoxycorticosterone in normal rat serum by enzyme immunoassay and gas chromatography-mass spectrometry.
Immediate plasma renin response to propranolol: differentiation between essential and renal hypertension.
Immunological approach to blockade of the renin-substrate reaction.
Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
Implication of renal prostaglandin E in urinary sodium excretion.
In vivo and in vitro effects of atrial natriuretic peptide on renin release.
In-vivo activation of circulating inactive renin by the ischemic kidney in man.
Inactive renin in human plasma.
Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
Increase of total body potassium and decrease of exchangeable sodium after long-term treatment with a beta-receptor-blocking agent (prindolol) in essential hypertension.
Increased beta-adrenoceptor binding capacity is associated with blunted beta-adrenoceptor-mediated cardiovascular responses in essential hypertension.
Increased plasma adrenaline concentrations in benign essential hypertension.
Increased plasma vasopressin and serum uric acid in the low renin type of essential hypertension.
Increased plasma vasopressin in low renin essential hypertension.
Influence of age on blood pressure response to enalapril.
Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Influence of indomethacin on the natriuretic and renin-stimulating effect of bumetanide in essential hypertension.
Influence of nonhemodynamic factors on the microcirculation in moderate arterial essential hypertension.
Influence of prostaglandin inhibition on dihydralazine induced acute effects in patients with essential hypertension.
Influence of renin levels on the treatment of essential hypertension with thiazide diuretics.
Influence of sodium intake on hydrochlorothiazide-induced changes in blood pressure, serum electrolytes, renin and aldosterone in essential hypertension.
Influence of sodium intake on the reliability of active renin as a measure of the renin-angiotensin system in essential hypertension.
Influence of the renin-angiotensin system stimulation on erythropoietin production in patients with various forms of arterial hypertension.
Influence of water immersion on plasma erythropoietin concentration in patients with essential hypertension.
Inhibitors of the renin-angiotensin system. Clinical pharmacology studies on kinetics, dynamics and concentration-effect relationships.
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients.
Insulin resistance in essential hypertension is related to plasma renin activity.
Inter-relationship of sympathetic nervous system and renin-angiotensin-aldosterone system in three renin subgroups of borderline and persistent essential hypertension.
Interaction between renin and the autonomic nervous system in hypertension.
Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension.
Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension.
Interrelations between plasma renin activity, aldosterone, and sympathetic nervous system activity in essential hypertension.
Interrelationships between sodium clearance, plasma aldosterone, plasma renin activity, renal hemodynamics and blood pressure in renal disease.
Intracellular sodium concentration in lymphocytes and erythrocytes of patients with essential hypertension.
Intralymphocytic sodium and free calcium and plasma renin in essential hypertension.
Investigation of the renin gene as a putative locus for essential hypertension (EH) in Vincentian African Caribbeans.
Involvement of (pro)renin receptor in the glomerular filtration barrier.
Involvement of endogenous prostaglandins in salt-induced hypertension.
Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension?
Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?
Is renin a factor in the etiology of essential hypertension?
Is single oral administration of captopril beneficial in screening for primary aldosteronism?
Is the plasma aldosterone-to-renin ratio associated with blood pressure response to treatment in general practice?
Kinetic variations of plasma renin and aldosterone during active orthostatism in three subtypes of essential hypertension.
Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight.
Lack of correlation between Mbo I restriction fragment length polymorphism of renin gene and essential hypertension in Japanese.
Lack of evidence for the interaction between renin-angiotensin-aldosterone system and endothelin in vivo.
Left ventricular adaptation to hypertension and plasma renin activity.
Letter: Adrenergic reactivity in low renin and normal renin essential hypertension.
Letter: Renin and filtration fraction in essential hypertension.
Letter: Timolol, hydrochlorothiazide, blood-pressure, and renin in essential hypertension.
Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.
Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans.
Linkage analysis of candidate genes and gene-gene interactions in chinese hypertensive sib pairs.
Lithium-sodium countertransport in erythrocytes of normal and hypertensive subjects. Relationship with age and plasma renin activity.
Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.
Long-term effect of captopril on kidney function in various forms of hypertension.
Long-term systemic hypertension in children after successful repair of coarctation of the aorta.
Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity.
Low and high renin essential hypertension: a comparison of clinical and biochemical characteristics.
Low plasma renin activity and high aldosterone/renin ratio are associated with untreated isolated systolic hypertension.
Low renin essential hypertension in a child.
Low renin essential hypertension.
Low renin essential hypertension: failure to demonstrate excess 11-deoxycorticosterone production.
Low renin hypertension.
Low-renin hypertension. Occurrence in vascular complications.
Low-renin hypertension: nephrosclerosis?
Markedly elevated specific renin levels in the adrenal in genetically hypertensive rats.
Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension.
Mechanisms of suppression of renal kallikrein activity in low renin essential hypertension and renoparenchymal hypertension.
Mediation of renin release in essential hypertension by alpha-adrenoreceptors.
Membrane abnormality of erythrocytes is highly dependent on salt intake and renin profile in essential hypertension: an electron spin resonance study.
Membrane fluidity of erythrocytes and its relevance to renin profile in essential hypertension.
Mendelian hypertension with brachydactyly as a molecular genetic lesson in regulatory physiology.
Metabolic and hormonal studies in patients with essential hypertension.
Metoprolol in high renin hypertension. A comparison with propranolol.
Mild essential hypertension in nonobese premenopausal women is characterized by low renin.
Mild high-renin essential hypertension. Neurogenic human hypertension?
Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low renin hypertension: a single-center retrospective study.
Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity.
Modification of stepped care approach to antihypertensive therapy.
Molecular variants of the sodium/hydrogen exchanger type 3 gene and essential hypertension.
Multiple endocrine disorders and Rathke's cleft cyst with Klinefelter's syndrome: a case report.
Multiple oral doses of nicardipine, a calcium-entry blocker: effects on renal function, plasma renin activity, and aldosterone concentration in mild-to-moderate essential hypertension.
Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis.
Negative association between plasma aldosterone concentration/plasma renin activity and morning blood pressure surge in never-treated hypertensive patients.
Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension.
Neurogenic factors in low renin essential hypertension.
Neurohormonal responses to antihypertensive treatment with captopril or hydrochlorothiazide.
New therapeutic prospects of renin-angiotensin system inhibition.
Nocturnal blood pressure and relation to vasoactive hormones and renal function in hypertension and chronic renal failure.
Nocturnal oscillations in plasma renin activity during sleep in hypertensive patients: the influence of perindopril.
Nocturnal urinary electrolyte excretion and its relationship to the renin system and sympathetic activity in normal and hypertensive man.
Normal plasma renin activity in low renin hypertension.
Normal vitamin D and mineral metabolism in essential hypertension.
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity.
On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship.
One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.
Ontogeny of plasma renin activity in the Dahl rat model of essential hypertension.
Opposite associations of circulating aldosterone and atrial natriuretic peptide with left ventricular diastolic function in essential hypertension.
Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension.
Origin of urinary 16 beta-hydroxydehydroepiandrosterone in essential hypertension.
Outpatient screening tests for primary aldosteronism.
Oxidative stress may explain how hypertension is maintained by normal levels of angiotensin II.
Paradoxical effect of ethanol on plasma renin activity levels in hyperreninemic essential hypertension.
Parathyroid hormone and calcium. A relationship in hypertension.
Parathyroid hypertensive factor-like activity in human essential hypertension: relationship to plasma renin activity and dietary salt sensitivity.
Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension.
Pathogenesis of essential hypertension with a suppressed plasma renin activity.
Pathogenesis of essential hypertension with low renin: responses of plasma renin activity to various stimulation tests in essential hypertension.
Personality characteristics and renin in essential hypertension.
Pharmacodynamic Effects of an Angiotensin II Receptor-Antagonist in Phase I-Comparison between Healthy Subjects and Patients with Hypertension.
Pharmacologic treatment of uncomplicated essential hypertension: renin and/or echocardiography guided?
Plasma 19-hydroxyandrostenedione is elevated in patients with high renin essential hypertension.
Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension.
Plasma aldosterone in essential hypertension with low renin activity.
Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
Plasma antidiuretic hormone levels in patients with normal and low renin essential hypertension, and secondary hypertension.
Plasma bradykinin levels and urinary kallikrein excretion in normal renin essential hypertension.
Plasma catecholamines and renin activity in response to exercise in patients with essential hypertension.
Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man.
Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
Plasma endothelin-1 level in patients with renovascular hypertension - does the kidney with stenosis of the renal artery upregulate production of endthelin-1?
Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension.
Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension.
Plasma levels of 18-hydroxy-11-deoxycorticosterone in essential hypertension.
Plasma levels of beta-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine.
Plasma levels of brain natriuretic peptide in healthy subjects and patients with essential hypertension: response to posture.
Plasma noradrenaline and adrenaline and beta-adrenoreceptor responsiveness in renin subgroups of essential hypertension.
Plasma prolactin levels in patients with essential hypertension, malignant hypertension and secondary hypertension.
Plasma renin activity and cardiovascular disease.
Plasma renin activity and hypertension in diabetes mellitus.
Plasma renin activity and plasma aldosterone concentrations in untreated Nigerians with essential hypertension.
Plasma renin activity and vascular disease in essential hypertension.
Plasma renin activity in essential hypertension (a critical approach to its significance).
PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM. IMPORTANCE IN DIFFERENTIAL DIAGNOSIS AND IN RESEARCH OF ESSENTIAL HYPERTENSION.
Plasma renin activity in renal veins of renovascular patients.
Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
Plasma renin activity levels influence the effect of converting enzyme inhibitors in preserving renal function in hypertension.
Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension.
Plasma renin activity, reactivity, concentration and substrate following hypertension during pregnancy. Effect of oral contraceptive agents.
Plasma renin activity, sodium balance and sympathetic activity during progress of essential hypertension.
Plasma renin and "prorenin" in essential hypertension during sodium depletion, beta-blockade, and reduced arterial pressure.
Plasma renin concentration in essential hypertension during beta-adrenergic blockade and vasodilator therapy.
Plasma renin in hypertensive patients: significance in relation to clinical and other biochemical features.
Plasma renin levels and systemic haemodynamics in essential hypertension.
Plasma renin levels in Zulu hypertensives.
Plasma volume in men with low-, normal- and high-renin essential hypertension.
Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension.
Potential future developments in the field of antihypertensive drugs.
Predictive value of renin determinations in renal artery stenosis.
Pressor and hormonal responses to intravenous injection of metoclopramide in normotensive and hypertensive patients.
Pressor factors and cardiovascular pressor responsiveness after short-term antihypertensive therapy with the calcium antagonist nifedipine alone or combined with a diuretic.
Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects.
Pressor responsiveness, hemodynamics and plasma renin activity in essential hypertension.
Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
Pretreatment plasma renin activity levels correlate with the blood pressure response to telmisartan in essential hypertension.
Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertension.
Primary aldosteronism: are we diagnosing and operating on too few patients?
Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'?
Progression of Renal Insufficiency in Patients with Essential Hypertension Treated with Renin Angiotensin Aldosterone System Blockers: An Electrocardiographic Correlation.
Prolactin, renin and catecholamines in essential hypertension.
Prolonged anti-hypertensive effects of oral sitaxsentan, a selective ET(A) endothelin receptor antagonist, in spontaneoulsy hypertensive hamsters.
Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension.
Prolonged duration of blood pressure response to enalkiren, the novel dipeptide renin inhibitor, in essential hypertension.
Propranolol, renin and hypertension: a review.
Prorenin in essential hypertension.
Prostaglandin E synthesis in the kidney in renin subgroups of essential hypertension.
Psychologic differences between high-, normal-, and low-renin hypertensives.
Quantitative effects of timolol and hydrochlorothiazide on blood pressure, heart rate and plasma renin activity: results of a double-blind factorial trial in patients with essential hypertension.
Racial analysis of the volume-renin relationship in human hypertension.
Racial difference in salivary sodium-potassium ratio in low renin essential hypertension.
Racial differences in pressure, volume and renin interrelationships in essential hypertension.
Radioactive 86rubidium influx into red blood cells in essential hypertension in relation to the plasma renin activity.
Radioimmunoassay of plasma renin activity.
Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.
Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
Reciprocal relation between renin dependency and sodium dependency in essential hypertension.
Reduced plasma renin activity in essential hypertension: effects of blood pressure, age and sodium.
Reduced renin activity in essential hypertension: a reappraisal.
Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study.
Reflex control of renin release in essential hypertension.
Regulation of plasma endothelin by salt in salt-sensitive hypertension.
Regulation of platelet receptors for angiotensin II in man.
Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension.
Relation between plasma renin activity, angiotensin, and aldosterone and blood pressure in mild untreated hypertension.
Relation between renin and prorenin in plasma from hypertensive patients and normal people: evidence for different renin:prorenin ratios.
Relation of age, diastolic pressure and known duration of hypertension to presence of low renin essential hypertension.
Relationship between blood pressure and blood levels of angiotensin I converting enzyme inhibitor (SQ 14,225).
Relationship between plasma aldosterone concentration and plasma potassium in patients with essential hypertension during alprenolol treatment.
Relationship between plasma catecholamines and the renin-aldosterone system during exercise in normal and essential hypertensive subjects.
Relationship between plasma renin profile and leptinaemia in patients with essential hypertension.
Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.
Relationship of basal plasma noradrenaline to blood pressure, age, sex, plasma renin activity and plasma volume in essential hypertension.
Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
Relationship of blood pressure response and the renin-angiotensin system to first-dose prazosin.
Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension.
Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage.
Relationships between plasma catecholamines, renin, age and blood pressure in essential hypertension.
Relationships between sodium clearance, plasma renin activity, plasma aldosterone, renal hemodynamics and blood pressure in essential hypertension.
Remikiren (Ro 42-5892)--an orally active renin inhibitor in essential hypertension. Effects on blood pressure and the renin-angiotensin-aldosterone system.
Renal and endocrine response to saline infusion in essential hypertension.
Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.
Renal aspects of treatment by converting enzyme inhibitors in hypertension.
Renal blood flow and renin activity in renal venous blood in essential hypertension.
Renal characteristics and effect of angiotensin suppression in oral contraceptive users.
Renal effects of prostaglandin E1 in hypertensive patients.
Renal function in one-kidney, one-clip hypertension and low renin essential hypertension.
Renal haemodynamics and plasma renin in patients with essential hypertension.
Renal hemodynamics and renin-angiotensin system activity in humans with multifocal renal artery fibromuscular dysplasia.
Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Renal pathology of essential hypertension.
Renal prostaglandin E in essential hypertension: studies in patients with suppressed renin activity.
Renal prostaglandin E2 and the renin-angiotensin system in hypertensive disorders in man.
Renal prostaglandins in the control of renin.
Renal release of active and inactive renin in essential and renovascular hypertension.
Renal vein immunoreactive renin in patients with renal artery stenosis and essential hypertension.
Renal vein renin in essential hypertension.
Renal vein renin sampling in essential hypertension using hydralazine and the tourniquet test.
Renal vein renin: value and limitations in the prediction of operative results.
Renal venous renin in patients with renovascular hypertension.
Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program.
Renin and aldosterone in essential hypertension.
Renin and aldosterone measurements in the management of arterial hypertension.
Renin and angiotensin-converting enzyme genotypes in patients with essential hypertension and left ventricular hypertrophy.
Renin and blood volume in chronic renal failure: a comparison with essential hypertension.
Renin and body fluid volumes in chronic renal disease. Relations between arterial pressure, plasma renin activity, blood volume, and extracellular volume in chronic renal disease, as compared with essential hypertension.
Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension.
Renin angiotensin system and sympathetic nerve activity in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide treated hypertensive patients.
Renin angiotensinogen system gene polymorphisms and essential hypertension among people of West African descent: a systematic review.
Renin as a risk factor in essential hypertension: more evidence.
Renin content of kidneys in experimental renal and human essential hypertension.
Renin gene MboI dimorphism is a discriminator for hypertension in hyperlipidaemic subjects.
Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses.
Renin gene restriction fragment length polymorphisms in a Japanese family with a high incidence of essential hypertension.
Renin in essential hypertension.
Renin inhibition improves pressure natriuresis in essential hypertension.
Renin inhibition with A-64662: effect on blood pressure and hormonal response in man.
Renin levels and cardiovascular morbidity in essential hypertension. A prospective study.
Renin levels and cardiovascular morbidity: a prospective study of the effect of beta-adrenergic blocking drugs.
Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women.
Renin profile, race, and antihypertensive efficacy with atenolol and labetalol.
Renin profiling for diagnosis and treatment of hypertension.
Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone.
Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients.
Renin reactivity in plasma of patients with normal renin and low renin essential hypertension.
Renin reactivity, renin activity and renin concentration in patients with normal and low renin essential hypertension.
Renin release in patients with benign essential hypertension.
Renin stimulation during clonidine therapy in "low renin" essential hypertension.
Renin subgroups in essential hypertension.
Renin subgroups in essential hypertension. Further analysis of their pathophysiological and epidemiological characteristics.
Renin subgroups in essential hypertension: an analysis and critique.
Renin suppressibility and blood pressure response during acute sodium loading in patients with essential hypertension.
Renin suppression by saline is blunted in nonmodulating essential hypertension.
Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension.
Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
Renin, aldosterone, sodium and potassium in essential hypertension.
Renin, calcium metabolism and the pathophysiologic basis of antihypertensive therapy.
Renin, kallikrein and prostaglandin renal systems in normotensive boys with and without a family history of essential hypertension.
Renin, prorenin and the kidney: a new chapter in an old saga.
Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
Renin-hyporesponsiveness in essential hypertension. Dissociation between plasma renin and catecholamines or aldosterone following furosemide.
Reninlike enzymes in human vasculature.
Renovascular hypertension. Relationship between hepatic blood flow and plasma renin activity.
Renovascular hypertension: does the renal vein renin ratio predict operative results?
Reproducibility of plasma renin activity (PRA) profile in essential hypertension patients.
Response of several adrenal steroids to ACTH stimulation in essential hypertension.
Response to the captopril test is dependent on baseline renin profile.
Responses of catecholamines and blood pressure to beta-blockade in diuretic-treated patients with essential hypertension.
Responses of plasma catecholamine and plasma renin activity after glucagon stimulation in essential hypertension.
Responsiveness of the renin-aldosterone system during exercise in young patients with essential hypertension.
Restriction fragment length polymorphisms of the human renin gene: association study with a family history of essential hypertension.
Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
Role of 18-hydroxylated cortisols in hypertension.
Role of atrial natriuretic polypeptides for exaggerated natriuresis in essential hypertension.
Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension--some old and recent findings.
Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effects of converting enzyme inhibitor, alacepril.
Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertension.
Role of the aldosterone system in the salt-sensitivity of patients with benign essential hypertension.
Role of the renin-angiotensin-aldosterone system in hypertensive children with coarctation of the aorta.
Role of vascular wall renin: intracellular and extracellular mechanism.
Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Lack of hypotensive effects of inhibition of renin, converting enzyme, and angiotensin II receptor blocker after bilateral nephrectomy.
Salt and hypertension: water-sodium handling in essential hypertension.
Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension.
Salt sensitivity of hypertension and responses to angiotensin converting enzyme inhibition with benazepril.
Saralasin infusion in the recognition of renovascular hypertension.
Saralasin test as a diagnostic and prognostic aid in renovascular hypertensive patients subjected to renal operation.
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Sensitive direct radio-immunoassay for human renin.
Sequential changes in plasma renin activity and plasma catecholamines in mildly hypertensive patients during acute, furosemide-induced body-fluid loss.
Ser9Gly polymorphism in the dopamine D3 receptor gene is not associated with essential hypertension in the Japanese.
Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension.
Serum dopamine beta-hydroxylase as an index of sympathetic nervous system activity in man.
Sex differences in the endocrine predictors of essential hypertension. Vasopressin versus renin.
Sex-specific role of CYP24A1 rs2762939 in the risk of essential hypertension based on the serum vitamin D and total renin concentrations.
Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension.
Short-term plasma renin activity suppression by saline and release of a plasma endogenous Na/K ATPase inhibitor in essential hypertension.
Sib pair linkage analysis of renin gene haplotypes in human essential hypertension.
Significance of urinary angiotensinogen in essential hypertension as a function of plasma renin and aldosterone status.
Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension.
Similar frequencies of renin gene restriction fragment length polymorphisms in hypertensive and normotensive subjects.
Single oral administration of captopril may not bring an improvement in screening of primary aldosteronism.
Single-dose captopril scintigraphy in the diagnosis of renovascular hypertension.
Sodium and potassium status, plasma renin and aldosterone profiles in normotensive and hypertensive Johannesburg blacks.
Sodium chloride as regulator of renal prostaglandin E2 production in patients with essential hypertension.
Sodium chloride sensitivity, intracellular sodium concentration in erythrocytes and lymphocytes, and renin profile in essential hypertension.
Sodium chloride, extracellular fluid volume, and blood pressure regulation.
Sodium metabolism in essential hypertension. Natriuretic response to acute hypertonic saline load.
Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin.
Sodium-sensitive essential hypertension: emerging insights into an old entity.
Solitary kidney and ageing as causes of low renin and aldosterone concentrations: relevance to "low-renin" essential hypertension.
Some considerations about evolution of idiopathic primary aldosteronism.
Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity.
Stress, salt and hypertension.
Strong association of a renin intronic dimorphism with essential hypertension.
Strong association of the renin TaqI polymorphism with essential hypertension in Chinese Han and Tibetan populations.
Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
Studies on the activity of the sympathetic nervous system in essential hypertension.
Studies on the mechanism of hypernatriuresis in essential hypertension in relation to measurements of plasma renin concentration, body fluid compartments and renal function.
Studies on the molecular weight of active and inactive renins in essential hypertension.
Study on the renal kallikrein-kinin system in normal and low renin subgroups of essential hypertension.
Suppressed plasma renin activity in essential hypertension. Roles of plasma volume, blood pressure, and sympathetic nervous system.
Suppression of plasma renin activity by indomethacin in man.
Sympathetic activity in borderline and established hypertension in the elderly.
Sympathetic nerve activity in low renin essential hypertension.
Sympathetic nerve activity in patients with essential hypertension--a comparison of the activity among patients with labile and stable, or low, normal and high renin essential hypertension.
Sympathetic nerve activity, plasma renin activity and water-sodium balance in obese patients with essential hypertension.
Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
Systemic and regional hemodynamics in patients with salt-sensitive hypertension.
Systemic and renal haemodynamics, body fluids and renin in benign essential hypertension with special reference to natural history.
Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
T235 variant of the angiotensinogen gene and blood pressure in the Chilean population.
The antihypertensive efficacy of hydrochlorothiazide is not prostacyclin dependent.
The changes in active and inactive renin induced by various maneuvers in hypertensive patients.
The concept of autoregulation of total blood flow and its role in hypertension.
The contact phase of blood coagulation and renin activation in essential hypertension before and after captopril.
The effct of propranolol on plasma renin activity and blood pressure in mild essential hypertension.
The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension.
The effect of age on active and cryoactivatable inactive plasma renin in normal subjects and patients with essential hypertension.
The effect of beta-adrenergic blockade on patterns of urinary sodium excretion, blood pressure and plasma renin activity in patients with essential and renovascular hypertension.
The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
The effect of chronic prazosin therapy on the response of the renin-angiotensin system in patients with essential hypertension.
The effect of furosemide stimulation on renin secretion and its application in examining activity of the renin-angiotensin system.
The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension.
The effect of inhibition of prostaglandin synthesis on plasma renin activity and blood pressure in essential hypertension.
The effect of mental stress on catecholamines, their metabolites and plasma renin activity in patients with essential hypertension and in healthy subjects.
The effect of ouabain on pressor responses to infused noradrenaline in patients with essential hypertension.
The effect of pindolol on plasma renin activity in patients with essential hypertension.
The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.
The effects of a beta 1-blocking agent, atenolol, on blood pressure, plasma renin activity and prostaglandin F2 alpha excretion in patients with essential hypertension.
The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension.
The effects of clonidine and propranolol, separately and in combination, on blood pressure and plasma renin activity in essential hypertension.
The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
The excretion of human urinary kallikrein quantity and activity in normal and low renin subgroups of essential hypertension.
The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.
The influence of nifedipine treatment on counter-regulatory mechanisms in essential hypertension.
The integrated concentration of plasma renin activity and aldosterone in essential hypertension.
The intravenous furosemide test: a simple way to evaluate renin responsiveness.
The kidney and essential hypertension.
The mechanism of low-renin hypertension: aldosterone response to sodium restriction and upright posture, angiotensin II, ACTH and potassium in patients with hypertension.
The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects.
The multiple factors affecting plasma renin activity in essential hypertension.
The pathophysiological role of digitalis-like substance in essential hypertension.
The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertension.
The pathophysiological role of renal dopaminergic activity in patients with essential hypertension.
The patient with mild to moderate essential hypertension: peripheral renin activity and a comparative drug study.
The physiology of renin secretion in essential hypertension. Estimation of renin secretion rate and renal plasma flow from peripheral and renal vein renin levels.
The place of the calcium antagonist verapamil in antihypertensive therapy.
The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.
The postural plasma renin activity response in essential hypertension and primary hyperaldosteronism.
The pressor response to angiotensin II in patients with low renin essential hypertension.
The prognostic implication of plasma renin activity in untreated essential hypertension.
The prognostic implications of plasma renin in essential hypertension.
The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man.
The relation of the natriuretic hormone to essential hypertension.
The relationship of blood pressure to hospitalization, dietary sodium and serum renin in essential hypertension.
The relationship of plasma renin, angiotensin, and aldosterone levels to blood pressure variability and target organ damage in children with essential hypertension.
The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.
The renin system and new understanding of the complications of hypertension and their treatment.
The renin system for long-term control over vasoconstriction and sodium-volume homeostasis in the spectrum of hypertension: three new frontiers in research.
The renin-aldosterone system and thiazide-induced depletion of total body potassium in essential hypertension.
The renin-aldosterone system in exaggerated natriuresis of essential hypertension.
The renin-angiotensin system and hypertension.
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
The renin-angiotensin-aldosterone system and carotid artery disease in mild-to-moderate primary hypertension.
The role of endogenous digitalis-like factor in blood pressure regulation in essential hypertension.
The role of plasma angiotensin I converting enzyme in regulation of renin-angiotensin system activity in patients with essential hypertension.
The role of renin - angiotensin system in prothrombotic state in essential hypertension.
The role of sympathetic activity in normal renin essential hypertension.
The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertension.
The salivary sodium/potassium ratio in hypertension: relation to race and plasma renin activity.
The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
The substitutive role of ACTH in supporting aldosterone response to head-up tilt during acute renin suppression in patients with essential hypertension.
The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone.
The urinary excretion of prostaglandins E2 and F2 alpha in essential hypertension.
The vasodilating effect of atrial natriuretic peptide in normotensive and hypertensive humans.
Thiazide induced hypotension: the role of plasma volume reduction and the urinary kallikrein system.
Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy.
Time course of the changes in active and cryoactivatable renin in response to acute stimuli before and after diuretic therapy in man.
Time dependency of the antihypertensive efficacy of the new renin inhibitor Ro 42-5892.
Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
Triamterene-induced changes in aldosterone and renin values in essential hypertension. Evidence of a role for aldosterone in preventing blood pressure reduction.
Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.
Up-regulation in the expression of renin gene by the influence of aluminium.
Updated Report on Comparative Effectiveness of ACE inhibitors, ARBs, and Direct Renin Inhibitors for Patients with Essential Hypertension: Much More Data, Little New Information.
Updates on the treatment of essential hypertension: a summary of AHRQ's comparative effectiveness review of angiotensin- converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors.
Ureteral catheterization studies.
Urinary excretion of TXB2 after angiotensin converting enzyme inhibition in hypertensive patients.
Urinary kallikrein activity in the hypertension of renal parenchymal disease.
Urinary kallikrein and salt sensitivity in essential hypertensive males.
Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism.
Urinary kallikrein in normal renin essential hypertension.
Urinary prostaglandin and sodium metabolism in patients with essential hypertension.
Urinary prostaglandins and kallikrein in essential hypertension.
Utilization and Tolerability of Aliskiren (Rasilez) in the Primary Care Setting in England.
Variation of plasma and kidney renin activities among substrains of spontaneously hypertensive rats.
Vascular haemodynamic effects of perindopril in essential hypertension.
Vascular renin in hypertension.
Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.
Volume-pressure relationships during development of mineralocorticoid hypertension in man.
Why use angiotensin converting enzyme inhibitors to lower blood pressure?
Will renin inhibitors influence decision-making in antihypertensive therapy?
Within the Brain: The Renin Angiotensin System.
[A reduced aldosterone response to infused angiotensin II in low renin essential hypertension (author's transl)]
[Action of verapamil on renin activity in essential hypertension]
[Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone]
[Acute response to calcium inhibitors in secondary arterial hypertension: does renin play a role?]
[Acute treatment of arterial hypertension using calcium antagonists: comparison between diltiazem and nifedipine]
[Advances concerning aliskiren, direct renin inhibitor and aliskiren-hydrochlorothiazide]
[Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension]
[Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)]
[Anterior pituitary-adrenal axis in essential hypertension with distinct plasma renin activity]
[Association analysis of the essential hypertension susceptibility genes in adolescents: Kangwha study]
[Association of aldosterone synthase gene -344T/C polymorphism with plasma aldosterone and angiotensin II concentration in hypertensive patients]
[Atrial natriuretic peptide (ANP) in essential hypertension: a humoral marker for salt sensitivity and hypertensive heart disease at a clinically asymptomatic stage?]
[Behavior of blood volume and electrolytes in patients with essential hypertension with low plasmatic renin activity (PRA). Effects of treatment with propranolol]
[Behavior of cardiac output, plasma volume, plasma renin activity and aldosterone secretion in patients with essential hypertension treated with beta-blocking agents and diuretics]
[Behavior of the plasma renin activity and aldosterone after salt restriction and upright posture in essential hypertension]
[Behaviour of plasma renin activity during long-term treatment with propranolol (author's transl)]
[Blood pressure and renin activity in essential hypertension under pindolol]
[Blood pressure, renin, angiotension II and catecholamines in the plasma of healthy subjects and patients with essential hypertension before and after beta blockade]
[Blood volume, plasma renin activity and plasma aldosterone concentration in patients with essential hypertension who were treated for more than ten years (author's transl)]
[Calcium and hypertension]
[Cardiovascular regulation as a function of age. Determinants of antihypertensive treatment based on beta-blockers and calcium inhibitors]
[Changes in plasma neuropeptides before and after clonidine in patients with essential hypertension]
[Changes in responses of blood pressure and several hormones to infusions of angiotensin II and angiotensin III in patients with essential hypertension]
[Changes in sodium metabolism in essential hypertension patients]
[Changes in the indicators of the renin-angiotensin-aldosterone system, kallikrein-kinin system and arterial blood pressure in elderly patients with essential hypertension treated with captopril]
[Changes in water-electrolyte balance and central hemodynamics in hypertensive crises]
[Circadian rhythm of the renin-angiotensin-aldosterone system: a summary of our research studies]
[Classifying renin activity and angiotensin II levels in essential hypertension (clustering analysis)]
[Clinical application of ARB and ACEI]
[Clinical observation of 12 cases of primary aldosteronism, special reference to the diagnostic problem (author's transl)]
[Comparative evaluation of the efficacy of methods of cryo- and trypsin activation of inactive renin in vitro]
[Concentration of adrenocorticotrophic hormone and aldosterone secretion in essential hypertension and hyperaldosteronism]
[Concentration of somatotropic hormone in the blood in arterial hypertension of different origin]
[Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension]
[Correlation between plasma aldosterone concentration and aldosterone urinary excretion in essential hypertension with normal, high and low plasma renin activity]
[Correlation of the total activity of blood plasma renin with levels of active and inactive renin, angiotensinogen and angiotensin II under different functional loads in patients with hypertension]
[Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside]
[Correlations between blood pressure, blood volume, plasma renin and urinary catecholamines in normal subjects and in patients with benign essential hypertension]
[Critical analysis of the saralasintest in the diagnosis of hypertension (author's transl)]
[Current status of vaccination therapy for hypertension].
[Decreased excitability of renin secretion in patients with essential hypertension]
[Diagnosis of essential hypertension with primary elevated blood renin and treatment with captopril]
[Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
[Different reaction of plasma renin activity after propranolol in essential and renal hypertension]
[Does the captopril test improve the diagnosis of primary hyperaldosteronism?]
[Dopamine-beta-hydroxylase activity, aldosterone level, and plasma renin activity in patients with essential hypertension during exposure to physical load (author's transl)]
[Dyshomogeneity of responses of cryo-activated renin to orthostatism in normotensive subjects and those with essential hypertension]
[Effect of 12-week treatment with amlodipine on plasma renin activity and adrenal cortex function in patients with essential hypertension]
[Effect of a chronic alpha adrenergic receptor blockade on basal secretion of renin in essential hypertension]
[Effect of age on active and inactive plasma renin levels in normal subjects and in patients with essential hypertension (author's transl)]
[Effect of carbon baths on blood pressure level of aldosterone, renin, minerals in the blood and catecholamines in the urine of patients with essential hypertension]
[Effect of changes of posture, beta-blocking agents and the cold pressure test on the levels of plasma renin activity (PRA) in essential hypertension with low serum renin]
[Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)]
[Effect of chronic beta-receptor blockade in blood pressure and renin and aldosterone secretion in essential hypertension]
[Effect of chronic enalapril treatment on prorenin, renin and sex hormones during the menstrual cycle in patients with essential hypertension]
[Effect of dietary salt restriction and erect posture on plasma renin activity and aldosteronemia in patients with essential hypertension]
[Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]
[Effect of intravenous sodium chloride load on levels of atrial natriuretic peptide (ANP) and 3'5' guanosine monophosphate (cGMP) in plasma of patients with uncomplicated sodium-sensitive arterial hypertension maintained on different dietary sodium intake]
[Effect of nifedipine treatment on the renin-aldosterone system and secretion of cortisol and growth hormone in patients with essential hypertension]
[Effect of oral sodium load on the renin and aldosterone secretion in essential hypertension. Comparison to normal persons]
[Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension]
[Effect of potassium canrenoate on arterial pressure, plasma renin activity and urinary aldosterone in essential hypertension]
[Effect of Prindolol on intra-arterial pressure and plasma renin activity in essential hypertension]
[Effects of angiotensin I converting enzyme inhibitor (captopril) on blood pressure, pulse rate, plasma renin activity, and plasma aldosterone concentration in patients with essential hypertension and normal subjects]
[Effects of diltiazem on hemodynamics, plasma catecholamine and renin activity during exercise in hypertension]
[Effects of excessive salt-loading on blood pressure, plasma norepinephrine concentration, plasma renin activity, plasma aldosterone concentration and urinary aldosterone excretion in patients with essential hypertension and normotensive subjects]
[Effects of phenylephrine on atrial natriuretic factor and the renin-aldosterone axis in normal patients and essential hypertensive patients]
[Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency]
[Effects of potassium on renin and aldosterone]
[Effects of water immersion and captopril on secretion of atrial natriuretic peptide and the activity of the renin-angiotensin system in essential hypertension]
[Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)]
[Electrolyte balance, plasma renin concentration and reaction of blood pressure in patients with essential hypertension and control subjects during therapy with metolazone, a new diuretic]
[Endocrine arterial hypertension. Primary hyperaldosteronism]
[Endogenic activation of prorenin in hypertension]
[Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)]
[Essential hypertension and diabetes]
[Essential hypertension with low and high renin levels. Comparison of the results of long-term therapy]
[Essential hypertension with low levels of plasma renin activity: effects of propranolol on aldosteronemia, plasma volume and electrolyte balance]
[Essential hypertension with low plasmatic renin activity (PRA). Effects of propranolol on arterial pressure and reninemia]
[Essential hypertension with low plasmatic renin activity (PRA). Effects of propranolol on some indices of adrenergic system activity]
[Essential hypertension with reduced renin activity]
[Essential hypertension: Renin and aldosterone, key to pathogeny and therapy?]
[Evaluation of plasma renin activity and urinary excretion of aldosterone in patients with essential hypertension treated with D-L propranolol]
[Evaluation of the differences in responsiveness of plasma renin activity to five different stimulations in essential hypertension (author's transl)]
[Evaluation of the plasma renin activity and urinary aldosterone excretion in patients with essential hypertension treated with spironolactone. Note II]
[Evaluation of the renin angiotensin mechanism in experimental renovascular, human and essential hypertension. Usefullness of the analogs]
[Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach]
[Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)]
[Exercise hemodynamics and renin before and after acute beta block in patients with essential hypertension]
[Free urinary cortisol is elevated in patients with low-renin essential hypertension]
[Functional dependence of prostaglandin F2alpha concentration and plasma renin activity in essential hypertension (author's transl)]
[Functional status of the sympathetic nervous system in patients with essential hypertension and low as well as normal plasma renin]
[Hemodynamic changes in essential hypertension with normal, high and low renin level]
[High and low renin levels in essential hypertension: opposite extremes of sensitivity of the juxtaglomerular beta-adrenoreceptors to adrenergic stimulation]
[High-dose spironolactone therapy in essential hypertension patients with low plasma renin]
[Hormonal aspects of the pathogenesis of arterial hypertension in young obese patients]
[Hormone profile of the essential hypertension patient with ischemic cardiopathy. I. Renin, angiotensin and aldosterone]
[Incidence of suppressed plasma renin concentration in a population of patients with essential hypertension (author's transl)]
[Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension]
[Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)]
[Interrelationships between renin and arterial pressure in subjects with essential hypertension under diuretic treatment: effect of addition of oxprenolol and indomethacin]
[Juvenile essential hypertension. II. Plasma renin activity and levels of aldosterone at rest and after loading in children with juvenile essential hypertension]
[Level of prostaglandins, cyclic nucleotides, renin and aldosterone in the plasma of patients with essential hypertension]
[Long-term behavior of plasma renin activity in patients with essential hypertension]
[Long-term effects of nifedipine on blood pressure, cardiac dynamics, and plasma renin activity in patients with essential hypertension]
[Low renin essential hypertension]
[Low renin variant of hypertension: functional relations of the renin-aldosterone pressor system]
[Microsatellite marker AGAT of the mineralocorticoid receptor gene is associated with plasma renin activity in patients with essential hypertension.]
[Mutual interaction of the renin-angiotensin system and the atrial natriuretic factor in the renal response to acute volume loading]
[Nature of the reaction of blood plasma steroid hormones in hypertension to various types of stimulation]
[OP.4B.03] CIRCULATING ALDOSTERONE LEVELS ARE ASSOCIATED WITH CONCENTRIC LEFT VENTRICULAR GEOMETRY IN ESSENTIAL HYPERTENSIVE PATIENTS.
[Orthostatic changes of plasma renin levels, circulatory mechanics and kidney function as well as of plasma catecholamines in normal individuals and patients with essential hypertension]
[Oxoprenolol and plasmatic renin activity in essential hypertension: preliminary data]
[Pathogenesis of essential hypertension with low renin (author's transl)]
[Pathogenesis of essential hypertension with suppressed plasma renin activity]
[Pathogenesis of essential hypertension. Plasma noradrenaline, plasma renin and pressor effects of noradrenaline and angiotensin in normotensive patients and patients with essential hypertension]
[Pathogenetic, pathophysiological and biochemical aspects of essential hypertension (author's transl)]
[Pathophysiology and laboratory examinations of essential hypertension--a review of recent topics]
[Pattern of aldosterone and catecholamines in patients with essential hypertension and differnet plasma renin activity]
[Physiopathological study of low renin essential hypertension]
[Plasma adrenaline and noradrenaline in essential and renal hypertension (author's transl)]
[Plasma and urine steroids in essential hypertension with normal and suppressed renin and in primary hyperaldosteronism. Changes after ACTH stimulation]
[Plasma corticoids during renin releasing test in low renin essential hypertension]
[Plasma renin activity and aldosterone excretion in patients with essential hypertension, with hypertension in bilateral adrenal cortex hyperplasia and with aldosterone-producing adrenal cortex adenomas following various sodium tolerance tests]
[Plasma renin activity and aldosterone in patients with essential hypertension]
[Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure]
[Plasma renin activity in essential hypertension with respect to aging, hypertension severity and furosemide test (author's transl)]
[Plasma renin activity in essential hypertension: different short- und long-term effects of diuretics (author's transl)]
[Plasma renin activity in essential hypertension]
[Plasma renin activity in patients with essential hypertension. 1. Results]
[Plasma renin activity in patients with essential hypertension]
[Plasma renin activity in patients with sodium-responsive and unresponsive essential hypertension]
[Plasma renin activity, aldosterone and adrenergic activity in patients with hypertension and in normotensives with a family history of hypertension]
[Plasma renin activity, creatinine and uric acid in the serum of patients with essential hypertension]
[Plasma renin activity, plasma volume extracellular fluid volume and cardiac output in essential hypertension (author's transl)]
[Plasma renin and noradrenalin levels during hypotensive therapy using acebutolol (author's transl)]
[Plasma renin level, clinical findings and association of apoplexy in essential hypertension]
[Plasma volume, extracellular fluid volume and heart minute volume in subjects with essential hypertension with low plasma renin activity]
[Proceedings: The effect of beta receptor treatment with pindolol on the plasma renin activity and the left-ventricular dynamics in essential hypertension]
[Prostaglandins in the renal vascular bed in arterial hypertension of different etiologies]
[Radioimmunologic determination of aldosterone and renin in the blood in the diagnosis of different forms of arterial hypertension]
[Recent progress of diagnosis and treatment of primary aldosteronism].
[Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension]
[Reduced urinary prostaglandin E2-excretion and diminished responsiveness of plasma renin activity in patients with essential hypertension (author's transl)]
[Reflex influences on renal secretion of renin in essential hypertension]
[Relation between atrial natriuretic factor and the renin-angiotensin-aldosterone system in the renal reaction to acute volume loading in patients with essential hypertension]
[Relation between erythropoietin production and plasma renin activity in patients with essential hypertension]
[Relation between traditional Chinese medicine differential types and plasma levels of renin, angiotension II, aldosterone, atrial natriuretic factor in patients with essential hypertension]
[Relation of plasma renin activity and angiotensin II level and traditional Chinese medicine differentiation in essential hypertension]
[Relations between blood insulin concentration, renin-angiotensin-aldosterone system and clinical picture of hypertension]
[Relations between hypotensive effect and modifications of volemia and plasma renin activity in patients with essential hypertension treated using spironolactone]
[Renal response to acute volume expansion in primary hyperaldosteronism]
[Renal vein plasma renin activity in patients with essential hypertension and renovascular hypertension]
[Renin activity in plasma and kidneys upon sudden death of hypertension patients]
[Renin aldosterone profile in essential hypertension during pregnancy and after delivery]
[Renin and age, determinants of the beta-blocker effect in essential hypertension]
[Renin classification based on epidemiologic and biochemical factors in essential hypertension]
[Renin grouping in essential hypertension: a comparison of various conditions of stimulation (author's transl)]
[Renin plasma profile and sodium sensitivity of blood pressure in hypertensive patients with or without a family history of hypertension]
[Renin, angiotensin II, catecholamines and blood pressure in healthy subjects and in patients with essential hypertension prior and following beta-blockade]
[Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives]
[Renin-angiotensin-aldosterone system in hypertension patients who have had a cerebral stroke]
[Restriction fragment length polymorphism of human renin gene in essential hypertension]
[Results of radioimmunologic determination of renin activity and the concentration of angiotensin II in the plasma of hypertensive patients]
[Role of prostaglandins in the antihypertensive effect of the converting enzyme inhibitor, enalapril]
[Role of renal prostaglandins in the mechanism of renin release in patients with essential hypertension]
[Role of renin angiotensin system in the vasopressor mechanisms of hypertension--gene analyses and tissue renin angiotensin system]
[Several indicators of hormonal homeostasis (hypophysis--gonads) in patients with hypertension]
[Short-term effects of a treatment with methoprolol (a selective beta 1-blocking agent) in essential hypertension. Changes of haemodynamics, renin, aldosterone, sodium and potassium balance (author's transl)]
[Significance of renal dopamine on pathogenesis of essential hypertension]
[Sodium metabolism in essential hypertension. Renin subgroups and changes of urinary sodium excretion caused by furosemide]
[Studies of the effect of bromocriptine on the serum prolactin, aldosterone and cortisol levels and plasma renin activity in patients with essential hypertension]
[Studies on 17-alpha-hydroxylase deficiency--including etiological consideration on low renin essential hypertension]
[Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III]
[Studies on the blood pressure control mechanism in essential hypertension: the relation of plasma norepinephrine concentrations to plasma renin activity and haemodynamics (author's transl)]
[Studies on the role of the central and peripheral sympathetic nervous system and the renin-aldosterone system on the onset and maintenance of high blood pressure in essential hypertension]
[Systemic arterial hypertension: pathogentic role of the sympathetic nervous system]
[Temporal aspects of the function of the renin-angiotensin-aldosterone system. Contribution to the methodological standardization of explorative test (author's transl)]
[The circadian rhythm of serum aldosterone in the diagnostics of primary aldosteronism]
[The Diagnostic Value of Captopril Challenge Test for Primary Aldosteronism].
[The effect of a submaximal physical load on the beta 2-adrenoreceptor-dependent adenylate cyclase system of the lymphocytes in hypertension]
[The effect of acupuncture on endocrine regulation in hypertensive patients]
[The effect of clonidine on humoral factors in patients with arterial hypertension]
[The effect of naloxone on plasma renin activity in patients with essential hypertension treated with clonidine]
[The influence of aging on renin release stimulated by furosemide and upright posture in essential hypertension (author's transl)]
[The influence of propranolol, practolol and theophylline on the plasma renin activity (author's transl)]
[The influence of water immersion on serum erythropoietin concentration in patients with essential arterial hypertension]
[The level of plasma endothelin-1 in patients with essential hypertension]
[The renin-aldosterone system in essential hypertension--hypotensive action of beta adrenergic blocking agents and variation of the renin-aldosterone system (author's transl)]
[The renin-angiotensin system and its inhibition (author's transl)]
[The renin-angiotensin system and the sympathetic nervous system in essential hypertension]
[The role of exchangeable sodium content of the body in cases of hypertension of various etiology]
[The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)]
[The role of sympathetic beta-adrenergic receptor on renin secretion in essential hypertension]
[The treatment of severe arterial hypertension in patients with chronic kidney failure with captopril and beta-adrenoblockaders]
[The value of renin determination in the diagnosis of hypertension]
[The x-ray endovascular treatment of renin-dependent arterial hypertension with secondary aldosteronism in patients without vasorenal involvement]
[Total blood volume in essential and secondary hypertension]
[Total body potassium in low renin essential hypertension with reference to the renin-angiotensin-aldosterone system (author's transl)]
[Treatment of essential hypertension with spironolactone with reference to the plasma renin activity]
[Uncontrolled arterial hypertension: pharmaco-economic interest of hospital diagnostic work-up]
[Vascular changes in essential hypertension after treatment with enalapril]
Exanthema
A comparison of the effects of renin inhibition and angiotensin converting enzyme inhibition upon bradykinin potentiation.
Exfoliation Syndrome
Evaluation of renin and angiotensin II levels in pseudoexfoliation syndrome.
Eye Diseases
Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye.
Factor XII Deficiency
Captopril-induced changes on active and inactive renin in a patient with factor XII congenital deficiency.
Fatty Liver
Analysis of various etiologies of hypertension in patients hospitalized in the endocrinology division.
Angiotensinogen Exerts Effects Independent of Angiotensin II.
Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model.
The prorenin receptor and its soluble form contribute to lipid homeostasis.
Therapeutic effects of the direct renin inhibitor, aliskiren, on non-alcoholic steatohepatitis in fatty liver Shionogi ob/ob male mice.
Fetal Diseases
Atrial natriuretic factor, digoxin-like immunoreactive substance, norepinephrine, epinephrine, and plasma renin activity in human fetuses and their alteration by fetal disease.
Plasma renin activity in fetal disease.
Fetal Growth Retardation
Alterations in the 'local umbilical cord blood renin-angiotensin system' during pre-eclampsia.
Altered serum soluble furin and prorenin receptor levels in pregnancies with pre-eclampsia and fetal growth restriction.
Differential roles of renin and angiotensinogen in the feto-maternal interface in the development of complications of pregnancy.
Evaluation of the renin-angiotensin-aldosterone system in pregnancy complicated by preeclampsia with and without intrauterine growth retardation.
Function of the renin-angiotensin-aldosterone system in relation to electrolyte balance in the small-for-date neonate.
Immunosuppression improves blood pressure and endothelial function in a rat model of pregnancy-induced hypertension.
Intrauterine growth restriction is associated with persistent juxtamedullary expression of renin in the fetal kidney.
Placental insufficiency and fetal growth restriction lead to postnatal hypotension and altered postnatal growth in sheep.
Fetal Hypoxia
The effect of fetal hypoxia on adrenocortical function in the 7-day-old rat.
Fetofetal Transfusion
Renin is activated in monochorionic diamniotic twins with birthweight discordance who do not have twin-to-twin transfusion syndrome.
Fibroma
Mesenteric desmoid-type fibromatosis causing secondary hypertension in a young woman.
Fibromuscular Dysplasia
1D.11: RENAL MICROVASCULATURE AND RENIN SECRETION IN HUMANS WITH MULTIFOCAL RENAL ARTERY FIBROMUSCULAR DYSPLASIA.
Differences in renal hemodynamics and renin secretion between patients with unifocal and multifocal fibromuscular dysplasia.
High renin hypertension in focal renal fibromuscular dysplasia: turn off of renin system angiotensin overactivation by renal angioplasty cured high blood pressure and quickly reversed myocardial hypertrophy.
Lateralization of renal blood flow and renin secretion in fibromuscular dysplasia.
Percutaneous transluminal angioplasty of the renal arteries.
Percutaneous transluminal renal angioplasty (PTRA) as a method of therapy for renovascular hypertension in children.
Renal vein prostaglandins in renovascular hypertensive patients.
Successful blood pressure control with additive administration of eplerenone, an aldosterone receptor blocker, in a patient with bilateral renovascular hypertension treated with angioplasty.
[Early and late results of percutaneous transluminal angioplasty of renal artery stenoses]
[Lateralization of renin secretion in renovascular hypertension with bilateral arterial stenosis]
[Prognostic factors in percutaneous transluminal dilatation of the renal arteries in renovascular hypertension]
[Reno-vascular hypertension surgery and renal: systemic renin index (author's transl)]
Follicular Cyst
Analysis of latent forms of renin using antibodies raised against the propart segment of human prorenin: validation with representative samples of ovarian cyst and follicular fluids.
Renin and ovarian vascularization in cows with follicular cysts after epidural administration of a GnRH analogue.
Ganglioneuroma
Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Gastrointestinal Diseases
Systemic inhibition of the angiotensin-converting enzyme limits lipopolysaccharide-induced lung neutrophil recruitment through both bradykinin and angiotensin II-regulated pathways.
Gastrointestinal Hemorrhage
Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients.
Genetic Diseases, Inborn
A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis.
Apparent mineralocorticoid excess.
Expanding the spectrum of genetic mutations in antenatal Bartter syndrome type II.
Hormonal hypertension in children: 11beta-hydroxylase deficiency and apparent mineralocorticoid excess.
Liddle's disease: abnormal regulation of amiloride-sensitive Na+ channels by beta-subunit mutation.
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess.
Two novel homozygous missense mutations identified in the BSND gene in Moroccan patients with Bartter's syndrome.
Uromodulin biology and pathophysiology - an update.
Genital Diseases, Female
Plasma dehydroepiandrosterone-to-cortisol ratios as an indicator of stress in gynecologic patients.
Gestational Trophoblastic Disease
Clinical syndromes associated with tumors of the female genital tract.
Gingival Overgrowth
Angiotensin II Levels in Gingival Tissues from Healthy Individuals, Patients with Nifedipine Induced Gingival Overgrowth and Non Responders on Nifedipine.
Gitelman Syndrome
Diagnosis of a case of Gitelman's syndrome based on renal clearance studies and gene analysis of a novel mutation of the thiazide-sensitive Na-Cl cotransporter.
It is never too late for a genetic disease: ?a case of a 79-year-old man with persistent hypokalemia.
Loss of sodium chloride co-transporter impairs the outgrowth of the renal distal convoluted tubule during renal development.
Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity.
Review and Analysis of Two Gitelman Syndrome Pedigrees Complicated with Proteinuria or Hashimoto's Thyroiditis Caused by Compound Heterozygous SLC12A3 Mutations.
[Chondrocalcinosis and hypomagnesaemia in a patient with a new mutation in the gene of the thiazide-sensitive Na-Cl cotransporter]
[The Bartter-like syndrome in 2 twins]
Glaucoma
Effect of SPP 635, a renin inhibitor, on intraocular pressure in glaucomatous monkey eyes.
Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes.
Evaluation of Systemic Renin and Angiotensin II Levels in Normal Tension Glaucoma.
Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma.
Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model.
The comparison study of renin and angiotensin A II levels on normal tension glaucoma patients and normal individuals.
Therapeutic targets of renin-angiotensin system in ocular disorders.
[New developments in glaucoma medical treatment]
Glaucoma, Neovascular
Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma.
Glaucoma, Open-Angle
Aqueous humor renin, angiotensin I, and angiotensin II activity in primary open-angle glaucoma.
Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma.
Glioblastoma
Regulation of aminopeptidase A in human brain tumor vasculature: evidence for a role of transforming growth factor-beta.
Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma.
Renin in glioblastoma multiforme and its role in neovascularization.
Glioma
Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line.
Renin and angiotensin: the complete system within the neuroblastoma x glioma cell.
Renin angiotensin system and its role in biomarkers and treatment in gliomas.
Sex differences exist in brain renin-angiotensin system-regulating aminopeptidase activities in transplacental ethyl-nitrosourea-induced gliomas.
The renin-angiotensin system in hybrid NG108-15 cells. Renin gene is from mouse neuroblastoma, angiotensinogen and angiotensin-converting enzyme genes are of rat glioma origin.
Glomerulonephritis
Atrial natriuretic factor in the acute nephritic and nephrotic syndromes.
Clinical relevance of urinary angiotensinogen and renin as potential biomarkers in patients with overt proteinuria.
Direct inhibition of plasmatic renin activity with aliskiren: a promising but under-investigated therapeutic option for non-diabetic glomerulonephritis.
Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
Effects of indomethacin on the renal function and renin-aldosterone system in chronic glomerulonephritis.
Elevated plasma catecholamines in hypertensives with primary glomerular diseases.
Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis.
Hypertension in primary glomerulonephritis without renal insufficiency.
Interrelationships between sodium clearance, plasma aldosterone, plasma renin activity, renal hemodynamics and blood pressure in renal disease.
Issues in glomerulonephritis and renin system.
Issues in Glomerulonephritis and Renin System: Contributions to Nephrology, vol 43.
Juxtaglomerular cell tumor with retroperitoneal fibrosis and secondary immune-complex glomerulonephritis: a possible contribution of the renin angiotensin system to renal fibrosis.
Local delivery of a direct renin inhibitor into the kidney ameliorates progression of experimental glomerulonephritis.
Nephrotic syndrome and abdominal arterial bruits in a young hypertensive patient: a case report.
PCR analysis of human renal biopsies--renin gene regulation in glomerulonephritis.
Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension.
Plasma renin activity and hypertension in acute glomerulonephritis.
Plasma renin activity and prognosis in patients with chronic glomerulonephritis treated without hemodialysis.
Plasma renin activity in acute poststreptococcal glomerulonephritis and the haemolytic-uraemic syndrome.
Renin gene expression in human kidney biopsies from patients with glomerulonephritis or graft rejection.
Renin release and the juxtaglomerular apparatus in chronic renal failure due to glomerulonephritis.
Renin-angiotensin-aldosterone system in nephrotic syndrome.
Renoprotective Effects of Direct Renin Inhibition in Glomerulonephritis.
Steroid-induced hypertension in patients with nephrotic syndrome.
The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
Two Cases of Proliferative Glomerulonephritis With Monoclonal IgG Deposits Treated With Renin Angiotensin Inhibition Alone With Long-term Follow-up.
[A study on the pathogenesis of hyporeninemia in diabetics]
[Behavior of sodium and water excretion and of plasma renin activity (PRA) after administration of furosemide in patients with glomerulonephritis with various degrees of functional deficiency and arterial pressure levels]
[Changes in the renin-angiotensin-aldosterone system in glomerulonephritis]
[Clinical studies of hypertension in chronic glomerulonephritis. 2. Hypertension in the uremic phase: relationship between hemodynamic changes and plasma renin activity during hemodialysis]
[Correlations between heart rate variability, renin activity and plasma aldosteron concentration in chronic glomerulonephritis with intact function of the kidneys]
[Plasma aldosterone and plasma renin activity in patients with essential and renal hypertension under acute stimulation with saline depletion and acute suppression with saline infusion]
[Plasma renin activity and prognosis of chronic glomerulonephritis without hemodialysis treatment]
[Plasma renin activity in glomerulonephritis]
[Radioimmunologic studies of glomerulonephritis in children]
[Renal gene expression of renin and transforming growth factor Beta 1 in children with glomerulonephritis]
[Renal prostaglandins in glomerulonephritis in children]
[The morphofunctional parallels in arterial hypertension in patients with chronic glomerulonephritis]
[Value of extracorporeal radioimmunoassay in children with nephrotic syndrome]
[Vasoactive factors in chronic glomerulonephritis]
Glomerulonephritis, IGA
Abnormalities of renin-containing cells in human glomerular and vascular renal diseases.
Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy.
Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.
Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs.
Expression of prorenin receptor in renal biopsies from patients with IgA nephropathy.
Genetics of immunoglobulin A nephropathy.
Hypotensive and natriuretic actions of adrenomedullin in subjects with chronic renal impairment.
IgA nephropathy and inhibitors of the renin angiotensin system: is reduction in proteinuria adequate proof of efficacy?
Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system.
Mesangial medium with IgA1 from IgA nephropathy inhibits nephrin expression in mouse podocytes.
Prominent hyperplasia of renin-producing juxtaglomerular apparatus after chronic and complete blockade of the renin-angiotensin system in adult IgA nephropathy.
Selective hypoaldosteronism due to combined defects of the conversion from inactive renin to active renin and the aldosterone biosynthesis from corticosterone.
Successful Use of Aliskiren in a Case of IgA- Mesangial Glomerulonephritis Unresponsive to Conventional Therapies.
Glomerulonephritis, Membranoproliferative
A novel role of renin inhibitor in the complement cascade.
[The morphofunctional parallels in arterial hypertension in patients with chronic glomerulonephritis]
Glomerulonephritis, Membranous
Abnormalities of renin-containing cells in human glomerular and vascular renal diseases.
WT1 Is Necessary for the Proliferation and Migration of Cells of Renin Lineage Following Kidney Podocyte Depletion.
Glomerulosclerosis, Focal Segmental
Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis.
Role of autophagy and evaluation the effects of microRNAs 214, 132, 34c and prorenin receptor in a rat model of focal segmental glomerulosclerosis.
The role of kidney biopsy in diagnosis of preeclampsia in kidney transplant patients.
WT1 Is Necessary for the Proliferation and Migration of Cells of Renin Lineage Following Kidney Podocyte Depletion.
Glomus Tumor
[Juxtaglomerular cell tumor of the kidney: a clinicopathologic analysis of five cases]
Glucagonoma
[The glucagonoma syndrome. Review of the literature. Apropos of a case]
Glucose Intolerance
(Pro)renin receptor and insulin resistance: Possible roles of angiotensin II-dependent and -independent pathways.
Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes.
Association of arginine vasopressin-secreting cell, steroid-secreting cell, adrenal and islet cell antibodies in a patient presenting with central diabetes insipidus, empty sella, subclinical adrenocortical failure and impaired glucose tolerance.
Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion.
Chronic inhibition of 11 ? -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome.
Energy metabolism in human renin-gene transgenic rats: does renin contribute to obesity?
EXPRESSION AND NUTRITIONAL REGULATION OF THE (PRO)RENIN RECEPTOR IN RAT VISCERAL ADIPOSE TISSUE.
Prorenin/renin and insulin resistance.
Transgenic mice overexpressing Renin exhibit glucose intolerance and diet-genotype interactions.
[Arterial hypertension caused by low renin: comparison of the calcium antagonist nifedipine and the ACE-inhibitor enalapril as to antihypertensive efficacy]
glutamyl aminopeptidase deficiency
Knockout of aminopeptidase A in mice causes functional alterations and morphological glomerular basement membrane changes in the kidneys.
Glycosuria
Increased integrated concentration of norepinephrine, epinephrine, aldosterone, and growth hormone in patients with uncontrolled juvenile diabetes mellitus.
Goiter
[Regulation of aldosterone secretion in thyrotoxicosis. Thyroid hormones as possible stimulators of the activity of the renin-angiotensin-aldosterone system]
[State of the renin-angiotensin-aldosterone system in thyroid pathology based on the results of radioimmunoassay]
Gonadal Dysgenesis
Hyperreninemia and hypertension observed during Kaufmann therapy of patients with gonadal dysgenesis and hypopituitarism.
Graves Disease
Cardiovascular effects of thyroxine in combination with methimazole in premenopausal female Graves' disease patients: case-control study.
Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease.
[Aldosterone response to various stimuli in hyperthyroidism: in vivo and in vitro studies]
Guillain-Barre Syndrome
A case of Guillain-Barré syndrome accompanied by sympathetic overactivity and hypertensive encephalopathy.
Raised plasma renin activity in the hypertension of the Guillain-Barré syndrome.
Hallucinations
Visual hallucinations related to angiotensin-converting enzyme inhibitor use: case reports and review.
Hamartoma
Epithelial liver hamartoma, systemic arterial hypertension and renin hypersecretion.
Hearing Loss
Serum Renin Levels in Sudden Sensorineural Hearing Loss.
Hearing Loss, Sensorineural
Serum Renin Levels in Sudden Sensorineural Hearing Loss.
Heart Arrest
Accidental shock during epidural anesthesia in a patient with NSAID-induced hyporeninemic hypoaldosteronism.
Heart Defects, Congenital
Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease.
Plasma renin activity in infants with congenital heart disease.
Heart Diseases
Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency.
Activation of the renin-angiotensin system in heart failure and hypertrophy--studies in human hearts and transgenic rats.
Additive effects of a sodium chloride restricted diet and furosemide administration in healthy dogs.
Aldosterone and renin in cardiac patients referred for catheterization.
Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease.
Changes in plasma renin activity and haemodynamics during vasodilator therapy in conscious dogs with myocardial infarction or chronic volume overload.
Effect of the partial beta-agonist prenalterol on plasma renin activity in patients with left ventricular failure.
Elevated baseline renin levels as a possible cause of worse prognosis of COVID-19 in patients with heart disease.
Expression of renin and angiotensin-converting enzyme in human hearts.
Gene variants of the renin angiotensin aldosterone system for risk stratification in heart disease.
Hydrogen and potassium regulation of (pro)renin processing and secretion.
Influence of physical training on blood pressure, plasma renin, angiotensin and catecholamines in patients with ischaemic heart disease.
Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease.
Plasma renin activity in men with relation to the presence of ischaemic heart disease.
Plasma renin activity in patients with ischaemic heart disease.
Renin inhibition: a new modality for hypertension management.
Renin: at the heart of the mast cell.
Silencing of the Na+/H+ exchanger 1(NHE-1) prevents cardiac structural and functional remodeling induced by angiotensin II.
The effect of conjugated estrogens on the renin-angiotensin system.
The influence of acute blood volume changes on plasma renin activity in man.
The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013?
Unimpeded plasma renin increase after intravenous furosemide during saline replacement.
Vasopeptidase inhibitors.
[Endocrine response to extracorporeal circulation]
[Indices of sympathetic-adrenal system and renin activity in ischemic heart disease before and after obzidan treatment]
[Peculiarities of the renin-angiotensin-aldosterone-system in elderly patients with ischaemic heart diseases (author's transl)]
[The role of DNA polymorphism in the renin-angiotensin system and the pathogenesis of cardiovascular diseases]
[To the question of prognostic significance of plasma renin activity. Mean values in normotensive and hypertensive men with ischemic heart disease (author's transl)]
Heart Failure
"Blockade Of Renin Angiotensin System In Heart Failure Post-Myocardial Infarction: What Is The Best Therapy?"
18 F-Labeled Derivatives of Irbesartan for Angiotensin?II Receptor PET Imaging.
A comparison of plasma renin activity levels in patients with and without congestive heart failure after myocardial infarction.
A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
A continued method performance monitoring approach for the determination of pediatric renin samples - application within a European clinical trial.
A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
A decade of angiotensin-converting enzyme (ACE) inhibition.
A possible mechanism for the progression of chronic renal disease and congestive heart failure.
A practical approach to the management of heart failure.
A Primer to Angiotensin Peptide Isolation, Stability, and Analysis by Nano-Liquid Chromatography with Mass Detection.
A quality control system for ligand-binding assay of plasma renin activity: Proof-of-concept within a pharmacodynamic study.
A simplified technique for the production of heart failure in the dog by rapid ventricular pacing.
A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension.
ACE2 and Apelin-13: Biomarkers with a Prognostic Value in Congestive Heart Failure.
ACE2 gene expression is up-regulated in the human failing heart.
Action of endogenous atrial natriuretic peptide in calves with experimental acute central venous congestion and low cardiac output.
Activation of neurohumoral systems following acute myocardial infarction.
Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency.
Activation of the renin-angiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy.
Activity of the renin-angiotensin-aldosterone and sympathetic nervous system and their relation to hemodynamic and clinical abnormalities in infants with left-to-right shunts.
Acute changes in plasma renin activity, plasma aldosterone concentration and plasma electrolyte concentrations following furosemide administration in patients with congestive heart failure--interrelationships and diuretic response.
Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients.
Adding High-Dose Spironolactone to Tolvaptan Improves Acute Decompensated Heart Failure Due to Obstructive Hypertrophic Cardiomyopathy and Aortic Stenosis: A Case Report.
Adrenomedullin and heart failure.
Adriamycin cardiomyopathy in the rabbit: an animal model of low output cardiac failure with activation of vasoconstrictor mechanisms.
Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
Aldosterone status associates with insulin resistance in patients with heart failure-data from the ALOFT study.
Aldosterone, Renin, Cardiovascular Events, and All-Cause Mortality Among African Americans: The Jackson Heart Study.
Aliskiren attenuates myocardial apoptosis and oxidative stress in chronic murine model of cardiomyopathy.
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure.
Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure.
Alterations of the renin angiotensin system in human end-stage heart failure before and after mechanical cardiac unloading by LVAD support.
Altered effects of angiotensin ii type 1 and type 2 receptor blockers on cardiac norepinephrine release and inotropic responses during cardiac sympathetic nerve stimulation in aorto-caval shunt rats.
Angiotensin and bradykinin peptides in rats with myocardial infarction.
Angiotensin II in the evolution of experimental heart failure.
Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.
Angiotensin II receptor blockade and ventricular remodelling.
Angiotensin II type 1 receptor induced signal-transduction pathways as new targets for pharmacological treatment of the renin-angiotensin system.
Angiotensin II, but not aldosterone and renin, correlates positively with increased concentrations of N-terminal pro-brain natriuretic peptide in patients with chronic heart failure.
Angiotensin II-mediated vasoconstriction in chronic congestive heart failure, and response to converting enzyme inhibition.
Angiotensin III: a physiological relevant peptide of the renin angiotensin system.
Angiotensin receptors: physiology and pharmacology.
Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition.
Anti-necrotic and cardioprotective effects of a cytosolic renin isoform under ischemia-related conditions.
Aortic input impedence and neurohormonal activation in patients with mild to moderate chronic congestive heart failure.
Association between Cardiovascular Drugs and Chronic Kidney Disease in Non-Institutionalized Elderly Patients.
Association of hyponatremia with increased renin activity in chronic congestive heart failure: impact of diuretic therapy.
Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure.
AT1-receptor blockade, but not renin inhibition, reduces aneurysm growth and cardiac failure in fibulin-4 mice.
Atrial fibrillation in primary aldosteronism.
Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
Atrial natriuretic peptide in congestive heart failure.
Atrial natriuretic peptide, aldosterone, and plasma renin activity in peripartum heart failure.
Atrial natriuretic peptide, renin and aldosterone in obstructive lung disease and heart failure.
Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure.
Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide.
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?
Blockade of the renin angiotensin system in heart failure: the potential place of angiotensin II receptor blockers.
Blood pressure and renin angiotensin system responses to initiation of treatment with captopril or losartan in heart failure.
Bradykinin pathway is involved in acute hemodynamic effects of enalaprilat in dogs with heart failure.
Caffeine increases renal renin secretion in a rat model of genetic heart failure.
Caffeine potentiates vasodilator-induced renin release.
Captopril in congestive heart failure resistant to other vasodilators.
Captopril in heart failure.
Cardiac failure, the kidney, renin and atrial peptides.
Cardiac gene expression profile in rats with terminal heart failure and cachexia.
Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.
Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease.
Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
Cardiovascular actions of atrial natriuretic factor in sheep with cardiac failure.
Cardiovascular and neuroendocrine responses to water immersion in compensated heart failure.
Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era.
Cardiovascular prostaglandins: some comments on their involvement in circulatory physiology and pathophysiology.
Cardiovascular responses to graded treadmill exercise during the development of doxorubicin induced heart failure in rabbits.
Central hemodynamic effects of diuretic therapy in chronic heart failure.
Central mechanisms of abnormal sympathoexcitation in chronic heart failure.
Changes in control of renin release in congestive heart failure in dogs: response to acute and chronic vasodilator therapy.
Clinical and hemodynamic improvement of congestive heart failure by long-term vasodilator therapy with postjunctional alpha 1-adrenoceptor blockade.
Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction.
Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure.
Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure.
Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.
Combination Angiotensin Converting Enzyme and Direct Renin Inhibition in Heart Failure following Experimental Myocardial Infarction.
Combination Therapy of Renin Angiotensin System Inhibitors and ?-Blockers in Patients with Heart Failure.
Combined use of direct renin inhibitor and carvedilol in heart failure with preserved systolic function.
Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure.
Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction.
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Comparison of the effect of renin inhibition and angiotensin-converting enzyme inhibition in ovine heart failure.
Concentration of renin in renal venous blood in patients with chronic heart failure.
Concurrent alpha 1 adrenergic blockade and angiotensin converting enzyme inhibition in the treatment of congestive heart failure.
Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade.
Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment.
Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Correlation between aortic pulse wave velocity and norepinephrine, epinephrine, aldosterone and plasma renin activity in very elderly subjects and in patients with congestive heart failure.
Critical angioedema induced by a renin angiotensin system blocker in the contemporary era of increasing heart failure: A case report and commentary.
Current status of dual Renin Angiotensin aldosterone system blockade for the treatment of cardiovascular diseases.
Current Strategies to Achieve Further Cardiac and Renal Protection through Enhanced Renin-Angiotensin-Aldosterone System Inhibition.
Cytosolic renin is targeted to mitochondria and induces apoptosis in H9c2 rat cardiomyoblasts.
Development of a novel murine heart failure model overexpressing human renin and angiotensinogen.
Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
Differential effects of theophylline on sympathetic excitation, hemodynamics, and breathing in congestive heart failure.
Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
Direct renin inhibition exerts an anti-hypertrophic effect associated with improved mitochondrial function in post-infarction heart failure in diabetic rats.
Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study.
Direct renin inhibitor ameliorates insulin resistance by improving insulin signaling and oxidative stress in the skeletal muscle from post-infarct heart failure in mice.
Direct Renin Inhibitor Attenuates Left Ventricular Remodeling in Post-Myocardial Infarction Heart Failure Mice.
Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor.
Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction.
Disruption of the relationship between renin and atrial natriuretic peptide early in the course of ventricular dysfunction.
Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease.
Dissociation of the responses of the renin-angiotensin system and sympathetic nervous system to a vasodilator stimulus in congestive heart failure.
Diuretic therapy in congestive heart failure.
DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.
Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure.
Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction).
Effect of Aliskiren in Patients with Heart Failure According to Background Dose of ACE Inhibitor: A Retrospective Analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) Trial.
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial.
Effect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart Failure.
Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure.
Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure-prone SHHF/Mcc- fa cp rats.
Effect of the partial beta-agonist prenalterol on plasma renin activity in patients with left ventricular failure.
Effectiveness of low dose captopril versus propranolol therapy in infants with severe congestive failure due to left-to-right shunts.
Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
Effects of acetylsalicylic acid on renal function in patients with chronic heart failure.
Effects of aging on neuroendocrine activation in subjects and patients in the presence and absence of heart failure with left ventricular systolic dysfunction.
Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
Effects of bucindolol in heart failure.
Effects of bucindolol on neurohormonal activation in congestive heart failure.
Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Effects of captopril on pulmonary haemodynamics.
Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure.
Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
Effects of indomethacin in conscious dogs with experimental high-output heart failure.
Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure.
Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure.
Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure.
Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.
Effects of vagal blockade on neurohumoral systems in conscious dogs with heart failure.
Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial.
Efficacy of aliskiren supplementation for heart failure : A meta-analysis of randomized controlled trials.
Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.
Elevated level of erythropoietin in congestive heart failure relationship to renal perfusion and plasma renin.
Elevated plasma amylase levels in advanced chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy: correlation with circulating interleukin-6 activity.
Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT).
Emerging treatments for hypertension: potential role for vasopeptidase inhibition.
Endocrine mechanisms in congestive cardiac failure. Renin, aldosterone and atrial natriuretic hormone.
Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure.
Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy.
Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5' leader sequence of the receptor mRNA.
Evidence for a direct renal stimulating effect of prostaglandin E2 on renin release in patients with congestive heart failure.
Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure.
Evolving concepts of the intrarenal renin-angiotensin system in health and disease: contributions of molecular biology.
Experimental models of heart failure: implications for renin and the kidney.
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure.
Expression of type II cGMP-dependent protein kinase in rat kidney is regulated by dehydration and correlated with renin gene expression.
Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.
Further studies on the effect of intracellular angiotensins on heart cell communication: on the role of endogenous angiotensin II.
Gene polymorphism of angiotensin-converting enzyme and angiotensin II type 1 receptor in patients with congestive heart failure.
Guideline-Recommended Medications and Physical Function in Older Adults with Multiple Chronic Conditions.
Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure.
Haemodynamic and neurohumoral response in heart failure produced by rapid ventricular pacing.
Haemodynamic effects of aliskiren in decompensated severe heart failure.
Heart and lung hypertrophy, changes in blood volume, hematocrit and plasma renin activity in rats chronically exposed to increasing carbon monoxide concentrations.
Heart Failure and Changes in Kidney Function: Focus on Understanding, Not Reacting.
Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
Heart Failure and the Renin System: A Comprehensive Approach.
Heart failure: role of cardiovascular reflexes.
Hemodynamic and hormonal effects of renin inhibition in ovine heart failure.
Hemodynamic and neurohumoral effects of ibopamine in patients with chronic congestive heart failure.
Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hemodynamic and neurohumoral responses to dynamic exercise: normal subjects versus patients with heart disease.
Hemodynamic changes and renal plasma flow in early heart failure: implications for renin, aldosterone, norepinephrine, atrial natriuretic peptide and prostacyclin.
Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
Hemodynamic effects of captopril in patients with severe chronic heart failure.
Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure.
Hemodynamic effects of renin inhibitors.
Hepatic clearance of renin after angiotensin blockade.
Hepatic clearance of renin in canine experimental models for low- and high-output heart failure.
High renin in heart failure: a manifestation of hyponatremia.
High-output heart failure in the dog: systemic and intrarenal role of angiotensin II.
Historical perspectives on the renin-angiotensin-aldosterone system and angiotensin blockade.
Hormonal changes in patients with severe chronic congestive heart failure treated by ultrafiltration.
How Dangerous Is Hyperkalemia?
Hydrogen Sulfide Prevents Heart Failure Development Via Inhibition of Renin Release from Mast Cells in Isoproterenol-Treated Rats.
Hypersecretion of renin in dogs with a chronic aortic-caval fistula and high-output heart failure.
Hyponatraemia as a marker for high renin heart failure.
Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
Ibopamine in the treatment of heart failure.
Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics.
Identification of risk factors predisposing to the development of functional renal insufficiency during treatment with converting-enzyme inhibitors in chronic heart failure.
Immediate converting-enzyme inhibition with intravenous enalapril in chronic congestive heart failure.
Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis.
Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection Fraction.
Impaired response of plasma vasopressin to orthostatic stress in patients with congestive heart failure.
In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive pattern.
In vivo and in vitro effects of atrial natriuretic peptide on renin release.
Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system.
Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
Increased plasma angiotensinogen in cardiac transplantation patients.
Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors.
Increased renin immunostaining in preglomerular arterioles after myocardial infarction in the rat.
Increased susceptibility to structural acute kidney injury in a mouse model of presymptomatic cardiomyopathy.
Incremental Predictive Value of Plasma Renin Activity as a Prognostic Biomarker in Patients with Heart Failure.
Inflammation - Cause or Consequence of Heart Failure or Both?
Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure.
Inhibition of the renin-angiotensin-aldosterone system in heart failure: new insights from basic clinical research.
Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?
Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists.
Interaction between atrial natriuretic peptide, renin system and vasopressin in heart failure.
Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
Interactions between the renin-angiotensin system and the parasympathetic nervous system in heart failure.
Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure.
Interrupting the adaptive changes in congestive heart failure.
Intracellular angiotensin II disrupts chemical communication and impairs metabolic cooperation between cardiac myocytes.
Intrarenal distribution of blood flow and renin in chronic congestive heart failure.
Is the renin system necessary?
Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment?
Kidney Response to Chemotherapy-Induced Heart Failure: mRNA Analysis in Normotensive and Ren-2 Transgenic Hypertensive Rats.
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Lesson XXIV: on the major roles of the renin system in the pathogenesis of hypertension and of its sequelae, heart attack, heart failure, kidney failure, and stroke: replies to commonly asked questions.
Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
Long-term treatment of congestive heart failure with captopril.
Low angiotensinogen levels are related to the severity and liver dysfunction of congestive heart failure: implications for renin measurements.
Low- and High-renin Heart Failure Phenotypes with Clinical Implications.
Management of hypertension and heart failure in patients with Addison's disease.
Marked suppression of renin levels by beta-receptor blocker in patients treated with standard heart failure therapy: a potential mechanism of benefit from beta-blockade.
MicroRNA involvement in immune activation during heart failure.
Mildly Increased Renin Expression in the Absence of Kidney Injury in the Murine Transverse Aortic Constriction Model.
Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol.
Molecular biology and pathophysiology of the intrarenal renin-angiotensin system.
Myocardial angiotensin receptors in human hearts.
Myocardial beta-adrenoceptors in pacing-induced heart failure: regulation by enalapril?
Myocardial infarction, heart failure and sympathetic nervous system activity: new pharmacological approaches that affect neurohumoral activation.
Neonatal renal arterial embolism syndrome.
Neuroendocrine activation after acute myocardial infarction.
Neuroendocrine activity in congestive heart failure.
Neuroendocrine activity in untreated heart failure.
Neuroendocrine changes in heart failure and their clinical relevance.
Neuroendocrine response to standing and mild exercise in patients with untreated severe congestive heart failure and chronic constrictive pericarditis.
Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
Neurohormonal modulation in heart failure: ACE inhibition and beyond.
Neurohumoral activation during exercise in congestive heart failure.
Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms.
Neurohumoral and hemodynamic effects of lower body negative pressure in patients with congestive heart failure.
Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure.
Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study.
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.
Neurohumoral interactions contributing to renal vasoconstriction and decreased renal blood flow in heart failure.
Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction rats.
Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
New roles for renin and prorenin in heart failure and cardiorenal crosstalk.
New therapeutic prospects of renin-angiotensin system inhibition.
Normalizing Plasma Renin Activity in Experimental Dilated Cardiomyopathy: Effects on Edema, Cachexia, and Survival.
Novel angiotensin II inhibitors in cardiovascular medicine.
Novel therapies in acute and chronic heart failure.
Novel treatment strategy with direct renin inhibition against heart failure.
On the local cardiac renin angiotensin system. Basic and clinical implications.
One year temporal pattern of neurohumoral factors and natriuretic peptides compared with clinical variables in patients with dilated cardiomyopathy.
Optimising ACE inhibitor therapy of congestive heart failure. Insights from pharmacodynamic studies.
Patiromer: The First Potassium Binder Approved in Over 50 Years.
Persistence of myocardial failure following removal of chronic volume overload.
Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension.
Pharmacology of angiotensin-converting enzyme inhibitors as a guide to their use in congestive heart failure.
Pharmacology of renin inhibitors and their application to the treatment of hypertension.
Pharmacotherapy in congestive heart failure: Effect of the insertion/deletion polymorphism of the ACE gene on response to ACE inhibitors in patients with heart failure.
Physiology of the renal baroreceptor mechanism of renin release and its role in congestive heart failure.
Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension.
Plasma aldosterone and renin activity.
Plasma atrial natriuretic factor in low output heart failure syndromes.
Plasma cyclic guanosine monophosphate in chronic heart failure: hemodynamic and neurohormonal correlations and response to nitrate therapy.
Plasma hormones in patients with chronic heart failure before and early after orthotopic heart transplantation.
Plasma levels of renin and aldosterone in right-sided congestive heart failure due to canine dirofilariasis.
Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF.
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.
Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Plasma renin activity and its association with ischemic heart disease, congestive heart failure, and cerebrovascular disease in a large hypertensive cohort.
Plasma renin activity and plasma concentrations of norepinephrine and cyclic nucleotides in heart failure after prazosin.
Plasma renin activity in chagasic patients with and without congestive heart failure.
Plasma renin activity in heart failure-prone SHHF/Mcc-facp rats.
Plasma renin activity in infants with congenital heart disease.
Plasma renin activity in patients with heart failure and reduced ejection fraction on optimal medical therapy.
Plasma Renin Activity Is a Strong and Independent Prognostic Indicator in Patients With Acute Decompensated Heart Failure Treated With Renin-Angiotensin System Inhibitors.
Plasma Renin Activity Is an Independent Prognosticator in Patients With Myocardial Infarction.
Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.
Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial.
Plasma renin in chronic experimental heart failure and during renal sodium "escape" from mineralocorticoids.
Plasma renin in congestive heart failure in man.
Possible regulation of renin release by ANP in dogs with heart failure.
Possible role of juxtaglomerular apparatus in low cardiac output syndrome and multiple organ failure: modulation by high sodium load.
Posture determines the nature of the interaction between angiotensin converting enzyme inhibitors and loop diuretics in patients with chronic cardiac failure.
Potassium homeostasis and Renin-Angiotensin-aldosterone system inhibitors.
Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study.
Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.
Prognostic value of plasma catecholamines, plasma renin activity, and plasma atrial natriuretic peptide at rest and during exercise in congestive heart failure: comparison with clinical evaluation, ejection fraction, and exercise capacity.
Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.
Prognostic value of plasma renin activity in heart failure.
Prognostic value of renin and prorenin in heart failure patients with decreased kidney function.
Progress in Primary Aldosteronism: Translation on the Move.
Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding.
Prostaglandins, renin and atrial natriuretic peptide in the control of the circulation and renal function in heart failure in the dog.
Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.
Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure.
RAS inhibition in resident fibroblast biology.
Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling.
Rationale, background, and design of the randomized angiotensin receptor antagonist--angiotensin-converting enzyme inhibitor study (RAAS).
Reduction of cardiac endothelin-1 by angiotensin II type 1 receptor antagonist in viral myocarditis of mice.
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism.
Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat.
Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease.
Relationship between Soluble (pro)Renin Receptor and Renin Activity in Patients with Severe Heart Failure.
Relationships between plasma epinephrine, norepinephrine, dopamine and angiotensin II concentrations, renin activity, hemodynamic state and prognosis in acute heart failure.
Renal prostaglandins, renin release, and renal hemodynamic function in high renin states.
Renal studies in chronic congestive heart failure; the role of renin.
Renin - a historical biomarker of heart failure - .
Renin activity and norepinephrine, cation, and water contents of cardiovascular tissue of dogs with congestive heart failure, and ascites.
Renin Activity in Heart Failure with Reduced Systolic Function-New Insights.
Renin and aldosterone in the cardiomyopathic hamster in congestive heart failure.
Renin and angiotensin responses to posture and exercise in elderly patients with heart failure.
Renin angiotensin aldosterone and adrenergic modulation in chronic heart failure: contemporary concepts.
Renin angiotensin blockade in heart failure with preserved ejection fraction: the signal gets stronger.
Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials.
Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: different characteristics from renin angiotensin system-independent hypertrophy.
Renin Feedback Is an Independent Predictor of Outcome in HFpEF.
Renin Genetic Polymorphism in Heart Failure Patients.
Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure.
Renin inhibition in heart failure and diabetes: the real story.
Renin inhibitors in chronic heart failure: the Aliskiren Observation of Heart Failure Treatment study in context.
Renin inhibitors: cardiovascular drugs of the future?
Renin inhibitors: discovery and development. An overview and perspective.
Renin relationships in congestive cardiac failure, treated and untreated.
Renin system activity as a determinant of response to treatment in hypertension and heart failure.
Renin, aldosterone and cardiac decompensation: studies with an oral converting enzyme inhibitor in heart failure.
Renin, renin substrate, angiotensin II, and vasopressin in plasma during treatment with captopril in hypertension and heart failure.
Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).
Revealing the synergistic mechanism of Shenfu Decoction for anti-heart failure through network pharmacology strategy.
Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs.
Rodent models of cardiopulmonary disease: their potential applicability in studies of air pollutant susceptibility.
Role of nisoldipine on blood pressure, cardiac hypertrophy, and atrial natriuretic peptides in spontaneously hypertensive rats.
Role of renin in heart failure and therapeutic potential of direct renin inhibition.
Role of the circulating and tissue-based renin-angiotensin system in the development of heart failure: implications for therapy.
Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function.
Role of vasopressin in experimental congestive cardiac failure.
Role of vasopressin in experimental heart failure.
S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
Safety and efficacy of nesiritide in pediatric heart failure.
Secondary Prevention Beyond Hospital Discharge for Acute Coronary Syndrome: Evidence-Based Recommendations.
Sequential neurohumoral measurements in patients with congestive heart failure.
Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure.
Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial).
Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a renin inhibitor). II: A dose-ranging study in patients with congestive heart failure.
Single quantum dot based nanosensor for renin assay.
Stability and inter-relationships of hormone, haemodynamic and electrolyte levels in heart failure in man.
Successful Depressor Effect Concomitant with Complete Normalization of High Renin and Aldosterone Profile by Percutaneous Transluminal Renal Angioplasty in a Patient with Acute Exacerbated Heart Failure with Preserved Ejection Fraction.
Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy.
Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure.
Sympathetic drive stimulating diastolic dysfunction?
TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model.
Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.
Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure.
The activated immune system and the renin-angiotensin-aldosterone system in congestive heart failure.
The acute response of plasma norepinephrine, renin activity, and arginine vasopressin to short-term nitroprusside and nitroprusside withdrawal in patients with congestive heart failure.
The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.
The cardiac renin-angiotensin system in heart failure.
The clinical application of converting enzyme inhibitors.
The clinical potential of renin inhibitors and angiotensin antagonists.
The contribution of the renin-angiotensin system to limb vasoregulation in patients with heart failure: observations during orthostasis and alpha-adrenergic blockade.
The diurnal rhythm of plasma aldosterone and plasma renin activity in patients with congestive heart failure.
The Effect and Mechanism of Chinese Herbal Formula Sini Tang in Heart Failure after Myocardial Infarction in Rats.
The effect of Aliskiren on exercise capacity in older patients with heart failure and preserved ejection fraction: A randomized, placebo-controlled, double-blind trial.
The effects of bromocriptine in patients with congestive heart failure.
The haemodynamic, histopathological and hormonal features of alcoholic cardiac beriberi.
The level of plasma neuroendocrine activity and the concentration of digoxin in the serum of patients with mild chronic heart failure.
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan.
The occurrence of hyperaldosteronism in infants with congestive heart failure.
The renal excretion of prostaglandins and changes in plasma renin during treatment with either sulindac or naproxen in patients with rheumatoid arthritis and thiazide treated heart failure.
The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin.
The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
The renin angiotensin system and endothelial dysfunction in chronic heart failure: role of endogenous fibrinolysis.
The renin system and atrial natriuretic hormone in congestive heart failure.
The role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in mice.
The role of natriuretic peptides in cardioprotection.
The role of Renin Angiotensin system intervention in stage B heart failure.
The role of the renal afferent and efferent nerve fibers in heart failure.
The role of the renin-angiotensin-aldosterone system in heart failure.
The roles of epicardial adipose tissue in heart failure.
Thermal hydrotherapy improves quality of life and hemodynamic function in patients with chronic heart failure.
Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registries.
Traditional heart failure medications and sudden cardiac death prevention: a review.
Treatment of systemic hypertension in patients with pulmonary disease: COPD and asthma.
Tumour necrosis factor alpha in severe congestive cardiac failure.
Uric acid--a marker for systemic inflammatory response in patients with congestive heart failure?
Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Use of beta-blockers in chronic congestive heart failure.
Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.
Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
Usefulness of the Direct and/or Total Bilirubin to Predict Adverse Outcomes in Patients With Acute Decompensated Heart Failure.
Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities.
Vasopeptidase inhibitors.
Vasopressin and renin in high output heart failure of rats: hemodynamic effects of elevated plasma hormone levels.
Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
When Conventional Heart Failure Therapy is not Enough: Angiotensin Receptor Blocker, Direct Renin Inhibitor, or Aldosterone Antagonist?
[A novel agent in the treatment of heart failure with depressed systolic function].
[Activity of the sympathetic nervous system and of the renin-angiotensin system in the acute stage of myocardial infarction]
[Acute and chronic effects of bunazosin in patients with congestive heart failure]
[Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure]
[Advantages and limitations of renin inhibition with aliskiren].
[Angiotensin I receptor blockers for heart failure]
[Atrial natriuretic factor in cardiogenic shock, in hypovolemic shock and in the bradycardia-hypotension syndrome following acute myocardial infarction]
[Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor]
[Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters]
[Atrio-ventricular canal: possibilities of recovery]
[Beta-adrenergic blockers in congestive heart failure: pro et contra?]
[Blood levels of activated renin, aldosterone, catecholamine in congestive heart failure. I. Role of the adrenergic and dopaminergic systems]
[Blood levels of activated renin, aldosterone, catecholamine in congestive heart failure. II. Effects of dopaminergic stimulation with a dopamine agonist: ibopamine]
[Captopril and hypertensive cardiopathy : therapeutic effects and hormonal changes]
[Combined blockade of the renin-angiotensin system].
[Conversion enzyme inhibitors against the progression of renal and vascular diseases: yes but again]
[Correlation of hyponatremia with plasma renin activity, antidiuretic hormone and brain natriuretic peptide in chronic heart failure]
[Development of heart failure after myocardial infarct: changes in plasma renin activity, angiotensin II, catecholamines and atrial natriuretic peptide]
[Does captopril decrease endothelial production of endothelin?]
[Effect of hyperbaric oxygenation on the status of the renin-angiotensin-aldosterone system in chronic circulatory insufficiency in elderly patients with ischemic heart disease]
[Effects of captopril on plasma renin activity angiotensin II and aldosterone level in cardiac failure patients]
[Effects of dopamine infusion on the release of atrial natriuretic factor]
[Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure]
[Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure]
[Hemodynamics associated with the changes in catecholamine, plasma renin activity and antidiuretic hormone in chronic congestive heart failure]
[Hemofiltration and the neurohumoral system in patients with severe heart failure]
[Impact of comorbidities for the treatment of heart failure].
[Indomethacin and furosemide in patients with cardiac insufficiency. Kidney function, the renin-angiotensin system and renal prostaglandins]
[Inhibition of renin-angiotensin-aldosterone system in heart failure, or from CONSENSUS to PARADIGM-HF].
[Interaction between the renin system and parasympathetic nervous system in heart failure]
[Neuroendocrine activation in heart insufficiency II. Can diagnosis be confirmed and prognosis evaluated by a blood test?]
[Neuroendocrine changes in chronic heart failure]
[Neurohumoral regulation in heart failure]
[New pharmacological approaches in heart failure: should we treat the endothelium?]
[Pharmacological basis of antihypertensive drug therapy]
[Plasma renin activity and aldosterone concentration of patients with congestive cardiomyopathy]
[Plasma renin in patients with congestive heart failure]
[Prognostic evaluation in patients with heart failure]
[Prognostic significance of plasma renin activity and aldosterone levels in patients with chronic cardiac insufficiency]
[Recent advances in the investigation of the renin-angiotensin and cardiac natriuretic systems in patients with chronic heart insufficiency]
[Regulation of angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis provides a new target for the treatment of cardiac remodeling and heart failure].
[Regulation of the renin-angiotensin system in congestive heart failure: indications for a total body sodium-dependent regulation of the renin secretion]
[RENIN ACTIVITY AND THE STATUS OF THE JUXTAGLOMERULAR RENAL APPARATUS OF CADAVERS OF LIVER CIRRHOSIS WITH ASCITES AND CONGESTIVE HEART FAILURE PATIENTS.]
[Renin activity, norepinephrine, cations and water content of various cardiovascular tissues in hydropic heart failure in dogs]
[Renin, aldosterone and prostaglandins in heart failure]
[Renin-angiotensin-aldosterone system and heart failure: therapeutic aspects]
[Renin-angiotensin-aldosterone system and vasopressin in adult and aged patients with acquired mitral valve defects]
[SGLT2 inhibitors: A new era for our patients].
[Significance of neuroendocrine parameters in heart failure]
[Symposium on pathophysiology of congestive heart failure. 2. A clinical study of the "water-electrolyte regulation mechanism" in chronic congestive heart failure with emphasis on renin and catecholamine]
[The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure]
[The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure]
[The renin-angiotensin-aldosterone system and antidiuretic hormone in chronic circulatory failure in elderly subjects]
[The renin-angiotensin-aldosterone system in compensated and uncompensated cardiac insufficiency]
[The value of ACE inhibitors in heart failure (mechanism of action)]
[Treatment of heart failure with angiotensin converting enzyme inhibitors]
[Value of captopril in the treatment of systemic arterial and pulmonary hypertension with increased plasma renin in scleroderma]
Heart Failure, Systolic
Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure.
Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study.
Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.
Norepinephrine, plasma renin activity and cardiovascular mortality in systolic heart failure.
Traditional heart failure medications and sudden cardiac death prevention: a review.
Heart Septal Defects, Ventricular
Tetralogy of Fallot repair results in activation of the renin-angiotensin-aldosterone system.
Heart Valve Diseases
[Plasma renin activity and aldosterone concentration of patients with congestive cardiomyopathy]
[Plasma renin concentration in heart valve diseases with large and small blood pressure amplitudes as well as in polyglobulism]
Hemangioblastoma
Erythropoietin in capillary hemangioblastoma. An immunohistochemical study.
Immunohistochemistry of capillary hemangioblastoma. Immunoperoxidase-labeled antibody staining resolves the differential diagnosis with metastatic renal cell carcinoma, but does not explain the histogenesis of the capillary hemangioblastoma.
Hemangioma
Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas.
Expression of Cathepsins B, D, and G in Infantile Hemangioma.
Hemangiopericytoma
[Juxtaglomerular cell tumor of the kidney: a clinicopathologic analysis of five cases]
Hematologic Neoplasms
Renin expression in hematological malignancies and its role in the regulation of hematopoiesis.
Hematuria
A case of secondary hypertension associated with the nutcracker phenomenon.
Nutcracker syndrome accompanied by hypertension: a case report and literature review.
Hemolytic-Uremic Syndrome
Systemic hypertension and plasma renin activity in children with the hemolytic-uremic syndrome.
Hemorrhagic Fever with Renal Syndrome
[Renal hemodynamics and plasma renin activity in hemorrhagic fever with renal syndrome]
Hepatic Encephalopathy
Effects of 5-isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis.
Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B-associated fulminant hepatic failure.
Hepatitis
Atrial natriuretic peptide, arginine vasopressin, and the renin-angiotensin system in carbon tetrachloride-induced hepatitis in rats.
Effect of medical ozone therapy on renal blood flow and renal function of patients with chronic severe hepatitis.
Plasma renin activity and aldosterone concentration in dogs with acquired portosystemic collaterals.
Plasma renin activity and serum aldosterone level in children with acute viral hepatitis.
Relationship between hepatic angiotensinogen mRNA expression and plasma angiotensinogen in patients with chronic hepatitis.
[Plasma renin activity (PRA) in acute viral hepatitis (AVH) and chronic hepatopathies]
[Plasma renin activity in the course of acute viral hepatitis]
[Renin-angiotensin system in acute hepatitis (author's transl)]
[Systemic hyperdynamic circulation and serum hormone concentrations in portal hypertension]
Hepatitis B
Can cyclosporine blood level be reduced to half after heart transplantation?
Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis.
The renin-angiotensin-aldosterone system and vasopressin in early-stage liver cirrhosis after HBV infection in children.
Hepatitis, Chronic
Hypokalemia and sodium retention in patients with diabetes and chronic hepatitis receiving insulin and glycyrrhizin.
[Systemic hyperdynamic circulation and serum hormone concentrations in portal hypertension]
Hepatoblastoma
Renin-producing hepatoblastoma.
Severe hypertension and encephalopathy due to Renin-producing hepatoblastoma.
Hepatomegaly
Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index.
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.
Usefulness of the Direct and/or Total Bilirubin to Predict Adverse Outcomes in Patients With Acute Decompensated Heart Failure.
Hepatorenal Syndrome
Circadian rhythms of plasma atriopeptin, plasma renin activity and plasma aldosterone in patients with hepatorenal syndrome.
Circulatory function and hepatorenal syndrome in cirrhosis.
Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome.
Hepatorenal syndrome. Studies of the effect of vascular volume and intraperitoneal pressure on renal and hepatic function.
Hepatorenal syndrome: a disease mediated by the intrarenal action of renin.
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.
Left Ventricular Function Assessed by Echocardiography in Cirrhosis. Relationship to Systemic Hemodynamics and Renal Dysfunction.
Letter: Renin substrate depletion in hepatorenal syndrome.
Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.
Renin substrate infusions in hepatorenal syndrome.
Role of renal prostaglandins and the effects of nonsteroidal anti-inflammatory drugs in patients with liver disease.
Significance of altered renin substrate in the hepatorenal syndrome.
TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.
Hereditary Sensory and Motor Neuropathy
Linkage analysis of Charcot-Marie-Tooth neuropathy (HMSN type I).
Herpes Simplex
Peptidomimetic design.
Herpes Zoster
Absent aldosterone response to metoclopramide in patients with high spinal cord transection: evidence that metoclopramide stimulates aldosterone secretion through central pathways.
Adrenal and vascular renin-like activity in chronic 'two-kidney, one-clip' hypertensive rats.
Adrenal renin: a possible local hormonal regulator of aldosterone production.
Adrenal renin: a possible local regulator of aldosterone production.
Adrenal renin: regulation and function.
Adrenaline cells of the rat adrenal cortex and medulla contain renin and prorenin.
Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase.
Aldosterone-producing tumors (Conn's syndrome).
An alternative transcript of the rat renin gene can result in a truncated prorenin that is transported into adrenal mitochondria.
Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat.
Calcium antagonists and responsiveness of the adrenal glands to aldosterone-releasing stimuli in hypertensive patients.
Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Characterization of zona glomerulosa function in patients with classic and non-classic forms of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
Concurrent hypercortisolism and hypermineralocorticoidism.
Different effects of chronic K+ depletion on forebrain and peripheral angiotensin II receptors in young rats.
Effect of atrial natriuretic factor (ANF) on the secretory activity of zona glomerulosa in sodium-restricted rats.
Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice.
Effects of synthetic atrial natriuretic factor (ANF) on renin-aldosterone axis in the conscious newborn calf.
Evidence for extracellular, but not intracellular, generation of angiotensin II in the rat adrenal zona glomerulosa.
Evidence that endogenous somatostatin (SRIF) exerts a tonic inhibitory effect on the rat renin--angiotensin--aldosterone system.
Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism.
Further investigations on the atrial natriuretic factor (ANF)-induced inhibition of the growth and steroidogenic capacity of rat adrenal zona glomerulosa in vivo.
Immunohistological evidence for renin in human endocrine tissues.
In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.
Influence of captopril on fluid and electrolyte balances and adrenocortical responses during sodium deprivation in the rat.
Mineralocorticoids in congenital adrenal hyperplasia.
Multiple forms of immunoreactive renin in human adrenocortical tumour tissue from patients with primary aldosteronism.
Paracrine Regulation of Aldosterone Secretion in Physiological and Pathophysiological Conditions.
Presence of renin within intramitochondrial dense bodies of the rat adrenal cortex.
Production of rat renin fusion protein in Escherichia coli and the preparation of renin-specific antisera.
Prohormone convertase PC5 is a candidate processing enzyme for prorenin in the human adrenal cortex.
Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity.
Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma.
Regulation of adrenal renin messenger ribonucleic acid by dietary sodium chloride.
Regulation of renin gene expression in rat adrenal zona glomerulosa cells.
Regulation of the adrenal renin angiotensin system in cultured bovine zona glomerulosa cells: effect of catecholamines.
Renin-angiotensin system in the adrenal.
Selective hypoaldosteronism: a study of steroid biosynthetic pathways under adrenocorticotrophin and angiotensin II infusion.
Severe hyperaldosteronism in neonatal Task3 potassium channel knockout mice is associated with activation of the intraadrenal renin-angiotensin system.
Steroid characteristics of mineralocorticoid adrenocortical hypertension.
Structural studies of the adrenal zona glomerulosa and renal juxtaglomerular apparatus in pregnant sheep.
Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism.
Suppression of adrenal renin in Dahl salt-sensitive rats.
The conversion of corticosterone to aldosterone is the site of the oxygen sensitivity of the bovine adrenal zona glomerulosa.
The effect of oxygen on aldosterone release from bovine adrenocortical cells in vitro: PO2 versus steroidogenesis.
The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
The renin-angiotensin-aldosterone system. Past, present and future.
The role of adrenal medulla in endogenous dopaminergic inhibition of aldosterone secretion.
The use of theophylline as an in vivo probe of adrenocortical function.
Transforming growth factor-beta 1 inhibits aldosterone and stimulates adrenal renin in cultured bovine zona glomerulosa cells.
Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model.
Urotensin II Exerts Pressor Effects By Stimulating Renin And Aldosterone Synthase Gene Expression.
Vascular and adrenal reninlike activity in chronically diabetic rats.
[Diabetic nephropathy and isolated hyporeninemic hypoaldosteronism]
[Drug-induced exacerbation of hypoaldosteronism in autoimmune polyglandular syndrome type 2].
[Effect of carperitide (alpha-human atrial natriuretic polypeptide) on the cardiovascular system in experimental animals]
[The changes on plasma aldosterone concentration during acute respiratory acidosis in dogs. The relationship to renin-angiotensin system and electrolyte metabolism (author's transl)]
Hodgkin Disease
Hypertension as a paraneoplastic phenomenon in childhood Hodgkin's disease.
Pathobiological aspects of the local bone marrow renin-angiotensin system: a review.
Homozygous Familial Hypercholesterolemia
Effects of K+-deficient diets with and without NaCl supplementation on Na+, K+, and H2O transporters' abundance along the nephron.
Hydatidiform Mole
Expression of renin and angiotensinogen genes in the human placental tissues.
Hydrocephalus
[Massive natriuresis and polyuria after triple craniocervical subarachnoid hemorrhage: cerebral salt wasting syndrome?]
Hydronephrosis
Alterations in glomerular dynamics in congenital, unilateral hydronephrosis.
Arterial hypertension in infants with hydronephrosis. Report of six cases.
Curable hypertension with unilateral hydronephrosis. Studies on the role of circulating renin.
Effect of low sodium intake and ?-blockade on renin synthesis and secretion in mice with unilateral ureteral ligation.
Effects of angiotensin converting enzyme inhibition on glomerular number, juxtaglomerular cell activity and renin content in experimental unilateral hydronephrosis.
Effects of enalapril and Dup753 on renin synthesis in mice with one hydronephrotic kidney.
Hydronephrosis alters cardiac ACE2 and Mas receptor expression in mice.
Hydronephrosis causes salt-sensitive hypertension in rats.
Hypertension and Hydronephrosis: Rapid Resolution of High Blood Pressure Following Relief of Bilateral Ureteric Obstruction.
Hypertension and unilateral hydronephrosis.
Hypertension with elevated renal vein renin secondary to unilateral hydronephrosis.
Impaired nephrogenesis in rats with congenital obstructive uropathy.
Letter: Hydronephrosis, hypertension and plasma renin activity.
Normal renin secretion in hypertensive patients with primarily unilateral chronic hydronephrosis.
Pelvic-ureteric junction obstruction and hypertension with target organ damage: A case report and review of the literature.
Plasma renin activity in children after surgical relief of hydronephrosis.
Plasma Renin in ipsilateral renal vein in patients with chronic unilateral pelvic ureteric junction obstruction.
Prenatally diagnosed unilateral hydronephrosis: prognostic significance of plasma renin activity.
Rapid onset of salt induced hypertension in rats with hereditary hydronephrosis.
Ren1c homozygous null mice are hypotensive and polyuric, but heterozygotes are indistinguishable from wild-type.
Renal hypertension due to hydronephrosis with normal plasma renin activity.
Renin participation in hypertension associated with unilateral hydronephrosis.
Renin-angiotensin system dysregulation in fetuses with hydronephrosis.
Secondary Pseudohypoaldosteronism Associated With Mild Hydronephrosis in a Newborn.
The pattern of plasma renin activity and aldosterone system in patients with sustained hydronephrosis.
Uncompensated polyuria in a mouse model of Bartter's syndrome.
Ureteral catheterization studies.
Vascular versus tubular renin: role in kidney development.
[Hydronephrosis arterial hypertension. Report of 4 cases]
[Hypertension secondary to abdominal mass].
Hydrothorax
Chronic adriamycin treatment and its effect on the cardiac beta-adrenergic system in the rabbit.
Hyperaldosteronism
-344C/T polymorphism of CYP11B2 gene in Italian patients with idiopathic low renin hypertension.
1-adrenoceptor polymorphisms and blood pressure: 49S variant increases plasma renin but not blood pressure in hypertensive patients.
19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
6C.03: A CASE OF SEVERE HYPERALDOSTERONISM CAUSED BY A DE NOVO KCNJ5 MUTATION.
9B.06: COMPARISON BETWEEN ALDOSTERONE AND RENIN MEASUREMENT BY CHEMILUMINESCENT IMMUNOASSAY AND RADIOIMMUNOASSAY FOR THE DIAGNOSIS OF PRIMARY ALDOSTERONISM.
9B.07: EFFECT OF POSTURAL CHANGES ON ALDOSTERONE TO PLASMA RENIN RATIO IN PATIENTS WITH SUSPECTED SECONDARY HYPERTENSION.
A Bartter-like syndrome after jejunoileal bypass for obesity.
A Case of Juxtaglomerular Cell Tumor With Novel Histologic Features.
A case of normotensive primary aldosteronism--comparison with 13 previously experienced cases with hypertension.
A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism.
A Chinese pedigree with glucocorticoid remediable aldosteronism.
A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay for simultaneous quantification of aldosterone, renin activity, and angiotensin II in human plasma.
A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
A new Australian kindred with the syndrome of hypertension and hyperkalaemia has dysregulation of atrial natriuretic factor.
A new diagnostic test for primary aldosteronism.
A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).
A Patient with Bilateral Primary Aldosteronism Refractory to Oral Eplerenone Who Responded to Esaxerenone with Increased Renin Activity.
A pediatric Conn syndrome case.
A primary aldosteronism-like phenotype identified with the aldosterone-to-angiotensin II ratio in black men: the SABPA study.
A Rare Presentation of Primary Hyperparathyroidism with Concurrent Aldosterone-Producing Adrenal Carcinoma.
A renin-secreting tumor.
A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin.
A simplified screening test for differentiating primary aldosteronism from essential hypertension with low plasma renin activity.
A simulation study on renin and aldosterone secretions in primary aldosteronism.
A unique case of a benign adrenocortical tumor with triple secretion of cortisol, androgens, and aldosterone: development of multiple sclerosis after surgical removal of the tumor.
Abnormalities of aldosterone synthesis and action in children.
Abnormality of circulatory reflex and aldosterone response during head-up tilting in patients with primary aldosteronism.
Activated Intrarenal Renin Angiotensin Systems Is the Primary Source of Progressing Renal Damage in Primary Aldosteronism.
Active and inactive renin in low renin states: studies in human plasma.
Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism.
Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
Active, inactive and total renin concentrations in plasma of hypertensive patients.
Acute cerebral hemorrhage normalized plasma renin activity in a patient with primary aldosteronism.
Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.
Adrenal neuroblastoma in an elderly adult: a case report and review of the literature.
Age dependence of the levels of plasma norepinephrine, aldosterone, renin activity and urinary vanillylmandelic acid in normal and essential hypertensives.
Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
Aldosterone and other mineralocorticoids in Bartter's syndrome.
Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.
Aldosterone regulation in primary aldosteronism: differences between adenoma and bilateral hyperplasia.
Aldosterone to Active Renin Ratio as Screening Test for Primary Aldosteronism: Reproducibility and Influence of Orthostasis and Salt Loading.
Aldosterone to Renin Ratio as a Screening Instrument for Primary Aldosteronism in a Middle-Aged Population with Atrial Fibrillation.
Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism.
Aldosterone to renin ratios in the evaluation of primary aldosteronism.
Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Aldosterone-producing adenoma associated with non-suppressed renin: a case series.
Aldosterone-producing adenoma without hypertension: a report of two cases.
Aldosterone-producing tumors (Conn's syndrome).
Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
Aldosterone-to-Renin Ratio and the Relationship Between Urinary Salt Excretion and Blood Pressure in a Community of African Ancestry.
Aldosterone/direct renin concentration ratio as a screening test for primary aldosteronism: A meta-analysis.
Aldosteronism with elevated active renin concentration: Primary versus secondary? Importance of follow-up for the diagnosis.
Aldosteronoma in a dog with polyuria as the leading symptom.
Alpha-h-ANP injection in normals, low renin hypertension and primary aldosteronism.
Alterations in aldosterone secretion and metabolism in low renin hypertension.
Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome.
Amenorrhea and edema.
An Automated Assay for the Clinical Measurement of Plasma Renin Activity by immuno-MALDI (iMALDI).
An LC-MS/MS assay for analysis of equilibrium angiotensin II in human serum.
An unusual case of an aldosterone-producing adenoma in a prepubertal girl with severe post-surgical adrenal suppression.
Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism.
Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
Analytical variation in plasma renin activity: implications for the screening of primary aldosteronism.
Application of 3D printing technology in endophytic reninoma: A case report and literature review.
Are calcium antagonists helpful in the management of primary aldosteronism?
Are Women More at Risk of False-Positive Primary Aldosteronism Screening and Unnecessary Suppression Testing than Men?
Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry.
Associations Between Changes in Plasma Renin Activity and Aldosterone Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism.
Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.
Atrial fibrillation in primary aldosteronism.
Automated Mindray CL-1200i chemiluminescent assays of renin and aldosterone for the diagnosis of primary aldosteronism.
Bartter syndrome. Typical facies and normal plasma volume.
Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin.
Bartter's syndrome. Study of a 52 year old man with evidence for a defect in proximal tubular sodium reabsorption and comments on therapy.
Baseline plasma aldosterone level and renin activity allowing omission of confirmatory testing in primary aldosteronism.
Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.
Biochemical examination of mother's urine is useful for prenatal diagnosis of Bartter syndrome.
Biventricular Cardiac Hypertrophy in a Patient with Primary Aldosteronism and Atrial Septal Defect.
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients.
Captopril v aldosterone to plasma renin activity ratio in screening for primary aldosteronism.
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.
Case detection in primary aldosteronism: high-diagnostic value of the aldosterone-to-renin ratio when performed under standardized conditions.
Change in plasma renin activity by cold storage of plasma in normal subjects and patients with essential hypertension and primary aldosteronism.
Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.
Characterization and Management of Juxtaglomerular Cell Tumor: Analysis of 9 Cases and Literature Review
Childhood primary aldosteronism with bilateral adrenocortical hyperplasia: plasma renin activity as an aid to diagnosis.
Circadian rhythm of plasma renin activity in primary hyperaldosteronism.
Circulating vascular endothelial growth factor and active renin concentrations and prostaglandin E2 urinary excretion in patients with adrenal tumours.
Clinical Evaluation of Assays for Plasma Renin Activity and Aldosterone Measurement by Liquid Chromatography-Tandem Mass Spectrometry.
Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Clinical, biochemical and molecular genetic data in five children with Gitelman's syndrome.
Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism.
Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism.
Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass.
Comparison of the Chemiluminescence Immunoassay LIAISON® with the Radioimmunoassay for Aldosterone and Renin Measurement.
Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.
Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
Concurrent hypercortisolism and hyperaldosteronism due to an adrenal adenoma.
Confirmatory Testing in Primary Aldosteronism.
Conn's syndrome: a simple diagnostic approach.
Consider Beta-blocker withdrawal when using the Aldosterone Renin Ratio for case detection of Primary Aldosteronism.
Continuum of Renin-Independent Aldosteronism in Normotension.
Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
DEMONSTRATION BY PRESSOR AND STEROIDOGENIC ASSAYS OF INCREASED RENIN IN LYMPH OF DOGS WITH SECONDARY HYPERALDOSTERONISM.
Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
Determination of plasma renin concentration by angiotensin I immunoassay. Diagnotic import of precise measurement of subnormal renin in hyperaldosteronism.
Determination of the aldosterone/renin ratio in 269 patients with adrenal incidentaloma.
Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension.
Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism.
Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?
Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.
Diagnosis and treatment of primary hyperaldosteronism.
Diagnosis of hyperaldosteronism.
Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
Diagnosis of secondary forms of hypertension. A comprehensive protocol.
Diagnosis of secondary hypertension: an age-based approach.
Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism.
Diagnostic Accuracy of the Aldosterone-to-Active Renin Ratio for Detecting Primary Aldosteronism.
Diagnostic value of biochemical parameters in the differential diagnosis of an adrenal mass.
Diagnostic value of the post-captopril test in primary aldosteronism.
Differential diagnosis in primary aldosteronism.
Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism.
Does a digoxin-like substance participate in vascular and pressure control during dietary sodium changes in patients with primary aldosteronism?
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.
Effect of alpha-human atrial natriuretic peptide in low renin essential hypertension and primary aldosteronism.
Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
Effect of Atenolol on Aldosterone/Renin Ratio Calculated by Both Plasma Renin Activity and Direct Renin Concentration in Healthy Male Volunteers.
Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
Effect of dibutyryl cyclic AMP on plasma renin activity in normal men and patients with primary aldosteronism.
EFFECT OF HUMAN RENIN ON ALDOSTERONE SECRETION RATE IN NORMAL MAN AND IN PATIENTS WITH THE SYNDROME OF HYPERALDOSTERONISM, JUXTAGLOMERULAR HYPERPLASIA AND NORMAL BLOOD PRESSURE.
Effect of intravenous frusemide on plasma renin concentration: suppression of response in hypertension.
Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
Effect of moxonidine on the aldosterone/renin ratio in healthy male volunteers.
Effect of oral glucose loading on plasma insulin, potassium, renin and aldosterone in normal subjects and patients with primary hyperaldosteronism.
Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension.
Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension.
Effect of Sodium Glucose Co-Transporter-2 Inhibition on the Aldosterone/Renin Ratio in Type 2 Diabetes Mellitus.
Effect of spironolactone on urinary kallikrein excretion in patients with essential hypertension and in primary aldosteronism.
Effect of standard oral glucose loading on aldosterone secretion in primary hyperaldosteronism.
Effect of the partial beta-agonist prenalterol on plasma renin activity in patients with left ventricular failure.
Effects of 1-sarcosine-8-isoleucine-angiotensin II on blood pressure and plasma renin activity in various types of hypertension.
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism.
Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients.
Efficacy of Antihypertensive Therapy in a Child with Unilateral Focal Fibromuscular Dysplasia of the Renal Artery: A Case Study and Review of Literature.
Efficacy of low-dose spironolactone in subjects with resistant hypertension.
Electrolyte economy and its hormonal regulation in congenital chloride diarrhea.
Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice.
Elevated Plasma Renin Activity Caused by Accelerated-malignant Hypertension in a Patient with Aldosterone-producing Adenoma Complicated with Renal Insufficiency.
Elevation of plasma renin activity during pregnancy and rupture of a dissecting aortic aneurysm in a patient with primary aldosteronism.
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Endocrine Hypertension: Then and Now.
Endocrine responses in long-duration manned space flight.
Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension.
Enzyme immunoassay for plasma renin activity: II. Clinical application.
Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome.
Evaluation of patients for secondary hypertension.
Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism.
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.
Evidence of Primary Aldosteronism in a Predominantly Female Cohort of Normotensive Individuals: A Very High Odds Ratio for Progression into Arterial Hypertension.
Evolution of diagnostic criteria for primary aldosteronism: why is it more common in "drug-resistant" hypertension today?
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.
Exploration Of The Seated Saline Suppression Test For The Diagnosis Of Primary Aldosteronism In The Chinese Population.
Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism.
Familial and Phenotypic Associations of the Aldosterone Renin Ratio.
Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.
Familial hyperaldosteronism.
Feasibility of Screening Primary Aldosteronism by Aldosterone-to-Direct Renin Concentration Ratio Derived from Chemiluminescent Immunoassay Measurement: Diagnostic Accuracy and Cutoff Value.
Fludrocortisone suppression of sympathetic nervous activity.
Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism.
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up.
Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Gitelman Syndrome.
Glucocorticoid remediable aldosteronism: a case report.
Glucocorticoid-remediable aldosteronism.
Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism.
High and non-suppressible plasma renin activity in a patient with aldosterone producing adenoma: pathophysiologic and diagnostic implications.
High plasma renin activities in primary aldosteronism with malignant hypertension. A case report.
High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young-onset hypertension.
High prevalence of liddle syndrome phenotype among hypertensive US Veterans in Northwest Louisiana.
High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
High-renin malignant hypertension secondary to an aldosterone-producing adenoma.
Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus.
Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.
Historical perspectives on the renin-angiotensin-aldosterone system and angiotensin blockade.
Hormone and blood pressure relationships in primary aldosteronism.
Human prorenin determination by hybrid immunocapture liquid chromatography-mass spectrometry: A mixed-solvent-triggered digestion utilizing D-optimal design.
Hyperaldosteronism among black and white subjects with resistant hypertension.
Hyperaldosteronism and hyperprogesteronism in a cat.
Hyperaldosteronism due to unsuspected adrenal carcinoma: discovery during investigation of hypertension in a young woman.
Hyperaldosteronism in a cat with metastasised adrenocortical tumour.
Hyperaldosteronism in the sodium-depleted rat: mechanism of aldosterone stimulation by peritoneal dialysis with glucose solution.
Hyperaldosteronism: the internist's hypertensive disease.
Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case report.
Hypermineralocorticism without excessive aldosterone secretion: an adrenal carcinoma producing deoxycorticosterone.
Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty-two patients.
Hypertension and hypokalemia: unusual syndromes.
Hypertension associated with rhabdomyolysis.
Hypertension caused by an aldosterone-secreting adenoma. Occurrence in a 7-year-old child.
Hypertension corrected by discontinuing chronic sodium bicarbonate ingestion. Subsequent transient hypoaldosteronism.
Hypertension induced by adrenocortical dysfunction--hypertension in 17 alpha-hydroxylase deficiency and metopirone-induced hypertension.
Hypertension secondary to renin-secreting juxtaglomerular cell tumor: case report and review of 38 cases.
Hypokalemia-Induced Rhabdomyolysis Caused by Adrenal Tumor-Related Primary Aldosteronism: A Report of 2 Cases.
Hypokalemic metabolic alkalosis in normotensive infants with elevated plasma renin activity and hyperaldosteronism: role of dietary chloride deficiency.
Hypokalemic Paralysis Complicated by Concurrent Hyperthyroidism and Hyperaldosternoism: A Case Report.
Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism.
Idiopathic hyperplasia of the adrenal gland behaving like an aldosterone producing adenoma.
Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.
Importance of atrial natriuretic hormone in an exaggerated natriuresis during acute sodium load in primary aldosteronism.
In primary aldosteronism the circadian blood pressure rhythm is similar to that in primary hypertension.
Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Incidence of primary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria.
Incidence of suppressed renin activity and of normokalemic primary aldosteronism in hypertensive Negro patients.
Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients.
INCREASED PLASMA LEVEL OF RENIN IN EXPERIMENTAL SECONDARY HYPERALDOSTERONISM.
Increased plasma renin activity, secondary aldosteronism, and hypertension.
Indirect evidence for vascular uptake of circulating renin in hypertensive patients.
Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism: Implications for Case Detection.
Investigating mineralocorticoid hypertension.
Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension?
Is primary aldosteronism underdiagnosed in clinical practice?
Is single oral administration of captopril beneficial in screening for primary aldosteronism?
Junctional Bradycardia as Early Sign of Digoxin Toxicity in a Premature Infant with Congestive Heart Failure due to a Left to Right Shunt.
Juxtaglomerular cell tumor of the kidney--a new classification scheme.
Juxtaglomerular cell tumor: A morphological, immunohistochemical and genetic study of six cases.
Kinins in relation to renin activity in renal and inferior caval veins in normal individuals and patients with primary aldosteronism.
Lack of Cardiac Fibrosis in a New Model of High Prorenin Hyperaldosteronism.
Landmark article Oct 19, 1964: Suppression of plasma renin activity in primary aldosteronism. Distinguishing primary from secondary aldosteronism in hypertensive disease. By Jerome W. Conn, Edwin L. Cohen and David R. Rovner.
Landmark perspective: Renin in aldosteronism. Relating kidney and adrenal.
Left ventricular mass in hereditary human hypertension: glucocorticoid-suppressible hyperaldosteronism.
Liddle syndrome: A case report.
Low dose atrial natriuretic factor in primary aldosteronism: renal, hemodynamic, and vascular effects.
Low Levels of Renin and High Aldosterone-to-Renin Ratio Among Rheumatoid Patients and Ankylosing Spondylitis Patients: A Prospective Study.
Low renin hypertension.
Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation.
Low-Renin Hypertension.
Malignant hypertension due to a large reninoma: a case report.
Malignant hypertension due to an aldosterone producing adrenal adenoma.
Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration.
Malignant hypertension in association with primary aldosteronism.
Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension.
Metabolic and endocrine studies: the second manned Skylab mission.
Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low renin hypertension: a single-center retrospective study.
Mineralocorticoid and metabolic response to metyrapone on normotensive children and children with dexamethasone-suppressible and primary hyperaldosteronism.
Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism.
Mineralocorticoid hypertension.
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.
Mineralocorticoids, salt balance and blood pressure after prolonged ACTH administration in juvenile hypertension.
Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
Minor Change of Plasma Renin Activity during the Saline Infusion Test Provide an Auxiliary Diagnostic Value for Primary Aldosteronism.
Misleading diagnosis of renal artery stenosis by magnetic resonance angiography in a patient with primary aldosteronism.
Molecular mechanisms of ARMC5 mutations in adrenal pathophysiology.
Mouse Models of Primary Aldosteronism: From Physiology to Pathophysiology.
Multiple forms of immunoreactive renin in human adrenocortical tumour tissue from patients with primary aldosteronism.
Myocardial remodeling in low-renin hypertension: molecular pathways to cellular injury in relative aldosteronism.
Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation.
Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis.
Nearly fatal hypokalaemia due to non-hypertensive primary hyperaldosteronism in the post partum.
New aspects of mineralocorticoid hypertension.
New aspects on primary aldosteronism.
New genetic insights in familial hyperaldosteronism.
New-onset resistant hypertension in a newly diagnosed prostate cancer patient.
Night-day variations of renin-activity in primary aldosteronism.
Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
Normoaldosteronemic aldosterone-producing adenoma: immunochemical characterization and diagnostic implications.
Normokalemic hyperaldosteronism in patients with resistant hypertension.
Novel Approach to Establishing an Aldosterone: Renin Ratio Cutoff for Primary Aldosteronism.
Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism.
One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.
Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension.
Outpatient screening tests for primary aldosteronism.
Pathophysiology and diagnosis of primary aldosteronism.
Peptide and Protein Quantification Using Automated Immuno-MALDI (iMALDI).
Performance of the Aldosterone to Renin Ratio as a Screening Test for Primary Aldosteronism.
Persistent severe hyperkalemia following surgical treatment of aldosterone-producing adenoma.
Physiologic tailoring of treatment in resistant hypertension.
Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?
Plasma aldosterone-plasma renin activity ratio. A simple test to identify patients with primary aldosteronism.
Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.
Plasma concentration of renin in a patient with Conn's syndrome with fibrinoid lesions of the renal arterioles: the effect of treatment with spironolactone.
Plasma immunoreactive endothelin-1 in primary hyperaldosteronism.
Plasma prolactin levels in patients with essential hypertension, malignant hypertension and secondary hypertension.
Plasma renin activity and aldosterone secretion in a pregnant woman with primary aldosteronism.
Plasma renin activity and aldosterone secretion rate in hypertension. The distinction between primary and secondary hyperaldosteronism.
Plasma renin activity and blood volume in uncontrolled diabetes. Ketoacidosis, a state of secondary aldosteronism.
Plasma renin activity and plasma concentrations of aldosterone, cortisol, adrenocorticotropic hormone, and alpha-melanocyte-stimulating hormone in healthy cats.
PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM. IMPORTANCE IN DIFFERENTIAL DIAGNOSIS AND IN RESEARCH OF ESSENTIAL HYPERTENSION.
Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
Plasma renin and aldosterone measurements in low renin hypertensive states.
PLASMA RENIN IN A CASE OF CONN'S SYNDROME WITH FIBRINOID LESIONS: USE OF SPINONOLACTONE IN TREATMENT.
PLASMA RENIN IN ALDOSTERONISM.
Plasma Renin in Primary Aldosteronism.
Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity.
Plasma vasopressin variation and renin activity in normal active humans.
Pomc knockout mice have secondary hyperaldosteronism despite an absence of adrenocorticotropin.
Possible association of aldosterone producing adenoma and non-functioning adrenal tumor.
Pre-analytical and analytical considerations for the determination of plasma renin activity.
Pre-operative evaluation of the prognosis of hypertension in primary aldosteronism owing to adenoma.
Prediction of successful outcome in patients with primary aldosteronism.
Prenatal diagnosis of Bartter syndrome.
Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice.
Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism.
PREVELENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION.
Primary Aldosteronism and ARMC5 Variants.
Primary aldosteronism and hypertensive disease.
Primary aldosteronism associated with chronic renal failure. Report of a case.
Primary Aldosteronism Associated with Multiple Adrenocortical Micronodules in a Patient with Renal Cell Carcinoma.
Primary aldosteronism detected after renal transplantation.
Primary aldosteronism due to unilateral adrenal hyperplasia.
Primary aldosteronism due to unilateral adrenal hyperplasia: a case report.
Primary aldosteronism in normokalemic patients with adrenal incidentalomas.
Primary aldosteronism in the primary care setting.
Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman.
Primary aldosteronism with suppressed plasma renin activity due to bilateral nodular adrenocortical hyperplasia.
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis.
Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension.
Primary aldosteronism.
Primary aldosteronism. A follow-up study of 28 cases of surgically treated aldosterone-producing adenomas.
Primary aldosteronism: A common and curable form of hypertension.
Primary aldosteronism: a pictorial essay.
Primary aldosteronism: are we diagnosing and operating on too few patients?
Primary aldosteronism: cardiovascular, renal and metabolic implications.
Primary aldosteronism: case report with plasma renin suppression.
Primary aldosteronism: considerations about the evaluation of the aldosterone to renin ratio during canrenone treatment.
Primary aldosteronism: diagnosis and noninvasive lateralization procedures.
Primary aldosteronism: diagnosis and treatment.
Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Primary aldosteronism: management issues.
Primary aldosteronism: rare bird or common cause of secondary hypertension?
Primary aldosteronism: renaissance of a syndrome.
Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension.
Primary Hyperaldosteronism Due to Adrenocortical Adenoma: a Case Report.
Primary hyperaldosteronism Expanding the diagnostic net.
Primary hyperaldosteronism in England and Wales: a review of the use of a Supraregional Assay Service laboratory for the measurement of aldosterone and plasma renin activity.
Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Primary hyperaldosteronism in the era of laparoscopic adrenalectomy.
Primary hyperaldosteronism in two cats.
Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
Primary hyperaldosteronism, a mediator of progressive renal disease in cats.
Primary hyperaldosteronism--evaluation of procedures for diagnosis and localization.
Primary hyperaldosteronism.
Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'?
Primary hyperparathyroidism associated with primary hyperaldosteronism.
Progress in Primary Aldosteronism 2019: New Players on the Block?
PROGRESS IN PRIMARY ALDOSTERONISM: A review of the prevalence of primary aldosteronism in pre-hypertension and hypertension.
Prorenin cryoactivation as a possible cause of normal renin levels in patients with primary aldosteronism.
Prostaglandin E2 and the renin-angiotensin system in primary aldosteronism and Cushing's syndrome.
Pseudohyperaldosteronism: pathogenetic mechanisms.
Psychological aspects of primary aldosteronism.
Quadriplegia and rhabdomyolysis as a presenting feature of Conn's syndrome.
Quantitation of Plasma Renin Activity in Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Radiofrequency ablation compared with laparoscopic adrenalectomy for aldosterone-producing adenoma.
Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.
Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study.
Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.
Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays.
Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism.
Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.
Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol.
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism.
Regulation of aldosterone secretion in primary aldosteronism.
Relation between renin and prorenin in plasma from hypertensive patients and normal people: evidence for different renin:prorenin ratios.
Relationship between renin activity and aldosterone release in the patients with low cardiac output syndrome after open cardiac surgery.
Relationship between the circulating and vascular renin-angiotensin system and the vasodilating effect of captopril in human hypertension.
Relationship of bone and plasma magnesium in magnesium-deficient cirrhosis patients.
Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
Renal effects of prostaglandin E1 in hypertensive patients.
Renin a marker for left ventricular hypertrophy in primary aldosteronism: a cohort study.
Renin and juxtaglomerular apparatus in a patient with primary aldosteronism complicated by chronic renal failure.
Renin angiotensin aldosterone system altered in resistant hypertension in Sub-Saharan African diabetes patients without evidence of primary hyperaldosteronism.
Renin content of the kidney in primary aldosteronism.
Renin dependent hypertension caused by accessory renal arteries.
Renin gene expression in the adrenal and kidney of patients with primary aldosteronism.
Renin levels in normokalemic hyperaldosteronism.
Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity.
Renin secreting tumors: diagnosis, conservative surgical approach and long-term results.
Renin secretion from malignant pulmonary metastatic tumour cells of vascular origin.
Renin suppression in primary aldosteronism.
RENIN, ANGIOTENSIN AND ALDOSTERONE IN EXPERIMENTAL SECONDARY HYPERALDOSTERONISM.
Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism.
Renin-Independent hypermineralocorticoidism.
Renin-producing renal cell carcinomas--clinical and experimental investigations on a special form of renal hypertension.
Renin-producing serous cystoadenocarcinoma of the ovary: a case report.
Renin-secreting renal tumour with severe hypertension. case report with tumour renin analysis, histopathological and ultrastructural studies.
Renin/angiotensin system in hypertension after traumatic renal-artery thrombosis.
Resistant hypertension: who and how to evaluate.
Restoration of renin-aldosterone dynamics to normal following surgery in primary aldosteronism.
Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.
Reversible hypertension caused by calcium overloading in a patient with postoperative hypoparathyroidism.
Reversible nephrotic syndrome due to high renin state in renovascular hypertension.
Rhabdomyolysis due to primary hyperaldosteronism.
Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism.
Role of adrenal imaging in surgical management.
Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism.
Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney model.
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Screening for primary aldosteronism in pregnancy.
Screening for Primary Aldosteronism is Underutilized in Patients with Obstructive Sleep Apnea.
Screening for primary aldosteronism using the newly developed IDS-iSYS® automated assay system.
Screening for primary aldosteronism--normal ranges for aldosterone and renin in three South African population groups.
Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio.
Screening of primary aldosteronism by clinical features and daily laboratory tests: combination of urine pH, sex, and serum K.
Secondary aldosteronism and reduced plasma renin in hypertensive disease.
Secondary aldosteronism documented by plasma renin and aldosterone circadian rhythm in subjects with kidney or heart transplantation.
Secondary hypertension due to renin secreting tumor: a case report.
Secondary hypertension in adults.
Secondary hypertension. A streamlined approach to diagnosis.
Seizure and coma secondary to Conn's syndrome: a case report.
Selection of patients for surgery for primary aldosteronism.
Sensitive direct radio-immunoassay for human renin.
Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism.
Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12.
Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone.
Severe hypertension in a ten-year-old boy secondary to an aldosterone-producing tumour identified by adrenal sonography.
SEVERE HYPOKALEMIA INDUCED RHABDOMYOLYSIS BY PRIMARY HYPERALDOSTERONISM COEXISTENT WITH RECURRENT BILATERAL RENAL CALCULI.
Severe life-threatening hypokalemia in a cat with suspected distal renal tubular acidosis.
Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study.
Simple screening procedure for the diagnosis of primary aldosteronism.
Single dose captopril as a diagnostic test for primary aldosteronism.
Single oral administration of captopril may not bring an improvement in screening of primary aldosteronism.
Sodium-sensitive essential hypertension: emerging insights into an old entity.
Some considerations about evolution of idiopathic primary aldosteronism.
Spectrum of renin angiotensin aldosterone system disorders in young hypertensives.
Spindle Cell Hemangioma and Atypically Localized Juxtaglomerular Cell Tumor in a Patient with Hereditary BRIP1 Mutation: A Case Report.
Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
SSA 05-4 DIFFERENCES IN MANAGEMENT OF HYPERTENSION BETWEEN ETHNIC GROUPS.
Steroids and hypertension.
Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
Studies of renin and aldosterone in cirrhotic patients with ascites.
Studies on plasma renin activity in patients with primary aldosteronism.
Successful Depressor Effect Concomitant with Complete Normalization of High Renin and Aldosterone Profile by Percutaneous Transluminal Renal Angioplasty in a Patient with Acute Exacerbated Heart Failure with Preserved Ejection Fraction.
Suppressed plasma renin activity and primary aldosteronism.
Suppressed plasma renin activity in in hypertensive patients--its evaluation for the diagnosis of primary aldosteronism.
SUPPRESSION OF PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM.
Surgical treatment of primary hyperaldosteronism.
Synchronous changes in active and inactive renin secretion after furosemide in patients with primary aldosteronism.
Syndromes that Mimic an Excess of Mineralocorticoids.
The Aldosterone Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism.
The aldosterone to renin ratio in the diagnosis of primary aldosteronism: Promises and challenges.
The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma.
The aldosterone/renin ratio as a screening test for primary aldosteronism.
The Association between eGFR and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism.
The changes in active and inactive renin induced by various maneuvers in hypertensive patients.
The clinical utility of two renin mass methods to detect primary hyperaldosteronism compared with renin activity.
The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
The diagnosis of primary aldosteronism and separation of two major subtypes.
The diagnostic value of the 24 hour integrated concentration of plasma aldosterone.
The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
The effect of tyramine, noradrenaline, and angiotensin on the blood pressure in hypertensive patients with aldosteronism and low plasma renin.
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.
The influence of serum aldosterone and the aldosterone-renin ratio on pulse wave velocity in hypertensive patients.
The mTOR-inhibitor everolimus reduces hypervolemia in patients with primary aldosteronism.
The pathogenesis of hypertension in obese subjects.
The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism.
The postural plasma renin activity response in essential hypertension and primary hyperaldosteronism.
The prevalence of a raised aldosterone-renin ratio (ARR) among new referrals to a hypertension clinic.
The renin system and new understanding of the complications of hypertension and their treatment.
The role of aldosterone antagonists in the management of resistant hypertension.
The role of computed tomography in the localization of adrenal cortex tumors.
The simultaneous measurement of plasma-aldosterone- and -renin-concentration allows rapid classification of all disorders of the renin-aldosterone system.
The syndrome of juxtaglomerular hyperplasia with aldosteronism, hypokalemic alkalosis and normal blood pressure.
The syndromes of low-renin hypertension: "separating the wheat from the chaff".
The therapeutic effect of a new angiotensin-converting enzyme inhibitor, enalapril maleate, in idiopathic hyperaldosteronism.
The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.
The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertension.
Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
Topical Diagnosis and Determination of the Primary Hyperaldosteronism Variant.
Towards the Development of an Immuno MALDI (iMALDI) Mass Spectrometry Assay for the Diagnosis of Hypertension.
Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
Two neonates with Bartter syndrome.
Two novel homozygous missense mutations identified in the BSND gene in Moroccan patients with Bartter's syndrome.
Two-site automated chemiluminescent assay for measurement of immunoreactive renin.
Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.
Unilateral adrenal hypersecretion of both aldosterone and cortisol in two first cousins with a syndrome of mineralocorticoid excess but without signs of hypercortisolism.
Unilateral hypersecretion of aldosterone associated with adrenal hyperplasia as a cause of primary aldosteronism.
Unilateral renal artery stenosis seen initially as severe and symptomatic hypokalemia. Pathophysiologic assessment and effects of surgical revascularization.
Urinary aldosterone to creatinine ratio in cats before and after suppression with salt or fludrocortisone acetate.
Urinary Aldosterone/Creatinine Ratio After Fludrocortisone Suppression Consistent with PHA in a Cat.
Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism.
Use of an intravenous sodium load in screening for primary hyperaldosteronism.
Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature.
Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism.
Use of the saline infusion test to diagnose the cause of primary aldosteronism.
Validation of a new automated renin assay.
Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.
Validity of the aldosterone-renin ratio used to screen for primary aldosteronism.
Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism.
Vascular endothelial growth factor (VEGF), prostaglandin E2(PGE2) and active renin in hypertension of adrenal origin.
With a pinch of salt.
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism.
Would wider screening for primary aldosteronism give any health benefits?
[11 beta-hydroxysteroid dehydrogenase and steroid receptors]
[11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension]
[A brief history of diagnosis and treatment of primary aldosteronism.]
[A case of glucocorticoid-responsive hyperaldosteronism: follow-up study for 21 years--comparison with cases of 17 alpha-hydroxylase deficiency in Japan]
[A case of idiopathic hyperaldosteronism diagnosed by adrenal imaging]
[A patients with chronic renal failure due to Bartter's syndrome]
[A review of ten cases of aldosteronoma. Diagnostic and therapeutic conclusions (author's transl)]
[Activity of plasma renin in arterial hypertension with corticoadrenal adenoma. Conn's syndrome]
[Acute response to calcium inhibitors in secondary arterial hypertension: does renin play a role?]
[Adrenal gland adenoma sensitive to renin]
[Adrenocortical hypertension]
[Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)]
[Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism]
[Application of aldosterone/direct renin ratio before drug washout in the screening of primary aldosteronism].
[ARTERIAL HYPERTENSION AND HYPERALDOSTERONISM. APROPOS OF 2 CASES OF CONN'S SYNDROME. VALUE OF THE DETERMINATION OF PLASMA RENIN.]
[Arterial hypertension due to compression of the renal artery, revealing ovarian cancer]
[Arterial hypertension in renin-producing retroperitoneal leiomyosarcoma]
[Carcinoma of the kidney with production of renin. A special form of hypertension]
[Circulatory reflexes in primary aldosteronism (author's transl)]
[Clinical observation of 12 cases of primary aldosteronism, special reference to the diagnostic problem (author's transl)]
[Comparative evaluation of the efficacy of methods of cryo- and trypsin activation of inactive renin in vitro]
[Concentration of adrenocorticotrophic hormone and aldosterone secretion in essential hypertension and hyperaldosteronism]
[Conn's adenoma. Diagnostic and prognostic value of the measurement of potassium, renin, aldosterone levels and the aldosterone/renin ratio]
[Contribution of CYP11B2, REN and AGT genes in genetic predisposition to arterial hypertension associated with hyperaldosteronism]
[Corticoid secretion in primary aldosteronism. II. The renin releasing test and the angiotensin II analog infusion test (author's transl)]
[Determination of renin concentration in the venous peripheral plasma in the diagnosis of primary hyperaldosteronism]
[Diagnosis and therapy of endocrine hypertension]
[Diagnosis and treatment outcome of primary aldosteronism based on a retrospective analysis of 187 cases]
[Diagnosis of adrenal diseases focusing on morphological and endocrinological viewpoints]
[Diagnostic importance of determination of renin activity in primary hyperaldosteronism]
[Diagnostic value of determining the renin activity and potassium content in the blood plasma in arterial hypertension patients with Conn's syndrome]
[Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
[Does the captopril test improve the diagnosis of primary hyperaldosteronism?]
[Effect of a calcium inhibitor, nicardipine, on aldosterone secretion in primary hyperaldosteronism]
[Effect of long-term administration of spironolactone in massive dosage on the postoperative plasma renin activity in primary aldosteronism]
[Endocrine arterial hypertension. Primary hyperaldosteronism]
[Evaluation of the hypotensive effect of unilateral adrenalectomy in patients with low-renin hyperaldosteronism]
[Exact measurement of subnormal renin concentrations in primary aldosteronism using radioimmunologic demonstration of angiotension I]
[Excretion of aldosterone in the urine, renin activity in the plasma and some indices of the metabolism of potassium and sodium in patients with the iodiopathic edema syndrome]
[Fifty years of subclinical primary aldosteronism: importance of early diagnosis].
[For which hypertensive patient should angiotensin-converting enzyme inhibitor be prescribed or forbidden?]
[Genetics and arterial hypertension: monogenic forms.]
[High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension]
[Influence of angiotensin on the secretion of aldosterone in idiopathic hyperaldosteronism]
[Low renin variant of hypertension: functional relations of the renin-aldosterone pressor system]
[Low-renin hypertension and inherited mineralocorticoid diseases]
[Mineralocorticoid and glucocorticoid functions of the adrenal cortex and some mechanisms of their regulation in obesity]
[Monogenic hypertension]
[Occurrence of primary aldosteronism in a group of ambulatory hypertensive patients]
[Pathogenesis of arterial hypertension with a low renin activity in the blood plasma]
[Pathological and clinical studies on primary aldosteronism]
[Pathophysiological features of arterial hypertension in chronic nephritis]
[Performance Verification of Plasma Renin and Aldosterone Examination with Chemiluminescence Immunoassay and Its Screening Efficacy for Primary Aldosteronism].
[Pheochromocytoma with hyperaldosteronism and abnormalities of humoral immunity. Study of plasma renin activity]
[Plasma and urine steroids in essential hypertension with normal and suppressed renin and in primary hyperaldosteronism. Changes after ACTH stimulation]
[Plasma renin activity in primary hyperaldosteronism]
[Post-operative hyperaldosteronism and related endocrine perturbations (author's transl)]
[Potassium and the concentrations of plasma renin during primary hyperaldosteronism]
[Primary aldosteronism caused by aldosteronoma: problems in the etiologic diagnosis]
[Primary aldosteronism in gravidity]
[Primary aldosteronism: diagnosis, laterality and regulation of hormone secretion]
[Primary aldosteronism]
[Primary hyperaldosteronism and adrenal tumors. Clinico-surgical experience with 9 patients]
[Primary hyperaldosteronism in hypertension]
[Primary hyperaldosteronism--12 clinical cases]
[Primary hyperaldosteronism: common cause of secondary hypertension with higher cardiovascular risk].
[Primary hyperaldosteronism]
[Pseudohypoparathyroidism associated with hyperaldosteronism and polyglobulia]
[Quadric analysis applied to preoperative assessment between patients with or without adrenocortical tumors in hypertension with hyperaldosteronism and low plasma renin]
[Radioimmunoassay in the diagnosis of arterial hypertension]
[Radioimmunoassays of aldosterone and plasma renin activity. Application to the diagnosis of primary aldosteronism]
[Radioimmunologic determination of aldosterone and renin in the blood in the diagnosis of different forms of arterial hypertension]
[Rational diagnosis of endocrine forms of hypertension]
[Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension]
[Reduction of the vasopressor effect of tyramine in patients with hypertension, aldosteronism and low plasma renin]
[Regulation of aldosterone secretion in thyrotoxicosis. Thyroid hormones as possible stimulators of the activity of the renin-angiotensin-aldosterone system]
[Renin and aldosterone determinations in hypertensive patients].
[Renin studies in idiopathic edemas with secondary hyperaldosteronism]
[Renin-angiotensin-aldosterone system: effect of the hypertensive agents on plasma renin activity and clinical application, especially in screening of primary aldosteronism and other simialr diseases]
[Reninoma: A Rare Cause of Endocrine Hypertension].
[Reninoma: a rare cause of hypertension. Case report, review of the literature and possibility for organ preserving operation]
[Renovascular arterial hypertension complicated by diabetes insipidus: report of a case and review of the literature].
[Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III]
[Successful percutaneous angioplasty of renal artery in a patient with severe arterial hypertension and symptoms of hyperaldosteronism: a case report.]
[Surgical treatment of different forms of hyperaldosteronism with low renin activity in the blood plasma]
[The accuracy of combining aldosterone to renin ratio and low renin level in diagnosing primary aldosteronism]
[The circadian rhythm of serum aldosterone in the diagnostics of primary aldosteronism]
[The diagnostic value of determining renin activity and the plasma concentration of potassium in patients with Conn's syndrome and arterial hypertension]
[The dopaminergic system and aldosterone secretion. I. Suppressive effects of L-dopa on secondary hyperaldosteronism]
[The effect of noradrenalin and angiotensin on kidney function and plasma renin level in a patient with secondary aldosteronism and arterial hypotension]
[The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)]
[The localization of aldosterone-producing adenoma on computed tomography--a comparative study with adrenal scintigraphy and plasma aldosterone concentration in the adrenal or renal vein]
[The long-term administration of dexamethasone for the differentiation of the 4 types of hyperaldosteronism]
[The value of renin determination in the diagnosis of hypertension]
[Therapeutic experience of primary aldosteronism associated with chronic renal failure]
[Total blood volume in essential and secondary hypertension]
[Two case reports on resistant hypertension].
[Usefulness of converting enzyme inhibitors in the diagnosis of arterial hypertension]
[Variation in plasma renin activity at the hypochloremic state and postural change (from supine posture to standing and walking)--new diagnostic criteria for primary aldosteronism (with normal potassium value in the blood)]
[Various aspects of surgical treatment of vasorenal hypertension]
[Which screening tests should be chosen in 1994 in the cascade of primary hyperaldosteronism (Conn's syndrome)? Apropos of 3 personnel cases]
Hyperandrogenism
Prorenin is elevated in polycystic ovary syndrome and may reflect hyperandrogenism.
Study of three patients with congenital adrenal hyperplasia treated by bilateral adrenalectomy.
The Ovarian Renin-Angiotensin System (OVRAS): A Major Factor in Ovarian Function and Disease.
Hypercalcemia
Acute hypercalcemic hypertension in man: role of hemodynamics, catecholamines, and renin.
Analogs of 1alpha,25-dihydroxyvitamin D(3) as novel inhibitors of renin biosynthesis.
Calcium and blood pressure regulation in normal and hypertensive subjects.
Chronic continuous PTH infusion results in hypertension in normal subjects.
Clinical syndromes associated with tumors of the female genital tract.
Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice.
Effects of calcium on renin and aldosterone.
Hypercalcemia Reduces Plasma Renin via Parathyroid Hormone, Renal Interstitial Calcium, and the Calcium-Sensing Receptor.
Hyperprostaglandin E syndrome: use of indomethacin and steroid, and death due to necrotizing enterocolitis and sepsis.
Hypertension corrected by discontinuing chronic sodium bicarbonate ingestion. Subsequent transient hypoaldosteronism.
Hypertension in a patient with hypercalcemia: captopril and verapamil.
Influence of calcium infusion on plasma atrial natriuretic peptide in conscious dogs: intervention with calcium antagonist, verapamil.
Parathyroid hormone-related protein stimulates plasma renin activity via its anorexic effects on sodium chloride intake.
[Plasma renin activity in tachistin-stimulated hypercalcemia and under the effect of chlorazine]
Hypercholesterolemia
Cholesterol-induced upregulation of angiotensin II and its effects on monocyte-endothelial interaction and superoxide production.
Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects.
Effects of K+-deficient diets with and without NaCl supplementation on Na+, K+, and H2O transporters' abundance along the nephron.
Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.
Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
Pyrazinoylguanidine: antihypertensive, hypocholesterolemic, and renin effects.
Renin as a risk factor for atherogenesis. Effects of hypercholesterolemia and two-kidney--one-clip hypertension in the rabbit.
Renin as a risk factor for atherogenesis. Part 2. Effects of hypercholesterolemia and hyporeninemia in the rabbit.
Renin as a risk factor for atherogenesis. Part 3. Effects of hypercholesterolemia, hyporeninemia and one-kidney-one clip hypertension in the rabbit.
Severe hyperlipidemia causes impaired renin-angiotensin system function in apolipoprotein E deficient mice.
Hyperemia
Action of endogenous atrial natriuretic peptide in calves with experimental acute central venous congestion and low cardiac output.
Blood Pressure-Lowering Mechanisms of the DASH Dietary Pattern.
Bradykinin-induced renal hemodynamic alterations: renin and prostaglandin relationships.
Communication Through Gap Junctions in the Endothelium.
Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function.
Physiological assessment of renal artery stenosis: comparisons of resting with hyperemic renal pressure measurements.
Pyrogenic renal hyperemia: the role of prostaglandins.
Hyperglycemia
2,3,5,4'-Tetrahydroxystilbene-2-O-?-d-glucoside exerted protective effects on diabetic nephropathy in mice with hyperglycemia induced by streptozotocin.
Age is a Determinant of Acute Hemodynamic Responses to Hyperglycemia and Angiotensin II in Humans with Uncomplicated Type 1 Diabetes Mellitus.
Aldosterone and cortisol co-secreting bifunctional adrenal cortical carcinoma: A rare event.
Angiotensin II and its receptors in the diabetic kidney.
Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes.
Antihypertensive drugs and cardioprotection.
Arterial pressure control at the onset of type I diabetes: the role of nitric oxide and the renin-angiotensin system.
Chemical Communication between Heart Cells is Disrupted by Intracellular Renin and Angiotensin II: Implications for Heart Development and Disease.
Circadian rhythms and energy metabolism with special reference to the suprachiasmatic nucleus.
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
Diabetic nephropathy: A potential savior with 'rotten-egg' smell.
Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans.
Gallic acid attenuates type I diabetic nephropathy in rats.
Genetic markers of increased susceptibility to diabetic nephropathy.
Human Glomerular Endothelium: Interplay Among Glucose, Free Fatty Acids Angiotensin II And Oxidative Stress In Hyperglycemia.
Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans.
Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus.
Increased integrated concentration of norepinephrine, epinephrine, aldosterone, and growth hormone in patients with uncontrolled juvenile diabetes mellitus.
Insights into the regulation of renal hemodynamic function in diabetic mellitus.
Intracellular angiotensin II disrupts chemical communication and impairs metabolic cooperation between cardiac myocytes.
Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis.
Local bone interaction between renin-angiotensin system and kallikrein-kinin system in diabetic rat.
MEDICAL BASIS OF DIABETIC NEUROPATHY FORMATION (REVIEW).
Obesity, inflammation and endothelial dysfunction.
Plasma renin activity and blood volume in uncontrolled diabetes. Ketoacidosis, a state of secondary aldosteronism.
Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents.
Prorenin receptor (PRR)-mediated NADPH oxidase (Nox) signaling regulates VEGF synthesis under hyperglycemic condition in ARPE-19 cells.
Regulation of the Ku70 and apoptosis-related proteins in experimental diabetic nephropathy.
Role of inflammation in the pathogenesis of diabetic retinopathy.
Role of oxidative stress, inflammation, hypoxia and angiogenesis in the development of diabetic retinopathy.
Roles of the (pro)renin receptor in the kidney.
Shakuyaku-kanzo-to induces pseudoaldosteronism characterized by hypokalemia, rhabdomyolysis, metabolic alkalosis with respiratory compensation, and increased urinary cortisol levels.
The effect of sex on endothelial function responses to clamped hyperglycemia in type 1 diabetes.
The expanding role of oxidative stress, renin angiotensin system, and beta-cell dysfunction in the cardiometabolic syndrome and Type 2 diabetes mellitus.
The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome.
Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.
[Diagnosis and management of diabetic nephropathy].
Hyperinsulinism
Effects of a calcium channel blocker, manidipine, on insulin sensitivity in essential hypertensives.
Effects of the angiotensin converting enzyme inhibitor temocapril on insulin sensitivity and its effects on renal sodium handling and the pressor system in essential hypertensive patients.
Glucose load and renal sodium handling in mild essential hypertension on different sodium intakes.
Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive.
Impact of obesity on kidney function and blood pressure in children.
Insulin resistance and hypertension in Japanese.
Insulin resistance--not hyperinsulinemia--is pathogenic in essential hypertension.
Insulin sensitivity and the effects of insulin on renal sodium handling and pressor systems in essential hypertensive patients.
Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.
Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents.
[Insulin resistance in elderly patients with hypertension]
Hyperkalemia
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.
A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing.
A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene.
A molecular update on pseudohypoaldosteronism type II.
A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis.
A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension.
A Novel Mutation of the
A particular phenotype in a girl with aldosterone synthase deficiency.
A renal mechanism limiting the degree of potassium loss in severely hyperglycemic patients.
Abnormalities of aldosterone synthesis and action in children.
Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review.
Absence of amiloride-sensitive sodium absorption in the airway of an infant with pseudohypoaldosteronism.
Active and inactive renin in the adrenal.
Adequate intake of potassium does not cause hyperkalemia in hypertensive individuals taking medications that antagonize the renin angiotensin aldosterone system.
Aldosterone deficiency with a hormone profile mimicking pseudohypoaldosteronism.
Aliskiren-associated acute renal failure with hyperkalemia.
Big renin: identification, chemical properties and clinical implications.
Calcium-dependent low renin syndrome in a diabetic patient with prostaglandin deficiency.
Clinical features, genetic background, and outcome in infants with urinary tract infection and type IV renal tubular acidosis.
Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review.
Coincidence of pseudohypoaldosteronism with gluten-enteropathy.
Comparative risk of new-onset hyperkalemia for antihypertensive drugs in patients with diabetic nephropathy: A Bayesian network meta-analysis.
Congenital hyperreninemic hypoaldosteronism unlinked to the aldosterone synthase (CYP11B2) gene.
Corticosterone methyloxydase deficiency type II in a Croatian girl.
Development of hyperkalemia following treatment with dapagliflozin (DAPA) in a patient with type 2 diabetes after bilateral adrenalectomy.
Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be?
Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice.
Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis.
Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism.
Expanding the spectrum of genetic mutations in antenatal Bartter syndrome type II.
Failure to Thrive, Hyponatremia, Hyperkalemia - Differential Diagnostic Reflections of a Rare Genetic Disease.
Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible hereditary cell membrane defect.
Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II.
Generalized unresponsiveness to mineralocorticoid hormones: familial recessive pseudohypoaldosteronism due to aldosterone-receptor deficiency.
Gordon syndrome caused by a CUL3 mutation in a patient with short stature in Korea: a case report.
Heparin-induced hyperkalemia.
Hereditary interstitial kidney disease.
How Dangerous Is Hyperkalemia?
Hyperaldosteronemia and hypogammaglobulinemia secondary to atopic dermatitis-induced exudation in an infant presenting with growth failure.
Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation.
Hyperkalemia and renin deficiency.
Hyperkalemia and renin production.
Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease.
Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism.
Hyperkalemia in the elderly.
Hyperkalemia in very low birth weight infants.
Hyperkalemic distal renal tubular acidosis in salt-losing congenital adrenal hyperplasia.
Hyperpotassemia and bradycardia in a bedridden elderly woman with selective hypoaldosteronism associated with low renin activity.
Hypertension in pediatric patients with chronic kidney disease: management challenges.
Hyporeninemic hypoaldosteronism in a patient with diabetes mellitus: an unforgettable case report.
Hyporeninemic hypoaldosteronism in children with chronic renal failure.
Hyporeninemic hypoaldosteronism. An overlooked cause of hyperkalemia.
Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection Fraction.
Impaired control of renal hemodynamics and renin release during hyperkalemia in rabbits.
Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system.
Isolated hypoaldosteronism and abnormalities in renin, kallikrein, and prostaglandin.
Mechanisms by which nephrectomy stimulates adrenal renin.
Mechanisms of hyperkalemia in systemic lupus erythematosus.
Metabolic Acidosis, Hyperkalemia, and Renal Unresponsiveness to Aldosterone Syndrome: Response to Treatment with Low-Potassium Diet.
Mineralocorticoid deficiency in post-operative cerebral salt wasting.
Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism.
Mineralocorticoid resistance.
Mineralocorticoid-induced kaliuresis in type-II pseudohypoaldosteronism.
Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism.
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval.
No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers.
Patiromer: The First Potassium Binder Approved in Over 50 Years.
Potassium homeostasis and Renin-Angiotensin-aldosterone system inhibitors.
Potassium homeostasis in chronic diabetes mellitus.
Prediction and management of hyperkalemia across the spectrum of chronic kidney disease.
Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study.
Pseudo-Hypo Aldosteronism Type II.
Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia.
Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
Pseudohypoaldosteronism types I and II: little more than a name in common.
Pseudohypoaldosteronism.
Rare Cause of Hyperkalemia in the Newborn Period: Report of Two Cases of Pseudohypoaldosteronism Type 1.
Rare causes of acute hyperkalemia in the 1st week of life. Three case reports.
Reduced Na+, K(+)-ATPase activity in patients with pseudohypoaldosteronism.
Regulations of plasma aldosterone in young hyperkalemic patients with stable chronic renal failure.
Renal effects of nonsteroidal anti-inflammatory drugs.
RENAL FUNCTION AND PLASMA RENIN ACTIVITY AS POTENTIAL FACTORS CAUSING HYPERKALEMIA IN PATIENTS WITH THYROID CARCINOMA UNDERGOING THYROID HORMONE WITHDRAWAL FOR RADIOACTIVE IODINE THERAPY.
Renin in adrenal: an overview of its synthesis, subcellular localization, and functions.
Restoration of Epithelial Sodium Channel Function by Synthetic Peptides in Pseudohypoaldosteronism Type 1B Mutants.
Reversal of glucose-induced hyperkalemia by sodium restriction in "normaldosteronemic" diabetes mellitus.
Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy.
Reversible hyperkalemia induced by flufenamic acid in asymptomatic hyporeninemic patient.
Reversible suppression of the renin-aldosterone axis after unilateral adrenalectomy for adrenal adenoma.
Selective hypoaldosteronism in infancy. Report of a case.
Severe Arterial Hypertension from Cullin 3 Mutations Is Caused by Both Renal and Vascular Effects.
Severe pseudohypoaldosteronism in a pair of twins not associated with hydramnios.
Severity of virilization of external genitalia in Japanese patients with salt-wasting 21-hydroxylase deficiency.
Side effects and metabolic effects of converting-enzyme inhibitors.
Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia.
Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.
Stimulation of renin release by hyperkalemia in the nonfiltering kidney.
Studies of the renal vasoactive systems in hyporeninemic hypoaldosteronism.
Suppression of plasma renin activity in a boy with chronic hyperkalemia.
Systemic pseudohypoaldosteronism from deletion of the promoter region of the human Beta epithelial na(+) channel subunit.
Systemic Pseudohypoaldosteronism Type 1 due to 3 Novel Mutations in SCNN1Aand SCNN1BGenes.
Systemic pseudohypoaldosteronism-1 with episodic dyslipidemia in a Sudanese child.
The renin-angiotensin system in rats with hereditary hydronephrosis.
The syndrome of hypertension and hyperkalemia with normal GFR (Gordon's syndrome): is there increased proximal sodium reabsorption?
Three cases of Gordon syndrome with dominant KLHL3 mutations.
Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registries.
Tissue renin angiotensin systems: theoretical implications for the development of hyperkalemia using angiotensin-converting enzyme inhibitors.
Treatment of cardiac sensitivity to hyperkalemia with aldosterone, renin, or insulin.
Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
Two adult familial cases of selective hypoaldosteronism due to insufficiency of conversion of corticosterone to aldosterone.
Two novel mutations of the CYP11B2 gene in a Japanese patient with aldosterone deficiency type 1.
[21-hydroxylase deficit revealed by hyperkalemia in the absence of renal failure in an insulin-dependent diabetic (author's transl)]
[Effects of potassium on renin and aldosterone]
[Gordon's syndrome. Report of a case]
[Hypertension, hyperpotassemia and normal glomerular filtration (Gordon's syndrome): a case report]
[Hyporeninemic hypoaldosteronism. Case report and attempt at pathophysiological classification (author's transl)]
[Mineralocorticoid resistance: pseudohypoaldosteronism type 1]
[Multiple type I pseudohypoaldosteronism: neonatal management and outcome]
[Pharmacologic treatment of heart failure with reduced ejection fraction in chronic kidney disease].
[Transient pseudohypoaldosteronism secondary to congenital malformation pathology of the urinary tract (valves of the posterior urethra): a report of a case with elements of a physiopathological nature]
[Type II pseudohypoaldosteronism: proximal tubular acidosis and distal tubular hyperkalemia corrected by DDAVP]
Hyperlipidemias
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.
Increased enzymatic activity of renin and hyperlipidemia.
Introduction to part II of the hypertension symposium. Prorenin, renal hypertension; diuretics and hyperlipidemia; angiotensin receptors and blocking drugs; a new treatment system.
Smoking in diabetic nephropathy: sparks in the fuel tank?
The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade.
Hyperlipoproteinemia Type I
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Hyperlipoproteinemias
[Chronic ambulatory peritoneal dialysis]
[Plasma renin activity in patients with coronary arteriosclerosis with different types of hyperlipoproteinemia]
[Study of the relation of various genetic and pathophysiologic factors participating in the regulation of blood pressure in patients with hypertension]
Hypernatremia
Hydration state controls stress responsiveness and social behavior.
Hypodipsic hypernatremia with intact AVP response to non-osmotic stimuli induced by hypothalamic tumor: a case report.
Hyperoxaluria
SLC26A6 and NADC?1: Future direction of nephrolithiasis and calculus?related hypertension research (Review).
Hyperparathyroidism
Elevation of blood pressure in young rats fed a low calcium diet. Effects of nifedipine and captopril.
Hypertension associated with hyperparathyroidism is not responsive to angiotensin blockade.
Hypertension in primary hyperparathyroidism: the role of the renin-angiotensin system.
Parathyroid hormone: a determinant of posttransplant blood pressure regulation.
The renin-angiotensin-aldosterone system and hypertension in primary hyperparathyroidism.
[Changes in plasma renin and aldosterone after parathyroidectomy in patients with hyperparathyroidism]
[Endocrine and neurogenic hypertension in childhood]
[Pharmacological study on blood pressure in rats with bone disorders]
Hyperparathyroidism, Primary
A Rare Presentation of Primary Hyperparathyroidism with Concurrent Aldosterone-Producing Adrenal Carcinoma.
Absence of an acute effect of calcium or parathyroid hormone administration on plasma renin activity in man.
Hypertension and renal dysfunction in primary hyperparathyroidism: effect of parathyroidectomy.
Hypertension in primary hyperparathyroidism: the role of the renin-angiotensin system.
The renin-angiotensin-aldosterone system and hypertension in primary hyperparathyroidism.
The thyroid hormone, parathyroid hormone and vitamin D associated hypertension.
Hyperparathyroidism, Secondary
Cardiovascular disease in chronic kidney failure: the role of VDR activators.
Hyperphosphatemia
The Role of Fibroblast Growth Factor-23 in Cardiorenal Syndrome.
Hyperpigmentation
Delayed diagnosis of adrenal insufficiency in a patient with severe penoscrotal hypospadias due to two novel P450 side-change cleavage enzyme (CYP11A1) mutations (p.R360W; p.R405X).
Hyperprolactinemia
Clinical syndromes associated with tumors of the female genital tract.
Vasoactive intestinal polypeptide stimulation of prolactin release and renin activity in normal man and patients with hyperprolactinaemia: effects of pretreatment with bromocriptine and dexamethazone.
Hypersensitivity
Erratum: Renin angiotensin system blockers-associated angioedema in the Thai population.
Evaluation of Renin and Soluble (Pro)renin Receptor in Patients with IPF. A Comparison with Hypersensitivity Pneumonitis.
IgE receptor-mediated mast-cell renin release.
Immediate Hypersensitivity Elicits Renin Release from Cardiac Mast Cells.
Lyon genetically hypertensive rats: an animal model of "low renin hypertension".
Use of propranolol in the treatment of idiopathic orthostatic hypotension.
Hypersensitivity, Immediate
IgE receptor-mediated mast-cell renin release.
Immediate Hypersensitivity Elicits Renin Release from Cardiac Mast Cells.
Hypertension
'Pseudo-aldosteronism' induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients.
(Pro)renin receptors: are they biologically relevant?
-344C/T polymorphism of CYP11B2 gene in Italian patients with idiopathic low renin hypertension.
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.
11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
18 F-Labeled Derivatives of Irbesartan for Angiotensin?II Receptor PET Imaging.
19-hydroxyandrostenedione as a new hypertensinogenic agent.
19-Hydroxyandrostenedione: a potent hypertensinogenic steroid in man.
19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-?B Translocation and Promoter Binding.
20-hydroxyeicosatetraenoic acid, endothelial dysfunction and hypertension.
25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians.
6 beta-Hydroxyandrostenedione: evidence for a new hypertensinogenic agent.
6B.01: EFFECT OF RENAL DENERVATION ON BLOOD PRESSURE AND MICRORNA 181A IN HYPERTENSIVE SCHLAGER MICE.
6C.03: A CASE OF SEVERE HYPERALDOSTERONISM CAUSED BY A DE NOVO KCNJ5 MUTATION.
9B.07: EFFECT OF POSTURAL CHANGES ON ALDOSTERONE TO PLASMA RENIN RATIO IN PATIENTS WITH SUSPECTED SECONDARY HYPERTENSION.
A beta-blocker-based antihypertensive drug program guided by age and renin.
A case of adrenal tumor producing renin, aldosterone, and sex steroid hormones.
A case of bilateral aldosterone-producing adenomas differentiated by segmental adrenal venous sampling for bilateral adrenal sparing surgery.
A case of ectopic renin-secreting orbital hemangiopericytoma associated with juvenile hypertension and hypokalemia.
A case of functioning parathyroid carcinoma with hypereninemic hypertension.
A case of glucocorticoid-suppressible hyperaldosteronism with aldosterone producing adenoma.
A case of Guillain-Barré syndrome accompanied by sympathetic overactivity and hypertensive encephalopathy.
A case of hyperreninemic hypertension after extracorporeal shock-wave lithotripsy.
A Case of Juxtaglomerular Cell Tumor With Novel Histologic Features.
A case of male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency and hormonal profiles in the nuclear family.
A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.
A case of normotensive primary aldosteronism--comparison with 13 previously experienced cases with hypertension.
A case of pheochromocytoma presenting as secondary hyperaldosteronism, hyperparathyroidism, diabetes and proteinuric renal disease.
A case of primary aldosteronism due to unilateral adrenal hyperplasia.
A case of renal juxtaglomerular cell tumor: usefulness of segmental sampling to prove autonomic secretion of the tumor.
A case of reninoma with variant angina.
A case of Williams syndrome with suspected coexisting ectopic aldosterone-producing tumor in the liver.
A case report of Gordon's syndrome in a 20-year-old male with free medical family history.
A case report of reninoma: radiological and pathological features of the tumour and characterization of tumour-derived juxtaglomerular cells in culture.
A case with primary aldosteronism due to unilateral multiple adrenocortical micronodules.
A clinical approach in regression of glomerulosclerosis.
A comparative study of plasma renin activity, aldosterone and atrial natriuretic hormone between normotensive and hypertensive people living at below sea level altitude (Jordan Valley) and those residing at moderate altitude above.
A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: effects on clinical profile, neurohormones and survival.
A comparison of the development of renal hypertension in male and female rats.
A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
A critical interpretation of juvenile borderline hypertension.
A cross-over medication trial for patients with autosomal-dominant hypertension with brachydactyly.
A decade of angiotensin-converting enzyme (ACE) inhibition.
A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
A familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4.
A fluorogenic near-infrared imaging agent for quantifying plasma and local tissue renin activity in vivo and ex vivo.
A genetically clamped renin transgene for the induction of hypertension.
A High Fat Diet During Pregnancy and Lactation Induces Cardiac and Renal Abnormalities in GLUT4 +/- Male Mice.
A hypertensive emergency with acute visual impairment due to excessive liquorice consumption.
A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension.
A Late Diagnosis of Primary Aldosteronism.
A Link between the Intrarenal Renin Angiotensin System and Hypertension in Autosomal Dominant Polycystic Kidney Disease.
A locus on the long arm of chromosome 1 as a possible cause of essential hypertension.
A long-term study of plasma catecholamine levels and plasma renin activity in borderline hypertension.
A longitudinal study of arterial blood pressure in chronic haemodialysis patients with different levels of plasma renin concentration.
A micromethod for the measurement of renin in brain nuclei: its application in spontaneously hypertensive rats.
A Missense Mutation in the Extracellular Domain of ?ENaC Causes Liddle Syndrome.
A molecular update on pseudohypoaldosteronism type II.
A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis.
A multirange ELISA for the measurement of plasma renin in humans and primates.
A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
A new Australian kindred with the syndrome of hypertension and hyperkalaemia has dysregulation of atrial natriuretic factor.
A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension.
A new look at the hypertension problem: the role of the renin system for analysis and treatment.
A new mechanism in one-kidney, one clip hypertension.
A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension.
A new sensitive direct radioimmunoassay for human plasma renin and its clinical application.
A new subset of mineralocorticoid hypertension with excess of 21-deoxyaldosterone and Kelly's-M1 steroid: clinical and morphological findings.
A novel compound heterozygous mutation in the CYP17A1 gene in a patient with 17?-hydroxylase/17,20-lyase deficiency.
A novel compound heterozygous mutation of K494_V495 deletion plus R496L and D487_F489 deletion in extreme C-terminus of cytochrome P450c17 causes 17alpha-hydroxylase deficiency.
A novel epithelial sodium channel beta-subunit mutation associated with hypertensive Liddle syndrome.
A Novel Frameshift Mutation of SCNN1G Causing Liddle Syndrome with Normokalemia.
A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).
A Novel Interaction Between Sympathetic Overactivity and Aberrant Regulation of Renin by miR-181a in BPH/2J Genetically Hypertensive Mice.
A novel mouse model of advanced diabetic kidney disease.
A novel nonsense mutation in the ?-subunit of the epithelial sodium channel causing Liddle syndrome.
A pediatric Conn syndrome case.
A polymorphic GT short tandem repeat affecting beta-ENaC mRNA expression is associated with low renin essential hypertension.
A possible mechanism for hypertension induced by oral contraceptives. Diminished feedback suppression of renin release.
A potent new beta2-adrenoceptor blocking agent.
A Practical Synthesis of Renin Inhibitor MK-1597 (ACT-178882) via Catalytic Enantioselective Hydrogenation and Epimerization of Piperidine Intermediate.
A predictable error in use of renal vein renin in diagnosing hypertension.
A primary aldosteronism-like phenotype identified with the aldosterone-to-angiotensin II ratio in black men: the SABPA study.
A Primer to Angiotensin Peptide Isolation, Stability, and Analysis by Nano-Liquid Chromatography with Mass Detection.
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
A qualitative difference in plasma renin activity in Dahl rats susceptible or resistant to salt-induced hypertension.
A randomised controlled trial evaluating the effect of potassium supplementation on vascular function and the renin-angiotensin-aldosterone system.
A Rare Case of Adrenal Cysts Associated With Bilateral Incidentalomas and Diffuse Hyperplasia of the Zona Glomerulosa.
A rational approach to the treatment of hypertension in special populations.
A renal carcinoma secreting inactive renin.
A renin-secreting tumor.
A renin-secreting tumour sensitive to changes in central blood volume (presumably via sympathetics) but not to circulating angiotensin II.
A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II).
A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.
A step by step approach in differential diagnosing of adrenal incidentaloma (epinephroma), (with comments on the new Clinical Practice Guidelines of the European Society of Endocrinology).
A study of dose-proportionality in the pharmacokinetics of the oral direct renin inhibitor aliskiren in healthy subjects.
A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects.
A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
A study of urinary and intracellular sodium and potassium, renin, aldosterone, and hypertension in blacks and Indians in Natal.
A study of urinary sodium and potassium excretion rates among urban and rural Zulus and Indians.
A syndrome of post-transfusion hypertension, convulsion and cerebral hemorrhage in beta-thalassemia Hb E disease: a case report with high plasma renin activity.
A unifying pathway for essential hypertension.
A unique case of renovascular hypertension caused by combined renal artery disease.
A Unique Case of Renovascular Hypertension due to Fibromuscular Dysplasia in an Extra-renal Artery.
A widespread abnormality of renin gene expression in the spontaneously hypertensive rat: modulation in some tissues with the development of hypertension.
A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen gene.
Abnormal pressure-natriuresis in transgenic renin gene rats.
Abnormal regulation of proximal tubule renin mRNA in the Dahl/Rapp salt-sensitive rat.
Abnormal regulation of renin angiotensin aldosterone system is associated with right ventricular dysfunction in hypertension.
Abnormal relation of extracellular fluid volume and exchangeable sodium with systemic arterial pressure in early borderline essential hypertension.
Abnormal responses for blood pressure in children and adults with surgically corrected aortic coarctation.
Abnormal sodium metabolism and plasma renin activity (renal renin secretion) and the vasoconstriction volume hypothesis: implications for pathogenesis and treatment of hypertension and its vascular consequences (heart attack, stroke).
Abnormal urinary kallikrein in hypertension is not related to aldosterone or plasma renin activity.
Abnormalities in the renin-angiotensin-aldosterone system in normotensive subjects with a positive family history of hypertension.
Abnormalities of aldosterone synthesis and action in children.
Abnormalities of autonomic nervous control in borderline hypertension.
Abnormalities of renal perfusion and the renal pressor system in dogs with chronic aortic coarctation.
Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene.
Abrupt discontinuation of antihypertensive therapy.
Absence of an acute effect of calcium or parathyroid hormone administration on plasma renin activity in man.
Absence of Irreversible Effects of Aliskiren in Standard Juvenile Rat Toxicity Studies.
Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers.
Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension.
Accelerated hypertension in the rat: relation between renin, renal vascular lesions, salt intake and blood pressure.
Accelerated renovascular hypertension following intra-aortic balloon counter-pulsation.
Accurate determination of the size of the first intron deletion in the renin gene of SHR from an Australian colony.
Activation and function of prorenin: different viewpoints.
Activation and function of prorenin: different viewpoints. Satellite symposium, 13th scientific meeting of the International Society of Hypertension, Montreal, Canada, June 22, 1990.
Activation and measurement of plasma prorenin in the rat.
Activation of Renin-Angiotensin System Induces Osteoporosis Independently of Hypertension.
Activation of the (pro)renin receptor in the paraventricular nucleus increases sympathetic outflow in anesthetized rats.
Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts.
Active and inactive renin during acute reduction of renal perfusion pressure in essential hypertensives.
Active, inactive and total renin concentrations in plasma of hypertensive patients.
Activity of angiotensin-converting enzyme in hereditary stress-induced arterial hypertension.
Activity of erythropoietin and renin in renal venous blood of hypertensive patients.
Acute and long-term salt depletion and beta-blockade: plasma renin activity response and its relation to blood pressure reduction in long-term treatment.
Acute blockage of the renin system and differential renal vein renin determinations in the diagnosis of renovascular hypertension.
Acute effect of labetalol on blood pressure in relation to the sympathetic nervous system and plasma renin activity.
Acute effects of the calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension.
Acute hypercalcemic hypertension in man: role of hemodynamics, catecholamines, and renin.
Acute post-traumatic coarctation of the abdominal aorta.
Acute responses to arterial pressure and plasma renin activity to converting enzyme inhibition (SQ 20,881) in serially studied dogs with neonatally-induced coarctation hypertension.
Adenocarcinoma of the kidney and hypertension: report of 2 cases with special emphasis on renin.
Adenosine in renin-dependent renovascular hypertension.
Adiponectin as an Independent Predictor of Left Ventricular Hypertrophy in Nondiabetic Patients With Hypertension.
Adrenal adenoma with 18-hydroxycorticosterone excess and hypertension: a variant of aldosteronomas.
Adrenal and vascular renin-like activity in chronic 'two-kidney, one-clip' hypertensive rats.
Adrenal cancer with hypertension but low plasma renin and aldosterone.
Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism.
Adrenal neuroblastoma in an elderly adult: a case report and review of the literature.
Adrenal renin: a possible local regulator of aldosterone production.
Adrenal Tissue-Specific Deletion of TASK Channels Causes Aldosterone-Driven Angiotensin II-Independent Hypertension.
Adrenal tumor producing 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone and aldosterone.
Adrenocortical factors in hypertension. I. Significance of 18-hydroxy-11-deoxycorticosterone.
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males.
Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function.
Advances in the renin-angiotensin-aldosterone system: relevance to diabetic nephropathy.
African Americans, hypertension and the renin angiotensin system.
Age and antihypertensive response to calcium antagonists.
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.
Age and pathophysiology-oriented antihypertensive response to calcium antagonists.
Age and the renin-aldosterone system.
Age, blood pressure, renin and urinary electrolytes in primary hypertension and in the normotensive state.
Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Age-related changes in endocrine and renal function in patients with essential hypertension.
Albumin may prevent hypertension by inhibiting renin angiotensin aldosterone system.
Albuminuria as a marker of arterial stiffness in chronic kidney disease patients.
Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
Aldosterone and cortisol co-secreting bifunctional adrenal cortical carcinoma: A rare event.
Aldosterone and left ventricular hypertrophy in Afro-Caribbean subjects with low renin hypertension.
Aldosterone and renin in cardiac patients referred for catheterization.
Aldosterone and renin in relation to surrogate measures of sympathetic activity: the SABPA study.
Aldosterone and the risk of hypertension.
Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
Aldosterone excess and resistance to 24-h blood pressure control.
Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.
Aldosterone in primary hypertension relationship to plasma renin activity and urinary electrolytes and a comparison with normotensive subjects.
Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy.
Aldosterone mediates cardiac fibrosis in the setting of hypertension.
Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.
Aldosterone renin ratio in patients with resistant hypertension.
Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects.
Aldosterone to Active Renin Ratio Is Associated With Nocturnal Blood Pressure in Obese and Treated Hypertensive Patients: The Styrian Hypertension Study.
Aldosterone to renin ratio as a determinant of exercise blood pressure response in hypertensive patients.
Aldosterone to Renin Ratio as a Screening Instrument for Primary Aldosteronism in a Middle-Aged Population with Atrial Fibrillation.
Aldosterone to Renin ratio in a primary care setting: the Bussolengo study.
Aldosterone-binding globulin-induced hypertension in the rat. A new experimental model.
Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Aldosterone-producing-adenoma (A-P-A): effect of pregnancy.
Aldosterone-related genetic effects in hypertension.
Aldosterone-to-Renin Ratio and the Relationship Between Urinary Salt Excretion and Blood Pressure in a Community of African Ancestry.
Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice.
Aliskiren as an adjunct therapy for atypical hemolytic uremic syndrome.
Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study.
Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study.
Aliskiren combined with losartan in type 2 diabetes and nephropathy.
Aliskiren displays long-lasting interactions with human renin.
Aliskiren for Geriatric Lowering of Systolic Hypertension: a randomized controlled trial.
Aliskiren has chondroprotective efficacy in a rat model of osteoarthritis through suppression of the local renin-angiotensin system.
Aliskiren improves endothelium-dependent relaxation of thoracic aorta by activating PI3K/Akt/eNOS signal pathway in SHR.
Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats.
Aliskiren improves renal morphophysiology and inflammation in Wistar rats with 2K1C renovascular hypertension.
Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.
Aliskiren limits abdominal aortic aneurysm, ventricular hypertrophy and atherosclerosis in an apolipoprotein-E-deficient mouse model.
Aliskiren prevents hypertension and reduces asymmetric dimethylarginine in young spontaneously hypertensive rats.
Aliskiren protects against myocardial ischaemia-reperfusion injury via an endothelial nitric oxide synthase dependent manner.
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
Aliskiren reduces portal pressure in portal hypertensive rats.
Aliskiren, a direct Renin inhibitor, in clinical practice: a new approach in the treatment of hypertension.
Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension.
Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects.
Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension.
Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension.
Aliskiren, the first direct renin inhibitor for treatment of hypertension: The path of its development.
Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases.
Aliskiren, the first in a new class of direct renin inhibitors for hypertension: present and future perspectives.
Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness.
Aliskiren, the future of renin-angiotensin system blockade?
Aliskiren--an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension.
Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.
Aliskiren-induced QT interval prolongation.
Aliskiren.
Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.
Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases.
Aliskiren: a novel renin inhibitor for hypertension.
Aliskiren: a renin inhibitor offering a new approach for the treatment of hypertension.
Aliskiren: a review of its use as monotherapy and as combination therapy in the management of hypertension.
Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.
Aliskiren: an oral renin inhibitor for the treatment of hypertension.
Aliskiren: clinical experience and future perspectives of renin inhibition.
Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy.
Aliskiren: Renin inhibitor for hypertension management.
Aliskiren: the first direct renin inhibitor for hypertension.
Alleles of the spontaneously hypertensive rat decrease blood pressure at loci on chromosomes 4 and 13.
Allograft renal-artery stenosis: increased peripheral plasma renin activity as an early indicator of uncontrollable hypertension.
Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion.
alpha-Adducin Gly460Trp polymorphism is associated with low renin hypertension in younger subjects in the Ohasama study.
alpha-Adducin Gly460Trp polymorphism, left ventricular mass and plasma renin activity.
Alpha-adducin polymorphism in hypertensives of South African ancestry.
Alpha-adrenergic systems mediate chronic central AII hypertension in rats fed high sodium chloride diet from weaning.
Alpha-h-ANP injection in normals, low renin hypertension and primary aldosteronism.
Alteration in baroreceptor function in rats produces typical pressure changes during sleep.
Alteration of Cx37, Cx40, Cx43, Cx45, Panx1, and Renin Expression Patterns in Postnatal Kidneys of Dab1-/- (yotari) Mice.
Alteration of intracellular Ca2(+)-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats.
Alteration of the volume-renin component in borderline essential hypertension.
Alterations in aldosterone secretion and metabolism in low renin hypertension.
Alterations in the responses of the sympathetic nervous system and renin in borderline hypertension.
Alterations of angiotensin II receptor contents in hypertrophied hearts.
Altered age-dependent modulation of tissue renin messenger RNA levels in the spontaneously hypertensive rat.
Altered blood pressure and renin responses to converting enzyme inhibition after aprotinin-induced kallikrein-kinin-system blockade.
Altered expression of vascular natriuretic peptide receptors in experimental hypertensive rats.
Altered melatonin production in TGR(mREN2)27 rats: on the regulation by adrenergic agonists, antagonists and angiotensin II in cultured pinealocytes.
Altered renin release from isolated superfused rat glomeruli in DOCA-salt hypertensive rats.
Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat.
Alveolar soft-part sarcoma--A malignant angioreninoma: Histochemical, immunocytochemical, and electron-microscopic study of four cases.
Alzheimer disease is not associated with polymorphisms in the angiotensinogen and renin genes.
Ambulatory blood pressure monitoring and active renin in menopausal women treated with amlodipine and hormone replacement therapy.
Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.
Aminoglutethimide: review of pharmacology and clinical use.
Aminopeptidase A inhibitors as potential central antihypertensive agents.
Amlodipine and loop diuretics as the second anti-hypertensive medication for the treatment of hypertension with chronic kidney diseases.
An accelerated hypertension with neither malignant nephrosclerosis nor elevation of plasma renin activity.
An additional child case of an aldosterone-producing adenoma with an atypical presentation of peripheral paralysis due to hypokalemia.
An adrenal cyst associated with 19-nor-deoxycorticosterone excess and low renin hypertension.
An amyloidogenic determinant in N-terminal pro-brain natriuretic peptide (NT-proBNP): Implications for cardiac amyloidoses.
An Automated Assay for the Clinical Measurement of Plasma Renin Activity by immuno-MALDI (iMALDI).
An endogenous digitalis-like compound extracted from human urine: biochemical and chemical studies.
An epidemiological study of plasma renin activity in schoolchildren in Japan: distribution and its relation with family history of hypertension.
An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation.
An increase in high-molecular weight renin substrate associated with estrogenic hypertension.
An investigation into the pathogenesis of hypertension in acromegaly.
An MboI two-allele polymorphism may implicate the human renin gene in primary hypertension.
An unusual case of an aldosterone-producing adenoma in a prepubertal girl with severe post-surgical adrenal suppression.
Anaesthesia for laparoscopic cholecystectomy in Bartter's syndrome.
Anaesthetic management of renin secreting nephroblastoma.
Analysis of catecholamine and vasoactive peptide release in intracranial arterial venous malformations.
Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism.
Analysis of various etiologies of hypertension in patients hospitalized in the endocrinology division.
Androgen receptor independent cardiovascular action of the antiandrogen flutamide.
Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats.
Angiographic aspects of renovascular hypertension.
Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat.
Angiotensin blockade: its clinical significance.
Angiotensin converting enzyme 1 in the median preoptic nucleus contributes to chronic intermittent hypoxia hypertension.
Angiotensin Converting Enzyme Gene Polymorphism and its Association with Hypertension in South Indian Population.
Angiotensin converting enzyme inhibition reveals an important role for the renin system in the control of normal and high blood pressure in man.
Angiotensin generation in the brain: a re-evaluation.
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
Angiotensin II blockade in hypertensive dialysis patients.
Angiotensin II blockade in patients with essential hypertension.
Angiotensin II in primary hypertension, relationship to plasma renin activity, aldosterone and urinary electrolytes.
Angiotensin II induces CD62L shedding in human neutrophils.
Angiotensin II induces DNA damage in the kidney.
Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo.
Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
Angiotensin II stimulates alpha-skeletal actin expression in cadiomyocytes in vitro and in vivo in the absence of hypertension.
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes.
Angiotensin II type 1 receptor induced signal-transduction pathways as new targets for pharmacological treatment of the renin-angiotensin system.
Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile.
Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure.
Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
Angiotensin III: a physiological relevant peptide of the renin angiotensin system.
Angiotensin Mediated Oxidative Stress and Neuroprotective Potential of Antioxidants and AT1 Receptor Blockers.
Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats.
Angiotensin Receptor Blockade by Inhibiting Glial Activation Promotes Hippocampal Neurogenesis Via Activation of Wnt/?-Catenin Signaling in Hypertension.
Angiotensin receptors: physiology and pharmacology.
Angiotensin sensitivity and prostaglandins in dogs with renal hypertension.
Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats.
Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension.
Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes.
Angiotensin-converting enzyme inhibitor (SQ 20881) in the diagnosis of renovascular hypertension.
Angiotensin-converting enzyme inhibitors: medicinal chemistry and biological actions.
Angiotensin-I-converting enzyme and its relatives.
Angiotensin-II and endothelin-1 levels in children with renoprival hypertension.
Angiotensin-mediated renin suppression is altered in non-modulating hypertension.
Angiotensinogen concentration in the cerebrospinal fluid in different experimental conditions in the rat.
Angiotensinogen M235T variant and salt sensitivity in young normotensive Caucasians.
ANNALS EXPRESS: Associations between glycaemic control and activation of the Renin Angiotensin Aldosterone System in participants with Type 2 Diabetes Mellitus and Hypertension.
ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models.
Antagonists, inhibitors and antisera in the evaluation of vascular renin activity. The role of local generation of angiotensin II.
Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up.
Anthology of the renin-angiotensin system: a one hundred reference approach to angiotensin II antagonists.
Antifungal properties of the anti-hypertensive drug: aliskiren.
Antihypertensive action of captopril in angiotensin-salt hypertension.
Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.
Antihypertensive activity of ABBOTT-81282, a nonpeptide angiotensin II antagonist, in the renal hypertensive rat.
Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins.
Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension.
Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.
Antihypertensive comparison of furosemide with hydrochlorothiazide for black patients.
Antihypertensive drugs in combination: Effects of methyldopa on thiazide-induced changes in renal hemodynamics and plasma renin activity.
Antihypertensive effect of prostacyclin (PGI2) in experimental hypertension and its influence on plasma renin activity in rats.
Antihypertensive effects of dietary protein and its mechanism.
Antihypertensive Efficacy of the Direct Renin Inhibitor Aliskiren as Add-on Therapy in Patients with Poorly Controlled Hypertension.
Antihypertensive efficacy of the oral direct Renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy.
Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis.
Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II.
Antihypertensive medication uses and serum ACE2 levels: ACEIs/ARBs treatment does not raise serum levels of ACE2.
Antihypertensive responses to spironolactone in normal renin hypertension.
Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats.
Antihypertensive therapy: newer concepts and agents.
Antisense inhibition of angiotensinogen in hepatoma cell culture is enhanced by cationic liposome delivery.
Antisera to human renin normalize renin-dependent hypertension in the monkey: therapeutic implications.
Aortic endothelial cell activity in high renin and normal renin models of hypertension in the rat.
Apparent mineralocorticoid excess and deficient 11 beta-oxidation of cortisol in a young female.
Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation.
Apparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state.
Apparent Mineralocorticoid Excess in the Pediatric Population: Report of a Novel Pathogenic Variant of the 11?-HSD2 Gene and Systematic Review of the Literature.
Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
Apparent mineralocorticoid excess.
Apparent mineralocorticoid excess: report of six new cases and extensive personal experience.
Apparent mineralocorticoid excess: type I and type II.
Application of 3D printing technology in endophytic reninoma: A case report and literature review.
Approach to the patient with hypertension, unexplained hypokalemia, and metabolic alkalosis.
Appropriate regulation of renin and blood pressure in 45-kb human renin/human angiotensinogen transgenic mice.
Arachidonic acid inhibits the production of angiotensin-converting enzyme in human primary adipocytes via a NF-?B-dependent pathway.
Are angiotensin converting enzyme inhibition and aldosterone antagonism equivalent in hypertensive patients over fifty?
Arrhythmogenic Substrates for Atrial Fibrillation in Obesity.
Arterial hypertension and chronic liver disease.
Arterial hypertension as a paraneoplastic phenomenon in hepatocellular carcinoma.
Arterial hypertension due to a renin-producing renal carcinoma.
Arterial hypertension in infants with hydronephrosis. Report of six cases.
Arterial plasma vasopressin and aldosterone predict left ventricular mass in men who develop hypertension over 20 years.
Arterial pressure and renal function in two-kidney, one clip Goldblatt hypertensive rats maintained on a high-salt intake.
Arterial wall renin and renal venous renin in the hypertensive rat.
Arterial wall renin.
Artherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference.
Artificial mutations in P450c11AS (aldosterone synthase) can increase enzymatic activity: a model for low-renin hypertension?
Ask-Upmark Kidney, Imaging Features.
Aspartic peptidase inhibitors: implications in drug development.
Aspirin injection test to predict angioplasty outcome in unilateral renovascular hypertension: preliminary report.
Aspirin lowers blood pressure in patients with renovascular hypertension.
Assay of renin and hypertension with the isolated guineapig ileum.
Assessment of renin dependency of hypertension with a dipeptide renin inhibitor.
Assessment of serum sodium to urinary sodium divided by (serum potassium)² to urinary potassium as a screening tool for primary aldosteronism.
Association and linkage analyses of restriction fragment length polymorphisms for the human renin and antithrombin III genes in essential hypertension.
Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels.
Association between Cardiovascular Drugs and Chronic Kidney Disease in Non-Institutionalized Elderly Patients.
Association Between Pituitary-Adrenal Axis Dominance Over the Renin-Angiotensin-Aldosterone System and Hypertension.
Association Between Polymorphisms of ADRBK1 Gene and Plasma Renin Activity in Hypertensive Patients: A Case-Control Study.
Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks.
Association of arginine vasopressin and arterial blood pressure in a population-based sample.
Association of CYP17A1 Genetic Polymorphisms and Susceptibility to Essential Hypertension in the Southwest Han Chinese Population.
Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study.
Association of Mbo I-RFLP at the Renin Locus (rs2368564) with Essential Hypertension.
Association of plasma renin activity and echocardiographic left ventricular hypertrophy with frequency of new coronary events and new atherothrombotic brain infarction in older persons with systemic hypertension.
Association of Post-Saline Load Plasma Aldosterone Levels With Left Ventricular Hypertrophy in Primary Hypertension.
Association of renin-angiotensin system and natriuretic peptide receptor A gene polymorphisms with hypertension in a Hellenic population.
Association of Serum Aldosterone and Plasma Renin Activity With Ambulatory Blood Pressure in African Americans: The Jackson Heart Study.
Association of the renin gene polymorphism with essential hypertension in a Chinese population.
Association of the Renin gene polymorphism, three angiotensinogen gene polymorphisms and the haplotypes with essential hypertension in the mongolian population.
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.
Association study of eight candidate genes with renin status in mild-to-moderate hypertension in patients of African ancestry.
Associations between sympathetic activity, plasma concentrations of renin, aldosterone, and parathyroid hormone, and the degree of intractability of blood pressure control in modialysis patients.
AT1 and TxA2/PGH2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat.
AT1 receptor antisense therapy transiently lowers blood pressure in Ren-2 transgenic rats.
AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension.
AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats.
AT1 Receptors Prevent Salt-Induced Vascular Dysfunction in Isolated Middle Cerebral Arteries of 2 Kidney-1 Clip Hypertensive Rats.
AT2 receptor: Its role in obesity associated hypertension.
Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.
Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
Atherosclerotic Renal Artery Stenosis.
Atrial fibrillation and arterial hypertension: A common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role.
Atrial natriuretic factor in normal and hypertensive pregnancy.
Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.
Atrial natriuretic peptide in transient puerperal hypertension.
Atrial natriuretic peptide: a new factor in hormonal control of blood pressure and electrolyte homeostasis.
Attenuation by captopril of pressor responses to peripheral sympathetic nerve stimulation in rats is abolished after bilateral nephrectomy and during mineralocorticoid hypertension.
Augmented expression of cardiac atrial natriuretic peptide system in hypertensive rats.
Augmented intratubular renin and prorenin expression in the medullary collecting ducts of the kidney as a novel mechanism of angiotensin II-induced hypertension.
Augmented norepinephrine and renin output in response to maximal exercise in hypertensive coarctectomy patients.
Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
Autonomic function in hypertension. Are there racial differences?
Autoregulation of renal blood flow and pressure-dependent renin release in autosomal dominant polycystic kidney disease of rats.
Autosomal dominant polycystic kidney disease (ADPKD)--mechanisms of cyst formation and renal failure.
Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?
Baroreceptor reflex control of heart rate during development of coarctation hypertension.
Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
Baseline Serum Aldosterone-to-Renin Ratio is Associated with the Add-on Effect of Thiazide Diuretics in Non-Diabetic Essential Hypertensives.
Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy.
Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension.
Beta-adrenergic blockade and plasma renin activity in borderline hypertension.
Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
beta-Adrenoreceptor blockage and genetic hypertension development in rats.
Beta-blockers and plasma renin activity in hypertension.
beta-Endorphin and essential hypertension: importance of the clonidine-naloxone interaction.
Beta2-adrenergic receptor genotype affects the renin-angiotensin-aldosterone system response to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern.
Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.
Bilateral adrenal phaeochromocytomas associated with unilateral renal artery stenosis.
Bilateral congenital renal arteriovenous fistulas.
Binding thermodynamics of substituted diaminopyrimidine renin inhibitors.
Biochemical and genetic characterization of 11 beta-hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives.
Biochemical correction in the syndrome of hypertension and hyperkalaemia by severe dietary salt restriction suggests renin-aldosterone suppression critical in pathophysiology.
Biochemistry and regulation of angiotensinogen.
Biomarkers of inflammation and endothelial dysfunction and risk of hypertension among Inner Mongolians in China.
Bisoprolol: is this just another beta-blocker for hypertension or angina?
Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
Blood pressure and acidic renin forms in stroke-prone hypertensive rats.
Blood pressure and plasma renin activity after magnesium supplementation in the spontaneously hypertensive rat: a study during developing and established hypertension.
Blood pressure and plasma renin activity responses to chronic stress in the borderline hypertensive rat.
Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
Blood pressure and serum calcium responses to altered sodium intake in high renin hypertension.
Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance.
Blood pressure control in end-stage renal disease in man: indirect evidence of a complex pathogenic mechanism besides renin or blood volume.
Blood pressure in patients with primary hyperparathyroidism before and after parathyroidectomy.
Blood pressure lowering efficacy of renin inhibitors for primary hypertension.
Blood pressure lowering efficacy of renin inhibitors for primary hypertension: a Cochrane systematic review.
Blood pressure response of nephrectomized hypertensive rats to converting enzyme inhibition: evidence for persistent vascular renin activity.
Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
Blood pressure-dependent inhibition of Renin secretion requires A1 adenosine receptors.
Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy.
Blood pressure-independent ETA and AT1 receptor blocker effects on the coronaries of rats harboring human renin and angiotensinogen genes.
Blood renin in patients with renovascular arterial hypertension.
Blood renin levels in various types of arterial hypertension. Preliminary communication.
Blunt renal trauma-induced hypertension: prevalence, presentation, and outcome.
Body mass index predicts aldosterone production in hypertensive postmenopausal women.
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output.
Brain ACE2 Shedding Contributes to the Development of Neurogenic Hypertension.
Brain Areas Involved in Modulating the Immune Response Participating in Hypertension and Its Target Organ Damage.
Brain renin angiotensin system contributes to the salt-induced enhancement of hypertension in SHR.
Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.
Caffeine and hypertension.
Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms.
Calciotropic hormones in human and experimental hypertension.
Calcium and magnesium in essential hypertension.
Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
Calcium antagonists and diuretics as combined therapy.
Calcium antagonists in hypertension.
Calcium metabolism in hypertension and allied metabolic disorders.
Calcium, the renin-aldosterone system, and the hypotensive response to nifedipine.
Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake.
Candesartan in the treatment of hypertension: what have we learnt in the last decade?
Canine neonatally induced coarctation hypertension in the second year. Variably hyperresponsive plasma renin activity.
Captopril in Cushing's syndrome.
Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
Captopril in mild and severe hypertension.
Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Captopril suppression: Limitations for confirmation of primary aldosteronism.
Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity.
Captopril-stimulated renin in the diagnosis of restenosis after percutaneous transluminal renal angioplasty.
Captopril: pharmacology, metabolism and disposition.
Cardiomyocytes bind and activate native human prorenin : role of soluble mannose 6-phosphate receptors.
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects.
Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vivo studies.
Cardiovascular and Hematological Medicine in 2013 - Advances and Insights.
Cardiovascular and renal pathologic implications of prorenin, renin, and the (pro)renin receptor: promising young players from the old renin-angiotensin-aldosterone system.
Cardiovascular and renal surrogate markers in the clinical management of hypertension.
Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.
Cardiovascular complications in low renin hypertension.
Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion.
Cardiovascular disease in uremic patients on hemodialysis.
Cardiovascular drugs in children: angiotensin-converting enzyme inhibitors.
Cardiovascular drugs.
Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet.
Cardiovascular pathophysiology of essential hypertension: a clue to therapy.
Cardiovascular phenotypes and functional parameters in the general population--results of the MONICA/KORA studies.
Cardiovascular responses of conscious DOCA-salt hypertensive rats to acute intracerebroventricular and intravenous administration of captopril.
Cardiovascular risk factors in noise-exposed workers in china: Small area study.
Case Report: Segmental Arterial Mediolysis, a Rare Cause of Hypertension.
Catheter-Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN-3 Trial.
Causes and Consequences of the Dysregulated Maternal Renin-Angiotensin System in Preeclampsia.
CD39-adenosinergic axis in renal pathophysiology and therapeutics.
Cellophane perinephritis hypertension and its reversal in rabbits. Effect on plasma renin, renin substrate, and renal mass.
Cellular and functional aspects of the renal kallikrein system in health and disease.
Cellular expression of renal, cardiac and pulmonary inducible nitric oxide synthase in double-transgenic mice expressing human renin and angiotensinogen genes.
Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension.
Cellular localization, expression and regulation of neuropeptide Y in kidneys of hypertensive rats.
Central antihypertensive effects of inhibitors of the renin-angiotensin system in rats.
Central infusion of aldosterone increases blood pressure by mechanisms independent of Na retention.
Central infusion of aliskiren prevents sympathetic hyperactivity and hypertension in Dahl salt-sensitive rats on high salt intake.
Central integration and neural control of blood pressure during the cold pressor test: a comparison between hydrochlorothiazide and aliskiren.
Central nervous system G?i2-subunit proteins maintain salt resistance via a renal nerve-dependent sympathoinhibitory pathway.
Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects.
Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function.
Central Pressure and Biomarker Responses to Renin Inhibition with Hydrochlorothiazide and Ramipril in Obese Hypertensives: The ATTAIN Study.
Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen.
Cerebral vascular effects of angiotensin II: new insights from genetic models.
Cerebrospinal fluid angiotensin II immunoreactivity is not derived from the plasma.
Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk.
Challenges in the Management of Hypertension in Older Populations.
Change in haemoglobin concentration, haematocrit and vasoactive hormones in haemodialysis patients with erythropoietin-associated hypertension.
Change in the renin dependency of blood pressure induced by volume depletion and/or propranolol therapy in hypertensive patients.
Changes in cardiovascular responsiveness caused by age and high blood pressure: implications for therapy.
Changes in gene expression of the renin-angiotensin system in two-kidney, one clip hypertensive rats.
Changes in IgA and metals in serum and urine of human volume hypertension.
Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
Changes in renin activity, aldosterone level and electrolytes in pregnancy-induced hypertension.
Changes in renin content in kidneys of rats with experimental renal and NaCl hypertension.
Changes in renin, water balance, and sodium balance during development of high blood pressure in genetically hypertensive rats.
Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy.
Changes in the renin-angiotensin-aldosterone system and in sodium and potassium balance during development of renal hypertension in rats.
Changes induced by orthostatism in plasma renin activity and natriuresis. Influence of hypertension and renal failure.
Changes of gene expressions in spontaneously hypertensive rat model after losartan treatment.
Changes of plasma renin activity and atrial natriuretic factor during intravenous nicardipine treatment of severe hypertension.
Characteristics and treatment of African-American and European-American patients with resistant hypertension identified using the electronic health record in an academic health centre: a case-control study.
Characteristics of children with primary hypertension seen at a referral center.
Characteristics of hypertensive patients with increased plasma Na+-K+ pump inhibitory activity.
Characterization and Management of Juxtaglomerular Cell Tumor: Analysis of 9 Cases and Literature Review
Characterization of a radioimmunoassay to determine plasma total renin.
Characterization of a stable, hypertensive rat model suitable for the consecutive evaluation of human renin inhibitors.
Characterization of plasma and cerebrospinal fluid human angiotensinogen and des-angiotensin I-angiotensinogen by direct radioimmunoassay.
Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion.
Chemical renal medullectomy: effect on blood pressure in normal rats.
Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes.
Chromosomal mapping of the genetic basis of hypertension and renal disease in FHH rats.
Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats.
Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.
Chronic caffeine ingestion exacerbates 2-kidney, 1-clip hypertension and ameliorates deoxycorticosterone acetate-salt hypertension in rats.
Chronic depression symptoms desensitize renin activity to protect against volume-loading hypertension in Blacks: The SABPA study.
Chronic dexamethasone treatment suppresses hypertension development in the transgenic rat TGR(mREN2)27.
Chronic Direct Renin Inhibition With Aliskiren Prevents the Development of Hypertension in Cyp1a1-Ren2 Transgenic Rats With Inducible ANG II-Dependent Hypertension.
Chronic effects of focused electrohydraulic shock waves on renal function and hypertension.
Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats.
Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
Chronic hyperaldosteronism in Cryptochrome-null mice induces high-salt- and blood pressure-independent kidney damage in mice.
Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes.
Chronic hypertension in pregnancy: the impact of ethnicity and superimposed preeclampsia on placental, endothelial and renal biomarkers.
Chronic Increases in Circulating Prorenin Are not Associated With Renal or Cardiac Pathologies.
Chronic MK421 fails to modify evolution of hypertension in neonatally coarcted pups.
Chronic one-kidney hypertension in rabbits. I. Treatment with kidney extracts.
Chronic one-kidney hypertension in rabbits. III. Renopressin, a new hypertensive substance.
Chronic renal neuroadrenergic hypertension is associated with increased renal norepinephrine sensitivity and volume contraction.
Chronic renin inhibition lowers blood pressure and reduces upright muscle sympathetic nerve activity in hypertensive seniors.
Chronic steroid contraceptive treatment decreases renal alpha-adrenoceptor levels in the rat.
Chronobiological evidence for an uncoupling of the Na,K-ATPase to aldosterone in normal renin hypertension.
Cilazapril delays progression of hypertension and uremia in rat polycystic kidney disease.
Circadian changes in plasma renin activity and plasma aldosterone concentration in two-kidney hypertension rats.
Circadian renin rhythm during induced coarctation hypertension.
Circadian rhythms in renal function in hypertensive TGR(mRen-2)27 rats and their normotensive controls.
Circadian rhythms of plasma renin. Aldosterone and cortisol Effect of beta-adrenergic blockade by propranolol in patients with recent, advanced and complicated forms of essential hypertension.
Circulating levels of angiotensin I measured by radioimmunoassay in hypertensive subjects.
Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample.
Clinical and neurohormonal characteristics in African Americans with neurogenic orthostatic hypotension.
Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital.
Clinical characteristics of resistant hypertension in renal transplant patients.
Clinical characteristics of snoring patients with primary aldosteronism and obstructive sleep apnea-hypopnea syndrome.
Clinical evaluation of angiotensin II antagonist in advanced hypertension.
Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: The role of pathology.
Clinical parameters of concern in the pathology and treatment of hypertension.
Clinical pharmacokinetics and efficacy of renin inhibitors.
Clinical pharmacokinetics and pharmacodynamics of aliskiren.
Clinical pharmacology of enalkiren, a novel, dipeptide renin inhibitor.
Clinical Role of Direct Renin Inhibition in Hypertension.
Clinical significance of associated nodular lesions of the adrenal in patients with aldosteronoma.
Clinical syndromes associated with tumors of the female genital tract.
Clinical utility of valsartan in treatment of children and adolescents with high blood pressure.
Clinical value of plasma renin activity and aldosterone concentration in the evaluation of secondary hypertension, a case of reninoma.
Clinical value of plasma renin determinations in in renovascular and primary hypertension.
Clinical value of plasma renin estimation in the management of hypertension.
Clonidine in primary hypertension: effects on blood pressure, plasma renin activity, plasma and urinary aldosterone.
Cloning, characterization and site-directed mutagenesis of canine renin.
Close examination of steroidogenesis disorders in a DOC- and progesterone-producing adrenocortical carcinoma.
Co-expression of renin-angiotensin system genes in human adipose tissue.
Coarctation hypertension is renovascular, modified by ambulation. Coarctation hypertension renovascular variant.
Coarctation of the abdominal aorta: current options in surgical management.
Coexisting extraadrenal pheochromocytoma and renal artery stenosis: a case report and review of the pathophysiology.
Collecting Duct Prorenin Receptor Knockout Reduces Renal Function, Increases Na+ Excretion and Mitigates renal Responses in ANGII induced hypertensive mice.
Collecting Duct Renin Does Not Mediate DOCA-Salt Hypertension or Renal Injury.
Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats.
Collecting Duct Renin: A major player in Angiotensin II-dependent Hypertension.
Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention.
Collecting duct-specific knockout of renin attenuates angiotensin II-induced hypertension.
Column chromatographic analysis of relationship between hypertension-inducing potency and renin content of kidney extract.
Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.
Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
Combined 17-hydroxylase and 17,20-desmolase deficiencies: evidence for synthesis of a defective cytochrome P450c17.
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats.
Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
Combined Oral Contraceptive Pill-Induced Hypertension and Hypertensive Disorders of Pregnancy: Shared Mechanisms and Clinical Similarities.
Common questions and answers in the management of hypertension: routine measurement of plasma renin activity in the management of patients with essential hypertension: notes from the 19th Annual ASH Meeting.
Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension.
Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Comparative effectiveness of renin-angiotensin system inhibitors in hypertension.
Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African Americans with stage 2 hypertension and obesity or metabolic syndrome.
Comparative Efficacy of Aliskiren Monotherapy and Ramipril Monotherapy in Patients with Stage 2 Systolic Hypertension: Subgroup Analysis of a Double-blind, Active Comparator Trial.
Comparative studies on species-specific reactivity between renin and angiotensinogen.
Comparison of blood pressure, sodium intake, and other variables in offspring with and without a family history of high blood pressure.
Comparison of direct renin inhibitor and angiotensin II receptor blocker on clinic and ambulatory blood pressure profiles in hypertension with chronic kidney disease.
Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects.
Comparison of propranolol or hydrochlorothiazide alone for treatment of hypertension. III. Evaluation of the renin-angiotensin system.
Comparison of split function ratios with renal vein renin ratios in patients with curable hypertension caused by unilateral renal artery stenosis.
Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
Comparison of the Chemiluminescence Immunoassay LIAISON® with the Radioimmunoassay for Aldosterone and Renin Measurement.
Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with Stage 2 hypertension.
Comparison of the effects of diuretic therapy and low sodium intake in isolated systolic hypertension.
Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.
Comparison of the pressor activity and the renin content of the renal venous effluent in patients suspected of suffering from surgically remediable hypertension.
Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
Comparisons of body fluid volumes, plasma renin activity, hemodynamics and pressor responsiveness between juvenile and aged patients with essential hypertension.
Concomitant diseases in elderly hypertensives: the position of nicardipine.
Concurrent hypercortisolism and hypermineralocorticoidism.
Concurrent hypersecretion of aldosterone and cortisol from the adrenal cortical adenoma.
Conditional ablation of the prorenin receptor in nephron progenitor cells results in developmental programming of hypertension.
Confirmation that the renin gene distal enhancer polymorphism REN-5312C/T is associated with increased blood pressure.
Conformational and biological studies for a pair of novel synthetic AT1 antagonists: stereoelectronic requirements for antihypertensive efficacy.
Conformational Properties and Energetic Analysis of Aliskiren in Solution and Receptor Site.
Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families.
Congenital mesoblastic nephroma, renin production, and hypertension.
Conn's syndrome in a patient with acromegaly.
Connexin 40 is dispensable for vascular renin cell recruitment but is indispensable for vascular baroreceptor control of renin secretion.
Connexin40 regulates renin production and blood pressure.
Connexin43-dependent mechanism modulates renin secretion and hypertension.
Connexins, renin cell displacement and hypertension.
Considerations on physiopathological approaches to the treatment of hypertension.
Consistent activation of prorenin mRNA in renal hypertensive rats.
Continuing on J.P. Henry's path; studies of physiology and pathophysiology of cardiopulmonary receptors in humans.
Contraceptives, hypertension and renin.
Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling.
Contrasting effects of angiotensin type 1 and 2 receptors on nitric oxide release under pressure.
Contrasting effects of hypoglycemia on plasma renin activity and cyclic adenosine 3',5'-monophosphate (cyclic AMP) in low renin and normal renin essential hypertension.
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Contribution of REN gene MBbo I polymorphism in conferring risk for essential hypertension: a case control study from South India.
Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
Control of arterial pressure by angiotensin II and nitric oxide at the onset of diabetes.
Control of circulation by arterial baroreceptors and cardiopulmonary receptors in hypertension.
Control of hypertension and reversal of renal failure in undifferentiated connective tissue disease by enalapril.
Control of renin release in experimental hypertension.
Control of renin release: a review of experimental evidence and clinical implications.
Control of Renin Synthesis and Secretion.
Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease.
Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.
Controlling resistant hypertension.
Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Correction of hypertension by partial nephrectomy in segmental renal artery stenosis and electron microscopic studies of renin.
Correlation between evolution and treatment of hypertension in unilateral renal disease and values of renin activity in renal venous blood.
Correlation between granulation of juxtaglomerular cells and extractable renin in rats with experimental hypertension.
Correlation of Atrial Natriuretic Factor and Renin-Aldosterone System With Chronic Pulmonary Hypertension Among Residents in a High Altitude
Correlation of sodium-related factors with insulin sensitivity in young, lean, male offspring of hypertensive and normotensive subjects.
Correlation of the fibrinogen level with blood pressure and plasma renin activity in rats with early Goldblatt hypertension.
Corticosteroid modulation of the renin system and blood pressure in the spontaneously hypertensive rat.
Cosegregation of spontaneously hypertensive rat renin gene with elevated blood pressure in an F2 generation.
Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure.
Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.
Cost-Effectiveness of Renin-Guided Treatment of Hypertension.
Could angiotensin I be produced from a renin substrate by the HIV-1 protease?
Course of hypertension during prolonged treatment with heterologous renin.
COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system.
COX-2 mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla.
Critical roles of (pro)renin receptor-bound prorenin in diabetes and hypertension: sallies into therapeutic approach.
Cryoactivation and tryptic activation of blood 'prorenin' in normal man and animals.
Curable hypertension with unilateral hydronephrosis. Studies on the role of circulating renin.
Curable hypertension. Usefulness of renal vein renin ratio.
Curable renal parenchymatous hypertension: current diagnosis and management.
Cure With Cryoablation of Arterial Hypertension Due to a Renin-Producing Tumor.
Current concepts: renin inhibition in the treatment of hypertension.
Current status of dual Renin Angiotensin aldosterone system blockade for the treatment of cardiovascular diseases.
Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease.
Current Strategies to Achieve Further Cardiac and Renal Protection through Enhanced Renin-Angiotensin-Aldosterone System Inhibition.
Cushing's syndrome: all variants, detection, and treatment.
Cyclic AMP, renal function and dihydralazine-stimulated renin secretion in hypertensive patients.
Cyclooxygenase-2 inhibitors attenuate increased blood pressure in renovascular hypertensive models, but not in deoxycorticosterone-salt hypertension.
Cyclosporin-induced hypertension in marmosets: a new model of hypertension sensitive to angiotensin-converting enzyme inhibition.
CYP11B2 gene haplotypes independently and in concurrence with aldosterone and aldosterone to renin ratio increase the risk of hypertension.
CYP2C9 genotype modifies activity of the renin-angiotensin-aldosterone system in hypertensive men.
CYP450 4A inhibition attenuates O(2) induced arteriolar constriction in chronic but not acute Goldblatt hypertension.
Decreased expression of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats.
Decreased levels of circulating CD34(+) cells are associated with coronary heart disease in Japanese patients with type 2 diabetes.
Decreased myocardial Na+-K+-ATPase activity in one-kidney, one-clip hypertensive rats.
Decreased myocardial Na+K+ATPase activity in rats with reduced renal mass-saline hypertension.
Decreased pituitary response to insulin-induced hypoglycaemia in young lean male patients with essential hypertension.
Decreased prorenin processing develops before autonomic dysfunction in type 1 diabetes.
Decreased renal perfusion after correction of experimental coarctation.
Decreased venous distensibility and reduced renin responsiveness in hypertension.
Deep neural network modeling based virtual screening and prediction of potential inhibitors for renin protein.
Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat.
Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency.
Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue.
Deficiency of MicroRNA-181a Results in Transcriptome-Wide Cell-Specific Changes in the Kidney and Increases Blood Pressure.
Definition and use of renin reaction velocity in the study of human hypertension.
Delayed reversal of Goldblatt hypertension by angiotensin II infusion in the rat.
Deoxycorticosterone acetate salt hypertension in apolipoprotein E-/- mice results in accelerated atherosclerosis: the role of angiotensin II.
Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats.
Depressor activity of intracerebroventricularly administered pepstatin in young spontaneously hypertensive rats.
Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.
Design and optimization of new piperidines as renin inhibitors.
Design of potent aspartic protease inhibitors to treat various diseases.
Design of rat renin inhibitory peptides.
Detecting and treating primary aldosteronism: primary aldosteronism.
Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
Detection of renovascular hypertension: saralasin test versus renin determinations.
Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans.
Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension.
Determination of renin-dependency and sodium-dependency in the three renin sub-groups of essential hypertension.
Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension.
Development and maintenance of renal hypertension in normal and guanethidine sympathectomized rats.
Development of a high renin model of hypertension in the cynomolgus monkey.
Development of ideas on renovascular hypertension.
Development of inhibitors of the aspartyl protease renin for the treatment of hypertension.
Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy.
Development of malignant hypertension in patients with uremia under hemodialysis: a case report and discussions on its etiology.
Development of polyuria in Tsukuba hypertensive mice carrying human renin and angiotensinogen genes.
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors.
Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats.
Deveolpment of hypertension in rats maintained on a sodium deficient diet and bearing a mammotropic tumor (MtTF4).
Devising new drugs for the treatment of hypertension--"novel drugs targeting hypertension: renin inhibitors and beyond".
Dexamethasone hypertension in rats: role of prostaglandins and pressor sensitivity to norepinephrine.
Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
Dexamethasone-responsive hypertension in young women with suppressed renin and aldosterone.
Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.
Diagnosis and management of arterial stenosis causing hypertension after successful renal transplantation.
Diagnosis and treatment of low-renin hypertension.
Diagnosis and treatment of renin-secreting tumors. Report of three cases.
Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment.
Diagnosis of angiotensinogenic hypertension: the complementary roles of renal scintigraphy and the saralasin infusion test.
Diagnosis of hyperaldosteronism.
Diagnosis of renovascular hypertension by echo-Doppler velocimetry.
Diagnostic value of I-131 NP-59 SPECT/CT scintigraphy in patients with subclinical or atypical features of primary aldosteronism.
Diagnostic value of renal arteriography in polyarteritis nodosa.
Diagnostic value of the post-captopril test in primary aldosteronism.
Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension.
Dietary salt intake and hypertension.
Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
Dietary sodium restriction and the renin-angiotensin system in young spontaneously hypertensive rats.
Diets rich in saturated fat and/or salt differentially modulate atrial natriuretic peptide and renin expression in C57BL/6 mice.
Differences between black and white persons in blood pressure and related biological variables.
Differences in hypertension phenotypes between Africans and Europeans: role of environment.
Differences in kidney renin content between normotensive and spontaneously hypertensive rats: effect of captopril treatment.
Differences in renal hemodynamics and renin secretion between patients with unifocal and multifocal fibromuscular dysplasia.
Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.
Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
Different expression of renin-angiotensin system components in hearts of normotensive and hypertensive rats.
Different plasma ionized calcium correlations with blood pressure in high and low renin normotensive adults in Utah.
Differential development of early hypertension in heterozygous transgenic TGR(mREN2)27 rats.
Differential diagnosis in primary aldosteronism.
Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease.
Differential effects of sex steroids in young and aged female mRen2.Lewis rats: a model of estrogen and salt-sensitive hypertension.
Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat.
Differential regulation of angiotensinogen transcripts after renin infusion.
Differential role of cyclooxygenase-1 and -2 on renal vasoconstriction to ?1-adrenoceptor stimulation in normotensive and hypertensive rats.
Differential roles of renin and angiotensinogen in the feto-maternal interface in the development of complications of pregnancy.
Differing effects of the vasodilator drugs, prazosin and diazoxide on plasma renin activity in the dog.
Digital subtraction angiography in renal transplant recipients.
Digital subtraction angiography in the evaluation of renal vascular hypertension in children.
Digital vascular imaging and selective renin sampling in post-transplant hypertension. Which kidney is responsible?
Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.
Direct pro-inflammatory effects of prorenin on microglia.
Direct radio-immunoassay of renin substrate: effect of converting enzyme inhibition.
Direct renin inhibition : update on clinical investigations with aliskiren.
Direct renin inhibition exerts an anti-hypertrophic effect associated with improved mitochondrial function in post-infarction heart failure in diabetic rats.
Direct Renin Inhibition Improves Systemic Insulin Resistance and Skeletal Muscle Glucose Transport in a Transgenic Rodent Model of Tissue Renin Overexpression.
Direct renin inhibition in chronic kidney disease.
Direct renin inhibition is not enough to prevent reactive oxygen species generation and vascular dysfunction in renovascular hypertension.
Direct renin inhibition with aliskiren improves ischemia-induced neovascularization: blood pressure-independent effect.
Direct renin inhibition with aliskiren in hypertension and target organ damage.
Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
Direct Renin Inhibition With Aliskiren Normalizes Blood Pressure in Cyp1a1-Ren2 Transgenic Rats With Inducible Angiotensin II-Dependent Malignant Hypertension.
Direct renin inhibition--a promising strategy for renal protection?
Direct renin inhibition: an analysis of possible benefits.
Direct renin inhibition: extricating facts from facades.
Direct Renin Inhibitors as a New Therapy for Hypertension.
Direct renin inhibitors as antihypertensive agents.
Direct renin inhibitors in hypertension - approaching the moment of truth.
Direct renin inhibitors: a new approach to antihypertensive drug treatment.
Discoordinate re-expression of cardiac fetal genes in N(omega)-nitro-L-arginine methyl ester (L-NAME) hypertension.
Discoordinate regulation of renal nitric oxide synthase isoforms in ovariectomized mRen2.Lewis rats.
Discordant nephron function. A pathogenic factor in hypertension and its vascular complications of stroke and heart attack.
Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors.
Discovery of new sites for drug binding to the hypertension-related renin-angiotensinogen complex.
Discovery of remikiren as the first orally active renin inhibitor.
Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor.
Disorders of steroid 17 alpha-hydroxylase deficiency.
Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension.
Dissociated renin-aldosterone response to acute sodium depletion in patients with a previous history of pregnancy-associated hypertension.
Dissociation of blood pressure and sympathetic activation of renin release in sinoaortic-denervated rats.
Dissociation of renin and noradrenaline release in the renal circulation. Studies on patients with renal hypertension.
Dissociation of selective renal venous plasma endothelin-1 activity and corresponding plasma renin activity in a patient with hypertension, severe stenosis of unilateral renal artery and ipsilaterally decreased renal function.
Dissociation of the renin lowering and antihypertensive actions of propranolol.
Distinct determinants of muscle wasting in nonobese heart failure patients with and without type 2 diabetes mellitus.
Disturbances of the control of renin secretion in chronic one-kidney-Goldblatt hypertension in the rat.
Disturbed noradrenergic blood pressure control in normotensive members of hypertensive families.
Diuretic therapies in low renin and normal renin essential hypertension.
Diuretic therapy and response of essential hypertension to saralasin.
Diuretics and hypertension in black adults.
Diuretics, sodium intake, and renin in the management of hypertension.
Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity.
Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism.
Divided renal and caval vein plasma renin activity in two-kidney two-clip hypertension in rabbits and variations of blood pressure, plasma volume and renal function following unilateral nephrectomy.
DNA damage and augmented oxidative stress in bone marrow mononuclear cells from Angiotensin-dependent hypertensive mice.
Does a digoxin-like substance participate in vascular and pressure control during dietary sodium changes in patients with primary aldosteronism?
Does a renal vasodilator system mediate racial differences in essential hypertension?
Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Does antihypertensive therapy modify chronic allograft failure?
Does exposure to elevated levels of lead enhance sodium induced hypertension?
Does Extremely Low Birth Weight Predispose to Low-Renin Hypertension?
Does industrial environment influence the prevalence of arterial hypertension, plasma cholesterol and uric acid concentration and activity of the renin-aldosterone system?
Does pulsatile flow influence the incidence of postoperative hypertension?
Dose effects of human renin in rats transgenic for human angiotensinogen.
Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
Downregulated microRNA?133a induces HUVECs injury: Potential role of the (pro) renin receptor in angiotensin II?dependent hypertension.
Dramatic reduction of proteinuria in diabetic nephropathy by the use of spironolactone.
Drug therapy of renovascular hypertension.
Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat.
Dual inhibition with losartan and aliskiren: a promising therapeutic option for type 2 diabetic nephropathy?
Dual inhibitors for aspartic proteases HIV-1 PR and renin: advancements in AIDS-hypertension-diabetes linkage via molecular dynamics, inhibition assays, and binding free energy calculations.
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice.
Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-l-arginine methyl ester induced hypertension.
Early surgery in the management of pediatric blunt renal trauma.
Early-infantile galactosialidosis with multiple brain infarctions: morphological, neuropathological and neurochemical findings.
Echocardiographic left ventricular mass and electrolyte intake predict arterial hypertension.
Ectopic production of renin by ileal carcinoma.
Editorial: Low renin "essential'' hypertension; a variant of classic primary aldosteronism?
Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Effect of a Rational Drug Use Policy on the prescribing safety in outpatient settings in Thailand.
Effect of a spironolactone derivative (SC 14266) on Plasma renin activity in adrenal regeneration hypertension.
Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats.
Effect of aerobic exercise on plasma renin in overweight patients with hypertension.
Effect of age on diagnostic usefulness of stimulated plasma renin activity and saralasin test in detection of renovascular hypertension.
Effect of aliskiren on the anticonvulsant activity of antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.
Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers.
Effect of alprenolol and hydralazine on plasma renin concentration in patients with arterial hypertension.
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial.
Effect of an angiotensin II analogue upon blood pressure, plasma renin concentration and plasma aldosterone in hypertensive patients.
Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
Effect of angiotensin blockade and converting enzyme inhibition on renovascular hypertension: comparison between unilateral and bilateral renal artery stenosis.
Effect of angiotensin-converting enzyme inhibition on human tissue renin.
Effect of atenolol, a new cardioselective beta-blocker, on plasma renin activity in treatment of hypertension.
Effect of autonomic hyperreflexia on plasma renin.
Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure.
Effect of beta-adrenergic blockade on plasma-renin activity and intractable hypertension in patients receiving regular dialysis treatment.
Effect of captopril infusion on systemic and renal haemodynamics in conscious hypertensive rats with chronic, progressive aortic ligation.
Effect of captopril on blood pressure and on the renin-angiotensin-aldosterone system in coarctation of the aorta.
Effect of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive patients on hemodialysis.
Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease.
Effect of chloride on renin and blood pressure responses to sodium chloride.
Effect of chronic treatment with losartan potassium (DuP 753) on the elevation of blood pressure during chronic exposure of rats to cold.
Effect of chronic treatment with prazosin and L-arginine on the elevation of blood pressure during cold exposure.
Effect of clonidine on blood pressure in chronic one-kidney, one-clip and two-kidney, one-clip hypertensive rats.
Effect of combination of renin inhibitor and Mas-receptor agonist in DOCA-salt-induced hypertension in rats.
Effect of converting enzyme inhibition on glucocorticoid hypertension in the rat.
Effect of Cydonia oblonga Mill. leaf extracts or captopril on blood pressure and related biomarkers in renal hypertensive rats.
Effect of dietary chloride on salt-sensitive and renin-dependent hypertension.
Effect of diuretics on plasma renin activity in primary hypertension: A systematic review and meta-analysis.
Effect of enalapril on renin, angiotensin converting enzyme activity, aldosterone and prostaglandins in patients with hypertension.
Effect of experimentally-induced hypertension on angiotensin converting enzyme activity in the aortic endothelium and smooth muscle cum adventitia of the Sprague Dawley rat.
Effect of furosemide administration and upright position on plasma renin activity and angiotensin II in hypertension.
Effect of genetic background on cosegregation of renin alleles and blood pressure in Dahl rats.
Effect of heme oxygenase 1 and renin/prorenin receptor on oxidized low-density lipoprotein-induced human umbilical vein endothelial cells.
Effect of insulin pump therapy on blood pressure and the renin-angiotensin system of diabetic rats.
Effect of insulin, proinsulin, and amylin on renin release from perfused rat kidney.
Effect of intravenous frusemide on plasma renin concentration: suppression of response in hypertension.
Effect of nadolol in treatment of hypertension.
Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension.
Effect of nitrendipine on blood pressure, plasma renin, and exchangeable sodium in DOC-salt hypertension in the rat.
Effect of one year of thiazide therapy on plasma volume, renin, aldosterone, lipids and urinary metanephrines in systolic hypertension of elderly patients.
Effect of operant conditioning of heart rate on plasma renin activity.
Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.
Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure-prone SHHF/Mcc- fa cp rats.
Effect of oxprenolol on catecholamines and plasma renin activity: acute response to frusemide in hypertensive patients.
Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension.
Effect of posture on renal vein renin activity in hypertension; its implications in the management of patients with renovascular hypertension.
Effect of prazosin on blood pressure and plasma renin activity in man.
Effect of propranolol on blood pressure and renin in renal hypertension in the rat.
Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension.
Effect of propranolol on the renin response to frusemide in man.
Effect of removal of a clipped kidney or cessation of renin administration on hypertension.
Effect of removing the clipped kidney on renovascular hypertension in rabbits.
Effect of renal denervation on plasma renin activity after aortic baroreceptor deafferentation.
Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat.
Effect of repeated administration of cadmium, captopril and its combination on plasma renin activity in rats.
Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.
Effect of saralasin in hypertensive patients on chronic hemodialysis.
Effect of sodium depletion on plasma renin concentration before and during adrenergic beta-receptor blockade with propranolol in normotensive man.
Effect of somatostatin on plasma renin activity and blood pressure in patients with essential hypertension.
Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
Effect of the angiotensinogen genotype on experimental hypertension in mice.
Effect of the converting-enzyme inhibitor SQ 14 225 (captopril) in early one-kidney, one-clip hypertension in the rat.
Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
Effect of timolol versus propranolol on hypertension and hemodynamics.
Effect of varying perfusion pressures on the output of sodium and renin and the vascular resistance in kidneys of rats with "post-salt" hypertension and Kyoto spontaneous hypertension.
Effectiveness of furosemide in uncontrolled hypertension in the elderly: role of renin profiling.
Effectiveness of the direct renin inhibitor, aliskiren, in patients with resistant hypertension.
Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
Effects of 1-sarcosine-8-isoleucine-angiotensin II on blood pressure and plasma renin activity in various types of hypertension.
Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: the key role of vascular resistance changes in relation to partial agonist activity.
Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension.
Effects of a neutral endoprotease enzyme inhibitor, thiorphan, on hemodynamics and renal excretory function in four models of experimental hypertension.
Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension.
Effects of a reduction in maternal renal mass on pregnancy and cardiovascular and renal function of the pregnant ewe.
Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
Effects of aldosterone and spironolactone on arterial renin in rats.
Effects of aliskiren, a direct Renin inhibitor, on cardiac repolarization and conduction in healthy subjects.
Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats.
Effects of angiotensin II analog on blood pressure, renin and aldosterone in women on oral contraceptives and toxemia.
Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
Effects of Antihypertensive Agents on Intestinal Contractility in the Spontaneously Hypertensive Rat: Angiotensin Receptor System Downregulation by Losartan.
Effects of antihypertensive drugs on dialysis-resistant hypertension, plasma renin and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis: comparison of metoprolol, alphamethyldopa and clonidine in a cross-over trial.
Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats.
Effects of antihypertensive treatment on systolic blood pressure and renin in experimental hypertension in rats.
Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure.
Effects of calcium antagonists on deranged modulation of the renal function curve in salt-sensitive patients with essential hypertension.
Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
Effects of calcium on renin and aldosterone.
Effects of canrenone on blood pressure in rats with reduced renal mass.
Effects of celiprolol on plasma renin, aldosterone, norepinephrine and epinephrine in primary hypertension.
Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension.
Effects of diet on exaggerated natriuresis in hypertension.
Effects of different stages of aortic coarctation hypertension on aortic contraction and relaxation in rats.
Effects of diltiazem hydrochloride on cardiovascular response, platelet aggregation and coagulating activity during exercise testing in systemic hypertension.
Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial.
Effects of eplerenone versus losartan in patients with low-renin hypertension.
Effects of extracorporeal shock wave lithotripsy on plasma concentrations of endothelin and renin in humans.
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism.
Effects of guanethidine and methyldopa on a standardized test for renin responsiveness.
Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
Effects of indomethacin in rabbit renovascular hypertension.
Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride.
Effects of low-dose nifedipine GITS on sympathetic activity in young and older patients with hypertension.
Effects of nephrectomy and adrenalectomy on the renin-angiotensin system of transgenic rats TGR(mRen2)27.
Effects of nephrectomy on hypertension, renin activity and total renal function in patients with chronic renal artery occlusion.
Effects of nifedipine on blood pressure, regional hemodynamics, plasma renin activity and plasma catecholamines in patients with arterial hypertension.
Effects of omapatrilat in low, normal, and high renin experimental hypertension.
Effects of one-clip, one-kidney hypertension in chronically catheterized pregnant ewes.
Effects of ovariectomy and 17beta-estradiol treatment on the renin-angiotensin system, blood pressure, and endothelial ultrastructure.
Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.
Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension.
Effects of renin inhibition in systemic hypertension.
Effects of renovascular hypertension on reproductive function in male rats.
Effects of salt and water depletion on the early phase of hypertension in Goldblatt two-kidney hypertensive dogs.
Effects of SSRI medication on heart rate and blood pressure in individuals with hypertension and depression.
Effects of the blockade of the renin-angiotensin system in cyclosporin-induced hypertension.
Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension1.
Effects of the renin inhibitor MK-8141 (ACT-077825) in patients with hypertension.
Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population.
Effects of transplantation on the renin angiotensin system (RAS).
Effects of treatment strategy on endothelial function.
Effects of two forms of hypertension on atherosclerosis in the hyperlipidemic baboon.
Efficacy and safety of aliskiren, a direct renin inhibitor, compared with ramipril in Asian patients with mild to moderate hypertension.
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial.
Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
Efficacy and safety of the selective aldosterone blocker eplerenone in Japanese patients with hypertension: a randomized, double-blind, placebo-controlled, dose-ranging study.
Efficacy and tolerability of the renin inhibitor Ro 42-5892 in patients with hypertension.
Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders.
Efficacy of antihypertensive treatment based on plasma renin activity: an open label observational study.
Efficacy of captopril in experimental low renin hypertension.
Efficacy of low-dose spironolactone in subjects with resistant hypertension.
Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.
Elevated circulating renin activity in rats following doses of cadmium known to induce hypertension.
Elevated Plasma Levels of Soluble (Pro)Renin Receptor in Patients with Obstructive Sleep Apnea Syndrome in Parallel with the Disease Severity.
Elevated Plasma Renin Activity Caused by Accelerated-malignant Hypertension in a Patient with Aldosterone-producing Adenoma Complicated with Renal Insufficiency.
Elevated Renin and Aldosterone Levels in a Young Woman With Hypertension.
Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?
Elevated vascular angiotensin converting enzyme in chronic two-kidney, one clip hypertension in the dog.
Elevation of blood pressure in young rats fed a low calcium diet. Effects of nifedipine and captopril.
Enalapril and pressure-diuresis in hypertensive rats transgenic for mouse renin gene.
Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltering type 1 (insulin-dependent) diabetic children.
Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade.
Endocrine causes of hypertension in pregnancy--when to start looking for zebras.
Endocrine Conditions in Older Adults: Adrenal Tumors.
Endocrine Hypertension: Then and Now.
Endogenous angiotensin and pressure modulate brain angiotensinogen and AT1A mRNA expression.
Endogenous cardiotonic steroids.
Endogenous human renin expression and promoter activity in CALU-6, a pulmonary carcinoma cell line.
Endogenous intrarenal adenosine preserves renal blood flow in one-kidney, one clip rats.
Endogenous sodium-potassium pump inhibitor in low renin hypertension.
Endogenous tissue renin-angiotensin systems. From molecular biology to therapy.
Endothelial cell activity in experimental hypertension. Effects of hemodynamic factors.
Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty.
Endothelin inhibits renin release from juxtaglomerular cells via endothelin receptors A and B via a transient receptor potential canonical-mediated pathway.
Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension.
Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension.
Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats.
Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension.
Enhanced blood pressure buffering role of the brain nitrergic system in renin transgenic rats.
Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor.
Enhanced peripheral renin activity identifies high-renin hypertension in renal transplant patients with native kidneys.
Enhanced renin secretion in adrenalectomized rats with glucocorticoid-induced hypertension.
Enhanced sensitivity to acute angiotensin II is testosterone dependent in adult male growth-restricted offspring.
Enhancement by diuretics of the antihypertensive action of long-term angiotensin converting enzyme blockade.
Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats.
Enhancement of renal venous renin ratios by intravenous hydralazine in renovascular hypertension.
Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension.
Episodic hypertension associated with positive renin assays after renal transplantation.
Epithelial liver hamartoma, systemic arterial hypertension and renin hypersecretion.
Eplerenone: a selective aldosterone blocker.
Erythropoietin upregulates angiotensin receptors in cultured rat vascular smooth muscle cells.
Erythropoietin: physiology and pharmacology update.
Escherichia coli-based production of recombinant ovine angiotensinogen and its characterization as a renin substrate.
Essential hypertension: abnormal renal vascular and endocrine responses to a mild psychological stimulus.
Essential hypertension: relationship between renin and blood pressure.
Establishment of reference intervals for aldosterone and renin in a Caucasian population using the newly developed Immunodiagnostic Systems specialty immunoassay automated system.
Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring.
Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5' leader sequence of the receptor mRNA.
Ethnic differences of renin-sodium profile and renal prostaglandins in the pathogenesis of systemic arterial hypertension.
Ethnics differences in the reactions to drugs and xenobiotics. Antihypertensive agents.
Etiological considerations in Gordon's syndrome: possible role of prostaglandins.
Etiology of angiogenesis inhibition-related hypertension.
Etiopathogenesis of excess methylprednisolone arterial hypertension in the rat.
Evaluating the relationship of blood pressure, plasma angiotensin peptides and aldosterone with cognitive functions in patients with hypertension.
Evaluation of patients for secondary hypertension.
Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness.
Evaluation of surgical response in renovascular hypertension using angiotensin II blockade.
Evidence for a circulating sodium-potassium pump inhibitor in low renin hypertension.
Evidence for a potent angiotensin I degrading enzyme different from angiotensin I converting enzyme in rat vascular tissues.
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.
Evidence of direct smooth muscle relaxant effects of the fibrate gemfibrozil.
Evidence of Primary Aldosteronism in a Predominantly Female Cohort of Normotensive Individuals: A Very High Odds Ratio for Progression into Arterial Hypertension.
Evolution and hypertension: is the Renin system necessary?
Evolution of chronic nitric oxide inhibition hypertension: relationship to renal function.
Evolution of diagnostic criteria for primary aldosteronism: why is it more common in "drug-resistant" hypertension today?
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.
Evolving concepts on regulation and function of renin in distal nephron.
Exacerbated effects of prorenin on hypothalamic magnocellular neuronal activity and vasopressin plasma levels during salt-sensitive hypertension.
Exaggerated blood pressure response to angiotensin II in patients with Cushing's syndrome due to adrenocortical adenoma.
Exaggerated natriuresis in normotensive subjects with a previous history of pregnancy-associated hypertension.
Exaggerated renal vasodilator response to calcium entry blockade in first-degree relatives of essential hypertensive subjects.
Examination of the relationship of renin release to hypertension produced in the rabbit by renal-artery constriction.
Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism.
Excess cardiovascular mortality in the uremic patient--what does it teach for other risk factors in the non-renal patient?
Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect.
Excess prevalence of extracranial carotid artery lesions in renovascular hypertension.
Excess prevalence of supraaortic artery lesions in renovascular hypertension: an arteriographic study.
Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure.
Exchangeable sodium and renin in hypertension.
Exchangeable sodium in angiotensinogenic and nonangiotensinogenic renovascular hypertension.
Exchangeable sodium in experimental hypertension in rats.
Exchangeable sodium in Goldblatt one-kidney one-clip hypertension in the rat.
Exchangeable sodium in renal hypertension in the rat.
Exchangeable sodium, plasma renin activity and blood pressure changes during the development of 2 kidney 1 clip hypertension, and after subsequent contralateral nephrectomy.
Exercise Training Improves the Altered Renin-Angiotensin System in the Rostral Ventrolateral Medulla of Hypertensive Rats.
Experience with one-stage bilateral nephrectomy.
Experimental model of severe renal hypertension.
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Exploring the pH-Dependent Structure-Dynamics-Function Relationship of Human Renin.
Expression and regulation of the renin gene.
Expression of cytochrome P45011B1 mRNA in the brain of normal and hypertensive transgenic rats.
Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye.
Extra-adrenal pheochromocytoma causing renal artery stenosis. Relationship to hypertension and renin levels.
Extra-adrenal pheochromocytoma manifesting renovascular hypertension.
Extrarenal renin-secreting tumor associated with hypertension.
Extrarenal renin-secreting tumors: insights into hypertension and ovarian renin production.
Factor XII (Hageman factor) is a missing link between stress and hypercoagulability and plays an important role in the pathophysiology of ischemic stroke.
Factors determining cardiovascular and renal outcomes after adrenalectomy in patients with aldosterone-producing adrenal adenoma.
Factors in the control of plasma renin activity and concentration in Type 1 (insulin-dependent) diabetes.
Factors involved in the antihypertensive action of calcium antagonists.
Factors related to first dose hypotensive effect of captopril: prediction and treatment.
Failure of angiotensin II to reduce plasma renin activity in hypertensive pregnant women.
Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
Failure of patent aorto-renal grafts to cure hypertension in renin positive patients.
Failure of renin suppression by angiotensin II in hypertension.
Failure of the isolated perfused mammalian heart to destroy renin and hypertension.
False-negative saralasin responses in renovascular hypertension.
Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.
Familial hyperaldosteronism.
Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible hereditary cell membrane defect.
Fatal, low renin hypertension associated with a disturbance of cortisol metabolism.
Favorable outcome of neonatal aortic thrombosis and renovascular hypertension.
Fibromuscular dysplasia of the renal artery--management and outcome.
Firibastat: An Oral First-in-Class Brain Aminopeptidase A Inhibitor for Systemic Hypertension.
First dose effect of the oral angiotensin converting enzyme inhibitor captopril.
First orally active DRI Aliskiren--a new prospect in management of hypertension and beyond.
First renin inhibitor, aliskiren, for the treatment of hypertension.
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Five year prospective study of plasma renin activity and blood pressure in patients with longstanding reflux nephropathy.
Focal Segmental Glomerulosclerosis Secondary to Juxtaglomerular Cell Tumor during Pregnancy: A Case Report.
Follow-up of renin in essential hypertension.
Food protein-derived renin-inhibitory peptides: in vitro and in vivo properties.
Forms of mineralocorticoid hypertension.
Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques.
Free radical scavenging reverses fructose-induced salt-sensitive hypertension.
Frequency in hypertensives of alleles for a RFLP associated with the renin gene.
Frequency of renin gene restriction fragment length polymorphism in hypertensives with a genetic predisposition to hypertension.
Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene.
Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat.
Functional characterization of polymorphisms in the kidney enhancer of the human renin gene.
Functional characterization of the decoy peptide, [R10P]IFLKRMPSI[19P].
Functional effects of genetic variants in the 11beta-hydroxylase (CYP11B1) gene.
Functional renal involvement in normotensive patients with progressive systemic sclerosis: impaired sodium excretion during isotonic saline infusion.
G protein beta 3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy.
G protein beta3 subunit variant: tendency of increasing susceptibility to hypertension in Japanese.
Gaisböck's syndrome: its hematologic, biochemical and hormonal parameters.
Gap junction protein connexin40 is preferentially expressed in vascular endothelium and conductive bundles of rat myocardium and is increased under hypertensive conditions.
Gas chromatographic-mass spectrometric analysis of urinary glycyrrhetinic acid: an aid in diagnosing liquorice abuse.
Gender aspects in heart failure. Pathophysiology and medical therapy.
Gender differences of human tissue kallikrein and an erythrocyte kallikrein-like enzyme in essential hypertension.
Gender-specific cardiovascular adaptation due to circadian blood pressure variations in essential hypertension.
Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs.
Gene therapy for hypertension: sense and antisense strategies.
Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension.
Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes.
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Genetic forms and pathophysiology of essential arterial hypertension in minor indigenous peoples of Russia.
Genetic forms of human hypertension.
Genetic hypertension and the kidney.
Genetic polymorphism of CYP11B2 gene and hypertension in Japanese.
Genetic variation in P450c11AS in Chilean patients with low renin hypertension.
Genetic variation in the epithelial sodium channel: a risk factor for hypertension in people of African origin.
Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms.
Genetics of hypertension: what we know and don't know.
Genetics of hypertensive syndrome.
Genetics of the mineralocorticoid system in primary hypertension.
Genomic markers associated with successful treatment of hypertension with lisinopril: A pilot study.
Glia- and neuron-specific expression of the renin-angiotensin system in brain alters blood pressure, water intake, and salt preference.
Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography.
Glomerular hyperfiltration, high renin, and low- extracellular volume in high blood pressure.
Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation.
Glucocorticoid-induced hypertension in the elderly. Relation to serum calcium and family history of essential hypertension.
Glucocorticoid-suppressible hyperaldosteronism. Ultrastructural observation of a case.
Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism.
Haemodynamic and endocrine effects of deliberate hypotension with magnesium sulphate for cerebral-aneurysm surgery.
Haemodynamic characteristics of low-renin hypertension.
Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Haemodynamic diversity and plasma renin activity in labile arterial hypertension.
Haemodynamics of stable renal transplant recipients.
Haplotype analysis of the human renin gene and essential hypertension.
Headache and arterial hypertension.
Hemodynamic and cardiac adaptation in essential hypertension. Consequences for therapy.
Hemodynamic and hormonal response to induced hypotension with isosorbide dinitrate and nitroglycerin during anesthesia.
Hemodynamic and humoral characteristics of hypertension induced by prolonged stellate ganglion stimulation in conscious dogs.
Hemodynamic and metabolic profile in offspring of malignant hypertensive parents.
Hemodynamic and renin responses to nifedipine in renovascular hypertension.
Hemodynamic changes induced by reversal of early and late renovascular hypertension.
Hemodynamic effect of propranolol therapy in relationship to renin status and plasma catecholamines in primary hypertension.
Hemodynamic effects of bufalin in the anesthetized dog.
Hemodynamic effects of the converting enzyme inhibitor teprotide in normal- and high-renin hypertension.
Hemodynamic lesions in hypertension.
Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
Hepatic inactivation of renin in the treatment of hyperreninemic hypertension.
Hereditary causes of primary aldosteronism and other disorders of apparent excess mineralocorticoid activity.
Hereditary renal diseases.
Heritable forms of hypertension.
High beta 1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol.
High blood pressure and oral contraceptives. Changes in plasma renin and renin substrate and in aldosterone excretion.
High blood pressure in transgenic mice carrying the rat angiotensinogen gene.
High blood pressure: hunting the genes.
High human renin hypertension in transgenic rats.
High intraluminal pressure promotes vascular inflammation via caveolin-1.
High plasma aldosterone and low renin predict blood pressure increase and hypertension in middle-aged Caucasian populations.
High plasma renin activity associates with obesity-related diabetes and arterial hypertension, and predicts persistent hypertension after bariatric surgery.
High prevalence of primary aldosteronism in the Tayside hypertension clinic population.
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
High renin arterial hypertension due to occlusion of the adrenal veins in the rat.
High renin hypertension associated with renal cortical cyst.
High renin hypertension in association with a solitary renal cyst.
High renin hypertension in focal renal fibromuscular dysplasia: turn off of renin system angiotensin overactivation by renal angioplasty cured high blood pressure and quickly reversed myocardial hypertrophy.
High renin hypertension in the elderly.
High salt intake attenuates the development of hypertension in two-kidney, one-clip Goldblatt rats.
High salt intake damages the heart through activation of cardiac (pro) renin receptors even at an early stage of hypertension.
Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus.
Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions.
Historical perspective on renin system blockade in the treatment of hypertension.
History about the discovery of the renin-angiotensin system.
HIV protease inhibitors activate the adipocyte renin angiotensin system.
Home blood pressure and circadian variation of blood pressure in the evaluation of hypertensive patients.
Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.
Hormonal and hemodynamic effects of short- and long-term clonidine therapy in patients with mild-to-moderate hypertension.
Hormonal hypertension in children: 11beta-hydroxylase deficiency and apparent mineralocorticoid excess.
Hormonal response to orthostasis in elderly people with systemic systolic hypertension.
Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
How are physicians prescribing the direct renin inhibitor aliskiren in the management of essential hypertension? A French observational study.
Human brain aminopeptidase A: biochemical properties and distribution in brain nuclei.
Human fetal kidney morphometry during gestation and the relationship between weight, kidney morphometry and plasma active renin concentration at birth.
Human Glomerular Endothelium: Interplay Among Glucose, Free Fatty Acids Angiotensin II And Oxidative Stress In Hyperglycemia.
Human plasma renin activity in hypertension and renal diseases.
Human renin 5'-flanking DNA to nucleotide-2750.
Human renin gene BglI dimorphism associated with hypertension in two independent populations.
Human renin protein and gene structures: present and future targets for renin blockade in treatment of hypertension.
Human renin-dependent hypertension in rats transgenic for human angiotensinogen.
Human renovascular effects of dopexamine hydrochloride: a novel agonist of peripheral dopamine and beta 2-adreno-receptors.
Humoral factors and the sodium-potassium pump in low renin hypertension.
Humoral factors determining the blood pressure response to converting enzyme inhibition and calcium channel blockade.
Humoral mechanisms of arterial hypertension in patients in the acute phase of myocardial infarction.
Humoral sodium transport inhibitor in acute volume expansion and low renin hypertension.
Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
Hydrochlorothiazide is not additive to verapamil in treating essential hypertension.
Hydrogen and potassium regulation of (pro)renin processing and secretion.
Hygroma renale: pararenal lymphatic cysts associated with renin-dependent hypertension (Page kidney). Case report on bilateral cysts and successful therapy by marsupialization.
Hyperaldosteronism among black and white subjects with resistant hypertension.
Hyperaldosteronism due to unsuspected adrenal carcinoma: discovery during investigation of hypertension in a young woman.
Hyperaldosteronism: the internist's hypertensive disease.
Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation.
Hyperkalemia with mild ECF volume contraction: studies to provide a possible physiologic interpretation.
Hypermineralocorticism without excessive aldosterone secretion: an adrenal carcinoma producing deoxycorticosterone.
Hypermineralocorticoidism due to adrenal carcinoma: plasma corticosteroids and their response to ACTH and angiotensin II.
Hypernephroma and hypertension. Two case reports.
Hyperplasia of juxtaglomerular cells and renomedullary interstitial cells after renal arterial embolization in patients with renal cell carcinoma.
Hyperreninemia during renal transplantation.
HYPERSENSITIVITY TO ACUTE ANGIOTENSIN II IN FEMALE GROWTH-RESTRICTED OFFSPRING IS EXACERBATED BY OVARIECTOMY.
Hypertension after coronary operation. Can it be prevented by pulsatile perfusion?
Hypertension after ending captopril administration: pathogenesis in 2-kidney, 1-clip rat.
Hypertension after renal transplantation.
Hypertension after surgical management of renal duplication associated with an upper pole ureterocele.
Hypertension and adrenal disorders.
Hypertension and aldosterone overproduction without renin suppression in Cushing's syndrome from an adrenal adenoma.
Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty-two patients.
Hypertension and hypokalemia: unusual syndromes.
Hypertension and insulin resistant models have divergent propensities to learned helpless behavior in rodents.
Hypertension and liver disease.
Hypertension and low plasma renin activity: presumptive evidence for mineralocorticoid excess.
Hypertension and plasma renin activity in experimentally induced chronic pyelonephritis.
Hypertension and post-traumatic renal arteriovenous fistula: demonstration of unilaterally elevated renin secretion.
Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems.
Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases.
Hypertension and renin in human renal transplantation.
Hypertension and renovascular disease: follow-up on 100 renal vein renin samplings.
Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction.
Hypertension and the interrelated renal circulatory effects of prostaglandins and the renin-angiotensin system.
Hypertension and the vanishing kidney.
Hypertension and unilateral hydronephrosis.
Hypertension and unilateral parenchymal renal disease. Evidence for abnormal vasoconstriction-volume interaction.
Hypertension as a paraneoplastic phenomenon in childhood Hodgkin's disease.
Hypertension as the major problem of idiopathic arterial calcification of infancy.
Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension.
Hypertension associated with hyperparathyroidism is not responsive to angiotensin blockade.
Hypertension associated with increased renin concentrations in nephroblastoma.
Hypertension associated with multiple renal arteries may be renin-dependent.
Hypertension caused by an aldosterone-secreting adenoma. Occurrence in a 7-year-old child.
Hypertension caused by renal arteriovenous fistula.
Hypertension control with daily dialysis.
Hypertension corrected by discontinuing chronic sodium bicarbonate ingestion. Subsequent transient hypoaldosteronism.
Hypertension due to a deoxycorticosterone-secreting adrenal tumour diagnosed during pregnancy.
Hypertension due to chronic blockade of P1-purinoceptors.
Hypertension due to renal artery stenosis in transplanted kidneys.
Hypertension due to renal tuberculosis: assessment by renal vein renin sampling.
Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive.
Hypertension following carotid endarterectomy: the role of cerebral renin production.
Hypertension following coronary artery bypass surgery. Role of preoperative propranolol therapy.
Hypertension following myocardial revascularization: its prevalence and etiology.
Hypertension following renal transplantation. Causative factors and therapeutic implications.
Hypertension following renal transplantation: the role of the host's kidney.
Hypertension from ipsilateral renin hypersecretion following kidney upper pole compression by the spleen.
Hypertension from renal tuberculosis: operative cure predicted by renal vein renin.
Hypertension in a four-year-old child: gas chromatographic and mass spectrometric evidence for deficient hepatic metabolism of steroids.
Hypertension in a patient with hypercalcemia: captopril and verapamil.
Hypertension in autosomal dominant polycystic kidney disease: is renin acquitted as a culprit?
Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension.
Hypertension in childhood from renal vein thrombosis.
Hypertension in children with burns.
Hypertension in congenital adrenal hyperplasia and apparent mineralocorticoid excess.
Hypertension in connexin40-null mice: a renin disorder.
Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent.
Hypertension in dialysis patients.
Hypertension in end-stage renal disease. The relationship between blood pressure, plasma renin, plasma renin substrate and exchangeable sodium in chronic hemodialysis patients.
Hypertension in experimental diabetes mellitus. Renin-prostaglandin interaction.
Hypertension in kidney transplantation.
Hypertension in licorice abuse. A case report.
Hypertension in Mice with Transgenic Activation of the Brain Renin-Angiotensin System is Vasopressin-Dependent.
Hypertension in patients on chronic hemodialysis: the role of the renin-angiotensin system.
Hypertension in patients on maintenance hemodialysis: evaluation of peripheral renin activity and bilateral nephrectomy.
Hypertension in pregnancy: a physiological response to a pathological problem?
Hypertension in primary hyperparathyroidism: the role of the renin-angiotensin system.
Hypertension in radiation nephritis. Report of a patient with unilateral disease, elevated renin activity levels, and reversal after unilateral nephrectomy.
Hypertension in the (mRen-2)27 rat is not explained by enhanced kinetics of transgenic Ren-2 renin.
Hypertension in the elderly: conventional wisdom revisited.
Hypertension in the first month of life.
Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen.
Hypertension in the transplanted patient.
Hypertension induced by adrenocortical dysfunction--hypertension in 17 alpha-hydroxylase deficiency and metopirone-induced hypertension.
Hypertension induced by oral contraceptives containing estrogen and gestagen. Effects on plasma renin activity and aldosterone excretion.
Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen.
Hypertension management: differing points of view. Should we routinely measure renin levels to diagnose and treat patients with hypertension? The argument against.
Hypertension management: differing points of view. Should we routinely measure renin levels to diagnose and treat patients with hypertension? The argument for.
Hypertension of childhood with suppressed renin.
Hypertension produced by chemical renal medullectomy: evidence for a renomedullary vasodepressor function in the rat.
Hypertension produced in the rabbit by long continued infusions of renin.
Hypertension secondary to renin-secreting juxtaglomerular cell tumor: case report and review of 38 cases.
Hypertension treatment update: focus on direct renin inhibition.
Hypertension with elevated renal vein renin secondary to unilateral hydronephrosis.
Hypertension with renal arterial stenosis: humoral, hemodynamic and histopathologic factors.
Hypertension, adrenal abnormalities, and alterations in plasma renin activity.
Hypertension, creatinine, and plasma renin activity in heart transplant recipients.
Hypertension, hypokalemia and hypoaldosteronism with suppressed renin: a clinical study of a patient with Liddle's syndrome.
Hypertension, hypokalemia, hyporeninemia and severe target organ damage.
Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.
Hypertension, oedema, and suppressed renin aldosterone system due to unsupervised salt administration.
Hypertension-inducing potency and renin content of variously treated kidney extract.
Hypertension.
Hypertension: Renin-Angiotensin-Aldosterone System Alterations.
Hypertensive Crisis with Neurological Impairment Mimicking a Guillain-Barrè Syndrome: Searching for a Link.
Hypertensive Emergency in a Woman with Systemic Sclerosis.
Hypertensive renal rhabdomyosarcoma.
Hyperuricemia causes glomerular hypertrophy in the rat.
Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism.
Hyponatremic hypertensive syndrome and massive proteinuria in a patient with renin-producing leiomyosarcoma.
Hypotensive action and increased plasma renin activity by Ca2+ antagonist (Nifedipine) in hypertensive patients.
Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.
Hypotensive function of the brain angiotensin-(1-7) in Sprague Dawley and renin transgenic rats.
Identification and implications of new types of mineralocorticoid hypertension.
Identification of 19-nor-deoxycorticosterone in normal rat serum by enzyme immunoassay and gas chromatography-mass spectrometry.
Identification of a single cytosine base insertion mutation at Arg-597 of the beta subunit of the human epithelial sodium channel in a family with Liddle's disease.
Identification of angiotensinogenic hypertension in man using 1-sar-8-ala-angiotensin II (Saralasin, P-113).
Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis.
Identification of novel human renin inhibitors through a combined approach of pharmacophore modelling, molecular DFT analysis and in silico screening.
Idiopathic arterial calcification of infancy: effectiveness of prostaglandin infusion for treatment of secondary hypertension refractory to conventional therapy: case report.
Idiopathic hyperplasia of the adrenal gland behaving like an aldosterone producing adenoma.
Imbalance between Angiotensin II - Angiotensin (1-7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension.
Immediate Results and Long-Term Outcomes Following Percutaneous Radiofrequency Ablation of Unilateral Aldosterone-Producing Adenoma.
Immunohistochemical localization of renin in end-stage kidneys.
Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis.
Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
Immunoreactive renin and angiotensin II in the afferent glomerular arterioles of rats with hypertension due to unilateral renal artery constriction.
Immunosuppression improves blood pressure and endothelial function in a rat model of pregnancy-induced hypertension.
Impact of captopril on hemodynamic and hormonal effects of nitroprusside.
Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice.
Impact of obesity on kidney function and blood pressure in children.
Impaired 11?-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid Resistant Patients.
Impaired cortisol binding to glucocorticoid receptors in hypertensive patients.
Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen.
Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.
Impaired Neovascularization and Reduced Capillary Supply in the Malignant vs. Non-malignant Course of Experimental Renovascular Hypertension.
Impaired placental neovascularization in mice with pregnancy-associated hypertension.
Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
Impaired renal prostaglandin E2 biosynthesis in human hypertensive states.
Impaired renin response to hemorrhage in hypertensive rabbits.
Impaired weight gain and renovascular hypertension.
Implication of endogenous prostaglandin system in the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.
Implications of local angiotensin production in cardiovascular physiology and pharmacology.
Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Importance of plasma renin activity suppression and venous distensibility on pressor and natriuretic responses to intravenous salt load in borderline hypertension.
Importance of the renal nerves in the pathogenesis of experimental hypertension.
Improved diagnostic accuracy of renal venous renin ratios with stimulation of renin release.
Improvement in Angiotensin 1-7 precedes and correlates with improvement in Arterial stiffness and endothelial function following Renin-Angiotensin system inhibition in type 2 diabetes with newly diagnosed hypertension.
Improvement in renal hemodynamics following combined angiotensin II infusion and AT1R blockade in aged female sheep following fetal unilateral nephrectomy.
In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2.
In vitro determinants of plasma renin activity in serially-studied inbred dogs with neonatally induced coarctation hypertension: renin reactivity, renin substrate, and renin concentration.
In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess.
Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats.
Incidence of hypertension in infants on extracorporeal membrane oxygenation.
Incidence of primary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria.
Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium.
Increased bradykinin and "normal" angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats.
Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens.
Increased central blood volume: a poosible pathophysiological factor im mild low-renin essential hypertension.
Increased cytosolic sodium and reduced Na,K-ATPase activity in transgenic rats.
Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease.
Increased FDG Uptake on Juxtaglomerular Cell Tumor in the Left Kidney Mimicking Malignancy.
Increased hematocrit with normal red blood cell mass in early borderline essential hypertension.
Increased levels of a humoral digitalis-like factor in deoxycorticosterone acetate-induced hypertension in the pig.
Increased plasma adrenaline concentrations in benign essential hypertension.
Increased plasma aldosterone-to-renin ratio is associated with impaired left ventricular longitudinal functional reserve in patients with uncomplicated hypertension.
Increased plasma catecholamines in high renin hypertension.
Increased plasma renin activity in chronic renal failure associated with severe hypertension; relationship between plasma renin level and peritoneal dialysis.
Increased plasma renin activity, secondary aldosteronism, and hypertension.
Increased plasma vasopressin in low renin essential hypertension.
Increased sympathetic nerve activity at home in young subjects with hypertension.
Increased urinary cortisol and androgen metabolites in a young female with hypertension: partial glucocorticoid resistance syndrome.
Increased vascular angiotensin formation in female rats harboring the mouse Ren-2 gene.
Increased vascular formation of angiotensin II in one-kidney, one clip hypertension.
Independence of renin production and hypertension in abdominal aortic aneurysmectomy.
Indications for surgery on renal artery aneurysms.
Indomethacin decreases arterial blood pressure and plasma renin activity in rats with aortic ligation.
Indomethacin inhibits the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.
Inducible deletion of connexin 40 in adult mice causes hypertension and disrupts pressure control of renin secretion.
Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium, and the Renin-Angiotensin System in Humans.
Influence of Body Weight and Gender on the Pharmacokinetics, Pharmacodynamics, and Antihypertensive Efficacy of Aliskiren.
Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
Influence of enalapril on established pressure-overload cardiac hypertrophy in low and normal renin states in female rats.
Influence of family history of hypertension on the relationships between blood pressure, body weight, electrolyte metabolism, renin, prolactin and parathormone.
Influence of gestational salt restriction in fetal growth and in development of diseases in adulthood.
Influence of renin levels on the treatment of essential hypertension with thiazide diuretics.
Influence of sodium on experimental renovascular hypertension in rats.
Influence of somatostatin on blood pressure and plasma renin activity in the rat.
Influence of Temperature and Humidity on Physico-pharmaceutical Characteristics of Rasilez(®) Tablets.
Influence of the renal sympathetic nerves on renal renin and angiotensinogen gene expression in spontaneously hypertensive rats during development.
Influence of the renin-angiotensin system stimulation on erythropoietin production in patients with various forms of arterial hypertension.
Influence of thiazide on salt hypertension.
Inherited forms of mineralocorticoid hypertension.
Inhibition of hypertension and salt intake by oral taurine treatment in hypertensive rats.
Inhibition of renin and the (pro)renin receptor system.
Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.
Inhibitors of rat renin and their use in experimental hypertension.
Inhibitory effect of catechin-related compounds on renin activity.
Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure.
Insulin resistance and hypertension: studies in transgenic hypertensive TGR(mREN-2)27 rats.
Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans.
Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions.
Interaction between renin and the autonomic nervous system in hypertension.
Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure.
Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension.
Interaction of acetaldehyde with plasma proteins of the renin-angiotensin system.
Interaction of the renin inhibitor aliskiren with the SARS-CoV-2 main protease: a molecular docking study.
Interleukin-1 Receptor Activation Potentiates Salt Reabsorption in Angiotensin II-Induced Hypertension via the NKCC2 Co-transporter in the Nephron.
Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs.
Interrelations between age and plasma renin, aldosterone and cortisol, urinary catecholamines, and the body sodium/volume state in normal man.
Interrelations of renin, angiotensin II, and sodium in hypertension and renal failure.
Interrelationship of blood flow, juxtaglomerular cells, and hypertension: role of physical equilibrium and Ca.
Interrelationships of the renin angiotensin system and the sympathetic nervous system in the pathogenesis of hypertension in man-a hypothesis.
Interventional Cardiology and Catheter-Based Interventions in Pregnancy.
Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
Intracellular angiotensin II as a regulator of muscle tone in vascular resistance vessels. Pathophysiological implications.
Intracellular renin increases the inward calcium current in smooth muscle cells of mesenteric artery of SHR. Implications for hypertension and vascular remodeling.
Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension.
Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency.
Intrarenal angiotensin II augmentation in angiotensin II dependent hypertension.
Intrarenal Mouse Renin-angiotensin System during Ang II-induced Hypertension and ACE inhibition.
Intratubular Renin-Angiotensin System in Hypertension.
Intrauterine growth restriction is associated with persistent juxtamedullary expression of renin in the fetal kidney.
Intravenous labetalol for the treatment of hypertension after carotid endarterectomy.
Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
Intrinsic defect of aldosterone synthesis in dexamethasone-responsive hypertension with suppressed renin and aldosterone.
Introduction to part II of the hypertension symposium. Prorenin, renal hypertension; diuretics and hyperlipidemia; angiotensin receptors and blocking drugs; a new treatment system.
Introgression of the Brown Norway Renin Allele Onto the Dahl Salt-Sensitive Genetic Background Increases Cu/Zn SOD Expression in Cerebral Arteries.
Inverse relationship between upright plasma renin activity and twenty-four hour blood pressure variability in borderline hypertension.
Investigating mineralocorticoid hypertension.
Investigation of the mechanism of hypertension in apparent mineralocorticoid excess.
Involvement of activated prorenin in the pathogenesis of slowly progressive nephropathy in the non-clipped kidney of two kidney, one-clip hypertension.
Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension?
Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?
Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1-7)/Mas and the ACE/Ang II/AT1 axes?
Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension?
Is primary aldosteronism underdiagnosed in clinical practice?
Is Renin-based treatment a reasonable strategy to treat essential hypertension?
Is the peripheral sympatho-adrenal nervous system necessary for renal hypertension?
Is the Renal Resistive Index a Marker for Revascularization in Atherosclerotic Renal Artery Stenosis?
Is the renin system necessary?
Is there a future for direct renin inhibitors?
Is there a role for direct renin inhibitors in chronic kidney disease?
Is there a role for renal alpha 2-adrenoceptors in the pathogenesis of hypertension?
Ischemia and reactive oxygen species in sympathetic hyperactivity states: a vicious cycle that can be interrupted by renal denervation?
Isolated systolic hypertension in older patients.
Itraconazole, a P-Glycoprotein and CYP3A4 Inhibitor, Markedly Raises the Plasma Concentrations and Enhances the Renin-Inhibiting Effect of Aliskiren.
Juvenile hypertension caused by overproduction of renin within a renal segment.
Juvenile hypertension, the role of genetically altered steroid metabolism.
Juxtaglomerular cell tumor in an 8-year-old girl.
Juxtaglomerular cell tumor of the kidney treated with nephron-sparing surgery.
Juxtaglomerular cell tumor of the kidney--a new classification scheme.
Juxtaglomerular Cell Tumor of the Kidney: Case Report and Differential Diagnosis With Emphasis on Pathologic and Cytopathologic Features.
Juxtaglomerular cell tumor: A morphological, immunohistochemical and genetic study of six cases.
Juxtaglomerular cells, aldosterone, renin and hypertension.
Kallikrein genes: cloning in man and expression in rat renal hypertension.
Kallikrein, kininogen and kinins in control of blood pressure.
Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives.
Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework.
Kidney and hypertension: role of the juxtaglomerular apparatus.
Kidney and plasma renin in human renovascular hypertension.
Kidney angiotensin II receptors and converting enzyme in neonatal and adult Wistar-Kyoto and spontaneously hypertensive rats.
Kidney development and the fetal programming of adult disease.
Kidney hematoma due to extracorporeal shock wave lithotripsy causing transient renin mediated hypertension.
Kidney renin mRNA levels in the early and chronic phases of two-kidney, one clip hypertension in the rat.
Kidney transplant artery stenosis. Interrelationship between blood pressure, kidney function, renin-aldosterone system and body sodium content.
Kidney's role in hypertension.
Labetalol Infusion Attenuates Paradoxical Hypertension and Decreases Plasma Renin Activity After Repair of Coarctation of the Aorta in Children.
Labetalol Infusion Controls Paradoxical Hypertension and Decreases Plasma Renin Activity Following Repair of Coarctation of the Aorta in Children.
Labetalol: bioavailability, drug plasma levels, plasma renin and catecholamines in acute and chronic treatment of resistant hypertension.
Lack of association between C3123A polymorphism of the angiotensin II type 2 receptor gene and hypertension in Tunisian population.
Lack of Connexins 40 and 45 Reduces Local and Conducted Vasoconstrictor Responses in the Murine Afferent Arterioles.
Lack of correlation between Mbo I restriction fragment length polymorphism of renin gene and essential hypertension in Japanese.
Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
Laparoscopic Nephro-Sparing Surgery of a Reninoma Tumor in a Pediatric Patient.
Laparoscopic partial nephrectomy for Juxtaglomerular apparatus tumour: A rare cause of hypertension.
Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma.
Laparoscopic renal cryoablation: impact on renal function and blood pressure.
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Lesson XXIV: on the major roles of the renin system in the pathogenesis of hypertension and of its sequelae, heart attack, heart failure, kidney failure, and stroke: replies to commonly asked questions.
Lead-induced hypertension: role of oxidative stress.
Left ventricular adaptation to hypertension and plasma renin activity.
Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension.
Lessons From Africa: The Importance of Measuring Plasma Renin and Aldosterone in Resistant Hypertension.
Lessons Learned from Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets Patients on Vitamin D Functions.
Letter: Hydronephrosis, hypertension and plasma renin activity.
Letter: Low renin in experimental hypertension.
Letter: Renin and hypertension risks.
Letter: Renin in hypertension.
Letter: Renin profiling in hypertension.
Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.
Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity.
Licorice-related rhabdomyolysis: a big price for a sweet tooth.
Liddle syndrome due to a novel mutation in the ? subunit of the epithelial sodium channel (ENaC) in family from Russia: a case report.
Liddle syndrome in a Serbian family and literature review of underlying mutations.
Liddle's disease: abnormal regulation of amiloride-sensitive Na+ channels by beta-subunit mutation.
Liddle's syndrome associated with a point mutation in the extracellular domain of the epithelial sodium channel gamma subunit.
Liddle's syndrome in an African male due to a novel frameshift mutation in the beta-subunit of the epithelial sodium channel gene.
Liddle's syndrome: a 14-year follow-up of the youngest diagnosed case.
Life and death in the microcirculation: a role for angiotensin II.
Ligation of the renal vein in the solitary kidney: effects on renal function.
Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans.
Linkage analysis of candidate genes and gene-gene interactions in chinese hypertensive sib pairs.
Lipid metabolism alterations in normotensive subjects with positive family history of hypertension.
Liquorice-induced sodium retention. Merely an acquired condition of apparent mineralocorticoid excess? A case report.
Liver cirrhosis and arterial hypertension.
Local Renin Angiotensin Aldosterone Systems and Cardiovascular Diseases.
Localization of components of the renin-angiotensin system and site of action of inhibitors.
Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells.
Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
Long term treatment of moderate hypertension with penbutolol (Hoe 893d). II. Effect on the response of plasma catecholamines and plasma renin activity to insulin-induced hypoglycemia.
Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.
Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.
Long-Range Control of Renin Gene Expression in Tsukuba Hypertensive Mice.
Long-term cardiovascular role of nitric oxide in conscious rats.
Long-term control of hypertension and the predictive value of peripheral plasma renin activity after ablation of end stage kidneys with a new embolic agent.
Long-term effectiveness of indapamide in hypertension: neural, renin and metabolic responses.
Long-term experience of captopril in the treatment of primary (essential) hypertension.
Long-term prognosis of post-infectious renal scarring in relation to radiological findings in childhood--a 27-year follow-up.
Long-Term Results of a Prospective, Randomized Trial Comparing Retroperitoneoscopic Partial Versus Total Adrenalectomy for Aldosterone Producing Adenoma.
Long-Term Safety and Tolerability of the Oral Direct Renin Inhibitor Aliskiren with Optional Add-On Hydrochlorothiazide in Patients with Hypertension: A Randomized, Open-Label, Parallel-Group, Multicentre, Dose-Escalation Study with an Extension Phase.
Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.
Long-term safety, tolerability, and antihypertensive efficacy of aliskiren, an oral direct renin inhibitor, in Japanese patients with hypertension.
Long-term systemic hypertension in children after successful repair of coarctation of the aorta.
Losartan and atenolol on hypertension induced by adenosine receptor blockade.
Losartan prevents the imbalance between renal dopaminergic and renin angiotensin systems induced by fructose overload. l-Dopa/dopamine index as new potential biomarker of renal dysfunction.
Low and high renin essential hypertension: a comparison of clinical and biochemical characteristics.
Low birth weight-associated adult hypertension in the rat.
Low Levels of Renin and High Aldosterone-to-Renin Ratio Among Rheumatoid Patients and Ankylosing Spondylitis Patients: A Prospective Study.
Low Nitric Oxide Bioavailability Increases Renin Production in the Collecting Duct.
Low peripheral plasma renin activity as a critical marker in pediatric hypertension.
Low plasma renin activity and high aldosterone/renin ratio are associated with untreated isolated systolic hypertension.
Low plasma renin activity is an independent predictor of near-term incidence of hypertension in Asian populations.
Low renin hypertension (LRH): shades of John Laragh.
Low renin hypertension and the adrenal cortex.
Low renin hypertension in the next millennium.
Low renin hypertension.
Low renin hypertension. A distinct entity.
Low renin hypertension: a current review of definitions and controversies.
Low renin hypertension: a state of inappropriate secretion of aldosterone.
Low renin hypertensive states: perspectives, unsolved problems, future research.
Low renin in young mothers and their children following hypertension in pregnancy.
Low renin, "normal" aldosterone and hypertension: circadian rhythm of renin, aldosterone, cortisol and growth hormone.
Low renin, low aldosterone hypertension associated with hypokalemia. Report of two cases.
Low renin-aldosterone in "prehypertensive" young adults.
Low-renin hypertension of childhood.
Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation.
Low-renin hypertension. Restoration of normotension and renin responsiveness.
Low-renin hypertension: more common than we think?
Low-renin, low-aldosterone hypertension and abnormal cortisol metabolism in a 19-month-old child.
Lowering arterial pressure delays the oxidative stress generation in a renal experimental model of hypertension.
Lowering of hypertension by central saralasin in the absence of plasma renin.
Lyon genetically hypertensive rats: an animal model of "low renin hypertension".
Lys(173)Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension.
Macroarray analysis in the hypertrophic left ventricle of renin-dependent hypertensive rats: identification of target genes for renin.
Macrophage secretion of miR-106b-5p causes renin-dependent hypertension.
Magnesium and blood pressure. I. Animal studies.
Malignant human renin producing paraganglionoma-localization with 123I-MIBG and treatment with 131I-MIBG.
Malignant hypertension and uremia in scleroderma: efficacy of nephrectomy and hemodialysis.
Malignant hypertension due to a large reninoma: a case report.
Malignant hypertension in association with primary aldosteronism.
Malignant hypertension in children secondary to chronic pyelonephritis: laboratory and radiologic indications for partial or total nephrectomy.
Management of hypertensive crises: the scientific basis for treatment decisions.
Management of the clinically inapparent adrenal mass ("incidentaloma").
Management strategies for posttransplant hypertension.
Managing cardiovascular and renal risk: the potential of direct renin inhibition.
Managing chronic kidney disease in type 2 diabetes in family practice.
Markedly elevated specific renin levels in the adrenal in genetically hypertensive rats.
Markers of vascular function in hypertension due to Cushing's syndrome.
Measurement of Cardiac Angiotensin II by Immunoassays, HPLC-Chip/Mass Spectrometry, and Functional Assays.
Measurement of renin in both renal veins. Its use in diagnosis of renovascular hypertension.
Measures to increase the reliability in the diagnostics of renin dependent hypertension.
Mechanism of glucocorticoid-induced hypertension.
Mechanism of suppressed renin-angiotensin system in spontaneously hypertensive rat (SHR).
Mechanism of the blood pressure and renal hemodynamic effects of captopril.
Mechanisms of action and clinical use of calcium antagonists in hypertension.
Mechanisms of hypertension during and after orthotopic liver transplantation in children.
Mechanisms of hypertension during the chronic phase of the one-clip, two-kidney model in the dog.
Mechanisms of hypertension in renal radiation.
Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
Mechanisms of hypertension: the expanding role of aldosterone.
Mechanisms of partial renal infarct hypertension.
Mechanisms of portal hypertension-induced alterations in renal hemodynamics, renal water excretion, and renin secretion.
Mechanisms of spontaneous hypertension in rats.
Mechanisms of suppression of renal kallikrein activity in low renin essential hypertension and renoparenchymal hypertension.
Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice.
Mesenteric desmoid-type fibromatosis causing secondary hypertension in a young woman.
Metabolic Acidosis, Hyperkalemia, and Renal Unresponsiveness to Aldosterone Syndrome: Response to Treatment with Low-Potassium Diet.
Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.
Metabolic aromatization of N-alkyl-1,2,3,4-tetrahydroquinoline substructures to quinolinium by human liver microsomes and horseradish peroxidase.
Metabolic characteristics of hypertension: importance of positive family history.
Metabolic derivatives of aldosterone.
Metabolic domino: new concept in lifestyle medicine.
Metabolic syndrome.
Metformin attenuates cardiovascular and renal injury in uninephrectomized rats on DOCA-salt: Involvement of AMPK and miRNAs in cardioprotection.
Methylprednisolone-induced hypertension. Role for the autonomic and renin angiotensin systems.
Metoprolol in high renin hypertension. A comparison with propranolol.
Mice Overexpressing Both Human Angiotensinogen and Human Renin as a Model of Superimposed Preeclampsia on Chronic Hypertension.
Microalbuminuria and increased plasma prorenin. Prevalence in diabetics followed up for four years.
Microangiography of end-stage kidneys in relation to high renin hypertension.
Microglia-Derived NLRP3 Activation Mediates the Pressor Effect of Prorenin in the Rostral Ventrolateral Medulla of Stress-Induced Hypertensive Rats.
Migraine and hypertension.
Mild essential hypertension in nonobese premenopausal women is characterized by low renin.
Mild high-renin essential hypertension. Neurogenic human hypertension?
Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low renin hypertension: a single-center retrospective study.
Mineralocorticoid and metabolic response to metyrapone on normotensive children and children with dexamethasone-suppressible and primary hyperaldosteronism.
Mineralocorticoid hypertension and hypokalemia.
Mineralocorticoid hypertension in childhood.
Mineralocorticoid hypertension.
Mineralocorticoid Receptor Activation Contributes to the Supine Hypertension of Autonomic Failure.
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
MINERALOCORTICOID RECEPTOR ANTAGONISTS DECREASE THE RATES OF POSITIVE SCREENING FOR PRIMARY ALDOSTERONISM.
Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Mineralocorticoids in congenital adrenal hyperplasia.
Mineralocorticoids, salt balance and blood pressure after prolonged ACTH administration in juvenile hypertension.
Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system.
Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
Mixture models for partially unclassified data: a case study of renal venous renin in hypertension.
Moderate-intensity exercise and renin angiotensin system blockade improve the renovascular hypertension (2K1C)-induced gastric dysmotility in rats.
Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol.
Modification by preoperative beta-blockade of the renin response to infrarenal aortic cross-clamping.
Modification of experimental renal hypertension in the rat by indomethacin and hydralazine.
Modifications of myocardial Na+,K(+)-ATPase isoforms and Na+/Ca2+ exchanger in aldosterone/salt-induced hypertension in guinea pigs.
Modulation of 11?-hydroxysteroid dehydrogenase functions by the cloud of endogenous metabolites in a local microenvironment: The glycyrrhetinic acid-like factor (GALF) hypothesis.
Modulation of kidney renin messenger RNA levels during experimentally induced hypertension.
Modulation of urinary kallikrein and plasma renin activities does not affect established hypertension in the fawn-hooded rat.
Molecular analysis of human prorenin prosegment variants in vitro and in vivo.
Molecular and Cellular Mechanisms of Aldosterone Producing Adenoma Development.
Molecular and clinical investigations in patients with low-renin hypertension.
Molecular aspects of blood pressure regulation.
Molecular biology as a tool for genetic research in hypertension: application to the renin gene.
Molecular biology of renin. II: Gene control by messenger RNA, transfection and transgenic studies.
Molecular biology of the renin cascade in hypertension. Report of a meeting of physicians and scientists, University of Leicester.
Molecular biology of the renin-angiotensin system: implications for hypertension and beyond.
Molecular changes in the early phase of renin-dependent cardiac hypertrophy in hypertensive cyp1a1ren-2 transgenic rats.
Molecular dynamics studies on both bound and unbound renin protease.
Molecular genetics links renin to hypertension.
Molecular mechanisms in primary aldosteronism
Molecular mechanisms of ARMC5 mutations in adrenal pathophysiology.
Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals.
Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension.
Monogenic forms of hypertension.
Monogenic forms of low-renin hypertension: clinical and molecular insights.
Monogenic low renin hypertension.
Monogenic mineralocorticoid hypertension.
Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial.
Morphologic and functional changes of the aortic intima during experimental hypertension.
Morphological functional changes of aortic endothelium during different types of hypertension.
Morphology and function of the adrenal zona glomerulosa of transgenic rats TGR [mREN2] 27: effects of prolonged sodium restriction.
Mouse Models of Primary Aldosteronism: From Physiology to Pathophysiology.
Multi-Drug-Resistant Hypertension Caused by Severe Aortic Coarctation Presenting in Late Adulthood.
Multiple and large simple renal cysts are associated with prehypertension and hypertension.
Multiple forms of human plasma renin substrate.
Mutagenesis of the Cleavage Site of Pro Renin Receptor Abrogates Angiotensin II-Induced Hypertension in Mice.
Mutations in the 11 beta-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth.
Mutations in the first intron of the SHR renin gene disrupt putative regulatory elements.
My engagement with steroids: a review.
Myocardial (Na+,K+)-ATPase activity in Dahl salt-sensitive and resistant rats.
Myocardial Na+-K+-ATPase activity and [3H]ouabain binding sites in hypertensive rats.
Myocardial remodeling in hypertensive Ren-2 transgenic rats.
Myoendothelial communication in the renal vasculature and the impact of drugs used clinically to treat hypertension.
Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation.
Natriuretic hormones in low renin hypertension.
Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis.
Natriuretic responses in labile hypertension.
Nearly fatal hypokalaemia due to non-hypertensive primary hyperaldosteronism in the post partum.
Need for beta-blockade in hypertension reduced with long-term minoxidil.
Negative captopril renography on patients with renin mediated hypertension due to page kidney and reninoma.
Neonatal hypertension from a unilateral multicystic dysplastic kidney.
Nephrocalcinosis and renal cysts associated with apparent mineralocorticoid excess syndrome.
Nephron heterogeneity: clue to the pathogenesis of essential hypertension and effectiveness of angiotensin-converting enzyme inhibitor treatment.
Nephron-sparing surgery for treatment of reninoma: a rare renin secreting tumor causing secondary hypertension.
Nephrotic-range proteinuria in a patient with high renin hypertension: effect of treatment with an ACE-inhibitor.
Neural and humoral mechanisms involved in blood pressure variability.
Neural contribution to renal hypertension following acute renal artery stenosis in conscious rats.
Neural Control of Blood Pressure in Chronic Intermittent Hypoxia.
Neural regulation of renal tubular sodium reabsorption and renin secretion: integrative aspects.
Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension.
Neural suppression of miRNA-181a in the kidney elevates renin expression and exacerbates hypertension in Schlager mice.
Neurogenic activity--angiotensin II interaction during the development and maintenance of renal hypertension in the rat.
Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
Neurohormonal influences on maintenance and reversal of two-kidney one-clip renal hypertension.
Neurohumoral characteristics of older hypertensive patients with abnormal nocturnal blood pressure dipping.
Neurohumoral mechanisms and left ventricular hypertrophy: effects of hygienic therapy.
Neurohumoral mechanisms in acute aortic coarctation in conscious and anesthetized dogs.
Neuroinflammation and sympathetic overactivity: Mechanisms and implications in hypertension.
Neurovascular compression at the ventrolateral medulla in autosomal dominant hypertension and brachydactyly.
New approaches in the study of cardiovascular disease: aldosterone, renin, hypertension and juxtaglomerular cells.
New aspects on primary aldosteronism.
New class of agents for treatment of hypertension: focus on direct renin inhibition.
New developments in antihypertensive drugs.
New developments in drug therapy of hypertension.
New developments in our knowledge of the chemistry of renin.
New developments in renin and hypertension.
New directions for protease inhibitors directed drug discovery†.
New findings in apparent mineralocorticoid excess.
New genetic insights in familial hyperaldosteronism.
New Genetic Polymorphisms as Epidemiological Factor of Arterial Hypertension in Patients with Hyposodical Diet.
New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.
New mineralocorticoids and adrenocorticosteroids in hypertension.
New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitors.
New Therapeutic Options in Patients Prone to Hypertension: A Focus on Direct Renin Inhibition and Aldosterone Blockade.
Newly developed hypertension as an early marker of recurrence of adrenocortical carcinoma with high renin expression.
Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors.
NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma").
Nisoldipine--effects on the renin-angiotensin-aldosterone system and catecholamines. Studies in normotensive and hypertensive subjects.
Nitrendipine treatment in so-called therapy-resistant arterial hypertension; effect as monotherapy and in combination with propranolol on blood pressure, heart rate, other hemodynamic parameters, plasma renin activity, and catecholamines.
Nitric oxide may be required to prevent hypertension at the onset of diabetes.
Nocturnal blood pressure and relation to vasoactive hormones and renal function in hypertension and chronic renal failure.
Non-coding Single Nucleotide Variants of Renin and the (Pro)renin Receptor are Associated with Polygenic Diseases in a Bangladeshi Population.
Non-renin dependent hypertension in renal allograft rejections. A structural and functional analysis.
Nonfunctioning juxtaglomerular cell tumor.
Nonparallel effects of renin inhibitor treatment on plasma renin activity and angiotensins I and II in hypertensive subjects. An assay-related artifact.
Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension.
Noradrenaline content and adrenergic receptors in kidney and heart of the prehypertensive and hypertensive Lyon rat strain.
Norepinephrine and renin activity in chronic renal failure. Evidence for interacting roles in hemodialysis hypertension.
Normal plasma renin activity in low renin hypertension.
Normal renin uremic hypertension. Study of cardiac hemodynamics, plasma volume, extracellular fluid volume, and the renin angiotensin system.
Normalization of high plasma level of ouabain-like immunoreactivity in primary aldosteronism after removal of adenoma.
Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension.
Normoaldosteronemic aldosterone-producing adenoma: immunochemical characterization and diagnostic implications.
Normokalemic hyperaldosteronism in patients with resistant hypertension.
Normotension with decreased plasma renin activity and low serum ionic calcium levels: a prehypertensive state?
Normotension, hypertension and body fluid regulation: Brain and kidney.
Normotensive glucocorticoid-suppressible hyperaldosteronism in adult.
Novel 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin.
Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation.
Novel Approaches for the Treatment of the Patient with Resistant Hypertension: Renal Nerve Ablation.
Novel drugs targeting hypertension: renin inhibitors and beyond.
Novel drugs targeting hypertension: renin inhibitors.
Novel Role of the Renin-Angiotensin System in Preeclampsia Superimposed on Chronic Hypertension and the Effects of Exercise in a Mouse Model.
Nucleotide variations in intron 1 of the renin gene of the spontaneously hypertensive rat.
Observations of the role of body fluid volumes and plasma renin activity in the management of hypertension.
Observations on the use and limitations of renal vein renins in hypertensive patients.
Occurrence of big renin in human plasma, amniotic fluid and kidney extracts.
Occurrence of renovascular hypertension in two sisters.
Old and new genes in primary aldosteronism.
Olmesartan inhibits cardiac hypertrophy in mice overexpressing renin independently of blood pressure: its beneficial effects on ACE2/Ang(1-7)/Mas axis and NADPH oxidase expression.
On the inappropriate in hypertension research.
On the local cardiac renin angiotensin system. Basic and clinical implications.
On the mechanisms and clinical relevance of one-kidney, one-clip hypertension.
On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship.
On the role of renin in one-kidney, one-clip hypertension.
Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR(mREN2)27.
Opposite regulation of brain angiotensin type 1 and type 2 receptors in cold-induced hypertension.
Optimal dosage of ACE inhibitors in older patients.
Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension.
Optimizing Precision of Hypertension Care to Maximize Blood Pressure Control: A Pilot Study Utilizing a Smartphone App to Incorporate Plasma Renin Activity Testing.
Optimizing the assessment of the elderly patient with borderline hypertension: the Hypertension and Ambulatory Recording in the OLD (HAROLD) study.
Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.
Oral contraceptives. Renin, aldosterone, and high blood pressure.
Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug.
Oral renin inhibitors.
Orthostatic hypertension due to vascular adrenergic hypersensitivity.
Orthostatic hypertension with nephroptosis and aortitis disease.
Orthotopic renal autotransplantation in the treatment of renovascular hypertension.
OS 15-06 SEQUENTIAL ACTIVATION OF INTRARENAL ACE/ACE2 AS THE PROGRESSION OF HYPERTENSIVE NEPHROPATHY IN 2-KIDNEY 10CLIP (2K1C) GOLDBLATT RATS.
OS 22-08 Prevalence of primary aldosteronism and its cardio-metabolic factors Chinese hypertensive patients in Xinjiang of China.
OS 32-02 EFFECTS OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON VAGINA AND CARDIAC EXPRESSION OF RAAS COMPONENTS IN FEMALE SPONTANEOUSLY HYPERTENSIVE RATS.
OS 32-08 SYMPATHETIC NERVE ACTIVITY AND THE LOW RENIN PHENOTYPE: THE SABPA STUDY.
OS060. Exercise training promotes placental growth and development in an animal model of preeclampsia superimposed on chronic hypertension.
Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure.
Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats.
Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Oxidative Stress Causes Imbalance of Renal Renin Angiotensin System (RAS) Components and Hypertension in Obese Zucker Rats.
Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat.
Oxidative stress in the cardiorenal metabolic syndrome.
Oxidative stress may explain how hypertension is maintained by normal levels of angiotensin II.
P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage.
Page Kidney in a Child with Severe Pelviureteric Junction Obstruction.
Page kidney: case report and review of the literature.
PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey.
Paradoxical hypertension after repair of coarctation of the aorta in children: balloon angioplasty versus surgical repair.
Parathyroid hypertensive factor, a circulating factor in animal and human hypertension.
Parathyroid hypertensive factor.
Parenteral formulation development of renin inhibitor Abbott-72517.
Partial characterization of aortic renin in the spontaneously hypertensive rat and its interrelationship with plasma renin, blood pressure and sodium balance.
Partial characterization of unusual polar steroids in the urine of a child with low renin hypertension.
Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
Pathogenesis of hypertension in a mouse model for human CLCN2 related hyperaldosteronism.
Pathogenesis of hypertension in Cushing's syndrome.
Pathogenesis of lead-induced hypertension: role of oxidative stress.
Pathogenesis of paradoxical hypertension after coarctation repair.
Pathogenesis of paradoxical hypertension after coarctation resection.
Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factors.
Pathogenic factors involved in renovascular hypertension. State of the art.
Pathogenic role of angiotensin II and the NF-?B system in a model of malignant hypertensive nephrosclerosis.
Pathophysiologic features of hypertension in young men.
Pathophysiological clinical features of an infant with hypertension secondary to multicystic dysplastic kidney: a case report.
Pathophysiological differences between multifocal fibromuscular dysplasia and atherosclerotic renal artery stenosis.
Pathophysiological Links Between Diabetes and Blood Pressure.
Pathophysiological mechanisms of urbanisation-related hypertension and the sodium pressor response in black Zimbabweans.
Pathophysiology and treatment of posttransplant hypertension.
Pathophysiology of Glucocorticoid Signaling.
Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry.
Patiromer: The First Potassium Binder Approved in Over 50 Years.
Pediatric endocrine hypertension.
Pelvic-ureteric junction obstruction and hypertension with target organ damage: A case report and review of the literature.
Percutaneous recanalization of an occluded renal artery and delayed ethanol ablation of the kidney resulting in control of hypertension.
Percutaneous treatment of renovascular hypertension.
Perinatal DDT Exposure Induces Hypertension and Cardiac Hypertrophy in Adult Mice.
Perinephritis hypertension in Macaca fascicularis (cynomolgus monkey): studies of the renin-angiotensin-aldosterone axis and renal hemodynamic function.
Perinephritis hypertension in monkeys. I. An increase of plasma renin activity associated with increased permeability of retinal vessels and angionecrosis.
Peripheral and renal vein plasma renin activity in hypertensive urological patients.
Peripheral and renal venous plasma renin activity in hypertension.
Peripheral beta-adrenoceptor responsiveness in young normotensive and hypertensive subjects.
Peripheral plasma renin activity (PRA) in recipients with allograft artery stenosis; its diagnostic value in acute stage hypertension.
Peripheral plasma renin activity, hypertension and renal scarring in children.
Peripheral plasma renin levels in hypertension.
Peripheral pressor systems in hypertension caused by nucleus tractus solitarius lesions.
Peripheral renal vascular disease in essential hypertension: hemodynamic, angiographic, and endocrine assessment.
Persistence of normal BP after withdrawal of drug treatment in mild hypertension.
Persistence of unilateral secretion and contralateral renin suppression after successful percutaneous transluminal dilatation in a normotensive patient.
Persistent hypertension despite successful dilation of a stenotic renal artery in a boy with neurofibromatosis type 1.
Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy.
Persistent severe hyperkalemia following surgical treatment of aldosterone-producing adenoma.
Persisting hypertension after renal artery reconstruction. A follow-up study.
PGE2 upregulates renin through E-prostanoid receptor 1 via PKC/cAMP/CREB pathway in M-1 Cells.
Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine.
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment.
Pharmacokinetics and Pharmacodynamics of Aliskiren/Hydrochlorothiazide Single-Pill Combination Tablets and Free Combination of Aliskiren and Hydrochlorothiazide.
Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity.
Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension.
Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment.
Pharmacokinetics, safety and tolerability of single and multiple oral doses of aliskiren in healthy chinese subjects: a randomized, single-blind, parallel-group, placebo-controlled study.
Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment.
Pharmacologic agents for the in vivo detection of vascular sodium transport defects in hypertension.
Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension.
Pharmacological Potential of Exercise and RAS Vasoactive Peptides for Prevention of Diseases.
Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
Pharmacology of renin and hypertension.
Pharmacology of renin inhibitors and their application to the treatment of hypertension.
Pharmacotherapy in congestive heart failure: Effect of the insertion/deletion polymorphism of the ACE gene on response to ACE inhibitors in patients with heart failure.
Pheochromocytoma with renal artery stenosis and high plasma renin activity.
Phosphate as a factor in sodium sensitivity in normal and high renin hypertension.
Physical Activity and Adiposity-related Inflammation: The MESA.
Physiologic tailoring of therapy for resistant hypertension: 20 years' experience with stimulated renin profiling.
Physiological and immunopathological consequences of active immunization of spontaneously hypertensive and normotensive rats against murine renin.
Physiological changes during hemodialysis in patients with intradialysis hypertension.
Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27.
Physiological Phenotyping for Personalized Therapy of Uncontrolled Hypertension in Africa.
Physiological properties of renin and hypertension.
Physiological Regulation of Prostaglandins in the Kidney.
Physiology and Pathophysiology of Compensatory Adaptations of a Solitary Functioning Kidney.
Pivotal role of the renin-angiotensin system in Lyon hypertensive rats.
Placental insufficiency and fetal growth restriction lead to postnatal hypotension and altered postnatal growth in sheep.
Placental insufficiency results in temporal alterations in the renin angiotensin system in male hypertensive growth restricted offspring.
Plasma active and acid-activatable renin during the development of one-kidney, one-clip and two-kidney, one-clip hypertension in the rabbit.
Plasma active and inactive renin and fetal complications in women with high risk pregnancies.
Plasma aldosterone and left ventricular diastolic function in treatment-naïve patients with hypertension: tissue-Doppler imaging study.
Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.
Plasma aldosterone level in a female case of pseudohyperaldosteronism (Liddle's syndrome).
Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension.
Plasma antidiuretic hormone levels in patients with normal and low renin essential hypertension, and secondary hypertension.
Plasma brain natriuretic peptides and renal hypertension.
Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
Plasma catecholamines, thrombocyte alpha 2- and lymphocyte beta 2-adrenoceptor densities in hypertensive patients with low or normal plasma renin concentrations.
Plasma clonidine in relation to blood pressure, catecholamines, and renin activity during long-term treatment of hypertension.
Plasma levels of beta-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine.
Plasma levels of prorenin and Renin in blacks and whites: their relative abundance and associations with plasma aldosterone concentration.
Plasma markers of endothelial cells and platelet activation following handgrip in normals and hypertensive patients.
Plasma noradrenaline and dopamine in renin-mediated hypertension.
Plasma noradrenaline concentration in hypertensive and normotensive forty-year-old individuals: relationship to plasma renin concentration.
Plasma prolactin, renin and catecholamines in young normotensive and borderline hypertensive subjects.
Plasma renin activities and the detection of angiotensin dependent hypertension.
Plasma renin activity (P.R.A.) in patients with diabetes and arterial hypertension.
Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension.
Plasma renin activity (PRA) and plasma aldosterone (PA) in hypertensive kidney allograft recipients.
Plasma renin activity and aldosterone concentration are not altered by the novel calcium channel antagonist, azelnidipine, in hypertensive patients.
Plasma renin activity and aldosterone secretion rate in hypertension. The distinction between primary and secondary hyperaldosteronism.
Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Plasma renin activity and angiotensin pressor dose in hypertension correlation and diagnostic implications.
Plasma renin activity and cardiovascular disease.
Plasma renin activity and changes in tissue angiotensin converting enzyme.
Plasma renin activity and hypertension in acute glomerulonephritis.
Plasma renin activity and hypertension in diabetes mellitus.
Plasma renin activity and hypertensive organ manifestations in 50-year-old males.
Plasma renin activity and in vitro synthesis of aldosterone by the adrenal glands of rats with spontaneous, renal, or pinealectomy-induced hypertension.
Plasma renin activity and ischemic heart disease.
Plasma renin activity and oxygen content along the renal veins in hypertensive patients.
Plasma renin activity and plasma renin substrate in hypertension associated with steroid excess.
Plasma Renin Activity and Resting Heart Rate in a Population of Community-Dwelling Japanese: The Tanushimaru Study.
Plasma renin activity and sodium, potassium and water excretion during reversal of hypertension in the one-clip two-kidney hypertensive rat.
Plasma renin activity and systemic arterial hypertension.
Plasma renin activity and urinary aldosterone in Cushing's syndrome.
Plasma renin activity and urinary kallikrein excretion in lead-exposed workers as related to hypertension and nephropathy.
Plasma renin activity as a function of age in two new strains of spontaneously hypertensive and normotensive rats.
Plasma renin activity by LC-MS/MS: development of a prototypical clinical assay reveals a subpopulation of human plasma samples with substantial peptidase activity.
PLASMA RENIN ACTIVITY IN ACUTE TUBULAR NECROSIS AND OTHER RENAL DISEASES ASSOCIATED WITH HYPERTENSION.
Plasma renin activity in healthy subjects and patients with hypertension. Preliminary experience with a rapid and quantitative bio-assay.
Plasma renin activity in human hypertension.
Plasma renin activity in hypertension after renal homotransplantation.
Plasma renin activity in hypertension associated with coarctation of the aorta.
Plasma renin activity in hypertension.
Plasma renin activity in juvenile diabetes mellitus and effect of diazoxide.
Plasma renin activity in normal human pregnancy and in pregnancy-associated hypertension, with reference to cryoactivation.
Plasma renin activity in patients with coarctation of the aorta. A comment of the pathogenesis prestenotic hypertension.
Plasma renin activity in patients with sodium-sensitive and sodium-resistant symptomatic arterial hypertension.
Plasma renin activity in phaeochromocytoma: effects of beta-blockade and converting enzyme inhibition.
PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM. IMPORTANCE IN DIFFERENTIAL DIAGNOSIS AND IN RESEARCH OF ESSENTIAL HYPERTENSION.
Plasma renin activity in psychosocial hypertension of CBA mice.
Plasma renin activity in renal transplant patients with hypertension.
Plasma renin activity in segmental hypoplasia of the kidneys with hypertension.
Plasma renin activity in the evaluation of hypertension in renal transplant recipients.
Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension.
Plasma renin activity levels influence the effect of converting enzyme inhibitors in preserving renal function in hypertension.
Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.
Plasma Renin Activity Predicts the Improvement in Resistant Hypertension after Percutaneous Transluminal Renal Artery Angioplasty.
Plasma renin activity testing to guide triple antirenin system drug therapy in a patient with difficult-to-treat hypertension.
Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension.
Plasma renin activity, blood uric acid and plasma volume in pregnancy-induced hypertension.
Plasma renin activity, reactivity, concentration and substrate following hypertension during pregnancy. Effect of oral contraceptive agents.
Plasma renin activity, serum aldosterone concentration and selected organ damage indices in essential arterial hypertension.
Plasma renin activity, sodium balance, and hypertension in a group of renal transplant recipients.
Plasma renin activity-guided strategy for the management of hypertension.
Plasma renin activity: method of measurement and significance in the diagnosis of hypertension.
Plasma renin and aldosterone in an abdominal pregnancy with toxemia.
Plasma renin and angiotensin levels in experimental hypertension in the rat.
Plasma renin and angiotensin levels in human hypertension following treatment.
Plasma renin and cardiovascular responses to the cold pressor test differ in black and white populations: The SABPA study.
Plasma renin and cardiovascular risk: what is the evidence for an association?
Plasma renin and exchangeable sodium in the hypertension of chronic renal failure. The effect of bilateral nephrectomy.
Plasma renin and hypertension.
Plasma renin and hypertensive vascular complications: an observation in the stroke-prone spontaneously hypertensive rat.
Plasma renin and occurrence of hypertension in children with burn injuries.
Plasma renin and sodium balance during development of moderate and severe renal hypertension in rats.
Plasma renin and the antihypertensive effect of angiotensin-II antagonist in experimental hypertension.
Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.
Plasma renin and vascular complications in substrains of the spontaneously hypertensive rat, with a reference to water and electrolyte balance.
Plasma renin assays in the evaluation of hypertension.
Plasma renin concentration in human hypertension . II. Renin in relation to aetiology.
Plasma Renin Concentration in Human Hypertension-III: Renin in Relation to Complications of Hypertension.
Plasma renin concentration in human hypertension.
PLASMA RENIN CONCENTRATION IN HUMAN HYPERTENSION. 1. RELATIONSHIP BETWEEN RENIN, SODIUM, AND POTASSIUM.
Plasma Renin Concentration in Human Hypertension. IV: Renin in Relation to Treatment and Prognosis.
Plasma renin concentration in hypertension produced by unilateral renal artery constriction in the rat.
Plasma renin concentration in patients with hypertension.
Plasma renin concentration, activity and substrate in hypertension caused by oral contraceptives.
Plasma renin in hypertensive patients: significance in relation to clinical and other biochemical features.
Plasma renin in long-term diuretic treatment of hypertension: effect of discontinuation and restarting therapy.
Plasma renin levels and systemic haemodynamics in essential hypertension.
Plasma renin levels and vascular complications in hypertension.
Plasma renin measurement in the management of hypertension: the V and R hypothesis.
Plasma renin responses to mental stress and carotid intima-media thickness in black Africans: the SABPA study.
Plasma Renin Test-Guided Drug Treatment Algorithm for Correcting Patients With Treated but Uncontrolled Hypertension: A Randomized Controlled Trial.
Plasma renin, urinary sodium excretion and vascular disease.
Plasma sodium-potassium ATPase inhibition activity in low- and normal-renin hypertension.
Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity.
Plasma vasopressin variation and renin activity in normal active humans.
Plasma vasopressin, renin, and catecholamines during nitroprusside-induced maternal and fetal hypotension in sheep.
Plasmatic level of angiotensin I in normal subjects of various ages, in Cushing's syndrome and in normal and pathologic pregnancy.
Plasmatic renin and arterial hypertension.
Platt versus Pickering: what molecular insight to primary hyperaldosteronism tells us about hypertension.
Polycystic kidney disease presenting with hypertension and hypokalemia.
Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism.
Positive association between KCNJ5 rs2604204 (A/C) polymorphism and plasma aldosterone levels, but also plasma renin and angiotensin I and II levels, in newly diagnosed hypertensive Chinese: a case-control study.
Positive Captopril Renography Without Renal Artery Stenosis but a Renal Cell Carcinoma.
Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.
Possible significance of the pharmacological differentiation of beta-blockers for therapy of hypertension.
Post-carotid endarterectomy hypertension: association with elevated cranial norepinephrine.
Post-transplant hypertension in the rat: effects of captopril and native nephrectomy.
Postexercise hypotension differs between white and black women.
Postnatal development of renal function during the first year of life.
Postoperative hypertension after repair of coarctation of aorta in children: protective effect of propranolol?
Postpartum renal failure and malignant hypertension treated with captopril.
Posttransplant diastolic hypertension: associations with intragraft transforming growth factor-beta, endothelin, and renin transcription.
Postural augmentation of plasma renin activity. Importance in diagnosis of renovascular hypertension.
Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension.
Potassium homeostasis and Renin-Angiotensin-aldosterone system inhibitors.
Potassium Intake Prevents the Induction of the Renin-Angiotensin System and Increases Medullary ACE2 and COX-2 in the Kidneys of Angiotensin II-Dependent Hypertensive Rats.
PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance.
Practolol in hypertension: reduction in sympathetic nervous and renin responses.
Prazosin in severe in hypertension effect on blood pressure, plasma renin activity and in hypertensive emergencies.
Prazosin's effect in high renin hypertension complicating pheochromocytoma.
Pre-operative evaluation of the prognosis of hypertension in primary aldosteronism owing to adenoma.
Preclinical Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia with excessive secretion of 18-hydroxydeoxycorticosterone and corticosterone.
Predicted Release and Analysis of Novel ACE-I, Renin, and DPP-IV Inhibitory Peptides from Common Oat (Avena sativa) Protein Hydrolysates Using in Silico Analysis.
Predicting postoperative arterial pressure in renovascular hypertensive patients.
Prediction of blood pressure from plasma renin activity in reflux nephropathy.
Prediction of successful outcome in patients with primary aldosteronism.
Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension.
Predictors of impaired blood pressure homeostasis during acute and sustained orthostasis in patients with type 2 diabetes.
Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the 'ACTION' database in patients with angina.
Pregnancy-induced hypertension: development of a model in the pregnant primate (Papio anubis).
Prenatal Undernutrition Changes Renovascular Responses of Nimesulide in Rat Kidneys.
Prescribing Patterns of Antihypertensive Medications in Low- and Middle-Income Countries: A Systematic Review.
Presence of renin in plasma of patients with arterial hypertension.
Pressor effect of renin and hypertension.
Pressor effect of subcutaneous renin in dogs, and effect of reserpine, 1-hydrazinophthalazine and hexamethonium on renin hypertension.
Pressor factors and cardiovascular pressor responsiveness in borderline hypertension.
Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects.
Pressor factors and responsiveness in hypertension accompanying diabetes mellitus.
Pressor response to angiotensin II in hypertension. Correlation with plasma renin activity and response to norepinephrine and metaraminol.
Pressure control of renal renin release in Lyon hypertensive rats.
Pressure-dependent renin release during chronic blockade of nitric oxide synthase.
Pretreatment plasma renin activity levels correlate with the blood pressure response to telmisartan in essential hypertension.
Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism.
Prevalence of Liddle Syndrome Among Young Hypertension Patients of Undetermined Cause in a Chinese Population.
Prevalence of primary aldosteronism in primary care: a cross-sectional study.
Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.
Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension.
Prevalence of Somatic KCNJ5 Mutations in Thai Patients With Aldosterone-Producing Adrenal Adenomas.
Prevention of renal hypertension in the rat by neuropeptide Y.
Primary Aldosteronism and ARMC5 Variants.
Primary Aldosteronism and Pregnancy.
Primary Aldosteronism Associated with Multiple Adrenocortical Micronodules in a Patient with Renal Cell Carcinoma.
Primary aldosteronism caused by unilateral adrenal hyperplasia: rethinking the accuracy of imaging studies.
Primary aldosteronism due to unilateral adrenal hyperplasia.
Primary aldosteronism due to unilateral adrenal hyperplasia: a case report.
Primary aldosteronism in the primary care setting.
Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
Primary aldosteronism with normal aldosterone levels in blood and urine.
Primary aldosteronism, a common entity? the myth persists.
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis.
Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension.
Primary aldosteronism.
Primary aldosteronism: a pictorial essay.
Primary aldosteronism: a practical approach to diagnosis and treatment.
Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?
Primary aldosteronism: factors associated with normalization of blood pressure after surgery.
Primary Aldosteronism: New Answers, New Questions.
Primary aldosteronism: renaissance of a syndrome.
Primary aldosteronism: Treatment of the disease, and new therapeutic approaches.
Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension.
Primary hyperaldosteronism in childhood due to unilateral macronodular hyperplasia. Case report.
Primary hyperaldosteronism in two cats.
Pro Atrial Natriuretic Peptide (1-30) and 6-keto PGF1? Activity Affects Na(+) Homeostasis in Non-modulating Hypertension.
Probing the renin active site by collisional quenching of endogenous fluorescence.
Proceedings: Renin and lysosomal enzyme activities in the kidney of spontaneously hypertensive rats with accelerated hypertension.
Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type I receptor in response to elevated interleukin-6 during pregnancy.
Prognosis in low renin hypertension.
Prognostic factors of primary aldosteronism.
Prognostic value of renin profiling in hypertension.
Progress in Primary Aldosteronism 2019: New Players on the Block?
PROGRESS IN PRIMARY ALDOSTERONISM: A review of the prevalence of primary aldosteronism in pre-hypertension and hypertension.
Progress in Primary Aldosteronism: Translation on the Move.
Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
Prolonged alteration of renin responsiveness after spironolactone therapy. A cause of false-negative testing for low-renin hypertension.
Prolonged attenuation of cold-induced hypertension by adenoviral delivery of renin antisense.
Prolonged duration of blood pressure response to enalkiren, the novel dipeptide renin inhibitor, in essential hypertension.
Prolonged hypobaric hypoxemia attenuates vasopressin secretion and renal response to osmostimulation in men.
Propranolol alters renin release during nitroprusside-induced hypotension and prevents hypertension on discontinuation of nitroprusside.
Propranolol effects in long-term hemodialysis patients with renin-dependent hypertension.
Propranolol, renin and hypertension: a review.
Prorenin and beta-blockade in hypertension.
Prorenin and vascular complications of diabetes.
Prorenin Contributes to Angiotensin Peptide Formation in Transgenic Rats With Rat Prorenin Expression Targeted to the Liver.
Prorenin independently causes hypertension and renal and cardiac fibrosis in cyp1a1-prorenin transgenic rats.
Prorenin measurements and sensitivity to spironolactone: a clinical tool for pathophysiological characterization of low-renin hypertension.
Prorenin receptor blockers: effects on cardiovascular complications of diabetes and hypertension.
Prorenin receptor in distal nephron segments of 2-kidney, 1-clip goldblatt hypertensive rats.
Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension.
Prostaglandin E-prostanoid4 receptor mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla.
Prostaglandin levels and renin activity in renal venous blood of patients with renal hypertension.
Prostaglandins and sodium balance during the reversal of chronic two-kidney, one clip hypertension in rats.
Prostaglandins, the kidney, and hypertension.
Prostanoids and blood pressure: which way is up?
Prostasin and matriptase (ST14) in placenta from preeclamptic and healthy pregnant women.
Protection of the myocardium against ischemia/reperfusion injury by angiotensin-(1-9) through an AT2R and Akt-dependent mechanism.
Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.
Protracted anuria due to active vasoconstriction in primary or secondary malignant hypertension.
Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat.
Pseudoaldosteronism with increased serum cortisol associated with pneumonia, hypouricemia, hypocalcemia, and hypophosphatemia.
Pseudohyperaldosteronism (Liddle's syndrome): a case report.
Pseudohyperaldosteronism from liquorice-containing laxatives.
Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
Pseudohypoaldosteronism types I and II: little more than a name in common.
Pseudoprimary aldosteronism from the topical application of 9-alpha-fluorprednisolone to the skin.
Psychosocial stress induces high blood pressure in a population of mammals on a low-salt diet.
Pulmonary and cardiorenal cyclooxygenase-1 (COX-1), -2 (COX-2), and microsomal prostaglandin E synthase-1 (mPGES-1) and -2 (mPGES-2) expression in a hypertension model.
Purification and characterization of recombinant human renin for X-ray crystallization studies.
Pyrazinoylguanidine: antihypertensive, hypocholesterolemic, and renin effects.
Pyrido[2,3-d]pyrimidine angiotensin II antagonists.
Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin.
Quantitative analysis of renin gene expression in extrarenal tissues by polymerase chain reaction method.
Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man.
Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology.
Race, Plasma Renin Activity, and Morning Blood Pressure Surge--Results From the Dietary Approaches to Stop Hypertension Trial.
Racial difference in salivary sodium-potassium ratio in low renin essential hypertension.
Racial differences in aldosterone excretion and plasma aldosterone concentrations in children.
Racial differences in blood pressure control.
Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.
Racial differences of parameters associated with blood pressure levels in children--the Bogalusa heart study.
Radiofrequency ablation compared with laparoscopic adrenalectomy for aldosterone-producing adenoma.
Radioimmunoassay of free urinary 18-hydroxydeoxycorticosterone (18-OH-DOC) in patients with essential hypertension.
Radioisotopic renal function studies in essential hypertension.
Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats.
Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension.
Raised plasma renin activity in the hypertension of the Guillain-Barré syndrome.
Rapid and non-invasive screening of high renin hypertension using Raman spectroscopy and different classification algorithms.
Rare and curable renin-mediated hypertension: a series of six cases and a literature review.
Rare causes of adrenocortical hypertension.
RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.
Rat renal prorenin concentration in experimental hypertension.
Rat renin: purification and characterization.
Rational Design and Synthesis of AT1R Antagonists.
Rational Medical Therapy Is the Key to Effective Cardiovascular Disease Prevention.
Rats with Adenine-Induced Chronic Renal Failure Develop Low-Renin, Salt-Sensitive Hypertension and Increased Aortic Stiffness.
Re: Severe hypertension in a newborn associated with increased renin production by a hypoplastic kidney.
Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.
Recanalization and stenting of total occlusions of the renal arteries for blood pressure control in resistant to treatment hypertension.
Recent advances in preventing stroke recurrence.
Recent advances in the study of renin and angiotensinogen genes: from molecules to the whole body.
Recent aspect of the role of peripheral dopamine and its receptors in the pathogenesis of hypertension.
Recent progress on the discovery of non-peptidic direct renin inhibitors for the clinical management of hypertension.
Recent Updates on the Proximal Tubule Renin-Angiotensin System in Angiotensin II-Dependent Hypertension.
Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats.
Reciprocal relation between renin dependency and sodium dependency in essential hypertension.
Reciprocation of renin dependency with sodium volume dependency in renal hypertension.
Recruited renin-containing renal microvascular cells demonstrate the calcium paradox regulatory phenotype.
Reduced heart rate variability in hypertension: associations with lifestyle factors and plasma renin activity.
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
Reduced renin activity in essential hypertension: a reappraisal.
Reduced renin expression and altered gene transcript profiles in multicystic dysplastic kidneys.
Reduced responses of renin release to three different stimuli in essential hypertensive patients of stage II (WHO stage classification).
Reduced sodium-proton exchange activity in lymphocytes from transgenic rats.
Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
Refractory hypertension after renal transplantation.
Refractory hypertension and isosexual pseudoprecocious puberty associated with Renin-secreting ovarian steroid cell tumor in a girl.
Refractory hypertension: definition, prevalence, and patient characteristics.
Regional chromosomal assignment of human renin gene to 1q12----qter and use in linkage studies in Charcot-Marie-Tooth disease.
Registration of amiloride in South Africa: Cutting the Gordian knot.
Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
Regulation of intrarenal angiotensin II in hypertension.
Regulation of renin secretion in conscious adrenalectomized rats with glucocorticoid-induced hypertension.
Regulatory mechanisms in arterial hypertension: role of microRNA in pathophysiology and therapy.
Regulatory networks and complex interactions between the insulin and angiotensin II signalling systems: models and implications for hypertension and diabetes.
Relation between plasma renin activity, angiotensin, and aldosterone and blood pressure in mild untreated hypertension.
Relation between renal renin content and hypertension. I. Renal renin content in normal, unilaterally nephrectomized and renal hypertensive rats.
Relation between renin and prorenin in plasma from hypertensive patients and normal people: evidence for different renin:prorenin ratios.
Relation between renin release and blood pressure response to nonsteroidal anti-inflammatory drugs in hypertension.
Relation of age, diastolic pressure and known duration of hypertension to presence of low renin essential hypertension.
Relation of left ventricular hypertrophy, afterload, and contractility to left ventricular performance in Goldblatt hypertension.
Relation of renin status to neurogenic vascular resistance in borderline hypertension.
Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension.
RELATIONS BETWEEN RENIN, ALDOSTERONE AND EXPERIMENTAL HYPERTENSION IN RATS.
Relations between/labile arterial hypertension and blood renin. Preliminary results]
Relationship between Accessory Renal Artery and Clinical Characteristics of Middle-Aged Patients with Primary Hypertension.
Relationship between acute suppression of plasma renin activity and lymphocyte Na+:H+ exchange rate in young patients with borderline hypertension.
Relationship between hypertensive left ventricular hypertrophy, neurohormonal factors and ventricular arrhythmias in very old patients.
Relationship between hyperuricemia and chronic kidney disease.
Relationship between juxtaglomerular apparatus and plasma renin activity in human reno-vascular hypertension.
Relationship between plasma renin activity and blood pressure response to antihypertensive agents. A proposal for management of essential and renal hypertension.
Relationship between plasma renin activity and urinary catecholamines in various types of hypertension.
Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage.
Relationship of renal transplantation to hypertension in end-stage renal failure.
Relationships among alterations in renal membrane sodium transport, renin and aminopeptidase M activities in genetic hypertension.
Relationships between blood pressure and plasma renin, aldosterone and dopamine-beta--hydroxylase in the elderly. Studies in patients over 70 years of age.
Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension.
Relaxin Does Not Improve Angiotensin II-Induced Target-Organ Damage.
Release of active and inactive renin by the human kidney.
Relevance of salt, water, and renin to hypertension in chronic renal failure.
Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT.
Remission of hypertension and electrolyte abnormalities following renal transplantation in a patient with apparent mineralocorticoid excess well documented throughout childhood.
Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.
Renal actions of angiotensin II in renovascular hypertension.
Renal and cardiovascular protection in type 2 diabetes mellitus: angiotensin II receptor blockers.
Renal and dietary factors associated with hypertension in a setting of disadvantage in rural India.
Renal and endocrine response to saline infusion in essential hypertension.
Renal and extra-renal levels of renin mRNA in experimental hypertension.
Renal and systemic effects of enalapril in chronic one-kidney hypertension.
Renal and vascular lesions elicited by renin in rats with desoxycorticosterone hypertension.
Renal arteriovenous fistula: a model for renovascular hypertension in rat.
Renal arteriovenous fistulas.
Renal artery stenosis and hypertension after abdominal irradiation for Hodgkin disease. Successful treatment with nephrectomy.
Renal artery stenosis and polycystic kidney disease.
Renal artery stenosis in renal transplant recipients.
Renal artery stenosis of the transplanted kidney. Diagnosis and therapy of the hypertension.
Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
Renal artery stenosis with severe hypertension. A rare case with detailed assessment of renin-angiotensin system before and after development of lesion.
Renal denervation for the treatment of hypertension: Making a new start, getting it right.
Renal denervation in the treatment of resistant hypertension: Dead, alive or surviving?
Renal denervation normalizes pressure and baroreceptor reflex in high renin hypertension in conscious rats.
Renal denervation prevents sodium retention and hypertension in salt-sensitive rabbits with genetic baroreflex impairment.
Renal duplex scanning: correlation with angiography and isotopic renography.
Renal effects of methoxyverapamil in anesthetized rats.
Renal endothelin receptor type B upregulation in rats with low or high renin hypertension.
Renal function in hypertensive rats transgenic for mouse renin gene.
Renal function in one-kidney, one-clip hypertension and low renin essential hypertension.
Renal function, body fluid volumes, renin, aldosterone, and noradrenaline during treatment of hypertension with pindolol.
Renal function, plasma renin, and spontaneous diuresis in an advanced stage of hypertension in rats.
Renal functional reserve in patients with essential hypertension: effect of inhibition of the renin--angiotensin system.
Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents.
Renal hypertension and renin hypertension in intact and in adrenalectomized rats.
Renal hypertension in renin depleted rats (relation between renal renin content and hypertension II).
Renal hypertension. The renin system in hypertension with unilateral renal artery stenosis.
Renal hypotension in sodium and fluid deprivation: experimental findings in renin-depleted rats.
Renal innervation and renin activity in salt metabolism and hypertension.
Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension.
Renal medullary (pro)renin receptor contributes to angiotensin II-induced hypertension in rats via activation of the local renin-angiotensin system.
Renal microvasculature in spontaneously hypertensive rats.
Renal nerves contribute to hypertension in Schlager BPH/2J mice.
Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension.
Renal renin release in patients with essential arterial hypertension and with unilateral renal artery stenosis.
Renal sodium handling and responsiveness of plasma renin levels in hypertension.
Renal sodium transport in renin-deficient Dahl salt-sensitive rats.
Renal sympathetic denervation for treating resistant hypertension.
Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma.
Renal transplant arterial stenosis: percutaneous transluminal angioplasty.
Renal trauma and hypertension: the role of renin.
Renal tuberculosis and accelerated hypertension: the use of renal vein renin sampling to predict the outcome after nephrectomy.
Renal tuberculosis and hypertension: value of the renal vein renin ratio.
Renal tubular handling of sodium and familial predisposition to essential hypertension.
Renal vascular hypertension and low plasma renin activity. Interrelationship of volume and renin in the pathogenesis of hypertension.
Renal vasodepressor mechanism: characterization by chemical medullectomy.
Renal vein renin activity and prostaglandins A and E in hypertension.
Renal vein renin activity in primary hypertension: variability and influence of contrast material.
Renal vein renin concentration in the hypertension of unilateral reflux nephropathy.
Renal vein renin determinations in hypertension: falsely negative tests.
Renal vein renin in hypertension. Diagnostic and therapeutic implications.
Renal vein renin in renovascular hypertension: the experience of two Italian centers.
Renal vein renin measurement and arteriography in the investigation and management of severe childhood hypertension.
Renal vein renin measurements in children with hypertension.
Renal vein renin ratio. Predictive value in renal and renovascular hypertension.
Renal vein renins: inability to predict response to revascularization in patients with hypertension.
Renal venous plasma renin activity after unilateral splanchnicotomy in dogs with induced hypertension.
Renal venous renin activity in various forms of curable renal hypertension.
Renal venous renin determinations in renovascular hypertension. Diagnostic and prognostic value in unilateral renal artery stenosis treated by surgery or percutaneous transluminal angioplasty.
Renal venous renin determinations in the diagnosis of surgically correctable hypertension.
Renal venous renin in hypertension.
Renal venous renin ratio as a predictor of improvement in hypertension following nephrectomy for unilateral renal disease.
Renal-portal shunt to restore normal reninism and blood pressure in experimental renovascular hypertension in dogs.
Renin activity and aldosterone assay among Nigerians with hypertension and normotension: An insight into normative values and clinical correlates.
RENIN ACTIVITY IN BLOOD FROM PATIENTS WITH HYPERTENSION.
Renin activity in the brain, the kidneys and the peripheral plasma or rats with different experimental models of hypertension.
RENIN ACTIVITY IN THE KIDNEYS IN VASCULAR HYPERTENSION AND IN SYMPTOMATIC RENAL HYPERTENSION.
Renin activity of renal venous blood in experimental hypertension induced by ligation of one renal artery in dogs.
Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program.
Renin and aldosterone levels and hypertension following envenomation in humans by the yellow scorpion Leiurus quinquestriatus.
Renin and aldosterone measurements in the diagnosis and management of hypertension. I. Renin and aldosterone measurements in the etiological diagnosis of hypertension.
Renin and aldosterone measurements in the diagnosis and management of hypertension. II. Renin and aldosterone measurements as guide of drug therapy in hypertension.
Renin and aldosterone measurements in the management of arterial hypertension.
Renin and aldosterone suppression in the antihypertensive action of clonidine.
Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats.
Renin and angiotensin in hypertension.
Renin and blood volume in chronic renal failure: a comparison with essential hypertension.
Renin and body fluid volumes in chronic renal disease. Relations between arterial pressure, plasma renin activity, blood volume, and extracellular volume in chronic renal disease, as compared with essential hypertension.
Renin and hypertension in childhood.
Renin and hypertension.
Renin and Hypertension.
Renin and hypertension: a review article.
Renin and myocardial infarction in hypertension.
Renin and prorenin as biomarkers in hypertension.
Renin and prorenin receptor in hypertension: what's new?
Renin and the (pro)renin receptor in the renal collecting duct: Role in the pathogenesis of hypertension.
Renin and the IGFII/M6P receptor system in cardiac biology.
Renin and the juxtaglomerular apparatus in diabetic nephropathy.
Renin and the therapy of hypertension.
Renin angiotensin aldosterone system altered in resistant hypertension in Sub-Saharan African diabetes patients without evidence of primary hyperaldosteronism.
Renin angiotensin aldosterone system and adrenergic system in normotensive and hypertensive pregnancy.
Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
Renin angiotensin aldosterone system, urinary prostaglandins and kallikrein in pregnancy induced hypertension. Evidence for a disregulation of the renin-angiotensin-prostacyclin loop.
Renin angiotensin antagonists normalize aberrant activation of epithelial sodium channels in sodium-sensitive hypertension.
Renin angiotensin involvement in transient hypertension after renal injury.
Renin angiotensin system and ASCVD.
Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
Renin angiotensinogen system gene polymorphisms and essential hypertension among people of West African descent: a systematic review.
Renin antisense injected intraventricularly decreases blood pressure in spontaneously hypertensive rats.
Renin as a risk factor for atherogenesis. Effects of hypercholesterolemia and two-kidney--one-clip hypertension in the rabbit.
Renin as a risk factor for atherogenesis. Part 3. Effects of hypercholesterolemia, hyporeninemia and one-kidney-one clip hypertension in the rabbit.
Renin assays in hypertension: the use of peripheral renin as a screening test.
Renin Cells, the Kidney, and Hypertension.
Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.
Renin containing cells are present predominantly in scarred areas but not in dysplastic regions in multicystic dysplastic kidney.
Renin content and excretory function of the kidney in rats with experimental hypertension.
RENIN CONTENT OF KIDNEYS IN EXPERIMENTAL HYPERTENSION.
Renin content of kidneys in various types of experimental hypertension in rats.
Renin content of systemic blood of rats with desoxycorticosterone and metacorticoid hypertension.
Renin content of the kidney in renal and adrenal diseases associated with hypertension.
Renin dependency of blood pressure in isolated systolic hypertension.
Renin dependent hypertension by dissecting aortic aneurysm. A case report.
Renin dependent hypertension caused by accessory renal arteries.
Renin expression in adult renal epithelial tumors with granular cells.
Renin gene MboI dimorphism is a discriminator for hypertension in hyperlipidaemic subjects.
Renin gene polymorphism associated with aldosterone responsiveness to the renin-angiotensin system in patients with aldosterone-producing adenomas.
Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses.
Renin gene polymorphisms in bangladeshi hypertensive population.
Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD.
Renin in differential diagnosis of hypertension.
Renin in Experimental Hypertension.
Renin in hypertension.
Renin in hypertension: how important as a risk factor?
Renin in rats with spontaneous hypertension.
Renin in the arterial wall.
Renin inhibition and microalbuminuria development: meaningful predictor of kidney disease progression.
Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic ren2 rat.
Renin inhibition by pepstatin in experimental hypertension.
Renin Inhibition for Hypertension: Selecting the Right Role for a New Class of Drug.
Renin inhibition in hypertension.
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy.
Renin inhibition--benefit beyond hypertension control.
Renin inhibition: a new modality for hypertension management.
Renin inhibition: immunological procedures and renin inhibitor peptides.
Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?
Renin inhibition: what are the clinical perspectives?
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines.
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidines.
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.
Renin inhibitors in diabetes and hypertension: an update.
Renin inhibitors in hypertension.
Renin inhibitors in the management of hypertension.
Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
Renin inhibitors, clinical experience.
Renin inhibitors.
Renin inhibitors. Improvements in the stability and biological activity of small peptides containing novel Leu-Val replacements.
Renin inhibitors: An important advance in hypertension treatment?
Renin inhibitors: cardiovascular drugs of the future?
Renin inhibitors: discovery and development. An overview and perspective.
Renin inhibitors: novel agents for renoprotection or a better Angiotensin receptor blocker for blood pressure lowering?
Renin inhibitors: present and future. Satellite symposium of the 12th scientific meeting of the International Society of Hypertension. 28 May 1988, Osaka, Japan.
Renin kinetics in hypertension: effect of propranolol and penbutolol.
Renin levels and cardiovascular morbidity: a prospective study of the effect of beta-adrenergic blocking drugs.
Renin levels in hypertension.
Renin mechanisms and hypertension.
Renin messenger RNA localization in congenital mesoblastic nephroma using in situ hybridization.
Renin participation in hypertension associated with unilateral hydronephrosis.
Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women.
Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy.
Renin producing Wilms' tumor.
Renin profile in primary hypertension.
Renin profiling for diagnosis and treatment of hypertension.
Renin profiling for diagnosis, risk assessment, and treatment of hypertension.
Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone.
Renin reactivity in plasma of patients with normal renin and low renin essential hypertension.
Renin release from nonclipped kidneys of 2K-1C hypertensive rats.
Renin release.
Renin secreting tumour: a rare cause of secondary hypertension.
Renin secretion and captopril stimulation in hypertensive renal transplant recipients.
Renin secretion from malignant pulmonary metastatic tumour cells of vascular origin.
Renin secretion in essential and accelerated hypertension.
Renin secretion in patients with various nephropathies and coexistent arterial hypertension.
Renin secretion in the earliest stage of Goldblatt-type hypertension in rats.
Renin secretion in the patient with hypertension. Relationship to intrarenal blood flow distribution.
Renin Status in Association with Responsiveness to Behavioral Therapy in Hypertension.
Renin subgroups in essential hypertension.
Renin subgroups in essential hypertension: an analysis and critique.
Renin suppression in hypertension in relation to body fluid volumes, patterns of sodium excretion and renal haemodynamics.
Renin system activity as a determinant of response to treatment in hypertension and heart failure.
Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension.
Renin system of the kidney in ISIAH rats with inherited stress-induced arterial hypertension.
Renin tachyphylaxis and renin hypertension in the rabbit.
Renin test-guided drug treatment of hypertension: the need for clinical trials.
Renin, aldosterone, and hypertension. The hepatic metabolism of renin and aldosterone. A review with new observations on the hepatic clearance of renin.
Renin, aldosterone, sodium and hypertension.
Renin, angiotensin II, aldosterone, catecholamines, prostaglandins and vasopressin. The importance of pressor and depressor factors for hypertension in pregnancy.
Renin, blood volume and response to saralasin in patients on chronic haemodialysis: evidence against volume- and renin-'dependent' hypertension.
Renin, calcium metabolism and the pathophysiologic basis of antihypertensive therapy.
Renin, cyclooxygenase-2 and neuronal nitric oxide synthase in the kidneys of transgenic Tsukuba hypertensive mouse.
Renin, genes, and beyond: 40 years of molecular discoveries in the hypertension field.
Renin, Genes, MicroRNAs, and Renal Mechanisms Involved in Hypertension.
Renin, hypertensinogen, and hypertensinase concentration of blood of dogs during the development of hypertension by constriction of the renal artery.
Renin, kallikrein and prostaglandin renal systems in normotensive boys with and without a family history of essential hypertension.
Renin, prorenin and the kidney: a new chapter in an old saga.
Renin, renin inhibition and antihypertensive therapy.
Renin, renin substrate, angiotensin II, and vasopressin in plasma during treatment with captopril in hypertension and heart failure.
Renin, sodium, and hypertension in patients with renal transplants.
Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
Renin, the heart and hypertension.
Renin-aldosterone system and atrial natriuretic peptide during anesthesia in orthopedic patients over 80 years of age.
Renin-angiotensin and development of collateral circulation after renal ischemia.
Renin-angiotensin system and prostacyclin biosynthesis in streptozotocin diabetic rats.
Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
Renin-Angiotensin-Aldosterone Profiles in Pregnant Women With Chronic Hypertension.
Renin-Angiotensin-Aldosterone System Activity in Hyperthyroid Cats with and without Concurrent Hypertension.
Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).
Renin-angiotensin-aldosterone system in arterial hypertension.
Renin-angiotensin-aldosterone system in diabetes mellitus.
Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism.
Renin-angiotensin-aldosterone system, RR interval, and blood pressure variability during postural changes in borderline arterial hypertension.
Renin-angiotensin-aldosterone system.
Renin-angiotension-aldosterone system, urinary prostaglandins and kallikrein in pregnancy-induced hypertension: evidence for a dysregulation of the renin-angiotensin-prostacyclin loop.
Renin-dependent hypertension caused by nonfocal stenotic aberrant renal arteries: proof of a new syndrome.
Renin-dependent hypertension in children with reflux nephropathy.
Renin-dependent hypertension in patients with unilateral kidney disease not caused by renal artery stenosis.
Renin-dependent renovascular hypertension in infant with abdominal aortic atresia.
Renin-induced hypertension in Wilms tumor patients.
Renin-producing hepatoblastoma.
Renin-secreting clear cell carcinoma of the kidney.
Renin-secreting renal tumour with severe hypertension. case report with tumour renin analysis, histopathological and ultrastructural studies.
Renin-sodium profile and its therapeutical implications in arterial hypertension.
Renin-sodium profile and renal prostaglandins in the pathogenesis of systemic arterial hypertension in blacks.
Renin-stimulating test in children.
Renin/angiotensin system in hypertension after traumatic renal-artery thrombosis.
Renin: from 'pro' to promoter.
Reninoma Masked by the Use of an Angiotensin Receptor Blocker.
Reninoma: an uncommon cause of Renin-mediated hypertension.
Reninoma: case report and literature review.
Renovascular hypertension after kidney transplantation.
Renovascular hypertension from segmental renal artery stenosis: importance of segmental renal vein renin sampling.
Renovascular hypertension in children: current concepts in evaluation and treatment.
Renovascular hypertension with low-to-normal plasma renin: clinical and angiographic features.
Renovascular hypertension with unilateral atherosclerotic renal artery occlusion: diagnostic use of renal vein renins.
Report on Round Table on renin as a risk factor in hypertension.
Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
Reproducibility of plasma renin activity (PRA) profile in essential hypertension patients.
Reproductive tissue renin gene expression in preeclampsia.
Resistance to captopril in hypertension of coarctation of the aorta.
Resistant arterial hypertension: association with syncronous kidney cancer and adrenal adenoma.
Resistant hypertension and hyperaldosteronism.
Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat.
Response to atenolol in arterial hypertension in relation to renal function, pharmacokinetics and renin activity.
Response to Evolution and Hypertension: Is the Renin System Necessary?
Responses of plasma renin to sodium load in two types of experimental renal hypertension.
Responses to furosemide in normotensive and hypertensive subjects.
Restoration of Connexin 40 (Cx40) in Renin-Producing Cells Reduces the Hypertension of Cx40 Null Mice.
Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration.
Results of renal artery balloon angioplasty limit its indications.
Retroperitoneoscopic nephrectomy for juxtaglomerular cell tumor.
Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
Reversal of left ventricular hypertrophy with captopril: heterogeneity of response among hypertensive patients.
Reversal of renal failure and control of hypertension in patients with occlusion of the renal artery.
Reversal of renovascular hypertension: a comparison of changes in blood pressure, plasma renin, and sodium balance in two models in rats.
Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
Reversible hypertension and hypothyroidism.
Reversible hypertension caused by calcium overloading in a patient with postoperative hypoparathyroidism.
Reversible malignant hypertension and azotemia due to urethral stricture.
Reversible nephrotic syndrome due to high renin state in renovascular hypertension.
Reversible renal failure in an elderly woman with renal artery stenosis.
Reversible renin mediated massive proteinuria successfully treated by nephrectomy.
Reversible suppression of the renin-aldosterone axis after unilateral adrenalectomy for adrenal adenoma.
Review of the state of renal nerve ablation for patients with severe and resistant hypertension.
Rhabdomyolysis due to primary hyperaldosteronism.
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren.
Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs.
Risk Factors for Pseudoaldosteronism with Rhabdomyolysis Caused by Consumption of Drugs Containing Licorice and Differences Between Incidence of These Conditions in Japan and Other Countries: Case Report and Literature Review.
Risk stratification in hypertension: new insights from the Framingham Study.
Rodent models of cardiopulmonary disease: their potential applicability in studies of air pollutant susceptibility.
Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
Role of 18-hydroxylated cortisols in hypertension.
Role of a humoral Na+ -K+ pump inhibitor in low renin hypertension.
Role of a humoral sodium-potassium pump inhibitor in experimental low renin hypertension.
Role of adrenal imaging in surgical management.
Role of adrenal renin in the regulation of adrenal steroidogenesis by corticotropin.
Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism.
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors.
Role of angiotensin II AT1 receptor activation in cardiovascular diseases.
Role of collecting duct renin in blood pressure regulation.
Role of Collecting Duct Renin in the Pathogenesis of Hypertension.
Role of complement 3 in renin generation during the differentiation of mesenchymal stem cells to smooth muscle cells.
Role of endothelin in human hypertension.
Role of epinephrine in the development of essential hypertension.
Role of haemodynamics, catecholamines and renin in acute hypercalcaemic hypertension in man.
Role of kidney in hypertension.
Role of nisoldipine on blood pressure, cardiac hypertrophy, and atrial natriuretic peptides in spontaneously hypertensive rats.
Role of nitric oxide in the arterial pressure and renal adaptations to long-term changes in sodium intake.
Role of nNOS in regulation of renal function in hypertensive Ren-2 transgenic rats.
Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension--some old and recent findings.
Role of persistent vascular renin after bilateral nephrectomy in Goldblatt-two kidney hypertension.
Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension.
Role of prostanoids in renin-dependent and renin-independent hypertension.
Role of renal prostaglandin E2 in chronic renal disease hypertension.
Role of renin and aldosterone in hypertension due to a renin-secreting tumor.
Role of renin in the pathogenesis of renal hypertension.
Role of renin secretion and kidney function in hypertension and attendant heart attack and stroke.
Role of renin-angiotensin system in cardiopulmonary bypass hypertension.
Role of renin-angiotensin system in experimental hypertension in rats: plasma renin and hypotensive effect of angiotensin II antagonist.
Role of sex, gonadectomy and sex hormones in the development of nitric oxide inhibition-induced hypertension.
Role of stimulated intrarenal angiotensinogen in hypertension.
Role of the anteroventral third ventricle region and the renin angiotensin system in methylprednisolone hypertension.
Role of the circulating renin-angiotensin system in the pathogenesis of hypertension in transgenic rats. TGR(mREN2)27.
Role of the peripheral renin profile in predicting blood pressure control after bilateral nephrectomy in renal-transplanted patients.
Role of the renal nerve in glucocorticoid hypertension.
Role of the renal nerves in one-kidney, one clip hypertension in rats.
Role of the renin-angiotensin-aldosterone system in hypertensive children with coarctation of the aorta.
Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats.
Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update.
Role of vascular wall renin: intracellular and extracellular mechanism.
Role of vasopressin in essential hypertension: racial differences.
Roles of collecting duct renin and (pro)renin receptor in hypertension: mini review.
Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Lack of hypotensive effects of inhibition of renin, converting enzyme, and angiotensin II receptor blocker after bilateral nephrectomy.
Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension.
Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS.
S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
S1P (Site-1 Protease)-Induced Release of the Soluble Prorenin Receptor in Hypertension: Do All Roads Lead to Ang II (Angiotensin II)?
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview.
Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension.
Safety and Tolerability of the Direct Renin Inhibitor Aliskiren in Combination With Angiotensin Receptor Blockers and Thiazide Diuretics: A Pooled Analysis of Clinical Experience of 12,942 Patients.
Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension.
Saline suppression of plasma aldosterone and plasma renin activity in hypertension.
Salivary sodium-potassium ratio and plasma renin activity in hypertension.
Salt and hypertension.
Salt and water balance and renin activity in renal hypertension of rats.
Salt sensitivity is associated with an increased mortality in both normal and hypertensive humans.
Salt sensitivity of Japanese from the viewpoint of gene polymorphism.
Salt sensitivity, pulse pressure, and death in normal and hypertensive humans.
Salt sensitivity: a review with a focus on non-Hispanic blacks and Hispanics.
Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats.
Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity.
Saralasin infusion in the recognition of renovascular hypertension.
Sarcopenia and COVID-19: A Manifold Insight on Hypertension and the Renin Angiotensin System.
SARS-CoV-2 associated COVID-19 in geriatric population: A brief narrative review.
Satellite symposium of the 12th scientific meeting of the International Society of Hypertension. New aspects of renin research. Kyoto, Japan, May 27, 1988. Proceedings.
Scarring following renal trauma in children.
Scleroderma renal crisis: a pathology perspective.
Screening and diagnosis of primary aldosteronism.
Screening for primary aldosteronism in a cohort of Brazilian patients with resistant hypertension.
Screening for primary aldosteronism in a primary care unit.
Screening for primary aldosteronism in pregnancy.
Screening for renovascular hypertension.
Screening for secondary endocrine hypertension in young patients.
Secondary hypertension and neurofibromatosis: bilateral renal artery stenosis and coarctation of the abdominal aorta.
Secondary hypertension due to renin secreting tumor: a case report.
Secondary hypertension in adults.
Secondary hypertension. An overview of its causes and management.
Segmental dearterialization in penetrating renal trauma.
Segmental kidney resection in children with small, hypertension-producing intrarenal vascular lesions.
Segmental renal hypoplasia and hypertension.
Segmental renal hypoplasia of vascular origin causing renal hypertension in a 3-year-old girl.
Segmental renal vein renin assay and segmental nephrectomy for correction of renal hypertension.
Segmental renin sampling and partial nephrectomy in renal hypertension.
Selection of patients for surgery for primary aldosteronism.
Selective angiotensin II receptor antagonism enhances whole-body insulin sensitivity and muscle glucose transport in hypertensive TG(mREN2)27 rats.
Selective deletion of Connexin 40 in renin-producing cells impairs renal baroreceptor function and is associated with arterial hypertension.
Selective Deletion of the Brain-Specific Isoform of Renin Causes Neurogenic Hypertension.
Selective large coronary endothelial dysfunction in conscious dogs with chronic coronary pressure overload.
Sensitivity and specificity of screening tests for renal vascular hypertension.
Sequential changes in the renin--angiotensin--aldosterone systems and plasma progesterone concentration in normal and abnormal human pregnancy.
Serum angiotensin converting enzyme activity and the capacity to develop hypertention-associated arterial disease. Studies during the induction phase of one-kidney perinephritis hypertension in rabbits.
Serum dopamine beta-hydroxylase as an index of sympathetic nervous system activity in man.
Serum sex hormone levels and renin-sodium profile in men with hypertension.
Serum uric acid and the renin-angiotensin system in hypertension.
Severe Arterial Hypertension from Cullin 3 Mutations Is Caused by Both Renal and Vascular Effects.
Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12.
Severe hypertension and elevated plasma renin activity following transplantation of "hepatorenal donor" kidneys into anephric recipients.
Severe hypertension and encephalopathy due to Renin-producing hepatoblastoma.
Severe hypertension in a newborn associated with increased renin production by a hypoplastic kidney.
Severe hypertension, hyperkalemia, and renal tubular acidosis responding to dietary sodium restriction.
Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension.
Sex differences in prenatal programming of hypertension by dexamethasone.
Sex differences in soluble prorenin receptor in patients with type 2 diabetes.
Sex Differences in the Renal Vascular Responses of AT1 and Mas Receptors in Two-Kidney-One-Clip Hypertension.
Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats.
Shakuyaku-kanzo-to induces pseudoaldosteronism characterized by hypokalemia, rhabdomyolysis, metabolic alkalosis with respiratory compensation, and increased urinary cortisol levels.
Short-term strenuous exercise training: effects on blood pressure and hormonal levels in mild hypertension.
Short-term treatment with captopril in hypertension due to acute glomerulonephritis.
Significance of angiotensinogen gene haplotypes and genotypes combinations in hypertension.
Significance of increase in labelled albumin disappearance rate in arterial hypertension.
Significance of renin and angiotensin in hypertension.
Significance of vascular renin for local generation of angiotensins.
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independents effects?
Simple renal cyst and high renin hypertension cured by cyst decompression.
Simple renal cyst and hypertension: cause or coincidence?
Single quantum dot based nanosensor for renin assay.
Single-dose captopril scintigraphy in the diagnosis of renovascular hypertension.
Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.
Site-1 Protease-Derived Soluble (Pro)Renin Receptor Contributes to Angiotensin II-Induced Hypertension in Mice.
SLC26A6 and NADC?1: Future direction of nephrolithiasis and calculus?related hypertension research (Review).
Small kidney and hypertension: selection of patients for surgery.
Sodium and potassium status, plasma renin and aldosterone profiles in normotensive and hypertensive Johannesburg blacks.
Sodium and renin in the hypertension of early renal disease.
Sodium and responses to infused noradrenaline and angiotensin II in subjects predisposed to hypertension.
Sodium balance, plasma renin, and aldosterone in hypertension.
Sodium chloride sensitivity, intracellular sodium concentration in erythrocytes and lymphocytes, and renin profile in essential hypertension.
Sodium intake regulates renin gene expression differently in the hypothalamus and kidney of rats.
Sodium is more important than calcium in essential hypertension.
Sodium metabolism in essential hypertension. Natriuretic response to acute hypertonic saline load.
Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin.
Sodium sensitivity of blood pressure in long-term detoxified alcoholics.
Sodium status, corticosteroid metabolism and blood pressure in normal human subjects and in a patient with abnormal salt appetite.
Sodium susceptibility and potassium effects in young patients with borderline hypertension.
Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus.
Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
Solitary intrarenal cyst causing hypertension, with plasma renin activity study before and after cyst aspiration.
Solitary renal cyst, hypertension and renin.
Soluble Form of the (Pro)Renin Receptor Is Augmented in the Collecting Duct and Urine of Chronic Angiotensin II-Dependent Hypertensive Rats.
Soluble Prorenin Receptor Increases Blood Pressure in High Fat-Fed Male Mice.
Somatic gene therapy for hypertension.
Some physiological outcomes of renin gene studies.
Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
Speckle-Tracking Echocardiographic Layer-Specific Strain Analysis on Subclinical Left Ventricular Dysfunction in Patients With Primary Aldosteronism.
Spectrum of renin angiotensin aldosterone system disorders in young hypertensives.
Splicing analysis of CYP11B1 mutation in a family affected with 11?-hydroxylase deficiency: case report.
Spontaneous improvement of hypertension in multicystic dysplastic kidney: a case report.
Spontaneously Resolving Hyperreninemic Hypertension Caused by Accessory Renal Artery Stenosis in a 13-Year-Old Girl: A Case Report.
SSA 05-4 DIFFERENCES IN MANAGEMENT OF HYPERTENSION BETWEEN ETHNIC GROUPS.
Statins Reverse Postpartum Cardiovascular Dysfunction in a Rat Model of Preeclampsia.
Stenting of a renal artery compressed by the diaphragm.
Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia.
Steroid characteristics of mineralocorticoid adrenocortical hypertension.
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess.
Stimulated renin: a screening test for hypertension.
Stimulation of plasma renin activity by captopril in renovascular hypertensive conscious dogs.
Stimulation of sodium transport by toad skin incubated with natural derivatives of corticosterone and deoxycorticosterone.
Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor.
Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets.
Structure of a juxtaglomerular cell tumor: the presence of a neural component: a light and electron microscopic study.
Structure, expression, and regulation of the murine renin genes.
Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.
Structure-based design of aliskiren, a novel orally effective renin inhibitor.
Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.
Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors.
Studies concerning the mechanism of suppression of renin secretion by clonidine.
Studies of plasma renin activity in patients with hypertension.
Studies of the effect of mode of delivery: obstetric analgesia and anaesthesia on maternal Plasma Renin Concentration (PRC) and Plasma Renin Activity (PRA) in the normotensive and hypertensive primigravidae.
Studies of the renin-angiotension-aldosterone system, cortisol, DOC, and ADH in normal and hypertensive pregnancy.
Studies on blood pressure regulation in hypertensive ren-2 transgenic rats.
STUDIES ON EXPERIMENTAL HYPERTENSION : XX. THE BIOASSAY OF RENIN.
STUDIES ON EXPERIMENTAL HYPERTENSION : XXI. THE PURIFICATION OF RENIN.
STUDIES ON PLANT HYPERTENSINASE.
Studies on renin-2 gene in transgenic rats.
Studies on thyroid activity in deoxycorticosterone-salt and Goldblatt two-kidney, one-clip hypertensive rats.
Study of correlation between elevation of blood pressure and tissue ACE activity during development of hypertension in 1K1C rats.
Study of renovascular hypertension in rats. III. Effects of converting enzyme inhibitor (captopril) on the plasma and renal renin activity in two-kidney goldblatt hypertension in rats.
Study of renovascular hypertension in rats. IV. Renal arterial blood velocity in one-clip, two-kidney hypertensive rats.
Substitution of connexin40 with connexin45 prevents hyperreninemia and attenuates hypertension.
Successful directional atherectomy of eccentric renal artery stenosis using the Simpson directional coronary atherocath as a primary therapy.
Successful long-term effects of direct renin inhibitor aliskiren in a patient with atherosclerotic renovascular hypertension.
Successful treatment of hypertension in anuric hemodialysis patients with a direct Renin inhibitor, aliskiren.
Successful treatment of primary aldosteronism due to computed tomography-negative microadenoma.
Successful treatment of scleroderma renal crisis with enalapril.
Successful treatment of severe hypertension with the combination of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker.
Successfully treated "accelerated" renovascular hypertension with intravascular stenting.
Suppressed plasma renin activity in adrenal regeneration hypertension.
Suppressed plasma renin activity in hypertension.
Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.
Suppression of plasma renin activity by cyclosporine.
Suppression of plasma renin and aldosterone in stress-salt hypertension in dogs.
Suppression of renin and aldosterone by small amounts of DOCA in normal man.
Suppression of renin production in patients undergoing coronary artery bypass.
Suppression of renin release by antagonism of endogenous opiates in the dog.
Surgical treatment of renovascular hypertension.
SY 12-1 RENIN ANGIOTENSIN PATHWAY BEYOND ACE AND ANGIOTENSIN II RECEPTORS: HOW IT RELATES TO THE PATHOPHYSIOLOGY OF HYPERTENSION.
SY 14-3 PRIMARY ALDOSTERONISM IN RESISTANT HYPERTENSION.
Sympathetic activation and contribution of genetic factors in hypertension with neurovascular compression of the rostral ventrolateral medulla.
Sympathetic hyperactivity in early stages of hypertension: the Ann Arbor data set.
Sympathetic nervous function and renin activity in hypertensives on long term drug treatment with propranolol, methyldopa or bendrofluazide.
Sympathetic nervous system and insulin resistance: from obesity to diabetes.
Symposium on hypertension: Part II. Renin profiling and drug therapy, childhood hypertension, prorenin, the physiology of renin secretion. Introduction.
Symposium on hypertension: part III. Sodium and potassium, catecholamines, renin and adrenal steroids as causal factors. Hypertension and atherosclerosis. Clonidine treatment and the renin axis.
Syndrome of idiopathic hyperkalaemia and hypertension with decreased plasma renin activity: effects on plasma renin and aldosterone of reducing the serum potassium level.
Synergic effects of renin and aldosterone on right ventricular function in hypertension: a tissue Doppler study.
Synergistic effects of hydralazine and alpha- or beta-adrenergic blockers: the role of plasma renin activity.
Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease.
Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension. Predictability of plasma renin status from hemodynamic changes.
Systemic and regional haemodynamic profile of captopril in conscious rabbits with bilateral cellophane perinephritis hypertension.
Systemic and renal-specific sympathoinhibition in obesity hypertension.
Systemic hypertension after surgical treatment of a congenital arteriovenous malformation.
Systemic hypertension and plasma renin activity in children with the hemolytic-uremic syndrome.
Systemic hypertension associated with coronary artery bypass surgery. Predisposing factors, hemodynamic characteristics, humoral profile, and treatment.
Systemic Succinate Homeostasis and Local Succinate Signaling Affect Blood Pressure and Modify Risks for Calcium Oxalate Lithogenesis.
Systemic systolic hypertension in the elderly: correlation of hemodynamics, plasma volume, renin, aldosterone, urinary metanephrines and response to thiazide therapy.
Targeted capture sequencing identifies genetic variations of GRK4 and RDH8 in Han Chinese with essential hypertension in Xinjiang.
Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.
TASK-3 channel deletion in mice recapitulates low-renin essential hypertension.
Task3 Potassium Channel Gene Invalidation Causes Low Renin and Salt-Sensitive Arterial Hypertension.
Tea Polyphenols as Novel and Potent Inhibitory Substances against Renin Activity.
Telmisartan: just an antihypertensive agent? A literature review.
Temporary mineralocorticoid receptor antagonism during the development of hypertension improves cerebral artery dilation.
Thalamic hemorrhage in a 4-year-old child induced by nephro-vascular hypertension.
The (pro)renin receptor and the kidney.
The absence of sympathoexcitation during the development of hypertension in Cyp1a1 Ren-2 transgenic rats.
The action of renin and hypertension on the pulmonary and hepatic circulations.
THE ACTION OF RENIN ON RABBITS WITH RENAL HYPERTENSION.
The administration of desoxycorticosterone and the response in intact and adrenalectomized rats to renin and hypertension.
The Ang-(1-7)/ACE2/mas axis in the Regulation of Nephron Function.
The area postrema in deoxycorticosterone-salt hypertension in rats.
The Ask-Upmark kidney: a curable cause of hypertension in young patients.
The association of hypertension, the Ask-Upmark kidney and other congenital abnormalities.
The association of plasma prorenin level with an oxidative stress marker, 8-OHdG, in nondiabetic hemodialysis patients.
The beneficial effects on blood pressure, dyslipidemia and oxidative stress of Sambucus nigra extract associated with renin inhibitors.
The benefits of angiotensin II receptor blockers in patients with renal insufficiency or failure.
The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.
The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes.
The brain renin-angiotensin system in transgenic mice carrying a highly regulated human renin transgene.
The captopril test for identifying renovascular disease in hypertensive patients.
The captopril test: an aid to investigation of hypertension.
The central effects of the renin-angiotensin system.
The changes of serum-ACE, plasma renin activity and aldosterone in the diabetics with hypertension.
The characterization of low renin hypertension by plasma renin activity and plasma aldosterone concentration.
The choice of antihypertensive drugs in patients with diabetes: angiotensin II and beyond.
The clinical application of converting enzyme inhibitors.
The clinical potential of renin inhibitors and angiotensin antagonists.
The Clinicopathologic Significance of Unilateral Adrenal Cortical Hyperplasia: Report of an Unusual Case and a Review of the Literature.
The Cockayne syndrome: an evaluation of hypertension and studies of renal pathology.
The concept of autoregulation of total blood flow and its role in hypertension.
The control of aldosterone secretion in normal and hypertensive man: abnormal renin-aldosterone patterns in low renin hypertension.
The current state of beta blockers in hypertension therapy.
The determinants of plasma-renin activity in essential hypertension.
The determinants of response to diltiazem in hypertension.
The development of the direct renin inhibitor aliskiren: treating hypertension and beyond.
The diagnostic and therapeutic uses of saralasin in renal transplant hypertension.
The Direct Renin Inhibitor Aliskiren in Combination with the Angiotensin Receptor Blocker Valsartan Provides Additional Blood Pressure-lowering Effects Compared with Either Agent Alone in Patients with Hypertension.
The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors.
The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death.
The Divergent Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Adult Patients With Type 2 Diabetes Mellitus.
The effect of 5 alpha-dihydrocortisol on the blood pressure of rats treated with deoxycorticosterone acetate and salt.
The effect of age and norepinephrine on renin release by rat kidney slices in vitro.
The effect of clonidine and penbutolol, respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients.
The effect of clonidine on plasma renin activity in human hypertension.
The effect of furosemide stimulation on renin secretion and its application in examining activity of the renin-angiotensin system.
The effect of high sodium intake and angiotensin antagonist in rabbits with severe and moderate hypertension induced by constriction of one renal artery.
The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients.
The effect of renal sympathectomy on blood pressure and plasma renin activity in spontaneously hypertensive and normotensive rats.
The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome.
The effect of sodium load on the development of hypertension, plasma renin and kininogen in rats with renal artery constriction.
The effect of spironolactone (Aldactone) and methyldopa in low and normal renin hypertension.
The effect of splanchnic block on renin production and renal haemodynamics in hypertensive patients.
The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle's syndrome.
The effects of caffeine on various body systems: a review.
The effects of dietary patterns on plasma renin activity: results from the Dietary Approaches to Stop Hypertension trial.
The effects of direct renin inhibitor, aliskiren, on arterial hypertension, chronic kidney disease and cardiovascular disease: optimal pharmacotherapy.
The effects of propranolol on spontaneous and experimental hypertension in the rat.
The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
The effects of sodium loading and deprivation on plasma renin and plasma and urinary aldosterone in hypertension.
THE EFFECTS ON RENAL RESISTANCE TO BLOOD FLOW OF RENIN, ANGIOTONIN, PITRESSIN AND ATROPINE, HYPERTENSION, AND TOXEMIA OF PREGNANCY.
The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks.
The Efficacy of Renin Inhibitors in Primary Hypertension.
The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia.
The endothelin receptor antagonist ameliorates the hypertensive phenotypes of transgenic hypertensive mice with renin-angiotensin genes and discloses roles of organ specific activation of endothelin system in transgenic mice.
The Enhanced Renin-Angiotensin-Aldosteron System Pharmacological Blockade - Which is the Best?.
The etiology of hypertension in nonrenovascular unilateral renal disease--two cases of renin induced hypertension in congenital renal dysplasia.
The evolution of angiotensin blockade in the management of cardiovascular disease.
The Evolution of Renin-Angiotensin Blockade: Angiotensin-Converting Enzyme Inhibitors as the Starting Point.
The evolving complexity of the collecting duct renin-angiotensin system in hypertension.
The expression of renin-binding protein and renin in the kidneys of rats with two-kidney one-clip hypertension.
The future of hypertension and renin research.
The genetics of pre-eclampsia: a feto-placental or maternal problem?
The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension.
The heterogeneity of vascular findings in the kidneys of patients with benign essential hypertension.
The human genome contains only two CYP11B (P450c11) genes.
The hypertension of autonomic failure and its treatment.
The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects.
The hypotensive mechanism of percutaneous transluminal dilatation (PTD) in renovascular hypertension due to bilateral renal artery stenosis.
The Impact of Nutritional Insults during Fetal Life on Blood Pressure.
The impact of obstructive sleep apnea syndrome on renin and aldosterone.
The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation.
The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.
The importance of genetic counseling and genetic screening: a case report of a 16-year-old boy with resistant hypertension and severe hypokalemia.
The importance of renin in post-transplantation (single-kidney) hypertension.
The importance of the renin angiotensin system in hypertension due to coarctation of the aorta.
The importance of the response of the renin-angiotensin system in determining blood pressure changes with sodium restriction.
The improvement of hypertension by probiotics: effects on cholesterol, diabetes, Renin, and phytoestrogens.
The influence of chronic high alcohol intake on blood pressure, plasma noradrenaline concentration and plasma renin concentration.
The influence of different sodium loads on renin release in hypertensive and normotensive states of chronic renal failure.
The interaction between prorenin, renin and the (pro)renin receptor: time to rethink the role in hypertension.
The intravenous furosemide test: a simple way to evaluate renin responsiveness.
The juxtaglomerular apparatus in malignant hypertension of man.
The long-term course of cyclosporine-associated chronic nephropathy.
The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor.
The mechanism of hypertension and bradycardia following lesions of the caudal ventrolateral medulla in the rabbit: the role of sympathetic nerves, circulating adrenaline, vasopressin and renin.
The mechanism of low-renin hypertension: aldosterone response to sodium restriction and upright posture, angiotensin II, ACTH and potassium in patients with hypertension.
The mechanism of mineralocorticoid action of carbenoxolone.
The mechanism of renomedullary antihypertensive action: haemodynamic studies in hydronephrotic rats with one-kidney renal-clip hypertension.
THE METABOLISM OF THE KIDNEY IN EXPERIMENTAL RENAL HYPERTENSION : II. THE CONCENTRATION OF CYTOCHROME C AND THE ACTIVITIES OF THE CYTOCHROME OXIDASE AND OF THE SUCCINIC DEHYDROGENASE SYSTEMS IN THE KIDNEY OF DOGS WITH EXPERIMENTAL RENAL HYPERTENSION. THE INHIBITORY EFFECT OF RENIN AND OF KIDNEY TISSUE PREPARATIONS FROM HYPERTENSIVE DOGS ON THE RESPIRATORY ENZYMES.
The molecular basis of primary aldosteronism: from chimeric gene to channelopathy.
The Myth of Water and Salt: From Aquaretics to Tenapanor.
The natriuretic peptide neurohormonal system modulation by vasopeptidase inhibitors--the novel therapeutical approach of hypertension treatment.
The natural history of hypertension in turkeys.
The natural history of traumatic branch renal artery injury.
The Page kidney: a correctable form of arterial hypertension.
The pathogenesis of essential hypertension.
The pathogenesis of small arterial lesions in nephrectomized rats by the administration of renin.
The pathophysiology of renovascular hypertension.
The Pharmacology of Autonomic Failure: From Hypotension to Hypertension.
The physiology and pathophysiology of the nitric oxide/superoxide system.
The place of renin in the mechanism of hypertension in chronic renal disease.
The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.
The possible significance of renin determinations in selection of kidney-transplanted patients for bilateral nephrectomy in treatment of hypertension.
The potential advantages of a modern antihypertensive therapy in the elderly.
The PPAR-gamma-binding sequence Pal3 is necessary for basal but dispensable for high-fat diet regulated human renin expression in the kidney.
The preclinical basis of the therapeutic evaluation of losartan.
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension.
The Prorenin and (Pro)renin Receptor: New Players in the Brain Renin-Angiotensin System?
The protective role of vitamin D on the heart and the kidney.
The quantitative determination of renin in the plasma of patients with arterial hypertension.
The radiology of juxtaglomerular tumors.
The rat renin gene: assignment to chromosome 13 and linkage to the regulation of blood pressure.
The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man.
The relation of plasma renin activity to left ventricular hypertrophy and retinopathy in patients with arterial hypertension.
The relationship between peroxisome proliferator-activated receptor-gamma and renin: a human genetics study.
The relationship between plasma renin activity and serum lipid profiles in patients with primary arterial hypertension.
The relationship between the plasma concentrations of renin and angiotensin with total exchangeable sodium in hypertension.
The relationship of plasma renin activity to clinic and ambulatory blood pressure in elderly people with isolated systolic hypertension.
The relative roles of sodium and renin in the hypertension of renal disease. An assessment based on the response to frusemide and propranolol.
The renal afferent nerves in the pathogenesis of hypertension.
The renal circulation in hypertensive disease.
The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
The Renin Angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.
The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.
The renin angiotensin system as a risk factor for coronary artery disease.
The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.
The renin gene and hypertension.
The renin inhibitor aliskiren as novel treatment for cardiovascular disease.
The renin inhibitor aliskiren protects rat lungs from the histopathologic effects of fat embolism.
The renin system and future trends in management of high blood pressure.
The renin system and new understanding of the complications of hypertension and their treatment.
The renin system for long-term control over vasoconstriction and sodium-volume homeostasis in the spectrum of hypertension: three new frontiers in research.
The renin system for understanding human hypertension: evidence for blood pressure control by a bipolar vasoconstriction-volume mechanism. Prorenin as a determinant of renin secretion.
The renin system in essential, renovascular and adrenocortical hypertension: an overview.
The renin system in high blood pressure, from disbelief to reality: converting-enzyme blockade for analysis and treatment.
The renin system in hypertension. A review.
The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
The renin-aldosterone axis in two models of reduced renal mass in the rat.
The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition.
The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.
The renin-angiotensin system and hypertension.
The renin-angiotensin system and sodium excretion during gestation.
The renin-angiotensin system as a target for therapeutic intervention.
The renin-angiotensin system in COVID-19: Why ACE2 targeting by coronaviruses produces higher mortality in elderly hypertensive patients?
The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
The renin-angiotensin system in the central control of blood pressure.
The renin-angiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDRR).
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
The renin-angiotensin-aldosterone system and hypertension in primary hyperparathyroidism.
The renin-angiotensin-aldosterone system in primary and secondary hypertension.
The role of aldosterone antagonists in the management of resistant hypertension.
The role of aliskiren in the management of hypertension and major cardiovascular outcomes: a systematic review and meta-analysis.
The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study.
The role of Angiotensin receptor blocker and calcium channel blocker combination therapy in treating hypertension: focus on recent studies.
The role of increased plasmatic renin level in the pathogenesis of arterial hypertension in young adults.
The role of partial nephrectomy in the treatment of pediatric renal hypertension.
The role of plasma renin activity, age, and race in selecting effective initial drug therapy for hypertension.
The Role of Real-Time Contrast-Enhanced Ultrasound in Guiding Radiofrequency Ablation of Reninoma: Case Report and Literature Review.
The role of renin and catecholamine production in postcarotid endarterectomy hypertension.
The role of renin in the exaggerated natriuresis of hypertension.
The role of renin inhibition in treating the hypertensive patient with diabetes: a summary of preclinical and clinical evidence.
The role of renin substrate in hypertension.
The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27.
The role of the kidney in hypertension.
The role of the renin-angiotensin system in arterial hypertension in hypercorticism.
The role of the renin-angiotensin system in malignant vascular injury affecting the systemic and cerebral circulations.
The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
The role of the renin-angiotensin system in the pathogenesis of preeclampsia - new insights into the renin-angiotensin system in preeclampsia.
The role of vascular protein and renin in chronic two-kidney, one clip Goldblatt hypertension.
The Safety After Fifty Evaluation trial: evaluation of the safety and efficacy of antihypertensive therapy with metoprolol in patients 50 to 75 years of age: study design.
The salivary sodium/potassium ratio in hypertension: relation to race and plasma renin activity.
The significance of body sodium content in hypertension following renal transplantation: exchangeable sodium and plasma renin concentration before and after renal transplantation.
The size of kidney with renovascular hypertension in patients with aortitis syndrome.
The Small Size and Superficial Location Suggest That Laparoscopic Partial Nephrectomy Is the First Choice for the Treatment of Juxtaglomerular Cell Tumors.
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study.
The state of the renin-angiotensin-aldosterone system in various clinical forms of hypertension in aging.
The subfornical organ: biochemical and neuroendocrine comparisons with the hypothalamo-neurohypophysial system.
The sympathetic nervous system and the renin-angiotensin system in borderline hypertension.
The sympathetic nervous system in clinical and experimental hypertension.
The sympathetic nervous system in hypertension due to unilateral renal artery stenosis in man.
The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure.
The syndrome of hypertension and hyperkalaemia with normal GFR. A unique pathophysiological mechanism for hypertension?
The syndrome of hypertension and hyperkalaemia with normal glomerular filtration rate: is there a deficiency in vasodilator prostaglandins?
The syndrome of hypertension and hyperkalemia with normal GFR (Gordon's syndrome): is there increased proximal sodium reabsorption?
The syndromes of low-renin hypertension: "separating the wheat from the chaff".
The therapeutic effect of a new angiotensin-converting enzyme inhibitor, enalapril maleate, in idiopathic hyperaldosteronism.
The tissue renin-angiotensin system in rats with fructose-induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue.
The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade.
The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes.
The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
The use of renin inhibitors in the management of hypertension.
The use of saralasin in the recognition of angiotensinogenic hypertension.
The usefulness of renal vein renin studies in hypertensive children: a 25-year experience.
The utility of renin profiling in childhood hypertension.
The vascular Na+-K+ pump in low renin hypertension.
The vasodilating effect of atrial natriuretic peptide in normotensive and hypertensive humans.
Therapeutic dimensions of ACE inhibitors- A review of literature and clinical trials.
Therapeutic dimensions of ACE inhibitors--a review of literature and clinical trials.
Therapeutic evaluation of rutin in two-kidney one-clip model of renovascular hypertension in rat.
Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
Therapeutic potential of renin inhibitors in the management of cardiovascular disorders.
Therapeutic vaccines against human and rat renin in spontaneously hypertensive rats.
Therapy and prognosis of hypertension in chronic nephritis.
Thiazide diuretics, hypokalemia and cardiac arrhythmias.
Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy.
Thiazide-like/calcium channel blocker agents: a major combination for hypertension management.
Three cases of Gordon syndrome with dominant KLHL3 mutations.
Three-dimensional structure, specificity and catalytic mechanism of renin.
Tight blood glycaemic and blood pressure control in experimental diabetic nephropathy reduces extracellular matrix production without regression of fibrosis.
Time-course of the changes in blood pressure and in plasma renin activity during the first week after dilation of renal artery stenosis.
Tissue kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein deficiency.
Tissue renin-angiotensin systems in renal hypertension.
Tissue renin-angiotensin systems. Their role in cardiovascular disease.
Topomer CoMFA and Virtual Screening Studies of Azaindole Class Renin Inhibitors.
Total synthesis of "aliskiren": the first Renin inhibitor in clinical practice for hypertension.
trans-3,4-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part II: Prime site exploration using an oxygen linker.
Transarterial embolization and ablation of renal arteriovenous malformations: efficacy and damages in 30 patients with long-term followup.
Transfer of a salt-resistant renin allele raises blood pressure in Dahl salt-sensitive rats.
Transgenic hypertensive rats show a reduced angiotensin II induced [Ca2+]i response in glomerular mesangial cells.
Transgenic models as tools for studying the regulation of human renin expression.
Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model.
Transient Induction of ANG II-Dependent Malignant Hypertension Causes Sustained Elevation of Blood Pressure and Augmentation of the Pressor Response to ANG II in CYP1A1-REN2 Transgenic Rats.
Translational studies on augmentation of intratubular renin-angiotensin system in hypertension.
Treating resistant hypertension: role of renal denervation.
Treatment of Diabetic Kidney Disease With Hypertension Control and Renin Angiotensin System Inhibition.
Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses.
Treatment of Elderly Hypertensive Patients With Diabetes, Renal Disease, and Coronary Heart Disease.
Treatment of high-renin hypertension with propranolol in children after renal transplantation.
Treatment of hypertension with calcium channel blockers: European data.
Treatment of neurofibromatosis associated renal artery stenosis with hypertension by percutaneous transluminal angioplasty.
Treatment of renovascular disease and of renovascular hypertension.
Treatment of severe hypertension in chronic renal failure by haemofiltration.
Treatment of Wilms tumor-related hypertension with losartan and captopril.
Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.
Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
Twin-to-twin transfusion syndrome. Role of the fetal renin-angiotensin system.
Two cases of low-renin hypertension thought to be due to excessive secretion of unknown mineralocorticoid.
Two polymorphisms in the Cx40 promoter are associated with hypertension and left ventricular hypertrophy preferentially in men.
Tyrosinemia with acute intermittent porphyria: aminolevulinic acid dehydratase deficiency related to elevated urinary aminolevulinic acid levels.
Ultrastructural immunocytochemical localization of renin and angiotensin II in the juxtaglomerular cells of the ischemic kidney in experimental renal hypertension.
Ultrastructure Study of Transgenic Ren2 Rat Aorta - Part 1: Endothelium and Intima.
Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction.
Uncontrolled hypertension and hyperreninemia after hemorrhage in a patient with end-stage renal disease and acquired renal cysts.
Unilateral adrenal hypersecretion of both aldosterone and cortisol in two first cousins with a syndrome of mineralocorticoid excess but without signs of hypercortisolism.
Unilateral hypersecretion of aldosterone associated with adrenal hyperplasia as a cause of primary aldosteronism.
Unilateral renal hypoplasia with associated venous anomaly and hypertension. A study of the juxtaglomerular cells.
Unilateral ureteral obstruction. A caue of reversible high renin content hypertension.
Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case.
Unmet needs in managing hypertension: potential role of direct renin inhibition.
Unraveling the Mystery of Goldblatt Hypertension.
Unstimulated renal venous renin ratio predicts improvement in hypertension following nephrectomy for unilateral renal disease.
Unsuccessfully Treated Hypertension: A Major Public Health Problem With a Potential Solution.
Unusual low plasma renin hypertension in a child.
Unusual manifestations of Henoch-Schönlein syndrome.
Uric acid and hypertension.
Uric acid and the state of the intrarenal renin-angiotensin system in humans.
Urinary catecholamines, plasma renin activity and blood pressure in newborns: effects of narcotic withdrawal.
Urinary excretion of prostaglandins (PGE2 and PGF2 alpha) and kallikrein in acute glomerulonephritis.
Urinary free 19-nor-deoxycorticosterone and deoxycorticosterone in human hypertension.
Urinary kallikrein activity in the hypertension of renal parenchymal disease.
Urinary kallikrein and plasma renin during the reversal of renovascular hypertension in rats.
Urinary serine proteases and activation of ENaC in kidney-implications for physiological renal salt handling and hypertensive disorders with albuminuria.
Use of ameroid constrictors in the development of renin-dependent hypertension in dogs.
Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;.
Use of direct renin inhibitor in an HIV positive subject.
Use of diuretics in treatment of hypertension secondary to renal disease.
Use of oral converting enzyme inhibitor, captopril for lateralizing renal venous renin activity.
Use of Plasma Renin Assays In the Evaluation of Patients With Hypertension.
Use of renin angiotensin system inhibitors in patients with chronic kidney disease.
Use of the captopril test to assess renin responsiveness in children with hypertension and renal disease.
Use of vitamin D in chronic kidney disease patients.
Vaccarin administration ameliorates hypertension and cardiovascular remodeling in renovascular hypertensive rats.
Vaccination against high blood pressure.
Vaccine for hypertension: modulating the renin-angiotensin system.
Vaccines against components of the renin-angiotensin system.
Validation of a new automated renin assay.
Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats.
Variable response of renin activity in primary and secondary hypertension.
Varieties of low renin hypertension.
Vascular angiotensin converting enzyme in the development of renal hypertension.
Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver.
Vascular endothelial growth factor (VEGF), prostaglandin E2(PGE2) and active renin in hypertension of adrenal origin.
Vascular lesions and angiotensin in malignant hypertension in the absence of vasopressin.
Vascular RAA system.
Vascular reactivity to angiotensin and noradrenaline in rats maintained on a sodium free diet or made hypertensive with desoxycorticosterone acetate and salt (DOCA/salt).
Vascular remodeling in hypertensive transgenic mice.
Vascular renin and hypertension. Uptake versus synthesis.
Vascular renin in hypertension.
Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats.
Vascular renin-like activity and blood pressure.
Vascular responses to ouabain and norepinephrine in low and normal renin hypertension.
Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo.
Vascular smooth muscle cells from the Milan hypertensive rat exhibit decreased functional angiotensin II receptors.
Vascular sodium-potassium pump activity in various models of experimental hypertension.
Vascular wall renin in spontaneously hypertensive rats. Potential relevance to hypertension maintenance and antihypertensive effect of captopril.
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.
Vasoconstrictor responses to components of the renin-angiotensin system in cyclosporin-induced hypertension in the rat.
Vasodepressor activity of renal medulla of spontaneously hypertensive rats.
Vasodepressor mechanisms in experimental hypertension: studies using chemical medullectomy.
Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension.
Vasopeptidase inhibitors.
Vasopressin actions in the kidney renin angiotensin system and its role in hypertension and renal disease.
Vasopressin does not effect hypertension caused by long-term nitric oxide inhibition.
Vasopressin/V2 receptor stimulates renin synthesis in the collecting duct.
Vaule of renin measurement, saralasin test, and acebutolol treatment in hypertension.
Verapamil-induced natriuretic and diuretic effects: dependency on sodium intake.
Very-low-dose combination: a first-line choice for the treatment of hypertension?
Viral transduction of renin rapidly establishes persistent hypertension in diverse murine strains.
Visit-to-visit blood pressure variability is common in primary care patients: Retrospective cohort study of 221,803 adults.
Vitamin D and human health: lessons from vitamin D receptor null mice.
Vitamin D and Vitamin D Receptor Activators in Treatment of Hypertension and Cardiovascular Disease.
Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice.
Vitamin d depletion aggravates hypertension and target-organ damage.
Vitamin D regulation of the renin-angiotensin system.
Vitamin D resistance.
Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.
Volume studies in men with mild to moderate hypertension.
Volume-pressure relationships during development of mineralocorticoid hypertension in man.
Voluntary exercise training enhances glucose transport but not insulin signaling capacity in muscle of hypertensive TG(mREN2)27 rats.
What can we learn from erythrocyte Na-K-Cl cotransporter NKCC1 in human hypertension?
What does the future hold for ACE inhibitors?
What is the role of obesity in hypertension and target organ injury in African Americans?
When is it useful to inhibit the renin-angiotensin system for treating hypertension?
Which antihypertensive drugs are the most nephroprotective and why?
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Whole-exome sequencing reveals an inherited R566X mutation of the epithelial sodium channel ?-subunit in a case of early-onset phenotype of Liddle syndrome.
Wilms Tumor with dilated hypertensive cardiomyopathy, acute myocarditis, pulmonary edema, and heart failure.
Wilms' tumor protein (-KTS) modulates renin gene transcription.
WITHDRAWN: Low renin hypertension (LRH): shades of John Laragh.
Zona glomerulosa of the adrenal gland in a transgenic strain of rat: a morphologic and functional study.
Zonal distribution and regulation of adrenal renin in a transgenic model of hypertension in the rat.
[11beta-hydroxysteroide dehydrogenases. Recent advances]
[5/6 nephrectomy as an experimental model of chronic renal failure and adaptation to reduced nephron number]
[A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency]
[A case of congenital nephrogenic diabetes insipidus accompanied by hypertension]
[A case of domestic violence-related Page kidney]
[A case of hypogammaglobulinemia associated with polyarteritis nodosa presenting a variety of symptoms in childhood]
[A case of idiopathic hyperaldosteronism with normal plasma aldosterone concentrations for 5 years after onset: a 12-year follow-up study]
[A case of juxtaglomerular cell tumor (reninoma) treated with laparoscopic partial nephrectomy].
[A case of mixed connective tissue disease complicated with malignant hypertension]
[A case of scleroderma with sclerodermic renal crisis and association with the Vogt-Koyanagi-Harada syndrome]
[A case of the benign adrenal adenoma with remarkably high concentrations of deoxycorticosterone and 11-deoxycortisol]
[A case report of juxtaglomerular cell tumor incidently found with a tumor hemorrhage]
[A case with juvenile rheumatoid arthritis who developed cerebral vasculitis and venovascular hypertension]
[A clinical analysis of reninoma-induced hypertensive crisis associated with reversible posterior encephalopathy syndrome].
[A juxtaglomerular cell tumor. Analysis of immunohistochemistry, electron microscopy and in situ hybridization]
[A patients with chronic renal failure due to Bartter's syndrome]
[A review of ten cases of aldosteronoma. Diagnostic and therapeutic conclusions (author's transl)]
[A study of mutation(s) of the epithelial sodium channel gene in a Liddle's syndrome family]
[Acebutolol in arterial hypertension. Hemodynamic effects and effects on plasma renin]
[Acebutolol in the treatment of arterial hypertension. Clinical study]
[Activity of plasma renin in arterial hypertension with corticoadrenal adenoma. Conn's syndrome]
[Activity of renin in blood plasma of patients with arterial hypertension]
[Activity of the sodium-proton exchanger and polymorphism of G-protein beta-3 subunit in patients with essential hypertension]
[Activity of the sympathetic nervous system and the levels of prostaglandins and intracellular electrolytes in patients with arterial hypertension and low plasma renin activity]
[Activity of the sympathetic-adrenal system and blood renin level in adolescents with primary arterial hypertension]
[Acute effect of nifedipine on arterial pressure and the renin-angiotensin system in healthy subjects and hypertensives]
[Acute oligoanuric renal insufficiency in malignant nephroangiosclerosis]
[Acute response to calcium inhibitors in secondary arterial hypertension: does renin play a role?]
[Adrenal hormones in the formation of atherosclerotic precursors in adolescents with primary arterial hypertension]
[Adrenal incidentaloma].
[Adrenal myelolipoma: two case reports]
[Advantages and limitations of renin inhibition with aliskiren].
[Alcohol and hypertension in sudden cardiac death, features of the status of the renin-angiotensin-aldosterone system]
[Aldosterone precursors and hypertension with hypokalemia and adrenal module non caused by primary hyperaldosteronism]
[Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism]
[Aldosteronemia and plasma renin activity in patients with hypertension treated with visken (prindolol)]
[Allergic granulomatous angiitis with subarachnoid hemorrhage--a case report]
[An experience with the use of direct renin inhibitor aliskiren in a patient with obesity and arterial hypertension]
[An incidental finding of renal cysts: routine occurrence or a finding deserving clarification?]
[Angiotensin II inhibitors for the diagnosis and treatment of hypertension]
[Angiotensin-converting enzyme inhibition: direct and indirect mechanisms]
[Another case of hypertension due to a tumour of the juxta-glomerular apparatus (author's transl)]
[Antihypertensive effect of repeated oral administration of MK-0521 in 2-kidney Goldblatt hypertensive dogs]
[Aortorenal angiography and other approaches in the diagnosis of arterial hypertension of renal origin]
[ARTERIAL HYPERTENSION AND HYPERALDOSTERONISM. APROPOS OF 2 CASES OF CONN'S SYNDROME. VALUE OF THE DETERMINATION OF PLASMA RENIN.]
[ARTERIAL HYPERTENSION AND PLASMA RENIN.]
[Arterial hypertension and renin producing tumors]
[Arterial hypertension and unilateral nephropathy. Value of the index of renal vein renin]
[Arterial hypertension caused by ingestion of licorice]
[Arterial hypertension caused by low renin: comparison of the calcium antagonist nifedipine and the ACE-inhibitor enalapril as to antihypertensive efficacy]
[Arterial hypertension due to abuse of sympathomimetic drugs. One case (author's transl)]
[Arterial hypertension due to compression of the renal artery, revealing ovarian cancer]
[Arterial hypertension in black patients]
[Arterial hypertension in patients on chronic hemodialysis]
[Arterial hypertension in periarteritis nodosa. 37 case reports]
[Arterial hypertension in renin-producing retroperitoneal leiomyosarcoma]
[Arterial hypertension in sub-Saharan Africa. Update and perspectives]
[Arterial hypertension of renal origin: abnormal secretion of renin]
[Arterial hypertension with low plasma renin activity]
[Arterial hypertension with renin hypersecretion secondary to pyelo-ureteral syndrome. Cure after corrective surgery]
[Arterial hypertension with undetectable or lowered plasma renin activity]
[Arterial hypertension with unilateral pressor kidney. Preliminary study, evaluation of the renin index in renal veins, and medical and surgical treatment and percutaneous transluminal angioplasty. Evaluation of the usefulness of captopril]
[Arterial hypertension, central and renal hemodynamics and plasma renin activity in patients with hemorrhagic fever and renal syndrome]
[ARTERIAL HYPERTENSION, RENIN, ANGIOTENSIN, AND ALDOSTERONE.]
[Arterial hypertension. A new classification and therapy based on renin plasma activity]
[Arterial hypertension: adenocarcinoma of the kidney or bilateral renal artery stenosis$]
[Arterial hypertension: how effective is the renin inhibitor aliskiren?].
[Atherosclerotic renovascular hypertension: clinical findings and results of treatment over 15 years]
[Basal and reactive renin and aldosterone secretion in arterial hypertension of insulin dependent diabetics]
[Behavior of aldosterone and plasma renin activity after ACTH administration and insulin-induced hypoglycemia in patients with essential arterial hypertension]
[Behavior of plasma renin concentration following acute natriuresis and orthostasis in healthy subjects and patients suffering from hypertension]
[Blood catecholamines, plasma renin activity and arterial blood pressure in patients with hypertension]
[Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)]
[Blood pressure observation during renal cyst decompression--case report on a benign solitary renal cyst as a cause of hypertension]
[Blood renin in patients with renovascular arterial hypertension]
[Blood renin level in various types of arterial hypertension]
[Bone metabolism and cardiovascular function update. Cross link of hypertension, bone loss and vascular calcification - common back grounds in renin angiotensin system with anti-aging aspect -].
[Carcinoma of the kidney with production of renin. A special form of hypertension]
[Cardiovascular complications in low renin hypertension]
[Catecholamines, prostaglandins and intracellular electrolyte levels in patients with hypertension and low plasma renin activity]
[Cause and therapeutic consequence of arterial hypertension and kidney tuberculosis]
[Central and renal hemodynamics in hypertension with high, normal and low renin activity in the blood plasma]
[Change in plasma renin activity in patients with hypertension and healthy persons after furosemide intake]
[Change in the cortical and medullary renal circulation in centrogenic forms of arterial hypertension]
[Changes in arterial pressure and concentration of several hormones in the blood effected by hemosorption in patients with arterial hypertension caused by parenchymatous diseases of the kidneys]
[Changes in plasmatic renin levels and sensitivity to the pressor action of angiotensin in dogs with hypertension induced by defrenation or by renal artery stenosis]
[Changes in the renin-angiotensin-aldosterone system in glomerulonephritis]
[Changes of components in the kinin system and plasma renin activity during different stages of hypertension in patients treated with captopril]
[Changes of renal vein renin activity in patients with unilateral artherosclerotic renal artery stenosis]
[Characteristics of the course of hypertension in relation to on plasma renin activity]
[Chronic kidney disease: classification, mechanisms of progression and strategies for renoprotection]
[Chronic sodium chloride load--a possibility for the increase of tolerance for ischemia in the kidney]
[Circadian rhythm of renin and aldosterone in essential arterial hypertension]
[Circadian rhythms of renin, aldosterone and cortisol in essential arterial hypertension with recent, confirmed and complicated appearance]
[Circulatory reflexes in primary aldosteronism (author's transl)]
[Clinical application of renin inhibitors in the treatment of hypertension]
[Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids]
[Clinical significance of anomalies of renin secretion in arterial hypertension]
[Clinical studies of hypertension in chronic glomerulonephritis. 2. Hypertension in the uremic phase: relationship between hemodynamic changes and plasma renin activity during hemodialysis]
[Clinical studies of hypertension in patients undergoing regular maintenance hemodialysis. 1) A comparison of hemodynamic data and plasma renin activity between responsive and resistant hypertension to regular dialysis alone. 2) Beta adrenergic blockade in resistant hypertension (author's transl)]
[Clinical studies of hypertension in the aged. Response of plasma renin activity to furosemide]
[Clinical, biochemical and hormonal characteristics of 84 patients with incidentally found adrenal tumor (incidentaloma)]
[Combined blockade of the renin-angiotensin system].
[Common salt and renin in nephrogenic hypertension]
[Comparative evaluation of the efficacy of methods of cryo- and trypsin activation of inactive renin in vitro]
[Comparative results of plasmatic renin determination and the angiotensin perfusion test in arterial hypertension]
[Comparative study of plasma levels of renin and aldosterone activity in essential arterial hypertension in relation to duration of the disease and the presence of complications]
[Comparison of captopril angioscintigraphy and the renin test in diagnosis of renovascular hypertension]
[Comparison of the effect of short-term treatment with nifedipine and verapamil on blood pressure, plasma atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in patients with primary arterial hypertension I degree according to WHO]
[Comparison of the effects of betablockers and captopril on the development of genetic hypertension in the rat]
[Complex clinical and morphofunctional study of vasorenal hypertension]
[Concentration of neuropeptide Y in serum of patients with primary hypertension]
[Concentrations of kininogen and prekallikrein in plasma and activity of plasma renin depending on the type of blood pressure response to captopril in patients with arterial hypertension]
[Conditions requiring determination of plasma renin activities in hypertension, and definition of low renin hypertension]
[Conn's adenoma. Diagnostic and prognostic value of the measurement of potassium, renin, aldosterone levels and the aldosterone/renin ratio]
[Conn's syndrome: surgical experience]
[Connexins, renin and hypertension]
[Contribution of CYP11B2, REN and AGT genes in genetic predisposition to arterial hypertension associated with hyperaldosteronism]
[Contribution to the prognostic value of plasma renin activity in systemic hypertension (author's transl)]
[Control of arterial hypertension in human chronic renal failure. Indirect evidence for a complex pathogenetic mechanism other than renin and sodium]
[Control of vascular tone by the endothelium: the coupling active vasodilation in the kidney to renin secretion]
[Conversion enzyme inhibitors against the progression of renal and vascular diseases: yes but again]
[Correction of aldosterone level as marker of RAAS dysfunction in patients with arterial hypertension degree II-III and chronic kidney diseases].
[Correlation between renal arteriography and renin levels in patients with hypertension]
[Correlation of the total activity of blood plasma renin with levels of active and inactive renin, angiotensinogen and angiotensin II under different functional loads in patients with hypertension]
[Correlations between heart rate variability, renin activity and plasma aldosteron concentration in chronic glomerulonephritis with intact function of the kidneys]
[Correlations between plasma levels of kininogen and prekallikrein, plasma renin and urinary excretion of adrenaline and noradrenaline in patients with arterial hypertension]
[Correlations between plasma renin activity and hemodynamic data in hypertension patients]
[Correlations between plasma renin activity and hemodynamic data in patients with hypertension]
[Correlations between plasmatic renin and aldosterone in essential arterial hypertension with sympathetic hyperactivity]
[Critical evaluation of the "wash-out" test in comparison with renin determination in revovascular hypertension]
[Definition and physiopathology of low renin hypertension]
[Density of alpha1-and alpha 2-adrenergic receptors in platelets, activity of plasma renin and level of noradrenaline, adrenaline and aldosterone in serum of women with uncomplicated pregnancy and women with hypertension during pregnancy]
[Detection of renin in chromophobe renal cell carcinomas]
[Determination of blood serum renin activity in nephrogenic hypertension]
[Determination of plasma renin activities in 47 cases of primary hypertension (author's transl)]
[Determination of plasma renin activity in the renal veins and inferior vena cava. Its value in the diagnosis and prognosis of hypertension of unilateral renal origin]
[Determination of plasma renin activity in the renal veins in essential arterial and nephrovascular hypertension: effect of trimethaphan infusion]
[Determination of renin activity in the blood in vasorenal hypertension]
[Determination of the renin content of the kidney in renal and adrenal diseases , with special reference to hypertension]
[Development of a model of human renin hypertension in rats]
[Development of hypertension and plasma renin activity in 7 anephric patients]
[Diabetes mellitus, arterial hypertension and serum levels of renin]
[Diagnosis of primary hyperaldosteronism]
[Diagnostic and prognostic significance of estimation of the activity of renin in the blood from peripheral and renal veins in vasorenal hypertension]
[Diagnostic and prognostic value of the determination of plasma renin activity in human arterial hypertension]
[Diagnostic and prognostic value of the separated renin in hypertension due to monolateral nephropathy]
[Diagnostic value of determining the renin activity and potassium content in the blood plasma in arterial hypertension patients with Conn's syndrome]
[Diazoxide test in the diagnosis of arterial hypertension: modifications in the levels of renin and aldosterone in blood of patients with various restrains of the renal function]
[Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
[Different reaction of plasma renin activity after propranolol in essential and renal hypertension]
[Differentiation of essential arterial hypertension by determination of plasma renin activity]
[Digoxin-like substance in blood and hypertension in dialysed patients with chronic renal failure]
[Discovery and study on potential effect of herbal pair of Uncariae Ramulus cum Uncis-Eucommiae Cortex on pregnancy hypertension based on network pharmacology and molecular docking].
[Disorders of renin secretion in arterial hypertension]
[Disorders of the kallikrein-kinin, renin-angiotensin and sympathetic-adrenal systems in chronic kidney failure patients during hemodialysis treatment]
[Dissecting arterial disease of the renal vessels as a cause of hypertension]
[Diurnal changes in serum noradrenaline levels and plasma renin activity in elderly persons with arterial hypertension]
[Diurnal fluctuations of plasma renin activity and aldosterone level in patients with arterial hypertension]
[Diurnal rhythm of renin activity in various forms of systemic arterial hypertension]
[Does spironolactone use at arterial hypertension therapy protect endothelium also in smoking patients?]
[Does the captopril test improve the diagnosis of primary hyperaldosteronism?]
[Dopamine and hypertension]
[Dopaminergic mechanisms in regulating the release of renin and aldosterone in arterial hypertension]
[Dynamic model of the circadian rhythm of renin activity and aldosterone concentration in the blood plasma of hypertension patients]
[Early and late results of percutaneous transluminal angioplasty of renal artery stenoses]
[Editorial: Renin, angiotensin and hypertension]
[Effect of alpha, beta blocker, labetol on the angiotensin renin system in arterial hypertension]
[Effect of captopril on arterial pressure, plasma renin activity and the autonomic nervous system in essential arterial hypertension with low-normal plasma renin activity]
[Effect of captopril on arterial pressure, systemic hemodynamics and renin activity in the blood plasma of rats with spontaneous hypertension]
[Effect of captopril on the renin activity in spontaneous hypertension in rats]
[Effect of captopril on various components of the kinin system and plasma renin activity in patients with idiopathic arterial hypertension]
[Effect of Cholecalciferol and Diuretics as Components of Combination Antihypertensive Therapy on Plasma Renin Activity and Endothelial Function in Patients With Arterial Hypertension].
[Effect of clonidine on three types of experimental hypertension and on plasma renin activity in dogs]
[EFFECT OF CORTEXONE AND NACL ON THE RENIN CONTENT OF THE KIDNEY, THE GRANULARITY OF THE JUXTAGLOMERULAR APPARATUS AND HYPERTENSION OBTAINED BY CONSTRICTION OF THE RENAL ARTERY IN THE RABBIT.]
[Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)]
[Effect of different amounts of dietary sodium on plasma atrial natriuretic peptide (ANP)in essential salt sensitive hypertension]
[Effect of enalapril maleate on arterial pressure and plasma renin activity in patients with primary arterial hypertension]
[Effect of hydrochlorothiazide on various components of the kinin system and plasma renin activity in patients with arterial hypertension treated with captopril]
[Effect of hypotensive drugs on plasma renin activity in primary hypertension]
[Effect of hypotensive preparations on humoral factors in blood circulation regulation]
[Effect of immersion (WI) in mineral water on plasma renin activity (PRA) and aldosterone (ALD) and vasopressin (VP) levels in the blood of patients with arterial hypertension]
[Effect of indomethacin on the plasma renin activity in patients with arterial hypertension]
[Effect of inhibition of angiotensin converting enzyme on hypertension following kidney transplantation]
[Effect of insulin in hypertension with high and low levels of renin]
[Effect of isosorbide mononitrate on hypotensive action of enalapril in patients with mild and moderate hypertension]
[Effect of long-term prazosin treatment on certain humoral and metabolic factors in patients with primary hypertension]
[Effect of nifedipine on effective renal plasma flow, plasma renin activity and serum aldosterone, noradrenaline and adrenaline levels in healthy persons and in patients with primary moderate arterial hypertension]
[Effect of nifedipine treatment on the renin-aldosterone system and secretion of cortisol and growth hormone in patients with essential hypertension]
[Effect of obzidan on hemodynamic indices and the renin and aldosterone levels of the blood plasma in patients with juvenile hypertension]
[Effect of oxprenolol on the plasma renin activity in essential arterial hypertension]
[Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension]
[Effect of salbutamol, indomethacin and atenolol on plasma renin activity in patients with essential arterial hypertension]
[Effect of saralasin on plasma renin activity and arginine-vasopressin in patients with angiotensin-dependent hypertension (author's transl)]
[Effect of sodium depletion on plasma renin activity in blood reflux from the renal veins in essential and nephrovascular hypertension]
[Effect of the angiotensin antagonist saralasin on blood pressure and hemodynamics in patients with terminal renal insufficiency]
[Effects of 4-hour erect posture and furosemide on the blood level of atrial natriuretic peptide in patients with primary arterial hypertension]
[Effects of a calcium antagonist, nifedipine, on arterial pressure and plasma renin activity in subjects with essential arterial hypertension]
[Effects of ACE2-Ang 1-7-Mas axis on blood vessel]
[Effects of an analogue of angiotensin II, [Sar1,Ile8] ATII, on blood pressure, plasma renin activity and plasma aldosterone in various forms of hypertension]
[Effects of changes in the sodium balance on plasma catecholamines and renin activity at rest and on their response to orthostatic stimulation in arterial hypertension]
[Effects of different patterns of hypoxia on renin angiotension system in serum and tissues of rats].
[Effects of diltiazem on hemodynamics, plasma catecholamine and renin activity during exercise in hypertension]
[Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency]
[Effects of propranolol on plasma lipids and renin activity in young men with labile borderline hypertension (author's transl)]
[Enalapril in the treatment of primary hypertension: its effect on blood pressure and plasma renin activity]
[Endocrine and neurogenic hypertension in childhood]
[Endocrine effects of nicardipine on intraoperative hypertension under droperidol-fentanyl-ketamine (DFK) anesthesia]
[Endogenic activation of prorenin in hypertension]
[Endothelins]
[Epidemiological characteristics of subclinical target organ damage in urban adult residents with hypertension in Tianjin and its relationships with renin-angiotensin-aldosterone system.]
[Essential arterial hypertension with low renin]
[Estimation of the renin-angiotensin-aldosterone system, water and electrolyte imbalance and endothelial function in newborns of women with chronic hypertension].
[Evaluation and significance of the plasma renin activity in hypertension]
[Evaluation of plasma renin activity as a cardiovascular risk factor in essential arterial hypertension]
[Evaluation of selected endocrine parameters in smoking patients with arterial hypertension]
[Evaluation of the hypotensive effect of unilateral adrenalectomy in patients with low-renin hyperaldosteronism]
[Extracellular metabolism of calcium in essential arterial hypertension. Relation to the functional status of the renin axis]
[For which hypertensive patient should angiotensin-converting enzyme inhibitor be prescribed or forbidden?]
[From gene to disease; 'apparent mineralocorticoid excess' syndrome, a syndrome with an apparent excess of mineral corticoids]
[Functional relationships between plasma renin activity and hemodynamic indices in essential arterial hypertension]
[Genetic polymorphism of the G-protein beta3 subunit, obesity and essential hypertension]
[Genetic polymorphisms of the renin-angiotensin system]
[Gordon syndrome: The importance of measuring blood pressure in children].
[Gordon's syndrome. Report of a case]
[Grawitz's tumor with arterial hypertension in children. Apropos of a case]
[Heart failure - are there gender aspects?]
[Hemodynamic effects and effects on plasma renin activity of injectable acebutolol in arterial hypertension]
[Hemodynamic effects of amrinone combined with dopamine in patients undergoing living renal transplantation]
[Hemodynamic indices and the renin and aldosterone levels of the blood plasma in patients with different forms of arterial hypertension undergoing combined kristepin and propranolol treatment]
[Hemolytic-uremic syndrome in the adult (author's transl)]
[Heredity in the prevalence of arterial hypertension. Its relation to plasma renin activity and noradrenaline excretion]
[High renin hypertension in the elderly]
[High renin hypertension]
[History of Instituto de Investigaciones Cardiológicas Alberto C. Taquini in its 60th anniversary]
[Hormonal aspects of the pathogenesis of arterial hypertension in young obese patients]
[Hormonal disorders in borderline arterial hypertension]
[Hormone levels of the blood of the adrenal veins and inferior vena cava in patients with adrenal and kidney diseases]
[Horseshoe kidney and hypertension (author's transl)]
[How to prove the role of renal artery stenosis as a cause of arterial hypertension]
[Humoral pressor substances in a constellation of rheumatic heart defects with systemic arterial hypertension]
[Hydronephrosis arterial hypertension. Report of 4 cases]
[Hypermineralcorticism syndrome secondary to topical application of 9-alpha-fluoroprednisolone (author's transl)]
[Hypertension and blood plasma renin activity in children with pyelonephritis of a single kidney]
[Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements]
[Hypertension and plasma renin activity in experimentally induced chronic pyelonephritis (author's transl)]
[Hypertension at pregnancy]
[Hypertension complicated with chronic kidney disease].
[Hypertension due to unilateral parenchymatous nephropathy (author's transl)]
[Hypertension in chronic kidney insufficiency in childhood. Significance of renin, aldosterone and blood volume]
[Hypertension in people of African descent].
[Hypertension in terminal chronic uremia: a new indication for determination of the renin activity in blood?]
[Hypertension in the Negro patient]
[Hypertension in unilateral (non-vascular) nephrosclerosis: renin activity in the venous kidney blood and effect of nephrectomy]
[Hypertension secondary to a "renin tumor". One case (author's transl)]
[Hypertension secondary to abdominal mass].
[Hypertension treatable with glucocorticoids: report of a case]
[Hypertension with low level of plasma renin. An epidemiologic study]
[Hypertension, atherosclerosis and kidney]
[Hypertension, hyperpotassemia and normal glomerular filtration (Gordon's syndrome): a case report]
[Hypertension-induced fibrosis: A balance story].
[Hyperuricemia and plasma renin activity in essential arterial hypertension]
[Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases]
[Hypotensive action of human renin inhibitor KRI-1314 in the common marmoset]
[Idiopathic primary hyperaldosteronism: significance of functional diagnosis]
[Immunologic approach of the blockage of the renin angiotensin system in vivo]
[Importance of determining the renin activity in the blood plasma of the renal veins in symptomatic hypertension]
[Importance of extrarenal renin systems in the pathogenesis of arterial hypertension]
[Importance of the longterm follow up of plasma renin activity in relation to arterial hypertension in chronic renal failure (author's transl)]
[Importance of the radioimmune method of determining renin activity in the blood plasma for the differential therapy of hypertension]
[Importance of the simultaneous estimation of aldosterone, 18-hydroxy-11-deoxycorticosterone and cortisol in the adrenal veins in arterial hypertension with suppressed renin (author's transl)]
[Improved interpretation of renal-vein-renin-ratio by simultaneous determination of renal 131I-hippuric-acid-clearance-ratio in patients with renovascular hypertension (author's transl)]
[Inadequate behavior of plasma renin and aldosterone in renoparenchymal hypertension]
[Incidence of primary hyperaldosteronism in hospitalized patients with hypertension]
[Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension]
[Intra-erythrocytic sodium and plasma renin activity in primary arterial hypertension before and after furosemide therapy]
[Is molecular biology useful to the practitioner?]
[Itraconazole: a new drug-related cause of hypertension].
[Juvenile essential hypertension. II. Plasma renin activity and levels of aldosterone at rest and after loading in children with juvenile essential hypertension]
[Juxtaglomerular cell tumor: a case report]
[Juxtaglomerular cells, renin and arterial hypertension.]
[Labile arterial hypertension. Hemodynamic study with measurement of renin activity]
[Letter: Effect of injectable clonidine on renin secretion in essential arterial hypertension]
[Letter: Renin and essential arterial hypertension]
[Levels of cholesterol, triglycerides, uric acid and glucose following prolonged treatment of hypertension with low and normal renin activity with hydrochlorothiazide]
[Liddle syndrome (or pseudo-hyperaldosteronism). Long-term development and erythrocyte potassium flow study in 4 cases]
[Long-term administration of trimepranol in young men with labile borderline hypertension and its influence on plasma renin activity (author's transl)]
[Long-term ambulatory follow-up of hypertension patients with low renin activity in blood]
[Long-term dispensary observation of patients with so-called low-renin forms of arterial hypertension]
[Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers]
[Low renin hypertension and aldosterone]
[Low renin hypertension: introduction]
[Low renin hypertension]
[Low renin variant of hypertension: functional relations of the renin-aldosterone pressor system]
[Low-renin hypertension and inherited mineralocorticoid diseases]
[Lowering of the blood pressure and renin suppression by beta receptor blockade with Visken in patients with borderline hypertension (author's transl)]
[Malignant arterial hypertension caused by segmentary aglomerular hypoplasia. Study of the activity of plasma renin]
[Management of renal atrophy in hypertensive patients: experience in Lille.]
[Markers of cardiovascular remodeling in hypertension]
[Measurement of plasma renin activity, blood volume and exchangeable sodium: an aid in the orientation of treatment of essential arterial hypertension]
[Mechanism of action of quinapril in the treatment of primary arterial hypertension]
[Mechanism of inclusion of the kidney in pathogenesis of experimental neurogenic hypertension. Formation of renin following denervation of the kidneys and in experimental neurogenic hypertension; preliminary communication.]
[Mechanism of kidney involvement in the pathogenesis of experimental neurogenic hypertension. II. Correlation between renal circulation and kidney renin content in experimental neurogenic hypertension and after denervation of kidneys.]
[Mechanisms of the development of arterial hypertension in hypertonic nephritis]
[Methodological features of renal vein catheterization during sample collection for the determination of renin activity and for directed phlebography in patients with arterial hypertension]
[Mineralocorticoid hypertension. A new form of secondary hypertension?]
[Mineralocorticoid-induced hypertension]
[Mineralocorticoid-like hypertension. "Apparent mineralocorticoid excess". A hereditary type of hypertension?]
[Monogenic hypertension]
[Morphological characteristic of renal injury in hypertensive rat strain transgenic for the mouse Ren-2 renin gene (TGR [mRen2] 27]
[Mutation T-->C of nucleotide 2238 in the gene of atrial natriuretic peptide (ANP) precursor and heterogeneity of sodium-sensitive hypertension. Preliminary report]
[Natural history of arterial hypertension due to primary hyperreninism]
[New data on mineralocorticoid hormones. Physiopathological implications]
[New strategy in the treatment of hypertension: inhibition of renin-angiotensin-aldosterone system with renin inhibitor]
[New treatments in hypertension: direct renin inhibitors]
[Normalization of renin secretion by neuropeptide Y in adrenalectomized rats with glucocorticoid-induced hypertension]
[ON CHANGES IN THE RENIN CONTENT OF THE KIDNEYS IN THE DYNAMICS OF DEVELOPMENT OF REFLEXOGENIC HYPERTENSION.]
[On the localization of renin granules in the juxtaglomerular apparatus of the kidney in normal conditions and in "Goldblatt's" experimental hypertension]
[Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension]
[Our experience in the determination of renin in patients with arterial hypertension]
[Paradoxical response of blood pressure to salt loading in renovascular hypertension]
[Particularities and management of arterial hypertension in sub-saharan Africa].
[Pathogenesis of arterial hypertension in diabetes mellitus]
[Pathogenesis of arterial hypertension with a low renin activity in the blood plasma]
[Pathogenesis of essential hypertension. Plasma noradrenaline, plasma renin and pressor effects of noradrenaline and angiotensin in normotensive patients and patients with essential hypertension]
[Pathogenetic participation of exchangeable sodium and plasma renin activity in the genesis and development of hypertension in patients with chronic renal insufficiency on maintenance dialysis]
[Pathogenic mechanism of primary hypertension].
[Pathophysiological features of arterial hypertension in chronic nephritis]
[Pathophysiology and laboratory examinations of essential hypertension--a review of recent topics]
[Percutaneous transluminal angioplasty]
[Peripheral blood plasma renin activity in children with chronic pyelonephritis and arterial hypertension]
[Peripheral blood renin-angiotensin system indices and the kallikrein-kinin system of the kidneys in hypertension]
[Pharmacological basis of antihypertensive drug therapy]
[Pharmacological study on blood pressure in rats with bone disorders]
[Physiologically active peptides and the regulation of arterial pressure in normal and pathological states]
[Physiopathogenesis of hypertension]
[Physiopathology of arterial hypertension in chronic hemodialysis patients]
[Plasma adrenaline and noradrenaline in essential and renal hypertension (author's transl)]
[Plasma aldosterone and plasma renin activity in patients with essential and renal hypertension under acute stimulation with saline depletion and acute suppression with saline infusion]
[Plasma aldosterone and renin activities in various types of hypertension]
[Plasma catecholamines, renin concentration, circulatory mechanics and kidney function as well as their changes through orthostasis in patients with reno-vascular hypertension]
[Plasma corticoids during renin-releasing test in normal renin hypertension]
[Plasma levels of adrenaline and noradrenaline, plasma renin activity and arterial blood pressure in patients after kidney transplantation]
[Plasma levels of catecholamine, renin activity and aldosterone during operations in patients with hypertension]
[Plasma noradrenaline and adrenaline, plasma renin activity and cyclic AMP during rest period and orthostatis in various types of hypertension]
[Plasma renin activity (PRA) in essential arterial hypertension (study of 79 cases)]
[Plasma renin activity (PRA), postural reflexes and sodium depletion in patients with primary and secondary hypertension]
[Plasma renin activity and aldosterone excretion in patients with essential hypertension, with hypertension in bilateral adrenal cortex hyperplasia and with aldosterone-producing adrenal cortex adenomas following various sodium tolerance tests]
[Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure]
[Plasma renin activity and urinary excretion of catecholamines and their metabolites in patients with primary arterial hypertension treated with metoprolol]
[Plasma renin activity determination in hypertension]
[Plasma renin activity in adolescents with primary arterial hypertension]
[Plasma renin activity in arterial hypertension of renal origin. Value of collecting by multiple selective catheterization]
[Plasma renin activity in arterial hypertension]
[Plasma renin activity in essential arterial hypertension. Critical review of its significance]
[Plasma renin activity in essential hypertension with respect to aging, hypertension severity and furosemide test (author's transl)]
[Plasma renin activity in human arterial hypertension. I. Results as a function of etiology in 261 hypertensive patients]
[Plasma renin activity in parenchymal nephropathies with arterial hypertension. Diagnostic and prognostic value]
[Plasma renin activity in patients with hypertension and unilateral parenchymal kidney disease]
[Plasma renin activity in renal veins in different types of arterial hypertension (author's transl)]
[Plasma renin activity of aortic and venous blood in arterial hypertension of different etiologies]
[Plasma renin activity, aldosterone and adrenergic activity in patients with hypertension and in normotensives with a family history of hypertension]
[Plasma renin activity, levels of catecholamines and aldosterone in essential arterial hypertension treated with ACE inhibitors. Base values and values after stress]
[Plasma renin activity, plasma aldosterone concentration in the differential diagnosis of curable forms of secondary hypertension]
[Plasma renin activity, plasma corticosterone levels, biosynthesis of adrenocorticoid, and participation of serum electrolytes in stress-induced hypertension]
[Plasma renin activity: urographic and angiographic study in nephrovascular hypertension]
[Plasma renin and angiotensinase activity in primary arterial hypertension in children and adolescents]
[Plasma renin and catecholamine activity in pheochromocytoma]
[Plasma renin and concentrations of sodium and potassium in plasma, erythrocytes and in the renal artery wall of patients with arterial hypertension]
[Plasma renin concentration in healthy persons, patients with hypertension and patients with nephrotic syndrome]
[Plasmatic concentration of renin in human arterial hypertension]
[Plasmatic renin activity and renal vasodepressive activity in human and experimental hypertension]
[Plasmatic renin activity in essential arterial hypertension. Hyporeninemic hypertension]
[Polypeptides and antagonists]
[Possibilities of predicting the hypotensive effect of surgical treatment of vasorenal hypertension]
[Postoperative hypertension in coarctation of the aorta associated with different plasma renin activities and catecholamine responses in two cases]
[Practical value of the determination of plasma renin activity in the study of arterial hypertension]
[Practical valve of determination of plasma renin activity in hypertension]
[Prazosin and peripheral renin activity in severe arterial hypertension]
[Preliminary clinical study of direct renin inhibitor aliskiren in the treatment of severe COVID-19 patients with hypertension].
[Preliminary experience in the determination of renin activity in the etiological study of arterial hypertension]
[Presence and regulation of plasma with natriuretic and Na-K ATPase inhibitory properties in normotensive subjects]
[Prevalence of true resistant hypertension among uncontrolled hypertensive patients referred to a tertiary health care center].
[Primary aldosteronism caused by aldosteronoma: problems in the etiologic diagnosis]
[Primary aldosteronism in gravidity]
[Primary aldosteronism: diagnosis, laterality and regulation of hormone secretion]
[Primary arterial hypertension. Treatment with captopril and function of the left heart ventricle, concentration of catecholamine in blood and activity of renin]
[Primary hyperaldosteronism by unilateral adrenal hyperplasia: a report of two cases].
[Primary hyperaldosteronism--4 clinical cases]
[Primary hyperaldosteronism: common cause of secondary hypertension with higher cardiovascular risk].
[Primary hyperaldosteronism: problems of diagnostic approaches].
[Primary hyperaldosteronism]
[Primary hypertension with low plasma renin level]
[Primary vesicoureteral reflux. II. Renal growth in kidneys with pyelonephritis]
[Proceedings: Changes in plasma renin activity in stress-induced hypertension and participation of the pituitary-adrenal system]
[Proceedings: Changes in the renin level and the structure of the juxtaglomerular apparatus during reduction of salt intake, administration of diuretics and at the onset of nephrovascular hypertension in rats]
[Proceedings: Correlations between blood pressure, body sodium/blood volume state and plasma renin in patients with terminal kidney insufficiency]
[Proceedings: Effect of propranolol on plasma renin activity in hypertension]
[Proceedings: Hypertension--correlation between chronological changes of plasma renin activity and aldosterone levels in spontaneous hypertension in rats]
[Proceedings: Renin activity in the renal veins in hypertension]
[Prognostic and therapeutic implications of plasma renin activity in essential arterial hypertension]
[Prognostic value of the activity of plasmatic renin in renal vascular hypertension]
[Progress in hypertension and diabetes mellitus]
[Progress in the study on roles of cathepsin in hypertension].
[Promoter variants of aldosterone synthase gene (CYP11B2) and salt-sensitivity of blood pressure]
[Propranolol and renin activity. New aspects on effects of beta blockaders in arterial hypertension]
[Prostaglandins and plasma renin activity during pregnancy and the puerperium in patients with hypertension]
[Prostaglandins in the renal vascular bed in arterial hypertension of different etiologies]
[Protracted high blood pressure following renin injections.]
[Putaminal hemorrhage in a case of Turner's syndrome with hyperaldosteronemia]
[Quadric analysis applied to preoperative assessment between patients with or without adrenocortical tumors in hypertension with hyperaldosteronism and low plasma renin]
[Radiographic appearances of a renin secreting renal tumor. A rare cause of hypertension (author's transl)]
[Radioimmunoassay in the diagnosis of arterial hypertension]
[Radioimmunologic determination of aldosterone and renin in the blood in the diagnosis of different forms of arterial hypertension]
[Radioimmunological evaluation of plasma renin activity (PRA) in patients with hypertension in orthostatism and after stimulation with natriuretic agents]
[Radiology of suprarenal glands (author's transl)]
[Raised renin stimulation following orthostasis in unstable or marginal hypertension]
[Rational criteria for the choice of ACE inhibitor adapted to the individual hypertensive patient]
[Reactivation of renin secretion by a contralateral kidney in the chronic phase of experimental renovascular hypertension]
[Reactivity of the adrenal cortex and the renin-angiotensin system in young rats with spontaneous hypertension]
[Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension]
[Reduction of the vasopressor effect of tyramine in patients with hypertension, aldosteronism and low plasma renin]
[Relation between erythropoietin production and plasma renin activity in patients with essential hypertension]
[Relation between plasma renin activity and cardiovascular complications in essential arterial hypertension]
[Relation between plasma renin activity and urinary catecholamines in individual types of hypertension (author's transl)]
[Relation of atrial natriuretic peptide, the renin-angiotensin-aldosterone system and kinin system in hypertensive and normotensive youngsters with or without a family history of essential arterial hypertension]
[Relation of plasma renin activity and aldosterone excretion rate in angiotensin II-test and its diagnostic value in arterial hypertension patients]
[Relations between renin activity and vascular complications of arterial hypertension]
[Relationship between blood pressure variations, severity of hypertension and plasma renin activity]
[Relationship between plasma noradrenaline (PNA), plasma renin activity (PRA), plasma aldosterone (PAC) and sodium excretion (U-Na+) in primary hypertension]
[Relationship of plasma renin activity and exchangeable sodium in various types of hypertension]
[Relationships between separated renin and renal and intrarenal flow (washout of Xe 133) in essential and secondary hypertension]
[Renal arterial aneurysms--diffuse renal arterial ectasia. (Review and case histories) (author's transl)]
[Renal arteriographic assessment and renal venous plasma renin activity in hypertension (author's transl)]
[Renal artery obstruction: from experimental models to logical approach to diagnosis and treatment]
[Renal hypertension]
[Renal Involvement in Connective Tissue Diseases].
[Renal thrombotic microangiopathy with benign hypertension and uremia secondary to oral contraceptives (author's transl)]
[Renal transplantation, arterial hypertension and plasma renin levels in dogs]
[Renin activity and electrolyte content of plasma and erythrocytes in different forms of arterial hypertension]
[Renin activity and functional status of the adrenal cortex in surgical intervention during ketamine anesthesia]
[Renin activity and plasma aldosterone content in hypertension]
[Renin activity and the aldosterone and cortisol content in the blood depending on the course of hypertension]
[Renin activity and the angiotensin content in the blood from the renal veins in arterial hypertension]
[Renin activity in arterial hypertension]
[Renin activity in plasma and kidneys upon sudden death of hypertension patients]
[Renin activity in the blood plasma in healthy persons and in hypertension patients of different ages and sexes]
[Renin activity in the blood plasma of healthy persons and in hypertension patients depending on age]
[Renin activity of blood plasma in a patient with arterial hypertension and stenosis of the renal artery]
[Renin activity of renal venous blood and separate kidney function in reno-vascular hypertension. Diagnostic and prognostic value]
[Renin and aldosterone in human arterial hypertension (excluding Conn's syndrome)]
[Renin and arterial hypertension]
[Renin and hypertension, physiological or pathological agents?]
[Renin and hypertension]
[Renin and sodium and the formation of vascular lesions in hypertension]
[Renin as a target of direct pharmacological block in arterial hypertension]
[Renin content in kidneys of men after death caused by hypertensive disease and in rabbits with experimental hypertension induced by coarctation and with cholesterin-induced atherosclerosis.]
[Renin dependent arterial hypertension in an infant with renal hypoplasia]
[Renin determination for the diagnosis, differential therapy and prognosis of hypertension]
[Renin gene and hypertension]
[Renin inhibition in hypertension]
[Renin inhibitors. Aliskiren for the treatment of high blood pressure]
[Renin levels in renal veins in patients with essential arterial hypertension]
[Renin plasma profile and sodium sensitivity of blood pressure in hypertensive patients with or without a family history of hypertension]
[Renin secreting tumor and severe hypertension. Apropos of a new case]
[Renin subgroups in borderline hypertension]
[Renin, angiotensin and aldosterone in the diagnosis of hypertension]
[Renin, angiotensin, aldosterone and arterial hypertension. II]
[Renin, angiotensin, aldosterone and arterial hypertension. I]
[Renin-aldosterone system in secretion of cortisol in patients with arterial hypertension in European North]
[Renin-angiotensin-aldosterone system and pulmonary hemodynamics in patients with pulmonary artery hypertension]
[Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives]
[Renin-dependent arterial hypertension in polycystic kidney operated on at a late period]
[Renin-producing pseudotumor: arterial hypertension caused by hypersecretion of renin from a zone of renal ischemia]
[Renin-secreting renal tumor. A case report]
[Renin: structure and expression regulation of the gene, biosynthesis, and cellular pathways of secretion]
[Reninoma: a rare but curable cause of high blood pressure, a case report]
[Reno-vascular hypertension surgery and renal: systemic renin index (author's transl)]
[Reno-vascular hypertension: prognosis variations according to the method; surgery, or medical treatment. Retrospective study of 114 cases (author's transl)]
[Renovascular arterial hypertension complicated by diabetes insipidus: report of a case and review of the literature].
[Renovascular hypertension - indications and type of operative method employed]
[Renovascular hypertension in childhood]
[Renovascular hypertension--a persistently difficult diagnostic problem]
[Renovascular hypertension. Studies of 16 cases with long-term follow-up]
[Restriction fragment length polymorphism of human renin gene in essential hypertension]
[Reversible "experimental" human arterial hypertension after fortuitous ligation of an isolated polar renal artery of aortic origin]
[Role of aldosterone in essential arterial hypertension complicated by chronic renal insufficiency]
[Role of renin angiotensin system in the vasopressor mechanisms of hypertension--gene analyses and tissue renin angiotensin system]
[Role of renin in experimental hypertension.]
[Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)]
[Role of renin-angiotensin system and vasopressin in the control of blood pressure in genetically hypertensive rats after sympathectomy]
[Roles of the kidney in activation and release of plasma inactive renin in the rat]
[Saralasin in subjects with low renin arterial hypertension]
[Saralasin test in the differential diagnosis of essential and renal hypertension]
[Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)]
[Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension]
[Senile pyelonephritis with the arterial hypertension syndrome: the use of trental]
[Separate and summary renal hemodynamics in renovascular hypertension (before and after surgery)]
[Serum ionized calcium, parathormone and plasma renin activity in essential arterial hypertension]
[Significance of brain renin for pathogenesis of hypertension: effect of antihypertensive drugs on active and inactive renins in the brain of spontaneously hypertensive rat]
[Significance of brain renin in pathogenesis of hypertension: effect of diltiazem on active and inactive renins in the brain of spontaneously hypertensive rat]
[Significance of brain renin in the pathogenesis of hypertension. Distribution of active and inactive renins in the brain of postmortem patients]
[Significance of determination of renin activity in patients with nephrogenic hypertension]
[Significance of family assessment and biological markers in the prevention of arterial hypertension]
[Significance of some changes induced in the vasoactive systems of renin and kallikrein during diuretic treatment of arterial hypertension]
[So-called juxtaglomerular benign tumor of the kidney with renin secretion. Optical and ultrastructural study]
[Sodium outflow rate through lymphocyte cell membranes, serum levels of sodium, potassium, aldosterone, total catecholamines, 6-keto- PGF2alpha and plasma renin activity in patients with primary arterial hypertension treated with captopril]
[Sodium restriction in hypertension. Sympathetic tonus, renin and vasopressin]
[SP 54 therapy in hypertension. The effect of SP 54 on blood pressure, renin and aldosterone as well as electrolyte balance in patients with hypertension]
[spACE, the last frontier? Renin inhibition in hypertension]
[Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)]
[State of the sympathetic-adrenal system and renin activity in the blood in children with primary arterial hypertension in the process of beta-blockader treatment]
[Status of the captopril test in the diagnosis of hypertension]
[Strategy for studying mineralocorticoids other than aldosterone in arterial hypertension of hormonal origin]
[Structure and function of angiotensin converting enzyme and its inhibitors]
[Studies on hypertension accompanying renal failure: plasma renin activity and plasma angiotensinase activity in renal failure]
[Studies on hypertension: I) The effects of angiotensin II and norepinephrine infusion on renal hemodynamics and renin angiotensin system in anesthetized dogs. II) The metabolism of 3H-DOPA in two kidney Goldblatt dogs (author's transl)]
[Studies on plasma renin activity in patients with hypertension]
[Studies on te effects of renin on the development of hypertension]
[Studies on the pathophysiology of pregnancy induced hypertension--endocrinological analysis by the method of angiotensin II and NaCl loading]
[Studies on the renin-angiotensin system in adrenal regeneration hypertension (author's transl)]
[Studies on the role of the central and peripheral sympathetic nervous system and the renin-aldosterone system on the onset and maintenance of high blood pressure in essential hypertension]
[Study of renin activity in the peripheral blood of patients with vasorenal hypertension and solitary kidney]
[Study of the renin-angiotensin system in 2 cases of Wilm's tumor with severe arterial hypertension]
[Study on the relation between hypertensive left ventricular hypertrophy in very old people with neurohormonal factors and ventricular arrhythmias]
[Surgical treatment of different forms of hyperaldosteronism with low renin activity in the blood plasma]
[Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years]
[Synthesis of renin and angiotensin-converting enzyme in human heart]
[Systemic arterial hypertension: pathogentic role of the sympathetic nervous system]
[The accuracy of combining aldosterone to renin ratio and low renin level in diagnosing primary aldosteronism]
[The activities of the renin-angiotensin-aldosterone and sympathetic-adrenal systems during hemodialysis]
[The activity of the components of the kinin system in renal vein blood in vasorenal arterial hypertension]
[The adrenergic system and the control of the renin and aldosterone circadian rhythm in essential arterial hypertension]
[The aldosterone to Renin ratio in secondary hypertension]
[The antagonistic effect of aspirin on the expression of prostaglandin participation in the antihypertensive activity of ACE inhibitors]
[The antihypertensive effect of saralasin in rabbits with neurogenic interoreceptive hypertension]
[The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children]
[The contribution of radio-isotopes to urological investigation (author's transl)]
[The correlation of atrial natriuretic peptide values with those of renin, angiotensin and aldosterone in hypertension patients below and above 50]
[The cortical collecting duct plays a pivotal role in the kidney's local renin-angiotensin system].
[The diagnosis of vasorenal arterial hypertension]
[The diagnostic importance of determining prostaglandins in patients with nephrogenic arterial hypertension]
[The Diagnostic Value of Captopril Challenge Test for Primary Aldosteronism].
[The diagnostic value of determining renin activity and the plasma concentration of potassium in patients with Conn's syndrome and arterial hypertension]
[The diagnostic value of renin activity after stimulation in the diagnosis of hypertension]
[The dopaminergic system and aldosterone secretion. I. Suppressive effects of L-dopa on secondary hyperaldosteronism]
[The dopaminergic system and aldosterone secretion. II. Effect of L-dopa and dexamethasone on aldosterone biosynthesis]
[The effect of clonidine on renin-release (author's transl)]
[The effect of fenigidin (nifedipine) and verapamil on renin activity, the levels of ionized calcium and aldosterone in the blood plasma and on the hemodynamic indices of rats with spontaneous hypertension]
[The effect of renal arterio- and phlebography on the function of the renin-angiotensin and hypophyseal-adrenal systems]
[The effect of some beta-blocking drugs on plasma renin activity, platelet adhesiveness and dilute blood clot lysis time in patients with essential arterial hypertension.]
[The future of renin inhibition]
[The heart in systolic hypertension]
[The hypotensive effect of propranolol: pathophysiological and clinical approach (author's transl)]
[The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers]
[The influence of nasal continual positive airway pressure on some vasoactive substances in patients with obstructive sleep apnea syndrome]
[The influence of the beta-blocking agent pindolol on blood pressure and heart weight of rats with Goldblatt-type hypertension (author's transl)]
[The juxtaglomerular apparatus and renin secretion in experimental arterial hypertension]
[The level of plasma renin and plasma aldosterone activity in normotensive women and in pregnancy-induced arterial hypertension in a group of women from Cameroon]
[The plasma renin activity in arterial hypertension with adrenocortical adenoma (Conn's syndrome)]
[The plasma renin concentration. Relation to Age and Duration of hypertension and its significance for the classification of patients with arterial hypertension]
[The prorenin receptor]
[The renin activity in the kidneys in hypertension and symptomatic renal hypertension.]
[The renin angiotensin system in the pathology of arterial hypertension of aortic coarctation]
[The renin saga]
[The renin, angiotensin and aldosterone system in secondary hypertension]
[The renin-aldosterone system in essential hypertension--aging, low renin hypertension and the relation between renin secretion and aldosterone secretion--]
[The renin-angiotensin system. Physiopathological aspects and clinical implications of hypertensive syndromes. A survey]
[The renin-angiotensin-aldosterone system and the adrenergic system in normal pregnancy and hypertension induced by pregnancy]
[The role of aldosterone in hypertension]
[The role of direct inhibitors of renin].
[The role of DNA polymorphism in the renin-angiotensin system and the pathogenesis of cardiovascular diseases]
[The role of renin and electrolyte disorders in the pathogenesis of hypertension in chronic renal insufficiency]
[The significance of renin in human hypertension. III.]
[The value of renin determination in the diagnosis of hypertension]
[The value of studying essential arterial hypertension with isotopic methods. Their application in arterial hypertension with low renin level]
[The variable number of tandem repeats in the renin gene of rats and possible significance in hypertension]
[The x-ray endovascular treatment of renin-dependent arterial hypertension with secondary aldosteronism in patients without vasorenal involvement]
[Therapeutic novelties in the management of arterial hypertension].
[Three cases of primary aldosteronism including one case with postoperative ventricular tachycardia]
[Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril]
[Total blood volume in essential and secondary hypertension]
[Transluminal angioplasty of the renal artery for renovascular hypertension (author's transl)]
[Treatment of arterial hypertension by plasmapheresis]
[Treatment of arterial hypertension patients depending on renin activity]
[Treatment of essential arterial hypertension with nifedipine: relation between changes of arterial pressure and plasma renin activity]
[Treatment of post-reno-contusive arterial hypertension by upper polar nephrectomy. Results after 10 years]
[Two cases of systemic lupus erythematosus accompanied by antiphospholipid syndrome nephropathy without immune complex nephritis]
[Type II pseudohypoaldosteronism: proximal tubular acidosis and distal tubular hyperkalemia corrected by DDAVP]
[Unmet needs in hypertension]
[Update in the clinical management of low renin hypertension].
[Urinary electrolyte excretion and plasma corticoid level at the furosemide administration test in low renin hypertension]
[Urinary kallikrein and plasma renin levels in patients with secondary hypertension]
[Urine catecholamine excretion and plasma renin activity in primary hypertension and renovascular hypertension due to renal artery stenosis]
[Use of crystepin in combination with obsidan in patients with diabetes mellitus with arterial hypertension]
[Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension]
[Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension]
[Value of determination of renin activity in the renal vein blood of patients with vasorenal hypertension]
[Value of determining plasma renin activity in patients with essential arterial hypertension and coronary disease]
[Value of measuring central renin for the etiologic study of hypertension with unilateral nephro-uropathy]
[Value of stimulation of plasmatic renin activity by physical exercise in the etiological diagnosis of arterial hypertension]
[Value of the determination of plasma renin activity in human arterial hypertension]
[Vascular risk and renin activity in essential arterial hypertension]
[Vasopressin and renin-aldosterone system in patients with arterial hypertension]
[Water-electrolyte and hemodynamic aspects of the lasix test in patients with various courses of hypertension]
[Ways of improving the diagnosis and prognosis in vasorenal hypertension]
[What is resistant hypertension and how to diagnose it?]
[What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?]
[Why screening for a renal artery stenosis?]
Hypertension, Malignant
20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.
A 3-year old girl with seizures, hypokalemia and metabolic alkalosis.
A case report of reninoma: radiological and pathological features of the tumour and characterization of tumour-derived juxtaglomerular cells in culture.
Abnormalities of vascular wall sodium content in dogs with benign and malignant renal hypertension.
Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats.
ANCA-related crescentic glomerulonephritis in a patient with scleroderma without marked dermatological change and malignant hypertension.
Angiotensin converting enzyme (ACE) is a modifier of hypertensive end-organ damage.
Angiotensin-converting enzyme gene I/D polymorphism in malignant hypertension.
Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.
AT1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet.
Avosentan is protective in hypertensive nephropathy at doses not causing fluid retention.
Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays.
Changes of plasma renin, angiotensin II and renin substrate during reversal of malignant renovascular hypertension.
Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
Despite low plasma renin ACE inhibitor treatment causes recovery from acute renal failure in a patient with malignant hypertension.
Development of malignant hypertension in patients with uremia under hemodialysis: a case report and discussions on its etiology.
Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.
Direct Renin Inhibition With Aliskiren Normalizes Blood Pressure in Cyp1a1-Ren2 Transgenic Rats With Inducible Angiotensin II-Dependent Malignant Hypertension.
Effects of 1-sarcosine-8-isoleucine-angiotensin II on blood pressure and plasma renin activity in various types of hypertension.
Effects of indomethacin in rabbit renovascular hypertension.
Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension.
Enzyme immunoassay for plasma renin activity: II. Clinical application.
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Fenofibrate Attenuates Malignant Hypertension by Suppression of the Renin-angiotensin System: A Study in Cyp1a1-Ren-2 Transgenic Rats.
Half-life of plasma renin activity in normal subjects and in malignant hypertension.
Hemodynamic and metabolic profile in offspring of malignant hypertensive parents.
High plasma renin activities in primary aldosteronism with malignant hypertension. A case report.
High-renin malignant hypertension secondary to an aldosterone-producing adenoma.
Histological and ultrastructural studies of the human juxtaglomerular apparatus in benign and malignant hypertension.
Historical perspectives on the renin-angiotensin-aldosterone system and angiotensin blockade.
Hyperrenin-hyperaldosterone-dependent malignant hypertension in polyarteritis nodosa.
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril.
Impaired Neovascularization and Reduced Capillary Supply in the Malignant vs. Non-malignant Course of Experimental Renovascular Hypertension.
Increased plasma renin substrate concentration in human malignant hypertension.
Increased plasma renin substrate concentrations in human malignant hypertension.
Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Malignant hypertension and uremia in scleroderma: efficacy of nephrectomy and hemodialysis.
Malignant hypertension due to renal artery stenosis. Greater renin release from the nonstenotic kidney.
Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration.
Malignant hypertension in Brattleboro (vasopressin-deficient) rats.
Malignant hypertension in pheochromocytoma: correlation with plasma renin activity.
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes.
Malignant hypertension: effect of therapy on renin and aldosterone.
Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes.
Neonatal renal arterial embolism syndrome.
Plasma antidiuretic hormone levels in patients with normal and low renin essential hypertension, and secondary hypertension.
Plasma prolactin levels in patients with essential hypertension, malignant hypertension and secondary hypertension.
Plasma renin activity and hypertension in diabetes mellitus.
Renal artery occlusion and malignant hypertension in polycystic kidney disease.
Renal functional responses to selective intrarenal renin inhibition in Cyp1a1-Ren2 transgenic rats with ANG II-dependent malignant hypertension.
Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Renin and angiotensin II studies in malignant hypertension after x-irradiation for seminoma.
Response of arterial blood pressure, plasma renin activity and plasma aldosterone concentration to long-term administration of captopril in patients with severe, treatment-resistant malignant hypertension.
Sodium and potassium status, plasma renin and aldosterone profiles in normotensive and hypertensive Johannesburg blacks.
Spontaneous remission of accelerated (malignant) hypertension in renal infarction.
Suppression of plasma renin activity by indomethacin in man.
The importance of the renin-angiotensin system in cardiovascular disease.
The renin gene in patients with malignant hypertension and raised plasma renin activity.
The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
The role of the renin-angiotensin system in malignant vascular injury affecting the systemic and cerebral circulations.
The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis.
Traumatic renal artery thrombosis with acute malignant hypertension and hyperreninemia.
[Aspects of hypertension of endocrine and adrenal origin]
[Endocrine structures of the kidney in hypertension]
[Pathophysiology and prognosis in malignant hypertension: comparison by underlying diseases]
[Peripheral plasma renin level in patients with essential, renal, renovascular and malignant hypertension]
Hypertension, Portal
Cardiovascular effects of canrenone in patients with preascitic cirrhosis.
Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and "low-renin" cirrhosis.
Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.
Diminished angiotensin-II and intact vasopressin response to hemorrhage in portal hypertension.
Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
Haemodynamic and renal evolution of the bile duct-ligated rat.
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
Renin inhibition in portal hypertension: novel indication beyond cardiovascular diseases?
Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats.
Spironolactone lowers portal hypertension by inhibiting liver fibrosis, ROCK-2 activity and activating NO/PKG pathway in the bile-duct-ligated rat.
Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome.
TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor.
Therapeutic potential of targeting the renin angiotensin system in portal hypertension.
Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.
[Behavior of blood ammonia, insulin, glucagon, renin and prolactin during propranolol therapy in cirrhosis patients with portal hypertension]
[Systemic hyperdynamic circulation and serum hormone concentrations in portal hypertension]
[The renin-angiotensin-aldosterone system in liver cirrhosis]
Hypertension, Pregnancy-Induced
Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism.
Atrial natriuretic peptide and plasma volume in pregnancy-induced hypertension.
Calcium and conjugated linoleic Acid reduces pregnancy-induced hypertension and decreases intracellular calcium in lymphocytes.
Changes in renin activity, aldosterone level and electrolytes in pregnancy-induced hypertension.
Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension.
Failure of angiotensin II to reduce plasma renin activity in hypertensive pregnant women.
Fetal sex and the circulating renin-angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension.
Increased fetoplacental active renin production in pregnancy-induced hypertension.
Plasma renin activity, blood uric acid and plasma volume in pregnancy-induced hypertension.
Pregnancy-induced hypertension: development of a model in the pregnant primate (Papio anubis).
Prorenin concentration in the hypertensive disorders in pregnancy.
Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension.
Renin angiotensin aldosterone system, urinary prostaglandins and kallikrein in pregnancy induced hypertension. Evidence for a disregulation of the renin-angiotensin-prostacyclin loop.
Renin-aldosterone relationships in pregnancy-induced hypertension.
Renin-angiotension-aldosterone system, urinary prostaglandins and kallikrein in pregnancy-induced hypertension: evidence for a dysregulation of the renin-angiotensin-prostacyclin loop.
Serum and urinary divalent cations and plasma renin activity in women with mild pregnancy-induced hypertension.
Sodium chloride, extracellular fluid volume, and blood pressure regulation.
Sodium excretion in normal and hypertensive pregnancy: a prospective study.
Stimulation of active renin release in normal and hypertensive pregnancy.
Studies of the effect of mode of delivery: obstetric analgesia and anaesthesia on maternal Plasma Renin Concentration (PRC) and Plasma Renin Activity (PRA) in the normotensive and hypertensive primigravidae.
Sympathetic activation during early pregnancy in humans.
The importance of angiotensin II subtype receptors for blood pressure control during mouse pregnancy.
The renin-aldosterone system during normal and hypertensive pregnancy.
[Clinical significance of endogenous digitalis-like substances in patients with pregnancy-induced hypertension]
[Renin-angiotensin-aldosterone system, blood volume, serum uric acid and urinary excretion of prostaglandins and kallikrein in the arterial hypertension induced by pregnancy]
[Studies on the pathophysiology of pregnancy induced hypertension--endocrinological analysis by the method of angiotensin II and NaCl loading]
Hypertension, Pulmonary
Atrial natriuretic factor in high-altitude pulmonary hypertension: the influence of acute hypoxia on plasma atrial natriuretic factor, renin, and aldosterone concentrations in highlanders with initially normal or elevated pulmonary artery pressure and without evidence of right ventricular hypertrophy.
Brain renin-angiotensin system in broiler chickens with cold-induced pulmonary hypertension.
Cardiac renin-angiotensin system (gene expression) and plasma angiotensin II in chickens with T3-induced pulmonary hypertension.
Evidence for Angiotensin Converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension.
Genetic polymorphisms of angiotensin system genes in congenital diaphragmatic hernia associated with persistent pulmonary hypertension.
Increased plasma levels of atrial natriuretic factor, renin activity, and leukotriene C4 in chronic obstructive pulmonary disease.
Pulmonary hypertension. Response of vasoactive peptides to a nonionic contrast medium in patients undergoing pulmonary angiography.
Reciprocal regulation of pulmonary and cardiac angiotensin-converting enzyme in rats with severe left ventricular hypertrophy.
The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.
The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease.
Volume homeostasis in calves with artificial atria and ventricles.
[Atrio-ventricular canal: possibilities of recovery]
[Effects of different patterns of hypoxia on renin angiotension system in serum and tissues of rats].
[Hemodynamic changes and their relationship with the renin-angiotensin-aldosterone system in chronic obstructive pulmonary disease]
[New animal models for drug discovery research: focus on cardiovascular diseases]
[Plasma renin activity, angiotensin II, angiotensin converting enzyme, thromboxane A2 and prostacyclin I2 levels in pigs with severe hypoxia and hypercapnea and acidosis shock]
[The changes in plasma renin angiotensin and arginine vasopressin in pulmonary hypertension rats]
[Value of captopril in the treatment of systemic arterial and pulmonary hypertension with increased plasma renin in scleroderma]
Hypertension, Renal
A comparison of the development of renal hypertension in male and female rats.
Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients.
Adrenal and vascular renin-like activity in chronic 'two-kidney, one-clip' hypertensive rats.
An inactive renin in human plasma.
Angiotensin antogonists as pharmacological tools.
Angiotensin II: evidence for its role as an intrarenal hormone.
Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension.
Antibodies to renin as proof of the pathogenesis of sustained renal hypertension.
Arterial wall renin and renal venous renin in the hypertensive rat.
Catecholamines, sodium and renin in unilateral renal hypertension in man.
Cellular localization, expression and regulation of neuropeptide Y in kidneys of hypertensive rats.
Curable renal hypertension: renin, marker or cause? Question answered.
Dependability of Renin in the Diagnosis of Renal Hypertension.
Development of ideas on renovascular hypertension.
Diazoxide-induced renin release in diagnosis of remediable renovascular hypertension.
Diazoxide-induced stimulation of renin release in renal vein renin sampling.
Dissociation of renin and noradrenaline release in the renal circulation. Studies on patients with renal hypertension.
Divided renal and peripheral venous renin as a means of predicting operative curability of renal hypertension.
Does renin determine the blood pressure response to calcium entry blockers?
Dynamic responses of active and inactive renin in patients with essential and renovascular hypertension.
Effect of propranolol on blood pressure and renin in renal hypertension in the rat.
Effect of sodium restriction on renal hypertension and on renin activity in the rat.
EFFECTS OF CORTEXONE AND SALT ON RENIN CONTENT, JUXTAGLOMERULAR INDEX AND RENAL HYPERTENSION IN RABBITS.
Experimental renal hypertension: renin content of kidneys in intact and adrenalectomized rats given cortexone.
Factors influencing acute ischaemia-induced renal hypertension in rats.
Immediate plasma renin response to propranolol: differentiation between essential and renal hypertension.
Introduction to part II of the hypertension symposium. Prorenin, renal hypertension; diuretics and hyperlipidemia; angiotensin receptors and blocking drugs; a new treatment system.
Is the peripheral sympatho-adrenal nervous system necessary for renal hypertension?
Mechanisms behind myocardial depression in rat renal hypertension.
New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions.
Plasma kininogen, plasma renin activity and blood pressure responses in sodium-induced renal hypertension in rats.
Plasma prolactin levels in patients with essential hypertension, malignant hypertension and secondary hypertension.
Plasma renin activity and in vitro synthesis of aldosterone by the adrenal glands of rats with spontaneous, renal, or pinealectomy-induced hypertension.
Plasma renin activity during development of experimental renal hypertension in dogs.
Plasma renin activity in the rabbit with renal hypertension.
Plasma renin and sodium balance during development of moderate and severe renal hypertension in rats.
Predictive value of renal-vein renin measurements in children with various forms of renal hypertension. An international study.
Preventive effect of captopril on the development of experimental hypertension in rats.
PRODUCTION OF ANTIRENIN TO HOMOLOGOUS RENIN AND ITS EFFECT OF EXPERIMENTAL RENAL HYPERTENSION.
Prognostic value of simultaneous renal venous renin and split function studies in unilateral renal hypertension.
Prostaglandin levels and renin activity in renal venous blood of patients with renal hypertension.
Reciprocation of renin dependency with sodium volume dependency in renal hypertension.
Reconsideration of split kidney function tests in hypertension: a new technique.
Relation between renin and prorenin in plasma from hypertensive patients and normal people: evidence for different renin:prorenin ratios.
Relation of plasma renin to sodium balance and arterial pressure in experimental renal hypertension.
Relation of renin, angiotensin II, and experimental renal hypertension to aldosterone secretion.
Relationship between plasma renin activity and blood pressure response to antihypertensive agents. A proposal for management of essential and renal hypertension.
Relationship of renin to acute phase of renal hypertension in the rabbit: tachyphylaxis.
Relationship of renin to early renal hypertension in the rabbit.
Release of renin by rat kidney slices; relationship to plasma renin after desoxycorticosterone and renal hypertension.
Renal hypertension and renin hypertension in intact and in adrenalectomized rats.
Renal hypertension due to hydronephrosis with normal plasma renin activity.
Renal hypertension in renin depleted rats (relation between renal renin content and hypertension II).
Renal hypertension. The renin system in hypertension with unilateral renal artery stenosis.
Renal hypertension: role for renin.
Renal tissue kallikrein, plasma renin and plasma aldosterone in renal hypertension.
Renal vein renin analysis: limitations of its use in predicting benefit from percutaneous angioplasty.
Renal vein renin on acute stimulation in diagnosis of renal hypertension.
Renal vein renin: value and limitations in the prediction of operative results.
Renal venous and peripheral plasma renin activity in renal hypertension in the rat.
Renal venous renin activity in various forms of curable renal hypertension.
Renal weight and content of lipids and phospholipid renin "preinhibitor" in rats with renal hypertension.
Renal-vein renin and renal hypertension.
Renal-vein renin in various forms of renal hypertension.
Renin activation in the venous plasma from the involved kidney in the patient with renal hypertension.
RENIN ACTIVITY IN THE KIDNEYS IN VASCULAR HYPERTENSION AND IN SYMPTOMATIC RENAL HYPERTENSION.
Renin and antirenin in treatment of long term experimental renal hypertension in the dog.
Renin and renal hypertension.
Renin in experimental renal hypertension in monkeys.
Renin in the control of drinking behaviour in the earliest stages of renal hypertension in the rat.
Renin kinetics in experimental renal hypertension.
Renin measurement in detecting surgically correctable renal hypertension.
Renin release in renal hypertension.
Renin secretion in renal hypertension.
Renin substrate and renal hypertension, including a one stage method for evisceration in the rabbit.
Renin, electrolytes, and water intake in two types of experimental renal hypertension.
Renin, sodium-retaining and sodium-excreting hormones and experimental renal hypertension.
Renin-angiotensin-aldosterone system.
Responses of plasma renin to sodium load in two types of experimental renal hypertension.
Reversal of renal hypertension: effects on renin, salt and water balance.
Role of renin in the pathogenesis of renal hypertension.
Salt and water balance and renin activity in renal hypertension of rats.
Salt, frusemide and renin in severe experimental renal hypertension.
Segmental renal vein renin assay and segmental nephrectomy for correction of renal hypertension.
Segmental renin sampling and partial nephrectomy in renal hypertension.
STUDIES ON PLANT HYPERTENSINASE.
Surgical correction of renovascular hypertension: dissociation between post-operative changes in plasma renin and blood pressure.
THE ACTION OF RENIN ON RABBITS WITH RENAL HYPERTENSION.
The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension.
The immediate plasma renin response to propranolol: evidence for a different mode of renin release in essential and renal hypertension.
THE METABOLISM OF THE KIDNEY IN EXPERIMENTAL RENAL HYPERTENSION : II. THE CONCENTRATION OF CYTOCHROME C AND THE ACTIVITIES OF THE CYTOCHROME OXIDASE AND OF THE SUCCINIC DEHYDROGENASE SYSTEMS IN THE KIDNEY OF DOGS WITH EXPERIMENTAL RENAL HYPERTENSION. THE INHIBITORY EFFECT OF RENIN AND OF KIDNEY TISSUE PREPARATIONS FROM HYPERTENSIVE DOGS ON THE RESPIRATORY ENZYMES.
The permeability state of the blood-brain barrier in relation with the plasma renin activity in early stage of experimental renal hypertension.
The place of renin in the mechanism of hypertension in chronic renal disease.
The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension.
The renin-angiotensin system and sodium appetite.
The renin-angiotensin-aldosterone system. Past, present and future.
The role of renin in experimental renal hypertension.
The unexpected pheochromocytoma.
Treatment and prophylaxis of experimental renal hypertension with renin.
Treatment of experimental renal hypertension with renin and with antirenin.
Ultrastructural immunocytochemical localization of renin and angiotensin II in the juxtaglomerular cells of the ischemic kidney in experimental renal hypertension.
Urology: Very Selective Renal Vein Renin Determination in the Diagnosis of Segmental Renal Hypertension.
Use of captopril in the diagnosis of renal hypertension.
Variations of plasma and kidney renin contents during experimental acute renal hypertension induced by extracts from different tissues.
Vasoactive peptides in experimental renal hypertension.
[Angiography and renin determination in the diagnosis of renal hypertension]
[Aortorenal angiography and other approaches in the diagnosis of arterial hypertension of renal origin]
[Arterial hypertension in patients on chronic hemodialysis]
[Changes in the expression of alpha- and beta-myosin heavy chain gene during the development of renal hypertension in rats]
[Depressor prostaglandin-like substances and renin in the kidneys in experimental renal hypertension]
[Determination of plasmatic renin in renal hypertension (renovascular or parenchymatous). Effects of vascular reconstruction, of nephrectomy and of renal grafting]
[Different reaction of plasma renin activity after propranolol in essential and renal hypertension]
[Differential renin excretion in the urine of rats with renal hypertension]
[Effect of sodium depletion on experimental renal hypertension and renin activity in rats]
[Endocrine system of the kidneys in nephrogenic arterial hypertension: functional and morphological analysis]
[Fundus oculi and renin activity in venous blood in patients with occlusive renal hypertension and hypertensive disease]
[Interrelation of water, sodium and potassium in the arterial wall and renin activity in the kidney in renal hypertension]
[Introduction to the problem of relationship between renin, sodium and hydric spaces in the pathogenesis of renal hypertension]
[Kidney diseases and hypertension]
[Plasma aldosterone and plasma renin activity in patients with essential and renal hypertension under acute stimulation with saline depletion and acute suppression with saline infusion]
[Plasma renin activity after the injection of orthortase and diazoxide in primary and renal hypertension]
[Plasma renin activity in peripheral and renal venous blood in the diagnosis of renal hypertension]
[Plasma renin and aldosterone in parenchymal renal hypertension during stimulation and suppression conditions]
[Plasma renin level and therapy in renal hypertension]
[Prognostic significance of the plasma renin activity in renal hypertension]
[Renin activity in plasma in the acute state of experimental renal hypertension]
[Renin and renal hypertension]
[Renin in human and experimental renal hypertension]
[Renin-angiotensin-aldosterone system : brief history and questions related to the COVID-19 pandemic].
[Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)]
[Split renal and peripheral vein renin activities in patients with renal hypertension]
[The diagnosis of renal hypertension. A comparative study of the value of roentgen urography and radioisotope renography connected with the determination of renin activity in renal venous blood]
[The possibility of stimulation and suppression of renin secretion by sodium deprivation and sodium loading in primary and renal hypertension]
[The renin activity in the kidneys in hypertension and symptomatic renal hypertension.]
[Transcatheter arterial embolization for severely dysfunctioning kidney]
[Typology of renal hypertension according to traditional Chinese medicine and changes of prostaglandins, renin, angiotensin II, and cyclic nucleotides in plasma]
[Unilateral shrunken kidney, renal hypertension and elevated plasma renin concentration]
[Urological diseases causing renal hypertension (author's transl)]
Hypertension, Renovascular
A case of adrenal tumor producing renin, aldosterone, and sex steroid hormones.
A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis.
A new, simple test for renin sampling.
A prospective evaluation of a simplified captopril test for the detection of renovascular hypertension.
A Unique Case of Renovascular Hypertension due to Fibromuscular Dysplasia in an Extra-renal Artery.
Abdominal aortic aneurysm of unknown origin and renovascular hypertension in a 25 year old male.
Active and inactive renin during acute reduction of renal perfusion pressure in essential hypertensives.
Active, inactive and total renin concentrations in plasma of hypertensive patients.
Activity of erythropoietin and renin in renal venous blood of hypertensive patients.
Acute blockage of the renin system and differential renal vein renin determinations in the diagnosis of renovascular hypertension.
Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients.
Acute renal thrombosis induced by angiotensin-converting enzyme inhibitors in patients with renovascular hypertension.
Adenosine in renin-dependent renovascular hypertension.
Aldosteronoma coexisting with renal artery stenosis in secondary hypertension.
Aliskiren improves renal morphophysiology and inflammation in Wistar rats with 2K1C renovascular hypertension.
Angiographic imaging.
Angiotensin blockade in renovascular hypertension: a controlled, prospective study.
Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome.
Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
Angiotensin-induced myocardial necrosis and renal failure in the rabbit: distribution of lesions and severity in relation to plasma angiotensin II concentration and arterial pressure.
Anti-hypertensive effect of water extract of danshen on renovascular hypertension through inhibition of the renin angiotensin system.
Aspirin lowers blood pressure in patients with renovascular hypertension.
Aspirin test for differentiation of unilateral renovascular hypertension from hyperreninemic essential hypertension.
Assessment of renal artery stenosis severity by pressure gradient measurements.
Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension.
Bilateral renal artery aneurysms: in-situ and extracorporeal repair.
Caffeine potentiates vasodilator-induced renin release.
Captopril affects blood pressure equally in renovascular and essential hypertension and in the fluid-depleted anephric state.
Captopril-stimulated renal vein renin in hypertensive patients with or without renal artery stenosis.
Captopril-stimulated renal vein renin measurements in the diagnosis of atherosclerotic renovascular hypertension.
Captopril-stimulated renin secretion in the diagnosis of renovascular hypertension.
Captopril: pharmacology, metabolism and disposition.
Carotid sinus reflex control of renin release in hypertensive subjects with high renin secretion.
Central and peripheral contributions of the renin-angiotensin system in two models of experimental hypertension in rats.
Cerebral hemorrhage in turner syndrome: a case report.
Change in pressor responsiveness to angiotensin II as a determinant of blood pressure after unclipping in two-kidney, one clip hypertensive rats.
Changes in active and inactive renin and in angiotensin II across the kidney in essential hypertension and renal artery stenosis.
Changes of plasma renin, angiotensin II and renin substrate during reversal of malignant renovascular hypertension.
Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats.
Circadian rhythm of renin and aldosterone in unilateral renovascular hypertension. Pre- and post-operative studies.
Clinical evaluation of renovascular hypertension and therapeutic decisions.
Clinical experience with saralasin infusion in hypertensive patients.
Clinical significance of plasma renin activity in human renovascular hypertension.
Comparison of a new renin inhibitor and enalaprilat in renal hypertensive dogs.
Comparison of aortography, renal vein renin sampling, radionuclide scans, ultrasound and the IVU in the investigation of childhood renovascular hypertension.
Comparison of immunoreactive renin and plasma renin activity in human plasma.
Comparison of renal vein renin activity in hypertensive patients with stenosis of one or both renal arteries.
Comparison of the Chemiluminescence Immunoassay LIAISON® with the Radioimmunoassay for Aldosterone and Renin Measurement.
Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism.
Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension.
Correlation of the fibrinogen level with blood pressure and plasma renin activity in rats with early Goldblatt hypertension.
Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension.
Cyclooxygenase-2 up-regulation in reflux nephropathy.
Decreased expression of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats.
Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP.
Detection of renovascular hypertension: saralasin test versus renin determinations.
Development and application of a simple microassay for adenosine in rat plasma.
Development of two-kidney Goldblatt hypertension in rats under dietary sodium restriction.
Diagnosis of unilateral renovascular hypertension: comparative effect of intravenous enalaprilat and oral captopril.
Diagnostic and predicative value of renal vein renin activity in renovascular hypertension.
Diagnostic procedure in renovascular hypertension.
Diagnostic Role of Renal Doppler Ultrasound and Plasma Renin Activity as Screening Tools for Renovascular Hypertension in Children.
Diagnostic value of captopril test in hypertensive patients with renal artery stenosis.
Diagnostic value of plasma renin activity and plasma angiotensin II in renovascular hypertension.
Diazoxide-induced renin release in diagnosis of remediable renovascular hypertension.
Different secretion patterns of active and inactive renin in man.
Differential glomerular filtration rate in diagnosis of renovascular hypertension and follow-up of balloon angioplasty.
Differential renal venous renin activity in diagnosis of renovascular hypertension. Review of 29 cases.
Differentiation between renovascular and essential hypertension by means of changes in single kidney 99mTc-DTPA clearance induced by angiotensin-converting enzyme inhibition.
Differing patterns of renal vein renin secretion in patients with renovascular hypertension, and their role in predicting the response to angioplasty.
Digital intravenous angiography combined with renal vein renin sampling for diagnosis of renovascular hypertension.
Direct renin inhibition is not enough to prevent reactive oxygen species generation and vascular dysfunction in renovascular hypertension.
Disappearance of renin-induced proteinuria by an ACE-inhibitor: a case report.
Dissociation of selective renal venous plasma endothelin-1 activity and corresponding plasma renin activity in a patient with hypertension, severe stenosis of unilateral renal artery and ipsilaterally decreased renal function.
Duplex derived intrarenal resistance index correlates with invasive pressure gradient measurements in detecting relevant unilateral renal artery stenosis.
Dynamic responses of active and inactive renin in patients with essential and renovascular hypertension.
Effect of age on diagnostic usefulness of stimulated plasma renin activity and saralasin test in detection of renovascular hypertension.
Effect of aging on the renin angiotensin system in patients with renovascular hypertension.
Effect of amlodipine on renin secretion and renin gene expression in rats.
Effect of atrial natriuretic factor on blood pressure, renin, and aldosterone in Goldblatt hypertension.
Effect of beta-adrenoreceptor blockade on the renin response to acute natriuresis.
Effect of celecoxib on the antihypertensive effect of losartan in a rat model of renovascular hypertension.
Effect of central norepinephrine depletion on renovascular hypertension and on the renin system.
Effect of indomethacin on blood pressure in rats with renovascular hypertension: dependence on plasma renin activity.
Effect of indomethacin on renal function and plasma renin activity in dogs with chronic renovascular hypertension.
Effect of posture on renal vein renin activity in hypertension; its implications in the management of patients with renovascular hypertension.
Effect of posture on renal vein renin in the diagnosis and followup of renovascular hypertension.
Effect of sodium depletion on renin activity of renal venous plasma in renovascular hypertension.
Effect of volume depletion and subsequent propranolol treatment on blood pressure and plasma renin activity in patients with essential and with renovascular hypertension.
Effective renal plasma flow (ERPF) of the individual kidney and renal venous renin activity (RVRA) determined simultaneoulsy before and after the administration of dihydralazine in renovascular hypertension.
Effects of 1-sarcosine-8-isoleucine-angiotensin II on blood pressure and plasma renin activity in various types of hypertension.
Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension.
Effects of converting enzyme inhibition on split renal function in renovascular hypertension.
Effects of enalapril maleate on plasma level of inactive renin in renovascular hypertension.
Effects of graded renal artery constriction on blood pressure, renal artery pressure, and plasma renin activity in Goldblatt hypertension.
Effects of indomethacin in dogs with acute and chronic renovascular hypertension.
Effects of indomethacin in rabbit renovascular hypertension.
Effects of peripherally and centrally applied ghrelin on the oxidative stress induced by renin angiotensin system in a rat model of renovascular hypertension.
Effects of propranolol in chronic two-kidney Goldblatt hypertension in rats.
Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
Effects of sodium intake and Goldblatt hypertension on renin release in rat kidney slices.
Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
Enhancement of renal venous renin ratios by intravenous hydralazine in renovascular hypertension.
Evidence for activation of circulating inactive renin by the human kidney.
Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension.
Excess prevalence of supraaortic artery lesions in renovascular hypertension: an arteriographic study.
Extra-adrenal pheochromocytoma manifesting renovascular hypertension.
Factors affecting the aldosterone/renin ratio.
Failure of patent aorto-renal grafts to cure hypertension in renin positive patients.
Fibrinolytic and renin activity in renal vein blood of patients with renovascular hypertension.
Flow versus pressure in the control of renin release in conscious dogs.
Functional testing: renin studies.
George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis.
Goldblatt phenomenon in a single kidney: the importance of subselective renal vein renins.
Hemodynamic and renin responses to nifedipine in renovascular hypertension.
Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
High plasma renin activity and hypokalemia in rabbits with chronic renovascular hypertension.
High renin hypertension in focal renal fibromuscular dysplasia: turn off of renin system angiotensin overactivation by renal angioplasty cured high blood pressure and quickly reversed myocardial hypertrophy.
High renin hypertension in the elderly.
Hydralazine and the tourniquet test in renal vein renin sampling: a comparison.
Hydrogen Sulfide Inhibits Plasma Renin Activity.
Hypertension and renal artery stenosis with aneurysm formation in a solitary kidney in a patient with neurofibromatosis.
Hypertension and renovascular disease: follow-up on 100 renal vein renin samplings.
Hypertension and the interrelated renal circulatory effects of prostaglandins and the renin-angiotensin system.
Hypertension: strategies for laboratory diagnosis.
Hyponatraemia and renovascular hypertension. Case report with plasma renin and vascular sensitivity studies.
Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis.
Immunoreactive renin and angiotensin II in the afferent glomerular arterioles of rats with hypertension due to unilateral renal artery constriction.
Impaired renal prostaglandin E2 biosynthesis in human hypertensive states.
Importance of the renal nerves in the pathogenesis of experimental hypertension.
Improved diagnostic accuracy of renal venous renin ratios with stimulation of renin release.
In vivo and in vitro effects of atrial natriuretic peptide on renin release.
Increase in heme oxygenase-1 levels ameliorates renovascular hypertension.
Increase in plasma renin level and aldosterone excretion in response to bethanidine sulfate (Esbatal) in a patient with renovascular hypertension.
Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens.
Increased circulating levels of an endogenous digoxin-like factor in hypertensive monkeys.
Increased oxidative stress in experimental renovascular hypertension.
Influence of pulsatile perfusion upon renin release from the isolated perfused rat kidney.
Influence of sympathetic nerve activity on renal haemodynamics and release of renin. A preliminary communication.
Inhibition of angiotensin conversion and prevention of renal hypertension.
Inhibitory effect of somatostatin on the aldosterone response to angiotensin II: in vitro studies.
Interactions between the sympathetic nervous system and Angiotensin system in renovascular hypertension.
Intrarenal aneurysm of the renal artery in children.
Intrarenal renin-angiotensin-sodium interdependent mechanism controlling postclamp renal artery pressure and renin release in the conscious dog with chronic one-kidney Goldblatt hypertension.
Intravascular ultrasound detects coarctation of the renal artery in a patient with Moyamoya disease.
Involvement of activated prorenin in the pathogenesis of slowly progressive nephropathy in the non-clipped kidney of two kidney, one-clip hypertension.
Kidney and plasma renin in human renovascular hypertension.
Kidney renin mRNA levels in the early and chronic phases of two-kidney, one clip hypertension in the rat.
Low-dose captopril scintigraphy in the evaluation of renovascular hypertension.
Measurement of plasma renin concentration and angiotensin II in peripheral and renal venous plasma in the management of renovascular hypertension.
Measurement of renin in both renal veins. Its use in diagnosis of renovascular hypertension.
Methylxanthines augment the renin response to suprarenal-aortic constriction.
Mild Renal Artery Stenosis Can Induce Renovascular Hypertension and is Associated with Elevated Renal Vein Renin Secretion.
Moderate-intensity exercise and renin angiotensin system blockade improve the renovascular hypertension (2K1C)-induced gastric dysmotility in rats.
Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism.
Natriuretic peptides buffer renin-dependent hypertension.
New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions.
Nitric oxide and the role of blood pressure variability to the kidney.
Norepinephrine overflow and renin pattern of the individual kidney in patients with unilateral renal artery stenosis.
Observations on the use and limitations of renal vein renins in hypertensive patients.
Parallel regulation of constitutive NO synthase and renin at JGA of rat kidney under various stimuli.
Pediatric hypertension: an approach to imaging.
Peptide inhibitors of renin in cardiovascular studies.
Peripheral and renal vein renin activity in patients with renovascular hypertension due to nonspecific aortoarteritis.
Persistence of unilateral secretion and contralateral renin suppression after successful percutaneous transluminal dilatation in a normotensive patient.
Phase-contrast magnetic resonance flow quantification in renal arteries: comparison with 133Xenon washout measurements.
Pheochromocytoma presenting with pulmonary edema and hyperamylasemia.
Plasma endothelin-1 level in patients with renovascular hypertension - does the kidney with stenosis of the renal artery upregulate production of endthelin-1?
Plasma erythropoietin concentrations in renal venous blood of patients with unilateral renovascular hypertension.
Plasma prolactin levels in patients with essential hypertension, malignant hypertension and secondary hypertension.
Plasma renin activity following operations for renovascular hypertension.
Plasma renin activity in patients with renovascular hypertension.
Plasma renin activity in renovascular hypertension.
Plasma renin activity revealed renal artery stenosis concealed by aneurysms.
Plasma renin concentrations in cases with renovascular hypertension.
Post-hydralazine renin release in the diagnosis of renovascular hypertension.
Postoperative course of blood pressure and plasma renin activity in patients with renovascular hypertension.
Postural augmentation of plasma renin activity. Importance in diagnosis of renovascular hypertension.
Pre-operative renal function and selective renal vein renin levels as markers of favourable outcome in renovascular hypertension.
Predictive value of renal-vein renin measurements in children with various forms of renal hypertension. An international study.
Predictive value of renin determinations in renal artery stenosis.
Preoperative diagnosis of renovascular hypertension. The use of acute stimulation of renin secretion.
Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism.
Prognostic value of plasma renin activity in renovascular hypertension.
Prognostic value of renal vein renin determination in suspected renovascular hypertension.
Propranolol, renin and hypertension: a review.
Prorenin as a further indicator of the surgically curable renovascular hypertension.
Prospective analysis of strategies for diagnosing renovascular hypertension.
Prostaglandin E2, renin and angiotensin II in renovascular hypertension.
Prostaglandin I(2)/E(2) ratios in unilateral renovascular hypertension of different severities.
Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
Reciprocation of renin dependency with sodium volume dependency in renal hypertension.
Relationship between collateral development and renin in experimental renal arterial stenosis.
Renal and systemic sympathetic counterregulation in response to vasodilators in renovascular hypertension.
Renal artery digital-subtraction angiography. An outpatient investigation for renovascular hypertension.
Renal effects of prostaglandin E1 in hypertensive patients.
Renal extraction of atrial natriuretic peptide in hypertensive patients with or without renal artery stenosis.
Renal kallikrein activity and urinary kallikrein excretion in rats with experimental renal hypertension.
Renal prostaglandins, renin release, and renal hemodynamic function in high renin states.
Renal release of active and inactive renin in essential and renovascular hypertension.
Renal scintigraphy versus renal vein renin activity for identifying and treating renovascular hypertension.
Renal secretion of inactive renin.
Renal vein plasma adenosine 3',5'-cyclic monophosphate in renovascular hypertension.
Renal vein plasma renin activity in patients with unilateral renovascular hypertension.
Renal vein prostaglandins in renovascular hypertensive patients.
Renal vein renin activity and prostaglandins A and E in hypertension.
Renal vein renin activity in the prognosis of surgery for renovascular hypertension.
Renal vein renin and renovascular hypertension.
Renal vein renin and saralasin testing in renovascular hypertension.
Renal vein renin in renovascular hypertension.
Renal vein renin in renovascular hypertension: the experience of two Italian centers.
Renal vein renin measurements accurately identify renovascular hypertension caused by total occlusion of the renal artery.
Renal vein renin ratio. Predictive value in renal and renovascular hypertension.
Renal vein renin ratios and collateral vessels in renovascular hypertension.
Renal vein renins: inability to predict response to revascularization in patients with hypertension.
Renal venous blood renin level in patients with renovascular hypertension.
Renal venous plasma renin reactivity in clinical and experimental renovascular hypertension: renin reactivity in renovascular hypertension.
Renal venous renin activity in renovascular hypertension.
Renal venous renin determinations in renovascular hypertension. Diagnostic and prognostic value in unilateral renal artery stenosis treated by surgery or percutaneous transluminal angioplasty.
Renal venous renin in patients with renovascular hypertension.
Renal venous renin ratio in the diagnosis of renovascular hypertension: measurement during active secretion of renin.
Renal: systemic renin indices and renal vein renin ratios as prognostic indicators in remedial renovascular hypertension.
Renin activity, renin secretion rate and renal hemodynamics as functional tests renovascular hypertension.
Renin in the diagnosis of renovascular hypertension. Activity in renal and peripheral vein plasma.
Renin release during acute reduction of arterial pressure in normotensive subjects and patients with renovascular hypertension.
Renin secretion and captopril stimulation in hypertensive renal transplant recipients.
Renin, aldosterone, body fluid volumes, and the baroreceptor reflex in the development and reversal of Goldblatt hypertension in conscious dogs.
Renin, Endothelial NO Synthase and Endothelin Gene Expression in the 2Kidney-1clip Goldblatt Model of Long-term Renovascular Hypertension.
Renin--angiotensin antagonists and the regulation of blood pressure.
Renin-aldosterone system suppression during water immersion in renovascular hypertension.
Renin-angiotensin system in an infant with malignant renovascular hypertension.
Renin-induced massive proteinuria in man.
Renin-specific antibody for study of cardiovascular homeostasis.
Renovascular hypertension and plasma renin activity.
Renovascular hypertension from segmental renal artery stenosis: importance of segmental renal vein renin sampling.
Renovascular hypertension in blacks.
Renovascular hypertension in pediatric patients: update on diagnosis and management.
Renovascular hypertension in sodium-depleted dogs: role of renin and carotid sinus reflex.
Renovascular hypertension with low-to-normal plasma renin: clinical and angiographic features.
Renovascular hypertension.
Renovascular hypertension. Relationship between hepatic blood flow and plasma renin activity.
Renovascular hypertension. Relationship of surgical curability to renin-angiotensin activity.
Renovascular hypertension: does the renal vein renin ratio predict operative results?
Renovascular hypertension: etiology and pathophysiology.
Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability.
Renovascular hypertension: the diagnostic value of renal vein renin ratios.
Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis.
Response to the captopril test is dependent on baseline renin profile.
Reversal of renovascular hypertension: a comparison of changes in blood pressure, plasma renin, and sodium balance in two models in rats.
Reversible nephrotic syndrome due to high renin state in renovascular hypertension.
Reversible renin-dependent renovascular hypertension successfully treated with percutaneous transluminal renal angioplasty and stenting.
Role of balloon dilatation in the treatment of renovascular hypertension.
Role of L-arginine-nitric oxide pathway in hypertension.
Role of macula densa cyclooxygenase-2 in renovascular hypertension.
Role of neuropeptide Y in the development of two-kidney, one-clip renovascular hypertension in the rat.
Role of renin in the pathogenesis of renal hypertension.
Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effects of converting enzyme inhibitor, alacepril.
Saralasin infusion in screening patients for renovascular hypertension.
Screening for renovascular hypertension.
Sensitive direct radio-immunoassay for human renin.
Serum angiotensin converting enzyme activity and plasma renin activity in experimental models of rats.
Severe hyperlipidemia causes impaired renin-angiotensin system function in apolipoprotein E deficient mice.
Similar prevalence of renovascular hypertension in selected blacks and whites.
Six missense mutations of the epithelial sodium channel beta and gamma subunits in Japanese hypertensives.
Sodium balance and plasma renin activity during the development of two-kidney Goldblatt hypertension in rats.
Stimulation of plasma renin activity by captopril in renovascular hypertensive conscious dogs.
Studies on plasma renin activity in patients with renovascular hypertension.
Studies on the active and inactive renin in renovascular hypertension.
Study of renovascular hypertension in rats. III. Effects of converting enzyme inhibitor (captopril) on the plasma and renal renin activity in two-kidney goldblatt hypertension in rats.
Study of renovascular hypertension in rats. IV. Renal arterial blood velocity in one-clip, two-kidney hypertensive rats.
Successful blood pressure control with additive administration of eplerenone, an aldosterone receptor blocker, in a patient with bilateral renovascular hypertension treated with angioplasty.
Successful long-term effects of direct renin inhibitor aliskiren in a patient with atherosclerotic renovascular hypertension.
Successfully treated "accelerated" renovascular hypertension with intravascular stenting.
Suppression of renal vein renin profiles by mannitol prophylaxis: implications in the evaluation of renovascular hypertension.
Suppression of renin release by antagonism of endogenous opiates in the dog.
Surgical correction of renovascular hypertension: dissociation between post-operative changes in plasma renin and blood pressure.
Surgical reversal of renovascular hypertension in rats: changes in blood pressure, plasma and aortic renin.
Surgical treatment of renovascular hypertension: a 10-year review.
The captopril test for identification of renovascular hypertension: value and immediate adverse effects.
The captopril test for identifying renovascular disease in hypertensive patients.
The cardiac response to a small i.v. dose of dihydralazine, a safe drug for diagnostic tests?
The changes in active and inactive renin induced by various maneuvers in hypertensive patients.
The early phase of experimental acute renal failure. V. The influence of suppressing the renin-angiotensin system.
The effect of beta-adrenergic blockade on patterns of urinary sodium excretion, blood pressure and plasma renin activity in patients with essential and renovascular hypertension.
The effect of caffeine on renal vein renin concentration in patients with renal arterial disease.
The effect of phentolamine on active and inactive renin release in human renovascular hypertension.
The influence of dietary salt and plasma renin activity on myosin heavy chain gene expression in rat hearts.
The pathophysiology of renin release in renovascular hypertension.
The postural plasma renin response in renovascular hypertension.
The predictive accuracy of renal vein renin activity in the surgery of renovascular hypertension.
The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension.
The role of extrarenal renin in Goldblatt hypertension.
The role of renin in the control of the circulation and in hypertensive disease.
The role of vascular protein and renin in chronic two-kidney, one clip Goldblatt hypertension.
The significance of renin and angiotensin in renovascular hypertension in man.
The value of plasma renin concentration per se, and in relation to plasma and extracellular fluid volume in diagnosis and prognosis of human renovascular hypertension.
The value of the captopril test and the effect of captopril on renal function.
Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis.
Treatment of renovascular hypertension using stent implantation in an elderly patient with NIDDM.
Troponin T as a marker of differentiation revealed by proteomic analysis in renal arterioles.
Tubuloglomerular feedback in rat kidneys of different renin contents.
Two-year clinical follow-up of children and adolescents after percutaneous transluminal angioplasty for renovascular hypertension.
Upregulation of angiotensin II type 1 receptor gene expression in chronic renovascular hypertension.
Ureteral catheterization studies.
Urinary kallikrein and plasma renin during the reversal of renovascular hypertension in rats.
Use of captopril in the diagnosis of renal hypertension.
Vascular renin in hypertension.
Water-salt balance, plasma renin activity and catecholamine excretion in renovascular hypertension in the rat.
[A case of renovascular hypertension due to chondrosarcoma arising from lumbar vertebrae]
[A case report of renovascular hypertension due to renal artery branch obstruction--determination of segmental renal venous renin activity and intra renal tissue renin concentration]
[Abnormal secretion of renin: theoretical and practical repercussions on renovascular hypertension]
[Acute response to calcium inhibitors in secondary arterial hypertension: does renin play a role?]
[Angioplasty of the renal arteries. Our experience with a 12-month follow-up]
[Aortorenal angiography and other approaches in the diagnosis of arterial hypertension of renal origin]
[Apresoline stimulation of renal-vein plasma renin activity in the diagnosis of renovascular hypertension]
[Association of pheochromocytoma and renovascular hypertension]
[Behavior of blood pressure, renal plasma flow and renal vein renin activity in renovascular hypertensive patients before and after PTA]
[Captopril renography in the diagnosis of renovascular hypertension]
[Captopril test in renovascular hypertension: effects of ACE inhibition on the reno-renal renin index]
[Captopril-stimulated plasma renin activity in the diagnosis of renovascular hypertension]
[Case of renovascular hypertension with jet-type renal aneurysm--with special reference to the observation on dynamics of electrolytes, and renin angiotensin-aldosterone system before and after treatment]
[Catecholamines and plasma renin activity in renovascular hypertension]
[Circulatory and renin response to the administration of nifedipine in renovascular hypertension]
[Clinical and experimental study on vascular reconstruction for one-kidney renovascular hypertension]
[Coexistence of renovascular hypertension and pheochromocytoma. Description of 2 clinical cases]
[Comparison of captopril angioscintigraphy and the renin test in diagnosis of renovascular hypertension]
[Complex clinical and morphofunctional study of vasorenal hypertension]
[Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension]
[Critical analysis of the saralasintest in the diagnosis of hypertension (author's transl)]
[Determination of blood renin activity in the diagnosis of renovascular hypertension]
[Determination of renin in renovascular hypertension]
[Determination of renin in the renal veins and results of the surgical treatment of renovascular hypertension]
[Diagnostic value of the captopril test in patients with arterial hypertension]
[Dynamic evaluation of the renin-angiotensin system with captopril in screening for renovascular hypertension]
[Effect of captopril on renal vein plasma renin ratio--diagnosis and predicting response to surgery in renovascular hypertension]
[Effect of somatostatin on renin, aldosterone and blood pressure in unilateral renovascular hypertension]
[Effects of beta-blocking agents on blood pressure and plasma renin activity in experimental renovascular hypertension (author's transl)]
[Etiologic diagnosis of renovascular hypertension by the determination of serum renin tension in renal veins (46 cases)]
[Evaluation of the effect of intravenous furosemide on the plasma renin activity of renal vein blood in patients with renovascular hypertension]
[Experimental studies on interrelationship of renin release and sodium metabolism in acute stage of unilateral renovascular hypertension (author's transl)]
[Expression of the renin and angiotensinogen genes]
[Hemodynamics, body fluid balance, plasma renin and plasma catecholamines in various phases of renovascular hypertension in sheep]
[Hypertension from the nephrologist's point of view]
[Hypertension therapy in patients with renal artery stenosis].
[Initial experiences in nuclear medicine and endocrine diagnosis with captopril in unilateral renal artery stenosis]
[Juxtaglomerular apparatus, renin, renovascular hypertension]
[Lateralization of renin secretion in renovascular hypertension with bilateral arterial stenosis]
[Level of depressor prostaglandin-like substances and renin activity in the kidneys of patients with renovascular hypertension]
[Level of vasopressin in renal venous blood of patients with renovascular hypertension due to unilateral stenosis of renal arteries]
[Levels of 1,25-dihydroxyvitamin D3 concentration in renal venous blood serum of patients with renovascular hypertension caused by unilateral renal artery stenosis]
[Malignant renovascular hypertension caused by intraparenchymal anomalies of the left renal artery with lack of contralateral renin suppression. Cure by nephrectomy]
[Measurement of the kidney blood supply and plasma renin determination in the diagnosis of renovascular hypertension]
[Plasma renin activity in patients with renovascular hypertension]
[Plasma renin activity in renal vein blood in essential and renovascular hypertension]
[Plasma renin and proteinuria in renovascular hypertension in the rat]
[Prognostic factors in percutaneous transluminal dilatation of the renal arteries in renovascular hypertension]
[Prognostic value of intravenous urography, renal arteriography, specific kidney function exploration, and plasma renin activity in renovascular hypertension]
[Prognostic value of plasma renin activity in renovascular hypertension]
[Prognostic value of plasma renin in renovascular hypertension]
[Prognostic value of the determination of renin activity in renal veins in renal and renovascular hypertension]
[Prognostic value of the plasma renin activity in renovascular hypertension]
[Prognostic value of the plasma renin activity index in renal venous blood in patients with renovascular hypertension treated surgically]
[Prorenin determination optimizes the prognostic criteria for surgical treatment of renovascular hypertension]
[Prostaglandins in the renal vascular bed in arterial hypertension of different etiologies]
[Proteomic analysis of proteins involved in the renal phenotype in renovascular hypertension]
[Radioimmunoassay in the diagnosis of arterial hypertension]
[Reactivation of renin secretion by a contralateral kidney in the chronic phase of experimental renovascular hypertension]
[Renal ablation by transcatheter renal arterial embolization in the treatment of benign renal disease]
[Renal vein plasma renin activity in patients with essential hypertension and renovascular hypertension]
[Renin activity in blood plasma and renovascular hypertension]
[Renin level in the blood of renal veins in patients with renovascular hypertension]
[Renovascular hypertension - indications and type of operative method employed]
[Renovascular hypertension. II. Isotopic nephrogram, intravenous urography, gradients of pressure, renal biopsy, renin activity in renal venous blood. Results of surgery]
[Renovascular hypertension. Prognostic value of renal venous renin determinations (author's transl)]
[Renovascular hypertension. Radionuclide renography for detection and prediction of clinical response to revascularization]
[Renovascular hypertension. Studies of 16 cases with long-term follow-up]
[Renovascular hypertension: fluctuation of postoperative blood pressure and plasma renin activity]
[Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension]
[Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)]
[Split renal and peripheral vein renin activities in the unilateral renovascular hypertension in rabbits]
[Split renal function studies: Comparative study of various split renal function tests and renal vein renin ratio in diagnosing renovascular hypertension (author's transl)]
[Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III]
[The captopril test as a part of the examination in arterial hypertension. Value and immediate complications]
[The concentration of prostaglandin-like substances and the activity of renin in the kidneys of rabbits with renovascular hypertension and unilateral nephrectomy]
[The importance of plasma renin determination to the choice of therapy of renovascular hypertension (author's transl)]
[The prognostic value of preoperative renin determination in renovascular hypertension]
[The value of differential renal vein renin activity on the diagnosis of renovascular hypertension and prediction of its prognosis regarding surgical treatment (author's transl)]
[The value of renin determination in the diagnosis of hypertension]
[Treatment effectiveness in renovascular hypertension depending on the indices of blood renin activity and of arterial resilient, elastic properties]
[Urine catecholamine excretion and plasma renin activity in primary hypertension and renovascular hypertension due to renal artery stenosis]
[Use of intravenous nicardipine for the diagnosis of renovascular hypertension]
[Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension]
[Value of renin determination and of the angiotensin test in the diagnosis of renovascular hypertension]
[Value of separate hemodynamic exploration and of plasma renin activity for the surgical treatment of renovascular hypertension]
[Value of the separate hemodynamics exploration and of the plasma renin activity for the surgical treatment of renovascular hypertension]
Hypertensive Encephalopathy
Effects of acute hypertension on brain metabolism in normotensive, renovascular hypertensive and spontaneously hypertensive rats.
Hypertensive Retinopathy
Hypotensive action of nifedipine (Ca2+-antagonist) and propranolol in acute trials and its long-term therapy of hypertensive coronary heart disease patients.
Hyperthyroidism
Aldosterone and plasma renin activity in hyperthyroid rats: effects of propranolol and propylthiouracil.
Aliskiren, Fosinopril, and Their Outcome on Renin-Angiotensin-Aldosterone System (RAAS) in Rats with Thyroid Dysfunction.
Aortic elastic properties are impaired in patients with Graves' ophtalmopathy.
Association between urinary vascular endothelial growth factor excretion and chronic kidney disease in hyperthyroid cats.
Changes of poststimulatory plasma renin activity in women with hyperthyroidism or hypothyroidism in relation to therapy.
Clinical syndromes associated with tumors of the female genital tract.
Effect of thyroid hormones on angiotensinogen production in the rat in vivo and in vitro.
Effects of hyper- and hypothyroidism on the basal levels of angiotensin I and kinetic parameters of renin-angiotensin system in male rats.
Hypertension and Hyperthyroidism: Association and Pathogenesis.
Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Interactions between thyroid disorders and kidney disease.
Involvement of renin-angiotensin system in the reduced pressure natriuresis response of hyperthyroid rats.
Mechanism of hyperthyroidism-induced renal hypertrophy in rats.
Normalization of thyroid hormone levels in patients with either hyper- or hypothyroidism results in a profound change of atrial natriuretic peptide (ANP) levels.
Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease.
Plasma inactive renin in patients with hyperthyroidism.
Plasma renin activity and aldosterone concentration of patients with hyperthyroidism and hypothyroidism.
Plasma renin activity in hyperthyroid rats: effect of adrenergic blocking agents.
Plasma renin activity, active and inactive renin concentrations, and their responses to beta 1-adrenoceptor blockade with metoprolol in hyperthyroidism.
Renin-angiotensin system in thyroid dysfunction in rats.
Renin-Angiotensin-Aldosterone System Activity in Hyperthyroid Cats with and without Concurrent Hypertension.
Renin-angiotensin-aldosterone system in hyper- and hypothyroid rats during sodium depletion.
Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism.
Serum angiotensin-converting enzyme and plasma atrial natriuretic peptide levels in hyperthyroid and hypothyroid rabbits.
The effect of eplerenone on the renin-angiotensin-aldosterone system of rats with thyroid dysfunction.
The effect of thyroid hormone on renin production and release by rat kidney slices.
The influence of plasma renin substrate on the relationship between plasma renin activity and plasma renin concentration. An experimental study in hyper- and hypothyroid rats.
Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system.
Thyroid hormones and renin secretion.
Urinary 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) excretion and its relation to plasma renin activity in hyperthyroidism.
[Endocrine and neurogenic hypertension in childhood]
[Influence of cardiac structure, blood flow velocity and heart function on circulating atrial natriuretic peptide and renin-angiotension system]
[Plasma renin activity in women with hyperthyroidism]
[Propranolol effect on renin-angiotensin system kinetics during experimental hyperthyroidism (author's transl)]
[Renin-angiotensin-aldosterone system in thyroid disorders]
[Responses of plasma bradykinin and the renin angiotensin axis to angiotensin II in hyperthyroid patients]
[Serum angiotensin I converting enzyme activity in patients with hyperthyroidism and hypothyroidism: relation to renin and aldosterone]
[Some observations on the mechanism of increase of plasma renin activity in hyperthyroidism (author's transl)]
[Urinary excretion of 6-ketoprostaglandin F1 alpha (6-keto-PGF1 alpha) and its relation to plasma renin activity in hyperthyroidism]
Hypertriglyceridemia
Chronic inhibition of 11 ? -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome.
Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents.
Severe hyperlipidemia causes impaired renin-angiotensin system function in apolipoprotein E deficient mice.
Hypertrophy, Left Ventricular
Aldosterone and left ventricular hypertrophy in Afro-Caribbean subjects with low renin hypertension.
Alteration of Cardiac ACE2/Mas Expression and Cardiac Remodelling in Rats with Aortic Constriction.
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
Association of plasma renin activity and echocardiographic left ventricular hypertrophy with frequency of new coronary events and new atherothrombotic brain infarction in older persons with systemic hypertension.
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.
Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats.
Cardiac weight in hypertension induced by nitric oxide synthase blockade.
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension.
Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II.
Cardiovascular phenotypes and functional parameters in the general population--results of the MONICA/KORA studies.
Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
Diets rich in saturated fat and/or salt differentially modulate atrial natriuretic peptide and renin expression in C57BL/6 mice.
Effect of chronic dihydropyridine (isradipine) on the large arterial walls of spontaneously hypertensive rats.
Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.
Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
Erythrocyte ion transport as indicator of sensitivity to antihypertensive drugs.
Excess cardiovascular mortality in the uremic patient--what does it teach for other risk factors in the non-renal patient?
G protein beta 3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy.
Genetic variants of proteins from the renin angiotensin system are associated with pressure load cardiac hypertrophy.
Hemodynamic and cardiac adaptation in essential hypertension. Consequences for therapy.
I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience.
Impaired control of vasopressin release in hypertensive subjects with cardiac hypertrophy.
Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
Left ventricular adaptation to hypertension and plasma renin activity.
Left ventricular hypertrophy and function in high, normal, and low-renin forms of essential hypertension.
Local renin-angiotensin system regulates left ventricular hypertrophy induced by swimming training independent of circulating renin: a pharmacological study.
Macroarray analysis in the hypertrophic left ventricle of renin-dependent hypertensive rats: identification of target genes for renin.
Myocardial adrenergic dysfunction in rats with transgenic, human renin-dependent hypertension.
Pathophysiologic mechanisms in essential hypertension: a clue to the therapeutic approach.
Plasma renin activity could be a useful predictor of left ventricular hypertrophy in essential hypertensives.
Racial differences among children with primary hypertension.
Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients.
Renal extraction of atrial natriuretic peptide in hypertensive patients with or without renal artery stenosis.
Renal Sympathetic Denervation for the Treatment of Systemic Hypertension.
Renin a marker for left ventricular hypertrophy in primary aldosteronism: a cohort study.
Renin and angiotensin-converting enzyme genotypes in patients with essential hypertension and left ventricular hypertrophy.
Renin Inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling.
Renin-secreting tumors.
Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
Role of intracellular cation abnormalities in development of left ventricular hypertrophy.
Role of neurohumoral systems for pressure induced left ventricular hypertrophy in experimental supravalvular aortic stenosis in rats.
Studies to Elucidate the Mechanism of Cardio Protective and Hypotensive Activities of Anogeissus acuminata (Roxb. ex DC.) in Rodents.
Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
The pathogenesis of hypertension in obese subjects.
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension.
The relation of plasma renin activity to left ventricular hypertrophy and retinopathy in patients with arterial hypertension.
The renin angiotensin system as a risk factor for coronary artery disease.
The renin-angiotensin system and the heart: beyond 2000.
The role of nonpharmacologic device interventions in the management of drug-resistant hypertension.
[Different cardiovascular and hormonal consequences of A-V fistula in uremic patients (author's trans)]
[Effect of a non-antihypertensive dose of ramipril on the plasma and tissue renin-angiotensin system in 27 TGR (mRen2) rats.]
[Effect of alpha, beta blocker, labetol on the angiotensin renin system in arterial hypertension]
[Hypertensive hypertrophy of the left ventricle: its regression in hypertensive patients with different profiles of plasma renin activity, treated with enalapril]
[Pharmacological basis of antihypertensive drug therapy]
[The interrelation of the secretory activity of the myocardium with its hypertrophic characteristics in patients with ischemic heart disease]
Hypertrophy, Right Ventricular
Atrial natriuretic factor in high-altitude pulmonary hypertension: the influence of acute hypoxia on plasma atrial natriuretic factor, renin, and aldosterone concentrations in highlanders with initially normal or elevated pulmonary artery pressure and without evidence of right ventricular hypertrophy.
The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease.
Hypoaldosteronism
Active and inactive renin in low renin states: studies in human plasma.
Acute renal failure and hyperkalaemia associated with cyclooxygenase-2 inhibitors.
Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications.
Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
Big renin and biosynthetic defect of aldosterone in diabetes mellitus.
Big renin: identification, chemical properties and clinical implications.
Control of plasma aldosterone in diabetic patients with hyporeninemic hypoaldosteronism.
Cyclosporin A-induced hyperreninemic hypoaldosteronism. A model of adrenal resistance to angiotensin II.
Dynamic and biochemical responses to single and repeated doses of clonidine during dynamic physical activity.
Effect of alterations of sodium intake in patients with hyporeninemic hypoaldosteronism.
Effects of extracorporeal shockwave lithotripsy on renal growth and function: an animal model.
Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism.
Functional and histologic alterations in growing solitary rat kidney as result of extracorporeal shockwaves.
Heparin-induced hyperkalemia.
Hyperkalaemia and selective hypoaldosteronism in myotonic dystrophy.
Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
Hyperkalemia due to selective hypoaldosteronism.
Hyperpotassemia and bradycardia in a bedridden elderly woman with selective hypoaldosteronism associated with low renin activity.
Hyperreninemic hypoaldosteronism in the critically ill: a new entity.
Hyperreninemic hypoaldosteronism syndrome, plasma concentrations of interleukin-6 and outcome in critically ill patients with liver cirrhosis.
Hypertension, hypokalemia and hypoaldosteronism with suppressed renin: a clinical study of a patient with Liddle's syndrome.
Hyporeninemic hypoaldosteronism after renal transplantation.
Hyporeninemic hypoaldosteronism associated with multiple myeloma: 11 years of follow-up.
Hyporeninemic hypoaldosteronism in diabetes mellitus. Studies of the autonomic nervous system's control of renin release.
Hyporeninemic hypoaldosteronism--case report and observation of dissociated renin and erythropoietin activity.
Impaired renin responsiveness with secondary hypoaldosteronism.
Inactive renin and prostaglandin E2 production in hyporeninemic hypoaldosteronism.
Induction of renin release by exogenous prostaglandins in hyporeninemic hypoaldosteronism.
Interrelationships of renin and aldosterone in a patient with hypoaldosteronism.
Isolated hypoaldosteronism and abnormalities in renin, kallikrein, and prostaglandin.
Mineralocorticoid Dysfunction during Critical Illness: A Review of the Evidence.
New findings in apparent mineralocorticoid excess.
Potential effects of renin activation on the regulation of renin production.
Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency.
Prolonged hyperkalemia following unilateral adrenalectomy for primary hyperaldosteronism.
Reciprocal changes in active and inactive renin after converting enzyme inhibition in normal man.
Renin-angiotensin-aldosterone system in diabetes mellitus.
Restoration of Epithelial Sodium Channel Function by Synthetic Peptides in Pseudohypoaldosteronism Type 1B Mutants.
Reversible hyperkalemia induced by flufenamic acid in asymptomatic hyporeninemic patient.
Reversible hyporeninemic hypoaldosteronism in a patient with tetraplegia.
Selective hypoaldosteronism despite prolonged pre- and postoperative hyperreninemia in primary aldosteronism.
Selective hypoaldosteronism due to combined defects of the conversion from inactive renin to active renin and the aldosterone biosynthesis from corticosterone.
Selective hypoaldosteronism: a study of steroid biosynthetic pathways under adrenocorticotrophin and angiotensin II infusion.
Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism.
Studies of the renal vasoactive systems in hyporeninemic hypoaldosteronism.
The Aldosterone/Renin Ratio as a Diagnostic Tool for the Diagnosis of Primary Hypoaldosteronism in Newborns and Infants.
The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
The endocrine response to critical illness.
Urinary prostaglandins following frusemide treatment and salt depletion in normal subjects and subjects with diabetic hyporeninaemic hypoaldosteronism.
[21-hydroxylase deficit revealed by hyperkalemia in the absence of renal failure in an insulin-dependent diabetic (author's transl)]
[A study on the pathogenesis of hyporeninemia in diabetics]
[Drug-induced exacerbation of hypoaldosteronism in autoimmune polyglandular syndrome type 2].
[Hyperreninemic hypoaldosteronism syndrome induced by plasma exchange]
[Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia]
[Hyporeninemic hypoaldosteronism. Case report and attempt at pathophysiological classification (author's transl)]
[Paraneoplastic hypercorticism. Hypokalemia, increased plasma renin activity and hypoaldosteronism during cancer of the pancreas]
[Regulation of aldosterone secretion in thyrotoxicosis. Thyroid hormones as possible stimulators of the activity of the renin-angiotensin-aldosterone system]
[The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism]
Hypobetalipoproteinemias
Renin "preinhibitor" in blood of anephric patients, in a case of hypobetalipoproteinemia, and evidence of its major association with plasma alpha lipoproteins.
Hypocalcemia
Acquired Bartter-Like Phenotype.
Anaesthesia for laparoscopic cholecystectomy in Bartter's syndrome.
Calcium-dependent low renin syndrome in a diabetic patient with prostaglandin deficiency.
Effect of acute and long-standing hypocalcemia on blood pressure and plasma renin activity in man.
Licorice-related rhabdomyolysis: a big price for a sweet tooth.
The effects of changes in serum calcium and parathormone on plasma renin activity in intact mongrel dogs.
[A case of pseudo-Bartter's syndrome associated with hypokalemic myopathy]
Hypoglycemia
Aldosterone response to hypoglycemia: evidence of ACTH mediation.
Brain angiotensin receptors and sympathoadrenal regulation during insulin-induced hypoglycemia.
Catecholamines, cyclic AMP and renin in two contrasting forms of essential hypertension.
Channelopathies of inwardly rectifying potassium channels.
Childhood hypoglycemia: plasma glucose and renin response to deoxglucose for assessment of adrenal medulla responsiveness.
Clinical syndromes associated with tumors of the female genital tract.
Contrasting effects of hypoglycemia on plasma renin activity and cyclic adenosine 3',5'-monophosphate (cyclic AMP) in low renin and normal renin essential hypertension.
Effect of beta adrenergic blockade on renin response to renal nerve stimulation.
Effect of hypoglycemia on plasma renin activity in dogs.
Effect of insulin-induced hypoglycemia on plasma renin activity and aldosterone and cortisol concentration in humans.
Effect of insulin-induced hypoglycemia upon plasma renin activity in man.
Effect of the dopamine agonist bromocriptine on blood pressure, catecholamines and renin activity in acromegalics at rest, following exercise and during insulin induced hypoglycemia.
Evaluation of the renin-aldosterone system during hypo- and hyperglycemia in children and adolescents.
Long term non-selective and cardioselective beta-receptor blockade in hypertensive patients. Effects on circulatory parameters, catecholamines and renin activity under basal conditions and in connection with exercise and hypoglycemia.
Long term treatment of moderate hypertension with penbutolol (Hoe 893d). II. Effect on the response of plasma catecholamines and plasma renin activity to insulin-induced hypoglycemia.
Plasma cAMP and renin in diabetics during insulin induced hypoglycemia.
Responses of active and inactive plasma renin to insulin-induced hypoglycemia in normal subjects.
Sepiapterin reductase gene-disrupted mice suffer from hypertension with fluctuation and bradycardia.
The effect of alpha- and beta-adrenergic blocking agents on the renin response to hypoglycemia and epinephrine in dogs.
The effect of clonidine and penbutolol, respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients.
Unimpaired beta adrenergic responses during prazosin administration.
Vasodepressor effects of prazosin during insulin-induced hypoglycemia in hypertensive patients.
[Behavior of aldosterone and plasma renin activity after ACTH administration and insulin-induced hypoglycemia in patients with essential arterial hypertension]
[Blood cortisol changes due to insulin hypoglycemia and serum renin dynamics in the cold pressor test in normal and hypertensive subjects]
[Effect of nifedipine treatment on the renin-aldosterone system and secretion of cortisol and growth hormone in patients with essential hypertension]
[The renin-angiotensin-aldosterone system in hypertension of hypothalamic origin]
Hypogonadism
Combined 17-hydroxylase and 17,20-desmolase deficiencies: evidence for synthesis of a defective cytochrome P450c17.
Six new cases confirm the clinical molecular profile of complete combined 17?-hydroxylase/ 17,20-lyase deficiency in Brazil.
Hypokalemia
'Pseudo-aldosteronism' induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients.
11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
19-hydroxyandrostenedione as a new hypertensinogenic agent.
6C.03: A CASE OF SEVERE HYPERALDOSTERONISM CAUSED BY A DE NOVO KCNJ5 MUTATION.
A 3-year old girl with seizures, hypokalemia and metabolic alkalosis.
A case of 17 alpha-hydroxylase deficiency syndrome associated with right adrenal tumor.
A case of congenital chloride diarrhea: information obtained through long-term follow-up with reduced electrolyte substitution.
A case of Gitelman syndrome associated with idiopathic intracranial hypertension.
A case of glucocorticoid-suppressible hyperaldosteronism with aldosterone producing adenoma.
A Case of Juxtaglomerular Cell Tumor With Novel Histologic Features.
A case of male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency and hormonal profiles in the nuclear family.
A case of nephrotic syndrome associated with renovascular hypertension successfully treated with candesartan.
A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.
A case of normotensive primary aldosteronism with hypopituitarism, epilepsy, and medullary sponge kidney.
A case of primary aldosteronism associated with renal artery stenosis and preclinical Cushing's syndrome.
A Case of Primary Aldosteronism Due to A Primary Adrenal Adenoma Diagnosed by Segmental Adrenal Venous Sampling (S-AVS) Using a Modified Catheter System and Lateral Cine Angiography.
A case of primary aldosteronism due to unilateral adrenal hyperplasia.
A case of reninoma with variant angina.
A case of unilateral adrenal hyperplasia: the diagnostic dilemma of hyperaldosteronism.
A case of Williams syndrome with suspected coexisting ectopic aldosterone-producing tumor in the liver.
A case report of reninoma: radiological and pathological features of the tumour and characterization of tumour-derived juxtaglomerular cells in culture.
A kidney tumor in an adolescent with severe hypertension and hypokalemia: an uncommon case--case report and review of the literature on reninoma.
A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension.
A novel compound heterozygous mutation in the CYP17A1 gene in a patient with 17?-hydroxylase/17,20-lyase deficiency.
A novel compound heterozygous mutation of K494_V495 deletion plus R496L and D487_F489 deletion in extreme C-terminus of cytochrome P450c17 causes 17alpha-hydroxylase deficiency.
A Novel Frameshift Mutation of SCNN1G Causing Liddle Syndrome with Normokalemia.
A patient with cystinosis presenting transient features of Bartter syndrome.
A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5.
A pediatric Conn syndrome case.
A Rare Cause of Chronic Hypokalemia with Metabolic Alkalosis: Case Report and Differential Diagnosis.
A renin-secreting tumor.
A step by step approach in differential diagnosing of adrenal incidentaloma (epinephroma), (with comments on the new Clinical Practice Guidelines of the European Society of Endocrinology).
A Therapeutic Challenge: Liddle's Syndrome Managed with Amiloride during Pregnancy.
A Woman with Normotensive Primary Hyperaldosteronism.
Abnormal captopril scintigraphy in Bartter syndrome.
Abnormalities of aldosterone synthesis and action in children.
Acquired Bartter-Like Phenotype.
Adrenal adenoma with excess secretion of corticosterone and 18-hydroxycorticosterone.
Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism.
Adrenal neuroblastoma in an elderly adult: a case report and review of the literature.
Adrenal tumor producing 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone and aldosterone.
Aldosterone and cortisol co-secreting bifunctional adrenal cortical carcinoma: A rare event.
Aldosterone and testosterone producing adrenal adenoma in childhood.
Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Aldosterone-producing adenoma without hypertension: a report of two cases.
Aldosterone-producing-adenoma (A-P-A): effect of pregnancy.
An additional child case of an aldosterone-producing adenoma with an atypical presentation of peripheral paralysis due to hypokalemia.
An ectopic renin-secreting adrenal corticoadenoma in a child with malignant hypertension.
An unusual case of an aldosterone-producing adenoma in a prepubertal girl with severe post-surgical adrenal suppression.
Analysis of claudin genes in pediatric patients with Bartter's syndrome.
Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism.
Antihypertensive drugs in combination: Effects of methyldopa on thiazide-induced changes in renal hemodynamics and plasma renin activity.
Apparent Mineralocorticoid Excess in the Pediatric Population: Report of a Novel Pathogenic Variant of the 11?-HSD2 Gene and Systematic Review of the Literature.
Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
Apparent mineralocorticoid excess.
Apparent mineralocorticoid excess: type I and type II.
Application of 3D printing technology in endophytic reninoma: A case report and literature review.
Approach to the patient with hypertension, unexplained hypokalemia, and metabolic alkalosis.
Association of Bartter's syndrome and empty sella.
Asymptomatic Bartter's syndrome.
Attenuation of hydrochlorothiazide-induced hypokalemia in dogs by a beta-adrenergic blocking drug, timolol.
Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome.
Bartter syndrome in a neonate: early treatment with indomethacin.
Bartter's syndrome in a 74-year-old woman: response to anti-inflammatory agents.
Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
Bartter's syndrome with gouty arthritis.
Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin.
Bartter's syndrome with type 2 diabetes mellitus.
Bartter's syndrome: renal scintigraphic appearance after captopril administration.
Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.
Bilateral aldosterone-producing adenomas in two patients diagnosed by immunohistochemical analysis of steroidogenic enzymes.
Characterization and Management of Juxtaglomerular Cell Tumor: Analysis of 9 Cases and Literature Review
Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
Close examination of steroidogenesis disorders in a DOC- and progesterone-producing adrenocortical carcinoma.
Coexistence of pheochromocytoma, adrenal adenoma and hypokalemia.
Competitive effects of hypokalemia and volume depletion on plasma renin activity, aldosterone and catecholamine concentrations in hemodialysis patients.
Computerized-tomography-guided percutaneous tumor ablation using acetic acid injection in an aldosterone-producing tumor--a novel therapy.
Concurrent hypercortisolism and hypermineralocorticoidism.
Concurrent hypersecretion of aldosterone and cortisol from the adrenal cortical adenoma.
Cystinosis presenting with findings of bartter syndrome.
Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism.
Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?
Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.
Diagnosis and management of primary aldosteronism.
Diagnosis and treatment of renin-secreting tumors. Report of three cases.
Diagnostic accuracy of adrenal venous sampling in comparison with other parameters in primary aldosteronism.
Diagnostic approach to patients with primary hyperaldosteronism.
Diagnostic value of the post-captopril test in primary aldosteronism.
Differential diagnosis in primary aldosteronism.
Digenetic inheritance of SLC12A3 and CLCNKB genes in a Chinese girl with Gitelman syndrome.
Disorders of steroid 17 alpha-hydroxylase deficiency.
Dual Paraneoplastic Endocrine Syndromes Heralding Onset of Extrapulmonary Small Cell Carcinoma: A Case Report and Narrative Review.
Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be?
Effect of insulin-induced hypokalemia on lumbar sympathetic nerve activity in anesthetized rats.
Effects of propranolol on cardiovascular and neurohumoral actions of alcohol in hypertensive patients.
Efficacy of Antihypertensive Therapy in a Child with Unilateral Focal Fibromuscular Dysplasia of the Renal Artery: A Case Study and Review of Literature.
Endovascular treatment of renal artery stenosis improves contralateral renal hypertrophy with nephrotic syndrome.
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.
Evidence for an intrarenal beta receptor in control of renin release.
Evolution of diagnostic criteria for primary aldosteronism: why is it more common in "drug-resistant" hypertension today?
Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
Feline primary hyperaldosteronism.
Forms of mineralocorticoid hypertension.
From Bartter's syndrome to renal tubular acidosis in a patient with Hashimoto's thyroiditis: A case report?.
Functional Study of Novel Bartter's Syndrome Mutations in ClC-Kb and Rescue by the Accessory Subunit Barttin Toward Personalized Medicine.
Genetic alterations in patients with primary aldosteronism.
Genotype-phenotype analysis of a newly discovered family with Liddle's syndrome.
Gitelman's syndrome with exercise-induced ventricular tachycardia.
Glucocorticoid remediable aldosteronism: a case report.
Glucocorticoid-suppressible hyperaldosteronism. Ultrastructural observation of a case.
High plasma renin activity and hypokalemia in rabbits with chronic renovascular hypertension.
High renin hypertension in focal renal fibromuscular dysplasia: turn off of renin system angiotensin overactivation by renal angioplasty cured high blood pressure and quickly reversed myocardial hypertrophy.
High renin hypertension in the elderly.
Hyperaldosteronism: the internist's hypertensive disease.
Hyperprostaglandin E syndrome: use of indomethacin and steroid, and death due to necrotizing enterocolitis and sepsis.
Hypertension and adrenal disorders.
Hypertension and hypokalemia: unusual syndromes.
Hypertension caused by an aldosterone-secreting adenoma. Occurrence in a 7-year-old child.
Hypertension corrected by discontinuing chronic sodium bicarbonate ingestion. Subsequent transient hypoaldosteronism.
Hypertension secondary to renin-secreting juxtaglomerular cell tumor: case report and review of 38 cases.
Hypertension, hypokalemia and hypoaldosteronism with suppressed renin: a clinical study of a patient with Liddle's syndrome.
Hypertension, hypokalemia, hyporeninemia and severe target organ damage.
Hypertensive Crisis with Neurological Impairment Mimicking a Guillain-Barrè Syndrome: Searching for a Link.
Hypodipsic hypernatremia with intact AVP response to non-osmotic stimuli induced by hypothalamic tumor: a case report.
Hypokalemia and metabolic alkalosis: algorithms for combined clinical problem solving.
Hypokalemia and sodium retention in patients with diabetes and chronic hepatitis receiving insulin and glycyrrhizin.
Hypokalemia from beta 2-receptor stimulation by circulating epinephrine.
Hypokalemia from beta2-receptor stimulation by circulating epinephrine.
Hypokalemia secondary to primary hyperaldosteronism in a renal transplant recipient.
Hypokalemia with normal blood pressure, aldosterone and renin levels secondary to a renal or adrenal tumor.
Hypokalemic metabolic alkalosis with hypomagnesuric hypermagnesemia and severe hypocalciuria: a new syndrome?
Hypokalemic paralysis in a middle-aged female with classic Bartter syndrome.
Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism.
Hyponatremic hypertensive syndrome and massive proteinuria in a patient with renin-producing leiomyosarcoma.
Identification and implications of new types of mineralocorticoid hypertension.
Idiopathic hyperplasia of the adrenal gland behaving like an aldosterone producing adenoma.
Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
Impaired water diuresis in a patient with pseudo-Bartter syndrome.
Improvement of Cardiac Function by Laparoscopic Adrenalectomy in a Patient with Severe Heart Failure Attributable to Primary Aldosteronism.
Influence of 19-nor-deoxycorticosterone on blood pressure, saline consumption, and serum electrolytes, corticosterone, and renin activity.
Inherited forms of mineralocorticoid hypertension.
Itraconazole induced hypertension and hypokalemia: Mechanistic evaluation.
Japanese family with glucocorticoid-remediable aldosteronism diagnosed by long-polymerase chain reaction.
Junctional Bradycardia as Early Sign of Digoxin Toxicity in a Premature Infant with Congestive Heart Failure due to a Left to Right Shunt.
JUXTAGLOMERULAR CELL CAUSE OF SECONDARY HYPERTENSION IN AN ADOLESCENT.
Juxtaglomerular cell tumor of the kidney--a new classification scheme.
Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives.
Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases.
Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity.
Licorice-related rhabdomyolysis: a big price for a sweet tooth.
Liddle's syndrome associated with a point mutation in the extracellular domain of the epithelial sodium channel gamma subunit.
Liquorice-induced sodium retention. Merely an acquired condition of apparent mineralocorticoid excess? A case report.
Low renin essential hypertension in a child.
Low renin hypertension.
Low renin, low aldosterone hypertension associated with hypokalemia. Report of two cases.
Malignant hypertension due to a large reninoma: a case report.
Mesangial proliferative glomerulonephritis with aldosterone-producing adenoma.
Mineralocorticoid hypertension and hypokalemia.
Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone.
Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
Molecular and Cellular Mechanisms of Aldosterone Producing Adenoma Development.
Molecular mechanisms in primary aldosteronism
Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals.
Mood Disorders in Uncontrolled Hypertension Despite Multiple Anti-Hypertensive Medications: Searching for a Link.
MR findings of renin-secreting tumor: a case report.
Multifactorial analysis of chronic hypertension induced by electrolyte-active steroids in trained, unanesthetized dogs.
Myasthenia gravis complicated with primary aldosteronism and hypokalemic myopathy.
Myxoid Adrenal Cortical Carcinoma Presenting as Primary Hyperaldosteronism: Case Report and Review of the Literature.
Nephrocalcinosis and renal cysts associated with apparent mineralocorticoid excess syndrome.
New aspects of mineralocorticoid hypertension.
New aspects on primary aldosteronism.
New diagnostic procedure for primary aldosteronism: adrenal venous sampling under adrenocorticotropic hormone and angiotensin II receptor blocker--application to a case of bilateral multiple adrenal microadenomas.
New-onset resistant hypertension in a newly diagnosed prostate cancer patient.
Newly developed hypertension due to juxtaglomerular cell tumor in pregnancy.
Nonfunctioning juxtaglomerular cell tumor.
Normalization of high plasma level of ouabain-like immunoreactivity in primary aldosteronism after removal of adenoma.
Normotensive presentation in primary aldosteronism: A report of two cases.
Old and new genes in primary aldosteronism.
Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells.
Partial versus total adrenalectomy for the treatment of unilateral aldosterone-producing adenoma: a systematic review and meta-analysis.
Pathogenesis of hypertension in a mouse model for human CLCN2 related hyperaldosteronism.
Pathogenesis of hypertension in Cushing's syndrome.
Persistent severe hyperkalemia following surgical treatment of aldosterone-producing adenoma.
Polycystic kidney disease presenting with hypertension and hypokalemia.
Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism.
Preclinical Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia with excessive secretion of 18-hydroxydeoxycorticosterone and corticosterone.
Prediction of successful outcome in patients with primary aldosteronism.
Prevalence of Liddle Syndrome Among Young Hypertension Patients of Undetermined Cause in a Chinese Population.
Primary aldosteronism due to unilateral adrenal hyperplasia.
Primary aldosteronism due to unilateral adrenal hyperplasia: a case report.
Primary aldosteronism due to unilateral adrenal hyperplasia: report of two cases and review of the literature.
Primary aldosteronism.
Primary aldosteronism. Issues in diagnosis and management.
Primary aldosteronism: a practical approach to diagnosis and treatment.
Primary aldosteronism: diagnosis and treatment.
Primary hyperaldosteronism in childhood due to unilateral macronodular hyperplasia. Case report.
Primary hyperaldosteronism in two cats.
Pseudo-Bartter's Syndrome in Patients with Cystic Fibrosis: A Case Series and Review of the Literature.
Pseudoaldosteronism in an elderly man believed to be caused by the health food Shin-Gojoshin.
Pseudoaldosteronism with increased serum cortisol associated with pneumonia, hypouricemia, hypocalcemia, and hypophosphatemia.
Pseudohyperaldosteronism from liquorice-containing laxatives.
Pseudoprimary aldosteronism from the topical application of 9-alpha-fluorprednisolone to the skin.
Rare and curable renin-mediated hypertension: a series of six cases and a literature review.
Rare causes of adrenocortical hypertension.
Renal potassium wasting in distal renal tubular acidosis: role of aldosterone.
Renin dependent hypertension caused by accessory renal arteries.
Renin-producing ovarian tumor. A case report with immunohistochemical and electron-microscopic study.
Renin-secreting clear cell carcinoma of the kidney.
Renin-secreting renal tumour with severe hypertension. case report with tumour renin analysis, histopathological and ultrastructural studies.
Reninoma: case report and literature review.
Resolution of Hyperreninemia, Secondary Hyperaldosteronism, and Hypokalemia With 177Lu-DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy in a Patient With Pancreatic Neuroendocrine Tumor.
Review and Analysis of Two Gitelman Syndrome Pedigrees Complicated with Proteinuria or Hashimoto's Thyroiditis Caused by Compound Heterozygous SLC12A3 Mutations.
Rhabdomyolysis due to primary hyperaldosteronism.
Risk Factors for Pseudoaldosteronism with Rhabdomyolysis Caused by Consumption of Drugs Containing Licorice and Differences Between Incidence of These Conditions in Japan and Other Countries: Case Report and Literature Review.
Role of epinephrine-induced hypokalemia in the regulation of renin and aldosterone in humans.
Screening for genetic causes of hypertension.
Secondary hypertension due to renin secreting tumor: a case report.
Seizure and coma secondary to Conn's syndrome: a case report.
Selection of patients for surgery for primary aldosteronism.
Selective hypoaldosteronism in a patient with Sjögren's syndrome: insensitivity to angiotensin II.
Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone.
Shakuyaku-kanzo-to induces pseudoaldosteronism characterized by hypokalemia, rhabdomyolysis, metabolic alkalosis with respiratory compensation, and increased urinary cortisol levels.
Splicing analysis of CYP11B1 mutation in a family affected with 11?-hydroxylase deficiency: case report.
Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia.
Steroid characteristics of mineralocorticoid adrenocortical hypertension.
Steroids and hypertension.
Studies on renal function in healthy women with different degrees of induced potassium depletion. 1) Hormonal changes relevant to salt and water balance.
Subclinical hormone secretion by incidentally discovered adrenal masses.
Subtle 17alpha-hydroxylase/17,20-lyase deficiency with homozygous Y201N mutation in an infertile woman.
Successful treatment of primary aldosteronism due to computed tomography-negative microadenoma.
Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis.
The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle's syndrome.
The Role of Real-Time Contrast-Enhanced Ultrasound in Guiding Radiofrequency Ablation of Reninoma: Case Report and Literature Review.
The Small Size and Superficial Location Suggest That Laparoscopic Partial Nephrectomy Is the First Choice for the Treatment of Juxtaglomerular Cell Tumors.
The syndromes of low-renin hypertension: "separating the wheat from the chaff".
The therapeutic effect of a new angiotensin-converting enzyme inhibitor, enalapril maleate, in idiopathic hyperaldosteronism.
Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy.
Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
Unilateral adrenal hypersecretion of both aldosterone and cortisol in two first cousins with a syndrome of mineralocorticoid excess but without signs of hypercortisolism.
Unilateral hypersecretion of aldosterone associated with adrenal hyperplasia as a cause of primary aldosteronism.
Variant of Bartter's syndrome with a distal tubular rather than loop of Henle defect.
Whole-exome sequencing reveals an inherited R566X mutation of the epithelial sodium channel ?-subunit in a case of early-onset phenotype of Liddle syndrome.
[11beta-hydroxysteroide dehydrogenases. Recent advances]
[A 87-year-old woman with mineralocorticoid excess due to 11 beta-HSD2 deficiency]
[A brief history of diagnosis and treatment of primary aldosteronism.]
[A case of bilateral aldosterone-producing adrenal adenomas]
[A case of distal renal tubular acidosis complicated with renal diabetes insipidus, showing aggravation of symptoms with occurrence of diabetes mellitus].
[A case of idiopathic hyperaldosteronism with normal plasma aldosterone concentrations for 5 years after onset: a 12-year follow-up study]
[A case of pseudo-Bartter's syndrome associated with hypokalemic myopathy]
[A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia]
[A case of the benign adrenal adenoma with remarkably high concentrations of deoxycorticosterone and 11-deoxycortisol]
[A clinical analysis of reninoma-induced hypertensive crisis associated with reversible posterior encephalopathy syndrome].
[A patients with chronic renal failure due to Bartter's syndrome]
[A review of ten cases of aldosteronoma. Diagnostic and therapeutic conclusions (author's transl)]
[A study of mutation(s) of the epithelial sodium channel gene in a Liddle's syndrome family]
[Arterial hypertension in renin-producing retroperitoneal leiomyosarcoma]
[Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)]
[Bartter's syndromes]
[Bilateral Conn's adenoma. Diagnostic discussions]
[Chondrocalcinosis and hypomagnesaemia in a patient with a new mutation in the gene of the thiazide-sensitive Na-Cl cotransporter]
[Conn's syndrome: surgical experience]
[Evaluation of the hypotensive effect of unilateral adrenalectomy in patients with low-renin hyperaldosteronism]
[From gene to disease; 'apparent mineralocorticoid excess' syndrome, a syndrome with an apparent excess of mineral corticoids]
[High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension]
[Juxtaglomerular cell tumor: a case report]
[Liddle syndrome (or pseudo-hyperaldosteronism). Long-term development and erythrocyte potassium flow study in 4 cases]
[Liddle's syndrome: late diagnosis of a rare cause of arterial hypertension]
[Mineralocorticoid-like hypertension. "Apparent mineralocorticoid excess". A hereditary type of hypertension?]
[Paraneoplastic hypercorticism. Hypokalemia, increased plasma renin activity and hypoaldosteronism during cancer of the pancreas]
[Plasma renin concentration during hypokalemia induced by pneumencephalography]
[Primary aldosteronism--hypertension associated with hypokalemia and reduced plasma renin activities]
[Primary hyperaldosteronism by unilateral adrenal hyperplasia: a report of two cases].
[Primary hyperaldosteronism: problems of diagnostic approaches].
[Primary hyperaldosteronism]
[Pseudo-Bartter syndrome in a case of cystic fibrosis caused by C1529G and G3978A compound heterozygosity]
[Renovascular arterial hypertension complicated by diabetes insipidus: report of a case and review of the literature].
[Strategy for studying mineralocorticoids other than aldosterone in arterial hypertension of hormonal origin]
[Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years]
[Tetany as a sole manifestation in a patient with Bartter's syndrome and a successful treatment with indomethacin]
[The Bartter-like syndrome in 2 twins]
[The glucagonoma syndrome. Review of the literature. Apropos of a case]
[Three cases of primary aldosteronism including one case with postoperative ventricular tachycardia]
[Two case reports of unilateral adrenal hyperplasia with contralateral renal cell carcinoma]
Hypokinesia
Changes of hormones regulating electrolyte metabolism after space flight and hypokinesia.
[Effect of beta-adrenergic blockaders and trental on plasma levels of renin and aldosterone in healthy persons during antiorthostatic hypokinesia]
[Effect of space flight factors on the hormonal regulation of water-salt metabolism]
Hyponatremia
A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing.
A case of congenital chloride diarrhea: information obtained through long-term follow-up with reduced electrolyte substitution.
A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene.
A Novel Mutation of the
A novel mutation of the StAR gene with congenital adrenal hyperplasia and its association with heterochromia iridis: a case report.
Abnormalities of aldosterone synthesis and action in children.
Absence of amiloride-sensitive sodium absorption in the airway of an infant with pseudohypoaldosteronism.
Acquired Bartter-Like Phenotype.
Aldosterone deficiency with a hormone profile mimicking pseudohypoaldosteronism.
Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review.
Association of hyponatremia with increased renin activity in chronic congestive heart failure: impact of diuretic therapy.
Bartter syndrome in a neonate: early treatment with indomethacin.
Cerebral salt wasting in children. The need for recognition and treatment.
Clinical features, genetic background, and outcome in infants with urinary tract infection and type IV renal tubular acidosis.
Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review.
Coincidence of pseudohypoaldosteronism with gluten-enteropathy.
Congenital hyperreninemic hypoaldosteronism due to aldosterone synthase deficiency type I in a Portuguese patient - Case report and review of literature.
Congenital hyperreninemic hypoaldosteronism unlinked to the aldosterone synthase (CYP11B2) gene.
Corticosterone methyloxydase deficiency type II in a Croatian girl.
Development of malignant hypertension in patients with uremia under hemodialysis: a case report and discussions on its etiology.
Dilutional hyponatremia in patients with cirrhosis and ascites.
Effect of demeclocycline on renal function and urinary prostaglandin E2 and kallikrein in hyponatremic cirrhotics.
Effects of chronic sodium depletion on canine brain renin and cathepsin D activities.
Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice.
Efficacy of Antihypertensive Therapy in a Child with Unilateral Focal Fibromuscular Dysplasia of the Renal Artery: A Case Study and Review of Literature.
Expanding the spectrum of genetic mutations in antenatal Bartter syndrome type II.
Failure to Thrive, Hyponatremia, Hyperkalemia - Differential Diagnostic Reflections of a Rare Genetic Disease.
Generalized unresponsiveness to mineralocorticoid hormones: familial recessive pseudohypoaldosteronism due to aldosterone-receptor deficiency.
GPR48 increases mineralocorticoid receptor gene expression.
High renin in heart failure: a manifestation of hyponatremia.
Hormonal and hemodynamic changes during percutaneous nephrolithotomy.
Hyperaldosteronemia and hypogammaglobulinemia secondary to atopic dermatitis-induced exudation in an infant presenting with growth failure.
Hyperkalemic distal renal tubular acidosis in salt-losing congenital adrenal hyperplasia.
Hyperprostaglandin E syndrome: use of indomethacin and steroid, and death due to necrotizing enterocolitis and sepsis.
Hyponatremic hypertensive syndrome - a retrospective cohort study.
Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.
In right or biventricular chronic heart failure addition of thiazides to loop diuretics to achieve a sequential blockade of the nephron is associated with increased risk of dilutional hyponatremia: results of a case-control study.
Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis.
Mineralocorticoid deficiency in post-operative cerebral salt wasting.
Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism.
Mineralocorticoid resistance.
Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism.
More on renal salt wasting without cerebral disease: response to saline infusion.
Postnatal development of renin-angiotensin-aldosterone system, RAAS, in relation to electrolyte balance in premature infants.
Pseudo-Bartter's Syndrome in Patients with Cystic Fibrosis: A Case Series and Review of the Literature.
Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia.
Pseudohypoaldosteronism types I and II: little more than a name in common.
Quantification and predictors of plasma volume expansion from mannitol treatment.
Rare Cause of Hyperkalemia in the Newborn Period: Report of Two Cases of Pseudohypoaldosteronism Type 1.
Reduced Na+, K(+)-ATPase activity in patients with pseudohypoaldosteronism.
Renal and systemic hemodynamics, in falciparum malaria.
Restoration of Epithelial Sodium Channel Function by Synthetic Peptides in Pseudohypoaldosteronism Type 1B Mutants.
Role of vasopressin in regulation of sodium excretion.
Selective hypoaldosteronism in infancy. Report of a case.
Selective hypopituitarism with severe hyponatremia and secondary hyporeninism.
Severe pseudohypoaldosteronism in a pair of twins not associated with hydramnios.
Severity of virilization of external genitalia in Japanese patients with salt-wasting 21-hydroxylase deficiency.
Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia.
Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma.
Systemic Pseudohypoaldosteronism Type 1 due to 3 Novel Mutations in SCNN1Aand SCNN1BGenes.
Systemic pseudohypoaldosteronism-1 with episodic dyslipidemia in a Sudanese child.
The hyponatremia of neonatal urinary ascites: clinical observations, experimental confirmation and proposed mechanism.
Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia.
Transient Hyponatremia During Hospitalization for Acute Heart Failure.
Treatment of an infant with congenital sodium diarrhea by oral rehydration.
Treatment of Ascites.
Treatment of hypothyroidism in elderly patients and in patients with cardiac disease.
Trimethoprim-Associated Hyponatremia.
Two novel mutations of the CYP11B2 gene in a Japanese patient with aldosterone deficiency type 1.
Vasopressin excess: relative contribution of volume retention versus direct actions on renin secretion and sodium excretion.
[Aggravation of salt loss due to hydrocortisone in the first days of treatment of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency]
[Correlation of hyponatremia with plasma renin activity, antidiuretic hormone and brain natriuretic peptide in chronic heart failure]
[Hemofiltration and the neurohumoral system in patients with severe heart failure]
[Indomethacin and furosemide in patients with cardiac insufficiency. Kidney function, the renin-angiotensin system and renal prostaglandins]
[Mineralocorticoid resistance: pseudohypoaldosteronism type 1]
[Multiple type I pseudohypoaldosteronism: neonatal management and outcome]
[Pathogenesis of hyponatremia observed in the treatment of acute subarachnoid hemorrhage]
[Pseudo-Bartter syndrome in a case of cystic fibrosis caused by C1529G and G3978A compound heterozygosity]
[Severe hyponatremia in a case of severe spinal injury: sequential examination of factors affecting water-electrolyte balance]
Hypoparathyroidism
Reversible hypertension caused by calcium overloading in a patient with postoperative hypoparathyroidism.
Hypophosphatemia
Licorice-related rhabdomyolysis: a big price for a sweet tooth.
Hypophosphatemia, Familial
PCSK9 in diabetic kidney disease.
Hypopituitarism
Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
Regulation of aldosterone biosynthesis during sodium deficiency. Evidence for an essential role of the pituitary gland.
Selective hypopituitarism with severe hyponatremia and secondary hyporeninism.
[Plasma aldosterone and renin activity in hypopituitarism (author's transl)]
Hypoproteinemia
Effects of sustained lymph drainage on cardiovascular function and thoracic duct lymph in sheep.
Hyperaldosteronemia and hypogammaglobulinemia secondary to atopic dermatitis-induced exudation in an infant presenting with growth failure.
Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
Hypotension
A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing.
A Premature Baby with Severe Oligohydramnios and Hypotension: a Case Report of Renal Tubular Dysgenesis.
A primitive type of renin-expressing lymphocyte protects the organism against infections.
ACTH, cortisol, and renin responses to arterial hypotension in sheep.
Activation of the renal pressure system following severe hypotension and its pathophysiologic significance.
Activity of the renin-angiotensin-aldosterone and sympathetic nervous system and their relation to hemodynamic and clinical abnormalities in infants with left-to-right shunts.
Adenosine inhibits renin release induced by suprarenal-aortic constriction and prostacyclin.
Adrenergic regulation of renin secretion and renal hemodynamics during deliberate hypotension in humans.
Adrenergic responsiveness in prehypertensive subjects.
Alteration of cardiovascular, neurogenic, and humoral responses to acute hypovolemic hypotension by administered prostacyclin.
Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
An orally active inhibitor of renin.
Anaesthetic management for hiatal hernia repair in a child with Bartter's syndrome: A case report.
Angiotensin converting enzyme inhibitors and moderate hypertension.
Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia.
Angiotensins II and III prevent captopril-induced renin release in the rat.
Anterior ischemic optic neuropathy. VIII. Clinical features and pathogenesis of post-hemorrhagic amaurosis.
Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models.
Arterial baroreceptors control plasma vasopressin responses to graded hypotension in conscious dogs.
Atrial natriuretic peptide blocks renin response to renal hypotension.
Baroreceptor and prostanoid control of fetal renal cortical blood flow and plasma renin activity.
Bartter's syndrome: an overview.
Blood pressure and renin responses to captopril in anesthetized rats pretreated with indomethacin or aprotinin.
Blood pressure reduction in hypertensive-diabetic rats by the somatostatin analog MK-678.
Blood pressure-dependent inhibition of Renin secretion requires A1 adenosine receptors.
Captopril increases renin release stimulated by furosemide and hypotension in isolated perfused guinea pig kidneys.
Cardiovascular afferent signals and drinking in response to hypotension in dogs.
Cardiovascular, renal, and endocrine response to atrial natriuretic peptide in angiotensin II mediated hypertension.
Carotid baroreceptor unloading decreases plasma atrial natriuretic factor in hypertensive patients.
Central and peripheral adrenergic modulation of carotid sinus-induced renin release.
Central and splanchnic hemodynamics in the dog during controlled hypotension with adenosine.
Changes in control of renin release in congestive heart failure in dogs: response to acute and chronic vasodilator therapy.
Changes in plasma catecholamines and plasma renin activity during hypotension in conscious rats with lesions of the nucleus tractus solitarii.
Chronic effects of a physiological dose of ANP on arterial pressure and renin release.
Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
Clinical pharmacology of angiotensin antagonists.
Clonidine after renal ischemia to lessen acute renal failure and microvascular damage.
CNS pathways mediating cardiovascular regulation of vasopressin.
Comparison of hormonal responses to hypotension in mature and immature fetal lambs.
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.
Conditions for augmentation of renin release by theophylline.
Conditions for stimulation of renin release by cyclic AMP in anaesthetized dogs.
Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation.
Contribution of beta-adrenergic receptor mediated renin release to the maintenance of blood pressure during nitroprusside infusion in conscious rats.
Controlled hypotension with adenosine or sodium nitroprusside during cerebral aneurysm surgery: effects on renal hemodynamics, excretory function, and renin release.
Cortisol-induced inhibition of ovine renin and aldosterone responses to hypotension.
Ctcf is required for renin expression and maintenance of the structural integrity of the kidney.
Deliberate hypotension with nicardipine or nitroprusside during total hip arthroplasty.
Differences in reflex control of arterial pressure and renin release during head-up tilting in the cat.
Direct effect of prostaglandins in renal function and renin release in the presence of renal ischemia in the dog.
Discordant orthostatic reflex renin-angiotensin and sympathoneural responses in premenopausal exercising-hypoestrogenic women.
Disturbed homeostasis in sodium-restricted mice heterozygous and homozygous for aldosterone synthase gene disruption.
Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
Effect of atrial natriuretic factor on release of arginine vasopressin and renin in fetal lambs.
Effect of cortisol on blood pressure and the renin-angiotensin system in fetal sheep during late gestation.
Effect of elevated atrial pressure on plasma renin activity in hypotensive fetal lambs.
Effect of loading right atrial and ventricular receptors on stimulated AVP, ACTH, and renin secretion in awake dogs.
Effect of ovariectomy on vasopressin, ACTH, and renin activity responses to hypotension.
Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome.
Effects of adenosine-induced hypotension on myocardial hemodynamics and metabolism during cerebral aneurysm surgery.
Effects of angiotensins II and III on glomerulotubular balance in rats.
Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction.
Effects of AT(1A) receptor deletion on blood pressure and sodium excretion during altered dietary salt intake.
Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension.
Effects of experimental hypotension on hemodynamics and renin secretion rate.
Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs.
Effects of K-351 on hemodynamics and renin release in anesthetized dogs.
Effects of KRN2391-induced hypotension on the endocrine system and carbohydrate metabolism in halothane-anesthetized dogs.
Effects of levodopa alone and in combination with dopa-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease.
Effects of naloxone on renin and pressor responses to acute renal hypotension in rats.
Effects of prazosin on blood pressure and plasma renin activity during onset and withdrawal of action in the anaesthetized rat.
Effects of progesterone on blood pressure, plasma volume, and responses to hypotension.
Effects of propranolol on the cardiovascular and renin-angiotensin systems during hypotension produced by sodium nitroprusside in humans.
Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis.
Elevated cardiac pressure inhibits renin release after arterial hypotension in conscious dogs.
Elevated dietary salt suppresses renin secretion but not thirst evoked by arterial hypotension in rats.
Enalaprilat effects renin-angiotensin and adrenergic response to induced hypotension in the rabbit.
Esmolol for potentiation of nitroprusside-induced hypotension: impact on the cardiovascular, adrenergic, and renin-angiotensin systems in man.
Evaluation of a blood sample-transfusion protocol in rats: blood gases, renin, and ACTH.
Exercise training hypotension: implications for plasma volume, renin, and vasopressin.
Expression of neuronal type nitric oxide synthase and renin in the juxtaglomerular apparatus of angiotensin type-1a receptor gene-knockout mice.
First dose effect of the oral angiotensin converting enzyme inhibitor captopril.
Forebrain pathways mediating stress-induced renin secretion.
Glomerular and vascular atrial natriuretic factor receptors in adrenalectomized rats.
Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome.
Haemodynamic and endocrine effects of deliberate hypotension with magnesium sulphate for cerebral-aneurysm surgery.
Haemodynamic and renal evolution of the bile duct-ligated rat.
Haemodynamic effects of prazosin.
Hemodynamic effects of adenosine agonists in the conscious spontaneously hypertensive rat.
Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey.
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension.
Hepatorenal syndrome.
Hepatorenal syndrome: a disease mediated by the intrarenal action of renin.
High renin low blood pressure and its treatment with calcium glycyrrhetinyl-glycinate.
Hormonal and cardiovascular effects of losulazine hydrochloride in relation to sodium balance in nonhuman primates.
Human renin inhibiting dipeptide.
Hypererythropoietinemia and hyperreninemia in a continuous ambulatory peritoneal dialysis patient with chronic severe hypotension.
Hypertension during anesthesia on discontinuation of sodium nitroprusside-induced hypotension.
Hypotension in NKCC1 null mice: role of the kidneys.
Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril.
Hypotension-induced hypokalaemia in sheep.
Hypotensive and vasodilatory activity of (+/-) 1-o-octadecyl-2-acetyl glyceryl-3-phosphorylcholine in the normotensive rat.
Impact of surgical stress on the haemodynamic profile of isoflurane-induced hypotension.
Influence of age on orthostatic changes in plasma renin activity and urinary catecholamines in man.
Influence of dietary sodium on renin angiotensin system involvement in sodium nitroprusside hypotension in conscious rats.
Inhibition of angiotensin conversion and prevention of renal hypertension.
Intrarenal renin-angiotensin system in primitive vertebrates.
Investigation of midazolam's influence on physiological and hormonal responses to hypotension.
Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats.
Involvement of renal alpha- and beta-adrenoceptors in release of renin by carotid baroreflex.
Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?
Isoproterenol-induced thirst: renal and extrarenal mechanisms.
Kinetic Changes of Plasma Renin Levels Predict Acute Kidney Injury in Cardiac Surgery Patients.
Lack of inhibitory effect of atrial natriuretic factor on renin release induced by renal hypotension.
Left heart and arterial baroreceptors interact in control of plasma vasopressin, renin, and cortisol in awake dogs.
Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.
Low renin-aldosterone in "prehypertensive" young adults.
Mechanism of inhibition of renin response to hypotension by atrial natriuretic factor.
Mechanism of inhibition of renin secretion by increased left atrial pressure.
Mechanism of renin release during renal nerve stimulation in dogs.
Mechanism of suppression of vasopressin and adrenocorticotropic hormone secretion by clonidine in anesthetized dogs.
Methylxanthines augment the renin response to suprarenal-aortic constriction.
Modifications of arterial pressure and plasma renin: their effects on the norepinephrine content of hypothalamus and medulla oblongata.
Negative-feedback inhibition of fetal ACTH secretion by maternal cortisol.
Norepinephrine and renin activity in chronic renal failure. Evidence for interacting roles in hemodialysis hypertension.
Orthostatic hypotension after spinal cord injury: treatment with fludrocortisone and ergotamine.
Oxytocin antagonist disrupts hypotension-evoked renin secretion and other responses in conscious rats.
Oxytocin-induced renin secretion in conscious rats.
Participation of renal, but not of submaxillary renin in the homeostasis of the blood pressure after experimentally induced hypotension in mice.
Peptide inhibitors of renin in cardiovascular studies.
Persistent arterial hypotension after bilateral nephrectomy in a 4-month-old infant.
Persistent peripheral vasodilation and sympathetic activity in hypotension after maximal exercise.
Physiological evolution of the renin-angiotensin system.
Placental insufficiency and fetal growth restriction lead to postnatal hypotension and altered postnatal growth in sheep.
Plasma atrial natriuretic factor in low output heart failure syndromes.
Plasma catecholamines, plasma renin activity and haemodynamics during sodium nitroprusside-induced hypotension and additional beta-blockage with bunitrolol.
Plasma renin activity, renal artery blood flow and cortical tissue oxygen tensionin haemorrhagic hypotension.
Plasma renin and angiotensin II in acute renal failure.
Plasma renin, catecholamine, and vasopressin during nitroprusside-induced hypotension in ewes.
Plasma renin, catecholamines, vasopressin and aldosterone during hypotension induced by labetalol with isoflurane.
Plasma vasopressin, renin and catecholamines during nitroprusside-induced hypotension in the newborn lamb.
Plasma vasopressin, renin, and catecholamines during nitroprusside-induced maternal and fetal hypotension in sheep.
Possible mechanisms of cardiac contractile dysfunction and electrical changes in ammonium chloride induced chronic metabolic acidosis in Wistar rats.
Prazosin does not alter canine renin release in response to systemic hypotension or intrarenal isoprenaline and prostaglandin I2 infusion.
Pressor and depressor hormones during alcohol-induced blood pressure reduction in hypertensive patients.
Pressure independence of renin release by isolated kidneys of Lyon hypertensive rats.
Prevention of fatal hemorrhagic shock in dog by pretreatment with chronic high-salt diet.
Propranolol alters renin release during nitroprusside-induced hypotension and prevents hypertension on discontinuation of nitroprusside.
Propranolol prevents hemodynamic and humoral events after abrupt withdrawal of nitroprusside.
Rapid increase in desflurane concentration is associated with greater transient cardiovascular stimulation than with rapid increase in isoflurane concentration in humans.
Rare Cause of Hyperkalemia in the Newborn Period: Report of Two Cases of Pseudohypoaldosteronism Type 1.
Reduced angiotensin receptors and pressor responses in hypotensive hemodialysis patients.
Reduced plasma renin activity in elderly subjects in response to vasovagal hypotension and head-up tilt.
Reduced renal arterial perfusion pressure stimulates renin release from domestic fowl kidneys.
Relation of renal thromboxane A2 production to urine flow, electrolyte excretion and plasma renin activity in control state and drug induced hypotension.
Relationship between renin and intrarenal hemodynamics in hemorrhagic hypotension.
Relationship of alpha receptor types to hypotension and renal vasodilation caused by alpha blockers in conscious dogs.
Renal effects of continuous infusion of recombinant interleukin-2 in children.
Renal hypotension in sodium and fluid deprivation: experimental findings in renin-depleted rats.
Renal intracortical blood flow and renin secretion after denervation by 6-hydroxydopamine.
Renal PGE2 release may not be responsible for captopril-induced renal effects in anesthetized dogs.
Renin angiotensin aldosterone system and drug allergies complicated with hypotension.
Renin enhancer is crucial for full response in Renin expression to an in vivo stimulus.
Renin release and pressor response to renal arterial hypotension: effect of dietary sodium.
Renin release during controlled hypotension with sodium nitroprusside, nitroglycerin and adenosine: a comparative study in the dog.
Renin release in turtles: effects of volume depletion and furosemide administration.
Renin response and angiotensinogen control during graded hemorrhage and shock in the dog.
Renin response to hemorrhage and hypotension in the aglomerular toadfish Opsanus tau.
Renin response to hemorrhage in conscious rats: effect of acute reductions in hematocrit.
Renin-angiotensin system in sepsis.
Renin-Expressing Cells Require ?1-Integrin for Survival and for Development and Maintenance of the Renal Vasculature.
Response by the corpuscles of Stannius to hypotensive stimuli in three divergent ray-finned fishes (Amia calva, Anguilla rostrata, and Catastomus commersoni): cardiovascular and morphological changes.
Restoration of Epithelial Sodium Channel Function by Synthetic Peptides in Pseudohypoaldosteronism Type 1B Mutants.
Reversible hyporeninemic hypoaldosteronism in a patient with tetraplegia.
Role of adenosine in noradrenergic neurotransmission during hemorrhagic hypotension.
Role of L-arginine-nitric oxide pathway in hypertension.
Role of renal sympathetic nerves in renin inhibition by elevated left atrial pressure.
Role of right heart receptors in the control of renin, vasopressin, and cortisol secretion in dogs.
Saralasin-induced renin release: its blockade by prostaglandin synthesis inhibitors in the conscious rat.
Sensitivity of cortisol-induced inhibition of ACTH and renin in fetal sheep.
Severe hypotension with bradycardia during renin inhibition with H142 in sodium deplete man.
Severe ovarian hyperstimulation syndrome: role of peripheral vasodilation.
Side effects and metabolic effects of converting-enzyme inhibitors.
Sinoaortic denervation attenuates the reflex responses to hypotension in fetal sheep.
Stretch receptor control of renin release in perfused rat kidney: effect of high perfusate potassium.
Studies concerning the mechanism of suppression of renin secretion by clonidine.
Super-enhancers maintain renin-expressing cell identity and memory to preserve multi-system homeostasis.
Surgical treatment of vasorenal hypertension in nonspecific aorto-arteritis (Takayasu's disease).
Sustained ventricular unloading action of the alpha-adrenergic antagonist nicergoline in the dog.
Sympathetic blockade by thoracic epidural anaesthesia suppresses renin release in response to hypotension, but activates the vasopressin system.
Sympathetic neural blockade by thoracic epidural anesthesia suppresses renin release in response to arterial hypotension.
Sympathoadrenal inhibition by atrial natriuretic peptide is not attenuated during development of congestive heart failure in dogs.
Systemic and carotid haemodynamics and plasma renin activity during deliberate hypotension in dogs: a comparison of sodium nitroprusside with nicergoline.
Temporal pattern of secretion of renin in the hemorrhaged dog.
The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart.
The effect of hemorrhagic hypotension on urinary kallikrein excretion, renin activity, and renal cortical blood flow in the pig.
The effects of altered sodium balance and adrenergic blockade on renin release induced in rats by angiotensin antagonism.
The effects of captopril on the renin-angiotensin system and the sympathetic nervous system during sodium nitroprusside-induced hypotension in the halothane-anesthetized rabbit.
The effects of frusemide, saralasin and hypotension on fetal plasma renin activity and on fetal renal function.
The effects of stress on salt and water balance.
The endocrine control of blood volume, blood pressure and sodium balance: atrial hormone and renin system interactions.
The neuronal isoform of constitutive nitric oxide synthase is up-regulated in the macula densa of angiotensinogen gene-knockout mice.
The renin-angiotensin system and thirst: a reevaluation.
The renin-angiotensin system in nonmammalian vertebrates.
The renin-angiotensin-aldosterone system in fulminant hepatic failure.
The stress response to induced hypotension for cerebral aneurysm surgery: a comparison of two hypotensive techniques.
The transcriptional regulator RBP-J regulates the number and plasticity of renin cells.
Time course of changes in plasma renin after blockade of the renin-system. Studies of conscious and anaesthetized, normal, adrenalectomized and spontaneously hypertensive rats.
Transient hyponatremia of prematurity caused by mild Bartter syndrome type II: a case report.
Vagal and sinoaortic reflexes in postural control of circulation and renin release.
Vasopressin and angiotensin II in reflex regulation of ACTH, glucocorticoids, and renin: effect of water deprivation.
Vasopressor hormone response following mesenteric traction during major abdominal surgery.
[A comparison of the endocrine effects of hypotension induced by nicardipine with those by sodium nitroprusside in dogs]
[Atrial natriuretic factor in cardiogenic shock, in hypovolemic shock and in the bradycardia-hypotension syndrome following acute myocardial infarction]
[Blood pressure and renin in long-term hemodialysis patients]
[Comparison of endocrine effects of hypotension induced by sodium nitroprusside, trimetaphan camsylate and a nitroprusside-trimetaphan mixture in rabbits]
[Effect of thiopental anesthesia on plasma renin, adrenaline and noradrenaline in neurosurgical operations with induced hypotension]
[Endocrine effects of hypotension induced by diltiazem in rabbits]
[Endocrine effects of hypotension induced by nicardipine in rabbits]
[Endocrine effects of induced hypotension by ketanserin in anesthetized dogs]
[Kidney renin-angiotensin system and water intake]
[Parkinson's disease with syncope as a chief complaint induced by prominent postprandial hypotension]
[Plasma renin activity and prostaglandin E2 in hypotension induced by nicergoline]
[Plasma renin activity and prostaglandin E2 in hypotension induced by sodium nitroprusside]
[Plasma renin activity in chronic adrenal gland insufficiency]
[Pseudo-hypoaldosteronisms]
[Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration]
[Studies on renin secretion--plasma renin releasing factor in hemorrhagic hypotension in bilaterally nephrectomized dogs]
[The activities of the renin-angiotensin-aldosterone and sympathetic-adrenal systems during hemodialysis]
[The effect of noradrenalin and angiotensin on kidney function and plasma renin level in a patient with secondary aldosteronism and arterial hypotension]
Hypotension, Orthostatic
Adrenal insufficiency attributable to adrenal hemorrhage: long-term follow-up with reference to glucocorticoid and mineralocorticoid function and replacement.
Adrenocortical insufficiency with normal serum cortisol levels and hyporeninaemia in a patient with acquired immunodeficiency syndrome (AIDS).
Autonomic dysfunction and sleep apnea in olivopontocerebellar degeneration.
Catecholamines, renin and aldosterone in postural hypotension.
Decreased response of plasma renin activity to orthostasis in diabetic patients with orthostatic hypotension.
Diabetic orthostatic hypotension: the role of total exchangeable sodium and nephropathy.
Elevated atrial natriuretic factor in the plasma: cause or effect in "idiopathic orthostatic hypotension"?
Hemodynamics in diabetic orthostatic hypotension.
Hyporeninemic normoaldosteronism in severe autonomic failure.
Hypovolemia contributes to the pathogenesis of orthostatic hypotension in patients with diabetes mellitus.
Lithium inhibits the action of fludrocortisone on the kidney.
Pathophysiological significance of plasma total renin and prorenin in patients with diabetes mellitus.
Plasma renin activity and cyclic adenosine monophosphate in orthostatic hypotension of spinal transections.
Plasma renin activity in diabetic autonomic neuropathy.
Plasma renin and serum dopamine-beta-hydroxylase during orthostatic hypotension in quadriplegic man.
Plasma renin in idiopathic orthostatic hypotension: differential response in subjects with probable afferent and efferent autonomic failure.
PRIMARY ADRENAL INSUFFICIENCY SECONDARY TO CHRONIC POSACONAZOLE USE.
Renin responses in patients with orthostatic hypotension: case reports.
Renin, aldosterone and electrolytes in idiopathic orthostatic hypotension.
Renin-angiotensin-aldosterone system in diabetes mellitus.
Spectrum of autonomic cardiovascular neuropathy in diabetes.
Treatment of diabetic orthostatic hypotension with pindolol.
Urinary electrolyte excretion and orthostatic response of blood pressure and plasma renin activity in children with postural hypotension before and after treatment with Dihydergot.
[Orthostatic hypotension in complicated diabetes mellitus: study of the renin-angiotensin-aldosterone system (author's transl)]
[Renin and catecholamine secretions in a case of orthostatic hypotension: its physiopathological value]
[The responses of norepinephrine, renin and aldosterone to standing in diabetic patients with orthostatic hypotension]
[The role of the sympatho-adrenomedullary system and adrenergic receptors in the pathogenesis of orthostatic hypotension in diabetes mellitus]
[Treatment of neurogenic orthostatic hypotension by an association of tyramine and a monoamine oxidase inhibitor (author's transl)]
Hypothyroidism
Changes of poststimulatory plasma renin activity in women with hyperthyroidism or hypothyroidism in relation to therapy.
Effects of hyper- and hypothyroidism on the basal levels of angiotensin I and kinetic parameters of renin-angiotensin system in male rats.
Effects of two different experimental situations of hypothyroidism on serum aldosterone concentration and plasma renin in rats.
Interactions between thyroid disorders and kidney disease.
Kinetics of the renin system in hyper and hypothyroidism.
Normalization of thyroid hormone levels in patients with either hyper- or hypothyroidism results in a profound change of atrial natriuretic peptide (ANP) levels.
Plasma renin activity and aldosterone concentration of patients with hyperthyroidism and hypothyroidism.
Plasma renin activity and aldosterone in untreated hypothyroidism.
Plasma renin activity in hyper- and hypothyroidism: effect of adrenergic blocking agents.
RENAL FUNCTION AND PLASMA RENIN ACTIVITY AS POTENTIAL FACTORS CAUSING HYPERKALEMIA IN PATIENTS WITH THYROID CARCINOMA UNDERGOING THYROID HORMONE WITHDRAWAL FOR RADIOACTIVE IODINE THERAPY.
Renin and aldosterone in hypothyroidism: relation to excretion of sodium and potassium.
Renin-angiotensin system in hypothyroid rats: effects of potassium iodide and triiodo-L-thyronine.
Renin-angiotensin system in thyroid dysfunction in rats.
Renin-angiotensin system in thyroidectomized rats at different periods of development.
The effect of eplerenone on the renin-angiotensin-aldosterone system of rats with thyroid dysfunction.
The renin-angiotensin system in hypothyroidism of short duration.
Thyroid hormones and renin secretion.
Thyroxine treatment induces upregulation of renin-angiotensin-aldosterone system due to decreasing effective plasma volume in patients with primary myxoedema.
[Aldosterone content and renin activity in the plasma of hypothyroidism patients before and during treatment with thyroid preparations]
[Plasma renin activity in women with hypothyroidism]
[Renin-angiotensin-aldosterone system in thyroid disorders]
[Serum angiotensin I converting enzyme activity in patients with hyperthyroidism and hypothyroidism: relation to renin and aldosterone]
[State of the renin-angiotensin-aldosterone system in thyroid pathology based on the results of radioimmunoassay]
IgA Vasculitis
[Arterial hypertension in patients with systemic connective tissue diseases and hemorrhagic vasculitis]
Ileal Neoplasms
Ectopic production of renin by ileal carcinoma.
Inappropriate ADH Syndrome
Artificial Syndrome of Inappropriate Antidiuresis Model as Potential Use for Diagnostic and Therapeutic Strategies.
Involvement of arginine vasopressin and renal sodium handling in pathogenesis of hyponatremia in elderly patients.
More on renal salt wasting without cerebral disease: response to saline infusion.
Trimethoprim-Associated Hyponatremia.
Infarction, Middle Cerebral Artery
Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
Infections
A five-year prospective follow-up of women with non-obstructive pyelonephritic renal scarring.
A rapid, quantitative bioassay based on the human immunodeficiency virus trans-activator.
Adhesion molecules as a prognostic marker of liver cirrhosis.
Aspartic peptidase inhibitors: implications in drug development.
Changes in atrial natriuretic factor and plasma renin activity in dogs infected with Trypanosoma brucei.
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers.
Cytomegalovirus infection causes an increase of arterial blood pressure.
Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells.
Essential role for collectrin in renal amino acid transport.
Five year prospective study of plasma renin activity and blood pressure in patients with longstanding reflux nephropathy.
How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis.
Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis.
Immunology of pyelonephritis. VIII. E. coli causes granulocytic aggregation and renal ischemia.
Impact of common functional polymorphisms in renin angiotensin system genes on the risk of renal parenchymal scarring following childhood urinary tract infection.
Implication of inflammation-related cytokines in the natural history of liver cirrhosis.
Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Persistent renin-angiotensin system activation after anti-reflux surgery and its management.
Pseudohypoaldosteronism with pyloric stenosis--a patient report.
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.
The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection.
The premenstrual syndrome.
The renin-angiotensin-aldosterone system and vasopressin in early-stage liver cirrhosis after HBV infection in children.
Unexpected role of the human cytomegalovirus contribute to essential hypertension in the Kazakh Chinese population of Xinjiang.
[Effect of captopril on plasma renin activity and blood aldosterone in patients with chronic pyelonephritis and urinary tract infection]
[Hypertension in the elderly: particularities and precautions]
Infertility
Serum total renin levels after ovarian electrocautery in women with polycystic ovary syndrome.
Total renin after gonadotropin stimulation in polycystic ovarian disease.
Insulin Resistance
(Pro)renin receptor and insulin resistance: Possible roles of angiotensin II-dependent and -independent pathways.
Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose tissue.
Aldosterone and aldosterone: renin ratio associations with insulin resistance and blood pressure in African Americans.
Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study.
Angiotensin II, corticosteroids, type II diabetes and the metabolic syndrome.
Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
Antihypertensive drugs and cardioprotection.
Antihypertensive effects of dietary protein and its mechanism.
Association of Sympathovagal Imbalance With Cardiovascular Risks in Young Prehypertensives.
Associations of Sleep Quality and Awake Physical Activity with Fluctuations in Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors.
Biochemical predictors of hypertension. Utility in prevention and treatment.
Blood pressure, sodium intake, insulin resistance, and urinary nitrate excretion.
Cardiovascular risk and obesity.
Characteristics of children with primary hypertension seen at a referral center.
Chronic inhibition of 11 ? -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome.
Chronic renin inhibition with aliskiren improves glucose tolerance, insulin sensitivity, and skeletal muscle glucose transport activity in obese Zucker rats.
Correlation of sodium-related factors with insulin sensitivity in young, lean, male offspring of hypertensive and normotensive subjects.
Cortisol/cortisone ratio and matrix metalloproteinase-9 activity are associated with pediatric primary hypertension.
Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat.
Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentrations in hypertensive patients.
Dietary sodium intake and cardiovascular mortality: controversy resolved?
Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
Direct Renin Inhibition Improves Systemic Insulin Resistance and Skeletal Muscle Glucose Transport in a Transgenic Rodent Model of Tissue Renin Overexpression.
Direct renin inhibition modulates insulin resistance in caveolin-1-deficient mice.
Direct renin inhibitor ameliorates insulin resistance by improving insulin signaling and oxidative stress in the skeletal muscle from post-infarct heart failure in mice.
Direct renin inhibitor prevents and ameliorates insulin resistance, aortic endothelial dysfunction and vascular remodeling in fructose-fed hypertensive rats.
Diuretic-induced potassium depletion and glucose intolerance are not related to hyperactivity of the renin-angiotensin-aldosterone system in hypertensive patients with the metabolic syndrome.
DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs.
Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat.
Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension.
Effects of short-term glucocorticoids on cardiovascular biomarkers.
Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients.
Effects of Vitamin D Supplementation on Cardiovascular and Glycemic Biomarkers.
Endothelial nitric oxide synthase gene polymorphisms are associated with cardiovascular risks in prehypertensives.
Fibrinolysis and diabetes.
Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade.
Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.
Hypertension and insulin resistant models have divergent propensities to learned helpless behavior in rodents.
Identification of bona fide alternative renin transcripts expressed along cortical tubules and potential roles in promoting insulin resistance in vivo without significant plasma renin activity elevation.
Impact of adipose tissue in chronic kidney disease development (Review).
Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
Impairment of insulin-induced vasodilation is associated with muscle insulin resistance in type 2 diabetes.
Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity.
Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome.
Influence of insulin resistance on total renin level in normotensive women with polycystic ovary syndrome.
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients.
Insulin resistance in essential hypertension is related to plasma renin activity.
Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake.
Is there relationship between the A1166C polymorphism of the angiotensin II receptor AT1 and plasma renin activity, insulin resistance and reduction of blood pressure after angiotensin-converting enzyme inhibitor therapy?
Left ventricular contractility and insulin resistance in essential hypertension.
Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets.
Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2.
Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Modulation of insulin resistance by renin angiotensin system inhibitors: implications for cardiovascular prevention.
Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.
Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats.
Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat.
Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat.
New Genetic Polymorphisms as Epidemiological Factor of Arterial Hypertension in Patients with Hyposodical Diet.
Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches.
Obesity, inflammation and endothelial dysfunction.
Obesity-induced Vitamin D Deficiency Contributes to Lung Fibrosis and Airway Hyperresponsiveness.
Ovariectomy modify local renin-angiotensin-aldosterone system gene expressions in the heart of ApoE (-/-) mice.
Plasma renin activity and insulin resistance in African American and white children: the Bogalusa Heart Study.
Plasma renin activity and insulin sensitivity in normotensive subjects.
Plasma Renin Activity and Resting Heart Rate in a Population of Community-Dwelling Japanese: The Tanushimaru Study.
Plausible anti-inflammatory mechanism of resveratrol and caffeic acid against chronic stress-induced insulin resistance in mice.
Positive association between KCNJ5 rs2604204 (A/C) polymorphism and plasma aldosterone levels, but also plasma renin and angiotensin I and II levels, in newly diagnosed hypertensive Chinese: a case-control study.
Possible contribution of the non-proteolytic activation of prorenin to the development of insulin resistance in fructose-fed rats.
Possible involvement of the (pro)renin receptor-dependent system in the development of insulin resistance.
Progress in Primary Aldosteronism: Translation on the Move.
Renin Inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling.
Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic ren2 rat.
Renin-Angiotensin-Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA.
Role of endothelin in human hypertension.
Role of GLUT4 on angiotensin 2-induced systemic and renal hemodynamics.
Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension.
Selective angiotensin II receptor antagonism enhances whole-body insulin sensitivity and muscle glucose transport in hypertensive TG(mREN2)27 rats.
Sex-dependent effects of antenatal glucocorticoids on insulin sensitivity in adult sheep: Role of the adipose tissue renin angiotensin system.
Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives.
Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
The antihypertensive effect of arginine.
The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention.
The improvement of hypertension by probiotics: effects on cholesterol, diabetes, Renin, and phytoestrogens.
The interaction between burn injury and vitamin D metabolism and consequences for the patient.
The protective effect of Liu-Wei-Di-Huang-Fang in salt-sensitive hypertension rats.
The renin angiotensin aldosterone system and insulin resistance in humans.
The Renin Angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.
The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.
The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance.
The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome.
The roles of epicardial adipose tissue in heart failure.
Transgenic mice overexpressing Renin exhibit glucose intolerance and diet-genotype interactions.
Treatment of arterial hypertension in obese patients.
Ultrastructure Study of Transgenic Ren2 Rat Aorta - Part 1: Endothelium and Intima.
Use of vitamin D in chronic kidney disease patients.
Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women.
Voluntary exercise training enhances glucose transport but not insulin signaling capacity in muscle of hypertensive TG(mREN2)27 rats.
What is the role of obesity in hypertension and target organ injury in African Americans?
[Advances in the relationship between leptin and hypertensive-left ventricular hypertrophy].
[Effect of insulin in hypertension with high and low levels of renin]
[Effect of NF-?B on the pathogenic course of non-alcoholic fatty liver disease].
Insulinoma
Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.
Intellectual Disability
Physiology and pharmacology of the (pro)renin receptor.
Intracranial Aneurysm
Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: A case-control study.
Association of nosocomial infections with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.
Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.
Associations of renin-angiotensin system genetic polymorphisms and clinical course after aneurysmal subarachnoid hemorrhage.
Controlled hypotension with adenosine or sodium nitroprusside during cerebral aneurysm surgery: effects on renal hemodynamics, excretory function, and renin release.
Endothelial Nitric Oxide Synthase Polymorphism Is Associated with Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage.
Loss of consciousness at onset of aneurysmal subarachnoid hemorrhage in good-grade patients.
PHASES score applied to a prospective cohort of aneurysmal subarachnoid hemorrhage patients.
The role of endothelial nitric oxide synthase -786 T/C polymorphism in cardiac instability following aneurysmal subarachnoid hemorrhage.
The stress response to induced hypotension for cerebral aneurysm surgery: a comparison of two hypotensive techniques.
[Effect of thiopental anesthesia on plasma renin, adrenaline and noradrenaline in neurosurgical operations with induced hypotension]
Intracranial Hemorrhages
Oxidative stress through activation of NAD(P)H oxidase in hypertensive mice with spontaneous intracranial hemorrhage.
Iron Overload
Iron Overload Accelerates the Progression of Diabetic Retinopathy in Association with Increased Retinal Renin Expression.
Ischemic Attack, Transient
Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
Ischemic Stroke
Association between renin-angiotensin-aldosterone system genotypes and haplotypes and risk of ischemic stroke of atherosclerotic etiology.
Candesartan pre-treatment is cerebroprotective in a rat model of endothelin-1 induced middle cerebral artery occlusion.
COVID-19 and ischemic stroke.
Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
Hypotension and ischaemic stroke associated with aliskiren in the ALTITUDE trial: sensitisation of the Bezold-Jarisch reflex?
Ischemia Induced Brain Damage Is Enhanced in Human Renin and Angiotensinogen Double Transgenic Mice.
RAAS and stress markers in acute ischemic stroke: preliminary findings.
Renin Angiotensin System Inhibitors Reduce Aortic Stiffness and Flow Reversal After a Cryptogenic Stroke.
Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: Insight from preclinical stroke studies and therapeutic potential.
The effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on ischemic stroke and the possible underlying mechanisms.
Therapeutic potential of the renin angiotensin system in ischaemic stroke.
[The influence of hormones of stress-promoting system on the course of acute ischemic stroke]
Keloid
Expression of Components of the Renin-Angiotensin System by the Embryonic Stem Cell-Like Population within Keloid Lesions.
Ketosis
Plasma renin activity and blood volume in uncontrolled diabetes. Ketoacidosis, a state of secondary aldosteronism.
Kidney Calculi
Effect of hypothermic renal ischaemia on renin secretion rate in man.
SLC26A6 and NADC?1: Future direction of nephrolithiasis and calculus?related hypertension research (Review).
Systemic Succinate Homeostasis and Local Succinate Signaling Affect Blood Pressure and Modify Risks for Calcium Oxalate Lithogenesis.
Kidney Diseases
A novel disease-causing mutation in the Renin gene in a Tunisian family with autosomal dominant tubulointerstitial kidney disease.
ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Activation of the renal GLP-1R leads to expression of Ren1 in the renal vascular tree.
Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases.
An International Cohort Study of Autosomal Dominant Tubulointerstitial Kidney Disease due to REN Mutations Identifies Distinct Clinical Subtypes.
Autosomal Dominant Tubulointerstitial Kidney Disease with Adult Onset due to a Novel Renin Mutation Mapping in the Mature Protein.
Autosomal Dominant Tubulointerstitial Kidney Disease.
Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management-A KDIGO consensus report.
Calcium antagonists: effects on cardio-renal risk in hypertensive patients.
Capacity for purinergic control of renin promoter via P2Y(11) receptor and cAMP pathways.
Cells of renin lineage are adult pluripotent progenitors in experimental glomerular disease.
Direct renin inhibition: extricating facts from facades.
Discovery of a novel dominant mutation in the REN gene after forty years of renal disease: a case report.
Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease.
Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial.
Effects of Antihypertensive Agents on Intestinal Contractility in the Spontaneously Hypertensive Rat: Angiotensin Receptor System Downregulation by Losartan.
Enhanced cardiovascular pressor reactivity to norepinephrine in mild renal parenchymal disease.
Heart Failure and Changes in Kidney Function: Focus on Understanding, Not Reacting.
Hereditary interstitial kidney disease.
Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension.
Hypertension secondary to early-stage kidney disease: the pathogenetic role of altered cytosolic calcium (Ca2+) homeostasis of vascular smooth muscle cells.
Is there a role for direct renin inhibitors in chronic kidney disease?
Lifelong genetic minipumps.
Lupus nephritis: An approach to diagnosis and treatment in South Africa.
Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin System.
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey.
Physiology and Pathophysiology of Compensatory Adaptations of a Solitary Functioning Kidney.
Renin and the (pro)renin receptor in the renal collecting duct: Role in the pathogenesis of hypertension.
Renin inhibition and microalbuminuria development: meaningful predictor of kidney disease progression.
Renin-dependent hypertension in patients with unilateral kidney disease not caused by renal artery stenosis.
Role of 11?HSD Type 2 Enzyme Activity in Essential Hypertension and Children with Chronic Kidney Disease (CKD).
Role of aliskiren in blood pressure control and renoprotection.
Secondary hypertension. An overview of its causes and management.
Sex and the renin angiotensin system: implications for gender differences in the progression of kidney disease.
The diagnostic and therapeutic uses of saralasin in renal transplant hypertension.
The effect of angiotensin 1-7 and losartan on renal ischemic/reperfusion injury in male rats.
The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Which antihypertensive drugs are the most nephroprotective and why?
[Hypertension, atherosclerosis and kidney]
[Plasma renin activity in patients with hypertension and unilateral parenchymal kidney disease]
[Plasmatic renin in patients with kidney diseases]
[The captopril test in nonselected hypertensive patients: absence of value for screening of renovascular patients and for unilateral small kidneys]
Kidney Diseases, Cystic
Polycystic kidney disease presenting with hypertension and hypokalemia.
The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.
Kidney Failure, Chronic
Activity of the renin-angiotensin-aldosterone (RAA) and secretion of the atrial natriuretic peptide (ANP) in patients with chronic renal failure.
Acute effect of erythropoietin on plasma renin activity and aldosterone levels in end-stage renal disease.
Adrenal aldosterone biosynthesis is elevated in a model of chronic renal failure--role of local adrenal renin-angiotensin system.
An International Cohort Study of Autosomal Dominant Tubulointerstitial Kidney Disease due to REN Mutations Identifies Distinct Clinical Subtypes.
Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies.
Atrial natriuretic peptide and sodium homeostasis in chronic renal failure.
Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis.
Atrial natriuretic peptides and renin release.
Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
Blood pressure control in end-stage renal disease in man: indirect evidence of a complex pathogenic mechanism besides renin or blood volume.
Captopril: pharmacology, metabolism and disposition.
Changes in atrial natriuretic peptide and plasma renin activity following changes in right atrial pressure in patients with chronic renal failure.
Changes in plasma levels of vasoactive peptides during standard bicarbonate hemodialysis.
Changes of blood pressure, renin, and angiotensin after bilateral nephrectomy in patients with chronic renal failure.
Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease.
Correlates of atrial natriuretic factor in chronic renal failure.
Correlation between blood prostaglandins and blood pressure in chronic renal failure.
Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up.
Different mechanisms for the increased enzymatic activity of renin in plasma of patients with chronic renal failure and patients receiving glucocorticoid therapy.
Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure.
Effect of haemodialysis on plasma ADH levels, plasma renin activity and plasma aldosterone levels in patients with end-stage renal disease.
Effect of water immersion on plasma renin activity and aldosteronaemia in chronic renal failure.
Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography.
Hypererythropoietinemia and hyperreninemia in a continuous ambulatory peritoneal dialysis patient with chronic severe hypotension.
Hypertension in end-stage renal disease. The relationship between blood pressure, plasma renin, plasma renin substrate and exchangeable sodium in chronic hemodialysis patients.
Hyporeninemic hypoaldosteronism in children with chronic renal failure.
Immunohistochemical localization of renin in end-stage kidneys.
Increased enzymatic activity of renin and hyperlipidemia.
Increased plasma renin activity in chronic renal failure associated with severe hypertension; relationship between plasma renin level and peritoneal dialysis.
Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients.
Influence of hemodialysis on the plasma levels of the atrial natriuretic factor in chronic renal failure.
Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure.
Methods of cardio-renal protection in non-diabetic chronic nephropathies.
Microangiography of end-stage kidneys in relation to high renin hypertension.
Modern peptide biomarkers and echocardiography in cardiac healthy haemodialysis patients.
Nocturnal blood pressure and relation to vasoactive hormones and renal function in hypertension and chronic renal failure.
Non-invasive blood pressure measurements in cats: clinical significance of hypertension associated with chronic renal failure.
Norepinephrine and renin activity in chronic renal failure. Evidence for interacting roles in hemodialysis hypertension.
Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.
Pharmacodynamics and kinetics of etozolin/ozolinone in hypertensive patients with normal and impaired kidney function.
Piperidine renin inhibitors: from leads to drug candidates.
Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
Plasma renin activity and plasma aldosterone level in patients with chronic renal failure on maintenance haemodialysis.
Plasma renin activity in end-stage kidney disease.
Plasma renin activity, plasma aldosterone and distal urinary acidification in diabetics with chronic renal failure.
Plasma renin activity: An early marker of progressive renal disease in posterior urethral valves.
Plasma renin and exchangeable sodium in the hypertension of chronic renal failure. The effect of bilateral nephrectomy.
Plasma vasopressin, catecholamines and atrial natriuretic factor during hemodialysis and sequential ultrafiltration.
Plasma volumes, noradrenaline levels and renin activity during posture changes in end-stage renal failure.
Presence of insulin-renin-aldosterone-potassium interrelationship in normal subjects, disrupted in chronic hemodialysis patients.
Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
Regulations of plasma aldosterone in young hyperkalemic patients with stable chronic renal failure.
Relationship between blood glucose control, pathogenesis and progression of diabetic nephropathy.
Relevance of salt, water, and renin to hypertension in chronic renal failure.
Renin and blood volume in chronic renal failure: a comparison with essential hypertension.
Renin and juxtaglomerular apparatus in a patient with primary aldosteronism complicated by chronic renal failure.
Renin release and the juxtaglomerular apparatus in chronic renal failure due to glomerulonephritis.
Renin, aldosterone and other mineralocorticoids in hyperkalemic patients with chronic renal failure showing mild azotemia.
Renoprotective effects of the novel prostaglandin EP4 receptor-selective antagonist ASP7657 in 5/6 nephrectomized chronic kidney disease rats.
Response of vasoactive substances to intermittent ultrafiltration in normotensive hemodialysis patients.
Revisiting RAAS blockade in CKD with newer potassium-binding drugs.
SGLT2 inhibition to address the unmet needs in diabetic nephropathy.
SSA 02-4 DISPARITIES IN HYPERTENSION MANAGEMENT OF CKD IN SOUTH ASIA.
The effect of extracorporeal dialysis on plasma renin activity in patients with acute and chronic renal failure.
The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
The influence of different sodium loads on renin release in hypertensive and normotensive states of chronic renal failure.
The relatinship between body fluid compartment volumes, renin, and blood pressure in chronic renal failure.
The relationship between body fluid compartment volumes, renin activity and blood pressure in chronic renal failure.
The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure.
The renin-angiotensin system in cats with chronic renal failure.
The role of kidney biopsy in diagnosis of preeclampsia in kidney transplant patients.
The role of the kidney in hypertension.
Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.
Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction.
Vasoactive hormones in children with chronic renal failure.
Vasopressin in end-stage renal disease: relationship to salt, catecholamines and renin activity.
Water immersion induced alterations of plasma vasopressin levels and activity of the renin-angiotensin-aldosterone system in noninflammatory acute renal failure and end-stage renal failure.
Water immersion-induced alterations of plasma atrial natriuretic peptide level and its relationship to the renin-angiotensin-aldosterone system and vasopressin secretion in acute and chronic renal failure.
[A study of the pressor effect of angiotensin (Kaplan's test) and of renin activity in chronic renal failure treated by repeated extra-renal dialysis. The effect of diuretics, fluid loss and potassium depletion]
[Arterial hypertension in patients on chronic hemodialysis]
[Clinical pharmacology of enalapril in hypertension with chronic renal failure]
[Control of arterial hypertension in human chronic renal failure. Indirect evidence for a complex pathogenetic mechanism other than renin and sodium]
[Correlation between renin activity in peripheral venous blood and blood pressure in chronic kidney failure at the stage of decompensated retention]
[Disorders of the kallikrein-kinin, renin-angiotensin and sympathetic-adrenal systems in chronic kidney failure patients during hemodialysis treatment]
[Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)]
[Effect of extracorporeal dialysis on plasma renin activity in patients with acute and chronic renal failure]
[Effect of naloxone on plasma renin activity and aldosteronemia in patients with chronic renal failure]
[Effect of physical exertion on levels of vasopressin (AVP) and plasma renin activity in patients with chronic kidney failure]
[Hemodynamic effects of amrinone combined with dopamine in patients undergoing living renal transplantation]
[Importance of the longterm follow up of plasma renin activity in relation to arterial hypertension in chronic renal failure (author's transl)]
[Inactive renin in patients with chronic and terminal renal insufficiency]
[Neonatal chronic kidney failure associated with cyclo-oxygenase-2 inhibitors administered during pregnancy]
[Plasma renin activity and total peripheral resistance in chronic end-stage renal disease (author's transl)]
[Relationship between vasoactive substances and changes in blood pressure during hemodialysis]
[Renin-angiotensin-aldosterone system (RAA) and vasopressin secretion in patients with chronic renal failure]
[SGLT2 inhibitors: A new era for our patients].
[Significance of plasma renin activity in patients with chronic kidney failure and undergoing hemodialysis]
[The treatment of severe arterial hypertension in patients with chronic kidney failure with captopril and beta-adrenoblockaders]
[Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure]
Kidney Neoplasms
Renin angiotensin system deregulation as renal cancer risk factor.
Renin expression in adult renal epithelial tumors with granular cells.
[Erythrocytosis associated with kidney cancer. Erythropoietin and renin levels]
Klinefelter Syndrome
Multiple endocrine disorders and Rathke's cleft cyst with Klinefelter's syndrome: a case report.
Kwashiorkor
Effective renin activity in plasma of children with kwashiorkor.
Plasma renin activity in oedematous and marasmic children with protein energy malnutrition.
The role of renin in kwashiorkor: an hypothesis.
Laron Syndrome
Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function.
Leiomyosarcoma
A case of renin producing leiomyosarcoma originating in the lung.
Hyponatremic hypertensive syndrome and massive proteinuria in a patient with renin-producing leiomyosarcoma.
Renin-producing leiomyosarcoma originating in the uterus.
[Arterial hypertension in renin-producing retroperitoneal leiomyosarcoma]
Leukemia
Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences.
Is increased renin activity as a paraneoplastic phenomenon in acute leukemia a protective mechanism against hyperkalemia?
Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML.
Renin expression in hematological malignancies and its role in the regulation of hematopoiesis.
Within-patient variability of hormone and cytokine concentrations in heart failure.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
Renin expression in hematological malignancies and its role in the regulation of hematopoiesis.
Leukemia, Myeloid, Acute
Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML.
Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells.
Relevance of renin expression by real-time PCR in acute myeloid leukemia.
Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide.
Renin expression in hematological malignancies and its role in the regulation of hematopoiesis.
Leukemia-Lymphoma, Adult T-Cell
Design of potent aspartic protease inhibitors to treat various diseases.
Lichen Planus, Oral
Renin Promotes STAT4 Phosphorylation to Induce IL-17 Production in Keratinocytes of Oral Lichen Planus.
Liddle Syndrome
A novel epithelial sodium channel beta-subunit mutation associated with hypertensive Liddle syndrome.
Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Genetic variants in the epithelial sodium channel in relation to aldosterone and potassium excretion and risk for hypertension.
Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism: a multi-centre cross-sectional study.
Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity.
Liddle syndrome in a Serbian family and literature review of underlying mutations.
Prevalence of Liddle Syndrome Among Young Hypertension Patients of Undetermined Cause in a Chinese Population.
Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man.
The importance of genetic counseling and genetic screening: a case report of a 16-year-old boy with resistant hypertension and severe hypokalemia.
[A Case of Perioperative Hypokalemia and Hypertension due to Concomitant Use of Multiple Herbal Medicines].
[Hypokalemic paralysis after prolonged absorption of a non-alcoholic pastis in a diabetic]
lipoprotein lipase deficiency
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Liver Cirrhosis
Activation of RAAS in a rat model of liver cirrhosis: no effect of losartan on renal sodium excretion.
Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis.
Caffeine potentiates vasodilator-induced renin release.
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.
Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis.
Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model.
Effect of a diet with unrestricted sodium on ascites in patients with hepatic cirrhosis.
Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
Effects of sympathetic nerves and angiotensin II on renal sodium and water handling in rats with common bile duct ligature.
Elevated Renin levels in patients with liver cirrhosis and hepatocellular carcinoma.
Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis.
Glucagon-independent renal hyperaemia and hyperfiltration after an oral protein load in Child A liver cirrhosis.
Haemodynamic effects of angiotensin II in conscious, non-ascitic cirrhotic rats.
Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis.
Impairment of blood pressure control in patients with liver cirrhosis during tilting: study on adrenergic and renin-angiotensin systems.
Increased renin release by exogenous prostaglandin E1 in liver cirrhosis with and without ascites.
Internal dysregulation of the renin system in patients with stable liver cirrhosis.
Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
Loss of tubuloglomerular feedback in decompensated liver cirrhosis: physiopathological implications.
Perioperative plasma concentrations of endothelin and natriuretic peptides in children undergoing living-related liver transplantation.
Plasma human atrial natriuretic peptide levels in patients with liver cirrhosis.
Plasma norepinephrine, weak neurotransmitters, and renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function.
Plasma renin activity predicts prognosis and liver disease-related events in liver cirrhosis patients with ascites treated by tolvaptan.
Plasma renin level in hepatic cirrhosis. Relaton to functional renal failure.
Renal function impairment induced by change in posture in patients with cirrhosis and ascites.
Renal tubular events following passage from the supine to the standing position in patients with compensated liver cirrhosis: loss of tubuloglomerular feedback.
Renin, aldosterone and arginine vasopressin in patients with liver cirrhosis: the influence of ascites retransfusion.
Renin, angiotensin II and juxtaglomerular apparatus in liver cirrhosis.
Spironolactone lowers portal hypertension by inhibiting liver fibrosis, ROCK-2 activity and activating NO/PKG pathway in the bile-duct-ligated rat.
The renin-angiotensin-aldosterone system and vasopressin in early-stage liver cirrhosis after HBV infection in children.
The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice.
Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis.
[Aldosterone and renin in liver cirrhosis with ascites]
[ANP in the cirrhotic patient. A clinical contribution]
[Catecholamine and renin-angiotensin system in blood pressure control in patients with liver cirrhosis]
[Circadian rhythm of atrial natriuretic peptide, plasma renin and aldosterone activity in healthy subjects and in patients with compensated liver cirrhosis]
[Concentration-reinfusion methods in intractable ascites caused by liver cirrhosis. Importance of monitoring plasma renin activity and urinary sodium]
[Effect of neutrophil gelatinase-associated lipocalin on prognosis of patients with type 2 hepatorenal syndrome].
[Effect of passive leg lifting on sodium excretion in patients with liver cirrhosis]
[Hepatic extraction and clearance of renin in liver cirrhosis]
[Mutual interaction of the renin-angiotensin system and the atrial natriuretic factor in the renal response to acute volume loading]
[RENIN ACTIVITY AND THE STATUS OF THE JUXTAGLOMERULAR RENAL APPARATUS OF CADAVERS OF LIVER CIRRHOSIS WITH ASCITES AND CONGESTIVE HEART FAILURE PATIENTS.]
[Renin angiotensin system and liver fibrosis or cirrhosis]
[Systemic hyperdynamic circulation and serum hormone concentrations in portal hypertension]
[The clinical importance of determining aldosterone in the ascitic fluid]
[The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)]
[The plasma renin activity (basal and after stimulation) in liver cirrhosis in connection with the effective renal plasma perfusion]
Liver Cirrhosis, Alcoholic
Atrial natriuretic peptide, arginine vasopressin, aldosterone and plasma renin activity in carbon tetrachloride-induced cirrhosis in rats.
High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems.
Plasma renin substrate sensitivity to oestrogens and oestrogen metabolism in cirrhosis.
Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems.
Splanchnic and hepatic renin metabolism in alcoholic cirrhosis. Lack of evidence of a splanchnic source of production or of significantly impaired hepatic clearance.
[Cirrhotic ascites and the renin-angiotensin system]
Liver Diseases
Arterial hypertension and chronic liver disease.
Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume.
Elevated Renin levels in patients with liver cirrhosis and hepatocellular carcinoma.
High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease.
Low angiotensinogen levels are related to the severity and liver dysfunction of congestive heart failure: implications for renin measurements.
Plasma levels and hepatic extraction of renin and aldosterone in alcoholic liver disease.
Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.
Plasma renin activity and renin-substrate concentration in patients with liver disease.
Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
Propranolol in the treatment of cirrhotic ascites.
Renin angiotensin system in liver diseases: Friend or foe?
Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.
Sodium status and the renin-angiotensin-aldosterone system in compensated liver disease.
Study of substance P, renin and aldosterone in chronic liver disease in Egyptian children.
The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes.
The kallikrein-kininogen-kinin system in patients with liver disease and ascites.
[Hepatic catabolism of renin in normal subjects and in patients with liver diseases]
Liver Diseases, Alcoholic
Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease.
Plasma levels and hepatic extraction of renin and aldosterone in alcoholic liver disease.
Plasma renin activity in alcoholic liver disease.
Liver Failure
Hepatorenal syndrome: a disease mediated by the intrarenal action of renin.
Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis.
Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study.
The role of renin in renal failure associated with hepatic failure.
Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function.
Liver Failure, Acute
Hemodynamics and metabolic studies on septic shock in patients with acute liver failure.
Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure.
Renin-angiotensin system, blood pressure homeostasis and renal function in galactosamine-induced fulminant hepatic failure in the guinea pig.
Low Tension Glaucoma
Evaluation of Systemic Renin and Angiotensin II Levels in Normal Tension Glaucoma.
The comparison study of renin and angiotensin A II levels on normal tension glaucoma patients and normal individuals.
Lung Diseases
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration.
[A case report of high plasma renin activity in chronic pulmonary disease and the effect of angiotensin-II-analogue (1-sarcosine, 8-isoleucine-angiotensin-II)]
[A comparative study of plasma converting enzyme and renin in sarcoidosis]
[Variations in plasma angiotensin-converting enzyme and renin in sarcoidosis]
Lung Diseases, Obstructive
Atrial natriuretic peptide, renin and aldosterone in obstructive lung disease and heart failure.
Lung Injury
Degradation of Lung Protective Angiotensin Converting Enzyme-2 by Meconium in Human Alveolar Epithelial Cells: A Potential Pathogenic Mechanism in Meconium Aspiration Syndrome.
VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system.
Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic.
Vitamin D alleviates lipopolysaccharide?induced acute lung injury via regulation of the renin?angiotensin system.
What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury.
Lung Neoplasms
A prospective study of patients with lung cancer and hyponatremia of malignancy.
Serum angiotensin converting enzyme activity in pulmonary diseases: correlation with lung function parameters.
Lupus Erythematosus, Systemic
Normotensive hyperreninemia in systemic lupus erythematosus. An indicator of tubular dysfunction.
Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus.
Severe hypertension associated with multiple intrarenal microaneurysms in a patient with systemic lupus erythematosus and antiphospholipid antibodies.
Lupus Nephritis
Steroid-induced hypertension in patients with nephrotic syndrome.
Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL-lpr Mice.
Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis.
[A case of lupus nephritis with hyporeninemic hypoaldosteronism]
Lymphocele
Isoelectric heterogeneity of human prorenin (inactive renin) in body fluids.
Lymphohistiocytosis, Hemophagocytic
PRIMARY ADRENAL INSUFFICIENCY SECONDARY TO CHRONIC POSACONAZOLE USE.
Lymphoma
A functional (pro)renin receptor is expressed in human lymphocytes and monocytes.
Involvement of the receptor-associated prorenin system in the pathogenesis of human conjunctival lymphoma.
Macular Degeneration
(Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system.
Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma.
Therapeutic targets of renin-angiotensin system in ocular disorders.
Magnesium Deficiency
Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors.
Renin immunochemistry, sodium excretion and relative heart weight in cyclosporine- or alimentary-induced magnesium deficiency in rats.
Malaria
Aspartic peptidase inhibitors: implications in drug development.
Design of potent aspartic protease inhibitors to treat various diseases.
New directions for protease inhibitors directed drug discovery†.
Renal and systemic hemodynamics, in falciparum malaria.
Malnutrition
A study of the renin-angiotensin-aldosterone system in severe infantile malnutrition.
Anaesthetic management for hiatal hernia repair in a child with Bartter's syndrome: A case report.
Enalapril and losartan restored blood pressure and vascular reactivity in intrauterine undernourished rats.
Kidney development and the fetal programming of adult disease.
Plasma renin activity in children with protein energy malnutrition (kwashiorkor).
Plasma renin activity in oedematous and marasmic children with protein energy malnutrition.
Plasma renin activity, water excretion and the decay of injected hormones and hormonal effects in rats with protein energy malnutrition.
The effect of protein energy malnutrition on plasma renin and oedema in the pig.
Mastocytoma
Cardiac Renin levels are not influenced by the amount of resident mast cells.
E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.
Mastocytosis
Cardiac Renin levels are not influenced by the amount of resident mast cells.
Meconium Aspiration Syndrome
Serial plasma concentrations of atrial natriuretic peptide, plasma renin activity, aldosterone, and antidiuretic hormone in neonates on extracorporeal membrane oxygenation.
Melanoma
The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention.
Melena
Plasma atrial natriuretic factor in low output heart failure syndromes.
Memory Disorders
Attenuation of Brain Damage and Cognitive Impairment by Direct Renin Inhibition in Mice With Chronic Cerebral Hypoperfusion.
Effect of losartan and enalapril on cognitive deficit caused by Goldblatt induced hypertension.
Meniere Disease
Low plasma renin concentration in patients with Meniere's disease (preliminary report).
Menorrhagia
The site of renin in the human uterus.
Mental Retardation, X-Linked
A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor.
Metabolic Diseases
Intestinal dysbiosis activates renal renin-angiotensin system contributing to incipient diabetic nephropathy.
RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.
Metabolic Syndrome
Adiponectin Expression Protects against Angiotensin II-Mediated Inflammation and Accelerated Atherosclerosis.
Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats.
Angiotensin II causes beta cell dysfunction through an ER stress induced pro-inflammatory response.
Cardiovascular and Hematological Medicine in 2013 - Advances and Insights.
Co-expression of renin-angiotensin system genes in human adipose tissue.
Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndrome.
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial.
Effects of blocking of angiotensin system on the prevalence of metabolic syndrome in type 2 diabetic patients.
High Concentrations of Uric Acid and Angiotensin II Act Additively to Produce Endothelial Injury.
History of gestational hypertension is associated with the metabolic syndrome and masked hypertension but not arterial stiffness in women with essential hypertension.
Homocysteine, renin and aldosterone in patients with Cushing's syndrome.
Hypothalamic angiotensinergic-noradrenergic systems interaction in fructose induced hypertension.
Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis.
Insulin resistance in essential hypertension is related to plasma renin activity.
Mechanisms underlying prorenin actions on hypothalamic neurons implicated in cardiometabolic control.
Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
New Therapeutic Options in Patients Prone to Hypertension: A Focus on Direct Renin Inhibition and Aldosterone Blockade.
Plasma aldosterone is independently associated with the metabolic syndrome.
PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance.
Primary Aldosteronism and ARMC5 Variants.
Renin angiotensin system polymorphisms in patients with metabolic syndrome (MetS).
Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats.
Role of Renin-Angiotensin system and oxidative stress on vascular inflammation in insulin resistence model.
Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome.
Spotlight on renin. The renin-angiotensin-aldosterone system and metabolic syndrome.
The expanding role of oxidative stress, renin angiotensin system, and beta-cell dysfunction in the cardiometabolic syndrome and Type 2 diabetes mellitus.
The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.
The renin angiotensin system and the metabolic syndrome.
The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome.
The role of the renin angiotensin hormonal system in the metabolic syndrome and type 2 diabetes.
The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade.
Vasculometabolic and Inflammatory Effects of Aldosterone in Obesity.
Migraine Disorders
ACE and ARB Agents in the Prophylactic Therapy of Migraine-How Effective Are They?
Headache and arterial hypertension.
Mast cells activate the renin angiotensin system and contribute to migraine: a hypothesis.
Migraine and hypertension.
Renin angiotensin system: A novel target for migraine prophylaxis.
Renin-angiotensin system in pain: existing in a double life?
Mineralocorticoid Excess Syndrome, Apparent
In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess.
Steroid characteristics of mineralocorticoid adrenocortical hypertension.
MINOCA
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries.
Mitral Valve Insufficiency
Effects of mild mitral valve insufficiency, sodium intake, and place of blood sampling on the renin-angiotensin system in dogs.
Modulation of the tissue reninangiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve.
[Changes in PTCA. A model of ischemia in humans]
Mitral Valve Prolapse
AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients.
Mitral Valve Stenosis
Atrial natriuresis under the condition of a constant renal perfusion pressure: experiments on conscious dogs.
Atrial natriuretic peptide response to postural changes in patients with left atrial hypertension.
Neurohormones in mitral stenosis before and after percutaneous balloon mitral valvotomy.
Moyamoya Disease
Intravascular ultrasound detects coarctation of the renal artery in a patient with Moyamoya disease.
Mucormycosis
PRIMARY ADRENAL INSUFFICIENCY SECONDARY TO CHRONIC POSACONAZOLE USE.
Multicystic Dysplastic Kidney
Neonatal hypertension from a unilateral multicystic dysplastic kidney.
Reduced renin expression and altered gene transcript profiles in multicystic dysplastic kidneys.
Renin containing cells are present predominantly in scarred areas but not in dysplastic regions in multicystic dysplastic kidney.
[Renin-dependent arterial hypertension in polycystic kidney operated on at a late period]
Multiple Sclerosis
High Fat Diet Exacerbates Neuroinflammation in an Animal Model of Multiple Sclerosis by Activation of the Renin Angiotensin System.
Multiple System Atrophy
Cardiovascular and renin responses to head-up tilt tests in parkinsonism.
Diagnosis and treatment of supine hypertension in autonomic failure patients with orthostatic hypotension.
L-threo-3,4-dihydroxyphenylserine enhances the orthostatic responses of plasma renin activity and angiotensin II in multiple system atrophy.
Muscle Cramp
Cirrhosis and muscle cramps: evidence of a causal relationship.
Response to head-up tilt in cramping and noncramping hemodialysis patients.
Muscle Spasticity
[Anuria due to bilateral renal artery spasm during hysterectomy and oophorectomy]
Muscle Weakness
Abnormal captopril scintigraphy in Bartter syndrome.
Hyperaldosteronism in a cat with metastasised adrenocortical tumour.
Muscular Diseases
Shakuyaku-kanzo-to induces pseudoaldosteronism characterized by hypokalemia, rhabdomyolysis, metabolic alkalosis with respiratory compensation, and increased urinary cortisol levels.
Muscular Disorders, Atrophic
Plasma renin activity in hemodialyzed patients during long-term follow-up.
Myocardial Infarction
A comparison of plasma renin activity levels in patients with and without congestive heart failure after myocardial infarction.
Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension.
Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarction.
Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice.
Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice.
An Alternative Promoter in Intron1 of the Renin Gene is Regulated by Glucose Starvation via Serum Response Factor.
Angiotensin and bradykinin peptides in rats with myocardial infarction.
Angiotensin II receptor blockade and ventricular remodelling.
Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins.
Angiotensin III: a physiological relevant peptide of the renin angiotensin system.
Angiotensin, LDL peroxidation and atherosclerosis.
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.
Baroreflex sensitivity and neurohormonal activation in patients with acute myocardial infarction.
Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage.
Beta-blockade benefits patients following a subarachnoid haemorrhage.
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren.
Capacity for purinergic control of renin promoter via P2Y(11) receptor and cAMP pathways.
Cardiac angiotensin converting enzyme and endothelin receptor in rats with chronic myocardial infarction.
Cardiac angiotensin-converting enzyme activity in myocardial infarction.
Cardiac infarcts increase sodium transporter transcripts (rBSC1) in the thick ascending limb of Henle.
Cardiac natriuretic peptides--hope or hype?
Changes in control of renin release in congestive heart failure in dogs: response to acute and chronic vasodilator therapy.
Changes in plasma renin activity and haemodynamics during vasodilator therapy in conscious dogs with myocardial infarction or chronic volume overload.
Changes in the levels of plasma atrial natriuretic peptide, hemodynamic measurements, and the levels of vasoactive hormones during the clinical course of congestive heart failure.
Changes of atrial natriuretic peptide in brain areas of rats with chronic myocardial infarction.
Clinical evaluation and differential diagnosis of the individual hypertensive patient.
Combination Angiotensin Converting Enzyme and Direct Renin Inhibition in Heart Failure following Experimental Myocardial Infarction.
Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction.
Comparison of atrial natriuretic peptide versus nitroglycerin for reducing blood pressure in acute myocardial infarction.
Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans.
Differences in the expression of the renin angiotensin system and the kallikrein-kinin system during the course of myocardial infarction in male and female Wistar rats.
Direct renin inhibitor ameliorates insulin resistance by improving insulin signaling and oxidative stress in the skeletal muscle from post-infarct heart failure in mice.
Discordant nephron function. A pathogenic factor in hypertension and its vascular complications of stroke and heart attack.
Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1.
Effect of direct renin inhibitor on left ventricular remodeling in patients with primary acute myocardial infarction.
Effect of direct renin inhibitor, aliskiren, on peripheral blood monocyte subsets and myocardial salvage in patients with primary acute myocardial infarction.
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.
Effect of enalapril on plasma atrial natriuretic peptide in late recovery phase of acute myocardial infarction.
Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction.
Effects of growth hormone on renal renin gene expression in normal rats and rats with myocardial infarction.
Effects of low dose of aliskiren on isoproterenol-induced acute myocardial infarction in rats.
Essential hypertension: renin and aldosterone, heart attack and stroke.
Ethnic differences of renin-sodium profile and renal prostaglandins in the pathogenesis of systemic arterial hypertension.
Evaluation of neurohumoral activation (adrenomedullin, BNP, catecholamines, etc.) in patients with acute myocardial infarction.
Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure.
Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction.
Follow-up of renin in essential hypertension.
Functional significance of prorenin internalization in the rat heart.
Histamine H3 Receptor Agonist Imetit Attenuated Isoproterenol Induced Renin Angiotensin System and Sympathetic Nervous System Overactivity in Myocardial Infarction of Rats.
Immunological probes in cardiovascular disease.
Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a prospective cohort study from Korea Acute Myocardial Infarction Registry (KAMIR).
Implications of recently published trials of blood pressure-lowering drugs in hypertensive or high-risk patients.
Importance of RAA system and the treatment of patients with ACE inhibition after myocardial infarction.
Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system.
Increased renin immunostaining in preglomerular arterioles after myocardial infarction in the rat.
Influence of dobutamine and dopamine on hemodynamics and plasma concentrations of noradrenaline and renin in patients with low cardiac output following acute myocardial infarction.
Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.
Intracellular Renin Disrupts Chemical Communication between Heart Cells. Pathophysiological Implications.
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Lesson XXIV: on the major roles of the renin system in the pathogenesis of hypertension and of its sequelae, heart attack, heart failure, kidney failure, and stroke: replies to commonly asked questions.
Left ventricular remodelling after acute myocardial infarction--solved and unsolved issues.
Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren.
Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.
Marked suppression of renin levels by beta-receptor blocker in patients treated with standard heart failure therapy: a potential mechanism of benefit from beta-blockade.
Neuroendocrine activation after acute myocardial infarction.
Neuroendocrine activation and markers of early reperfusion in the acute phase of myocardial infarction.
Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure.
Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction rats.
Plasma atrial natriuretic factor in low output heart failure syndromes.
Plasma atrial natriuretic factor in patients with acute myocardial infarction.
Plasma cathepsin D isoforms and their active metabolites increase after myocardial infarction and contribute to plasma renin activity.
Plasma renin activity and coronary heart disease: are they related?
Plasma renin activity and insulin sensitivity in normotensive subjects.
Plasma renin activity and ischemic heart disease.
Plasma renin activity in myocardial infarction.
Plasma renin activity in the emergency department and its independent association with acute myocardial infarction.
Plasma Renin Activity Is an Independent Prognosticator in Patients With Myocardial Infarction.
Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients.
Polymorphisms of renin-angiotensin system and natriuretic peptide receptor A genes in patients of Greek origin with a history of myocardial infarction.
Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction.
Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.
Progress in Primary Aldosteronism: Translation on the Move.
Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling.
Reciprocal changes in vasoactive hormones in the rat myocardial infarction model of heart failure.
Renin and myocardial infarction in hypertension.
Renin and the complications of acute myocardial infarction.
Renin and the IGFII/M6P receptor system in cardiac biology.
Renin Inhibition by Aliskiren Protects Rats Against Isoproterenol Induced Myocardial Infarction.
Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure.
Renin inhibition improves the survival of mesenchymal stromal cells in a mouse model of myocardial infarction.
Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence.
Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients.
Role of renin secretion and kidney function in hypertension and attendant heart attack and stroke.
Secretory and cytosolic (pro)renin in kidney, heart, and adrenal gland.
Studies of the interrelationship between plasma norepinephrine, plasma renin activity and acute myocardial infarction in dogs.
The cardiac renin-angiotensin system in heart failure.
The Effect and Mechanism of Chinese Herbal Formula Sini Tang in Heart Failure after Myocardial Infarction in Rats.
The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction.
The potential role of the angiotensin subtype 2 receptor in cardiovascular protection.
The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
The renin-angiotensin system as a target for therapeutic intervention.
The renin-angiotensin--aldosterone system and the clinical course of acute myocardial infarction.
Tissue-specific expression of a rat renin transcript lacking the coding sequence for the prefragment and its stimulation by myocardial infarction.
Vane blood-bathed technique reveals the significance of adrenergic reaction in myocardial infarction.
[Activity of plasma renin and aldosterone excretion in patients with macrofocal myocardial infarct and its complications]
[Arterial damage and the renin-angiotensin system in essential hypertension. Study of 63 cases]
[Behavior of plasma renin activity in acute myocardial infarct]
[Certain humoral factors in acute myocardial infarct complicated by cardiogenic shock]
[Changes in renin activity in patients with acute myocardial infarction]
[Changes in the atrial natriuretic factor and the renin-angiotensin-aldosterone axis induced by maximum exertion in subjects with a recent myocardial infarct]
[Development of heart failure after myocardial infarct: changes in plasma renin activity, angiotensin II, catecholamines and atrial natriuretic peptide]
[Effect of puerarin on plasma endothelin, renin activity and angiotensin II in patients with acute myocardial infarction]
[Evaluation of plasma renin activity in acute myocardial infarction patients treated with primary percutaneous coronary interventions].
[New animal models for drug discovery research: focus on cardiovascular diseases]
[Obsidan treatment of neuroendocrine disorders and hyperkinetic syndrome in patients with macrofocal myocardial infarction]
[Plasma renin activity and catecholamine excretion in acute myocardial infarct]
[Plasma renin activity and renal indices of water retention in non-complicated myocardial infarct]
[Plasma renin activity and urinary excretion of catecholamines and vanilmandelic acid in cases of myocardial infarct]
[Plasma renin activity in myocardial infarct]
[Relation of plasma renin activity stroke and heart attack in the epidemiological survey (author's transl)]
[Relationship between the level of plasma renin activity and heart function in acute myocardial infarct]
[Renin and aldosterone in the first 24 hours after acute myocardial infarct]
[Renin and various factors of its regulation in acute myocardial infarct]
[Synthesis of renin and angiotensin-converting enzyme in human heart]
[The activity of renin and angiotensinase in blood plasma of patients with acute myocardial infarct]
[The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril]
[The effect of climatic treatment in the central highlands on the lipid, cortisol, renin and aldosterone content of the blood in patients with an acute myocardial infarct]
[The effect of obsidan on the content of catecholamines and renin in the blood in myocardial infarct]
[The role of DNA polymorphism in the renin-angiotensin system and the pathogenesis of cardiovascular diseases]
Myocardial Ischemia
Abrupt discontinuation of antihypertensive therapy.
Beta-adrenoceptor-blocking drugs in the elderly.
Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.
Chemical Communication between Heart Cells is Disrupted by Intracellular Renin and Angiotensin II: Implications for Heart Development and Disease.
Coronary vasoconstriction in experimental myocardial ischemia.
Distinct determinants of muscle wasting in nonobese heart failure patients with and without type 2 diabetes mellitus.
Intracellular angiotensin II disrupts chemical communication and impairs metabolic cooperation between cardiac myocytes.
Intracellular sorting of renin: cell type specific differences and their consequences.
Ischemic heart disease, prescription of optimal medical therapy and geriatric syndromes in community-dwelling older men: A population-based study.
Plasma renin activity and ischemic heart disease.
Plasma renin activity and its association with ischemic heart disease, congestive heart failure, and cerebrovascular disease in a large hypertensive cohort.
Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction.
Renin Angiotensin system as a regulator of cell volume. Implications to myocardial ischemia.
Role of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heart.
Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.
The renin-angiotensin system as a target for therapeutic intervention.
The renin-angiotensin system during acute myocardial ischemia in dogs.
[Changes in the atrial natriuretic factor and the renin-angiotensin-aldosterone axis induced by maximum exertion in subjects with a recent myocardial infarct]
[Hormone profile of the essential hypertension patient with ischemic cardiopathy. I. Renin, angiotensin and aldosterone]
[Indices of sympathetic-adrenal system and renin activity in ischemic heart disease before and after obzidan treatment]
[Plasma renin activity and ischemic heart disease]
[Renin activity and aldosterone levels in the blood plasma in chronic ischemic heart disease in the elderly]
[To the question of prognostic significance of plasma renin activity. Mean values in normotensive and hypertensive men with ischemic heart disease (author's transl)]
Myocardial Stunning
Angiotensin converting enzyme inhibitor therapy in severe postcardiotomy dysfunction: a prospective randomized study.
Myocarditis
Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.
Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.
Rodent models of cardiopulmonary disease: their potential applicability in studies of air pollutant susceptibility.
Suppression of murine autoimmune myocarditis achieved with direct renin inhibition.
Myoglobinuria
Burn and trauma associated proteinuria: the role of lipid peroxidation, renin and myoglobin.
Prospective study of tetanus-induced acute renal dysfunction: role of adrenergic overactivity.
Recurrent seizures alter renal function and plasma atrial natriuretic peptide levels in rats.
Myxedema
[State of the renin-angiotensin system in thyrotoxicosis]
nad+-protein-arginine adp-ribosyltransferase deficiency
Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue.
Neoplasm Metastasis
A case of renin-producing adrenocortical cancer.
A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
A renal carcinoma secreting inactive renin.
Anti-Angiotensin and Hypoglycemic Treatments Suppress Liver Metastasis of Colon Cancer Cells.
Aspartic peptidase inhibitors: implications in drug development.
Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.
Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer.
Incidentally detected adrenal tumours (incidentalomas): histological heterogeneity and differentiated therapeutic approach.
The renin angiotensin system regulates Kupffer cells in colorectal liver metastases.
Therapeutic potential of renin angiotensin system inhibitors in cancer cells metastasis.
[Arterial hypertension in renin-producing retroperitoneal leiomyosarcoma]
[Tumor syndromes with inappropriate renin secretion. Diagnostic criteria and review of published cases]
Neoplasms
(Pro)renin receptor and prorenin: their plausible sites of interaction.
A case of adrenal tumor producing renin, aldosterone, and sex steroid hormones.
A case of ectopic renin-secreting orbital hemangiopericytoma associated with juvenile hypertension and hypokalemia.
A case of renal juxtaglomerular cell tumor: usefulness of segmental sampling to prove autonomic secretion of the tumor.
A case of renin producing leiomyosarcoma originating in the lung.
A case of renin-producing juxtaglomerular tumor: effect of ACE inhibitor or angiotensin II receptor antagonist.
A case of reninoma with variant angina.
A case report of reninoma: radiological and pathological features of the tumour and characterization of tumour-derived juxtaglomerular cells in culture.
A Meta-Analysis of Somatic KCNJ5 K(+) Channel Mutations In 1636 Patients With an Aldosterone-Producing Adenoma.
A Pit-1 binding site in the human renin gene promoter stimulates activity in pituitary, placental and juxtaglomerular cells.
A Rat Model to Study the Effects of Diet-Induced Obesity on Radiation-Induced Mammary Carcinogenesis.
A renal carcinoma secreting inactive renin.
A renin secreting ovarian steroid cell tumour associated with secondary polycythaemia.
A renin-secreting tumor.
A renin-secreting tumour sensitive to changes in central blood volume (presumably via sympathetics) but not to circulating angiotensin II.
A very small juxtaglomerular cell tumor preoperatively identified by magnetic resonance imaging.
A Young Female With Refractory Hypertension.
ACE2/Angiotensin-(1-7)/Mas receptor axis in human cancer: Potential role for pediatric tumors.
Activation of renin in an anaplastic pulmonary adenocarcinoma.
Adenocarcinoma of the kidney and hypertension: report of 2 cases with special emphasis on renin.
Adhesion molecules as a prognostic marker of liver cirrhosis.
Adrenal renin: a possible local regulator of aldosterone production.
Adrenal renin: regulation and function.
Adrenal tumor producing 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone and aldosterone.
Adult-onset giant juxtaglomerular cell tumor of the kidney.
Aldosterone-producing tumors (Conn's syndrome).
Aliskiren targets multiple systems to alleviate cancer cachexia.
Altered renin and aldosterone excretion in patients treated for metastatic germ cell tumours.
Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor.
Alveolar soft-part sarcoma. A review on its histogenesis and further studies based on electron microscopy, immunohistochemistry, and biochemistry.
An ectopic renin-secreting adrenal corticoadenoma in a child with malignant hypertension.
An ultrastructural and immunocytochemical study of a renal carcinoma secreting inactive renin.
Anatomy of the renin-angiotensin system in the normal and pathological kidney.
Angiotensin II type 1 receptor expression in two cases of juxtaglomerular cell tumor: correlation to negative feedback of renin secretion by angiotensin II.
Angiotensinogen-producing hepatocellular carcinoma.
Application of 3D printing technology in endophytic reninoma: A case report and literature review.
Association of AGTR1 (A1166C) and ACE (I/D) Polymorphisms with Breast Cancer Risk in North Indian Population.
Associations between the levels of soluble (pro)renin receptor in maternal and umbilical cord blood and hypertensive disorder of pregnancy.
Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
Beta-adrenergic regulation of renin expression in differentiated U-937 monocytic cells.
Big renin: identification, chemical properties and clinical implications.
Biochemical and immunological characterization of ectopic tumoral renin.
Biomarker profile in stable Fontan patients.
Biosynthesis of renin in mouse kidney tumor As4.1 cells.
Blunted sympathetic response in diabetic patients with decompensated congestive heart failure.
Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.
Brain inflammation and hypertension: the chicken or the egg?
Calcitriol derivatives with two different side chains at C-20 III. An epimeric pair of the gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition.
Cancer progression in COVID-19: integrating the roles of renin angiotensin aldosterone system, angiopoietin-2, heat shock protein-27 and epithelial mesenchymal transition.
Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure.
Cardiovascular benefits of vitamin D.
Case Report of Atypical Juxtaglomerular Cell Tumor.
Change in plasma renin activity by cold storage of plasma in normal subjects and patients with essential hypertension and primary aldosteronism.
Characterization and Management of Juxtaglomerular Cell Tumor: Analysis of 9 Cases and Literature Review
Characterization of inactive renin ("prorenin") from renin-secreting tumors of nonrenal origin. Similarity to inactive renin from kidney and normal plasma.
Chromosome 8 alterations accompany tumorigenesis in renin-SV40 T antigen transgenic mice.
Chronic heart failure and cardiac cachexia and links between the endocrine and immune systems.
Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines.
Circulating vascular endothelial growth factor and active renin concentrations and prostaglandin E2 urinary excretion in patients with adrenal tumours.
Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.
Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.
Clinical syndromes associated with tumors of the female genital tract.
Concomitant release of renin, angiotensin I, and angiotensin II during superfusion of human juxtaglomerular cell tumor.
Congenital mesoblastic nephroma, renin production, and hypertension.
Congestive heart failure as an initial manifestation of reninoma.
Congestive heart failure, hypertension, and hyperreninemia in bilateral Wilms' tumor: successful medical management.
Control of aldosterone in 17 alpha-hydroxylase deficiency.
Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression.
Demonstration of both primary and secondary reninism in renal tumors in children.
Demonstration of renin gene expression in nephroblastoma by in situ hybridization.
Deoxycorticosterone producing tumor as a cause of resistant hypertension.
Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer.
Diagnosis and treatment of renin-secreting tumors. Report of three cases.
Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentrations in hypertensive patients.
Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluation.
Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancer.
Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol.
Ectopic production of renin by ileal carcinoma.
Effects of cadmium ingestion in rats with opposite genetic predisposition to hypertension.
Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure.
Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study.
Effects of Rubus occidentalis extract on blood pressure in patients with prehypertension: Randomized, double-blinded, placebo-controlled clinical trial.
Effects of tumor necrosis factor-alpha on luteinizing hormone-stimulated prorenin production by bovine ovarian thecal cells in vitro.
Elevated plasma amylase levels in advanced chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy: correlation with circulating interleukin-6 activity.
Endogenous human renin expression and promoter activity in CALU-6, a pulmonary carcinoma cell line.
Epidermal growth factor, renin, and peptidase in cultured tumor cells of submandibular gland origin.
Erythropoietin and renin substrate in cerebellar haemangioblastoma.
Excessive muscle paralysis due to pulmonary carcinoid -a case report.
Expression of murine renin genes in subcutaneous connective tissue.
Extrarenal renin-secreting tumor associated with hypertension.
Extrarenal renin-secreting tumors: insights into hypertension and ovarian renin production.
Follicular maturation and atresia--possible role of intraovarian regulatory factors.
Genetics of primary aldosteronism.
Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
Hormonal changes associated with hypertension in neoplasia-induced hypercalcemia.
Hormones in renal cancer.
Human prorenin: pathophysiology and clinical implications.
Human renin gene of renin-secreting tumor.
Hypermineralocorticoidism due to adrenal carcinoma: plasma corticosteroids and their response to ACTH and angiotensin II.
Hypertension and Hydronephrosis: Rapid Resolution of High Blood Pressure Following Relief of Bilateral Ureteric Obstruction.
Hypertension due to a deoxycorticosterone-secreting adrenal tumour diagnosed during pregnancy.
Hypertension due to a renin-secreting tumour localised by segmental renal vein sampling.
Hypertension in a cohort of African children with renal tumours.
Hypertension secondary to renin-secreting juxtaglomerular cell tumor: case report and review of 38 cases.
Hypertension with renal carcinoma. An effect of arterial embolization.
Hypertensive Cardiotoxicity in Cancer Treatment-Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies-Epidemiology, Incidence, and Pathophysiology.
Hypertensive renal rhabdomyosarcoma.
Hypokalemia with normal blood pressure, aldosterone and renin levels secondary to a renal or adrenal tumor.
Hyponatraemia secondary to nivolumab-induced primary adrenal failure.
Hyponatremic hypertensive syndrome and massive proteinuria in a patient with renin-producing leiomyosarcoma.
Identification of ATF2 as a transcriptional regulator of renin gene.
Immunocytochemical localisation of renin in nephroblastoma.
Immunocytochemistry of renin in renal tumours.
Immunohistochemical expression of renin is a prognostic factor for recurrence in nonmetastatic renal cell carcinoma.
Immunohistochemical localization of renin in renal tumors.
Immunohistochemical renin study of DES-induced renal tumor in the Syrian hamster.
Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Immunohistochemistry of renin in human diseased kidney.
Immunoreactive prorenin and its profragment peptide are present in human juxtaglomerular cells.
Implication of inflammation-related cytokines in the natural history of liver cirrhosis.
Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium.
In primary aldosteronism the circadian blood pressure rhythm is similar to that in primary hypertension.
In vitro biosynthesis of human renin and identification of plasma inactive renin as an activation intermediate.
Inactive renin levels in recurrent nephroblastoma.
Inactive renin: a tumor marker in nephroblastoma.
Incidentally detected adrenal tumours (incidentalomas): histological heterogeneity and differentiated therapeutic approach.
Increased FDG Uptake on Juxtaglomerular Cell Tumor in the Left Kidney Mimicking Malignancy.
Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.
Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension.
Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors.
Induction of renin activity by gonadotropic hormones in cultured Leydig tumor cells.
Influence of unilateral adrenalectomy on renin-angiotensin-aldosterone system in primary aldosteronism.
Inhibition of adenosine deaminase attenuates endotoxin-induced release of cytokines in vivo in rats.
Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-?-dependant interleukin-17.
Inhibition on angiotensin-converting enzyme exerts beneficial effects on trabecular bone in orchidectomized mice.
Interferon-gamma inhibits the synthesis and release of renin from human decidual cells.
Interleukin-1 inhibits renin gene expression in As4.1 cells but not in native juxtaglomerular cells.
Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct.
Juxtaglomerular apparatus tumor: a rare, surgically correctable cause of hypertension.
Juxtaglomerular cell tumor cell line producing active renin and its precursors.
Juxtaglomerular cell tumor in a young male presenting with new onset congestive heart failure.
Juxtaglomerular cell tumor in an 8-year-old girl.
Juxtaglomerular cell tumor of kidney with CD34 and CD117 immunoreactivity: report of 5 cases.
Juxtaglomerular cell tumor of the kidney.
Juxtaglomerular cell tumor of the kidney. Morphological, immunohistochemical and ultrastructural studies of a new case.
Juxtaglomerular cell tumor of the kidney: a case report.
Juxtaglomerular Cell Tumor With Atypical Pathological Features: Report of a Case and Review of Literature.
Juxtaglomerular cell tumor with elevation of serum erythropoietin.
Juxtaglomerular cell tumor with retroperitoneal fibrosis and secondary immune-complex glomerulonephritis: a possible contribution of the renin angiotensin system to renal fibrosis.
Juxtaglomerular cell tumor--a rare cause of secondary hypertension.
Juxtaglomerular cell tumor. An immunohistochemical, electron-microscopic, and in situ hybridization study.
Juxtaglomerular cell tumor: A morphological, immunohistochemical and genetic study of six cases.
Juxtaglomerular cell tumor: importance of clinical suspicion.
Juxtaglomerular tumour: diagnostic renal vein renin measurements obscured by chronic captopril therapy.
Laparoscopic Nephro-Sparing Surgery of a Reninoma Tumor in a Pediatric Patient.
Laparoscopic partial nephrectomy for Juxtaglomerular apparatus tumour: A rare cause of hypertension.
Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications.
Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders.
Losartan and Vitamin D Inhibit Colonic Tumor Development in a Conditional Apc-Deleted Mouse Model of Sporadic Colon Cancer.
Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
Malignant human renin producing paraganglionoma-localization with 123I-MIBG and treatment with 131I-MIBG.
Malignant hypertension due to a large reninoma: a case report.
Malignant hypertension due to a renin-secreting renal cell carcinoma--an ultrastructural and immunocytochemical study.
Management of the clinically inapparent adrenal mass ("incidentaloma").
Metastatic juxtaglomerular cell tumor in a 52-year-old man.
Modulation of active renin secretion by renin-binding protein (RnBP) in mouse pituitary AtT-20 cells transfected with human renin and RnBP cDNAs.
Molecular biology and nuclear medicine in pediatric hydronephrosis.
Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.
Morphological and immunohistochemical characteristics of dimethylnitrosamine-induced malignant mesenchymal renal tumor in F-344 rats.
Morphological characteristics of a transplantable nephroblastoma (NB-Y) in F344 rats and the relation of tumour growth to hyper-reninaemia in NB-Y-bearing rats.
Multiple forms of human renin. Purification and characterization.
Multiple forms of immunoreactive renin in human adrenocortical tumour tissue from patients with primary aldosteronism.
Myxoid Adrenal Cortical Carcinoma Presenting as Primary Hyperaldosteronism: Case Report and Review of the Literature.
Nephron-sparing surgery for treatment of reninoma: a rare renin secreting tumor causing secondary hypertension.
Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia.
Neurohumoral activation and ventricular arrhythmias in patients with decompensated congestive heart failure: role of endothelin.
New aspects of mineralocorticoid hypertension.
Nonfunctioning juxtaglomerular cell tumor.
Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2.
Nucleus of the solitary tract (pro)renin receptor-mediated antihypertensive effect involves nuclear factor-?B-cytokine signaling in the spontaneously hypertensive rat.
Occurrence of big renin in human plasma, amniotic fluid and kidney extracts.
Paracrine regulation of the renin-aldosterone system.
Paraneoplastic secondary hypertension due to a renin-secreting desmoplastic small round cell tumor: A case report.
PCR analysis of human renal biopsies--renin gene regulation in glomerulonephritis.
Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.
Pheochromocytoma with renal artery stenosis and high plasma renin activity.
Plasma aldosterone concentrations and plasma renin activity in healthy dogs and dogs with hyperadrenocorticism.
Plasma bradykinin levels in human chronic congestive heart failure.
Plasma endothelin-1 level in patients with renovascular hypertension - does the kidney with stenosis of the renal artery upregulate production of endthelin-1?
Plasma markers of myocardial inflammation at isolated atrial fibrillation.
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
Plasma renin levels in patients with thoracic neuroblastoma.
Polydipsia, polyuria, and hypertension associated with renin-secreting Wilms tumor.
Posterior reversible encephalopathy syndrome (PRES) in mesenteric leiomyosarcoma: A case report.
Potential effects of renin activation on the regulation of renin production.
Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: Results from a pilot study in elderly chronic heart failure patients.
Prevalence of Somatic KCNJ5 Mutations in Thai Patients With Aldosterone-Producing Adrenal Adenomas.
Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Primary hyperaldosteronism in the era of laparoscopic adrenalectomy.
Primary hyperaldosteronism in two cats.
Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles.
Prognostic value of serum cytokines in patients with congestive heart failure.
Properties of renin-binding protein.
Prorenin induces ERK activation in endothelial cells to enhance neovascularization independently of the renin-angiotensin system.
Prorenin stimulates a pro-angiogenic and pro-inflammatory response in retinal endothelial cells and an m1 phenotype in retinal microglia.
Protection against ischemia: a physiological function of the renin-angiotensin system.
Protective effect of perindopril on tumor progression and angiogenesis in animal model of breast cancer.
Proteolytic processing of human prorenin in renal and non-renal tissues.
Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin.
Rare and curable renin-mediated hypertension: a series of six cases and a literature review.
Recurrent hypertensive cerebral hemorrhages in a boy caused by a reninoma: rare manifestations and distinctive electron microscopy findings.
Refractory hypertension and isosexual pseudoprecocious puberty associated with Renin-secreting ovarian steroid cell tumor in a girl.
Regulation of aminopeptidase A in human brain tumor vasculature: evidence for a role of transforming growth factor-beta.
Regulation of renin angiotensins by gonadotropic hormones in cultured murine Leydig tumor cells. Release of angiotensin but not renin.
Regulation of Renin Gene Expression by Oxidative Stress.
Regulation of the prorenin - angiotensin system by oxygen and miRNAs; parallels between placentation and tumour development?
Relative adrenal insufficiency in decompensated cirrhosis: Relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death.
Renal metabolism in mice of exogenously administered 125I labelled renin.
Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma.
Renin and angiotensins in cultured mouse adrenocortical tumour cells.
Renin and inactive renin (prorenin) in the plasma of patients with malignant renal tumours.
Renin angiotensin system inhibition attenuates adipocyte-breast cancer cell interactions.
Renin angiotensin system inhibitors may attenuate low LDL cholesterol-related cancer risk in type 2 diabetes.
Renin biosynthesis by human tumoral juxtaglomerular cells. Evidences for a renin precursor.
Renin expression in adult renal epithelial tumors with granular cells.
Renin gene expression in human kidney biopsies from patients with glomerulonephritis or graft rejection.
Renin gene expression in nephroblastoma.
Renin gene polymorphism associated with aldosterone responsiveness to the renin-angiotensin system in patients with aldosterone-producing adenomas.
Renin in adrenal: an overview of its synthesis, subcellular localization, and functions.
Renin in angiolymphoid hyperplasia with eosinophilia. Its possible effect on vascular proliferation.
Renin in blood vessels in human pulmonary tumors. An immunohistochemical and biochemical study.
Renin in glioblastoma multiforme and its role in neovascularization.
Renin in mesoblastic nephroma: an immunohistochemical study.
Renin in renal cell carcinoma--an immunocytochemical study using an antibody to pure human renin.
Renin in Wilms' tumor: prorenin as an indicator.
Renin levels in nephroblastoma (Wilms' tumour). Report of a renin secreting tumour.
Renin messenger RNA localization in congenital mesoblastic nephroma using in situ hybridization.
Renin mRNA is upregulated in testes and testicular cells in response to treatment with aflatoxin B1.
Renin producing neuroendocrine pancreatic carcinoma--a case report and review of the literature.
Renin producing Wilms' tumor.
Renin production in congenital mesoblastic nephroma in comparison with that in Wilms' tumor.
Renin secreting tumors: diagnosis, conservative surgical approach and long-term results.
Renin secreting tumour of kidney--a case report.
Renin secreting tumour: a rare cause of secondary hypertension.
Renin secretion from malignant pulmonary metastatic tumour cells of vascular origin.
Renin storage and cell differentiation in juxtaglomerular cell tumors: an immunohistochemical and ultrastructural study of three cases.
Renin-angiotensin system inhibitors to mitigate cancer treatment-related adverse events.
Renin-producing adrenal tumor: report of a case.
Renin-producing germ cell tumor in the pineal apparatus and mediastinum: A rare case report.
Renin-producing hepatoblastoma.
Renin-producing leiomyosarcoma originating in the uterus.
Renin-producing ovarian tumor. A case report with immunohistochemical and electron-microscopic study.
Renin-producing renal cell carcinoma.
Renin-producing renal cell carcinomas--clinical and experimental investigations on a special form of renal hypertension.
Renin-producing serous cystoadenocarcinoma of the ovary: a case report.
Renin-producing Tumour in the Kidney of a Cat.
Renin-promoter SV40 large T-antigen transgenes induce tumors irrespective of normal cellular expression of renin genes.
Renin-secreting clear cell carcinoma of the kidney.
Renin-secreting renal tumour with severe hypertension. case report with tumour renin analysis, histopathological and ultrastructural studies.
Renin-secreting tumors.
Reninoma Masked by the Use of an Angiotensin Receptor Blocker.
Reninoma: case report and literature review.
Reninoma: the importance of renal vein renin ratios for lateralisation and diagnosis.
Response of plasma prorenin and active renin to chronic and acute alterations of renin secretion in normal humans. Studies using a direct immunoradiometric assay.
Review of juxtaglomerular cell tumor with focus on pathobiological aspect.
Rhabdoid tumor of the kidney: a report of two cases with respective tumor markers and a specific chromosomal abnormality, del(11p13).
Role of CREB1 and NF{kappa}B-p65 in the down-regulation of renin gene expression by tumor necrosis factor {alpha}.
Role of cyclic AMP in renin secretion by human transfected juxtaglomerular cells.
Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth.
Role of proximal promoter elements in regulation of renin gene transcription.
Role of renin and aldosterone in hypertension due to a renin-secreting tumor.
Role of stimulated intrarenal angiotensinogen in hypertension.
Secondary hypertension due to renin secreting tumor: a case report.
Secondary hypertension. An overview of its causes and management.
Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage.
Secretion of prorenin by a virilizing ovarian tumor.
Secretion of renin-angiotensin system (RAS) components by normal and tumoral lactotropes. A comparative study using reverse hemolytic plaque assay (RHPA) and immunoelectron microscopy.
Seven lessons from seven renin secreting tumors.
Severe hypertension and encephalopathy due to Renin-producing hepatoblastoma.
Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism.
Single quantum dot based nanosensor for renin assay.
Sodium Intake Is associated With Endothelial Damage Biomarkers and Metabolic Dysregulation.
State of systemic hemodynamics in a case of juxtaglomerular cell tumor.
Steroid characteristics of mineralocorticoid adrenocortical hypertension.
Steroids and hypertension.
Stimulation of nitric oxide-cyclic guanosine monophosphate pathway in bovine ovarian theca cells by tumor necrosis factor alpha (TNF alpha). Is this pathway implicated in the TNF alpha-induced inhibition of luteinizing hormone-stimulated prorenin production?
Structure of a juxtaglomerular cell tumor: the presence of a neural component: a light and electron microscopic study.
Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy.
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.
Temporal changes in gene expression following cryogenic rat brain injury.
Testosterone induces apoptosis in cardiomyocytes by increasing proapoptotic signaling involving tumor necrosis factor-? and renin angiotensin system.
The activated immune system and the renin-angiotensin-aldosterone system in congestive heart failure.
The changes in active and inactive renin induced by various maneuvers in hypertensive patients.
The Effect of Local Renin Angiotensin System in the Common Types of Cancer.
The immunocytochemical demonstration of renin in a juxtaglomerular cell tumour by light and electron microscopy.
The importance of the renin-angiotensin system in cardiovascular disease.
The radiology of juxtaglomerular tumors.
The renin and iso-renin-angiotensin system in rats with experimental pitutary tumors (38585).
The renin angiotensin system regulates Kupffer cells in colorectal liver metastases.
The renin gene and aldosterone-producing adenomas.
The renin-angiotensin system in association with hyperreninaemic hypoaldosteronism in neoplasia induced hypercalcaemia.
The role of insulin and renin in the pathogenesis of hormone-dependent neoplasias. a). Insulin.
The role of insulin and renin in the pathogenesis of hormone-dependent neoplasias. b). Renin.
The Role of Real-Time Contrast-Enhanced Ultrasound in Guiding Radiofrequency Ablation of Reninoma: Case Report and Literature Review.
Therapeutic effect of forest bathing on human hypertension in the elderly.
Therapeutic potential of renin angiotensin system inhibitors in cancer cells metastasis.
Transcription of the prorenin gene in normal and diseased breast.
Translational studies on augmentation of intratubular renin-angiotensin system in hypertension.
Tumor necrosis factor and interleukin-1 may regulate renin secretion.
Tumor necrosis factor-alpha activates NFkappaB to inhibit renin transcription by targeting cAMP-responsive element.
Tumor necrosis factor-alpha and interleukin-1 beta inhibit the synthesis and release of renin from human decidual cells.
Tumor necrosis factor-alpha inhibits renin gene expression.
Tumour necrosis factor alpha in severe congestive cardiac failure.
Unexpected role of the human cytomegalovirus contribute to essential hypertension in the Kazakh Chinese population of Xinjiang.
Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis.
Usefulness of 6-minute walk test, plasma neurohumoral and cytokine activation in the assessment of symptomatic patients with left ventricle dysfunction caused by chronic severe mitral valve regurgitation.
Vascular endothelial growth factor D is a biomarker of fluid overload in haemodialysis patients.
Wilms' tumor protein (-KTS) modulates renin gene transcription.
Within-patient variability of hormone and cytokine concentrations in heart failure.
Zona fasciculata-like histotype and aldosterone response to upright posture are not related in aldosterone-producing adenomas.
[A case of renin secreting juxtaglomerular cell tumor diagnosed by CT during renal arteriography]
[A case of renovascular hypertension due to chondrosarcoma arising from lumbar vertebrae]
[A clinical analysis of reninoma-induced hypertensive crisis associated with reversible posterior encephalopathy syndrome].
[A juxtaglomerular cell tumor. Analysis of immunohistochemistry, electron microscopy and in situ hybridization]
[A rare cause of hypertension with hypokalemia: A case of reninoma].
[Adipose tissue as an endocrine organ].
[Adrenal incidentaloma].
[Androgen-producing steroid cell ovarian tumor. Report of a case]
[Another case of hypertension due to a tumour of the juxta-glomerular apparatus (author's transl)]
[Anuria due to bilateral renal artery spasm during hysterectomy and oophorectomy]
[Aortorenal angiography and other approaches in the diagnosis of arterial hypertension of renal origin]
[Application of angiotensin II receptor blocker in prostate cancer]
[Arterial hypertension and renin producing tumors]
[Arterial hypertension due to compression of the renal artery, revealing ovarian cancer]
[Arterial hypertension in renin-producing retroperitoneal leiomyosarcoma]
[Arterial hypertension: adenocarcinoma of the kidney or bilateral renal artery stenosis$]
[Carcinoma of the kidney with production of renin. A special form of hypertension]
[Chronic heart failure and cardiac cachexia and links between the endocrine and immune systems]
[Clinical aspects and chemotherapy of adenocarcinoma of the kidney]
[Clinicopathologic features of glomus tumor of the kidney].
[Congenital adrenal hyperplasia and testicular hypertrophy]
[Detection of renin in chromophobe renal cell carcinomas]
[Endocrine and neurogenic hypertension in childhood]
[Expression of CD34 and CD117 in juxtaglomerular cell tumor of kidney]
[Grawitz's tumor with arterial hypertension in children. Apropos of a case]
[Histologic and ultrastructural forms of benign tumors of the kidney with renin secretion. Functional implications]
[Hypertension secondary to a "renin tumor". One case (author's transl)]
[Juxtaglomerular cell tumor: a case report]
[Paraneoplastic hypercorticism. Hypokalemia, increased plasma renin activity and hypoaldosteronism during cancer of the pancreas]
[Pharmacological therapy of age-related macular degeneration based on etiopathogenesis].
[Polymorphism of angiotensin converting enzyme (ACE) and TNF-beta genes in men with disorders of spermatogenesis--pilot study]
[Prognostic value of cytokines and neurohormones in severe heart failure]
[Quadric analysis applied to preoperative assessment between patients with or without adrenocortical tumors in hypertension with hyperaldosteronism and low plasma renin]
[Radiographic appearances of a renin secreting renal tumor. A rare cause of hypertension (author's transl)]
[Radionuclide study of the function of the kidneys and their hormonal regulation in cancer of the uterus]
[Remarkable hypotensive effect of converting enzyme inhibitor on a possible case of renin producing neoplasm]
[Renal hypertension]
[Renin producing tumors]
[Renin secreting kidney tumors]
[Renin secreting renal tumors]
[Renin secreting tumor and severe hypertension. Apropos of a new case]
[Renin secreting tumor and urinary excretion of kallikrein]
[Renin-secreting renal tumor. A case report]
[Renin-secreting tumor detected by MRI]
[Renin-secreting tumour: about a new diagnosed case during pregnancy]
[Reninoma: a rare but curable cause of high blood pressure, a case report]
[So-called juxtaglomerular benign tumor of the kidney with renin secretion. Optical and ultrastructural study]
[Studies on the existence of renin in the human testis]
[Study of the renin-angiotensin system in 2 cases of Wilm's tumor with severe arterial hypertension]
[Study on changes in circulatory renin-angiotensin system in rats with endotoxemia.]
[The glucagonoma syndrome. Review of the literature. Apropos of a case]
[Tumor syndromes with inappropriate renin secretion. Diagnostic criteria and review of published cases]
Neoplasms, Germ Cell and Embryonal
Altered renin and aldosterone excretion in patients treated for metastatic germ cell tumours.
Renin-producing germ cell tumor in the pineal apparatus and mediastinum: A rare case report.
Neoplasms, Glandular and Epithelial
Renin expression in adult renal epithelial tumors with granular cells.
Nephritis
(Pro)renin receptor promotes crescent formation via the ERK1/2 and Wnt/?-catenin pathways in glomerulonephritis.
Activation of the renin-angiotensin system in anti-glomerular basement membrane antibody-induced glomerulonephritis.
Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.
Changes in IgA and metals in serum and urine of human volume hypertension.
Combining angiotensin II blockade and renin receptor inhibition results in enhanced antifibrotic effect in experimental nephritis.
Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
Enhanced intrarenal receptor-mediated prorenin activation in chronic progressive anti-thymocyte serum nephritis rats on high salt intake.
Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism.
Hypertension in radiation nephritis. Report of a patient with unilateral disease, elevated renin activity levels, and reversal after unilateral nephrectomy.
Plasma renin activity during development of experimental antiserum glomerular nephritis.
Plasma renin activity in patients with chronic nephritis.
Renin-angiotensin vaccine: old story, new project 'efficacy versus safety'.
Response to frusemide in acute renal failure: dissociation of renin and diuretic responses.
The influence of upright position and sodium restriction in the diet on plasma renin activity (PRA) and aldosteronemia in patients with chronic nephritis.
Unusual manifestations of Henoch-Schönlein syndrome.
[Changes in the renin-angiotensin-aldosterone system in glomerulonephritis]
[Mechanisms of the development of arterial hypertension in hypertonic nephritis]
[Pathophysiological features of arterial hypertension in chronic nephritis]
[Plasma renin activity in patients with chronic nephritis]
[Renin and the juxtaglomerular apparatus in experimental nephritis.]
Nephrocalcinosis
A syndrome resembling Bartter's syndrome in sarcoidosis.
Hypertension corrected by discontinuing chronic sodium bicarbonate ingestion. Subsequent transient hypoaldosteronism.
Immune-related potassium-losing interstitial nephritis: a comparison with distal renal tubular acidosis.
In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess.
Nephrocalcinosis and renal cysts associated with apparent mineralocorticoid excess syndrome.
Transient hyponatremia of prematurity caused by mild Bartter syndrome type II: a case report.
Nephroma, Mesoblastic
Congenital mesoblastic nephroma, renin production, and hypertension.
Hyperreninemia and congenital mesoblastic nephroma: case report and review of the literature.
Renin in mesoblastic nephroma: an immunohistochemical study.
Renin messenger RNA localization in congenital mesoblastic nephroma using in situ hybridization.
Renin production in congenital mesoblastic nephroma in comparison with that in Wilms' tumor.
[Cardiac failure by major arterial hypertension secondary to nephroblastoma]
Nephrosclerosis
An accelerated hypertension with neither malignant nephrosclerosis nor elevation of plasma renin activity.
Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats.
Angiotensin receptor antagonists in patients with nephropathy due to type 2 diabetes.
Failure of renin suppression by angiotensin II in hypertension.
Gelfoam embolization of the kidneys for treatment of malignant hypertension.
Hemodynamic and cardiac adaptation in essential hypertension. Consequences for therapy.
Hypertension in black patients. Epidemiologic and pathophysiologic considerations.
Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans.
Low-renin hypertension: nephrosclerosis?
Renal renin in experimental nephrosclerosis.
Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations.
Salt and water balance and renin activity in renal hypertension of rats.
Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis.
The diagnostic and therapeutic uses of saralasin in renal transplant hypertension.
Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?
[Hypertension in unilateral (non-vascular) nephrosclerosis: renin activity in the venous kidney blood and effect of nephrectomy]
[The renin saga]
Nephrosis
A decade of angiotensin-converting enzyme (ACE) inhibition.
Effect of captopril on urinary excretion of renin and angiotensinogen in aminonucleoside nephrosis.
Elevation of plasma angiotensinogen in rats with experimentally induced nephrosis.
Glomerular renin synthesis and storage in the remnant kidney in the rat.
Renin in the kidneys of rats with aminonucleoside nephrosis.
Renin-angiotensin-aldosterone system in nephrotic syndrome.
Renin-sodium profile in experimental nephrosis induced by puromycin aminonucleoside.
Nephrosis, Lipoid
Abnormalities of renin-containing cells in human glomerular and vascular renal diseases.
Renin-angiotensin-aldosterone system in nephrotic syndrome.
Role of renin angiotensin aldosterone on minimal change nephrotic syndrome.
[Renin activity and aldosterone level in the plasma of children with lipoid nephrosis]
Nephrotic Syndrome
Acid-base disturbances in nephrotic syndrome: analysis using the CO2/HCO3 method (traditional Boston model) and the physicochemical method (Stewart model).
Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice.
Atrial natriuretic factor in the acute nephritic and nephrotic syndromes.
Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome.
Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
Connexin Signaling in the Juxtaglomerular Apparatus (JGA) of Developing, Postnatal Healthy and Nephrotic Human Kidneys.
Distal nephron sodium-potassium exchange in children with nephrotic syndrome.
Downregulation of nitric oxide synthase in nephrotic syndrome: role of proteinuria.
Effect of a high protein diet in patients with the nephrotic syndrome.
Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.
Elevation of plasma angiotensinogen in rats with experimentally induced nephrosis.
Evidence for a role of angiotensin converting enzyme 2 in proteinuria of idiopathic nephrotic syndrome.
Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome.
Focal Segmental Glomerulosclerosis Secondary to Juxtaglomerular Cell Tumor during Pregnancy: A Case Report.
Gel filtration profile of plasma active and inactive renin in normals and patients with nephrotic syndrome.
High renin hypertension in the elderly.
Hormonal regulation of water metabolism in children with nephrotic syndrome.
Immunohistochemical analysis of renin activity in chronic cyclosporine nephropathy in childhood nephrotic syndrome.
Increased norepinephrine secretion in patients with the nephrotic syndrome and normal glomerular filtration rates: evidence for primary sympathetic activation.
Interrelationships between sodium clearance, plasma aldosterone, plasma renin activity, renal hemodynamics and blood pressure in renal disease.
Juxtaglomerular apparatus hyperplasia under dual angiotensin blockade. A footprint of adequate RAS inhibition or a concern for renal fibrosis?
Lack of effect of captopril on the sodium retention of the nephrotic syndrome.
Observations on plasma renin substrate in the nephrotic syndrome.
Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
PPAR-? transcriptional activity is required to combat doxorubicin-induced podocyte injury in mice.
Proteinuria and nephrotic syndrome induced by renin in patients with renal artery stenosis.
Renin, prorenin, and renin gene expression in rats with acute nephrotic syndrome.
Renin-sodium profile in experimental nephrosis induced by puromycin aminonucleoside.
Reversible nephrotic syndrome due to high renin state in renovascular hypertension.
Role of glomerular filtration rate in the impaired sodium and water excretion of patients with the nephrotic syndrome.
Role of renin angiotensin aldosterone on minimal change nephrotic syndrome.
Serum angiotensin converting enzyme activity and plasma renin activity in experimental models of rats.
Steroid-induced hypertension in patients with nephrotic syndrome.
Urinary serine proteases and activation of ENaC in kidney-implications for physiological renal salt handling and hypertensive disorders with albuminuria.
[Aldosterone secretion, plasma renin activity and nephrotic syndromes in rats]
[Circulating blood volume and plasma renin activity in the nephrotic syndrome. Effect of prednisolone therapy]
[Endogenous vasoactive factors in children with nephrotic syndrome]
[Nephrotic syndrome as indication for one-stage bilateral renal embolisation (author's transl)]
[Plasma renin concentration in healthy persons, patients with hypertension and patients with nephrotic syndrome]
[Renin activity and aldosterone level in the plasma of children with lipoid nephrosis]
[Studies of plasma active and inactive renins in patients with nephrotic syndrome. Part IV. Molecular forms of renin in nephrotic syndrome (author's transl)]
Nervous System Diseases
Molecular Basis of the Brain Renin Angiotensin System in Cardiovascular and Neurologic Disorders: Uncovering a Key Role for the Astroglial Angiotensin Type 1 Receptor AT1R.
Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension.
Neuralgia
Neuropathic pain-attenuating potential of aliskiren in chronic constriction injury model in rats.
Neuroblastoma
Brain renin.
Determination of plasma total renin level by RIA with a monoclonal antibody: value as a marker for nephroblastoma.
Endogenous renin inhibitor in neuroblastoma cells.
Generation of angiotensinogen by cultured neuroblastoma and glioma cells.
Immunoreactive renin in human brain: distribution and properties.
Local generation of angiotensin in the kidney and in tissue culture.
Molecular characterization of inactive renin: complete purification of prorenin in hog kidney and isolation of inactive renin from neuroblastoma cells: evidence for 2 different types of inactive renin.
Plasma renin levels in patients with thoracic neuroblastoma.
Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line.
Renin and angiotensin-converting enzyme in human neuroblastoma tissue.
Renin and angiotensin: the complete system within the neuroblastoma x glioma cell.
Renin in the brain and neuroblastoma cells: an endogenous and intracellular system.
Renin, angiotensins, and angiotensin-converting enzyme in neuroblastoma cells: evidence for intracellular formation of angiotensins.
Syntenic assignment of human chromosome 1 homologous loci in the bovine.
Synthesis of angiotensinogen by renin-containing neuroblastomas.
The renin-angiotensin system in hybrid NG108-15 cells. Renin gene is from mouse neuroblastoma, angiotensinogen and angiotensin-converting enzyme genes are of rat glioma origin.
Neuroectodermal Tumors
Heritable formation of neuroectodermal tumor in transgenic mice carrying the combined E1 region gene of adenovirus type 12 with the deregulated human renin promoter.
Neurofibromatoses
Treatment of neurofibromatosis associated renal artery stenosis with hypertension by percutaneous transluminal angioplasty.
Neurogenic Inflammation
Mast cells activate the renin angiotensin system and contribute to migraine: a hypothesis.
Neuroinflammatory Diseases
High Fat Diet Exacerbates Neuroinflammation in an Animal Model of Multiple Sclerosis by Activation of the Renin Angiotensin System.
Neuroinflammation and sympathetic overactivity: Mechanisms and implications in hypertension.
Neurologic Manifestations
Severe hypertension and encephalopathy due to Renin-producing hepatoblastoma.
[Role of various endocrine glands in the pathogenesis of the neurologic symptoms of lumbar osteochondrosis]
Non-alcoholic Fatty Liver Disease
Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats.
TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor.
[Effect of NF-?B on the pathogenic course of non-alcoholic fatty liver disease].
Obesity
Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose tissue.
Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity.
Arachidonic acid inhibits the production of angiotensin-converting enzyme in human primary adipocytes via a NF-?B-dependent pathway.
Association of parental obesity with concentrations of select systemic biomarkers in nonobese offspring: the Framingham Heart Study.
AT2 receptor: Its role in obesity associated hypertension.
Cardiovascular risk and obesity.
Cellular and RAS Changes in the Hearts of Young Obese Rats.
Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.
Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African Americans with stage 2 hypertension and obesity or metabolic syndrome.
Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity.
Effects of aerobic exercise training on cardiac renin-angiotensin system in an obese Zucker rat strain.
Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins.
Energy metabolism in human renin-gene transgenic rats: does renin contribute to obesity?
Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
Gaisböck's syndrome: its hematologic, biochemical and hormonal parameters.
Gastric mucosal devitalization improves blood pressure, renin and cardiovascular lipid deposition in a rat model of obesity.
High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.
How does obesity affect the endocrine system? A narrative review.
Hypertension in congenital adrenal hyperplasia and apparent mineralocorticoid excess.
Impact of obesity on kidney function and blood pressure in children.
Impact of obesity on the association of active renin and plasma aldosterone concentrations, and aldosterone-to-renin ratio with preeclampsia.
Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin.
Increased prevalence of cardiovascular complications in women with furosemide resistant essential hypertension.
Late-onset obesity in mice transgenic for the human renin gene.
Mechanisms of obesity-induced hypertension.
Obesity and aging affects skeletal muscle renin-angiotensin system and myosin heavy chain proportions in pre-diabetic Zucker rats.
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity.
Obesity and the diagnostic accuracy for primary aldosteronism.
Obesity related kidney disease.
Obesity-induced hypertension develops in young rats independently of the renin-angiotensin-aldosterone system.
Peripheral signalling involved in energy homeostasis control.
Postnatal early overfeeding induces cardiovascular dysfunction by oxidative stress in adult male Wistar rats.
Racial (black-white) contrasts of risk for hypertensive disease in youth have implications for preventive care: the Bogalusa Heart Study.
Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults.
Role of endothelin in human hypertension.
Sex differences in the metabolic effects of the renin-angiotensin system.
Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats.
Sympathetic nerve activity, plasma renin activity and water-sodium balance in obese patients with essential hypertension.
T-Lymphocyte-Based Renin Angiotensin System in Obesity.
The Aldosterone/Renin Ratio predicts cardiometabolic disorders in subjects without classic primary aldosteronism.
The effect of immersion in water on the levels of plasma renin activity and aldosterone, vasopressin, ACTH, cortisol, adrenaline and noradrenaline in serum of persons with simple obesity.
The pathogenesis of hypertension in obese subjects.
The PPAR-gamma-binding sequence Pal3 is necessary for basal but dispensable for high-fat diet regulated human renin expression in the kidney.
The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.
The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance.
The renin, angiotensin, aldosterone, and obesity connection.
The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade.
Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan.
What does the future hold for ACE inhibitors?
[An experience with the use of direct renin inhibitor aliskiren in a patient with obesity and arterial hypertension]
[Daily variations in the secretion of several hormones in obesity]
[Effect of water immersion on plasma renin activity and aldosterone and vasopressin levels in the blood of patients with simple obesity]
[Hormonal aspects of the pathogenesis of arterial hypertension in young obese patients]
[Hormonal regulation of sodium excretion by the kidneys during hunger therapy of obese patients]
[Influence of dopamine receptors agonists on clinical and hemodynamic and neurohumoral indicators in hypertensive patients with concomitant obesity].
[Interrelationships between prolactin and the renin-aldosterone system in patients with various endocrine diseases]
[Plasma renin activity and aldosteronemia in patients with simple obesity and in persons with normal body weight at rest and after stimulation with furosemide and upright posture]
Obesity, Abdominal
Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects.
Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering.
Obesity, Morbid
Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity.
Left ventricular structure and diastolic function in subjects with two hypertensive parents.
Obstetric Labor, Premature
Activation of the renin-angiotensin system during ritodrine treatment in preterm labor.
Elevated concentrations of prorenin and renin in amniotic fluid of women with chorioamnionitis.
The endothelin system and renin in human fetal membranes.
The plasma renin-angiotensin system in preeclampsia: effects of magnesium sulfate.
Ocular Hypertension
The renin-angiotensin system in the rabbit eye.
Oculocerebrorenal Syndrome
On the Origin of Urinary Renin: A Translational Approach.
Oligohydramnios
A Premature Baby with Severe Oligohydramnios and Hypotension: a Case Report of Renal Tubular Dysgenesis.
Oliguria
Aldosteronemia in patients with acute renal failure.
Association between renal and sympathetic responses to nonhypotensive systemic sepsis.
Effects of indomethacin in rabbit renovascular hypertension.
Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome.
Haemodynamic, renal and hormonal responses to enalkiren in four patients with post-surgical oliguria.
Immunoreactive endothelin plasma levels in severe ovarian hyperstimulation syndrome.
Intrauterine growth restriction is associated with persistent juxtamedullary expression of renin in the fetal kidney.
Ligation of the renal vein in the solitary kidney: effects on renal function.
Renal effects of continuous infusion of recombinant interleukin-2 in children.
Renin gene expression in fetal kidneys of pregnancies complicated by twin-twin transfusion syndrome.
Risk Factors for Pseudoaldosteronism with Rhabdomyolysis Caused by Consumption of Drugs Containing Licorice and Differences Between Incidence of These Conditions in Japan and Other Countries: Case Report and Literature Review.
The renal response produced by nonhypotensive sepsis in a large animal model.
[Aldosteroneia in acute kidney failure]
[Protection against acute renal insufficiency by means of forced diuresis in an ischemic rat model]
Olivopontocerebellar Atrophies
Autonomic dysfunction and sleep apnea in olivopontocerebellar degeneration.
Orthostatic Intolerance
Blood pressure and plasma renin activity as predictors of orthostatic intolerance.
Effect of head-down bed rest on the neuroendocrine response to orthostatic stress in physically fit men.
Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system.
The physiological conundrum of hyperadrenergic orthostatic intolerance.
Osteoarthritis
Prorenin-renin axis in synovial fluid in patients with rheumatoid arthritis and osteoarthritis.
Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis.
[Expressions of Renin, angiotensin converting enzyme, angiotensin receptor 1, and angiotensin receptor 2 in synovial tissue of osteoarthritis at different stages].
Osteochondritis
[Role of various endocrine glands in the pathogenesis of the neurologic symptoms of lumbar osteochondrosis]
Osteolysis
Idiopathic carpotarsal osteolysis with Bartter's syndrome. A case report and review of the literature.
Osteoporosis
Activation of Renin-Angiotensin System Induces Osteoporosis Independently of Hypertension.
Inhibition of tanshinone IIA on renin activity protected against osteoporosis in diabetic mice.
Involvement of the skeletal Renin-Angiotensin system in age-related osteoporosis of ageing mice.
Renin inhibition improves ovariectomy-induced osteoporosis of lumbar vertebra in mice.
Osteoporosis, Postmenopausal
Effects of anti-osteoporosis therapy on plasma aldosterone and renin.
Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
Otosclerosis
No Evidence for the Expression of Renin-Angiotensin-Aldosterone System in Otosclerotic Stapes Footplates.
Relation between renin-angiotensin-aldosterone system and otosclerosis: a genetic association and in vitro study.
Ovarian Cysts
Analysis of latent forms of renin using antibodies raised against the propart segment of human prorenin: validation with representative samples of ovarian cyst and follicular fluids.
Prorenin in ovarian cyst fluid.
Ovarian Diseases
Immunohistochemical localization of renin and angiotensin in the ovary: comparison between normal women and patients with histologically proven polycystic ovarian disease.
Total renin after gonadotropin stimulation in polycystic ovarian disease.
Ovarian Hyperstimulation Syndrome
Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome.
High renin and prorenin in plasma and pleural exudate of a patient with the ovarian hyperstimulation syndrome.
Increased ascitic fluid prorenin in the ovarian hyperstimulation syndrome.
Increased concentrations of renin, aldosterone and Ca125 in a case of spontaneous, recurrent, familial, severe ovarian hyperstimulation syndrome.
Inhibition of ovarian-derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome.
Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome.
Pathophysiology of the ovarian hyperstimulation syndrome.
Predicted value of renin activity in a woman who had severe ovarian hyperstimulation syndrome with internal jugular vein thrombosis.
Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome.
The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin.
The pathophysiology of ovarian hyperstimulation syndrome (OHSS). A proposal role of the ovarian derived prorenin to angiotensin cascade (ODPAC).
[Association between renin activity, angiotensin II and ovarian hyperstimulation syndrome]
Overnutrition
Effects of early overnutrition on the renal response to Ang II and expression of RAAS components in rat renal tissue.
Postnatal early overnutrition dysregulates the intrarenal renin-angiotensin system and extracellular matrix-linked molecules in juvenile male rats.
Overweight
Augmented transcripts of kidney injury markers and renin angiotensin system in urine samples of overweight young adults.
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output.
Effect of aerobic exercise on plasma renin in overweight patients with hypertension.
Effects of antihypertensive therapy on glucose, insulin metabolism, left ventricular diastolic dysfunction and renin system in overweight and obese hypertensives.
EXPRESSION AND NUTRITIONAL REGULATION OF THE (PRO)RENIN RECEPTOR IN RAT VISCERAL ADIPOSE TISSUE.
Multiple risk factor clustering and risk of hypertension in the Mongolian ethnic population of China.
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity.
Pathophysiologic features of hypertension in young men.
Plasma renin levels and renin-blood pressure relationship in normal-weight and overweight children with obstructive sleep apnea and matched controls.
Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects.
Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
The role of atrial natriuretic peptide in natriuresis of fasting.
Urinary sodium excretion: association with hyperinsulinaemia, hypertension and sympathetic nervous system activity in obese and control children.
Pancreatic Diseases
The renin-angiotensin system: from the renal basis to an organ-specific subsystem in the pancreas.
Pancreatic Neoplasms
[Paraneoplastic hypercorticism. Hypokalemia, increased plasma renin activity and hypoaldosteronism during cancer of the pancreas]
Pancreatitis
Activation of the renin system in acute pancreatitis.
The Effect of Renin Angiotensin System Genetic Variants in Acute Pancreatitis.
The renin-angiotensin system: from the renal basis to an organ-specific subsystem in the pancreas.
Paracoccidioidomycosis
Adrenocortical dysfunction in paracoccidioidomycosis: comparison between plasma beta-lipotrophin/adrenocorticotrophin levels and adrenocortical tests.
Paraganglioma
Multiple neuropeptide immunoreactivities in a renin-producing human paraganglioma.
The coexistence of renal artery stenosis and pheochromocytoma.
Paralysis
Changes in plasma renin activity and plasma aldosterone in the induced paralytic attack of thyrotroxic periodic paralysis.
Hyperkalemic periodic paralysis in Gordon's syndrome: a possible defect in atrial natriuretic peptide function.
Immediate endocrine and metabolic consequences of traumatic quadriplegia in a young woman.
Persistent severe hyperkalemia following surgical treatment of aldosterone-producing adenoma.
Renin-angiotensin and development of collateral circulation after renal ischemia.
[Changes in serum cortisol, aldosterone and plasma renin activity during spontaneous attacks of paralysis in thyrotoxic patients (author's transl)]
Paraparesis, Tropical Spastic
Design of potent aspartic protease inhibitors to treat various diseases.
Paraplegia
Renin release in chronic paraplegia.
Parathyroid Neoplasms
Systemic hemodynamic pattern in primary hyperparathyroidism and its changes after parathyroidectomy.
Parkinson Disease
Cardiovascular and renin responses to head-up tilt tests in parkinsonism.
Effects of levodopa alone and in combination with dopa-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease.
Plasma renin activity (PRA) in Parkinson's disease before and after stereotaxic operation.
Plasma renin activity and levodopa in Parkinson's disease.
The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death.
Parkinsonian Disorders
Cardiovascular and renin responses to head-up tilt tests in parkinsonism.
Effects of levodopa alone and in combination with dopa-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease.
Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of ?-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Peptic Ulcer
Hypertension corrected by discontinuing chronic sodium bicarbonate ingestion. Subsequent transient hypoaldosteronism.
NSAID-induced gastrointestinal and cardiovascular injury.
Plasma atrial natriuretic factor in low output heart failure syndromes.
Pericardial Effusion
Minoxidil.
Pericardial effusion leading to acute renal failure: two case reports and discussion of pathophysiology.
Perinatal Death
Paradoxic activation of the renin-angiotensin system in twin-twin transfusion syndrome: an explanation for cardiovascular disturbances in the recipient.
Perinephritis
Cellophane perinephritis hypertension and its reversal in rabbits. Effect on plasma renin, renin substrate, and renal mass.
Effects of two forms of hypertension on atherosclerosis in the hyperlipidemic baboon.
Perinephritis hypertension in monkeys. I. An increase of plasma renin activity associated with increased permeability of retinal vessels and angionecrosis.
Serum angiotensin converting enzyme activity and the capacity to develop hypertention-associated arterial disease. Studies during the induction phase of one-kidney perinephritis hypertension in rabbits.
Systemic and regional haemodynamic profile of captopril in conscious rabbits with bilateral cellophane perinephritis hypertension.
Peripheral Arterial Disease
Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.
Manipulation of the renin angiotensin system in peripheral arterial disease.
Peripheral Nervous System Diseases
The relationship between active renin concentration and plasma renin activity in Type 1 diabetes.
Peripheral Vascular Diseases
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis.
Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin-aldosterone system in humans.
Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature.
Successful directional atherectomy of eccentric renal artery stenosis using the Simpson directional coronary atherocath as a primary therapy.
Treatment of hypertension with calcium channel blockers: European data.
Peritonitis
Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
Increased levels of immunoreactive plasma renin substrate during infectious peritonitis in patients on continuous ambulatory peritoneal dialysis.
Increased plasma interleukin 6 and renin substrate levels during bacterial peritonitis in CAPD patients.
[Various aspects of hormonal disorders in peritonitis]
Phenylketonurias
Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension.
Pheochromocytoma
Activation of renin-angiotensin system in maintenance of high blood pressure in uncomplicated pheochromocytoma--a case report.
Biochemical identification of renin in human pheochromocytoma.
Captopril improves hypertension and cardiomyopathy in rats with pheochromocytoma.
Clinical and hemodynamic improvement of congestive heart failure by long-term vasodilator therapy with postjunctional alpha 1-adrenoceptor blockade.
Coexisting extraadrenal pheochromocytoma and renal artery stenosis: a case report and review of the pathophysiology.
Diagnostic value of biochemical parameters in the differential diagnosis of an adrenal mass.
Excessive Catecholamine Secretion and the Activation of the Renin-Angiotensin-Aldosterone-System in Patients with Pheochromocytoma: A Single Center Experience and Overview of the Literature.
Extra-adrenal pheochromocytoma causing renal artery stenosis. Relationship to hypertension and renin levels.
Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Local generation of angiotensin in the kidney and in tissue culture.
Malignant hypertension in pheochromocytoma: correlation with plasma renin activity.
Management of the clinically inapparent adrenal mass ("incidentaloma").
Patients with pheochromocytoma exhibit low aldosterone renin ratio-preliminary reports.
Pheochromocytoma with lateralizing renal vein renin activity.
Pheochromocytoma with renal artery stenosis and high plasma renin activity.
Pheochromocytoma with renal artery stenosis: A case-based review of literature.
Physiologic tailoring of treatment in resistant hypertension.
Plasma prolactin levels in patients with essential hypertension, malignant hypertension and secondary hypertension.
Plasma renin activity and intrarenal blood flow distribution in a child with a pheochromocytoma.
Plasma renin activity in pheochromocytoma.
Prazosin's effect in high renin hypertension complicating pheochromocytoma.
Renal vein renin studies in a patient with renal hilar pheochromocytoma and renal artery stenosis.
Renin and aldosterone secretion in pheochromocytoma. Effect of chronic alpha-adrenergic receptor blockade.
Solitary renal myofibromatosis: an unusual cause of infantile hypertension.
The renin-angiotensin-aldosterone system in Cushing's syndrome and pheochromocytoma.
Vascular endothelial growth factor (VEGF), prostaglandin E2(PGE2) and active renin in hypertension of adrenal origin.
[Aldosterone, cortisol and plasma renin activity in pheochromocytoma (author's transl)]
[Association of pheochromocytoma and renovascular hypertension]
[Catecholamines, their enzymes and renin activity in the blood of patients with pheochromocytoma]
[Changes in plasma renin activities in patients with pheochromocytoma in pre- and post-operative periods]
[Critical analysis of the saralasintest in the diagnosis of hypertension (author's transl)]
[Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
[Pheochromocytoma with high blood renin levels (proceedings)]
[Pheochromocytoma with hyperaldosteronism and abnormalities of humoral immunity. Study of plasma renin activity]
[Plasma renin activity in patients with pheochromocytoma]
[Plasma renin activity in pheochromocytoma]
[Plasma renin and catecholamine activity in pheochromocytoma]
[Radioimmunoassay in the diagnosis of arterial hypertension]
[Renin activity in the blood plasma in pheochromocytoma]
[Renin plasmatic activity and plasma aldosterone in three cases of pheochromocytoma (author's transl)]
[Serum renin activity in pheochromocytoma]
[The effect of clonidine on humoral factors in patients with arterial hypertension]
[Tumor syndromes with inappropriate renin secretion. Diagnostic criteria and review of published cases]
Pituitary ACTH Hypersecretion
Diurnal 18-hydroxy-11-deoxycorticosterone pattern in human stable hypertension.
Do weak mineralocorticoids affect the pathogenesis of hypertension in Cushing's disease?
Renin exists in human adrenal tissue.
[Variations of the renin aldosterone system in Cushing's disease (author's transl)]
Pituitary Diseases
Acute adrenocortical crisis: three different presentations.
Pituitary Neoplasms
Different secretory pathways of renin from mouse cells transfected with the human renin gene.
Glycosylation influences intracellular transit time and secretion rate of human prorenin in transfected cells.
Presence of renin, angiotensinogen, and converting enzyme in human pituitary lactotroph cells and prolactin adenomas.
The renin and iso-renin-angiotensin system in rats with experimental pitutary tumors (38585).
Placental Insufficiency
Effects of placental insufficiency on the ovine fetal renin-angiotensin system.
Placental insufficiency results in temporal alterations in the renin angiotensin system in male hypertensive growth restricted offspring.
plasma kallikrein deficiency
Studies of the renal vasoactive systems in hyporeninemic hypoaldosteronism.
Pleural Effusion
Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery.
Tissue edema and arterial lesions produced by pure submaxillary gland renin of mouse.
Pleurisy
Effects of Aliskiren, an RAAS inhibitor, on a carrageenan-induced pleurisy model of rats.
Pneumonia
Evaluation of Renin and Soluble (Pro)renin Receptor in Patients with IPF. A Comparison with Hypersensitivity Pneumonitis.
More on renal salt wasting without cerebral disease: response to saline infusion.
The Cholinergic and ACE-2-Dependent Anti-Inflammatory Systems in the Lung: New Scenarios Emerging From COVID-19.
[Proteinase-inhibitors and renin in the pathogenesis of vascular insufficiency in acute pneumonia]
Pneumoperitoneum
Clonidine provides opioid-sparing effect, stable hemodynamics, and renal integrity during laparoscopic cholecystectomy.
Effect of intrathoracic pressure on plasma arginine vasopressin levels.
Hemodynamic and hormonal changes during pneumoperitoneum and trendelenburg positioning for operative gynecologic laparoscopy surgery.
Laparoscopic cholecystectomy: haemodynamic and neuroendocrine responses after pneumoperitoneum and changes in position.
Polyarteritis Nodosa
Perinephritis hypertension in monkeys. I. An increase of plasma renin activity associated with increased permeability of retinal vessels and angionecrosis.
[Arterial hypertension in periarteritis nodosa. 37 case reports]
Polycystic Kidney Diseases
A Link between the Intrarenal Renin Angiotensin System and Hypertension in Autosomal Dominant Polycystic Kidney Disease.
A Premature Baby with Severe Oligohydramnios and Hypotension: a Case Report of Renal Tubular Dysgenesis.
Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.
Autoregulation of renal blood flow and pressure-dependent renin release in autosomal dominant polycystic kidney disease of rats.
Hereditary renal diseases.
Hypertension in autosomal dominant polycystic kidney disease: is renin acquitted as a culprit?
Pathogenesis and treatment of hypertension in polycystic kidney disease.
Relationships of the renin-angiotensin-aldosterone system and sodium balance to blood pressure regulation in chronic renal failure of polycystic kidney disease.
Renal artery occlusion and malignant hypertension in polycystic kidney disease.
Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.
Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease.
The anatomy of the renin-secreting cell in adult polycystic kidney disease.
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
Urinary angiotensinogen, related factors and clinical implications in normotensive autosomal dominant polycystic kidney disease patients.
Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.
[Progression of autosomic dominant polycystic kidney disease. Influence of endothelial NO synthase (ecNOS) and renin angiotensin system gene polymorphisms]
[SGLT2 inhibitors: A new era for our patients].
Polycystic Kidney, Autosomal Dominant
A Link between the Intrarenal Renin Angiotensin System and Hypertension in Autosomal Dominant Polycystic Kidney Disease.
Aliskiren corrects recurrent hyperreninemia and hyperaldosteronism in autosomaldominant polycystic kidney disease.
Autoregulation of renal blood flow and pressure-dependent renin release in autosomal dominant polycystic kidney disease of rats.
Autosomal dominant polycystic kidney disease (ADPKD)--mechanisms of cyst formation and renal failure.
Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
Expression of components of the renin-angiotensin system in autosomal recessive polycystic kidney disease.
Hereditary renal diseases.
Hypertension in autosomal dominant polycystic kidney disease: is renin acquitted as a culprit?
Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
Pathogenesis and treatment of hypertension in polycystic kidney disease.
Progression of renal failure in the Han: SPRD polycystic kidney rat.
Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD.
Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.
Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease.
The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.
Urinary Renin-Angiotensin Markers in Polycystic Kidney Disease.
Polycystic Kidney, Autosomal Recessive
A Premature Baby with Severe Oligohydramnios and Hypotension: a Case Report of Renal Tubular Dysgenesis.
Expression of components of the renin-angiotensin system in autosomal recessive polycystic kidney disease.
The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.
Polycystic Ovary Syndrome
Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.
Determinants of Maternal Renin-Angiotensin-Aldosterone-System Activation in Early Pregnancy: Insights From 2 Cohorts.
Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome.
Influence of insulin resistance on total renin level in normotensive women with polycystic ovary syndrome.
Polycystic ovary syndrome: Implications of measurement of plasma aldosterone, renin activity and progesterone.
Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome.
Prorenin is elevated in polycystic ovary syndrome and may reflect hyperandrogenism.
Serum total renin is elevated in women with polycystic ovarian syndrome.
Serum total renin levels after ovarian electrocautery in women with polycystic ovary syndrome.
The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.
Treatment of polycystic ovary syndrome with spironolactone plus licorice.
Uterine arterial blood flow and the substances of ovarian renin-angiotensin system in women with polycystic ovaries undergoing in vitro fertilization.
[Changes of plasma renin activity and angiotensin II levels in women with polycystic ovary syndrome]
[Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].
Polycythemia
Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease.
Blood pressure control and erythrocytosis in rats: theory and observations.
Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor.
Enhanced expression of the local haematopoietic bone marrow renin-angiotensin system in polycythemia rubra vera.
Hypererythropoietinemia and hyperreninemia in a continuous ambulatory peritoneal dialysis patient with chronic severe hypotension.
Hypertension after renal transplantation.
Hypertension in the transplanted patient.
Juxtaglomerular cell tumor with elevation of serum erythropoietin.
Metabolic effects of long-term diversion of renal venous blood into the portal system.
Multiple site estimates of erythropoietin and renin in polycythemic kidney transplant patients.
[Erythrocytosis associated with kidney cancer. Erythropoietin and renin levels]
[Erythropoietin, renin, aldosterone, and blood volume in primary and secondary polycythemia]
Polycythemia Vera
Enhanced expression of the local haematopoietic bone marrow renin-angiotensin system in polycythemia rubra vera.
Polyhydramnios
Prenatal diagnosis of Bartter syndrome.
Renin gene expression in fetal kidneys of pregnancies complicated by twin-twin transfusion syndrome.
Polyuria
An extreme example of the neonatal form of Bartter's syndrome.
Anaesthetic management for hiatal hernia repair in a child with Bartter's syndrome: A case report.
Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome.
Computerized-tomography-guided percutaneous tumor ablation using acetic acid injection in an aldosterone-producing tumor--a novel therapy.
Development of polyuria in Tsukuba hypertensive mice carrying human renin and angiotensinogen genes.
Dissociation of antipolyuric action and increase in plasma renin activity caused by chlorothiazide in Brattleboro rats.
Effects of experimental potassium depletion on renal function and urinary prostanoid excretion in normal women during moderate anti-diuresis.
Failure to Thrive, Hyponatremia, Hyperkalemia - Differential Diagnostic Reflections of a Rare Genetic Disease.
Hypertension in experimental diabetes mellitus. Renin-prostaglandin interaction.
Renal prostanoids: physiological relevance in healthy salt-depleted women.
Renin gene expression in fetal kidneys of pregnancies complicated by twin-twin transfusion syndrome.
The soluble (Pro) renin receptor does not influence lithium-induced diabetes insipidus but does provoke beiging of white adipose tissue in mice.
Uncompensated polyuria in a mouse model of Bartter's syndrome.
Vitamin D Increases Plasma Renin Activity Independently of Plasma Ca2+ via Hypovolemia and ?-Adrenergic Activity.
[A case of congenital nephrogenic diabetes insipidus accompanied by hypertension]
[Hyperreninism without hyperaldosteronism in diuretic abuse: a report of a case with identification of mefruside and ethacrynic acid in urine (author's transl)]
[Massive natriuresis and polyuria after triple craniocervical subarachnoid hemorrhage: cerebral salt wasting syndrome?]
Porcine Reproductive and Respiratory Syndrome
Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension.
Post-Exercise Hypotension
Persistent peripheral vasodilation and sympathetic activity in hypotension after maximal exercise.
Posterior Leukoencephalopathy Syndrome
Posterior reversible encephalopathy syndrome (PRES) in mesenteric leiomyosarcoma: A case report.
Potassium Deficiency
Effect of a potassium-deficient diet on arterial blood pressure, plasma and tissue cations, and tissue norepinephrine in the hypertensive dog.
Effects of chronic potassium deficiency on plasma renin activity.
Mechanism of hyperreninemia in the potassium-depleted rat.
Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
The effects of antidiuretic hormone and state of potassium balance on the renin-angiotensin system in rats with diabetes insipidus.
Pre-Eclampsia
A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes.
A Longitudinal Pilot Study on Cognition and Cerebral Hemodynamics in a Mouse Model of Preeclampsia Superimposed on Hypertension: Looking at Mothers and Their Offspring.
A model of preeclampsia. II. Changes in renin content produced by anti-placenta serum.
A prediction model for superimposed preeclampsia in women with chronic hypertension during pregnancy.
Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia.
Alterations in the 'local umbilical cord blood renin-angiotensin system' during pre-eclampsia.
Altered serum soluble furin and prorenin receptor levels in pregnancies with pre-eclampsia and fetal growth restriction.
Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression.
Association study between the human Renin gene and preeclampsia.
Atrial natriuretic factor in normal and hypertensive pregnancy.
Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism.
Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension.
Diagnostic Indicators of Superimposed Preeclampsia in Women With CKD.
Diurnal rhythms of blood pressure, plasma renin activity, angiotensin II and catecholamines in normotensive and hypertensive pregnancies.
Effective prediction of preeclampsia by measuring serum angiotensin II, urinary angiotensinogen and urinary transforming growth factor ?1.
Elevation of plasma renin activity during pregnancy and rupture of a dissecting aortic aneurysm in a patient with primary aldosteronism.
Evaluation of the renin-angiotensin-aldosterone system in pregnancy complicated by preeclampsia with and without intrauterine growth retardation.
Experimental toxemia of pregnancy in the monkey, with a preliminary report on renin and aldosterone.
Fetal sex and the circulating renin-angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension.
Functional changes in the uterine artery precede the hypertensive phenotype in a transgenic model of hypertensive pregnancy.
Genophenotypic Analysis of Angiotensinogen Gene M235T Polymorphism and Preeclampsia.
Impact of obesity on the association of active renin and plasma aldosterone concentrations, and aldosterone-to-renin ratio with preeclampsia.
Impaired placental neovascularization in mice with pregnancy-associated hypertension.
Impaired renin stimulation in pre-eclampsia.
Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis.
Interactions between AT1 and AT2 receptors in uterine arteries from pregnant ewes.
Linking the old and new -- do angiotensin II type 1 receptor antibodies provide the missing link in the pathophysiology of preeclampsia?
Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia.
Maternal and fetal atrial natriuretic peptide levels, maternal plasma renin activity, angiotensin II, prostacyclin and thromboxane A2 levels in normal and preeclamptic pregnancies.
Maternal angiotensinogen (AGT) haplotypes, fetal renin (REN) haplotypes and risk of preeclampsia; estimation of gene-gene interaction from family-triad data.
Megalin, Proton Pump Inhibitors and the Renin-Angiotensin System in Healthy and Pre-Eclamptic Placentas.
Mice Overexpressing Both Human Angiotensinogen and Human Renin as a Model of Superimposed Preeclampsia on Chronic Hypertension.
Novel Role of the Renin-Angiotensin System in Preeclampsia Superimposed on Chronic Hypertension and the Effects of Exercise in a Mouse Model.
OS060. Exercise training promotes placental growth and development in an animal model of preeclampsia superimposed on chronic hypertension.
Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia.
Plasma renin activity and aldosterone serum concentration are decreased in severe preeclampsia but not in the HELLP-syndrome.
Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia.
PP018. Does altitude affect the placental renin angiotensin system (RAS) in pre-eclampsia (PE)?
Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels.
Preeclampsia -- a state of prostaglandin deficiency? Urinary prostaglandin excretion, the renin-aldosterone system, and circulating catecholamines in preeclampsia.
Preeclampsia: new insights.
Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia.
Prorenin concentration in the hypertensive disorders in pregnancy.
Prorenin periconceptionally and in pregnancy: Does it have a physiological role?
Prostaglandins, catecholamines, renin and aldosterone during hypertensive and normotensive pregnancy.
Prostaglandins, renin, aldosterone, and catecholamines in preeclampsia.
Prostasin and matriptase (ST14) in placenta from preeclamptic and healthy pregnant women.
Raised prorenin and renin concentrations in pre-eclamptic placentae when measured after acid activation.
Rapid genotyping of the human renin (REN) gene by the LightCycler® instrument: identification of unexpected nucleotide substitutions within the selected hybridization probe area.
Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy.
Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype.
Renin angiotensin signaling in normal pregnancy and preeclampsia.
Renin gene restriction fragment length polymorphisms do not show linkage with preeclampsia and eclampsia.
Renin-angiotensin system gene variants and risk of early- and late-onset preeclampsia: A single center case-control study.
Reproductive tissue renin gene expression in preeclampsia.
Role of the renin-angiotensin system in the pathogenesis of preeclampsia.
Selective hypoaldosteronism due to combined defects of the conversion from inactive renin to active renin and the aldosterone biosynthesis from corticosterone.
Sex differences in soluble prorenin receptor in patients with type 2 diabetes.
Stimulation of aldosterone by ACTH in normal and hypertensive pregnancy.
Sympathetic activation during early pregnancy in humans.
THE EFFECTS ON RENAL RESISTANCE TO BLOOD FLOW OF RENIN, ANGIOTONIN, PITRESSIN AND ATROPINE, HYPERTENSION, AND TOXEMIA OF PREGNANCY.
The endothelin system and renin in human fetal membranes.
The genetics of pre-eclampsia: a feto-placental or maternal problem?
The plasma renin-angiotensin system in preeclampsia: effects of magnesium sulfate.
The relationship between aldosterone to renin ratio and RI value of the uterine artery in the preeclamptic patient vs. normal pregnancy.
The renin-angiotensin-aldosterone system in pre-eclampsia.
The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate balance between good and bad.
The role of LNPEP and ANPEP gene polymorphisms in the pathogenesis of pre-eclampsia.
The role of RAS in the pathogenesis of preeclampsia.
The role of the renin-angiotensin system in the pathogenesis of preeclampsia - new insights into the renin-angiotensin system in preeclampsia.
Total renin in pre-eclampsia.
Urinary serine proteases and activation of ENaC in kidney-implications for physiological renal salt handling and hypertensive disorders with albuminuria.
[Animal experiment models of hypertension in pregnancy--an alternative to clinical studies?]
[Behavior of the plasma renin activity in normal pregnancy, in pregnancy toxemias and in the umbilical cord blood of the newborn]
[Plasma renin activity in normal pregnancy and in pregnancy toxemias]
[Renin activity and plasma aldosterone levels in ulnar and uterine veins and in cord blood in normal pregnancy and pregnancy toxemias]
[Renin activity in amniotic fluid and maternal and cord blood in toxemia of pregnancy]
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Renin expression in hematological malignancies and its role in the regulation of hematopoiesis.
Prediabetic State
Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study.
Pregnancy Complications
The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications.
[Determination of plasma renin during the menstrual cycle, normal pregnancy and pregnancy complications in the 3d trimester of pregnancy]
Pregnancy, Abdominal
Plasma renin and aldosterone in an abdominal pregnancy with toxemia.
Pregnancy, Ectopic
Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome.
Predictive value of the active renin assay for the diagnosis of ectopic pregnancy.
Prehypertension
Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1-7)/Mas and the ACE/Ang II/AT1 axes?
Multiple and large simple renal cysts are associated with prehypertension and hypertension.
Premature Birth
Association of circulating uric acid and angiotensin-(1-7) in relation to higher blood pressure in adolescents and the influence of preterm birth.
Preterm Birth and Renin-Angiotensin-Aldosterone System: Evidences of Activation and Impact on Developmental Cardiovascular Disease Risks.
Very preterm birth is a risk factor for increased systolic blood pressure at a young adult age.
Primary Dysautonomias
The physiological conundrum of hyperadrenergic orthostatic intolerance.
Prolactinoma
Biochemical evidence for existence of immunoreactive renin in human prolactinoma tissue.
Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
prostaglandin-e synthase deficiency
Role of microsomal prostaglandin E synthase 1 in the kidney.
Prostatic Hyperplasia
Plasma renin activity and cardiovascular changes in patients with chronic bladder distension.
Prostatic Neoplasms
A Comprehensive Urine Proteome Database Generated From Patients With Various Renal Conditions and Prostate Cancer.
V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN loss.
Protein-Energy Malnutrition
Plasma renin activity in children with protein energy malnutrition (kwashiorkor).
Plasma renin activity in oedematous and marasmic children with protein energy malnutrition.
Plasma renin activity, water excretion and the decay of injected hormones and hormonal effects in rats with protein energy malnutrition.
The effect of protein energy malnutrition on plasma renin and oedema in the pig.
Proteinuria
(Pro) Renin Receptor Mediates Albumin Induced Cellular Responses: Role of Site-1 Protease-Derived Soluble (Pro) Renin Receptor in Renal Epithelial Cells.
A case of nephrotic syndrome associated with renovascular hypertension successfully treated with candesartan.
A case of pheochromocytoma presenting as secondary hyperaldosteronism, hyperparathyroidism, diabetes and proteinuric renal disease.
A Longitudinal Pilot Study on Cognition and Cerebral Hemodynamics in a Mouse Model of Preeclampsia Superimposed on Hypertension: Looking at Mothers and Their Offspring.
Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months.
Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
Angiotensin receptor antagonists in patients with nephropathy due to type 2 diabetes.
Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria.
Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis.
Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy.
Association of a nocturnal rise in plasma alpha-atrial natriuretic peptide and reversed diurnal blood pressure rhythm in hospitalized normotensive subjects with non-insulin dependent diabetes mellitus.
Blood pressure and renal function in autosomal dominant polycystic kidney disease.
Burn and trauma associated proteinuria: the role of lipid peroxidation, renin and myoglobin.
Clinical relevance of urinary angiotensinogen and renin as potential biomarkers in patients with overt proteinuria.
Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat.
Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs.
Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats.
Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage.
Corticoid effects on angiotensin- and norepinephrine-induced proteinuria in rats.
Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.
DD genotype of the angiotensin I-converting enzyme gene is a risk factor for early onset of essential hypertension in Japanese patients.
Direct Renin Inhibition: Promising Treatment in Renoprotection?
Diuretics for Hypertension: A Review and Update.
Dramatic reduction of proteinuria in diabetic nephropathy by the use of spironolactone.
Effect of a high protein diet in patients with the nephrotic syndrome.
Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease.
Effect of Combination Therapy with Angiotensin Receptor Blocker and 1,25-Dihydroxyvitamin D(3) in Type 2 Diabetic Nephropathy in KK-A/Ta Mice.
Effect of direct renin inhibitor monotherapy on proteinuria in overt diabetic nephropathy.
Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria.
Effect of renin on proteinuria and PAH clearance at low plasma levels.
Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial.
Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function.
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
Effects of dietary protein in patients with chronic renal transplant rejection.
Effects of endothelin on hemodynamics, prostaglandins, blood coagulation and renal function.
Effects of Renin-Angiotensin System Inhibitors on Renal Expression of Renalase in Sprague-Dawley Rats Fed With High Salt Diet.
Effects of telmisartan on proteinuria and systolic blood pressure in dogs with chronic kidney disease.
Efficacy and Safety of Complete RAAS Blockade with ALISKIREN in Patients with Refractory Proteinuria Who were already on Combined ACE Inhibitor, ARB, and Aldosterone Antagonist.
Efficacy and Safety of Mineralocorticoid Receptor Antagonists with ACEI/ARB Treatment for Diabetic Nephropathy: A meta-analysis.
Efficacy of Antihypertensive Therapy in a Child with Unilateral Focal Fibromuscular Dysplasia of the Renal Artery: A Case Study and Review of Literature.
Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?
Endothelin Receptor Antagonism and Renin Inhibition as Treatment Options for Scleroderma Kidney.
Endothelin-aldosterone interaction and proteinuria in low-renin hypertension.
Enterocystoplasty in children with neuropathic bladders: long-term follow-up.
Factors influencing renin diuresis and proteinuria.
Focal Segmental Glomerulosclerosis Secondary to Juxtaglomerular Cell Tumor during Pregnancy: A Case Report.
Functional changes in the uterine artery precede the hypertensive phenotype in a transgenic model of hypertensive pregnancy.
Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.
High renin hypertension in the elderly.
Hyponatremic hypertensive syndrome and massive proteinuria in a patient with renin-producing leiomyosarcoma.
IgA nephropathy and inhibitors of the renin angiotensin system: is reduction in proteinuria adequate proof of efficacy?
Immunosuppression improves blood pressure and endothelial function in a rat model of pregnancy-induced hypertension.
Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis.
Involvement of (pro)renin receptor in the glomerular filtration barrier.
Involvement of the renin angiotensin system in the pathogenesis of postexercise proteinuria.
Is There a Role for IgA/C3 Ratio in IgA Nephropathy Prognosis? An Outcome Analysis on An European Population.
Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism.
Ligation of the renal vein in the solitary kidney: effects on renal function.
Low birth weight-associated adult hypertension in the rat.
Low-Grade Proteinuria and Microalbuminuria in Renal Transplantation.
Low-protein diet supplemented with ketoacids ameliorates proteinuria in 3/4 nephrectomised rats by directly inhibiting the intrarenal renin-angiotensin system.
Mechanism of proteinuria. IV. Effect of renin on hemoglobin excretion.
Mechanism of renin proteinuria.
Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.
Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Moyamoya disease complicated with renal artery stenosis and nephrotic syndrome: reversal of nephrotic syndrome after nephrectomy.
Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats.
Nephroprotective Action of Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease Patients: The Landscape After ALTITUDE and VA NEPHRON-D Trails.
Nephrotic-range proteinuria in a patient with high renin hypertension: effect of treatment with an ACE-inhibitor.
New options and perspectives for proteinuria management after kidney transplantation.
Occurrence of big renin in human plasma, amniotic fluid and kidney extracts.
Oxidative stress in hypertension: role of the kidney.
Pathophysiological significance of plasma total renin and prorenin in patients with diabetes mellitus.
Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
PLASMA ALBUMIN METABOLISM DURING TRANSIENT RENIN PROTEINURIA.
Plasma prorenin and renin levels in non-insulin-dependent diabetes mellitus.
Plasma renin activity in renal transplant patients with hypertension.
Plasma renin and aldosterone in adult-onset diabetics with persistent proteinuria.
Prediction of renal insufficiency in Pima Indians with nephropathy of type 2 diabetes mellitus.
Predictors of proteinuria reduction by monotherapy with an angiotensin receptor blocker, olmesartan.
Prorenin receptor is essential for normal podocyte structure and function.
Prostasin and matriptase (ST14) in placenta from preeclamptic and healthy pregnant women.
Proteinuria and nephrotic syndrome induced by renin in patients with renal artery stenosis.
Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney size.
Recent progress in the pathophysiology and treatment of FSGS recurrence.
Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.
Renal function during exercise. With special reference to exercise proteinuria and the release of renin.
Renal function during recovery from minimal lesions nephrotic syndrome.
Renal lesions in renin proteinuria.
Renal medullary (pro)renin receptor contributes to angiotensin II-induced hypertension in rats via activation of the local renin-angiotensin system.
Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma.
Renin and the juxtaglomerular apparatus in diabetic nephropathy.
Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Renin induced proteinuria and the effects of adrenalectomy. I. Haemodynamic changes in relation to function.
Renin induced proteinuria and the effects of adrenalectomy. II. Morphology in relation to function.
Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents.
Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Renin proteinuria in the rat; the relation between the proteinuria and the pressor effect of renin.
Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.
Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions.
Renin-induced massive proteinuria in man.
Repeated albumin infusions do not lower blood pressure in preeclampsia.
Reversible nephrotic syndrome due to high renin state in renovascular hypertension.
Reversible renin mediated massive proteinuria successfully treated by nephrectomy.
Review: combination therapy with renin angiotensin inhibitors reduces proteinuria more than single drugs alone in renal disease.
Role of sex, gonadectomy and sex hormones in the development of nitric oxide inhibition-induced hypertension.
Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients.
Severe hypertension and massive proteinuria in a newborn with renal artery stenosis.
SSA 02-4 DISPARITIES IN HYPERTENSION MANAGEMENT OF CKD IN SOUTH ASIA.
Studies of the renin-angiotension-aldosterone system, cortisol, DOC, and ADH in normal and hypertensive pregnancy.
Studies on glomerular permeability using inert polymers.
STUDIES ON THE MECHANISM OF EXPERIMENTAL PROTEINURIA INDUCED BY RENIN.
The (pro)renin receptor and the kidney.
The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia.
The influence of aldosterone on the development of left ventricular geometry and hypertrophy in patients with essential hypertension.
The long-term course of cyclosporine-associated chronic nephropathy.
The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients.
The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
The renin-aldosterone axis in two models of reduced renal mass in the rat.
The renin-angiotensin system, adrenomedullins and urotensin II in the kidney: possible renoprotection via the kidney peptide systems.
The role of renin angiotensin system inhibition in kidney repair.
Therapeutic measures in proteinuric nephropathy.
Therapeutic Use Of Calcitriol.
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes.
Uncompensated polyuria in a mouse model of Bartter's syndrome.
Urinary excretion of renin and angiotensinogen in nephrotic rats.
Urinary serine proteases and activation of ENaC in kidney-implications for physiological renal salt handling and hypertensive disorders with albuminuria.
Vitamin D and Glomerulonephritis.
Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.
Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms.
Which antihypertensive drugs are the most nephroprotective and why?
Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?
[Action of ACTH on renin proteinuria in normal and adrenalectomized rat.]
[Case report: neonatal hypertension]
[Chronic kidney disease: classification, mechanisms of progression and strategies for renoprotection]
[Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases]
[Hypertensive nephrosclerosis.]
[Nitric oxide and the kidneys]
[Plasma and urine renin concentration in patients with and without pathologic proteinuria]
[Plasma renin and proteinuria in renovascular hypertension in the rat]
[The effect of captopril on proteinuria in glomerular diseases]
[Therapeutic novelties in the management of arterial hypertension].
[Two cases of systemic lupus erythematosus accompanied by antiphospholipid syndrome nephropathy without immune complex nephritis]
Pseudohypoaldosteronism
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.
A molecular update on pseudohypoaldosteronism type II.
A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis.
A partial form of pseudohypoaldosteronism type I without renal sodium wasting.
Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations.
Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice.
Generalized unresponsiveness to mineralocorticoid hormones: familial recessive pseudohypoaldosteronism due to aldosterone-receptor deficiency.
Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation.
Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism.
Pseudohypoaldosteronism type 1 due to a novel mutation in the mineralocorticoid receptor gene.
Pseudohypoaldosteronism.
Pseudohypoaldosteronism: decreased aldosterone levels with age without significant change in urinary sodium excretion.
Pseudohypoaldosteronism: report of a case presenting as failure to thrive.
Pulmonary complications of endocrine and metabolic disorders.
Rare Cause of Hyperkalemia in the Newborn Period: Report of Two Cases of Pseudohypoaldosteronism Type 1.
Renin-angiotensin-aldosterone system.
Restoration of Epithelial Sodium Channel Function by Synthetic Peptides in Pseudohypoaldosteronism Type 1B Mutants.
Secondary pseudohypoaldosteronism causing cardiopulmonary arrest and cholelithiasis.
Transient pseudohypoaldosteronism with complex malformation of internal genitalia. A case report.
Unimpaired postnatal respiratory adaptation in a preterm human infant with a homozygous ENaC-? unit loss-of-function mutation.
[Pseudohypoaldosteronism--renal salt loss syndrome. Therapy and course exemplified by 2 siblings]
Pseudohypoparathyroidism
Effectiveness of 1,25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity.
Pseudotumor Cerebri
Plasma renin activity and aldosterone determination in patients with pseudotumor cerebri.
Successful long-term effects of direct renin inhibitor aliskiren in a patient with atherosclerotic renovascular hypertension.
Psoriasis
Captopril-induced proteinuria in hypertensive psoriatic patients.
Puberty, Precocious
Effect of cyproterone acetate on active and inactive renin secretion in patients with precocious puberty and genetic short stature.
Splicing analysis of CYP11B1 mutation in a family affected with 11?-hydroxylase deficiency: case report.
Pulmonary Arterial Hypertension
Correlation of Atrial Natriuretic Factor and Renin-Aldosterone System With Chronic Pulmonary Hypertension Among Residents in a High Altitude
Pulmonary Disease, Chronic Obstructive
Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease.
Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease.
Effect of acute hypercapnia on alpha atrial natriuretic peptide, renin, angiotensin II, aldosterone, and vasopressin plasma levels in patients with COPD.
Effects of hypoxia on renal hormonal balance in normal subjects and in patients with COPD.
Increased plasma levels of atrial natriuretic factor, renin activity, and leukotriene C4 in chronic obstructive pulmonary disease.
Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease.
Plasma levels of atrial natriuretic factor, renin activity, and aldosterone in patients with chronic obstructive pulmonary disease. Response to O2 removal and to hyperoxia.
The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease.
[Activation of neurohormonal system as an independent mechanism of heart remodeling in patients with chronic obstructive pulmonary disease].
[Atrial natriuretic peptide and plasma renin activity in patients with stable chronic obstructive pulmonary disease]
[Changes of angiotensin II and angiotensin-converting enzyme in cor pulmonale with respiratory failure]
[Hemodynamic changes and their relationship with the renin-angiotensin-aldosterone system in chronic obstructive pulmonary disease]
[High plasma renin activity in chronic obstructive pulmonary disease]
[Influence of acute respiratory failure on plasma renin activity and plasma angiotensin II level in advanced chronic obstructive pulmonary disease and chronic cor pulmonale]
[The renin-angiotensin-aldosterone system changes in chronic obstructive pulmonary disease]
Pulmonary Edema
Renin angiotensin aldosterone system and ACE I/D gene polymorphism in high-altitude pulmonary edema.
[Clinical significance of changes in plasma renin-angiotensin aldosterone system in patients with high altitude pulmonary edema]
[Why screening for a renal artery stenosis?]
Pulmonary Embolism
A new experimental model for measurement of pulmonary arterial haemodynamic variables in conscious rats before and after pulmonary embolism and during general anaesthesia.
Reciprocal changes in atrial natriuretic peptide levels and plasma renin activity during treatment of pulmonary embolism.
Transarterial embolization and ablation of renal arteriovenous malformations: efficacy and damages in 30 patients with long-term followup.
Pulmonary Fibrosis
Biochemical and histological impact of direct renin inhibition by aliskiren on myofibroblasts activation and differentiation in bleomycin induced pulmonary fibrosis in adult mice.
Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis.
Renin is an angiotensin-independent profibrotic mediator. Role in pulmonary fibrosis.
The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.
Pulmonary Heart Disease
Plasma renin activity in patients with chronic cor pulmonale syndrome.
[Changes of angiotensin II and angiotensin-converting enzyme in cor pulmonale with respiratory failure]
[Influence of acute respiratory failure on plasma renin activity and plasma angiotensin II level in advanced chronic obstructive pulmonary disease and chronic cor pulmonale]
[Plasma renin activity in patients with chronic cor pulmonale syndrome]
[The renin-angiotensin-aldosterone system changes in chronic obstructive pulmonary disease]
Pulmonary Valve Stenosis
Cardiovascular effects of AVP and ANG in experimental pulmonic stenosis in rats.
Changes in ventricular size and plasma renin activity after cardiac surgery in children.
Pure Autonomic Failure
Diagnosis and treatment of supine hypertension in autonomic failure patients with orthostatic hypotension.
Identification of a renin threshold and its relationship to salt intake in a patient with pure autonomic failure.
The hypertension of autonomic failure and its treatment.
Pyelonephritis
Chronic pyelonephritis: the significance of renal renin and the vascular changes in the human kidney.
Elevated plasma renin activity in patients with acute pyelonephritis.
Hypertension and plasma renin activity in experimentally induced chronic pyelonephritis.
Malignant hypertension in children secondary to chronic pyelonephritis: laboratory and radiologic indications for partial or total nephrectomy.
Renin localization in segmental renal hypoplasia. Immunohistochemical demonstration in two cases.
Role of hypervolemia and renin in the blood pressure control of patients with pyelonephritis renal scarring.
Salt-losing crisis in infants-not always of adrenal origin.
The relation between experimentally induced pyelonephritis and hypertension.
The unexpected pheochromocytoma.
[Blood lipoprotein, renin and cortisol contents in chronic pyelonephritis in children]
[Effect of captopril on plasma renin activity and blood aldosterone in patients with chronic pyelonephritis and urinary tract infection]
[Hypertension and blood plasma renin activity in children with pyelonephritis of a single kidney]
[Hypertension and plasma renin activity in experimentally induced chronic pyelonephritis (author's transl)]
[Peripheral blood plasma renin activity in children with chronic pyelonephritis and arterial hypertension]
[Prostaglandins in the renal vascular bed in arterial hypertension of different etiologies]
[Senile pyelonephritis with the arterial hypertension syndrome: the use of trental]
[Serum renin activity and water-electrolyte balance in chronic pyelonephritis]
Pyonephrosis
Secondary pseudohypoaldosteronism causing cardiopulmonary arrest and cholelithiasis.
Quadriplegia
Adrenal adenoma with excess secretion of corticosterone and 18-hydroxycorticosterone.
Changes in plasma renin activity and plasma aldosterone in the induced paralytic attack of thyrotroxic periodic paralysis.
Orthostatic hypotension after spinal cord injury: treatment with fludrocortisone and ergotamine.
Orthostatic responses to nitric oxide synthase inhibition in persons with tetraplegia.
Partial angiotensin-converting enzyme inhibition during acute orthostatic stress in persons with tetraplegia.
Renin and aldosterone release during sympathetic stimulation in tetraplegia.
receptor protein-tyrosine kinase deficiency
Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function.
Renal Artery Obstruction
'Captopril test', with blood pressure and peripheral renin as response variables in hypertensive patients with suspected renal artery stenosis.
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis.
A stereological study of the trophic effects of the renin-angiotensin system on the rat adrenal zona glomerulosa.
Acquired renal artery stenosis and a positive renal-vein renin ratio.
Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
Acute upregulation of COX-2 by renal artery stenosis.
Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
Angiographic aspects of renovascular hypertension.
Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function.
Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
Angiotensin-converting enzyme inhibitors and glycosuria.
Are plasma renin activity and aldosterone levels useful as a screening test to differentiate between unilateral and bilateral renal artery stenosis in hypertensive patients?
Arterial reconstructive surgery for renovascular hypertension.
Assessment of renal artery stenosis severity by pressure gradient measurements.
Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis.
Atherosclerotic Renal Artery Stenosis.
Bilateral adrenal phaeochromocytomas associated with unilateral renal artery stenosis.
Blockade of the Renin-Angiotensin system in hypertensive patients with atherosclerotic renal artery stenosis.
Captopril and kidney function in renovascular and essential hypertension.
Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
Captopril renography in the diagnosis of renovascular disease.
Captopril-stimulated renal vein renin in hypertensive patients with or without renal artery stenosis.
Cardiomyocytes bind and activate native human prorenin : role of soluble mannose 6-phosphate receptors.
Cardiovascular and neurohormonal changes following central sympathetic blockade with clonidine in human unilateral renal artery stenosis.
Change in pressor responsiveness to angiotensin II as a determinant of blood pressure after unclipping in two-kidney, one clip hypertensive rats.
Changes in active and inactive renin and in angiotensin II across the kidney in essential hypertension and renal artery stenosis.
Circulatory and renin responses in man to unilateral reduction of the renal perfusion pressure.
Clinical evaluation of renovascular hypertension and therapeutic decisions.
Clonidine in unilateral renal artery stenosis and unilateral renal parenchymal disease--similar antihypertensive but different renin suppressive effects.
Clonidine lowers blood pressure independently of renin suppression in patients with unilateral renal artery stenosis.
Coarctation of the abdominal aorta: current options in surgical management.
Coexistence of renal artery stenosis and uretheropelvic junction obstruction in hypertensive patients with elevated renin.
Coexisting extraadrenal pheochromocytoma and renal artery stenosis: a case report and review of the pathophysiology.
Comparison of split function ratios with renal vein renin ratios in patients with curable hypertension caused by unilateral renal artery stenosis.
Concentration and molecular forms of active and inactive renin in human fetal kidney, amniotic fluid and adrenal gland: evidence for renin-angiotensin system hyperactivity in 2nd trimester of pregnancy.
Correction of hypertension by partial nephrectomy in segmental renal artery stenosis and electron microscopic studies of renin.
Corticosterone-secreting tumours: with and without renal artery stenosis.
Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP.
Diagnosis of angiotensinogenic hypertension: the complementary roles of renal scintigraphy and the saralasin infusion test.
Diagnosis of secondary forms of hypertension. A comprehensive protocol.
Diagnostic value of captopril test in hypertensive patients with renal artery stenosis.
Diazoxide-induced renin release in diagnosis of remediable renovascular hypertension.
Differentiation between renovascular and essential hypertension by means of changes in single kidney 99mTc-DTPA clearance induced by angiotensin-converting enzyme inhibition.
Differing patterns of renal vein renin secretion in patients with renovascular hypertension, and their role in predicting the response to angioplasty.
Distribution of juxtaglomerular cells and synthesis and release of renin granules in patients with renal artery stenosis.
Divided renal and caval vein plasma renin activity in two-kidney two-clip hypertension in rabbits and variations of blood pressure, plasma volume and renal function following unilateral nephrectomy.
Does captopril reduce renal function in renovascular disease by postglomerular vasodilatation?
Drug therapy of renovascular hypertension.
Duplex ultrasound and renin ratio predict treatment failure after revascularization for renal artery stenosis.
Early surgery in the management of pediatric blunt renal trauma.
Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease.
Effect of postural change on plasma renin activity in peripheral and renal veins in hypertensive patients with or without renal artery stenosis.
Effect of prostaglandin A1 infusion in hypertensive patients with renal artery stenosis.
Effects of enalapril maleate on plasma level of inactive renin in renovascular hypertension.
Effects of propranolol on renin release during chronic thoracic caval constriction or acute renal artery stenosis in dogs.
Effects of two forms of hypertension on atherosclerosis in the hyperlipidemic baboon.
Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function.
Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty.
Enhanced activity of sympathetic renal nerves in hypertensive patients with unilateral renal ischemia--its relationship to plasma renin activity in renal venous blood.
Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension.
Experience with renal vein renin ratios in the identification of a pressor kidney.
Expression of angiotensin-converting enzyme in renovascular hypertensive rat kidney.
Extra-adrenal pheochromocytoma causing renal artery stenosis. Relationship to hypertension and renin levels.
Factors affecting renal vein renin ratio in renal artery stenosis. Secretion of inactive renin.
Failure of renin suppression by angiotensin II in hypertension.
False-negative saralasin responses in renovascular hypertension.
Flow versus pressure in the control of renin release in conscious dogs.
Hemodynamic and renin responses to nifedipine in renovascular hypertension.
Humoral factor in pressor hyperresponsiveness in renal prehypertensive rabbits.
Hyperrenin-hyperaldosterone-dependent malignant hypertension in polyarteritis nodosa.
Hypertension following renal transplantation: the role of the host's kidney.
Hypertension in pregnancy: a physiological response to a pathological problem?
Hypertension, renal vein thrombosis and renal failure (occurring in a patient on an oral contraceptive agent).
Hyponatremic hypertensive syndrome - a retrospective cohort study.
Idiopathic granulomatous nephritis in a patient with hypertension and an atrophic kidney.
In-vivo activation of circulating inactive renin by the ischemic kidney in man.
Incidence of renal artery stenosis in a population having cardiac catheterization.
Increase of plasma renin activity at renal blood flow estimations with the xenon133 wash-out technique in patients with renal artery stenosis.
Increased plasma endothelin concentration in atherosclerotic renovascular hypertension.
Influence of pulsatile perfusion upon renin release from the isolated perfused rat kidney.
Influence of resting before sonographic examination on Doppler measurements of renal blood flow.
Influence of salt depletion and hydralazine-induced vasodilatation on accuracy of selective renal vein sampling in patients with essential hypertension and renal artery stenosis.
Influence of the status of the renin-angiotensin system on the effect of cilazapril on neointima formation after vascular injury in rats.
Interrelationships between sodium clearance, plasma aldosterone, plasma renin activity, renal hemodynamics and blood pressure in renal disease.
Intrarenal de novo production of angiotensin I in subjects with renal artery stenosis.
Inverse relation of exchangeable sodium and blood pressure in hypertensive patients with renal artery stenosis.
Isolated renal artery and combined aortic and renal artery reconstruction for renovascular hypertension. Late results of surgical treatment.
Kidney and plasma renin in human renovascular hypertension.
Late hypertension following renal allotransplantation.
Low Levels of Renin and High Aldosterone-to-Renin Ratio Among Rheumatoid Patients and Ankylosing Spondylitis Patients: A Prospective Study.
Low salt diet and frusemide in the treatment of hypertension.
Malignant hypertension due to renal artery stenosis. Greater renin release from the nonstenotic kidney.
Mild Renal Artery Stenosis Can Induce Renovascular Hypertension and is Associated with Elevated Renal Vein Renin Secretion.
Negative captopril renography on patients with renin mediated hypertension due to page kidney and reninoma.
Noninvasive diagnosis of renovascular disease.
Norepinephrine overflow and renin pattern of the individual kidney in patients with unilateral renal artery stenosis.
Observations on the use and limitations of renal vein renins in hypertensive patients.
Pathophysiology and treatment of posttransplant hypertension.
Percutaneous transluminal angioplasty of the renal arteries.
Percutaneous treatment of renovascular hypertension.
Peripheral and renal vein renin activity in patients with renovascular hypertension due to nonspecific aortoarteritis.
Persistence of unilateral secretion and contralateral renin suppression after successful percutaneous transluminal dilatation in a normotensive patient.
Pheochromocytoma and fibromuscular hyperplasia.
Pheochromocytoma with renal artery stenosis and high plasma renin activity.
Pheochromocytoma with renal artery stenosis: A case-based review of literature.
Plasma endothelin levels: a meaningless number?
Plasma erythropoietin concentrations in renal venous blood of patients with unilateral renovascular hypertension.
Plasma renin activity in the evaluation of hypertension in renal transplant recipients.
Plasma renin activity revealed renal artery stenosis concealed by aneurysms.
Plasma renin, plasma aldosterone and exchangeable sodium in normotensive and hypertensive kidney transplant recipients with and without transplant renal artery stenosis.
Plasma renin, plasma aldosterone, exchangeable sodium and renal hemodynamics in normotensive and hypertensive recipients of a kidney transplant with and without transplant renal artery stenosis.
Positive Captopril Renography Without Renal Artery Stenosis but a Renal Cell Carcinoma.
Pre- and postoperative studies in 72 hypertensive patients with renal artery stenosis, with special reference to renin activity and aldosterone.
Pre-interventional prognostic value of renal endocrine, hemodynamic and arteriographic parameters in hypertensive patients with uni- and bilateral renal artery stenosis: a ten years' experience.
Predictive value and changes of renin secretion in hypertensive patients with unilateral renovascular disease undergoing successful renal angioplasty.
Predictive value of renin determinations in renal artery stenosis.
Pressor responses to vasopressin in rabbits with 3-day renal artery stenosis.
Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension.
Proceedings: Renal venous renin secretion and intrarenal haemodynamics in patients with renal artery stenosis.
Prospective analysis of strategies for diagnosing renovascular hypertension.
Prostanoids and blood pressure: which way is up?
Proteinuria and nephrotic syndrome induced by renin in patients with renal artery stenosis.
Pseudo renal artery stenosis (PRAS) syndrome.
Quantitation of Plasma Renin Activity in Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Rat renin gene transcription is initiated at a single start site.
Relationship of renal transplantation to hypertension in end-stage renal failure.
Renal actions of angiotensin II in renovascular hypertension.
Renal arterial and venous endothelin in hypertensive patients with or without renal artery stenosis.
Renal artery duplex ultrasonography: a reliable new screening test for functionally significant renal artery stenosis.
Renal artery occlusion and malignant hypertension in polycystic kidney disease.
Renal artery stenosis and nephrotic syndrome: a rare combination in an infant.
Renal artery stenosis towards the year 2000.
Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
Renal artery stenosis with severe hypertension. A rare case with detailed assessment of renin-angiotensin system before and after development of lesion.
Renal extraction of atrial natriuretic peptide in hypertensive patients with or without renal artery stenosis.
Renal hypertension. The renin system in hypertension with unilateral renal artery stenosis.
Renal prostaglandin E2 and the renin-angiotensin system in hypertensive disorders in man.
Renal renin release in patients with essential arterial hypertension and with unilateral renal artery stenosis.
Renal secretion of inactive renin and extraction of angiotensin II in renal artery stenosis in man: factors determining renal vein renin ratio.
Renal vein immunoreactive renin in patients with renal artery stenosis and essential hypertension.
Renal vein plasma adenosine 3',5'-cyclic monophosphate in renovascular hypertension.
Renal vein renin activity in primary hypertension: variability and influence of contrast material.
Renal vein renin in renovascular hypertension: the experience of two Italian centers.
Renal vein renin ratio. Predictive value in renal and renovascular hypertension.
Renal vein renin studies in a patient with renal hilar pheochromocytoma and renal artery stenosis.
Renal venous renin determinations in renovascular hypertension. Diagnostic and prognostic value in unilateral renal artery stenosis treated by surgery or percutaneous transluminal angioplasty.
Renal venous renin in patients with renovascular hypertension.
Renal-portal shunt ameliorates renovascular hypertension in pigs.
Renal-portal shunt to restore normal reninism and blood pressure in experimental renovascular hypertension in dogs.
Renin activity and aldosterone in 72 hypertensive patients before and after surgery for renal artery stenosis.
Renin secretion and captopril stimulation in hypertensive renal transplant recipients.
Renin, Endothelial NO Synthase and Endothelin Gene Expression in the 2Kidney-1clip Goldblatt Model of Long-term Renovascular Hypertension.
Renin, renin substrate and angiotensin II concentration in renal venous blood.
Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
Renin-dependent hypertension in patients with unilateral kidney disease not caused by renal artery stenosis.
Renin-secreting renal tumour with severe hypertension. case report with tumour renin analysis, histopathological and ultrastructural studies.
Renovascular hypertension from segmental renal artery stenosis: importance of segmental renal vein renin sampling.
Renovascular hypertension with unilateral atherosclerotic renal artery occlusion: diagnostic use of renal vein renins.
Renovascular hypertension. Predictability of surgical cure of unilateral renal artery stenosis and bilateral renal artery stenosis.
Renovascular hypertension: does the renal vein renin ratio predict operative results?
Reversible nephrotic syndrome due to high renin state in renovascular hypertension.
Role of blood pressure to mediate the influence of salt intake on renin expression in the kidney.
Role of endogenous endothelins in the renin system of normal and two-kidney, one clip rats.
Role of renal nerves in the stimulation of the renin system by reduced renal arterial pressure.
Role of the autonomic nervous system in the acute responses to renal artery pressure reduction in conscious dogs.
Saralasin infusion in the recognition of renovascular hypertension.
Selection of patients for renal artery repair using captopril testing.
Sodium-sensitive essential hypertension: emerging insights into an old entity.
Spontaneous variations in renal vein renin activity in man.
Studies on patients with renal artery stenosis (the diagnostic value of plasma renin activity measurements).
Studies on the active and inactive renin in renovascular hypertension.
Substitution of connexin40 with connexin45 prevents hyperreninemia and attenuates hypertension.
Surgical approach to combined abdominal aortic aneurysm and renal artery stenosis.
Surgical correction of renovascular hypertension: dissociation between post-operative changes in plasma renin and blood pressure.
Surgical management and results of renal artery revascularization.
Surgical treatment of renovascular hypertension associated with bilateral renal artery stenosis.
Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease.
Telling Tails: Very High Plasma Renin Levels Prompt the Diagnosis of Renal Artery Stenosis, Despite Initial Negative Imaging.
The captopril test in the detection of renovascular disease in hypertensive patients.
The coexistence of renal artery stenosis and pheochromocytoma.
The effect of salt restriction and furosemide in patients investigated for renovascular hypertension.
The importance of renal vascular tone in determining the severity of renal artery stenosis in dogs.
The pathophysiology of renovascular hypertension.
The relationship between the sympathetic nervous system and the renin-angiotensin system in renovascular hypertension.
The renin angiotensin system--its physiology and role in disease states.
The renin-angiotensin system and hypertension.
The renin-secreting cell in polyarteritis--an immunocytochemical study.
The simplified captopril test: an effective tool to diagnose renovascular hypertension.
The sympathetic nervous system in hypertension due to unilateral renal artery stenosis in man.
The utility of renal venous renin studies in selection of patients with renal artery stenosis for angioplasty: a retrospective study.
The value of tests predicting renovascular hypertension in patients with renal artery stenosis treated by angioplasty.
Time-course of the changes in blood pressure and in plasma renin activity during the first week after dilation of renal artery stenosis.
Transient renal artery stenosis produced by a pheochromocytoma.
Transrenal changes in active and inactive renin and angiotensin II in renal artery stenosis: effects of converting enzyme inhibition.
Unilateral renal artery stenosis and hypertension. II. Angiographic findings correlated with blood pressure response after surgery.
Unilateral renal artery stenosis presented with hyponatremic-hypertensive syndrome - case report and literature review.
Unraveling the Mystery of Goldblatt Hypertension.
What is critical renal artery stenosis? Implications for treatment.
Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
[Acute renal failure, renal artery stenosis and angiotensin-converting enzyme (ACE) inhibitor]
[Arterial hypertension due to compression of the renal artery, revealing ovarian cancer]
[Arterial hypertension: adenocarcinoma of the kidney or bilateral renal artery stenosis$]
[Assessment of split renal function before and after angioplasty or bypass grafting in the patients with renovascular hypertension]
[Behavior of the renin-angiotensin-aldosterone system and vasopressin secretion in patients with renovascular hypertension or small kidney]
[Captopril test for detecting renal artery stenosis: changes in plasma renin concentration]
[Case of kidney failure with thrombotic microangiopathy lesions in renal biopsy caused by accelerated hypertension in young adult]
[Changes in plasmatic renin levels and sensitivity to the pressor action of angiotensin in dogs with hypertension induced by defrenation or by renal artery stenosis]
[Changes of renal vein renin activity in patients with unilateral artherosclerotic renal artery stenosis]
[Circulatory and renin response to the administration of nifedipine in renovascular hypertension]
[Clinical usefulness of saralasin in human hypertension (author's transl)]
[Coexistence of renovascular hypertension and pheochromocytoma. Description of 2 clinical cases]
[Comparison of renin activity, angiotensin infusion test, separate urine studies according to Rapoport and isotope nephrogram in renal artery stenosis]
[Diagnostic and prognostic value of the separated renin in hypertension due to monolateral nephropathy]
[Diagnostic value of atrial natriuretic peptide in hypertension and heart insufficiency]
[Dynamic evaluation of the renin-angiotensin system with captopril in screening for renovascular hypertension]
[Lateralization of renin secretion in renovascular hypertension with bilateral arterial stenosis]
[Modification of renal hemodynamics and proteinuria in patients with arterial hypertension and kidney diseases]
[Plasma renin activity, blood circulation and oxygen consumption of kidneys as parameters for the evaluation of functional efficiency in renal artery stenoses]
[Prediction of results of surgery for renal artery stenosis: significance of renal venous renin activity and response to 1-sar-8-ile-angiotensin II (AII-A) (author's transl)]
[Renal hypertension]
[Renal scintigraphy with captopril in the evaluation of renovascular hypertension]
[Renin activity in renal artery stenosis in the peripheral blood and renal vein blood in comparison with other kidney function tests]
[Renin concentration in the peripheral and renal venous blood and kidney function tests in hypertensive patients with renal artery stenosis]
[Renin determination and renal artery obstruction]
[Renovascular hypertension - indications and type of operative method employed]
[Severe renal failure during treatment with angiotensin-converting enzyme inhibitors]
[Studies on the differential determination of renin activity in renal venous blood in renal artery stenosis]
[Surgical and medical treatment of renovascular hypertension (author's transl)]
[The renin activity in renal artery stenosis in the peripheral blood and in kidney venous blood in comparison with other kidney function tests]
[The value of renin determination in the diagnosis of hypertension]
[Treatment of renovascular hypertension by renal angioplasty]
[Urine catecholamine excretion and plasma renin activity in primary hypertension and renovascular hypertension due to renal artery stenosis]
[Why screening for a renal artery stenosis?]
Renal Insufficiency
A case of nephrotic syndrome associated with renovascular hypertension successfully treated with candesartan.
A Comprehensive Urine Proteome Database Generated From Patients With Various Renal Conditions and Prostate Cancer.
A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants.
Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension.
Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease - Demystifying controversies.
Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
AT2 receptor agonist Compound 21: A silver lining for diabetic nephropathy.
Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.
Autosomal dominant mutation in the signal peptide of renin in a kindred with anemia, hyperuricemia, and CKD.
Blood pressure control in end-stage renal disease in man: indirect evidence of a complex pathogenic mechanism besides renin or blood volume.
Blood pressure, circulating renin and the body sodium/volume state in patients with mild renal failure.
Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage.
BR 04-1MANAGEMENT OF TREATMENT-RESISTANT HYPERTENSION.
Changes induced by orthostatism in plasma renin activity and natriuresis. Influence of hypertension and renal failure.
Chronic continuous PTH infusion results in hypertension in normal subjects.
Clonidine after renal ischemia to lessen acute renal failure and microvascular damage.
Contrast nephropathy may be partly mediated by autonomic dysfunction: Renal failure considered as a modern maladaptation of the prehistoric trauma response.
Control of aldosterone responsiveness in terminal renal failure.
Control of plasma aldosterone during chronic hemodialysis.
Control of plasma aldosterone in terminal renal failure before and after nephrectomy and after renal transplantation.
Ctcf is required for renin expression and maintenance of the structural integrity of the kidney.
Dehydration and renal failure in older persons during heatwaves-predictable, hard to identify but preventable?
Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index.
Differential regulation of angiotensin converting enzyme 2 and nuclear factor-?B by angiotensin II receptor subtypes in type 2 diabetic kidney.
Direct Renin Inhibitor Induced Renal Failure.
Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure.
Early Results of Human Atrial Natriuretic Peptide Infusion in Non-Dialysis Patients with Chronic Kidney Disease Undergoing Isolated Coronary Artery Bypass Grafting: the NU-HIT Trial for CKD-II.
Effect of a high protein diet in patients with the nephrotic syndrome.
Effect of renin immunization on mercuric chloride and glycerol-induced renal failure.
Effect of water immersion on plasma renin activity, aldosteronaemia and vasopressinaemia in patients with acute non-inflammatory renal failure.
Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome.
Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure.
Effects of indomethacin in rabbit renovascular hypertension.
Effects of low protein intake on the development of the remaining kidney in subtotally nephrectomized immature rats: expression of inducible and endothelial NO synthase.
Elevated Plasma Renin Activity Caused by Accelerated-malignant Hypertension in a Patient with Aldosterone-producing Adenoma Complicated with Renal Insufficiency.
Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism.
Excess cardiovascular mortality in the uremic patient--what does it teach for other risk factors in the non-renal patient?
Expanding targets of vitamin D receptor activation: downregulation of several RAS components in the kidney.
Gender Difference in Renal Blood Flow Response to Angiotensin II Administration after Ischemia/Reperfusion in Rats: The Role of AT2 Receptor.
Glomerular angiotensin II receptors in gentamicin-induced renal failure in the rat.
Glycerol-induced acute renal failure in the two kidney Goldblatt rat.
Heart & kidney failure: Who's afraid of renin angiotensin system blockade?
Hereditary renal diseases.
High renin activity accompanying angiotensin II inhibition in rats with ischemic renal failure.
Hypertension and the interrelated renal circulatory effects of prostaglandins and the renin-angiotensin system.
Hypertension in the transplanted patient.
Hypertensive Crisis with Neurological Impairment Mimicking a Guillain-Barrè Syndrome: Searching for a Link.
Identification of renin inhibitors in normal and uremic plasma.
Immune Dysfunction in Uremia 2020.
Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.
Interrelations of renin, angiotensin II, and sodium in hypertension and renal failure.
Interrelationships between blood pressure, renin, renin substrate and blood volume in terminal renal failure.
Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency.
Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Lesson XXIV: on the major roles of the renin system in the pathogenesis of hypertension and of its sequelae, heart attack, heart failure, kidney failure, and stroke: replies to commonly asked questions.
Left Ventricular Function Assessed by Echocardiography in Cirrhosis. Relationship to Systemic Hemodynamics and Renal Dysfunction.
Mechanisms of hypertension during and after orthotopic liver transplantation in children.
Mechanisms of hypertension in renal radiation.
Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies -- related scleroderma renal crisis treated with double-filtration plasmapheresis.
Na intake, renal renin, and the severity of myohemoglobinuric renal failure in rats.
Natriuresis-induced protection in acute myohemoglobinuric renal failure without renal cortical renin content depletion in the rat.
Nicousamide attenuates renal dysfunction and glomerular injury in remnant kidneys by inhibiting TGF-?1 internalisation and renin activity.
Overhydratation and renin in hypertensive patients with terminal renal failure: a hemodynamic study.
P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage.
Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets.
Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in man.
Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: effect of clonidine.
Plasma renin activity and blood pressure in terminal renal failure.
Plasma renin activity during the development of paracetamol (acetaminophen) induced acute renal failure in man.
Plasma renin activity in diabetics with and without microangiopathy.
Plasma renin level in hepatic cirrhosis. Relaton to functional renal failure.
Postnatal development of renal function during the first year of life.
Postpartum renal failure and malignant hypertension treated with captopril.
Primary aldosteronism detected after renal transplantation.
Progress in Primary Aldosteronism: Translation on the Move.
Progression of renal failure after subtotal nephrectomy in transgenic rats carrying an additional renin gene [TGR(mREN2)27].
Progression of renal failure in the Han: SPRD polycystic kidney rat.
Progression of Renal Insufficiency in Patients with Essential Hypertension Treated with Renin Angiotensin Aldosterone System Blockers: An Electrocardiographic Correlation.
Prorenin receptor is essential for normal podocyte structure and function.
Pseudo-Hypo Aldosteronism Type II.
Rats with Adenine-Induced Chronic Renal Failure Develop Low-Renin, Salt-Sensitive Hypertension and Increased Aortic Stiffness.
Reciprocal changes in active and inactive renin after converting enzyme inhibition in normal man.
Red blood cell catechol-o-methyl transferase, plasma catecholamines and renin in renal failure.
Relationship of vascular reactivity to plasma renin concentration in patients with terminal renal failure.
Renal and systemic hemodynamics, in falciparum malaria.
Renal function in fulminant hepatic failure: haemodynamics and renal prostaglandins.
Renal kallikrein excretion in cirrhotics with ascites: relationship to renal hemodynamics.
Renal response to central volume expansion induced by water immersion (WI) in heart transplant patients.
Renin and acute circulatory renal failure in the rabbit.
Renin and control of arterial blood pressure during terminal renal failure treated by haemodialysis and by transplantation.
Renin and renal failure.
Renin release and the refractoriness to acute renal failure of rats recovering from prior renal failure.
Renin-Expressing Cells Require ?1-Integrin for Survival and for Development and Maintenance of the Renal Vasculature.
Resistance to acute renal failure afforded by prior renal failure: examination of the role of renal renin content.
Response to frusemide in acute renal failure: dissociation of renin and diuretic responses.
Role of serum renin and aldosterone in animal adaptation to high-altitude conditions.
Serial studies of the renin system in rats with glycerol-induced renal failure.
Sodium and potassium status, plasma renin and aldosterone profiles in normotensive and hypertensive Johannesburg blacks.
Studies on the pathophysiology of acute renal failure. I. Correlation of ultrastructure and function in the proximal tubule of the rat following administration of mercuric chloride.
Suppression of plasma renin activity by cyclosporine.
The renin-angiotensin system in kidney development: role of COX-2 and adrenal steroids.
The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
The role of renin in renal failure associated with hepatic failure.
Therapy and prognosis of hypertension in chronic nephritis.
Treatment of ascites and renal failure in cirrhosis.
Tubular proteinuria in reflux nephropathy: post ureteric re-implantation.
Uncompensated polyuria in a mouse model of Bartter's syndrome.
Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
[21-hydroxylase deficit revealed by hyperkalemia in the absence of renal failure in an insulin-dependent diabetic (author's transl)]
[A study on inactive renin in the plasma of patients with diabetes mellitus]
[Activity of plasma renin and plasma aldosterone in terminal renal failure]
[Activity of plasma renin in patients with terminal renal insufficiency kept on chronic hemodialysis]
[Chronic renal insufficiency of single kidney associated with genital, bone, and palpebral malformations]
[Combined blockade of the renin-angiotensin system].
[Comparison of urinary output during general anesthesia, between patients administered with remifentanil and those without remifentanil administration]
[Effect of the angiotensin antagonist saralasin on blood pressure and hemodynamics in patients with terminal renal insufficiency]
[Estimation of the plasma renin activity in terminal renal failure and its use for the factor determining indication of the bilateral nephrectomy]
[Function of the renin-angiotensin-aldosterone system and atrial natriuretic peptide secretion in patients with acute non-inflammatory renal insufficiency]
[Hepatorenal syndrome: pathogenesis and treatment]
[Hydronephrosis arterial hypertension. Report of 4 cases]
[Hypertension, atherosclerosis and kidney]
[Hyporeninemic hypoaldosteronism. Case report and attempt at pathophysiological classification (author's transl)]
[Inactive renin in patients with chronic and terminal renal insufficiency]
[Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure]
[Pathophysiological features of arterial hypertension in chronic nephritis]
[Proceedings: Correlations between blood pressure, body sodium/blood volume state and plasma renin in patients with terminal kidney insufficiency]
[Proceedings: Renin secretion and juxtaglomerular apparatus in folic-acid-induced kidney failure in the rat]
[Pulse therapy of patients with nephritis: effect on arterial pressure, electrolyte metabolism and the renin-aldosterone system]
[Role of renin in the reulation of the arterial pressure course of terminal renal insufficiency treated by hemodialysis and transplantation]
[Studies on hypertension accompanying renal failure: plasma renin activity and plasma angiotensinase activity in renal failure]
[The effect of renal arterio- and phlebography on the function of the renin-angiotensin and hypophyseal-adrenal systems]
Renal Insufficiency, Chronic
(Pro) Renin Receptor Mediates Albumin Induced Cellular Responses: Role of Site-1 Protease-Derived Soluble (Pro) Renin Receptor in Renal Epithelial Cells.
A possible mechanism for the progression of chronic renal disease and congestive heart failure.
Acute acid load in chronic kidney disease increases plasma potassium, plasma aldosterone and urinary renin.
Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management.
Addition of hydrochlorothiazide to angiotensin receptor blocker therapy can achieve a lower sodium balance with no acceleration of intrarenal renin angiotensin system in patients with chronic kidney disease.
Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria.
Albuminuria as a marker of arterial stiffness in chronic kidney disease patients.
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Aldosterone renin ratio and chronic kidney disease.
Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study.
Analysis of polymorphism in renin angiotensin system and other related genes in South Indian chronic kidney disease patients.
Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.
Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies.
Application of direct renin inhibition to chronic kidney disease.
Association between the Intrarenal Renin-Angiotensin System and Renal Injury in Chronic Kidney Disease of Dogs and Cats.
Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease.
Association of plasma renin activity and aldosterone-renin ratio with prevalence of chronic kidney disease: the Kaiser Permanente Southern California cohort.
AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
Cardiovascular and Hematological Medicine in 2013 - Advances and Insights.
Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II.
Chronic kidney disease: cardiac and renal angiotensin converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.
Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice.
Comparison of direct renin inhibitor and angiotensin II receptor blocker on clinic and ambulatory blood pressure profiles in hypertension with chronic kidney disease.
Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results.
Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease.
Current Strategies to Achieve Further Cardiac and Renal Protection through Enhanced Renin-Angiotensin-Aldosterone System Inhibition.
Diabetic nephropathy: newer therapeutic perspectives.
Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
Direct renin inhibition in chronic kidney disease.
Direct Renin Inhibition in Non-diabetic chronic Kidney disease (DRINK): a prospective randomized trial.
Direct Renin inhibitor: aliskiren in chronic kidney disease.
Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor.
Drug discovery for overcoming chronic kidney disease (CKD): new therapy for CKD by a (pro)renin-receptor-blocking decoy peptide.
Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be?
Effect of a Rational Drug Use Policy on the prescribing safety in outpatient settings in Thailand.
Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease.
Effect of aliskiren in chronic kidney disease patients with refractory hypertension undergoing hemodialysis: a randomized controlled multicenter study.
Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial.
Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial.
Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial.
Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure.
Effects of Direct Renin Inhibition versus Angiotensin II Receptor Blockade on Angiotensin Profiles in Non-Diabetic Chronic Kidney Disease.
Establishing a novel assay system for measuring renin concentration using cost effective recombinant ovine angiotensinogen.
Evidence for the existence of an acetone soluble renin inhibiting factor in normal human plasma.
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Functional role of endogenous adenosine in human chronic renal disease.
Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
Impaired post-infarction cardiac remodeling in chronic kidney disease is due to excessive renin release.
Inappropriately high plasma renin activity accompanies chronic loss of renal function.
Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1-7)/Mas and the ACE/Ang II/AT1 axes?
Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Is there a role for direct renin inhibitors in chronic kidney disease?
Juxtaglomerular apparatus hyperplasia under dual angiotensin blockade. A footprint of adequate RAS inhibition or a concern for renal fibrosis?
Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model.
Lab monitoring and acute care utilization during initiation of renin angiotensin aldosterone inhibitors or diuretics in chronic kidney disease.
Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.
Methods of cardio-renal protection in non-diabetic chronic nephropathies.
Novel Agents for the Prevention and Management of Hyperkalemia.
Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.
PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey.
Patiromer: The First Potassium Binder Approved in Over 50 Years.
Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
Plasma aldosterone concentrations in chronic renal disease.
Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study.
Potassium homeostasis and Renin-Angiotensin-aldosterone system inhibitors.
Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study.
Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.
Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study.
Renin and body fluid volumes in chronic renal disease. Relations between arterial pressure, plasma renin activity, blood volume, and extracellular volume in chronic renal disease, as compared with essential hypertension.
Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease: A Difficult Equation.
Renin Angiotensin System and cytokines in chronic kidney disease: Clinical and experimental evidence.
Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients.
Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD.
Renin inhibition in patients with chronic kidney disease: is it conclusively non-indicated?
Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents.
Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin.
Retarding the progression of chronic kidney disease with renin angiotensin system blockade.
Revisiting RAAS blockade in CKD with newer potassium-binding drugs.
Role of renal prostaglandin E2 in chronic renal disease hypertension.
SARS-CoV-2 associated COVID-19 in geriatric population: A brief narrative review.
Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease.
Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink.
Sex differences in soluble prorenin receptor in patients with type 2 diabetes.
SGLT2 inhibition to address the unmet needs in diabetic nephropathy.
Spotlight on renin: cardiovascular outcomes in chronic kidney disease and suppression of the renin-angiotensin system.
Targeting the renin angiotensin system for remission/regression of chronic kidney disease.
The anti-ageing hormone klotho induces Nrf2-mediated antioxidant defences in human aortic smooth muscle cells.
The effects of direct renin inhibitor, aliskiren, on arterial hypertension, chronic kidney disease and cardiovascular disease: optimal pharmacotherapy.
The Myth of Water and Salt: From Aquaretics to Tenapanor.
The paradox of the renin-angiotensin system in chronic renal disease.
The place of renin in the mechanism of hypertension in chronic renal disease.
The protective role of vitamin D on the heart and the kidney.
The renin-angiotensin system, adrenomedullins and urotensin II in the kidney: possible renoprotection via the kidney peptide systems.
The role of the renin angiotensin system in chronic renal disease.
THE TRANSCRIPTION FACTOR ETS-1 REGULATES ANGIOTENSIN II STIMULATED FIBRONECTIN PRODUCTION IN MESANGIAL CELLS.
Treatment of severe hypertension in chronic renal failure by haemofiltration.
Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
Urinary Angiotensinogen and Renin Excretion are Associated with Chronic Kidney Disease.
Urinary angiotensinogen as a surrogate marker predicting the antiproteinuric effects of angiotensin receptor blockers in patients with overt proteinuria: a multicenter prospective study.
Urinary angiotensinogen levels reflect the severity of renal histopathology in patients with chronic kidney disease.
Urinary sodium excretion has positive correlation with activation of urinary renin angiotensin system and reactive oxygen species in hypertensive chronic kidney disease.
Uromodulin-associated kidney disease.
Use of renin angiotensin system inhibitors in patients with chronic kidney disease.
Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats.
Vasoactive factors and tubulointerstitial injury.
Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
[Antihypertensive therapy in renal failure]
[Change in the activity of blood plasma renin in chronic renal insufficiency during treatment with hemodialysis]
[Changes in the activity of plasma renin and blood aldosterone and in that of the enzyme converting angiotensin I to angiotensin II during the dialytic treatment of patients with chronic renal insufficiency]
[Correction of aldosterone level as marker of RAAS dysfunction in patients with arterial hypertension degree II-III and chronic kidney diseases].
[Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency]
[Hypertension in chronic kidney insufficiency in childhood. Significance of renin, aldosterone and blood volume]
[Pathogenetic participation of exchangeable sodium and plasma renin activity in the genesis and development of hypertension in patients with chronic renal insufficiency on maintenance dialysis]
[Plasma renin activity in hypertonic patients with chronic renal insufficiency in a long-term dialysis program]
[Plasmatic activity of renin by radioimmunoassay in patients with terminal chronic renal insufficiency]
[Proteases and antiproteases in the progression of chronic renal insufficiency lesions. The role of the tissue renin-angiotensin system and the renin receptor]
[Role of aldosterone in essential arterial hypertension complicated by chronic renal insufficiency]
[Role of connective tissue growth factor in angiotensin II induced human proximal tubular cell hypertrophy]
[Tensional regulation of chronic renal insufficiency patients treated by hemodialysis. Roles in constrictive action of angiotensin and renin activity]
[The role of plasma renin activity (PRA) in hypertensive patients with chronic kidney insufficiency]
[The role of renin and electrolyte disorders in the pathogenesis of hypertension in chronic renal insufficiency]
renin deficiency
Hyperkalemia and renin deficiency.
Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency.
Renal sodium transport in renin-deficient Dahl salt-sensitive rats.
Selective hypoaldosteronism despite prolonged pre- and postoperative hyperreninemia in primary aldosteronism.
Selective hypoaldosteronism: a study of steroid biosynthetic pathways under adrenocorticotrophin and angiotensin II infusion.
[21-hydroxylase deficit revealed by hyperkalemia in the absence of renal failure in an insulin-dependent diabetic (author's transl)]
Reperfusion Injury
Aliskiren attenuates myocardial apoptosis and oxidative stress in chronic murine model of cardiomyopathy.
Anti-necrotic and cardioprotective effects of a cytosolic renin isoform under ischemia-related conditions.
CD39-adenosinergic axis in renal pathophysiology and therapeutics.
Effect of the Renin Inhibitor Aliskiren against Retinal Ischemia-Reperfusion Injury.
Increased susceptibility to structural acute kidney injury in a mouse model of presymptomatic cardiomyopathy.
Increased vulnerability of hypertrophied myocardium to ischemia and reperfusion injury. Relation to cardiac renin-angiotensin system.
Measurement of plasma renin concentration in cats by use of a fluorescence resonance energy transfer peptide substrate of renin.
Role of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heart.
The effect of neprilysin and renin inhibition on the renal dysfunction following ischemia-reperfusion injury in the rat.
Therapeutic modulation of tissue kallikrein expression.
Respiratory Distress Syndrome
A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
Atrial natriuretic peptide in the preterm newborn.
Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: A pilot study.
Protective Role of Angiotensin II Type 1 Receptor Blocker on Short Time Effect of Oleic Acid Induced Lung and Kidney Injury.
Respiratory Insufficiency
Effects of captopril on pulmonary haemodynamics.
Hormonal abnormalities affecting sodium and water balance in acute respiratory failure due to chronic obstructive lung disease.
Treatment of status asthmaticus--hormone changes before and after aminophylline i.v. drip therapy.
[ADH (anti-diuretic hormone), aldosterone (PA) and renin activity (PRA) in patients with respiratory failure]
[Changes of angiotensin II and angiotensin-converting enzyme in cor pulmonale with respiratory failure]
[Influence of acute respiratory failure on plasma renin activity and plasma angiotensin II level in advanced chronic obstructive pulmonary disease and chronic cor pulmonale]
Retinal Detachment
Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy.
Retinal Diseases
Prorenin and the (pro)renin receptor: do they have a pathogenic role in the retina?
Receptor-associated prorenin system in the pathogenesis of retinal diseases.
Retinal Neovascularization
Retinal neovascularization is prevented by blockade of the renin-angiotensin system.
Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization.
Role of prorenin in the pathogenesis of retinal neovascularization.
Retinopathy of Prematurity
Prorenin and the (pro)renin receptor: do they have a pathogenic role in the retina?
Prorenin levels in retinopathy of prematurity.
Retinal neovascularization is prevented by blockade of the renin-angiotensin system.
Rhabdomyolysis
Shakuyaku-kanzo-to induces pseudoaldosteronism characterized by hypokalemia, rhabdomyolysis, metabolic alkalosis with respiratory compensation, and increased urinary cortisol levels.
[Case of rhabdomyolysis induced by the approved daily dose of a traditional Chinese medicine]
Rheumatic Heart Disease
Changes in ventricular size and plasma renin activity after cardiac surgery in children.
[Humoral pressor substances in a constellation of rheumatic heart defects with systemic arterial hypertension]
[Influence of cardiac structure, blood flow velocity and heart function on circulating atrial natriuretic peptide and renin-angiotension system]
[The renin-angiotensin-aldosterone system in chronic heart failure]
Rheumatoid Vasculitis
Raised plasma renin and prorenin in rheumatoid vasculitis.
Sarcoidosis
Plasma renin activity and angiotensin II concentrations in sarcoidosis.
Serum angiotensin converting enzyme activity in pulmonary diseases: correlation with lung function parameters.
[A comparative study of plasma converting enzyme and renin in sarcoidosis]
[Kininase II (SACE) and renin in sarcoidosis patients and healthy probands in exercise testing]
[Variations in plasma angiotensin-converting enzyme and renin in sarcoidosis]
Sarcoma
Alveolar soft-part sarcoma--A malignant angioreninoma: Histochemical, immunocytochemical, and electron-microscopic study of four cases.
Syntenic assignment of human chromosome 1 homologous loci in the bovine.
Sarcoma, Avian
Synthetic "interface" peptides alter dimeric assembly of the HIV 1 and 2 proteases.
Sarcopenia
Sarcopenia and COVID-19: A Manifold Insight on Hypertension and the Renin Angiotensin System.
Scleroderma, Diffuse
Plasma renin activity in progressive systemic sclerosis.
Renal vasoactive hormones in scleroderma (progressive systemic sclerosis).
Renin-angiotensin system in normotensive and hypertensive patients with progressive systemic sclerosis: hyporesponsiveness of renin during captopril test.
Scleroderma, Systemic
Failure of cold pressor testing to induce changes in plasma renin activity or renal duplex sonography in patients with systemic sclerosis.
Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies -- related scleroderma renal crisis treated with double-filtration plasmapheresis.
[Plasma renin activity in patients with systemic scleroderma and renal lesions]
[Potential dangers of diuretics...]
[Renal Involvement in Connective Tissue Diseases].
Seizures
A syndrome of post-transfusion hypertension, convulsion and cerebral hemorrhage in beta-thalassemia Hb E disease: a case report with high plasma renin activity.
Effect of aliskiren on the anticonvulsant activity of antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.
Effect of aliskiren, a direct renin inhibitor, on the protective action of antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice.
Evaluation and comparison of anticonvulsant activity of telmisartan and olmesartan in experimentally induced animal models of epilepsy.
Recurrent seizures alter renal function and plasma atrial natriuretic peptide levels in rats.
Seminoma
Renin and angiotensin II studies in malignant hypertension after x-irradiation for seminoma.
Sepsis
A canine model of hyperdynamic sepsis induced by intestinal ischemia.
Angiotensin aldosterone inhibitors improve survival and ameliorate kidney injury induced by sepsis through suppression of inflammation and apoptosis.
Antihypertensive agents acting on the renin angiotensin system and the risk of sepsis.
Association between renal and sympathetic responses to nonhypotensive systemic sepsis.
Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?
The plasma kallikrein/kinin and renin angiotensin systems in blood pressure regulation in sepsis.
Severe Acute Respiratory Syndrome
A review on SARS-CoV-2 and stroke pathogenesis and outcome.
Essential role for collectrin in renal amino acid transport.
Physical Exercise and the Renin Angiotensin System: Prospects in the COVID-19.
Severe Dengue
Plasma renin activity in children with dengue hemorrhagic fever.
Sexual Infantilism
A novel compound heterozygous mutation in the CYP17A1 gene in a patient with 17?-hydroxylase/17,20-lyase deficiency.
A novel compound heterozygous mutation of K494_V495 deletion plus R496L and D487_F489 deletion in extreme C-terminus of cytochrome P450c17 causes 17alpha-hydroxylase deficiency.
Shock, Cardiogenic
Plasma atrial natriuretic factor in low output heart failure syndromes.
Plasma renin activity levels in two patients with impending cardiogenic shock.
[Atrial natriuretic factor in cardiogenic shock, in hypovolemic shock and in the bradycardia-hypotension syndrome following acute myocardial infarction]
[Cardiogenic shock and sudden cardiac death]
[Certain humoral factors in acute myocardial infarct complicated by cardiogenic shock]
Shock, Septic
Angiotensin II receptor antagonism increases gut oxygen delivery but fails to improve intestinal mucosal acidosis in porcine endotoxin shock.
Erythropoietin and renin as biological markers in critically ill patients.
Hemodynamics and metabolic studies on septic shock in patients with acute liver failure.
Implications of Plasma Renin Activity and Plasma Aldosterone Concentration in Critically Ill Patients with Septic Shock.
Plasma Renin Concentration is Associated with Hemodynamic Deficiency and Adverse Renal Outcome in Septic Shock.
Renin aldosterone vasopressin and copeptin kinetics in patients with septic shock, a post-hoc Hyper2S randomized trial analysis.
The plasma kallikrein/kinin and renin angiotensin systems in blood pressure regulation in sepsis.
[The ultrastructural changes in the glomeruli and juxtaglomerular apparatus at different periods of endotoxic shock]
Shy-Drager Syndrome
Postural changes in plasma renin activity and responses to vasoactive drugs in a case of Shy-Drager syndrome.
The mechanism of aldosterone response to furosemide test in patients with Shy-Drager syndrome.
Sleep Apnea Syndromes
Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives.
Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity.
[Significance of the changes of urinary uric acid, ANP, renin and aldosterone in sleep apnea syndrome patients]
Sleep Apnea, Obstructive
Effects of obstructive sleep apnea on endothelin-1 and blood pressure.
Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone.
Plasma renin levels and renin-blood pressure relationship in normal-weight and overweight children with obstructive sleep apnea and matched controls.
The impact of obstructive sleep apnea syndrome on renin and aldosterone.
[Clinical Characteristics of Aldosterone Producing Adenoma and Idiopathic Hyperaldosteronism with Obstructive Sleep Apnea Hypopnea Syndrome].
[Correlation between(Pro) renin receptor levels and gender and disease severity in patients with obstructive sleep apnea syndrome].
Sleep Deprivation
Aldosterone release during the sleep-wake cycle in humans.
Plasma renin activity and serum aldosterone during prolonged physical strain. The significance of sleep and energy deprivation.
Relationship between blood pressure and airway obstruction during sleep in the dog.
Sleep deprivation blunts the night time increase in aldosterone release in humans.
The renin secretion profile under the influence of sleep deprivation and the neuropeptides CRH and GHRH.
Sleep Initiation and Maintenance Disorders
Prognostic Significance of Insomnia in Heart Failure.
Sleep Wake Disorders
Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.
Solitary Kidney
Acquired oligonephropathy and diabetic nephropathy.
Congenital ureteral valves: report of 2 patients, including one with a solitary kidney and associated hypertension.
Differential regulation of rat glomerular and proximal tubular renin mRNA following uninephrectomy.
Differentiation between renovascular and essential hypertension by means of changes in single kidney 99mTc-DTPA clearance induced by angiotensin-converting enzyme inhibition.
Functional and molecular evaluation of using aliskiren during acute and chronic partial ureteral obstruction in rat solitary kidney.
Half-life of circulating renin under different experimental conditions.
Hypertension and the vanishing kidney.
Purification and characterization of human kidney renin.
Renal vein renin ratio. Predictive value in renal and renovascular hypertension.
Solitary kidney and ageing as causes of low renin and aldosterone concentrations: relevance to "low-renin" essential hypertension.
Unilateral renal hypoplasia with associated venous anomaly and hypertension. A study of the juxtaglomerular cells.
[Hypertension and blood plasma renin activity in children with pyelonephritis of a single kidney]
[Mechanism of the stimulating effect of furosemide, ethacrynic acid and novurit on renin secretion by the kidneys]
[Study of renin activity in the peripheral blood of patients with vasorenal hypertension and solitary kidney]
Spasm
Low plasma renin level is associated with the occurrence of angiographic radial artery spasm in patients undergoing transradial coronary procedures.
Transmural myocardial infarction during pregnancy.
Spinal Cord Diseases
Design of potent aspartic protease inhibitors to treat various diseases.
New directions for protease inhibitors directed drug discovery†.
Spinal Cord Injuries
Absent aldosterone response to metoclopramide in patients with high spinal cord transection: evidence that metoclopramide stimulates aldosterone secretion through central pathways.
Effect of autonomic hyperreflexia on plasma renin.
Plasma catecholamines, plasma renin activity and plasma aldosterone in tetraplegic man, horizontal and tilted.
Plasma renin studies in patients with traumatic spinal cord injuries.
The determination of vasoactive substances during autonomic dysreflexia.
[Severe hyponatremia in a case of severe spinal injury: sequential examination of factors affecting water-electrolyte balance]
Splenic Infarction
Severe hypertension associated with multiple intrarenal microaneurysms in a patient with systemic lupus erythematosus and antiphospholipid antibodies.
Spondylitis, Ankylosing
Low Levels of Renin and High Aldosterone-to-Renin Ratio Among Rheumatoid Patients and Ankylosing Spondylitis Patients: A Prospective Study.
ST Elevation Myocardial Infarction
Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction.
[Evaluation of plasma renin activity in acute myocardial infarction patients treated with primary percutaneous coronary interventions].
Starvation
Aldosterone and blood pressure in obese subjects during short-term starvation.
An Alternative Promoter in Intron1 of the Renin Gene is Regulated by Glucose Starvation via Serum Response Factor.
Anti-necrotic and cardioprotective effects of a cytosolic renin isoform under ischemia-related conditions.
Fluid balance during food deprivation and after intraruminal loads of water or isotonic saline in lactating and anoestral goats.
Starvation---an interesting model for the study of the renin-angiotensin-aldosterone system.
The roles of carbohydrate, renin, and aldosterone in sodium retention during and after total starvation.
Urinary proteins and plasma renin activity during total starvation.
Urine dopamine in starving obese subjects.
Stenosis, Pulmonary Artery
Action of endogenous atrial natriuretic peptide in calves with experimental acute central venous congestion and low cardiac output.
steroid 11beta-monooxygenase deficiency
Abnormalities of aldosterone synthesis and action in children.
Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia.
steroid 21-monooxygenase deficiency
A case of silent 21-hydroxylase deficiency with persistent adrenal insufficiency after removal of an adrenal incidentaloma.
Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age.
Congenital adrenal hyperplasia: epidemiology, management and practical drug treatment.
Congenital adrenal hyperplasia: renin and steroid values during treatment.
Dissociation of plasma renin activity and plasma aldosterone level during dexamethasone suppression test in non-salt-losers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Enzyme immunoassay for plasma renin activity: II. Clinical application.
Mineralocorticoids in congenital adrenal hyperplasia.
Siblings of 21-hydroxylase deficiency (non-salt-losing) with aldosterone hypersecretion.
The interaction of plasma renin activity and plasma atrial natriuretic peptide in 21-hydroxylase deficiency patients.
The measurement of 11 beta-hydroxy-4-pregnene-3,20-dione (21-deoxycorticosterone) by radioimmunoassay in human plasma.
Value of direct measurement of active renin concentrations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
[Aggravation of salt loss due to hydrocortisone in the first days of treatment of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency]
[Clinical significance of plasma renin, testosterone, 17-alpha-hydroxyprogesterone and ACTH activities in the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. A review of 31 cases]
[Renin-angiotensin and hypophyseo-adrenal systems in children suffering from congenital adrenocortical hyperplasia resulting from 21-hydroxylase deficiency]
[State of the renin-angiotensin system in children with different clinical variants of congenital adrenal cortex hyperplasia caused by 21-hydroxylase deficiency]
[Study of renin activity and aldosterone secretion in 7 cases of adrenal hyperplasia due to 21-hydroxylase deficiency]
[Study of renin activity and aldosterone secretion in adrenal hyperplasia due to 21-hydroxylase deficiency]
Stomach Ulcer
Inhibiting renin angiotensin system in rate limiting step by aliskiren as a new approach for preventing indomethacin induced gastric ulcers.
Stroke
A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
A cross-over medication trial for patients with autosomal-dominant hypertension with brachydactyly.
A review on SARS-CoV-2 and stroke pathogenesis and outcome.
Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension.
ACE inhibition improves vagal reactivity in patients with heart failure.
Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
Aldosterone, Renin, Cardiovascular Events, and All-Cause Mortality Among African Americans: The Jackson Heart Study.
Anti-hypertensive adrenergic-blocking agents: effects on sodium balance, the renin-angiotensin system and haemodynamics.
Are patients with essential hypertension and low renin protected against stroke and heart attack?
Arterial pulse pressure and vasopressin release in humans during lower body negative pressure.
Assessing the effects of Ang-(1-7) therapy following transient middle cerebral artery occlusion.
Association between renin-angiotensin-aldosterone system genotypes and haplotypes and risk of ischemic stroke of atherosclerotic etiology.
Association of Low Urinary Sodium Excretion With Increased Risk of Stroke.
Association of Sympathovagal Imbalance With Cardiovascular Risks in Young Prehypertensives.
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.
beta-Adrenoreceptor blockage and genetic hypertension development in rats.
beta-Endorphin and essential hypertension: importance of the clonidine-naloxone interaction.
Biochemical and hemodynamic changes in normal subjects during acute and rigorous bed rest and ambulation.
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren.
Cardiovascular actions of nitrous oxide or halothane in hypovolemic swine.
Cardiovascular and neurohormonal responses to lower body negative pressure (LBNP): effect of training and 3 day bed rest.
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
Cardiovascular responses to lower body negative pressure before and after 4-hours of head-down bed-rest and seated control in men and women.
Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect.
Chronic effects of enalapril on blood pressure, stroke, plasma renin, urinary electrolytes and PGE2 excretion in stroke-prone spontaneously hypertensive rats.
Clinical and Functional Correlates of Platelet Cyclic GMP in Essential Hypertensives.
Comparison between the effects of ST 600 and catapres.
Comparison between the effects of ST 600 and clonidine.
Comparison of the effects of carbon dioxide and helium pneumoperitoneum on renal function.
Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
Decreased venous distensibility and reduced renin responsiveness in hypertension.
Dehydration and renal failure in older persons during heatwaves-predictable, hard to identify but preventable?
Different endocrinal and hemodynamic response patterns to various noxious stimuli.
Discordant nephron function. A pathogenic factor in hypertension and its vascular complications of stroke and heart attack.
Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial.
Effect of 6-week endurance training on hemodynamic and neurohormonal responses to lower body negative pressure (LBNP) in healthy young men.
Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
Effect of endothelin on regional hemodynamics and renal function in awake normotensive rats.
Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes.
Effects of infusing alpha-atrial natriuretic peptide in primary hypertension during converting enzyme inhibition.
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels.
Essential hypertension: renin and aldosterone, heart attack and stroke.
Ethnic differences of renin-sodium profile and renal prostaglandins in the pathogenesis of systemic arterial hypertension.
Excess prevalence of extracranial carotid artery lesions in renovascular hypertension.
Excess prevalence of supraaortic artery lesions in renovascular hypertension: an arteriographic study.
Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension.
Fenofibrate lowers blood pressure in two genetic models of hypertension.
Genetically determined chloride-sensitive hypertension and stroke.
Haemodynamic responses to exercise and acute beta-receptor blockade in renin sub-types of essential hypertension.
Haplotypes of the human renin gene associated with essential hypertension and stroke.
Hemodynamic and hormonal changes during pneumoperitoneum and trendelenburg positioning for operative gynecologic laparoscopy surgery.
Hemodynamic and neuroendocrine predictors of lower body negative pressure (LBNP) intolerance in healthy young men.
Hemodynamic and plasma renin effects of propranolol in essential hypertension.
Implications of recently published trials of blood pressure-lowering drugs in hypertensive or high-risk patients.
Inhaled Beta2-Agonists Increase In-Hospital Mortality in ICU Patients with Heart Failure.
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Lesson XXIV: on the major roles of the renin system in the pathogenesis of hypertension and of its sequelae, heart attack, heart failure, kidney failure, and stroke: replies to commonly asked questions.
Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease.
Low-renin hypertension. Occurrence in vascular complications.
Mechanism of thirst attenuation during head-out water immersion in men.
Mineralocorticoid Antagonism and Diabetic Kidney Disease.
Multiple arterial occlusions and hypertension probably caused by an oral contraceptive: a patient in whom the development of renovascular hypertension has been followed.
Neurohumoral profile in congestive heart failure: response to beta-blockade.
No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers.
OS 32-03 ANGIOTENSIN II TYPE 2 RECEPTOR AGONIST EXERTS SUSTAINED NEUROPROTECTIVE EFFECTS IN AGED RATS.
Pharmaceutical Modulation of the Renin Angiotensin Aldosterone System for Stroke Prevention: A Review of Experimental and Clinical Evidence.
Pharmaceutical modulation of the Renin Angiotensin aldosterone system for stroke prevention: a review of experimental and clinical evidence.
Physiological effects of sleeping with the head of the bed elevated 18 in. in young healthy volunteers.
Plasma renin activity in stroke patients.
Plasma renin and cardiovascular responses to the cold pressor test differ in black and white populations: The SABPA study.
Plasma volume restoration with salt tablets and water after bed rest prevents orthostatic hypotension and changes in supine hemodynamic and endocrine variables.
Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
Prehypertensive treatment with losartan, however not amlodipine, leads to long?term effects on blood pressure and reduces the risk of stroke in spontaneously hypertensive stroke?prone rats.
Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism.
Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
Prostacyclin infusion does not prevent ACTH-induced hypertension in sheep.
RAAS and stress markers in acute ischemic stroke: preliminary findings.
Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats.
Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients.
Reversal by naloxone of the antihypertensive action of clonidine: involvement of the sympathetic nervous system.
Risk factors and progression of small vessel disease-related cerebral abnormalities.
Role of Blood Pressure Management in Stroke Prevention: A Systematic Review and Network Meta-Analysis of 93 Randomized Controlled Trials.
Role of renin secretion and kidney function in hypertension and attendant heart attack and stroke.
Significant relationship between renin suppression and atrial natriuretic peptide (alpha-hANP) during volume loading in hypertensive men.
Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: Insight from preclinical stroke studies and therapeutic potential.
The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade.
Therapies for perioperative hypertension: pharmacodynamic considerations.
[Arterial damage and the renin-angiotensin system in essential hypertension. Study of 63 cases]
[Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension]
[Hemodynamics of coronary surgery patients following magnesium aspartate infusion]
[Pharmacological basis of antihypertensive drug therapy]
[Plasma renin level, clinical findings and association of apoplexy in essential hypertension]
[Relation of plasma renin activity stroke and heart attack in the epidemiological survey (author's transl)]
[Renin-angiotensin-aldosterone system in hypertension patients who have had a cerebral stroke]
[The influence of hormones of stress-promoting system on the course of acute ischemic stroke]
Struma Ovarii
Clinical syndromes associated with tumors of the female genital tract.
Stupor
Influence of pentobarbitalnatrium (Nembutal) narcosis on blood pressure, plasma renin activity, aldosterone, sodium and potassium in normotensive and spontaneously hypertensive rats.
Narcosis, blood glucose, plasma insulin and renin concentrations: experimental research with Althesin, thiopental and ketamine.
Subarachnoid Hemorrhage
Associations of endothelin polymorphisms and aneurysm size at the time of rupture.
Associations of renin-angiotensin system genetic polymorphisms and clinical course after aneurysmal subarachnoid hemorrhage.
Plasma renin activity in patients after a subarachnoid hemorrhage--a possible predictor of outcome.
[Pathogenesis of hyponatremia observed in the treatment of acute subarachnoid hemorrhage]
Syncope
Application of acute maximal exercise to protect orthostatic tolerance after simulated microgravity.
Different humoral responses during head-up tilt testing among patients with neurocardiogenic syncope.
Epinephrine, vasodilation and hemoconcentration in syncopal, healthy men and women.
Greater orthostatic tolerance in young black compared with white women.
Hormonal responses during orthostasis following 4 hours of head-down tilt.
Neural monitoring of vasovagal syncope.
Reduced plasma renin activity in elderly subjects in response to vasovagal hypotension and head-up tilt.
Response of plasma renin activity to postural change in vasovagal syncope in children, with observations on syncope.
The response of arginine vasopressin and plasma renin to postural change in normal man, with observations on syncope.
[Renin-angiotensin-aldosterone system activity during head-up tilt testing in patients with vasovagal syncope]
Syncope, Vasovagal
Different humoral responses during head-up tilt testing among patients with neurocardiogenic syncope.
Gene polymorphisms of renin angiotensin system and serotonin transporter gene in patients with vasovagal syncope.
Neural monitoring of vasovagal syncope.
Response of plasma renin activity to postural change in vasovagal syncope in children, with observations on syncope.
Tachycardia
A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs.
A study of permanent adipsia induced by medial forebrain lesions.
Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmacokinetics and clinical use.
Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
Analysis of beta-adrenoceptors mediating renin release produced by isoproterenol in conscious dogs.
Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
Beta-adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man.
Blunting of exercise-induced tachycardia and renin release 24 hours after a single dose of sotalol.
Captopril-induced hypotension is inhibited by the bradykinin blocker HOE-140 in Na(+)-depleted marmosets.
Cardiac angiotensin receptors in experimental hyperthyroidism in dogs.
Cardiac effects of calcium antagonists in systemic hypertension.
Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats.
Circulatory collapse and sudden death in respirator-dependent amyotrophic lateral sclerosis.
Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients.
Dose effects of human renin in rats transgenic for human angiotensinogen.
Effect of acute administration of prazosin on blood pressure, heart rate and plasma renin level in the conscious normotensive rat.
Effects of activation of renal adenosine A2 receptor on renal function and renin release in dogs.
Effects of indomethacin and (+/-)-propranolol on the cardiovascular and renin responses to vasoactive intestinal polypeptide (VIP) infusion in man.
Efferent limb of the atrial receptor reflex decrease in plasma renin activity in anaesthetized dogs.
Evaluation of minoxidil.
General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome.
Haemodynamic effects of prazosin.
Haemodynamic responses to exercise and acute beta-receptor blockade in renin sub-types of essential hypertension.
Hemodynamic and hormonal response to induced hypotension with isosorbide dinitrate and nitroglycerin during anesthesia.
Hemodynamic and metabolic effects of the calcium channel blocking agent nitrendipine.
Hormonal responses to synthetic atrial natriuretic peptide in patients on regular hemodialysis.
Hypertensive crisis treated with orally administered captopril.
Hypokalemia from beta2-receptor stimulation by circulating epinephrine.
Increased plasma angiotensin II in postural tachycardia syndrome (POTS) is related to reduced blood flow and blood volume.
Influence of low- and high-pressure baroreceptors on plasma renin activity in humans.
Inhibition of adenosine deaminase attenuates endotoxin-induced release of cytokines in vivo in rats.
Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes.
Nitrendipine vs. long-acting nifedipine in mild, moderate and severe hypertension.
Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent.
Prazosin and oxprenolol therapy in pregnancy hypertension.
Propranolol alters renin release during nitroprusside-induced hypotension and prevents hypertension on discontinuation of nitroprusside.
Renin inhibition.
Role of calcium antagonists in systemic hypertension.
Severe ovarian hyperstimulation syndrome: role of peripheral vasodilation.
The effects of altered sodium balance and adrenergic blockade on renin release induced in rats by angiotensin antagonism.
Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
Yohimbine induces sympathetically mediated renin release in the conscious rat.
[Calcium antagonists: an antihypertensive alternative]
[Dynamics of plasma catecholamines and beta-adrenoreceptor functions. Use of a new radio-enzymatic micro-method]
[Effect of obzidan on hemodynamic indices and the renin and aldosterone levels of the blood plasma in patients with juvenile hypertension]
[State of the renin-angiotensin system in thyrotoxicosis]
Tachycardia, Ventricular
Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells.
Nesiritide: past, present, and future.
Neuroendocrine activation after acute myocardial infarction.
Tachypnea
The pathogenesis of heart failure in infants with congenital heart disease.
Takayasu Arteritis
Elevated plasma renin activity in aortitis syndrome.
Hemodynamic and volume characteristics, and peripheral plasma renin activity in Takayasu's arteritis.
Tension-Type Headache
[The relationship between tension headache or vascular headache and plasma renin activity or angiotensin II level]
Tetanus
Preparation of a specific high-titer antibody against rat kidney renin.
Specific antibody to hog renal renin and its application to the direct radioimmunoassay of renin in various organs.
Vesicle-associated Membrane Protein-2 (VAMP2) Mediates cAMP-stimulated Renin Release in Mouse Juxtaglomerular Cells.
Tetralogy of Fallot
Amino-terminal fragment of pro-brain natriuretic hormone identifies functional impairment and right ventricular overload in operated tetralogy of fallot patients.
Changes in ventricular size and plasma renin activity after cardiac surgery in children.
Plasma N-terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair.
Tetralogy of Fallot repair results in activation of the renin-angiotensin-aldosterone system.
Thalassemia
Evaluation of the glucocorticoid, mineralocorticoid, and adrenal androgen secretion dynamics in a large cohort of patients aged 6-18 years with transfusion-dependent ?-thalassemia major, with an emphasis on the impact of cardiac iron load.
Thrombocytopenia
Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.
[Case report: neonatal hypertension]
Thrombocytosis
A case of pseudo-Bartter's syndrome associated with hypergastrinemia, thrombocytosis and increased serum thyroxine-binding globulin.
Thrombophilia
Factor XII (Hageman factor) is a missing link between stress and hypercoagulability and plays an important role in the pathophysiology of ischemic stroke.
Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences.
Thrombosis
Assembly and activation of the plasma kallikrein/kinin system: a new interpretation.
Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin.
Co-existence of renovascular hypertension, polyarteritis nodosa, antiphospholipid syndrome and methylenetetrahydrofolate reductase mutation.
COVID-19 and ischemic stroke.
Epidemiology and management of severe symptomatic neonatal hypertension.
Hypertension and renal artery aneurysm: spontaneous cure.
Physiologic activities of the contact activation system.
Predicted value of renin activity in a woman who had severe ovarian hyperstimulation syndrome with internal jugular vein thrombosis.
Renin and aldosterone are not associated with vulnerable plaque characteristics in patients with carotid artery disease.
Renin angiotensin system blockade and activated vitamin D as a means of preventing deep vein thrombosis in renal transplant recipients.
The shift in the "paradigm" of the pharmacology of hypertension.
Tissue factor modulation by Angiotensin II: a clue to a better understanding of the cardiovascular effects of renin-angiotensin system blockade?
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
[Acute renal failure, renal artery stenosis and angiotensin-converting enzyme (ACE) inhibitor]
[New animal models for drug discovery research: focus on cardiovascular diseases]
[Renal arterial aneurysms--diffuse renal arterial ectasia. (Review and case histories) (author's transl)]
[The effect of some beta-blocking drugs on plasma renin activity, platelet adhesiveness and dilute blood clot lysis time in patients with essential arterial hypertension.]
Thrombotic Microangiopathies
Abnormalities of renin-containing cells in human glomerular and vascular renal diseases.
Progenitor Renin Lineage Cells are not involved in the regeneration of glomerular endothelial cells during experimental renal thrombotic microangiopathy.
Thyroid Diseases
Plasma renin and aldosterone in thyroid diseases.
Thyroid Neoplasms
RENAL FUNCTION AND PLASMA RENIN ACTIVITY AS POTENTIAL FACTORS CAUSING HYPERKALEMIA IN PATIENTS WITH THYROID CARCINOMA UNDERGOING THYROID HORMONE WITHDRAWAL FOR RADIOACTIVE IODINE THERAPY.
Thyrotoxicosis
Plasma renin and aldosterone in thyroid diseases.
[Mineralocorticoid function of the adrenal cortex in adolescent girls with thyrotoxicosis]
[Plasms renin activity and its changes after stimulation in patients with thyrotoxicosis]
[State of the renin-angiotensin system in thyrotoxicosis]
[State of the renin-angiotensin-aldosterone system in thyroid pathology based on the results of radioimmunoassay]
Torsades de Pointes
Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AV block dog.
Toxemia
Effects of angiotensin II analog on blood pressure, renin and aldosterone in women on oral contraceptives and toxemia.
Elevation of plasma renin activity during pregnancy and rupture of a dissecting aortic aneurysm in a patient with primary aldosteronism.
Experimental toxemia of pregnancy in the monkey, with a preliminary report on renin and aldosterone.
Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.
Plasma renin and aldosterone in an abdominal pregnancy with toxemia.
Selective hypoaldosteronism due to combined defects of the conversion from inactive renin to active renin and the aldosterone biosynthesis from corticosterone.
Sequential changes in the renin--angiotensin--aldosterone systems and plasma progesterone concentration in normal and abnormal human pregnancy.
THE EFFECTS ON RENAL RESISTANCE TO BLOOD FLOW OF RENIN, ANGIOTONIN, PITRESSIN AND ATROPINE, HYPERTENSION, AND TOXEMIA OF PREGNANCY.
[Renin activity in amniotic fluid and maternal and cord blood in toxemia of pregnancy]
[Serum renin activity in women during the normal course of pregnancy and in late toxemias]
[The investigation of renin in pregnancy complicated by late toxemia]
Tremor
Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmacokinetics and clinical use.
Trophoblastic Neoplasms
Clinical syndromes associated with tumors of the female genital tract.
Trophoblastic Tumor, Placental Site
Clinical syndromes associated with tumors of the female genital tract.
Tuberculosis
[Etiology and clinical features of primary adrenal insufficiency].
Tuberculosis, Pulmonary
A Bartter's-like syndrome from capreomycin, and a similar gentamicin tubulopathy.
Tuberculosis, Renal
Hypertension due to renal tuberculosis: assessment by renal vein renin sampling.
Hypertension from renal tuberculosis: operative cure predicted by renal vein renin.
Renal tuberculosis and accelerated hypertension: the use of renal vein renin sampling to predict the outcome after nephrectomy.
Renal tuberculosis and hypertension: value of the renal vein renin ratio.
Undifferentiated Connective Tissue Diseases
Control of hypertension and reversal of renal failure in undifferentiated connective tissue disease by enalapril.
Uremia
Estimation of hydroxylysine in urine and serum of patients with chronic uremia.
Malignant hypertension and uremia in scleroderma: efficacy of nephrectomy and hemodialysis.
Plasma renin substrate changes in experimental uremia.
Scleroderma renal crisis complicated by hemolytic uremic syndrome in a case of elderly onset systemic sclerosis.
[Effect of the betamimeticum fenoterol on the renal transport of water and electrolytes as well as on plasma renin and plasma aldosterone in normal persons, pregnant women and patients with uremia]
[Hypertension in terminal chronic uremia: a new indication for determination of the renin activity in blood?]
[Multifactor analysis of the influence of blood volume, renin activity and plasma potassium on aldosterone levels in chronic uremia]
[Osmotherapy of acute kidney failure with special reference to plasma renin activity and mineral balance]
Ureteral Obstruction
Aliskiren Restores Renal AQP2 Expression during Unilateral Ureteral Obstruction by Inhibiting the Inflammasome.
Arrested development of the neonatal kidney following chronic ureteral obstruction.
Cells of renin lineage express hypoxia inducible factor 2? following experimental ureteral obstruction.
Complement 3 activates the renal renin-angiotensin system by induction of epithelial-to-mesenchymal transition of the nephrotubulus in mice.
Expression of renin and its mRNA in the adult rat kidney with chronic ureteral obstruction.
Functional and molecular evaluation of using aliskiren during acute and chronic partial ureteral obstruction in rat solitary kidney.
In situ localization of renin and its mRNA in neonatal ureteral obstruction.
Increased plasma prorenin but not renin after bilateral ureteral ligation in dogs.
Influence of renin depletion on renal function after release of 24-hour ureteral obstruction.
Inhibition of IL-1? by Aliskiren Improved Renal AQP2 Expression and Urinary Concentration Defect in Ureteral Obstruction and Release.
Interaction between V-ATPase B2 and (Pro) renin Receptors in Promoting the progression of Renal Tubulointerstitial Fibrosis.
Internal cRNA standards for quantitative northern analysis.
Neonatal ureteral obstruction stimulates recruitment of renin-secreting renal cortical cells.
Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction.
Renal apoptosis and clusterin following ureteral obstruction: the role of maturation.
Renal nerves modulate renin gene expression in the developing rat kidney with ureteral obstruction.
Renal prostaglandins in postobstructive diuresis. Comparative study of unilateral and bilateral obstruction in conscious dogs.
Renin release: effects of vasodilators and bilateral ureteral obstruction.
Renin-angiotensin I activity in renin lymph during acute ureteral obstruction.
Role of the renin-angiotensin system in arterial hypertension secondary to acute unilateral urinary obstruction.
The effect of aliskiren on the renal dysfunction following unilateral ureteral obstruction in the rat.
The intrarenal renin-angiotensin system.
The kininogen gene family in obstructive uropathy.
The synergistic effect of mizoribine and a direct Renin inhibitor, aliskiren, on unilateral ureteral obstruction induced renal fibrosis in rats.
Unilateral ureteral obstruction. A caue of reversible high renin content hypertension.
Upregulation of Cortical Renin and Downregulation of Medullary (Pro)Renin Receptor in Unilateral Ureteral Obstruction.
Urinary Bladder Neck Obstruction
Renal renin-angiotensin system dysregulation caused by partial bladder outlet obstruction in fetal sheep.
Urinary Tract Infections
A five-year prospective follow-up of women with non-obstructive pyelonephritic renal scarring.
Impact of common functional polymorphisms in renin angiotensin system genes on the risk of renal parenchymal scarring following childhood urinary tract infection.
Persistent renin-angiotensin system activation after anti-reflux surgery and its management.
Pseudohypoaldosteronism with pyloric stenosis--a patient report.
[Effect of captopril on plasma renin activity and blood aldosterone in patients with chronic pyelonephritis and urinary tract infection]
Urologic Diseases
Peripheral and renal vein plasma renin activity in hypertensive urological patients.
The distribution of renin containing cells in scarred kidneys.
Uterine Hemorrhage
Plasma renin substrate in the prediction of pregnancy outcome in threatened abortion.
Uveitis
A Novel Single-Strand RNAi Therapeutic Agent Targeting the (Pro)renin Receptor Suppresses Ocular Inflammation.
Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.
Effects of ciclosporin on plasma renin activity, catecholamines and prostaglandins in patients with idiopathic uveitis.
Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma.
Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization.
Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin.
Therapeutic targets of renin-angiotensin system in ocular disorders.
Uveomeningoencephalitic Syndrome
[A case of scleroderma with sclerodermic renal crisis and association with the Vogt-Koyanagi-Harada syndrome]
Varicocele
Concentrations of cortisol and renin in the internal spermatic vein of men with varicocele.
Correlative changes of plasma renin activity and serum testosterone in human internal spermatic vein after single administration of human chorionic gonadotropin.
Demonstration of gonadotropin-induced plasma renin activity in human internal spermatic vein.
Induction of renin-angiotensin system in human testis in vivo.
[Induction of plasma renin activity in human internal spermatic vein after treatment of HCG]
[Study of cortisone and renin in spermatica interna and a refined sperm analysis in patients with varicocele]
[The role of disorders of mineralocorticoid function of the adrenal glands in the development of infertility in patients with left-side varicocele]
[The role of the functional interrelation of the adrenals and testes in the pathogenesis of sterility in patients with left-sided varicocele]
Vascular Calcification
The Role of Fibroblast Growth Factor-23 in Cardiorenal Syndrome.
Vitamin d and stage 5 chronic kidney disease: a new paradigm?
Vitamin D3 supplementation does not modify cardiovascular risk profile of adults with inadequate vitamin D status.
[Bone metabolism and cardiovascular function update. Cross link of hypertension, bone loss and vascular calcification - common back grounds in renin angiotensin system with anti-aging aspect -].
Vascular Diseases
A role for uric acid in the progression of renal disease.
Accelerated hypertensive vascular disease from saline and renin in nephrectomized dogs.
Acute diffuse vascular disease elicited by renin in rats pretreated with cortisone.
Chronic Stimulation of Renin Cells Leads to Vascular Pathology.
Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular disease.
Experimental vascular disease elicited by aldosterone and renin.
HYPERTENSIVE VASCULAR DISEASE PRODUCED BY HOMOLOGOUS RENIN.
Increased arterial stiffness in young normotensive patients with Turner syndrome: associations with vascular biomarkers.
Intracrine angiotensin II functions originate from noncanonical pathways in the human heart.
Plasma renin activity and vascular disease in essential hypertension.
Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.
Plasma renin, urinary sodium excretion and vascular disease.
Polymorphism in the angiotensin II type 1 receptor (AGTR1) is associated with age at diagnosis in pulmonary arterial hypertension.
Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity.
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease.
rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling.
Role of angiotensin II type 1 receptor in cerebral aneurysm formation in rats.
The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death.
The Divergent Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Adult Patients With Type 2 Diabetes Mellitus.
The renin-angiotensin system and the pathogenesis of vascular disease in malignant hypertension.
Tooth loss is associated with an increased risk of hypertension in postmenopausal women.
Vascular disease: High plasma renin activity linked to increased risk of death.
Vascular Headaches
[The relationship between tension headache or vascular headache and plasma renin activity or angiotensin II level]
Vascular System Injuries
Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension.
Circulating renin in essential hypertension: an evaluation of its significance in the Japanese population.
Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease.
Coronary artery aneurysms, aortic dissection, and hypertension secondary to primary aldosteronism: a rare triad. A case report.
Increased concentrations of angiotensin-converting enzyme in the intimal hyperplasia of experimental vein grafts.
Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.
Major role of the renin angiotensin system in the neointima formation after vascular injury in guinea pigs.
Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomy.
Possible prorenin activating mechanisms in the blood vessel wall.
Prorenin in diabetes mellitus.
RAAS Inhibition/Blockade in patients with Cardiovascular disease : Implications of recent large scale randomized trials for clinical practice.
Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).
[Relationship of collagen content, intimal thickening and angiotensin II level of iliac arteries after balloon injury in rabbits]
Vasculitis
Case Report: Segmental Arterial Mediolysis, a Rare Cause of Hypertension.
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes.
Progressive interstitial renal fibrosis due to Chinese herbs in a patient with calcinosis Raynaud esophageal sclerodactyly telangiectasia (CREST) syndrome.
Raised plasma renin and prorenin in rheumatoid vasculitis.
[SGLT2 inhibitors: A new era for our patients].
Vasoplegia
Use of Angiotensin II in Severe Vasoplegia After Left Pneumonectomy Requiring Cardiopulmonary Bypass: A Renin Response Analysis.
Venous Thromboembolism
Inhibition of renin angiotensin axis may be associated with reduced risk of developing venous thromboembolism in patients with atherosclerotic disease.
Venous Thrombosis
ACE DD genotype: an independent predisposition factor to venous thromboembolism.
Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: A case-control study.
Renin angiotensin system blockade and activated vitamin D as a means of preventing deep vein thrombosis in renal transplant recipients.
Ventricular Dysfunction
Disruption of the relationship between renin and atrial natriuretic peptide early in the course of ventricular dysfunction.
The cardiac renin-angiotensin system in heart failure.
The role of Renin Angiotensin system intervention in stage B heart failure.
Ventricular Dysfunction, Left
Activation of neurohumoral systems following acute myocardial infarction.
Angiotensin II in the evolution of experimental heart failure.
Cardiac angiotensin converting enzyme and endothelin receptor in rats with chronic myocardial infarction.
Cardiomegaly and vasoactive hormones in rats with chronic myocardial infarction: long-term effects of chlorothiazide.
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Disruption of the relationship between renin and atrial natriuretic peptide early in the course of ventricular dysfunction.
Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1.
Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat.
Neuroendocrine activity in congestive heart failure.
Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
Prognostic value of plasma renin activity in heart failure.
Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators.
Relationship of renin, angiotensin II and atrial natriuretic factor to clinical status in the early post-infarct period in patients with left ventricular dysfunction.
Secondary Prevention Beyond Hospital Discharge for Acute Coronary Syndrome: Evidence-Based Recommendations.
The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
The renin-angiotensin system as a target for therapeutic intervention.
[Prognostic value of cytokines and neurohormones in severe heart failure]
Ventricular Dysfunction, Right
Abnormal regulation of renin angiotensin aldosterone system is associated with right ventricular dysfunction in hypertension.
Synergic effects of renin and aldosterone on right ventricular function in hypertension: a tissue Doppler study.
Ventricular Fibrillation
E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.
Involvement of the renin-angiotensin system in ischemic damage and reperfusion arrhythmias in the isolated perfused rat heart.
Ventricular Premature Complexes
[Influence of renin on the effects of electric stimulation on the ventromedial hypothalamus]
Vesico-Ureteral Reflux
Captopril test in children with reflux nephropathy.
Posterior urethral valve: Prognostic factors and renal outcome.
[Blood renin activity in children with various degrees of vesico-ureteral reflux]
[Status of hemodynamics and plasma renin activity in children with vesico-ureteral reflux]
Vesicular Stomatitis
SARS-CoV-2 colonization of maternal and fetal cells of the human placenta promotes alteration of local renin-angiotensin system.
Virus Diseases
Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
Des-aspartate-angiotensin I exerts antiviral effects and attenuates ICAM-1 formation in rhinovirus-infected epithelial cells.
Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells.
SARS-CoV-2 colonization of maternal and fetal cells of the human placenta promotes alteration of local renin-angiotensin system.
Vitamin D Deficiency
25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System.
Maternal vitamin D deficiency programmes adult renal renin gene expression and renal function.
The interaction between burn injury and vitamin D metabolism and consequences for the patient.
Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice.
Vitamin D, the renin-angiotensin system, and insulin resistance.
Whooping Cough
Effect of pertussis toxin on the adrenergic regulation of plasma renin activity.
Juxtaglomerular cell CaSR stimulation decreases renin release via activation of the PLC/IP(3) pathway and the ryanodine receptor.
Mode of inhibition of renin release by angiotensin II.
Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism.
Pertussis toxin attenuates angiotensin II-induced vasoconstriction and inhibition of renin release.
Pertussis toxin enhances the beta-adrenergic and blocks the alpha 2-adrenergic regulation of renin secretion in renal cortical slices.
Pertussis toxin potentiates anesthesia-induced renin secretion.
Pertussis toxin reverses adenosine receptor-mediated inhibition of renin secretion in rat renal cortical slices.
Second messengers involved in the control of renin secretion in cultured human nephroblastoma cells.
Williams Syndrome
A case of Williams syndrome with suspected coexisting ectopic aldosterone-producing tumor in the liver.
Wilms Tumor
Activation and function of prorenin: different viewpoints.
Anaesthetic management of renin secreting nephroblastoma.
Atrial natriuretic peptide suppresses isoprenaline and dibutyryl cyclic adenosine monophosphate-induced cell growth in cultured renin-secreting human nephroblastoma cells. Comparison with forskolin-induced renin secretion.
Big renin: a possible prohormone in kidney and plasma of a patient with Wilm's tumor.
Characterization of a radioimmunoassay to determine plasma total renin.
Demonstration of renin gene expression in nephroblastoma by in situ hybridization.
Determination of plasma total renin level by RIA with a monoclonal antibody: value as a marker for nephroblastoma.
Hypertension associated with increased renin concentrations in nephroblastoma.
Immunocytochemical localisation of renin in nephroblastoma.
Immunocytochemistry of renin in renal tumours.
Immunohistochemical localization of renin in renal tumors.
Inactive renin levels in recurrent nephroblastoma.
Inactive renin: a tumor marker in nephroblastoma.
Juxtaglomerular Cell Tumor of the Kidney: Case Report and Differential Diagnosis With Emphasis on Pathologic and Cytopathologic Features.
Modulation of active renin secretion by renin-binding protein (RnBP) in mouse pituitary AtT-20 cells transfected with human renin and RnBP cDNAs.
Plasma renin activity in Wilms' tumour.
Plasma renin levels in patients with thoracic neuroblastoma.
Renin and inactive renin (prorenin) in the plasma of patients with malignant renal tumours.
Renin gene expression in nephroblastoma.
Renin in Wilms' tumor: prorenin as an indicator.
Renin levels in nephroblastoma (Wilms' tumour). Report of a renin secreting tumour.
Renin producing Wilms' tumor.
Renin production by nephroblastoma cells in culture.
Renin production in congenital mesoblastic nephroma in comparison with that in Wilms' tumor.
Second messengers involved in the control of renin secretion in cultured human nephroblastoma cells.
The beta-agonist, isoprenaline, stimulates renin release from cultured nephroblastoma cells.
Wilms' tumor protein (-KTS) modulates renin gene transcription.
[Cardiac failure by major arterial hypertension secondary to nephroblastoma]
Zollinger-Ellison Syndrome
Clinical syndromes associated with tumors of the female genital tract.